archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,1.7309e-08,1.2495,1.1745,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.5164e-08,1.1666,0.97399,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.8573e-08,1.0262,0.80439,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.019e-11,0.92884,0.92778,1,1
1,GO BLEB ASSEMBLY,2.457e-10,0.9284,0.98452,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,7.7166e-08,0.91228,0.7494,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.1098e-10,0.90122,0.88551,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.4499e-11,0.86679,0.79767,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.1815e-08,0.8194,0.6878,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,4.6784e-11,0.8146,0.7481,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.3074e-11,0.81216,0.80472,1,1
1,GO RESPONSE TO INTERFERON ALPHA,1.8594e-09,0.79012,0.7871,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.0493e-11,0.78394,0.7555,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.4302e-11,0.77223,0.70487,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.2682e-10,0.76366,0.78319,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.6711e-12,0.76338,0.7978,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,2.3933e-10,0.75639,0.77739,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.3752e-12,0.74494,0.69538,1,1
1,GO HEMIDESMOSOME ASSEMBLY,6.2993e-08,0.74258,0.77508,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.6451e-10,0.73226,0.71939,1,1
1,GO ETHANOL OXIDATION,3.6162e-06,0.72584,0.55995,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,3.192e-10,0.72173,0.69846,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,2.2117e-10,0.7199,0.7139,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,1.1579e-08,0.71765,0.66051,1,1
1,GO RESPONSE TO INTERFERON BETA,9.3415e-09,0.71686,0.70831,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.1815e-08,0.70863,0.6406,1,1
1,GO MEMBRANE RAFT ORGANIZATION,6.895e-08,0.70576,0.65282,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.9926e-08,0.70241,0.71411,1,1
1,GO HYALURONAN CATABOLIC PROCESS,8.0815e-10,0.69878,0.6861,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,3.2894e-09,0.68986,0.60052,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,6.3359e-07,0.68406,0.59589,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,2.6914e-06,0.68302,0.56258,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,8.2864e-09,0.67762,0.57275,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.9617e-06,0.67102,0.55579,1,1
1,GO RESPONSE TO TYPE I INTERFERON,3.247e-08,0.66524,0.55906,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.6407e-09,0.66384,0.61447,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.3933e-10,0.64984,0.60038,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.2202e-11,0.64783,0.62051,1,1
1,GO NEUTROPHIL HOMEOSTASIS,6.586e-10,0.64225,0.61743,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2565e-10,0.63037,0.63717,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.1815e-08,0.6302,0.53733,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.3769e-07,0.62624,0.52629,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.8001e-06,0.62599,0.5403,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,7.0522e-08,0.62313,0.534,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,4.3774e-08,0.62293,0.5889,1,1
1,GO TOLERANCE INDUCTION,1.9558e-07,0.62145,0.53835,1,1
1,GO FIBRINOLYSIS,1.7721e-08,0.62023,0.55365,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.2131e-09,0.6183,0.64621,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,3.357e-07,0.6174,0.54768,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,3.8301e-10,0.61465,0.54395,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.457e-10,0.61352,0.56456,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.5688e-10,0.61157,0.59129,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8573e-11,0.60127,0.5633,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,9.1996e-11,0.59886,0.54326,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.5713e-07,0.59606,0.48511,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,3.5427e-10,0.59549,0.6068,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,9.6538e-08,0.59125,0.57173,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,6.0565e-09,0.58975,0.50501,1,1
1,GO MUCUS SECRETION,1.064e-06,0.58914,0.59435,1,1
1,GO CYTOLYSIS,4.9872e-09,0.58763,0.52278,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.1595e-09,0.5855,0.50499,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.3228e-08,0.5809,0.53927,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,8.2543e-08,0.58045,0.5558,1,1
1,GO RESPONSE TO INTERLEUKIN 18,2.2286e-07,0.57979,0.62395,1,1
1,GO LEUKOCYTE AGGREGATION,1.6782e-07,0.57408,0.51756,1,1
1,GO ZYMOGEN INHIBITION,3.3629e-10,0.57366,0.59046,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,8.9047e-09,0.57252,0.53517,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,3.9822e-07,0.56739,0.52276,1,1
1,GO MYOBLAST MIGRATION,8.2686e-06,0.56696,0.48803,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.2886e-07,0.56587,0.55512,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,4.3774e-08,0.56423,0.50895,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,2.0478e-05,0.56382,0.50146,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.6792e-10,0.56256,0.57023,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.7442e-10,0.56009,0.48445,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0546e-09,0.55951,0.52485,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,6.586e-10,0.55292,0.48024,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.1691e-12,0.54948,0.53072,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,3.2094e-09,0.54868,0.55331,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.4487e-10,0.54588,0.50378,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,1.0279e-08,0.54408,0.54407,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3761e-09,0.54266,0.5236,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.6001e-09,0.54059,0.52594,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.7668e-07,0.54038,0.51386,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.2328e-07,0.53993,0.54927,1,1
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,3.094e-05,0.53917,0.40687,1,1
1,GO RESPONSE TO INTERFERON GAMMA,9.9064e-10,0.53897,0.49225,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,4.3774e-08,0.53603,0.57122,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.634e-09,0.53566,0.49674,1,1
1,GO EPIBOLY,2.8753e-10,0.535,0.5445,1,1
1,GO T CELL EXTRAVASATION,2.2775e-07,0.53213,0.46185,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,3.4553e-09,0.53213,0.56022,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.971e-06,0.53141,0.5042,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.1815e-08,0.53022,0.50212,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,5.3617e-10,0.52801,0.51186,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,7.5217e-06,0.5278,0.44811,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,4.0033e-09,0.52755,0.5233,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.0422e-09,0.52678,0.5253,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,1.6158e-05,0.52673,0.45842,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.5893e-10,0.5266,0.55015,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.4516e-10,0.52352,0.47186,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.725e-09,0.52313,0.62896,1,1
1,GO DETECTION OF BIOTIC STIMULUS,1.0527e-08,0.52292,0.50242,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.4586e-08,0.52077,0.54108,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,7.333e-07,0.52068,0.43846,1,1
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0035605,0.5206,0.24879,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.0546e-09,0.51983,0.55776,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.1097e-10,0.5198,0.46187,1,1
1,GO LATERAL MESODERM DEVELOPMENT,6.3569e-09,0.51951,0.49407,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,4.2784e-08,0.51904,0.51473,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.0546e-09,0.51419,0.52748,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.2505e-06,0.51367,0.51785,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3351e-08,0.51051,0.4692,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,5.4982e-08,0.5099,0.55006,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,8.0898e-09,0.50989,0.57702,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,7.6446e-07,0.50954,0.42315,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.0983e-10,0.5039,0.5216,1,1
1,GO HIPPO SIGNALING,5.5016e-10,0.50385,0.51984,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.9805e-09,0.50379,0.46213,1,1
1,GO TYPE 2 IMMUNE RESPONSE,2.3268e-09,0.50124,0.47293,1,1
1,GO NOTOCHORD DEVELOPMENT,4.4148e-09,0.49933,0.56336,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.5695e-09,0.49862,0.44571,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010673,0.4983,0.39017,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,3.2894e-09,0.49804,0.51033,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.0879e-07,0.49745,0.42193,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.0791e-07,0.49717,0.52999,1,1
1,GO INTERLEUKIN 2 PRODUCTION,2.9371e-11,0.4971,0.44696,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.9035e-08,0.49661,0.48355,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.1789e-06,0.49296,0.44148,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,2.538e-07,0.4922,0.48924,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,1.8573e-08,0.49109,0.45862,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.0004e-06,0.49082,0.46163,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0296e-10,0.49048,0.46018,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3671e-08,0.48946,0.4286,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.4553e-09,0.48802,0.46483,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,8.1361e-07,0.48602,0.5871,1,1
1,GO INTERLEUKIN 1 PRODUCTION,1.5217e-09,0.48546,0.4524,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,5.7536e-08,0.48475,0.47586,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.5427e-10,0.48171,0.46082,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,4.7125e-10,0.48021,0.44152,1,1
1,GO PINOCYTOSIS,9.1996e-11,0.47844,0.44162,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.9558e-07,0.47707,0.4734,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.2359e-09,0.476,0.42524,1,1
1,GO RETINAL METABOLIC PROCESS,1.0756e-05,0.47503,0.43597,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,9.3415e-09,0.47469,0.45729,1,1
1,GO INTERLEUKIN 8 PRODUCTION,5.6451e-10,0.47366,0.44901,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.5922e-10,0.47265,0.43615,1,1
1,GO BIOLOGICAL PHASE,1.8723e-07,0.47082,0.55064,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,2.188e-08,0.46978,0.47619,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.3853e-09,0.46768,0.52797,1,1
1,GO T CELL MEDIATED IMMUNITY,1.0161e-09,0.4674,0.42123,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,5.7051e-07,0.46688,0.51879,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.0279e-11,0.46684,0.43526,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.0756e-05,0.46677,0.49677,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,6.1583e-08,0.46556,0.56033,1,1
1,GO ZYMOGEN ACTIVATION,1.3769e-07,0.46387,0.45239,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,6.895e-08,0.4616,0.46736,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.4452e-09,0.46157,0.42103,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.6109e-10,0.4608,0.46552,1,1
1,GO MITRAL VALVE DEVELOPMENT,9.086e-06,0.45943,0.39641,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.0094e-07,0.45822,0.3613,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.7724e-05,0.45807,0.39375,1,1
1,GO ENDODERM FORMATION,5.4967e-09,0.45754,0.46428,1,1
1,GO INTERLEUKIN 13 PRODUCTION,5.9498e-07,0.45699,0.46617,1,1
1,GO ETHANOL METABOLIC PROCESS,9.9803e-06,0.45698,0.4099,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,4.2042e-09,0.45679,0.39765,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,7.6792e-10,0.45679,0.44855,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,5.2359e-09,0.45499,0.46741,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,3.0295e-08,0.45384,0.45448,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.1307e-08,0.4519,0.44107,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,3.3435e-06,0.45041,0.40752,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.8886e-07,0.45019,0.46475,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.2565e-10,0.45002,0.43533,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,1.2032e-06,0.44909,0.37785,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,9.028e-08,0.44901,0.39926,1,1
1,GO PEPTIDE CROSS LINKING,1.1789e-06,0.44841,0.38942,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.6362e-08,0.44796,0.43335,1,1
1,GO REGULATION OF FIBRINOLYSIS,1.0004e-06,0.44663,0.3905,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,4.0678e-07,0.44624,0.45407,1,1
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00096848,0.44578,0.34418,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.069e-09,0.44418,0.45799,1,1
1,GO INTERLEUKIN 17 PRODUCTION,2.1375e-08,0.44381,0.37848,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.3355e-07,0.44315,0.38614,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,1.7385e-05,0.44291,0.35062,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.004e-09,0.44199,0.4315,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,8.2686e-06,0.44172,0.37998,1,1
1,GO DEFENSE RESPONSE TO VIRUS,6.9323e-10,0.44112,0.39223,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,2.004e-09,0.44095,0.43615,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.1819e-07,0.44047,0.43402,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,1.3196e-05,0.44023,0.33324,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.5451e-08,0.44,0.426,1,1
1,GO APOPTOTIC CELL CLEARANCE,2.7676e-09,0.43977,0.43274,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6317e-09,0.43966,0.40984,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,4.2042e-09,0.43795,0.42941,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,3.7195e-09,0.43744,0.40984,1,1
1,GO BONE TRABECULA MORPHOGENESIS,3.628e-05,0.43725,0.42182,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,9.2321e-08,0.4352,0.5006,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,9.8716e-08,0.43445,0.5271,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,7.8976e-09,0.43415,0.45766,1,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00059648,0.43342,0.33571,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.7286e-10,0.43133,0.42836,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.3312e-10,0.43116,0.46506,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.8359e-10,0.43049,0.44684,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,1.9926e-08,0.43041,0.41882,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.77e-09,0.43006,0.41249,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,7.2964e-10,0.42956,0.4739,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.0033e-09,0.42937,0.46339,1,1
1,GO ENDODERM DEVELOPMENT,5.9116e-09,0.42907,0.40737,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0019819,0.42886,0.32332,1,1
1,GO RESPONSE TO HYDROPEROXIDE,7.5001e-05,0.42861,0.3669,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1.155e-06,0.42829,0.47073,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.4805e-07,0.42633,0.41458,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,5.4982e-08,0.42612,0.3781,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,5.1304e-06,0.42552,0.3988,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,2.0398e-08,0.42385,0.41161,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,7.2964e-10,0.42244,0.41127,1,1
1,GO REGULATION OF PINOCYTOSIS,4.4787e-08,0.42219,0.36215,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.9064e-09,0.42182,0.36313,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.1316e-06,0.42119,0.35934,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,4.5684e-06,0.42104,0.37627,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,5.9834e-06,0.4208,0.43324,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.5223e-10,0.41987,0.46642,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.7452e-06,0.41975,0.38855,1,1
1,GO CHEMOKINE PRODUCTION,1.1086e-06,0.41946,0.2979,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.0776e-06,0.41929,0.35434,1,1
1,GO ENTRY INTO HOST,4.8359e-10,0.41911,0.42055,1,1
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,9.4959e-05,0.41882,0.36918,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.9711e-06,0.41813,0.34002,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.5713e-07,0.41764,0.37534,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.249e-10,0.4172,0.42217,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.3325e-06,0.41692,0.43847,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,7.4873e-07,0.41612,0.39647,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,2.3239e-05,0.4155,0.37454,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,6.8348e-09,0.41539,0.41333,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.0212e-06,0.41523,0.41577,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,2.5223e-10,0.41511,0.38188,1,1
1,GO VASCULOGENESIS,9.9064e-10,0.41499,0.4156,1,1
1,GO TROPHOBLAST CELL MIGRATION,4.8198e-07,0.41469,0.40117,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00094089,0.41452,0.46147,1,1
1,GO REGULATION OF CELL KILLING,7.4873e-07,0.41444,0.31853,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,4.2271e-06,0.414,0.43434,1,1
1,GO PLASMINOGEN ACTIVATION,5.1351e-07,0.41373,0.43347,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,3.0302e-06,0.41309,0.41692,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.6877e-06,0.41204,0.37691,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.1034e-07,0.41193,0.43086,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.192e-10,0.41107,0.44294,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.1819e-07,0.40942,0.42415,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.8814e-05,0.40928,0.3338,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,5.7051e-07,0.409,0.45883,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.342e-06,0.40842,0.37505,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.1282e-07,0.40763,0.52419,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.8886e-07,0.40708,0.37334,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.0361e-05,0.40659,0.40502,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,9.2321e-08,0.40603,0.45929,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,5.6487e-06,0.40598,0.33327,1,1
1,GO RESPONSE TO INTERLEUKIN 15,3.2146e-06,0.40543,0.33148,1,1
1,GO CD40 SIGNALING PATHWAY,2.5066e-09,0.40542,0.41437,1,1
1,GO RESPONSE TO PROTOZOAN,5.3747e-08,0.40503,0.40734,1,1
1,GO PIGMENT ACCUMULATION,2.5756e-08,0.40484,0.42006,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.77e-09,0.40335,0.39119,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,6.757e-10,0.40254,0.43386,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.2926e-08,0.40216,0.3754,1,1
1,GO T CELL APOPTOTIC PROCESS,4.0817e-11,0.40198,0.38453,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,4.9872e-09,0.40182,0.40009,1,1
1,GO MONOCYTE CHEMOTAXIS,1.0554e-07,0.40177,0.36116,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.064e-06,0.4017,0.3305,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.3376e-10,0.40164,0.38803,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.3435e-06,0.40136,0.38988,1,1
1,GO KERATINOCYTE PROLIFERATION,3.8924e-05,0.40077,0.34739,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6981e-08,0.40052,0.37254,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.2131e-09,0.40018,0.39439,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0161e-09,0.40008,0.4411,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.6245e-08,0.39999,0.51612,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.6085e-05,0.39957,0.38589,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.9228e-07,0.3992,0.36714,1,1
1,GO LYMPH VESSEL DEVELOPMENT,2.856e-06,0.39899,0.3777,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,5.1351e-07,0.39897,0.40761,1,1
1,GO DETECTION OF OTHER ORGANISM,8.5867e-06,0.39879,0.43239,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.2733e-08,0.39859,0.41608,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.0398e-08,0.39852,0.39611,1,1
1,GO POSITIVE REGULATION OF COAGULATION,1.5037e-07,0.39794,0.35916,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.1282e-07,0.39763,0.4436,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.0776e-06,0.39698,0.35273,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,6.0565e-09,0.39609,0.36759,1,1
1,GO PROSTANOID METABOLIC PROCESS,7.2129e-08,0.39593,0.40378,1,1
1,GO HEME METABOLIC PROCESS,9.4157e-10,0.39589,0.38724,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0781e-08,0.39586,0.35653,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,5.6317e-09,0.39543,0.38125,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.1794e-07,0.39506,0.36828,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,6.4699e-07,0.39493,0.40426,1,1
1,GO CYTOKINE METABOLIC PROCESS,6.6717e-09,0.39442,0.34901,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,4.3946e-06,0.39436,0.44667,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.4415e-08,0.39396,0.318,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0979e-10,0.39375,0.36673,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.188e-08,0.39329,0.34675,1,1
1,GO I KAPPAB PHOSPHORYLATION,7.4854e-10,0.39278,0.36003,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.0527e-08,0.391,0.37118,1,1
1,GO SERTOLI CELL DEVELOPMENT,7.3772e-08,0.39041,0.40957,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.1828e-09,0.39007,0.39067,1,1
1,GO CELLULAR DEFENSE RESPONSE,1.0756e-05,0.38965,0.27499,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0002117,0.38891,0.39419,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,4.31e-06,0.38875,0.38586,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.9805e-09,0.38847,0.42303,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.5372e-07,0.38789,0.37253,1,1
1,GO VIRAL GENOME REPLICATION,3.7195e-09,0.3878,0.36366,1,1
1,GO REGULATION OF B CELL DIFFERENTIATION,6.1119e-05,0.38739,0.30336,1,1
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0067673,0.38708,0.31937,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,2.971e-06,0.38631,0.30193,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,6.9711e-06,0.3861,0.30558,1,1
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00037835,0.38597,0.41184,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,6.6066e-07,0.38578,0.41442,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.8723e-07,0.38521,0.32657,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,1.6654e-06,0.3841,0.34869,1,1
1,GO MONONUCLEAR CELL MIGRATION,1.3351e-08,0.38289,0.34766,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00010152,0.38234,0.53168,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,7.105e-06,0.38192,0.38605,1,1
1,GO PROTEIN ACTIVATION CASCADE,1.6782e-07,0.38172,0.36867,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,4.5922e-10,0.3812,0.45439,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,5.1304e-06,0.3812,0.36529,1,1
1,GO GERMINAL CENTER FORMATION,5.2344e-05,0.38118,0.3364,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.5027e-08,0.38112,0.34301,1,1
1,GO AMINE CATABOLIC PROCESS,2.2505e-06,0.38089,0.35443,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.7e-09,0.38053,0.31924,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.471e-07,0.38032,0.41235,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.5217e-09,0.38001,0.35469,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.475e-06,0.37958,0.39005,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,5.4356e-06,0.3795,0.38571,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.1034e-07,0.37938,0.3675,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.3569e-09,0.37886,0.34799,1,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00017741,0.3767,0.29171,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00028155,0.3763,0.26354,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.0364e-06,0.3756,0.35368,1,1
1,GO EPITHELIAL CELL CELL ADHESION,0.00073415,0.37537,0.36613,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.5576e-05,0.3753,0.31853,1,1
1,GO RESPONSE TO SALT STRESS,3.9035e-08,0.3751,0.33182,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.6914e-06,0.37505,0.39092,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00074504,0.37482,0.25588,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.1338e-07,0.37453,0.39876,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00012594,0.37423,0.35782,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.7154e-07,0.3739,0.34727,1,1
1,GO MUSCLE CELL FATE COMMITMENT,2.6914e-06,0.37379,0.32419,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.7166e-08,0.37353,0.35522,1,1
1,GO PROSTATE GLAND GROWTH,0.0013069,0.37274,0.39592,1,1
1,GO RESPONSE TO VIRUS,8.2903e-10,0.37212,0.33809,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.5372e-07,0.37182,0.31996,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,3.3228e-08,0.37164,0.3561,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,1.9558e-07,0.37092,0.38156,1,1
1,GO DNA DEAMINATION,7.8124e-06,0.37068,0.44051,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6317e-09,0.37021,0.36851,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.0546e-09,0.36988,0.35639,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,3.1479e-07,0.36946,0.35959,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.586e-10,0.36911,0.38562,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,4.2271e-06,0.36898,0.30913,1,1
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.037882,0.36897,0.2726,1,1
1,GO OSTEOBLAST DEVELOPMENT,5.7051e-07,0.36885,0.31904,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,9.2118e-07,0.36873,0.4231,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2886e-07,0.36846,0.43424,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.3039e-08,0.36794,0.39682,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.5359e-06,0.3678,0.32315,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,8.8282e-08,0.36776,0.42688,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.6578e-05,0.36722,0.33811,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,2.0478e-05,0.36695,0.38348,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.1245e-09,0.36665,0.35176,1,1
1,GO LYMPHANGIOGENESIS,7.8976e-09,0.3663,0.40285,1,1
1,GO AMYLOID BETA CLEARANCE,4.1815e-08,0.3662,0.33728,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.895e-08,0.36618,0.33364,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.0094e-07,0.36537,0.33118,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.1121e-10,0.36468,0.35294,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.0020092,0.3643,0.33488,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.2707e-10,0.36415,0.36716,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,3.0156e-07,0.36413,0.32618,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00015838,0.36351,0.26384,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,2.0478e-05,0.36332,0.28719,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,4.1552e-07,0.36324,0.42548,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,2.9514e-07,0.36301,0.47494,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,9.6129e-06,0.36286,0.34696,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.3617e-10,0.36285,0.42891,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7078e-07,0.36274,0.33143,1,1
1,GO INTERFERON BETA PRODUCTION,1.8135e-09,0.36008,0.34468,1,1
1,GO DENDRITIC CELL MIGRATION,4.7488e-06,0.35992,0.34679,1,1
1,GO MACROPHAGE MIGRATION,6.0565e-09,0.35988,0.33118,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.1356e-08,0.35971,0.35276,1,1
1,GO REGULATION OF HIPPO SIGNALING,8.1623e-05,0.35944,0.29153,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.00018923,0.35933,0.29954,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,6.8396e-06,0.35927,0.35196,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.0964e-09,0.3591,0.36023,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.1595e-09,0.35837,0.37874,1,1
1,GO CERAMIDE CATABOLIC PROCESS,2.6386e-06,0.35837,0.35398,1,1
1,GO TYPE I INTERFERON PRODUCTION,6.0979e-10,0.35829,0.33746,1,1
1,GO REGULATION OF TRANSPOSITION,5.0563e-05,0.35808,0.34636,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.9602e-08,0.35791,0.32202,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.8419e-06,0.3578,0.42031,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.734e-06,0.35777,0.34708,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00029976,0.35769,0.31564,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,8.0256e-05,0.35768,0.33379,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.0546e-09,0.35733,0.3213,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.2784e-06,0.35669,0.38225,1,1
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.9859e-05,0.35653,0.25925,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.4787e-08,0.35618,0.3406,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,7.8124e-06,0.35598,0.30079,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.3109e-11,0.35597,0.34381,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.7411e-08,0.3559,0.33122,1,1
1,GO FOCAL ADHESION ASSEMBLY,1.0094e-07,0.35548,0.36019,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,1.7687e-09,0.35537,0.31623,1,1
1,GO MACROPHAGE CHEMOTAXIS,2.188e-08,0.3551,0.31578,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,5.0278e-07,0.35425,0.3696,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,9.3752e-12,0.3537,0.3484,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.725e-09,0.35367,0.3727,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.6062e-07,0.35366,0.31852,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.5688e-10,0.35341,0.35708,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.5223e-10,0.35331,0.33253,1,1
1,GO RIG I SIGNALING PATHWAY,6.586e-10,0.35274,0.35567,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,2.3891e-06,0.35259,0.42297,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.1338e-07,0.35231,0.32834,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.3769e-07,0.35218,0.41424,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.5266e-09,0.35192,0.30535,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.3476e-09,0.35186,0.40073,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.1624e-06,0.35139,0.28697,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.8976e-09,0.35133,0.34762,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,1.8793e-06,0.35112,0.31371,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,1.0169e-05,0.35095,0.31334,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,1.5576e-05,0.35083,0.33272,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00054518,0.35071,0.32508,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00065224,0.35043,0.28401,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,4.1026e-05,0.35037,0.34628,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.00038422,0.35022,0.31475,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.0398e-08,0.34937,0.36976,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,2.0478e-05,0.34923,0.31216,1,1
1,GO CHONDROCYTE PROLIFERATION,6.8888e-05,0.34921,0.37164,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.6362e-08,0.34917,0.32868,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0041031,0.34916,0.2381,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.6362e-08,0.34893,0.33345,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.0278e-07,0.34869,0.4076,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,2.206e-06,0.34835,0.32926,1,1
1,GO ARTERY DEVELOPMENT,1.4741e-05,0.34825,0.27875,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00033955,0.3482,0.3339,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0084096,0.34731,0.23091,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.4877e-09,0.34634,0.30502,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.00042777,0.34624,0.36165,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00043435,0.34606,0.26588,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.1828e-09,0.34602,0.3379,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.5753e-08,0.34602,0.36992,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,6.0979e-10,0.3458,0.36599,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.3039e-08,0.34568,0.34902,1,1
1,GO HYALURONAN METABOLIC PROCESS,7.1819e-07,0.34564,0.30152,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.471e-07,0.34556,0.36731,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.2604e-07,0.34552,0.38844,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,2.5934e-07,0.34525,0.35693,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.6514e-08,0.34507,0.33733,1,1
1,GO PLATELET AGGREGATION,1.2058e-07,0.34388,0.34147,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.1004e-08,0.34318,0.34039,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.3419e-09,0.3429,0.36176,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.1361e-07,0.34262,0.29747,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,8.8389e-07,0.34259,0.34599,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,8.0815e-10,0.34221,0.36643,1,1
1,GO RESPONSE TO DSRNA,1.5372e-07,0.34136,0.28644,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.5606e-08,0.34127,0.31213,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,4.3946e-06,0.34068,0.32823,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,2.4586e-08,0.34046,0.32251,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.0527e-08,0.34015,0.31245,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.02e-08,0.3399,0.32633,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.2733e-08,0.33924,0.29302,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.1041e-08,0.33895,0.384,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,7.5266e-09,0.33879,0.32108,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,3.247e-08,0.33875,0.34337,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,8.2686e-06,0.3386,0.36047,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,2.4861e-06,0.33804,0.39014,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,1.6418e-07,0.33762,0.33089,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.1375e-08,0.33751,0.35509,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.1806e-05,0.33751,0.28471,1,1
1,GO INTERACTION WITH SYMBIONT,1.1398e-10,0.33745,0.31435,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.0776e-06,0.33684,0.32948,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,3.2784e-06,0.33601,0.40682,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.8052e-07,0.336,0.33797,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0026663,0.33593,0.27339,1,1
1,GO B CELL MEDIATED IMMUNITY,6.4434e-08,0.33591,0.34745,1,1
1,GO GRANULOCYTE MIGRATION,2.7078e-07,0.33564,0.27237,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,3.152e-06,0.33542,0.31725,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,2.4586e-08,0.33541,0.40834,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.5412e-09,0.33536,0.33718,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,6.2046e-07,0.33511,0.38605,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.9116e-09,0.33488,0.32868,1,1
1,GO INNATE IMMUNE RESPONSE,4.0033e-09,0.33474,0.31636,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.1375e-05,0.3347,0.2886,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.1165e-05,0.33465,0.35728,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.0437e-10,0.33376,0.38064,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,1.5994e-06,0.33333,0.29767,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.1234e-05,0.33297,0.29969,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.402e-08,0.33279,0.32604,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.719e-07,0.33255,0.33309,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,1.536e-06,0.33227,0.37199,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,2.1234e-05,0.33199,0.34024,1,1
1,GO RESPONSE TO X RAY,2.1064e-09,0.33188,0.40302,1,1
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00025617,0.33168,0.28384,1,1
1,GO T CELL CHEMOTAXIS,2.9602e-08,0.33102,0.31263,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.892e-08,0.33047,0.37222,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.3355e-07,0.33014,0.30949,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,5.3747e-08,0.33013,0.27387,1,1
1,GO PODOSOME ASSEMBLY,3.4796e-08,0.32994,0.41436,1,1
1,GO GRANULOCYTE CHEMOTAXIS,1.9563e-06,0.32974,0.25814,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,1.1165e-05,0.32933,0.34247,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,1.9136e-07,0.32916,0.38876,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8886e-07,0.32903,0.2912,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.6386e-06,0.32903,0.27216,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.2565e-10,0.32868,0.35775,1,1
1,GO REGULATION OF COAGULATION,1.734e-06,0.32821,0.34044,1,1
1,GO T CELL PROLIFERATION,1.5372e-07,0.32802,0.28366,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,3.8983e-07,0.32772,0.37582,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.7356e-07,0.32763,0.30679,1,1
1,GO TRNA CATABOLIC PROCESS,0.0050904,0.32762,0.25552,1,1
1,GO MYOBLAST PROLIFERATION,0.00076726,0.32759,0.22771,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,6.1583e-08,0.32732,0.33367,1,1
1,GO ALPHA BETA T CELL ACTIVATION,2.9514e-07,0.32727,0.29852,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.5164e-08,0.32695,0.32739,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.2286e-07,0.32676,0.29266,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00040235,0.32658,0.35274,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,4.7963e-08,0.32631,0.28376,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,3.3228e-08,0.32568,0.35658,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.4454e-06,0.32536,0.33906,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,2.0429e-07,0.32533,0.32588,1,1
1,GO NIK NF KAPPAB SIGNALING,4.6112e-12,0.32524,0.35374,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,2.2286e-07,0.32499,0.33781,1,1
1,GO INTERFERON ALPHA PRODUCTION,1.1858e-08,0.32487,0.35082,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.0212e-06,0.32468,0.33575,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.1579e-08,0.32467,0.33144,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,6.8348e-09,0.32467,0.3029,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.6877e-06,0.32448,0.29959,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.2117e-10,0.32425,0.3258,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.1706e-10,0.3236,0.34196,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.2321e-08,0.32341,0.32099,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,7.2129e-08,0.32307,0.32473,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.9136e-07,0.32256,0.377,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9175e-06,0.32205,0.3366,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.1356e-08,0.322,0.33509,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,6.7105e-06,0.32198,0.30394,1,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0098086,0.32157,0.19196,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,4.9694e-05,0.32132,0.32044,1,1
1,GO VIRAL LIFE CYCLE,1.1706e-10,0.32121,0.32118,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.0295e-08,0.32096,0.29122,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,2.4371e-06,0.32077,0.30438,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00011406,0.32049,0.24805,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.2487e-05,0.32031,0.31605,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.996e-06,0.32017,0.32864,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,2.4305e-07,0.32009,0.307,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,3.5606e-08,0.32005,0.31113,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.8369e-09,0.32004,0.31897,1,1
1,GO HYPOTONIC RESPONSE,1.4741e-05,0.31995,0.30337,1,1
1,GO LAMELLIPODIUM MORPHOGENESIS,1.2482e-05,0.31935,0.35256,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,2.0879e-07,0.31867,0.36584,1,1
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00068191,0.31865,0.28986,1,1
1,GO IMMUNE EFFECTOR PROCESS,6.0565e-09,0.3183,0.29651,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.2759e-09,0.31818,0.30614,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.1356e-08,0.3181,0.29727,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,4.1552e-07,0.31789,0.34571,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.4296e-07,0.31785,0.31838,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.4807e-06,0.31783,0.3117,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.5037e-07,0.31748,0.37193,1,1
1,GO TRANSPOSITION,8.7316e-05,0.31722,0.2967,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,3.0905e-06,0.317,0.41247,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.9711e-06,0.31554,0.28158,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,5.8698e-06,0.31513,0.35461,1,1
1,GO MYOBLAST FUSION,1.2792e-06,0.31466,0.33787,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,1.0424e-06,0.31464,0.312,1,1
1,GO FIBROBLAST MIGRATION,2.2397e-08,0.31463,0.34075,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.5864e-07,0.31454,0.28587,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,3.0295e-08,0.31443,0.30901,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.5412e-09,0.31423,0.2961,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.6317e-09,0.31418,0.30484,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.7963e-08,0.3137,0.35933,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,3.6435e-08,0.31358,0.30763,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,7.1819e-07,0.31346,0.27707,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,7.5451e-08,0.31345,0.37584,1,1
1,GO SERTOLI CELL DIFFERENTIATION,1.6994e-06,0.31342,0.30988,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,4.0657e-06,0.31337,0.30027,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.1041e-08,0.31326,0.38644,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.2397e-08,0.31311,0.29749,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,6.0759e-07,0.31305,0.33893,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2444e-07,0.31262,0.27902,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00025617,0.31255,0.2653,1,1
1,GO GENITALIA MORPHOGENESIS,0.00030928,0.31228,0.27318,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.9136e-07,0.31217,0.287,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.1583e-08,0.31205,0.32666,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.6062e-07,0.31195,0.30782,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,8.1361e-07,0.31187,0.32844,1,1
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0016575,0.31156,0.2648,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0212e-06,0.31133,0.2798,1,1
1,GO INTERLEUKIN 10 PRODUCTION,0.001483,0.31124,0.21726,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00017457,0.31114,0.24814,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.0004e-06,0.31113,0.27948,1,1
1,GO RESPONSE TO ESTROGEN,7.1726e-09,0.31095,0.3081,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.1479e-07,0.31092,0.32084,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.8701e-05,0.31062,0.27803,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,3.6567e-07,0.31042,0.36396,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.2414e-06,0.31006,0.36539,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.1165e-05,0.30983,0.23997,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.4454e-06,0.3096,0.3729,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,2.2958e-06,0.30946,0.28726,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,8.5858e-05,0.30929,0.29647,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.3196e-05,0.30925,0.26809,1,1
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00039018,0.30919,0.28059,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,7.2129e-08,0.30879,0.31628,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00010852,0.30857,0.32329,1,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,2.7804e-05,0.30824,0.28767,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,5.9432e-10,0.30818,0.27837,1,1
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.011411,0.30818,0.2632,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,7.8911e-05,0.30793,0.28257,1,1
1,GO ENAMEL MINERALIZATION,0.00017176,0.30791,0.36407,1,1
1,GO ARTERY MORPHOGENESIS,0.0005133,0.30764,0.23674,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0023637,0.30752,0.20699,1,1
1,GO TRACHEA DEVELOPMENT,3.3806e-05,0.30734,0.30291,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,7.6657e-06,0.30719,0.29914,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,7.1274e-05,0.30718,0.2693,1,1
1,GO MEMBRANE INVAGINATION,1.8318e-07,0.30697,0.29803,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,3.2859e-07,0.30653,0.34129,1,1
1,GO ARGININE METABOLIC PROCESS,2.0364e-06,0.30653,0.30636,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.7922e-07,0.30649,0.28048,1,1
1,GO CELLULAR RESPONSE TO VIRUS,2.8369e-09,0.30625,0.31186,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.1316e-06,0.30615,0.32715,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,2.5695e-09,0.30609,0.36599,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,4.0678e-07,0.30577,0.32793,1,1
1,GO REGULATION OF DNA METHYLATION,0.0071051,0.30566,0.17894,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.4371e-06,0.30561,0.27809,1,1
1,GO ACTIN FILAMENT SEVERING,3.5022e-05,0.30559,0.3861,1,1
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.0016347,0.30551,0.18531,1,1
1,GO REGULATION OF PROTEIN MATURATION,5.2253e-10,0.30532,0.31585,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.9078e-09,0.30529,0.27516,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00011596,0.30521,0.21438,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.1793e-10,0.30483,0.31091,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,1.475e-06,0.3048,0.32077,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0015038,0.30473,0.24468,1,1
1,GO NAD BIOSYNTHETIC PROCESS,0.00060545,0.30446,0.2386,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.7534e-07,0.30441,0.33731,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0066039,0.30429,0.22873,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,1.0958e-05,0.30413,0.27596,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00021857,0.30397,0.24505,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,3.758e-05,0.30369,0.27749,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.6986e-10,0.30368,0.31719,1,1
1,GO EMBRYO IMPLANTATION,1.0094e-07,0.30352,0.31929,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,8.8389e-07,0.30344,0.27076,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.0554e-07,0.30339,0.29426,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.2445e-07,0.30327,0.33024,1,1
1,GO NECROTIC CELL DEATH,5.2445e-07,0.30326,0.27512,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.538e-07,0.30303,0.32972,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,3.3435e-06,0.303,0.3301,1,1
1,GO NEUROBLAST DIVISION,0.0045438,0.30291,0.21333,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.2027e-05,0.30283,0.24211,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0033799,0.30279,0.35314,1,1
1,GO BARBED END ACTIN FILAMENT CAPPING,8.0256e-05,0.30257,0.30896,1,1
1,GO MACROPHAGE DIFFERENTIATION,2.1338e-07,0.30245,0.31172,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.7312e-05,0.30239,0.30283,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00069207,0.30238,0.24191,1,1
1,GO REGULATION OF STEROL TRANSPORT,2.1807e-07,0.30211,0.32267,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.1552e-07,0.30135,0.34422,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,2.8262e-08,0.30124,0.29647,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.8419e-06,0.30119,0.27666,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,2.2505e-06,0.30118,0.33506,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,2.9332e-05,0.30112,0.32994,1,1
1,GO RESPONSE TO CYTOKINE,2.634e-09,0.30109,0.28276,1,1
1,GO PSEUDOPODIUM ORGANIZATION,0.0060595,0.30101,0.26408,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.1543e-10,0.30079,0.29144,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.6362e-08,0.29923,0.28637,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,5.4967e-09,0.29923,0.31457,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.1858e-08,0.29885,0.31492,1,1
1,GO SEQUESTERING OF METAL ION,2.1196e-06,0.29878,0.29729,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.4528e-05,0.29868,0.26829,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.2784e-08,0.29847,0.28782,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,4.719e-07,0.29809,0.32125,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.1595e-09,0.29807,0.33671,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.3948e-05,0.2977,0.34207,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.0296e-10,0.29747,0.2891,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.3806e-05,0.29742,0.34063,1,1
1,GO REGULATION OF GASTRULATION,2.8369e-09,0.29723,0.3208,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.9465e-08,0.2967,0.32326,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,5.7582e-06,0.29668,0.32396,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,2.1807e-07,0.29661,0.28981,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.969e-07,0.29641,0.28897,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,2.6981e-08,0.29601,0.30888,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,4.2784e-08,0.29592,0.30375,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,4.9872e-09,0.29574,0.26904,1,1
1,GO AORTA DEVELOPMENT,0.00032408,0.29566,0.2467,1,1
1,GO RESPONSE TO INTERLEUKIN 1,3.1896e-11,0.29536,0.30517,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,8.4415e-08,0.29513,0.29629,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,4.3946e-06,0.29484,0.31218,1,1
1,GO NATURAL KILLER CELL ACTIVATION,9.5677e-09,0.29482,0.30918,1,1
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,7.7586e-05,0.29471,0.25015,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,3.8924e-05,0.29462,0.28558,1,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.032607,0.29457,0.24563,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.0781e-08,0.29448,0.29069,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.2733e-08,0.29439,0.30877,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.0879e-07,0.29432,0.3061,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6654e-06,0.2943,0.37637,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0044864,0.294,0.30395,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.3761e-09,0.29391,0.32947,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014599,0.29379,0.24679,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,4.3355e-07,0.29368,0.29362,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,2.65e-07,0.29349,0.34074,1,1
1,GO COPPER ION HOMEOSTASIS,9.4407e-08,0.29339,0.31333,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,5.8698e-06,0.29319,0.30912,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.7078e-07,0.29302,0.32682,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,1.7693e-06,0.293,0.34437,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6001e-09,0.29266,0.32241,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1034e-07,0.29214,0.33852,1,1
1,GO VAGINA DEVELOPMENT,1.2281e-06,0.29211,0.34666,1,1
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00087508,0.29185,0.27614,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,1.2434e-08,0.29172,0.26417,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0001862,0.29171,0.25155,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,6.0991e-06,0.29169,0.29467,1,1
1,GO INTERACTION WITH HOST,3.2764e-10,0.2916,0.32026,1,1
1,GO LAMELLIPODIUM ORGANIZATION,8.0712e-08,0.29157,0.27285,1,1
1,GO T CELL MIGRATION,4.6202e-07,0.29141,0.30143,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,2.8001e-06,0.2909,0.31163,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.6407e-09,0.29087,0.30345,1,1
1,GO LIVER REGENERATION,2.188e-08,0.29076,0.30577,1,1
1,GO CELL SUBSTRATE ADHESION,1.8318e-07,0.29055,0.31879,1,1
1,GO RECEPTOR CATABOLIC PROCESS,3.4003e-08,0.29042,0.34922,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1.9136e-07,0.29038,0.2859,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,7.0337e-07,0.2903,0.32463,1,1
1,GO PHAGOCYTOSIS,1.2143e-08,0.29027,0.31047,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.6514e-08,0.29011,0.29555,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.8262e-08,0.29007,0.2892,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.155e-06,0.29007,0.32107,1,1
1,GO OSTEOCLAST DEVELOPMENT,9.5999e-07,0.29004,0.3488,1,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.011411,0.28971,0.21793,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.0295e-08,0.28927,0.33245,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,3.7605e-06,0.28914,0.26233,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0007901,0.28852,0.19788,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.1819e-07,0.28808,0.28273,1,1
1,GO RETINOL METABOLIC PROCESS,5.8698e-06,0.28789,0.26134,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,5.5864e-07,0.28766,0.30371,1,1
1,GO PRIMARY MIRNA PROCESSING,4.8198e-07,0.28732,0.32295,1,1
1,GO AORTIC VALVE DEVELOPMENT,6.7724e-05,0.28709,0.31615,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,3.758e-05,0.287,0.28634,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,9.795e-06,0.28679,0.22295,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,1.6129e-08,0.28673,0.32016,1,1
1,GO P38MAPK CASCADE,5.4701e-07,0.2867,0.28104,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00091404,0.28655,0.23797,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.7676e-09,0.28648,0.26023,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.1086e-06,0.28639,0.29749,1,1
1,GO T CELL ACTIVATION,9.6538e-08,0.28543,0.27292,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0012705,0.28539,0.23949,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.7804e-05,0.28479,0.31754,1,1
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0029645,0.28409,0.24305,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.1583e-08,0.28367,0.31569,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,3.8161e-07,0.28335,0.28115,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.2143e-08,0.28333,0.26691,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4796e-08,0.28328,0.30332,1,1
1,GO RESPIRATORY BURST,0.0024609,0.28321,0.18708,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00032408,0.28318,0.19608,1,1
1,GO REPLACEMENT OSSIFICATION,9.9844e-05,0.2831,0.29307,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,3.7356e-07,0.28295,0.27234,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.0004e-06,0.28278,0.2734,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,5.9056e-05,0.28204,0.26007,1,1
1,GO SALIVARY GLAND DEVELOPMENT,6.9711e-06,0.28201,0.3757,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.8348e-09,0.28146,0.3071,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00015083,0.28131,0.33124,1,1
1,GO MUSCLE CELL MIGRATION,6.8396e-06,0.28112,0.26171,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.2864e-09,0.28086,0.28323,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,3.5461e-06,0.28071,0.25493,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00010497,0.28062,0.32586,1,1
1,GO CELL MATRIX ADHESION,6.0759e-07,0.28061,0.29679,1,1
1,GO WOUND HEALING,2.3274e-07,0.28059,0.27995,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,2.5868e-06,0.2804,0.28745,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.5756e-08,0.28039,0.2854,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,1.1086e-06,0.28029,0.3051,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00013899,0.28021,0.3019,1,1
1,GO MACROPHAGE PROLIFERATION,0.00072342,0.28019,0.28853,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,4.6202e-07,0.27998,0.31783,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,4.7501e-09,0.27984,0.32816,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,5.6245e-08,0.27963,0.35254,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.00095459,0.27958,0.21164,1,1
1,GO OXYGEN TRANSPORT,0.052083,0.27957,0.15376,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.086e-06,0.27852,0.24928,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.00020835,0.27852,0.39051,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.1807e-07,0.27805,0.27036,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.0898e-09,0.2779,0.2783,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.8049e-05,0.27716,0.25292,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.9228e-07,0.27704,0.25767,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.0979e-10,0.27679,0.3242,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.7452e-06,0.27632,0.27873,1,1
1,GO TONGUE DEVELOPMENT,0.00049802,0.27593,0.25731,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,9.7998e-07,0.27574,0.37831,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.001118,0.2756,0.22642,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,2.1196e-06,0.27526,0.27861,1,1
1,GO COAGULATION,1.155e-06,0.27522,0.24444,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.4787e-08,0.27521,0.29211,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,4.0678e-07,0.27505,0.28144,1,1
1,GO SPROUTING ANGIOGENESIS,5.7536e-08,0.27495,0.31279,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,9.3415e-09,0.27457,0.3063,1,1
1,GO RESPONSE TO UV B,0.00084997,0.27456,0.2559,1,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00030449,0.27451,0.26732,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,6.6066e-07,0.2742,0.30837,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00029511,0.27405,0.25687,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.0017e-09,0.27393,0.27293,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,9.6538e-08,0.27393,0.30405,1,1
1,GO FIBROBLAST ACTIVATION,3.2146e-06,0.27363,0.31393,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,4.5558e-05,0.27243,0.21682,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.4296e-07,0.27221,0.2692,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,9.8716e-08,0.27202,0.25843,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0001803,0.27198,0.22561,1,1
1,GO LEUKOCYTE PROLIFERATION,7.333e-07,0.27184,0.25933,1,1
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00024819,0.27181,0.32426,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00022565,0.27178,0.29746,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,3.628e-05,0.27176,0.27819,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.3415e-09,0.27159,0.25166,1,1
1,GO PROTEIN DEMANNOSYLATION,6.3249e-05,0.27159,0.25713,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.4163e-06,0.27152,0.27545,1,1
1,GO PROTEASOME ASSEMBLY,1.9393e-05,0.27148,0.20833,1,1
1,GO TISSUE REGENERATION,5.8262e-07,0.27144,0.26241,1,1
1,GO FOREGUT MORPHOGENESIS,9.0235e-07,0.27143,0.33191,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.001422,0.27124,0.2405,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.719e-07,0.27095,0.2537,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00094089,0.27086,0.19101,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,3.5646e-05,0.27057,0.25377,1,1
1,GO COMPLEMENT ACTIVATION,4.1456e-06,0.27053,0.32907,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00024045,0.27046,0.22752,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,3.2146e-06,0.27019,0.32987,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00026024,0.27011,0.2576,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,6.3249e-05,0.27009,0.25021,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00034485,0.26994,0.23824,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,7.892e-08,0.26989,0.27951,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00023294,0.26984,0.23696,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.00010673,0.26939,0.26582,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00022927,0.2693,0.25162,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.0036e-08,0.26922,0.29619,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.6162e-06,0.26882,0.2671,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,6.5906e-08,0.26879,0.28184,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,5.0278e-07,0.26877,0.34447,1,1
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00023667,0.26871,0.30069,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,4.6359e-05,0.26853,0.25798,1,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.00094089,0.26836,0.20733,1,1
1,GO GLAND MORPHOGENESIS,5.7582e-06,0.26823,0.32352,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,1.6457e-05,0.26792,0.33616,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,5.1356e-08,0.26773,0.27185,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0010865,0.26758,0.32249,1,1
1,GO CYTOKINE PRODUCTION,1.5027e-08,0.26751,0.27935,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00019541,0.26749,0.26032,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,2.4586e-08,0.26747,0.26922,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.4701e-07,0.26719,0.29486,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,1.5372e-07,0.26717,0.26681,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00080175,0.26702,0.33848,1,1
1,GO CELL REDOX HOMEOSTASIS,2.1338e-07,0.26634,0.23241,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.8839e-05,0.26629,0.30594,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.5461e-06,0.26628,0.2562,1,1
1,GO REGULATION OF WOUND HEALING,4.2271e-06,0.26628,0.27648,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.3274e-07,0.26618,0.28463,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00033432,0.26602,0.19293,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,3.9035e-08,0.26594,0.27726,1,1
1,GO KERATINOCYTE DIFFERENTIATION,0.00057029,0.26593,0.23707,1,1
1,GO NEUTROPHIL MIGRATION,8.1138e-06,0.26582,0.23051,1,1
1,GO REGULATION OF BONE DEVELOPMENT,2.1196e-06,0.26577,0.2856,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,2.3784e-07,0.26564,0.2611,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,7.71e-09,0.26555,0.26537,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00024045,0.26527,0.3193,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.0522e-08,0.26518,0.28191,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6129e-08,0.26504,0.28103,1,1
1,GO FOAM CELL DIFFERENTIATION,8.3013e-05,0.26497,0.26645,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8416e-06,0.26471,0.22049,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,1.5576e-05,0.26464,0.27823,1,1
1,GO VESICLE CARGO LOADING,1.9926e-08,0.26458,0.2976,1,1
1,GO BLOOD VESSEL REMODELING,0.00016901,0.26445,0.25065,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,9.9844e-05,0.26443,0.29169,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,2.5884e-05,0.26437,0.23011,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.856e-06,0.26429,0.26399,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00030928,0.26425,0.18714,1,1
1,GO SOMATIC STEM CELL DIVISION,0.05357,0.26402,0.22308,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.4434e-08,0.26387,0.2828,1,1
1,GO ERK1 AND ERK2 CASCADE,5.0278e-07,0.26376,0.23428,1,1
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.040981,0.26358,0.31099,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,6.4699e-07,0.26338,0.24543,1,1
1,GO PIGMENT GRANULE ORGANIZATION,4.4787e-08,0.2633,0.32097,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.0169e-05,0.26301,0.26746,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0756e-05,0.26287,0.25492,1,1
1,GO REGULATION OF T CELL ACTIVATION,2.4305e-07,0.26275,0.26103,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,2.2958e-06,0.26255,0.23072,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00026024,0.26249,0.24673,1,1
1,GO STEM CELL DIVISION,6.3249e-05,0.26236,0.25658,1,1
1,GO BONE GROWTH,3.094e-05,0.26213,0.32185,1,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0096941,0.26212,0.23202,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,9.819e-05,0.26203,0.30654,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,1.4207e-05,0.26192,0.25992,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.5217e-06,0.26186,0.27844,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,9.7998e-07,0.26181,0.21577,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.016386,0.26154,0.19008,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.8142e-08,0.2615,0.26008,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00014839,0.26144,0.3052,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,3.0395e-05,0.2609,0.22828,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.5037e-07,0.26089,0.28103,1,1
1,GO STEROL TRANSPORT,1.2253e-05,0.26087,0.2283,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2792e-06,0.26069,0.26873,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,1.9393e-05,0.26056,0.2212,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,2.4091e-05,0.26052,0.27623,1,1
1,GO MUSCLE FILAMENT SLIDING,8.3013e-05,0.26047,0.20898,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.5604e-09,0.26042,0.29816,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.1858e-08,0.26039,0.27101,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.3435e-06,0.26024,0.2679,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.2271e-06,0.25986,0.25218,1,1
1,GO PORE COMPLEX ASSEMBLY,1.0791e-07,0.25983,0.26388,1,1
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0023637,0.25979,0.23723,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.7461e-07,0.25973,0.28893,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,2.0364e-06,0.25967,0.27133,1,1
1,GO MICROVILLUS ASSEMBLY,0.0018006,0.25951,0.20679,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5293e-05,0.25923,0.25385,1,1
1,GO REPLICATIVE SENESCENCE,0.00072342,0.25904,0.22038,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.00029052,0.25902,0.2894,1,1
1,GO GLOMERULUS DEVELOPMENT,9.819e-05,0.25887,0.30914,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00019229,0.25882,0.19166,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,3.0302e-06,0.25873,0.27815,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.188e-08,0.25853,0.31292,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,2.7078e-07,0.25849,0.25378,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,2.7614e-08,0.25841,0.2767,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.4773e-06,0.25833,0.23867,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.475e-06,0.25831,0.25313,1,1
1,GO RESPONSE TO BACTERIUM,3.9941e-08,0.25794,0.26775,1,1
1,GO PLATELET DEGRANULATION,3.8347e-06,0.25783,0.30011,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,1.7693e-06,0.25779,0.2364,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,9.0235e-07,0.25778,0.29362,1,1
1,GO REGULATION OF CELL ADHESION,5.7582e-06,0.25733,0.23321,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,1.3948e-05,0.25727,0.27043,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.2397e-08,0.25712,0.25811,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.2886e-07,0.25689,0.25235,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.3355e-07,0.25634,0.24556,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,1.4207e-05,0.25625,0.24287,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,3.9872e-06,0.25621,0.23432,1,1
1,GO RESPONSE TO DEXAMETHASONE,8.1623e-05,0.25604,0.21148,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.5038e-07,0.25601,0.273,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.5014e-05,0.25565,0.22878,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,2.6386e-06,0.25529,0.27977,1,1
1,GO KERATINOCYTE MIGRATION,1.0361e-05,0.25526,0.23457,1,1
1,GO COPPER ION TRANSPORT,1.0861e-06,0.2552,0.281,1,1
1,GO REGULATION OF IMMUNE RESPONSE,2.7614e-08,0.25519,0.25724,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,9.4407e-08,0.25503,0.25826,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.8318e-07,0.25454,0.26625,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001235,0.25375,0.23864,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,4.4787e-08,0.25347,0.23141,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.0081133,0.25337,0.24616,1,1
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00024819,0.25337,0.20492,1,1
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.0044298,0.25325,0.31685,1,1
1,GO MATURATION OF SSU RRNA,5.4184e-05,0.25298,0.23217,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,3.4773e-06,0.25283,0.22653,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,1.9563e-06,0.25266,0.32775,1,1
1,GO CELL ACTIVATION,4.3774e-08,0.25266,0.24352,1,1
1,GO MATURATION OF 5 8S RRNA,0.00034485,0.2526,0.19143,1,1
1,GO BRONCHUS DEVELOPMENT,0.021053,0.25227,0.20846,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.3056e-06,0.25216,0.30977,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,2.8814e-05,0.25196,0.2315,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.000286,0.25183,0.21656,1,1
1,GO ERBB SIGNALING PATHWAY,8.3066e-07,0.25175,0.22741,1,1
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,4.5558e-05,0.25169,0.22469,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,1.8701e-05,0.25137,0.25305,1,1
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,9.1829e-05,0.25134,0.23308,1,1
1,GO RESPONSE TO MANGANESE ION,1.536e-06,0.25121,0.23868,1,1
1,GO CHOLESTEROL EFFLUX,3.4409e-05,0.25114,0.22412,1,1
1,GO CORNIFICATION,0.03902,0.25106,0.18342,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00010673,0.25087,0.22765,1,1
1,GO RESPONSE TO IONIZING RADIATION,8.6937e-09,0.25075,0.25021,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,9.1829e-05,0.25074,0.25434,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,1.8032e-05,0.25065,0.28231,1,1
1,GO GASTRULATION,4.3774e-08,0.25063,0.2782,1,1
1,GO MYOBLAST DIFFERENTIATION,8.6328e-08,0.25039,0.28247,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.001776,0.25032,0.20282,1,1
1,GO RESPONSE TO INTERLEUKIN 7,1.7071e-05,0.2503,0.22685,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.1086e-06,0.25021,0.26698,1,1
1,GO ASYMMETRIC CELL DIVISION,2.1621e-05,0.25021,0.25269,1,1
1,GO CELLULAR RESPONSE TO X RAY,9.4341e-06,0.24961,0.32899,1,1
1,GO OSTEOCLAST DIFFERENTIATION,4.8198e-07,0.24955,0.23869,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0016806,0.24928,0.30001,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00026858,0.24902,0.23911,1,1
1,GO GLIAL CELL ACTIVATION,2.7804e-05,0.24868,0.24183,1,1
1,GO BONE DEVELOPMENT,8.5867e-06,0.24859,0.23016,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.6994e-06,0.24842,0.22744,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,2.913e-06,0.2483,0.25807,1,1
1,GO VIRAL TRANSLATION,1.8032e-05,0.24829,0.2505,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.5164e-08,0.24806,0.25147,1,1
1,GO NEUTROPHIL CHEMOTAXIS,0.00014129,0.24794,0.2054,1,1
1,GO RESPONSE TO GAMMA RADIATION,1.6782e-07,0.24788,0.25239,1,1
1,GO REGULATION OF LIPASE ACTIVITY,1.6418e-07,0.24779,0.25076,1,1
1,GO PHOSPHOLIPID HOMEOSTASIS,0.0005056,0.2477,0.23527,1,1
1,GO LYMPHOCYTE ACTIVATION,1.3468e-07,0.24765,0.24254,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.8246e-05,0.24756,0.30356,1,1
1,GO TERPENOID METABOLIC PROCESS,0.00015583,0.24749,0.18993,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,2.9332e-05,0.24735,0.23023,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0002443,0.24728,0.24775,1,1
1,GO ERYTHROCYTE DEVELOPMENT,8.2686e-06,0.24727,0.22231,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.7078e-07,0.24707,0.26955,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00070238,0.24683,0.19392,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,1.536e-06,0.24679,0.24874,1,1
1,GO INTERFERON GAMMA PRODUCTION,3.9822e-07,0.24666,0.28049,1,1
1,GO VASCULATURE DEVELOPMENT,1.5372e-07,0.24663,0.26938,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,5.4982e-08,0.24641,0.25659,1,1
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00044103,0.24638,0.23353,1,1
1,GO TISSUE MIGRATION,7.333e-07,0.24598,0.2811,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,1.6407e-09,0.24576,0.2972,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.6352e-05,0.24556,0.22045,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00020835,0.24549,0.22699,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.734e-06,0.2453,0.26611,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.2281e-06,0.24521,0.2571,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.8389e-07,0.24518,0.24326,1,1
1,GO SECRETION BY TISSUE,0.00021511,0.24512,0.21304,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.001422,0.24441,0.19923,1,1
1,GO TUMOR NECROSIS FACTOR SECRETION,1.3693e-05,0.24433,0.21511,1,1
1,GO REGULATION OF STEM CELL DIVISION,0.017506,0.24425,0.1535,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,7.9617e-06,0.24413,0.25076,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00023294,0.24411,0.27627,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,8.8389e-07,0.2441,0.22884,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,2.0398e-08,0.24408,0.27928,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00062378,0.24396,0.22679,1,1
1,GO ACTIVATED T CELL PROLIFERATION,8.7316e-05,0.24395,0.20642,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0011836,0.24392,0.24331,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00019857,0.24338,0.26013,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,5.5412e-06,0.24325,0.27411,1,1
1,GO TRABECULA FORMATION,0.00070238,0.24288,0.29796,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00083767,0.24286,0.20823,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,1.1858e-08,0.24278,0.25418,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0012527,0.24269,0.20904,1,1
1,GO LINOLEIC ACID METABOLIC PROCESS,0.024428,0.24263,0.17076,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.8976e-09,0.24254,0.2735,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,2.2958e-06,0.24253,0.2234,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,2.5884e-05,0.24233,0.26215,1,1
1,GO LUNG MORPHOGENESIS,1.8363e-05,0.24221,0.30837,1,1
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.0020646,0.24213,0.29355,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0005618,0.24171,0.19399,1,1
1,GO SYNCYTIUM FORMATION,3.5038e-07,0.24152,0.31047,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,6.7461e-07,0.2414,0.28182,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,1.9044e-05,0.24125,0.23383,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,8.6937e-09,0.2407,0.2337,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.2926e-08,0.24054,0.25206,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,6.7461e-07,0.24051,0.29869,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.3747e-08,0.2405,0.27541,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,6.2046e-07,0.2405,0.24634,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.536e-06,0.24023,0.27298,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0014624,0.24014,0.14745,1,1
1,GO PSEUDOURIDINE SYNTHESIS,0.00055343,0.23993,0.1898,1,1
1,GO FIBROBLAST PROLIFERATION,1.2281e-06,0.23989,0.27561,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.6457e-05,0.23957,0.24218,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,6.3359e-07,0.23953,0.26915,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.3803e-06,0.23945,0.29111,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.3325e-06,0.23942,0.24136,1,1
1,GO REGULATION OF CELL FATE COMMITMENT,0.0014022,0.23941,0.22407,1,1
1,GO REGULATION OF CELL SHAPE,1.6321e-06,0.23934,0.25014,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,6.8348e-09,0.23923,0.2415,1,1
1,GO PERICARDIUM DEVELOPMENT,0.00030928,0.23916,0.25035,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00012186,0.23916,0.22407,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.0323e-06,0.23913,0.30698,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.0563e-05,0.23889,0.30542,1,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.5558e-05,0.23876,0.24023,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.2253e-05,0.23872,0.22246,1,1
1,GO ASTROCYTE DEVELOPMENT,6.0991e-06,0.23857,0.26218,1,1
1,GO ISOPRENOID METABOLIC PROCESS,4.5558e-05,0.23849,0.1865,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,2.8001e-06,0.23822,0.21954,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,4.4285e-07,0.23815,0.25991,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,3.6567e-07,0.2381,0.25847,1,1
1,GO TRNA METHYLATION,6.3249e-05,0.23808,0.19925,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.6418e-07,0.23803,0.27958,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.053071,0.23801,0.097771,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00022565,0.23785,0.26776,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,1.6457e-05,0.23782,0.27536,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,7.969e-07,0.23758,0.25261,1,1
1,GO REGULATION OF CELL ACTIVATION,3.4296e-07,0.23752,0.24403,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.31e-06,0.23751,0.20617,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00039622,0.23746,0.20095,1,1
1,GO B CELL HOMEOSTASIS,0.00034485,0.2374,0.22681,1,1
1,GO RESPONSE TO RETINOIC ACID,2.342e-06,0.23739,0.24993,1,1
1,GO AMELOGENESIS,0.0020929,0.23717,0.22774,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,7.5217e-06,0.23713,0.25944,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,2.2505e-06,0.23711,0.21416,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.7078e-07,0.23693,0.26589,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,3.0302e-06,0.23691,0.264,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0054872,0.23676,0.3001,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.3228e-08,0.23662,0.25124,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,7.6283e-05,0.23644,0.20199,1,1
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.001118,0.23606,0.1936,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,9.4341e-06,0.23605,0.22064,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,6.545e-05,0.23591,0.24163,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.4796e-08,0.23568,0.24532,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,3.4773e-06,0.23527,0.3012,1,1
1,GO REGULATION OF MAST CELL ACTIVATION,0.0019285,0.23503,0.21788,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.9514e-07,0.23466,0.24563,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,4.7172e-05,0.23462,0.2098,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,1.6129e-08,0.23459,0.2578,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00080175,0.23439,0.2735,1,1
1,GO PROTEIN HYDROXYLATION,0.001118,0.23437,0.25915,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.4163e-06,0.23425,0.25739,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00013899,0.23424,0.21302,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00032408,0.23423,0.26634,1,1
1,GO LEUKOTRIENE METABOLIC PROCESS,0.018693,0.23373,0.16296,1,1
1,GO DEFENSE RESPONSE,9.6538e-08,0.23369,0.24015,1,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.00040235,0.23362,0.22966,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.1165e-05,0.23351,0.28519,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00040857,0.23346,0.23516,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00033432,0.23319,0.21182,1,1
1,GO PIGMENT METABOLIC PROCESS,7.333e-07,0.23308,0.20357,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,5.6245e-08,0.23306,0.23535,1,1
1,GO RESPONSE TO VITAMIN,0.00084997,0.23256,0.18889,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00010152,0.23255,0.25547,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,1.6782e-07,0.23242,0.24205,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.4098e-06,0.23237,0.24032,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.0005211,0.23232,0.21644,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.1552e-07,0.23217,0.25215,1,1
1,GO ENDOTHELIAL CELL MIGRATION,1.8053e-06,0.23205,0.28499,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,1.2954e-05,0.23187,0.22964,1,1
1,GO AORTA MORPHOGENESIS,0.026838,0.23172,0.17439,1,1
1,GO LEUKOCYTE CHEMOTAXIS,9.3381e-05,0.23147,0.20385,1,1
1,GO PROTEIN NITROSYLATION,0.0075485,0.23101,0.16362,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00016098,0.23099,0.22298,1,1
1,GO MATURATION OF LSU RRNA,0.00016098,0.23085,0.2333,1,1
1,GO HISTONE H4 DEACETYLATION,0.00073415,0.23076,0.21384,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,2.2416e-05,0.23075,0.22945,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.5794e-07,0.23058,0.27944,1,1
1,GO EPIDERMAL CELL DIFFERENTIATION,0.0071918,0.23047,0.17421,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.7078e-07,0.23032,0.27243,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.0361e-05,0.23014,0.2751,1,1
1,GO CELLULAR EXTRAVASATION,2.971e-06,0.22967,0.24489,1,1
1,GO REGULATION OF LIPID KINASE ACTIVITY,1.3442e-05,0.22956,0.21655,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,3.4773e-06,0.22925,0.23062,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.7166e-08,0.22924,0.23915,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0085105,0.22924,0.16014,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.2859e-07,0.22912,0.2559,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,1.6761e-05,0.22907,0.23054,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,3.8246e-05,0.22893,0.27253,1,1
1,GO REGULATION OF HEMOPOIESIS,4.7501e-09,0.22889,0.25055,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,2.3239e-05,0.22888,0.25926,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.00012804,0.22887,0.20276,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.000662,0.22855,0.18522,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.1205e-09,0.22855,0.2553,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.5217e-09,0.22852,0.23771,1,1
1,GO CERAMIDE TRANSPORT,8.0256e-05,0.22851,0.28065,1,1
1,GO PLACENTA DEVELOPMENT,7.5217e-06,0.22847,0.20433,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00010323,0.22832,0.29638,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.1351e-07,0.22816,0.209,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,4.6359e-05,0.22795,0.20073,1,1
1,GO RESPONSE TO UV C,2.7804e-05,0.22795,0.27372,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.7488e-06,0.22789,0.22987,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,9.0235e-07,0.22767,0.25487,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,8.5867e-06,0.22753,0.25876,1,1
1,GO AUTOPHAGY OF NUCLEUS,7.5217e-06,0.22727,0.23786,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,7.4873e-07,0.22646,0.22842,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.152e-06,0.22612,0.28283,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.2958e-06,0.22597,0.2042,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,1.4207e-05,0.22586,0.24802,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0002117,0.22551,0.23615,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0071051,0.2255,0.22228,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,1.7071e-05,0.22547,0.19427,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2886e-07,0.22545,0.2757,1,1
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.019735,0.22523,0.14692,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00013451,0.22521,0.26014,1,1
1,GO RRNA MODIFICATION,9.9844e-05,0.22512,0.17212,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.5424e-05,0.2251,0.19049,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.002702,0.22507,0.19132,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,2.1338e-07,0.22505,0.23243,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.7051e-07,0.22452,0.21336,1,1
1,GO PLATELET ACTIVATION,3.3214e-05,0.22444,0.22712,1,1
1,GO SYMBIOTIC PROCESS,5.5078e-11,0.22435,0.23301,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,4.0657e-06,0.22427,0.22866,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.011411,0.22409,0.19078,1,1
1,GO DETOXIFICATION,4.4771e-05,0.22397,0.18796,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00095459,0.22393,0.21447,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,6.2169e-06,0.22336,0.22688,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,4.5822e-08,0.22329,0.20504,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00013899,0.2231,0.27197,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0050904,0.22309,0.22285,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,2.6352e-05,0.22303,0.25856,1,1
1,GO PROTEIN ADP RIBOSYLATION,1.0361e-05,0.22297,0.23831,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.9228e-07,0.22275,0.27418,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00067188,0.22261,0.18012,1,1
1,GO TOXIN TRANSPORT,4.31e-06,0.2226,0.21001,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0093576,0.22259,0.16147,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00073415,0.22257,0.23213,1,1
1,GO RNA 5 END PROCESSING,8.3013e-05,0.22249,0.20857,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,2.206e-06,0.22243,0.24558,1,1
1,GO SELECTIVE AUTOPHAGY,1.7721e-08,0.22243,0.23542,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00083767,0.2224,0.20851,1,1
1,GO PLATELET MORPHOGENESIS,7.105e-06,0.22239,0.28568,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,2.7312e-05,0.22234,0.26221,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,4.3997e-05,0.22229,0.21201,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5293e-05,0.22214,0.25059,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0012005,0.22185,0.25647,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,2.0853e-05,0.22184,0.23235,1,1
1,GO LAMELLIPODIUM ASSEMBLY,1.155e-06,0.2218,0.22898,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.00029976,0.22145,0.19716,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0046018,0.22136,0.22562,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.439e-07,0.22098,0.20559,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0074579,0.22078,0.21492,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,6.5837e-06,0.22072,0.24912,1,1
1,GO ETHANOL CATABOLIC PROCESS,0.029754,0.22055,0.23004,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00023294,0.22025,0.24159,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,2.3661e-05,0.22021,0.21844,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,8.5867e-06,0.22014,0.26294,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,7.0072e-05,0.22008,0.25383,1,1
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00038422,0.22006,0.18704,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0001862,0.21985,0.23512,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.6657e-06,0.21934,0.27255,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.3671e-08,0.21907,0.24565,1,1
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00069207,0.21902,0.21157,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.2286e-07,0.21882,0.26216,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.5027e-08,0.21881,0.24671,1,1
1,GO RESPONSE TO WOUNDING,1.1086e-06,0.21866,0.23901,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00030928,0.21859,0.27744,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00040857,0.21849,0.24312,1,1
1,GO LIPID STORAGE,2.2958e-06,0.21839,0.22642,1,1
1,GO CELL CHEMOTAXIS,1.1165e-05,0.21839,0.22275,1,1
1,GO STRESS FIBER ASSEMBLY,8.7502e-06,0.21836,0.2454,1,1
1,GO HISTONE H2B UBIQUITINATION,2.4371e-06,0.21829,0.22045,1,1
1,GO REGULATION OF B CELL ACTIVATION,2.011e-05,0.21823,0.22421,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.475e-06,0.21818,0.24139,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.5001e-05,0.21773,0.24607,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.1234e-05,0.21744,0.23425,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.3774e-08,0.21719,0.20801,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00082553,0.21719,0.20012,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.4091e-05,0.21715,0.26403,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.0424e-06,0.2171,0.22219,1,1
1,GO IRON ION HOMEOSTASIS,8.6328e-08,0.21693,0.23194,1,1
1,GO T CELL DIFFERENTIATION,4.4807e-06,0.21691,0.23009,1,1
1,GO RESPONSE TO CORTICOSTEROID,2.1234e-05,0.21686,0.20368,1,1
1,GO REGULATION OF DEFENSE RESPONSE,5.2538e-08,0.21673,0.23578,1,1
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00029052,0.21659,0.22946,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,3.3214e-05,0.21651,0.21005,1,1
1,GO ASTROCYTE ACTIVATION,2.6352e-05,0.21613,0.21666,1,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0010865,0.21606,0.19998,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0030038,0.21603,0.15413,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,7.2497e-05,0.21602,0.23672,1,1
1,GO MULTI ORGANISM LOCALIZATION,3.9941e-08,0.21598,0.23284,1,1
1,GO ERYTHROCYTE MATURATION,0.0003557,0.21586,0.25087,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0016347,0.21585,0.27064,1,1
1,GO INFLAMMATORY RESPONSE,1.1789e-06,0.21581,0.23273,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,8.7316e-05,0.21576,0.19839,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00040235,0.21559,0.2176,1,1
1,GO BLASTODERM SEGMENTATION,0.014332,0.21559,0.18593,1,1
1,GO AUTOPHAGOSOME MATURATION,1.5372e-07,0.21552,0.2254,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.3214e-05,0.21549,0.27857,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00049053,0.21539,0.18545,1,1
1,GO ANIMAL ORGAN REGENERATION,1.439e-07,0.21519,0.25713,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.00028155,0.21506,0.19604,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.001235,0.21464,0.19609,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,6.8885e-07,0.21453,0.24532,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,3.5794e-07,0.21446,0.23055,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016575,0.21445,0.16429,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,8.9166e-06,0.2144,0.24318,1,1
1,GO MYELOID CELL HOMEOSTASIS,9.028e-08,0.21432,0.22664,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,6.5906e-08,0.21431,0.24103,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.0205e-08,0.21422,0.22896,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.7356e-07,0.21408,0.22953,1,1
1,GO MALE GENITALIA DEVELOPMENT,0.0032078,0.21392,0.18301,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0756e-05,0.21389,0.31483,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00021511,0.21345,0.21452,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.024428,0.21337,0.20239,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00013673,0.21335,0.23049,1,1
1,GO MUSCLE CELL PROLIFERATION,1.439e-07,0.21317,0.26175,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,2.9514e-07,0.21304,0.21448,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00029511,0.21288,0.21257,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00055343,0.21285,0.2036,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,9.2118e-07,0.21268,0.24065,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.6362e-08,0.21259,0.24082,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0005133,0.21258,0.2,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.006444,0.21234,0.16198,1,1
1,GO MESODERM MORPHOGENESIS,1.3056e-06,0.21229,0.22541,1,1
1,GO PENTOSE METABOLIC PROCESS,0.00029511,0.21202,0.24046,1,1
1,GO LIVER MORPHOGENESIS,0.001483,0.21193,0.19783,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.2482e-05,0.21183,0.21926,1,1
1,GO TOOTH MINERALIZATION,0.0019819,0.2115,0.24814,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,3.7605e-06,0.21142,0.21745,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,7.0072e-05,0.21119,0.18345,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00027716,0.21106,0.17811,1,1
1,GO LEUKOCYTE DIFFERENTIATION,5.7051e-07,0.21089,0.23445,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,7.8052e-07,0.21084,0.2001,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.0811e-07,0.21084,0.23472,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.5684e-06,0.21081,0.27729,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00031907,0.21061,0.19598,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.0278e-07,0.21032,0.21389,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,9.2585e-06,0.21028,0.22803,1,1
1,GO B CELL ACTIVATION,4.6578e-06,0.21008,0.21999,1,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.047827,0.20964,0.15862,1,1
1,GO PROTEIN KINASE A SIGNALING,6.6578e-05,0.2095,0.17847,1,1
1,GO AXIS ELONGATION,0.00082553,0.20949,0.26999,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0052854,0.20949,0.26712,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.0527e-08,0.20949,0.21603,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0023637,0.20921,0.15201,1,1
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0012527,0.20917,0.22332,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012798,0.20907,0.14319,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.4454e-06,0.20903,0.21796,1,1
1,GO NEURAL TUBE PATTERNING,0.0018006,0.20888,0.19021,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00018323,0.20862,0.19684,1,1
1,GO FACE DEVELOPMENT,8.4424e-05,0.20861,0.23798,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00022208,0.20841,0.20721,1,1
1,GO MANGANESE ION TRANSPORT,0.00028155,0.20813,0.18838,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,9.086e-06,0.20809,0.2336,1,1
1,GO CELLULAR RESPONSE TO LIPID,7.969e-07,0.20801,0.20229,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0093576,0.20795,0.1634,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0046018,0.20792,0.15289,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,9.9803e-06,0.20777,0.2342,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.025743,0.20765,0.22932,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.3761e-09,0.20763,0.22457,1,1
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0023009,0.2076,0.23012,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0012527,0.20678,0.14667,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0019023,0.20664,0.19101,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,8.0256e-05,0.2066,0.27194,1,1
1,GO VIRION ASSEMBLY,8.8389e-07,0.20658,0.17951,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.9332e-05,0.20651,0.27047,1,1
1,GO GLYCOSIDE METABOLIC PROCESS,0.012945,0.20638,0.15999,1,1
1,GO ODONTOGENESIS,0.00092737,0.20633,0.20096,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00030449,0.2063,0.18417,1,1
1,GO LYMPHOCYTE MIGRATION,3.4098e-06,0.20626,0.23538,1,1
1,GO LIPID IMPORT INTO CELL,0.00045468,0.20618,0.20001,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00016901,0.20607,0.21144,1,1
1,GO CYTOKINETIC PROCESS,1.4163e-06,0.20571,0.22256,1,1
1,GO MYELOID CELL DIFFERENTIATION,7.7166e-08,0.20571,0.22518,1,1
1,GO REGULATION OF LIPID STORAGE,1.9563e-06,0.20561,0.2334,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,8.8389e-07,0.20508,0.20702,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00033432,0.20498,0.21778,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.4972e-05,0.20493,0.20765,1,1
1,GO REGENERATION,3.0156e-07,0.20487,0.21451,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1479e-07,0.20472,0.21756,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.011949,0.20471,0.15476,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00059648,0.20457,0.16634,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.3806e-05,0.20398,0.26342,1,1
1,GO LEUKOCYTE MIGRATION,3.6924e-05,0.20386,0.21101,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.003607,0.20376,0.26403,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,1.1375e-05,0.2037,0.25442,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0040509,0.20363,0.22331,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00048316,0.20355,0.23903,1,1
1,GO GAS TRANSPORT,0.0027747,0.20349,0.22324,1,1
1,GO VIRAL RELEASE FROM HOST CELL,1.9465e-08,0.20346,0.23342,1,1
1,GO REGULATION OF PROTEOLYSIS,2.4305e-07,0.20345,0.1948,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.5372e-07,0.20334,0.21897,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,8.5867e-06,0.20327,0.21038,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,7.3803e-06,0.20326,0.2977,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.1621e-05,0.20321,0.20028,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.3174e-07,0.20289,0.24836,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,1.9749e-05,0.2026,0.1954,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,1.2792e-06,0.20227,0.23556,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,1.5576e-05,0.20225,0.23921,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00019229,0.20206,0.21352,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0005789,0.20203,0.17507,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,4.4148e-09,0.20191,0.21648,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,1.2716e-05,0.20188,0.28779,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.0791e-07,0.20186,0.22998,1,1
1,GO PEPTIDE CATABOLIC PROCESS,3.0905e-06,0.20181,0.25554,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.0072795,0.20168,0.15937,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0062108,0.20161,0.18284,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,4.2487e-05,0.20152,0.20408,1,1
1,GO RESPONSE TO TESTOSTERONE,5.0323e-06,0.20125,0.22398,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,5.7051e-07,0.20118,0.21948,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,2.8271e-07,0.20101,0.21535,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,8.2864e-09,0.20086,0.21912,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00070238,0.20079,0.17643,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,3.0302e-06,0.2007,0.19759,1,1
1,GO LIPID OXIDATION,5.7059e-05,0.20059,0.17329,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,3.3435e-06,0.20045,0.19417,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.7605e-06,0.20038,0.23338,1,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0005618,0.19973,0.18308,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.4098e-06,0.19965,0.22543,1,1
1,GO CELLULAR PIGMENTATION,6.0759e-07,0.19938,0.22315,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,6.3249e-05,0.19937,0.21933,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,3.7356e-07,0.19927,0.19964,1,1
1,GO FATTY ACID BETA OXIDATION,0.00011986,0.19902,0.17135,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.3435e-06,0.19902,0.22108,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00023667,0.19883,0.19705,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00049802,0.19873,0.20118,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00016901,0.19864,0.26201,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00096848,0.19848,0.18038,1,1
1,GO EPIDERMIS DEVELOPMENT,0.0028118,0.19843,0.17279,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0070192,0.19834,0.18912,1,1
1,GO RESPONSE TO VITAMIN A,0.00084997,0.19819,0.18861,1,1
1,GO MITOCHONDRIAL RNA PROCESSING,0.03429,0.19797,0.13285,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,1.5994e-06,0.19779,0.19086,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0007901,0.19763,0.17202,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0005133,0.19761,0.2228,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,2.2958e-06,0.19757,0.22862,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,3.3214e-05,0.19746,0.20458,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.3274e-07,0.19745,0.20004,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,9.6129e-06,0.19738,0.17863,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,3.5461e-06,0.19709,0.18699,1,1
1,GO SKIN DEVELOPMENT,0.001776,0.19698,0.19055,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,1.5576e-05,0.19685,0.207,1,1
1,GO NUCLEAR PORE ORGANIZATION,2.8814e-05,0.19649,0.22625,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.3325e-06,0.1964,0.2604,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00012594,0.19635,0.19293,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.6657e-06,0.19628,0.1957,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,7.8911e-05,0.19621,0.17933,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,7.6657e-06,0.19617,0.19119,1,1
1,GO HETEROTYPIC CELL CELL ADHESION,0.017506,0.1961,0.14611,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.439e-07,0.19592,0.24032,1,1
1,GO TONGUE MORPHOGENESIS,0.015159,0.19587,0.20251,1,1
1,GO VIRAL GENE EXPRESSION,0.00015083,0.1958,0.17179,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.4677e-08,0.19575,0.19713,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,2.2824e-05,0.19567,0.18374,1,1
1,GO CELL CELL RECOGNITION,4.6356e-09,0.19557,0.21583,1,1
1,GO NCRNA PROCESSING,3.5022e-05,0.19555,0.179,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.1535e-07,0.19552,0.20049,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0010865,0.19528,0.2242,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0019023,0.19522,0.16242,1,1
1,GO ACUTE PHASE RESPONSE,0.00014839,0.19481,0.19636,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0065235,0.1947,0.17095,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00033432,0.1947,0.2217,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,2.3661e-05,0.19464,0.30692,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.9989e-07,0.19445,0.20166,1,1
1,GO RESPONSE TO ANTIBIOTIC,1.0424e-06,0.19445,0.2155,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,5.7582e-06,0.19444,0.19111,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.0047798,0.19441,0.13494,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0020929,0.19413,0.20789,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,9.8716e-08,0.19409,0.20588,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,1.9175e-06,0.19398,0.19544,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.3671e-08,0.19386,0.20748,1,1
1,GO TRNA PROCESSING,0.00030449,0.19369,0.13771,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00071283,0.19367,0.1782,1,1
1,GO GTP METABOLIC PROCESS,4.7172e-05,0.19347,0.21431,1,1
1,GO BODY FLUID SECRETION,5.1304e-06,0.1933,0.18884,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,6.5837e-06,0.19322,0.24735,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00013673,0.1931,0.1766,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0039992,0.19303,0.23073,1,1
1,GO MRNA TRANSCRIPTION,4.0657e-06,0.19303,0.26495,1,1
1,GO RNA METHYLATION,9.819e-05,0.1928,0.16974,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00022565,0.19268,0.21098,1,1
1,GO NADP METABOLIC PROCESS,0.0021798,0.19243,0.166,1,1
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.007921,0.19229,0.15338,1,1
1,GO POSITIVE CHEMOTAXIS,0.00159,0.19226,0.1956,1,1
1,GO RNA DESTABILIZATION,7.105e-06,0.19218,0.21299,1,1
1,GO RECEPTOR RECYCLING,0.00010673,0.19191,0.1743,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.3693e-05,0.19183,0.18036,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00023667,0.19179,0.22968,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.00040235,0.19173,0.18826,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0012177,0.1917,0.1644,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00026438,0.19162,0.23717,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,9.404e-07,0.19155,0.17601,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,1.8053e-06,0.19153,0.18785,1,1
1,GO REGULATION OF T CELL MIGRATION,0.00026024,0.19132,0.19733,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00015331,0.19131,0.1558,1,1
1,GO PROTEIN KINASE B SIGNALING,2.1234e-05,0.1913,0.18371,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,2.5934e-07,0.1913,0.17686,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0013633,0.19116,0.15603,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,4.7172e-05,0.19103,0.21064,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.3806e-05,0.191,0.18242,1,1
1,GO GLIAL CELL MIGRATION,0.0080166,0.19063,0.14905,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,2.6914e-06,0.19055,0.19156,1,1
1,GO LYMPHOCYTE COSTIMULATION,2.9332e-05,0.19054,0.22726,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00040235,0.19022,0.21629,1,1
1,GO VESICLE TARGETING,7.6657e-06,0.19016,0.17857,1,1
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.001955,0.19014,0.17065,1,1
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.020385,0.19007,0.1121,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,5.0563e-05,0.18993,0.21003,1,1
1,GO REGULATION OF CELL AGING,8.7502e-06,0.18991,0.18449,1,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.014013,0.18963,0.11917,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00072342,0.18954,0.17021,1,1
1,GO CYTOKINE SECRETION,0.0020929,0.18932,0.14771,1,1
1,GO RESPONSE TO CHEMOKINE,5.2445e-07,0.18926,0.21606,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00095459,0.18924,0.28887,1,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.022928,0.18919,0.13122,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.032938,0.189,0.16176,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00014839,0.18892,0.20251,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.003654,0.18871,0.19136,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0010865,0.18866,0.15688,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.00054518,0.18824,0.22666,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.015159,0.18816,0.18076,1,1
1,GO COPII COATED VESICLE CARGO LOADING,4.31e-06,0.18813,0.21207,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.9514e-07,0.18812,0.16248,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.00095459,0.18799,0.20131,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0024941,0.18791,0.15418,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00030449,0.18773,0.20213,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,7.6446e-07,0.18768,0.22573,1,1
1,GO RRNA METABOLIC PROCESS,0.00010323,0.18766,0.17579,1,1
1,GO CARTILAGE DEVELOPMENT,2.3661e-05,0.1876,0.21066,1,1
1,GO TRNA MODIFICATION,0.00052901,0.18723,0.14645,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.4415e-08,0.18715,0.17994,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0011668,0.18707,0.21436,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014129,0.18668,0.20955,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,3.5461e-06,0.18658,0.19289,1,1
1,GO TUBE MORPHOGENESIS,5.7582e-06,0.18635,0.21219,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0035605,0.18625,0.15201,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00053704,0.18617,0.1854,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00046165,0.18617,0.27679,1,1
1,GO RIBOSOME BIOGENESIS,7.0072e-05,0.18614,0.18527,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,8.4805e-07,0.1861,0.19311,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00049053,0.18596,0.21192,1,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0059852,0.18564,0.18151,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00011033,0.18554,0.19384,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00031414,0.18552,0.19652,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,2.0478e-05,0.18542,0.16293,1,1
1,GO RNA DECAPPING,1.2716e-05,0.18521,0.18821,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.2344e-05,0.18505,0.29429,1,1
1,GO NEURAL TUBE DEVELOPMENT,7.5001e-05,0.185,0.19346,1,1
1,GO ERAD PATHWAY,1.2253e-05,0.18484,0.17158,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00019857,0.18482,0.19899,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00030928,0.18439,0.20603,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,5.6085e-05,0.18434,0.18427,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00028155,0.18433,0.20024,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00011596,0.18423,0.22869,1,1
1,GO HISTONE PHOSPHORYLATION,4.9694e-05,0.18409,0.15513,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.004156,0.18402,0.1216,1,1
1,GO FATTY ACID TRANSPORT,0.00010152,0.18386,0.15375,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,1.8032e-05,0.18375,0.16517,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0012177,0.18373,0.16489,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.00033432,0.18367,0.19516,1,1
1,GO REGULATION OF GENE SILENCING,3.357e-07,0.18362,0.18704,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.0657e-06,0.18356,0.19108,1,1
1,GO MYELOID CELL DEVELOPMENT,0.00012594,0.18352,0.19963,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,7.7586e-05,0.18332,0.19559,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00011033,0.18308,0.19366,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.4807e-06,0.18307,0.24086,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0070192,0.18303,0.15176,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0037016,0.18279,0.27122,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,4.7172e-05,0.18265,0.19409,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,1.4472e-05,0.18259,0.23285,1,1
1,GO REGULATION OF BODY FLUID LEVELS,7.1274e-05,0.18254,0.17864,1,1
1,GO RESPONSE TO PROGESTERONE,0.0013069,0.18204,0.20088,1,1
1,GO RESPONSE TO ISCHEMIA,0.00013016,0.18201,0.18629,1,1
1,GO HEART VALVE DEVELOPMENT,0.0047798,0.18169,0.19181,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.971e-06,0.18162,0.17926,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0032928,0.18161,0.17331,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,9.2585e-06,0.18136,0.18862,1,1
1,GO ACTIN FILAMENT ORGANIZATION,3.8246e-05,0.18132,0.17155,1,1
1,GO AMYLOID BETA FORMATION,0.00058763,0.1813,0.1888,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00013451,0.18118,0.15861,1,1
1,GO RNA MODIFICATION,4.3236e-05,0.18107,0.16551,1,1
1,GO RESPONSE TO VITAMIN D,0.045155,0.18098,0.11548,1,1
1,GO BONE CELL DEVELOPMENT,0.003166,0.18077,0.2016,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,7.8124e-06,0.18069,0.1757,1,1
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00018923,0.18029,0.21335,1,1
1,GO NCRNA CATABOLIC PROCESS,0.0030038,0.18024,0.14237,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.05063,0.18009,0.11487,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00084997,0.18007,0.16816,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,2.6914e-06,0.17924,0.21068,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,1.4207e-05,0.17921,0.1692,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00010497,0.17915,0.19428,1,1
1,GO NEURAL TUBE FORMATION,7.7586e-05,0.17913,0.19508,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00012388,0.1787,0.1592,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0044864,0.1786,0.20044,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.022446,0.17857,0.13056,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.9694e-05,0.17856,0.21222,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.3039e-08,0.1785,0.18414,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0011668,0.17825,0.29788,1,1
1,GO NCRNA METABOLIC PROCESS,7.2497e-05,0.17818,0.15758,1,1
1,GO TRNA METABOLIC PROCESS,0.00036686,0.17811,0.1337,1,1
1,GO RESPONSE TO GROWTH HORMONE,0.0012177,0.17796,0.22852,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0014022,0.17775,0.18756,1,1
1,GO TRABECULA MORPHOGENESIS,0.0028492,0.17766,0.20567,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0021215,0.17756,0.15691,1,1
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.001118,0.1775,0.15134,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.028264,0.17729,0.12677,1,1
1,GO RESPONSE TO FATTY ACID,0.029754,0.17727,0.10812,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0022095,0.17724,0.19525,1,1
1,GO PIGMENT GRANULE LOCALIZATION,0.0037985,0.17684,0.14843,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,3.8347e-06,0.1766,0.21899,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.6994e-06,0.17643,0.21576,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00013451,0.17638,0.16089,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00040235,0.17635,0.16429,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00016098,0.17607,0.1951,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,1.9136e-07,0.17602,0.18091,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,1.5994e-06,0.17572,0.19356,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0023321,0.17569,0.16286,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.913e-06,0.17563,0.18847,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00039018,0.17555,0.20073,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.020605,0.17546,0.15844,1,1
1,GO REGULATION OF LIPID LOCALIZATION,6.9711e-06,0.1753,0.1906,1,1
1,GO GOLGI VESICLE BUDDING,1.0557e-05,0.17523,0.16454,1,1
1,GO PLASMA MEMBRANE FUSION,0.062114,0.1752,0.15291,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00014129,0.1749,0.16331,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0014624,0.17489,0.14969,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.013243,0.1747,0.21337,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00037257,0.17462,0.16298,1,1
1,GO REGULATION OF GASTRIC ACID SECRETION,0.012653,0.17446,0.19268,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,9.795e-06,0.17442,0.20364,1,1
1,GO REGULATION OF TELOMERASE ACTIVITY,0.00037257,0.17411,0.16011,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00042128,0.17399,0.19356,1,1
1,GO RENAL VESICLE DEVELOPMENT,0.013546,0.17398,0.15,1,1
1,GO TRACHEA MORPHOGENESIS,0.00016629,0.17368,0.25281,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,2.3891e-06,0.17349,0.20425,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.015501,0.17349,0.11469,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00069207,0.17344,0.2605,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,3.0302e-06,0.17331,0.22118,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,7.7586e-05,0.17321,0.16354,1,1
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0011503,0.17321,0.20889,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.00021511,0.173,0.16787,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00013232,0.1728,0.18003,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0043184,0.17263,0.17861,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0069343,0.17208,0.19349,1,1
1,GO REGULATION OF HEART GROWTH,0.00039622,0.17207,0.17163,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0024941,0.17198,0.17423,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00012186,0.17172,0.16773,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00033432,0.17167,0.17057,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,4.4807e-06,0.17164,0.21279,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.7154e-07,0.17124,0.21272,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,8.8282e-08,0.17119,0.19092,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,2.2824e-05,0.17103,0.19088,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.0037985,0.1709,0.21212,1,1
1,GO RRNA METHYLATION,0.00024819,0.17073,0.16888,1,1
1,GO NEPHRON TUBULE FORMATION,0.0083098,0.17071,0.23206,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.03068,0.17068,0.1334,1,1
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0039481,0.17008,0.17721,1,1
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0045438,0.17001,0.13947,1,1
1,GO RESPONSE TO OSMOTIC STRESS,2.3891e-06,0.16991,0.19165,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,4.1751e-05,0.16979,0.15274,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0046018,0.16978,0.13179,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.2118e-07,0.16973,0.16534,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00045468,0.16971,0.21695,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00033432,0.16969,0.1744,1,1
1,GO REGULATION OF VASCULOGENESIS,0.02915,0.16969,0.19655,1,1
1,GO REGULATION OF ORGAN GROWTH,1.3599e-06,0.16963,0.21776,1,1
1,GO GLYCINE METABOLIC PROCESS,0.056652,0.1696,0.09657,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00039622,0.16959,0.16582,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0104,0.1695,0.17585,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.00026024,0.16944,0.14806,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,2.2015e-05,0.16934,0.18193,1,1
1,GO DNA LIGATION,0.0021215,0.16929,0.15864,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,1.064e-06,0.16921,0.20535,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,3.0395e-05,0.16917,0.19929,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.0235e-07,0.16906,0.18474,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,9.028e-08,0.16889,0.19269,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,2.538e-07,0.16889,0.1711,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,4.4807e-06,0.16889,0.18218,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00012388,0.16837,0.20085,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0068504,0.16822,0.10884,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00015838,0.1682,0.16877,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.00064263,0.16811,0.10586,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00011406,0.16789,0.19382,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0039481,0.16782,0.19866,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.4741e-05,0.16765,0.185,1,1
1,GO BLASTOCYST FORMATION,1.6654e-06,0.16736,0.17978,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,4.1751e-05,0.16728,0.16135,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0054872,0.16726,0.15791,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.3946e-06,0.16723,0.18011,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.004156,0.16719,0.16719,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00016629,0.16714,0.16502,1,1
1,GO TRNA 5 END PROCESSING,0.00067188,0.16711,0.18039,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00044781,0.1671,0.16697,1,1
1,GO GENITALIA DEVELOPMENT,0.00075607,0.16709,0.14656,1,1
1,GO RESPONSE TO LIPID,1.8363e-05,0.16701,0.17097,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00045468,0.16698,0.18166,1,1
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0054192,0.16697,0.14544,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00012594,0.16679,0.15288,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.3806e-05,0.1667,0.18377,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.8396e-06,0.16639,0.17034,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0019819,0.16636,0.19479,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,1.5994e-06,0.16629,0.16719,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0049019,0.16627,0.14198,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00030928,0.16621,0.16787,1,1
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031907,0.16618,0.19473,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,2.9332e-05,0.16575,0.15072,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0031247,0.16554,0.18952,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,9.03e-05,0.16553,0.15793,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.0557e-05,0.16532,0.18001,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.4528e-05,0.16516,0.17325,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0014022,0.16504,0.16605,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00011986,0.16495,0.16634,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,8.5858e-05,0.16489,0.21903,1,1
1,GO CELL AGING,1.8053e-06,0.16488,0.1749,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,6.337e-06,0.16473,0.19825,1,1
1,GO MESODERM DEVELOPMENT,3.4773e-06,0.16472,0.17618,1,1
1,GO RESPONSE TO OXYGEN LEVELS,4.0657e-06,0.16466,0.15967,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0010408,0.16445,0.21295,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,3.3806e-05,0.16433,0.16195,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9069e-08,0.16433,0.18908,1,1
1,GO PROTEIN PROCESSING,2.011e-05,0.16419,0.17916,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084997,0.16343,0.1716,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00159,0.16327,0.14001,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,8.8796e-05,0.16327,0.18649,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.0019285,0.16321,0.14169,1,1
1,GO NEURAL CREST CELL MIGRATION,0.01585,0.16289,0.14839,1,1
1,GO TISSUE MORPHOGENESIS,2.9859e-05,0.16273,0.16309,1,1
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.012945,0.1626,0.16064,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.9044e-05,0.16257,0.14052,1,1
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00030928,0.16255,0.13706,1,1
1,GO TRANSCYTOSIS,0.004156,0.1625,0.1703,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.000286,0.16247,0.16618,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00016361,0.1624,0.16672,1,1
1,GO EPITHELIAL CELL DEVELOPMENT,0.0020646,0.16215,0.16207,1,1
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.010645,0.16196,0.14856,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0033361,0.16178,0.15776,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,6.3249e-05,0.16168,0.17461,1,1
1,GO BIOLOGICAL ADHESION,0.0010259,0.16147,0.15264,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.00042128,0.16122,0.12231,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00013451,0.16107,0.21275,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.0054192,0.16099,0.13296,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0030839,0.16097,0.14792,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.028556,0.16094,0.10755,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.00032408,0.16094,0.12219,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0032501,0.16078,0.15287,1,1
1,GO EXOCYTOSIS,0.00049053,0.16078,0.13813,1,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0045438,0.16071,0.15459,1,1
1,GO RESPONSE TO STEROID HORMONE,6.545e-05,0.1607,0.16563,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00036124,0.16048,0.15104,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.0137,0.16044,0.13425,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0034692,0.16023,0.10804,1,1
1,GO MITOTIC CYTOKINESIS,9.819e-05,0.16018,0.15156,1,1
1,GO LIPID MODIFICATION,0.00024819,0.15995,0.13595,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00011986,0.15986,0.19137,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,5.2445e-07,0.15981,0.14417,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00070238,0.15977,0.17472,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,5.2303e-06,0.15964,0.17527,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0030839,0.1596,0.18395,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00011033,0.15946,0.17101,1,1
1,GO FLUID TRANSPORT,0.00063314,0.15944,0.18248,1,1
1,GO CHROMATIN DISASSEMBLY,0.064418,0.15892,0.08736,1,1
1,GO STEM CELL DIFFERENTIATION,1.6321e-06,0.1588,0.177,1,1
1,GO LIPID HOMEOSTASIS,0.00044103,0.15841,0.14726,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.00013016,0.15834,0.1778,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00063314,0.15833,0.20506,1,1
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.011544,0.15832,0.19956,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00044781,0.15826,0.18617,1,1
1,GO CELLULAR RESPONSE TO UV,5.6487e-06,0.15812,0.17815,1,1
1,GO REGULATION OF MRNA BINDING,0.0024941,0.158,0.16617,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0032928,0.15795,0.16005,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0076401,0.15794,0.12327,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0023637,0.15793,0.12186,1,1
1,GO MAINTENANCE OF CELL NUMBER,0.00057029,0.1577,0.1636,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0029645,0.15769,0.12639,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.4098e-06,0.15754,0.1641,1,1
1,GO MEMBRANE DISASSEMBLY,0.016205,0.15748,0.14194,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.066192,0.15747,0.093305,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.9044e-05,0.15725,0.15809,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,6.0991e-06,0.15718,0.15614,1,1
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.00083767,0.15716,0.17306,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.1316e-06,0.15674,0.18197,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00059648,0.15651,0.14334,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,2.3661e-05,0.15632,0.15951,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0021505,0.15622,0.22656,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.9613e-05,0.15621,0.15752,1,1
1,GO REGULATION OF RESPONSE TO STRESS,3.0811e-07,0.1559,0.16929,1,1
1,GO PIGMENT CELL DIFFERENTIATION,0.011411,0.15588,0.13272,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0096941,0.15577,0.17537,1,1
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0013069,0.15571,0.17832,1,1
1,GO AMINO ACID ACTIVATION,0.011151,0.15554,0.11623,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00043435,0.15551,0.16827,1,1
1,GO REGULATION OF LIPID TRANSPORT,7.3739e-05,0.15547,0.17677,1,1
1,GO REGULATION OF CHEMOTAXIS,0.00046872,0.15534,0.15987,1,1
1,GO NUCLEOSIDE SALVAGE,0.0053519,0.15531,0.17184,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9361e-06,0.15529,0.15786,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.4528e-05,0.15525,0.16182,1,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00029052,0.15516,0.16077,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.0020367,0.15486,0.12007,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,9.03e-05,0.15481,0.16693,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.043025,0.1546,0.1654,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00015331,0.15441,0.16685,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.034636,0.15435,0.14042,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,5.1446e-05,0.15422,0.14368,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.5217e-06,0.15414,0.1895,1,1
1,GO GOLGI RIBBON FORMATION,0.00054518,0.15388,0.19323,1,1
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,7.7586e-05,0.15374,0.1916,1,1
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.031953,0.15369,0.11894,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0014624,0.15349,0.20061,1,1
1,GO LEFT RIGHT PATTERN FORMATION,0.0041031,0.15345,0.19152,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.5359e-06,0.15332,0.14757,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.00080175,0.15331,0.18106,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00091404,0.15315,0.19772,1,1
1,GO RNA INTERFERENCE,0.0062877,0.15295,0.12677,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001955,0.1529,0.18067,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.6457e-05,0.15286,0.21101,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0039481,0.15274,0.13233,1,1
1,GO RESPONSE TO NUTRIENT,0.00041488,0.15265,0.163,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,8.4805e-07,0.1526,0.17549,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.035336,0.15255,0.13098,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0013255,0.15232,0.15057,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0011836,0.1523,0.2704,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0013443,0.15229,0.15286,1,1
1,GO CARNITINE SHUTTLE,0.0025617,0.15228,0.16854,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,5.4184e-05,0.15224,0.14668,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00071283,0.15222,0.18248,1,1
1,GO REGULATION OF LIPID METABOLIC PROCESS,8.4424e-05,0.15202,0.1543,1,1
1,GO POSITIVE REGULATION OF JNK CASCADE,0.001704,0.15196,0.13907,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.020828,0.15194,0.12048,1,1
1,GO TUBE FORMATION,0.00049802,0.15193,0.15922,1,1
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0017517,0.15159,0.15701,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0020367,0.15155,0.1505,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026663,0.1515,0.14886,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00059648,0.15123,0.14396,1,1
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.00044781,0.151,0.1541,1,1
1,GO RNA CATABOLIC PROCESS,1.3599e-06,0.15071,0.15551,1,1
1,GO MESENCHYME DEVELOPMENT,0.00031414,0.15062,0.16701,1,1
1,GO REGULATION OF CELL DEATH,7.6657e-06,0.15062,0.14587,1,1
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00013673,0.15058,0.20264,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0010408,0.15057,0.11232,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.6321e-06,0.1505,0.16439,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,1.0958e-05,0.1505,0.17637,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0095807,0.15016,0.1632,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0024281,0.15014,0.16132,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0089251,0.14971,0.12903,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,2.0879e-07,0.14965,0.15984,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1.1034e-07,0.14952,0.16414,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,7.105e-06,0.14931,0.22949,1,1
1,GO VIRAL BUDDING,0.00073415,0.14915,0.13804,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00012388,0.14908,0.18783,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0093576,0.14876,0.16659,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,9.1829e-05,0.14873,0.12673,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.0853e-05,0.14868,0.18188,1,1
1,GO SPLEEN DEVELOPMENT,0.014494,0.14849,0.11052,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0013826,0.14841,0.13168,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.6761e-05,0.14835,0.16124,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.8001e-06,0.14832,0.15627,1,1
1,GO ENDOCRINE PROCESS,0.00029052,0.1483,0.17137,1,1
1,GO FATTY ACID METABOLIC PROCESS,4.3997e-05,0.14825,0.14873,1,1
1,GO RNA SURVEILLANCE,0.0070192,0.14793,0.10942,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.064418,0.14788,0.11579,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0039992,0.14786,0.16056,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0035146,0.1476,0.13839,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00049802,0.14756,0.17283,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0032501,0.14755,0.18702,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00045468,0.14751,0.14197,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.0057669,0.14745,0.12282,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00076726,0.14706,0.16563,1,1
1,GO REGULATION OF URINE VOLUME,1.7385e-05,0.14706,0.21667,1,1
1,GO HISTONE DEACETYLATION,0.0010408,0.14689,0.11574,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00049053,0.14665,0.18809,1,1
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0038977,0.14662,0.19016,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.4296e-07,0.14659,0.1408,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00049802,0.14658,0.13912,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00013016,0.14658,0.14573,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.0084096,0.14656,0.13296,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,6.0079e-05,0.14635,0.15023,1,1
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.00023667,0.14608,0.14922,1,1
1,GO PROTEIN POLYUBIQUITINATION,1.3056e-06,0.14606,0.15061,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,6.6578e-05,0.14604,0.18727,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0067673,0.14583,0.1437,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.00015583,0.1458,0.26058,1,1
1,GO CELLULAR RESPONSE TO ALCOHOL,0.0028118,0.14579,0.15543,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00035024,0.14577,0.16437,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.019312,0.14564,0.22165,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.012227,0.14558,0.11219,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0084096,0.14557,0.13326,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0011836,0.14554,0.14185,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0044864,0.1455,0.15462,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00024819,0.1454,0.15672,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.2416e-05,0.14535,0.15595,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0023957,0.1453,0.18021,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.0011341,0.14514,0.14567,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.014172,0.14514,0.17428,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.6994e-06,0.14509,0.17038,1,1
1,GO NEPHRON DEVELOPMENT,0.001955,0.14509,0.17662,1,1
1,GO UV PROTECTION,0.046921,0.14492,0.15018,1,1
1,GO MALE SEX DIFFERENTIATION,0.0010408,0.14481,0.14777,1,1
1,GO OSSIFICATION,0.00032916,0.14463,0.16591,1,1
1,GO VACUOLE ORGANIZATION,3.9613e-05,0.14463,0.15315,1,1
1,GO ACTIVATION OF JNKK ACTIVITY,0.0022396,0.14451,0.1826,1,1
1,GO REGULATION OF OSSIFICATION,0.00099681,0.14444,0.17213,1,1
1,GO EPITHELIAL TUBE FORMATION,0.00057029,0.14444,0.16226,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00059648,0.14439,0.14808,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,8.7316e-05,0.14404,0.16677,1,1
1,GO HISTONE MONOUBIQUITINATION,0.0137,0.14404,0.093632,1,1
1,GO MITOCHONDRIAL TRANSCRIPTION,0.038637,0.14397,0.089756,1,1
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0033799,0.14359,0.15277,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0005133,0.14352,0.13509,1,1
1,GO COPII COATED VESICLE BUDDING,9.086e-06,0.14345,0.1644,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0054192,0.14336,0.13855,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,6.1119e-05,0.14336,0.17871,1,1
1,GO PROTEIN SUMOYLATION,0.00011033,0.1433,0.13088,1,1
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.014658,0.14328,0.11517,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.0001179,0.14321,0.15733,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.0013255,0.14319,0.16268,1,1
1,GO EMBRYONIC HEMOPOIESIS,0.043444,0.14301,0.12922,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00082553,0.14293,0.15185,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.032278,0.14293,0.15045,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.1588e-05,0.14284,0.15893,1,1
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0028492,0.14284,0.12295,1,1
1,GO CELL MOTILITY,0.00092737,0.14281,0.13492,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.012367,0.14259,0.17343,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.086e-06,0.14254,0.18286,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.00087508,0.14248,0.19167,1,1
1,GO RESPONSE TO UV,7.3803e-06,0.14247,0.16753,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0012177,0.14221,0.11864,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,9.03e-05,0.14215,0.15568,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.9393e-05,0.14194,0.12912,1,1
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.014494,0.14192,0.11281,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0051547,0.14184,0.1059,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.010645,0.14172,0.15429,1,1
1,GO RIBOSOME ASSEMBLY,0.0037985,0.14164,0.14729,1,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.015329,0.14157,0.11442,1,1
1,GO PROTEIN O LINKED GLYCOSYLATION,0.009139,0.14157,0.12173,1,1
1,GO JNK CASCADE,0.0007786,0.14153,0.12968,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.028852,0.14152,0.12603,1,1
1,GO REGULATION OF JUN KINASE ACTIVITY,0.0039992,0.14139,0.13712,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0012005,0.1413,0.15279,1,1
1,GO PROTEIN IMPORT,3.4773e-06,0.14118,0.15128,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0014022,0.1411,0.15515,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.021973,0.14107,0.15658,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0054872,0.14105,0.15212,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.4184e-05,0.14098,0.15496,1,1
1,GO TUBE DEVELOPMENT,7.7586e-05,0.14093,0.17595,1,1
1,GO SARCOMERE ORGANIZATION,0.017315,0.14087,0.13191,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.004964,0.14079,0.10893,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0090315,0.14079,0.16719,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0019285,0.14056,0.13343,1,1
1,GO PROTEIN MATURATION,3.0395e-05,0.14039,0.13927,1,1
1,GO NUCLEAR MIGRATION,0.064418,0.14029,0.12295,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.3056e-06,0.14005,0.12759,1,1
1,GO SPERM EGG RECOGNITION,0.00026858,0.14005,0.12922,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0005618,0.14004,0.13204,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00019541,0.13999,0.15151,1,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0018006,0.13991,0.14564,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,4.9694e-05,0.13991,0.1245,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.1789e-06,0.13975,0.1703,1,1
1,GO FAT CELL DIFFERENTIATION,0.00044103,0.13971,0.15647,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0011503,0.13936,0.16675,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.05063,0.13935,0.091152,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0022095,0.13929,0.15557,1,1
1,GO LIPID LOCALIZATION,0.00049802,0.13925,0.13802,1,1
1,GO ENDOCYTIC RECYCLING,0.0043737,0.1391,0.13054,1,1
1,GO APICAL JUNCTION ASSEMBLY,0.011949,0.13904,0.15372,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.7534e-07,0.13881,0.1501,1,1
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0061347,0.13856,0.17582,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00044781,0.13835,0.14565,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0095807,0.13815,0.13505,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00064263,0.13808,0.11972,1,1
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.012087,0.13802,0.10203,1,1
1,GO RESPONSE TO STEROL,0.0074579,0.13786,0.15451,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.01251,0.13781,0.093407,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,3.9613e-05,0.13774,0.14362,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,5.4184e-05,0.13758,0.14693,1,1
1,GO RUFFLE ORGANIZATION,7.6283e-05,0.13756,0.16232,1,1
1,GO MIDBODY ABSCISSION,0.00061456,0.13731,0.18569,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.0010259,0.13729,0.18052,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,1.5014e-05,0.13719,0.11652,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,8.3013e-05,0.13716,0.15443,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.00042128,0.13713,0.13969,1,1
1,GO AGING,1.3442e-05,0.13712,0.14496,1,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0033799,0.13711,0.18616,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0083098,0.13701,0.13346,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0027381,0.13699,0.17035,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,2.4972e-05,0.13699,0.1665,1,1
1,GO ENDOSOME ORGANIZATION,2.8814e-05,0.13691,0.15472,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014658,0.13664,0.06473,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.019312,0.13655,0.11389,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.003166,0.13645,0.17593,1,1
1,GO TRNA TRANSPORT,0.0005211,0.13634,0.14121,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,4.5684e-06,0.13629,0.13559,1,1
1,GO VACUOLAR ACIDIFICATION,0.003166,0.13627,0.13012,1,1
1,GO IMPORT INTO NUCLEUS,1.4207e-05,0.13626,0.14808,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00018923,0.13621,0.1769,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.2146e-06,0.13606,0.14341,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00095459,0.13584,0.13145,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,3.5022e-05,0.13582,0.14857,1,1
1,GO NUCLEAR EXPORT,2.2824e-05,0.13575,0.14224,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.063258,0.13572,0.18626,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.4861e-06,0.13566,0.16485,1,1
1,GO GOLGI VESICLE TRANSPORT,1.0004e-06,0.13537,0.15358,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00094089,0.13528,0.18452,1,1
1,GO MAINTENANCE OF LOCATION,2.5424e-05,0.13526,0.15132,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00042777,0.13523,0.12242,1,1
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.011949,0.13519,0.11993,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.017315,0.13511,0.13751,1,1
1,GO ORGANELLE INHERITANCE,0.0075485,0.13505,0.096881,1,1
1,GO DRUG CATABOLIC PROCESS,0.040187,0.13498,0.12188,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0041031,0.13497,0.11592,1,1
1,GO MUSCLE ADAPTATION,0.0054192,0.13474,0.12421,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0052197,0.13462,0.11591,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,2.2015e-05,0.13458,0.16449,1,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.022686,0.13441,0.12476,1,1
1,GO NODAL SIGNALING PATHWAY,0.0094686,0.1344,0.11435,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.9803e-06,0.13432,0.15796,1,1
1,GO RNA LOCALIZATION,7.5001e-05,0.1343,0.13921,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0001862,0.13407,0.1382,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.011678,0.13403,0.11378,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0012005,0.1339,0.16088,1,1
1,GO RESPONSE TO KETONE,0.0010865,0.13388,0.13531,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,8.1623e-05,0.13378,0.13444,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0013255,0.13333,0.13076,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.00022565,0.13311,0.15192,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00015583,0.13289,0.13213,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.9711e-06,0.13261,0.146,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00036686,0.13256,0.18116,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,8.6579e-07,0.13247,0.12485,1,1
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00090088,0.13226,0.13886,1,1
1,GO MRNA TRANSPORT,9.819e-05,0.13222,0.13389,1,1
1,GO XENOBIOTIC TRANSPORT,0.0030436,0.13203,0.15573,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.029754,0.13174,0.11489,1,1
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.058787,0.13169,0.1586,1,1
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.055609,0.13155,0.10269,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0002443,0.13143,0.12524,1,1
1,GO FOLIC ACID METABOLIC PROCESS,0.020828,0.13123,0.11277,1,1
1,GO VIRAL LATENCY,0.051595,0.13114,0.069907,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,2.9332e-05,0.13107,0.15104,1,1
1,GO RNA POLYADENYLATION,0.0059852,0.13097,0.10992,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.00019541,0.13097,0.13119,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.030368,0.13093,0.13648,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,9.6562e-05,0.13093,0.13894,1,1
1,GO ORGAN GROWTH,0.00016361,0.13078,0.18105,1,1
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.022928,0.13057,0.1261,1,1
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.0011021,0.13057,0.12563,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0031247,0.13035,0.13611,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001071,0.12984,0.15255,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,8.1138e-06,0.12973,0.17252,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.3946e-06,0.12959,0.14751,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.4861e-06,0.12958,0.16084,1,1
1,GO LYSOSOMAL TRANSPORT,0.00038422,0.12956,0.1506,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0044298,0.12953,0.10879,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00032408,0.12941,0.16643,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,3.6924e-05,0.12922,0.15203,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.013093,0.12922,0.13953,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,6.545e-05,0.12917,0.14368,1,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0049019,0.12911,0.13197,1,1
1,GO ANION HOMEOSTASIS,0.0022095,0.12898,0.14931,1,1
1,GO HEART MORPHOGENESIS,0.0021215,0.12893,0.14298,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.8363e-05,0.12879,0.12494,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.009139,0.12875,0.11636,1,1
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0137,0.12831,0.13153,1,1
1,GO VACUOLAR TRANSPORT,0.00024045,0.12817,0.13575,1,1
1,GO MITOTIC RECOMBINATION,0.052575,0.12803,0.10214,1,1
1,GO PROTEIN STABILIZATION,0.00015331,0.12798,0.12778,1,1
1,GO P BODY ASSEMBLY,0.01251,0.12798,0.098926,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.018693,0.12795,0.099865,1,1
1,GO RESPONSE TO HEAT,4.4771e-05,0.1278,0.15003,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,6.9711e-06,0.12774,0.12269,1,1
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.021053,0.12772,0.10371,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0037016,0.12727,0.15861,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,2.5884e-05,0.12721,0.12571,1,1
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.037509,0.12718,0.091377,1,1
1,GO REGULATION OF CATABOLIC PROCESS,6.6066e-07,0.1271,0.13818,1,1
1,GO PROTEOLYSIS,7.6657e-06,0.12703,0.13293,1,1
1,GO PEPTIDE METABOLIC PROCESS,6.0991e-06,0.12696,0.12468,1,1
1,GO PIGMENTATION,0.019104,0.12693,0.10011,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0030038,0.12678,0.10125,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.017894,0.12672,0.1024,1,1
1,GO BLASTOCYST GROWTH,0.0005133,0.12668,0.19104,1,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.045591,0.12616,0.10257,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.05063,0.12609,0.10027,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012367,0.12607,0.14383,1,1
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.012798,0.12606,0.15015,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00016629,0.12604,0.14644,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0042095,0.12602,0.10752,1,1
1,GO CELLULAR RESPONSE TO FATTY ACID,0.024687,0.12595,0.12673,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0017277,0.1259,0.11065,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00016098,0.12588,0.15803,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0012527,0.12577,0.1295,1,1
1,GO APOPTOTIC PROCESS,4.1026e-05,0.12575,0.12697,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0037985,0.12574,0.12385,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.045591,0.1256,0.064426,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0001803,0.12548,0.13669,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.043866,0.12538,0.10338,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0023009,0.12533,0.10066,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.0057669,0.12512,0.087522,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00073415,0.12507,0.12809,1,1
1,GO CELLULAR RESPONSE TO RADIATION,4.2271e-06,0.12499,0.15332,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0061347,0.12487,0.13288,1,1
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.043025,0.12464,0.094404,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0037498,0.12456,0.13128,1,1
1,GO ANIMAL ORGAN FORMATION,0.016027,0.12451,0.12616,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.0084096,0.12425,0.10428,1,1
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0022095,0.12404,0.11469,1,1
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00024045,0.12403,0.13367,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0037498,0.12396,0.11204,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00067188,0.12387,0.1034,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00035024,0.12386,0.12967,1,1
1,GO LIPID CATABOLIC PROCESS,0.00040235,0.12386,0.12645,1,1
1,GO RESPONSE TO NITRIC OXIDE,0.015329,0.12384,0.090347,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.8698e-06,0.12381,0.13227,1,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.0058389,0.12372,0.096952,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0022095,0.12343,0.12193,1,1
1,GO RNA 3 END PROCESSING,0.00087508,0.12326,0.10571,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0023957,0.12311,0.11608,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001568,0.1229,0.13555,1,1
1,GO DE NOVO PROTEIN FOLDING,0.03429,0.12282,0.097142,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0033361,0.1228,0.11463,1,1
1,GO NCRNA 3 END PROCESSING,0.0078263,0.12273,0.12734,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,7.8124e-06,0.12256,0.13185,1,1
1,GO NUCLEUS LOCALIZATION,0.036772,0.12252,0.12878,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.8839e-05,0.1225,0.13227,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00049802,0.12247,0.14285,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00063314,0.12236,0.16729,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0010113,0.12229,0.17305,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.013856,0.12221,0.17385,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.001483,0.12207,0.14864,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015249,0.12206,0.097672,1,1
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.029754,0.12124,0.13417,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0037016,0.12121,0.11216,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00013899,0.12117,0.11053,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0039481,0.12093,0.10498,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00031907,0.12063,0.11191,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00018323,0.12056,0.12307,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00068191,0.12054,0.12486,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,6.7105e-06,0.12047,0.11518,1,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013443,0.12045,0.13564,1,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.059879,0.12044,0.069132,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,6.6578e-05,0.12034,0.15505,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00016629,0.12011,0.14519,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,7.105e-06,0.12007,0.12734,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00030449,0.11999,0.13135,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0033361,0.11998,0.14445,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0022095,0.11997,0.12968,1,1
1,GO REGULATION OF RNA BINDING,0.0027747,0.11988,0.13244,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,2.6352e-05,0.11969,0.13178,1,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0037498,0.11954,0.11371,1,1
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.039406,0.11945,0.11447,1,1
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0044864,0.11945,0.11684,1,1
1,GO SNRNA PROCESSING,0.0047798,0.11945,0.17775,1,1
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.0022095,0.11918,0.12596,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.012653,0.11903,0.13058,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00010852,0.11903,0.1397,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,6.1119e-05,0.119,0.132,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0001179,0.11895,0.12942,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.011949,0.11886,0.1243,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00029976,0.11875,0.12956,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0011503,0.11875,0.12972,1,1
1,GO RESPONSE TO DRUG,0.00075607,0.11874,0.12943,1,1
1,GO HYPEROSMOTIC RESPONSE,0.004156,0.11867,0.136,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00016361,0.11855,0.10476,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.00031414,0.11845,0.10027,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.001955,0.11836,0.10788,1,1
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0023637,0.11833,0.14148,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0013255,0.11833,0.1396,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0007786,0.11804,0.12486,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0023957,0.11801,0.12088,1,1
1,GO SNRNA METABOLIC PROCESS,0.0047198,0.11797,0.14175,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.8246e-05,0.11797,0.12003,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092737,0.11783,0.11239,1,1
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0030436,0.1178,0.16072,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0060595,0.11761,0.13637,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.048746,0.11756,0.076842,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0020367,0.11747,0.11644,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00021857,0.11745,0.13313,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.1375e-05,0.11732,0.12346,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0005789,0.11717,0.1303,1,1
1,GO CELL JUNCTION DISASSEMBLY,0.0056958,0.11716,0.18283,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.060432,0.11715,0.070161,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.034984,0.11715,0.081866,1,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.0089251,0.11704,0.11516,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0010408,0.11682,0.10891,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,2.1621e-05,0.11673,0.13592,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.015159,0.11666,0.1003,1,1
1,GO REGULATION OF PROTEIN STABILITY,2.6352e-05,0.11662,0.1281,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00073415,0.11641,0.14379,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,3.2859e-07,0.11576,0.13369,1,1
1,GO LIPID METABOLIC PROCESS,0.0005056,0.11567,0.11852,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,8.4262e-06,0.11562,0.12863,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0014022,0.11554,0.10064,1,1
1,GO DNA MODIFICATION,0.0039992,0.11494,0.094496,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,7.2414e-06,0.1149,0.11862,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0028118,0.11461,0.10792,1,1
1,GO TRANSLATIONAL INITIATION,0.0072795,0.11456,0.12139,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0026663,0.11443,0.12031,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0012177,0.11413,0.12628,1,1
1,GO DNA DEALKYLATION,0.0042095,0.114,0.15172,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0078263,0.11392,0.09195,1,1
1,GO RESPONSE TO PEPTIDE,0.0011503,0.11381,0.11039,1,1
1,GO MRNA CLEAVAGE,0.0012005,0.11381,0.10192,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.037509,0.11378,0.11548,1,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0014022,0.11369,0.13895,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.00040857,0.11356,0.12362,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.015501,0.1134,0.12762,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0098086,0.11317,0.1797,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029645,0.11287,0.092533,1,1
1,GO PEROXISOME ORGANIZATION,0.0005618,0.11282,0.12952,1,1
1,GO TELOMERE ORGANIZATION,0.00026024,0.11241,0.10529,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.02128,0.11235,0.13533,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0053519,0.11226,0.15967,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.0087156,0.11216,0.12846,1,1
1,GO NUCLEAR TRANSPORT,2.1621e-05,0.11209,0.12462,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.011813,0.11199,0.18054,1,1
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0094686,0.11172,0.15474,1,1
1,GO DNA METHYLATION,0.014823,0.11156,0.088335,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0034692,0.11131,0.1629,1,1
1,GO PEROXISOMAL TRANSPORT,0.00091404,0.11124,0.13323,1,1
1,GO CELL CYCLE PHASE TRANSITION,8.3013e-05,0.11083,0.098507,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,8.5858e-05,0.11062,0.10186,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0030839,0.11047,0.12916,1,1
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.026013,0.11043,0.098437,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00010152,0.11028,0.12098,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.014172,0.11005,0.084936,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00030449,0.11005,0.1224,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00070238,0.10991,0.12351,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00043435,0.10985,0.11504,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00059648,0.10973,0.12127,1,1
1,GO SULFATION,0.012653,0.10948,0.1661,1,1
1,GO REGULATION OF AUTOPHAGY,0.00016361,0.1094,0.11632,1,1
1,GO HISTONE UBIQUITINATION,0.028852,0.10932,0.070629,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.042197,0.10913,0.10118,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.01995,0.10907,0.12955,1,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.0018508,0.10901,0.14987,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0080166,0.10901,0.14178,1,1
1,GO GLYCEROLIPID METABOLIC PROCESS,0.00061456,0.10871,0.11831,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.9332e-05,0.10863,0.11143,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.013093,0.10811,0.066475,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.023173,0.10809,0.12157,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.9056e-05,0.10751,0.10234,1,1
1,GO PROTEIN AUTOUBIQUITINATION,0.014823,0.10743,0.081704,1,1
1,GO WHITE FAT CELL DIFFERENTIATION,0.062684,0.10741,0.09295,1,1
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.021973,0.10739,0.12419,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0049019,0.10731,0.11878,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,3.6162e-06,0.10708,0.13275,1,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0045438,0.10703,0.10644,1,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.016027,0.10677,0.097755,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.044722,0.10675,0.094375,1,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.0019819,0.1065,0.11883,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0028118,0.1064,0.12035,1,1
1,GO RUFFLE ASSEMBLY,0.0071051,0.10634,0.11822,1,1
1,GO ENDOSOMAL TRANSPORT,0.00012186,0.1063,0.11996,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.00042777,0.106,0.12874,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0029645,0.10598,0.1033,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.048285,0.10578,0.084662,1,1
1,GO MYOFIBRIL ASSEMBLY,0.055609,0.10565,0.11,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0019023,0.10556,0.1056,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0025617,0.10521,0.10253,1,1
1,GO RESPONSE TO ESTRADIOL,0.0048405,0.10504,0.11542,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.3256e-05,0.1048,0.13678,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0030839,0.10443,0.12439,1,1
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0027381,0.10408,0.10591,1,1
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.062684,0.10389,0.080573,1,1
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.024947,0.10385,0.095069,1,1
1,GO MITOPHAGY,0.0013069,0.10383,0.14815,1,1
1,GO TRANSLESION SYNTHESIS,0.002631,0.1038,0.097992,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0027747,0.10374,0.10996,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0035605,0.10337,0.11801,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0020646,0.10337,0.12222,1,1
1,GO SPINDLE LOCALIZATION,0.015501,0.10332,0.088127,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0012886,0.1033,0.10341,1,1
1,GO POSTREPLICATION REPAIR,0.001483,0.10326,0.093142,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00026024,0.1031,0.13231,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00018323,0.103,0.1172,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00040857,0.10258,0.11947,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.043866,0.10254,0.085442,1,1
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.0030038,0.10219,0.11913,1,1
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.00058763,0.10206,0.12236,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00035024,0.10182,0.12092,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.024687,0.10158,0.098361,1,1
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00022208,0.10153,0.12367,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,8.7316e-05,0.10152,0.11324,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0016806,0.10144,0.11235,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,6.6578e-05,0.10144,0.10157,1,1
1,GO RESPONSE TO ALCOHOL,0.036772,0.10133,0.086445,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00058763,0.10127,0.1115,1,1
1,GO CYTOKINESIS,0.018091,0.10118,0.073123,1,1
1,GO PROTEIN NEDDYLATION,0.027401,0.10112,0.087924,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022209,0.10109,0.093245,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0023009,0.10086,0.11749,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.015674,0.10079,0.079552,1,1
1,GO RNA PROCESSING,0.00040857,0.10063,0.11529,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0019285,0.10028,0.10538,1,1
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.016027,0.10018,0.089213,1,1
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00091404,0.10016,0.12939,1,1
1,GO GENE SILENCING,6.6578e-05,0.099895,0.12084,1,1
1,GO L GLUTAMATE IMPORT,0.059331,0.099767,0.10079,1,1
1,GO RESPONSE TO HORMONE,0.00098255,0.099649,0.11922,1,1
1,GO SIGNAL PEPTIDE PROCESSING,0.060988,0.099527,0.1107,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001704,0.099439,0.095066,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.01995,0.098799,0.12409,1,1
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.00014129,0.098549,0.10524,1,1
1,GO MRNA 3 END PROCESSING,0.0052854,0.098548,0.094161,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00047589,0.098523,0.10984,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00012594,0.098202,0.10932,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0029256,0.097998,0.10563,1,1
1,GO CENTRIOLE ASSEMBLY,0.029754,0.097982,0.081256,1,1
1,GO GOLGI ORGANIZATION,0.0012886,0.097961,0.12333,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.1829e-05,0.097873,0.10407,1,1
1,GO HEART DEVELOPMENT,0.00084997,0.097772,0.13781,1,1
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.022686,0.097734,0.10703,1,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.051595,0.097699,0.075847,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0016806,0.097531,0.10355,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0039992,0.097109,0.11086,1,1
1,GO LACTATION,0.014658,0.097054,0.12483,1,1
1,GO LIPID PHOSPHORYLATION,0.038258,0.096974,0.093621,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.001071,0.096922,0.10024,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.4528e-05,0.096696,0.12901,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0017517,0.096655,0.10343,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.004156,0.096361,0.10745,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0033361,0.096107,0.098899,1,1
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.020166,0.096048,0.10847,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0015463,0.095981,0.10695,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0016347,0.095976,0.11934,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.0005789,0.095749,0.13573,1,1
1,GO REGULATION OF BINDING,0.00044103,0.095538,0.11486,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.022446,0.095475,0.11151,1,1
1,GO REGULATION OF GTPASE ACTIVITY,0.014013,0.095455,0.10339,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.0018764,0.095133,0.12428,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0023637,0.09513,0.11825,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0054872,0.095101,0.10936,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.006444,0.095091,0.11504,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0068504,0.094809,0.096285,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0005211,0.094756,0.10236,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.0070192,0.094613,0.10267,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0022701,0.094508,0.08275,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,4.1751e-05,0.094471,0.12368,1,1
1,GO TRANSLATIONAL TERMINATION,0.0077327,0.094428,0.11588,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0070192,0.094061,0.14894,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,9.4959e-05,0.093944,0.12398,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029645,0.093844,0.091693,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.013093,0.093435,0.15311,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.019735,0.093376,0.099862,1,1
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.017894,0.093273,0.098263,1,1
1,GO OXIDATION REDUCTION PROCESS,0.00054518,0.093264,0.10133,1,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.031953,0.093015,0.086719,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00099681,0.092937,0.12638,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.054582,0.092803,0.093869,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0021505,0.092787,0.11294,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.021509,0.092666,0.10323,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00022927,0.092596,0.1154,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0012005,0.092555,0.093096,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00042777,0.092489,0.10448,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0013255,0.092444,0.095873,1,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.016938,0.09236,0.082467,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.028556,0.091969,0.091603,1,1
1,GO CELL DIVISION,0.0059852,0.091883,0.076349,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0012886,0.091353,0.087705,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0022396,0.091314,0.10024,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.065596,0.091307,0.076394,1,1
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.061549,0.091169,0.081983,1,1
1,GO CELLULAR SENESCENCE,0.0005056,0.091116,0.12925,1,1
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.0098086,0.0909,0.094653,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.026286,0.09047,0.089527,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.01128,0.09023,0.11832,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.018091,0.090158,0.081793,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0041031,0.090036,0.15102,1,1
1,GO MACROAUTOPHAGY,2.1621e-05,0.089792,0.12902,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.002702,0.08943,0.098019,1,1
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0038478,0.089114,0.090294,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0025617,0.088946,0.094876,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.8305e-05,0.088918,0.11226,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0023321,0.088905,0.10665,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.01849,0.088808,0.096845,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.7316e-05,0.088036,0.11563,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.016205,0.087956,0.075162,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00031907,0.087937,0.099299,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.00040857,0.087791,0.084315,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0010259,0.087733,0.10235,1,1
1,GO MRNA METABOLIC PROCESS,0.00047589,0.086735,0.10083,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022701,0.086668,0.094444,1,1
1,GO RNA STABILIZATION,0.037882,0.086609,0.075291,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0028872,0.086543,0.094716,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.017894,0.086318,0.09502,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.011544,0.0863,0.065874,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0104,0.086253,0.079657,1,1
1,GO REGULATION OF MYELINATION,0.044722,0.086202,0.098243,1,1
1,GO AMP METABOLIC PROCESS,0.031311,0.086079,0.14709,1,1
1,GO RESPONSE TO ACTIVITY,0.060988,0.085887,0.077125,1,1
1,GO HORMONE METABOLIC PROCESS,0.020166,0.085535,0.08899,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.015159,0.085527,0.085213,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.013394,0.085064,0.13256,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.003166,0.084833,0.093701,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.001483,0.084577,0.1021,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0075485,0.084511,0.083257,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0046018,0.084332,0.072014,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00040857,0.083922,0.10911,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.012367,0.083911,0.08571,1,1
1,GO CELL VOLUME HOMEOSTASIS,0.011022,0.083892,0.11595,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0023009,0.083664,0.13289,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.010645,0.083647,0.06294,1,1
1,GO NUCLEUS ORGANIZATION,0.0074579,0.083646,0.085052,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0028492,0.083415,0.090388,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.0048405,0.083194,0.10384,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.00022208,0.082597,0.092277,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.0030839,0.082107,0.090485,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.002631,0.081941,0.08792,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.030994,0.081845,0.048,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.019735,0.08171,0.090526,1,1
1,GO DNA GEOMETRIC CHANGE,0.0046018,0.080748,0.089587,1,1
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.010645,0.08066,0.087099,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.021509,0.080612,0.10696,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00040857,0.080334,0.081943,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.016568,0.079935,0.095628,1,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.051111,0.079859,0.095976,1,1
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.012227,0.079822,0.094779,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0059116,0.079611,0.076922,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00010497,0.079419,0.093756,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0078263,0.079389,0.11575,1,1
1,GO MUSCLE TISSUE DEVELOPMENT,0.058247,0.078647,0.076681,1,1
1,GO PROTEIN TETRAMERIZATION,0.0067673,0.078559,0.092903,1,1
1,GO HISTONE H3 ACETYLATION,0.049681,0.078469,0.063683,1,1
1,GO CELL CYCLE ARREST,0.033271,0.078416,0.062188,1,1
1,GO REGULATION OF DNA REPAIR,0.032607,0.078094,0.056069,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.011411,0.0779,0.11407,1,1
1,GO CYTOSKELETON ORGANIZATION,0.019312,0.077839,0.082003,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0020646,0.077684,0.097982,1,1
1,GO DNA RECOMBINATION,0.0056255,0.077623,0.078333,1,1
1,GO ORGANELLE DISASSEMBLY,0.0054872,0.077233,0.085276,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.046921,0.077143,0.047691,1,1
1,GO SPECIFICATION OF SYMMETRY,0.036048,0.076598,0.073943,1,1
1,GO MIRNA METABOLIC PROCESS,0.0055559,0.076223,0.12374,1,1
1,GO VITAMIN METABOLIC PROCESS,0.018091,0.075731,0.091799,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0057669,0.075577,0.083352,1,1
1,GO RESPONSE TO INSULIN,0.023419,0.07545,0.085484,1,1
1,GO MITOTIC CELL CYCLE,0.00072342,0.075397,0.082525,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0015249,0.073859,0.084902,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0059852,0.073524,0.11931,1,1
1,GO CELL CYCLE CHECKPOINT,0.012227,0.072966,0.06334,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.033948,0.072536,0.07233,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.012227,0.072427,0.076694,1,1
1,GO REGULATION OF CELL DIVISION,0.017506,0.072339,0.086039,1,1
1,GO DNA METABOLIC PROCESS,0.00099681,0.072012,0.070647,1,1
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.041789,0.071333,0.10323,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023173,0.071238,0.11069,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0027747,0.07081,0.095733,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.033948,0.070148,0.072354,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0012527,0.069774,0.090229,1,1
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.024687,0.069363,0.064929,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.020605,0.069237,0.062023,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0087156,0.068555,0.078265,1,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.036772,0.067205,0.067646,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00055343,0.067152,0.088234,1,1
1,GO REGULATION OF CELL CYCLE,0.002702,0.066792,0.068495,1,1
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.042609,0.066724,0.10256,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0104,0.066335,0.06776,1,1
1,GO RESPONSE TO RADIATION,0.0055559,0.066263,0.077451,1,1
1,GO CELL CYCLE PROCESS,0.0024281,0.065915,0.067187,1,1
1,GO SNRNA TRANSCRIPTION,0.026561,0.065267,0.070935,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0018508,0.065131,0.068345,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0022396,0.064875,0.10129,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.01016,0.064809,0.077254,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.046474,0.064603,0.058414,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.031631,0.064022,0.087355,1,1
1,GO CYTOSOLIC TRANSPORT,0.021053,0.06389,0.083915,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.048285,0.063573,0.063461,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.055609,0.06253,0.086754,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.019312,0.062212,0.064367,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.037139,0.061398,0.06896,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.010522,0.061389,0.13988,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0032078,0.061213,0.088536,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0062877,0.060598,0.082626,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0025277,0.060499,0.070927,1,1
1,GO CHROMOSOME SEGREGATION,0.056128,0.059797,0.03352,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0043184,0.058578,0.068776,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.031953,0.058406,0.081105,1,1
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.051595,0.058315,0.072809,1,1
1,GO NCRNA TRANSCRIPTION,0.046921,0.058281,0.064957,1,1
1,GO PROTEIN TARGETING,0.0070192,0.058085,0.075027,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.036772,0.057731,0.085025,1,1
1,GO MACROMOLECULE DEACYLATION,0.039795,0.056905,0.065743,1,1
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.027973,0.056768,0.069891,1,1
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.058787,0.05657,0.079853,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0022396,0.056044,0.10773,1,1
1,GO CELL CYCLE,0.0026663,0.056011,0.064253,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.019523,0.055859,0.08506,1,1
1,GO REGULATION OF DNA REPLICATION,0.033271,0.053228,0.069049,1,1
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.058787,0.053069,0.066222,1,1
1,GO INTRACELLULAR TRANSPORT,0.0039992,0.052593,0.069202,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.033271,0.05184,0.074073,1,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.052575,0.051753,0.064607,1,1
1,GO PROTEIN FOLDING,0.022928,0.051702,0.1012,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.042609,0.05159,0.046488,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.022686,0.051389,0.064512,1,1
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02128,0.051252,0.063213,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05357,0.050566,0.066343,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.056652,0.048019,0.051201,1,1
1,GO BLASTOCYST DEVELOPMENT,0.053071,0.04787,0.053526,1,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.043444,0.047078,0.059979,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.024173,0.044684,0.056678,1,1
1,GO DNA REPAIR,0.01585,0.044362,0.053629,1,1
1,GO DNA CONFORMATION CHANGE,0.059331,0.043945,0.041745,1,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.05357,0.04249,0.04664,1,1
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,5.5412e-06,0.44724,0.41916,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,2.2416e-05,0.40938,0.40708,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.7999e-05,0.39678,0.39162,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00029511,0.38641,0.31615,1,0
1,GO ALPHA BETA T CELL PROLIFERATION,4.1026e-05,0.37868,0.30255,1,0
1,GO RESPONSE TO TUMOR CELL,6.4341e-05,0.35524,0.29685,1,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0018764,0.34586,0.31697,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00044103,0.34254,0.31466,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.9361e-06,0.34189,0.35229,1,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.006444,0.33558,0.25138,1,0
1,GO PROSTATE GLAND DEVELOPMENT,2.1624e-06,0.3312,0.38394,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0053519,0.32225,0.27032,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.4163e-06,0.31306,0.2921,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0002117,0.30998,0.30727,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,4.9361e-06,0.3093,0.29179,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00023294,0.30172,0.22908,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.6202e-07,0.29364,0.30972,1,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,6.0079e-05,0.29351,0.31431,1,0
1,GO PROSTATIC BUD FORMATION,0.0037016,0.29142,0.29424,1,0
1,GO AMYLOID FIBRIL FORMATION,0.0017277,0.29053,0.27854,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.00036686,0.2894,0.30754,1,0
1,GO NEGATIVE T CELL SELECTION,4.6359e-05,0.28384,0.25953,1,0
1,GO GAP JUNCTION ASSEMBLY,6.3249e-05,0.28199,0.31175,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0005789,0.27352,0.25941,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,5.5412e-06,0.27191,0.3193,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00016098,0.27102,0.24295,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.8793e-06,0.26673,0.30071,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,3.0156e-07,0.26373,0.26544,1,0
1,GO PROTEIN OXIDATION,0.0026663,0.26308,0.27883,1,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00026024,0.26212,0.26236,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00083767,0.25791,0.23666,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,8.3013e-05,0.25591,0.23796,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00075607,0.25457,0.23354,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.6129e-06,0.25325,0.25548,1,0
1,GO RENAL ABSORPTION,0.013394,0.25315,0.25763,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.00012804,0.25105,0.30791,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00067188,0.2508,0.21456,1,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.060988,0.24944,0.20062,1,0
1,GO CELL KILLING,8.7502e-06,0.24826,0.24108,1,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.011678,0.24682,0.29321,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,5.9056e-05,0.24544,0.28575,1,0
1,GO REGULATION OF PLATELET AGGREGATION,0.030994,0.24395,0.19735,1,0
1,GO EPIDERMIS MORPHOGENESIS,0.010279,0.24311,0.25831,1,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00016361,0.2423,0.25877,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,1.2482e-05,0.24225,0.24841,1,0
1,GO PHAGOCYTOSIS RECOGNITION,4.5558e-05,0.24084,0.30583,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,5.8262e-07,0.23713,0.27125,1,0
1,GO REGULATION OF CELL CELL ADHESION,3.4098e-06,0.23054,0.23687,1,0
1,GO STEROID ESTERIFICATION,0.0054192,0.22885,0.17496,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,2.5359e-06,0.22778,0.25503,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034243,0.22599,0.2358,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.9228e-07,0.22406,0.25083,1,0
1,GO OLIGOPEPTIDE TRANSPORT,0.00046165,0.22348,0.24905,1,0
1,GO TISSUE REMODELING,0.00016629,0.222,0.22002,1,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.0052854,0.22183,0.2735,1,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.054582,0.2214,0.2222,1,0
1,GO RESPONSE TO THYROID HORMONE,0.00035024,0.22007,0.25458,1,0
1,GO INTERLEUKIN 12 PRODUCTION,7.1274e-05,0.21973,0.23395,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,5.0563e-05,0.21966,0.24706,1,0
1,GO URETER DEVELOPMENT,0.00034485,0.21956,0.23287,1,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.023668,0.21895,0.20222,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.022686,0.21866,0.18796,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.028556,0.21833,0.25598,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,3.4409e-05,0.21739,0.26761,1,0
1,GO LEUKOCYTE HOMEOSTASIS,1.5674e-06,0.21637,0.23776,1,0
1,GO INTERLEUKIN 6 PRODUCTION,0.00058763,0.21357,0.18904,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.018898,0.2129,0.14625,1,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.03006,0.21098,0.31361,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0066851,0.21013,0.13787,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00064263,0.20835,0.23188,1,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0061347,0.20789,0.24291,1,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.024947,0.20541,0.17487,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.026561,0.20334,0.19475,1,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.0068504,0.20232,0.23983,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,1.9393e-05,0.1995,0.19953,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00073415,0.19931,0.23182,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0092477,0.19864,0.22809,1,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.025743,0.19838,0.18617,1,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0023009,0.19736,0.15821,1,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0067673,0.19586,0.29216,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00074504,0.19524,0.19545,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00021511,0.19501,0.18717,1,0
1,GO METANEPHROS DEVELOPMENT,2.2015e-05,0.19435,0.22136,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.0033361,0.19429,0.18269,1,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0025277,0.19399,0.25202,1,0
1,GO EOSINOPHIL MIGRATION,0.0034692,0.19373,0.23431,1,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.010769,0.19131,0.13236,1,0
1,GO B CELL DIFFERENTIATION,1.0557e-05,0.19077,0.23031,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.02945,0.19029,0.17895,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,8.1623e-05,0.18345,0.19769,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.036772,0.18297,0.13017,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,2.342e-06,0.18155,0.19627,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.0087156,0.18096,0.16256,1,0
1,GO BONE MORPHOGENESIS,3.2631e-05,0.17985,0.23835,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.026561,0.17892,0.19969,1,0
1,GO ICOSANOID METABOLIC PROCESS,0.001442,0.17767,0.18335,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.003654,0.17622,0.23219,1,0
1,GO MIDGUT DEVELOPMENT,0.0067673,0.17472,0.20674,1,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.056128,0.17364,0.1547,1,0
1,GO B CELL PROLIFERATION,0.0012886,0.17308,0.18577,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,4.3997e-05,0.17212,0.23403,1,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0069343,0.17195,0.21984,1,0
1,GO HINDLIMB MORPHOGENESIS,0.022686,0.17168,0.15155,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.5576e-05,0.17131,0.19423,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0055559,0.17083,0.20256,1,0
1,GO CHOLESTEROL STORAGE,0.001422,0.17081,0.26452,1,0
1,GO INTERLEUKIN 4 PRODUCTION,9.4959e-05,0.16956,0.21388,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00044103,0.16895,0.15012,1,0
1,GO ETHER METABOLIC PROCESS,0.00029511,0.16828,0.22197,1,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0023321,0.16811,0.16909,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00035024,0.16642,0.22171,1,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00046872,0.16562,0.15563,1,0
1,GO STEROL HOMEOSTASIS,0.00039622,0.16455,0.20612,1,0
1,GO RESPONSE TO CADMIUM ION,0.0084096,0.16376,0.15477,1,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0048405,0.16348,0.2258,1,0
1,GO SUPEROXIDE ANION GENERATION,0.0044298,0.16327,0.19055,1,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.015501,0.16307,0.18023,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.028264,0.16171,0.12839,1,0
1,GO REGULATION OF HAIR CYCLE,0.00016901,0.1613,0.22969,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0011668,0.16075,0.14784,1,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.028264,0.15995,0.12324,1,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.0010259,0.15882,0.27327,1,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00025617,0.1582,0.20708,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0070192,0.15788,0.16604,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.00041488,0.15729,0.21187,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0048405,0.15719,0.19577,1,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.02174,0.15681,0.23817,1,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.054582,0.15677,0.12426,1,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.037139,0.15657,0.11208,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.040981,0.15636,0.16633,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0012177,0.15527,0.15415,1,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.019523,0.15485,0.14836,1,0
1,GO REGULATION OF ANOIKIS,0.016752,0.15452,0.18183,1,0
1,GO PRO B CELL DIFFERENTIATION,0.047372,0.15437,0.16747,1,0
1,GO O GLYCAN PROCESSING,0.013394,0.15341,0.15101,1,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0023957,0.15309,0.1832,1,0
1,GO RRNA TRANSCRIPTION,0.0021505,0.14911,0.156,1,0
1,GO TISSUE HOMEOSTASIS,0.0014624,0.14879,0.12531,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0066851,0.14873,0.15593,1,0
1,GO REGULATION OF TISSUE REMODELING,0.011678,0.14744,0.13981,1,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.066192,0.1474,0.13419,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00096848,0.14708,0.12683,1,0
1,GO OSTEOBLAST PROLIFERATION,0.013243,0.14657,0.19789,1,0
1,GO BONE REMODELING,0.0020092,0.14579,0.17223,1,0
1,GO CELL CELL ADHESION,0.0054192,0.14491,0.12954,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0016347,0.14444,0.1747,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.036772,0.14444,0.11956,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,6.2169e-06,0.14291,0.17224,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.00026858,0.14265,0.17603,1,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.017699,0.14226,0.14715,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.033608,0.14198,0.16634,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.009139,0.14178,0.23964,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.013394,0.14143,0.20299,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.017699,0.14131,0.18649,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.034636,0.14057,0.1248,1,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0011836,0.13994,0.17845,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.3442e-05,0.13869,0.1601,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0027747,0.1381,0.13902,1,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0023321,0.13744,0.15937,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0039992,0.13668,0.15821,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0001179,0.13612,0.15348,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0073682,0.1344,0.14285,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.010279,0.13395,0.12068,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.000286,0.1331,0.14371,1,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.05357,0.13297,0.096384,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0016575,0.13294,0.16887,1,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.039795,0.13258,0.14167,1,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021798,0.13193,0.19705,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.015674,0.13177,0.12215,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.009139,0.13161,0.19428,1,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0012886,0.13133,0.17547,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.00062378,0.13099,0.17085,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0067673,0.13095,0.15804,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0049019,0.129,0.1537,1,0
1,GO REGULATION OF MAPK CASCADE,7.7586e-05,0.12883,0.15161,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0071051,0.12857,0.18836,1,0
1,GO DRUG METABOLIC PROCESS,0.010895,0.12821,0.12906,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.5858e-05,0.12819,0.13679,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00015083,0.12816,0.15762,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0013255,0.12719,0.19516,1,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0094686,0.12681,0.11743,1,0
1,GO EPITHELIUM DEVELOPMENT,0.0027747,0.12666,0.12619,1,0
1,GO RESPONSE TO INTERLEUKIN 6,0.015159,0.1264,0.13677,1,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.011949,0.12629,0.13046,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00099681,0.12628,0.14546,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.001568,0.12574,0.17695,1,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.019523,0.12566,0.14854,1,0
1,GO GLIAL CELL PROLIFERATION,0.057711,0.12551,0.10743,1,0
1,GO RENAL TUBULE DEVELOPMENT,0.02945,0.1255,0.14042,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.065005,0.12506,0.14458,1,0
1,GO INTEGRIN ACTIVATION,0.0016575,0.12497,0.19321,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.045591,0.12449,0.14268,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.009139,0.12423,0.13723,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00030449,0.12322,0.14724,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0098086,0.12287,0.13146,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00018323,0.12206,0.18176,1,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.036772,0.12096,0.10466,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.004156,0.12085,0.15353,1,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.063258,0.12054,0.18604,1,0
1,GO B CELL APOPTOTIC PROCESS,0.0045438,0.12021,0.17103,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,6.3249e-05,0.11999,0.1806,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.027686,0.11995,0.12473,1,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.020828,0.11961,0.097202,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.023419,0.11958,0.15003,1,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0058389,0.11921,0.1493,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.017315,0.11918,0.095536,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.0073682,0.11914,0.14977,1,0
1,GO RENAL FILTRATION,0.035336,0.11854,0.22149,1,0
1,GO MOLTING CYCLE,0.016938,0.11776,0.13545,1,0
1,GO PHOSPHOLIPID TRANSPORT,0.046031,0.1177,0.10465,1,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.063836,0.11746,0.1552,1,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0046018,0.11735,0.13551,1,0
1,GO REGULATION OF CENTRIOLE REPLICATION,0.040981,0.1171,0.083406,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,6.7724e-05,0.11699,0.13681,1,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0048405,0.11681,0.16843,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00070238,0.1168,0.15961,1,0
1,GO SULFUR COMPOUND TRANSPORT,0.0010558,0.11607,0.13124,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.027686,0.11564,0.14595,1,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.037139,0.11542,0.12732,1,0
1,GO SCHWANN CELL DIFFERENTIATION,0.029754,0.11486,0.11068,1,0
1,GO MACROPHAGE ACTIVATION,0.0042636,0.11479,0.16031,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0062108,0.1146,0.16246,1,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.011813,0.11364,0.11331,1,0
1,GO CELLULAR RESPONSE TO DRUG,0.0019023,0.11196,0.12125,1,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.02521,0.11088,0.14888,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00026438,0.11077,0.13077,1,0
1,GO HEPARIN METABOLIC PROCESS,0.0077327,0.11056,0.22395,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0022095,0.10946,0.11011,1,0
1,GO ANOIKIS,0.05357,0.10937,0.12337,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.049681,0.10782,0.10127,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0017517,0.10772,0.14083,1,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.052575,0.10668,0.0955,1,0
1,GO BONE RESORPTION,0.0037016,0.10646,0.16025,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.060432,0.10607,0.12236,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.066192,0.10589,0.118,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0067673,0.10587,0.11827,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00040235,0.10582,0.12127,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0048405,0.10575,0.11282,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0012005,0.10547,0.14869,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.020605,0.10512,0.1073,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0067673,0.1045,0.14506,1,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.054582,0.10442,0.096376,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00086244,0.10429,0.1111,1,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.051595,0.10381,0.085107,1,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.021509,0.1038,0.18516,1,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.029754,0.10293,0.10837,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.0071051,0.10286,0.13949,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0080166,0.10238,0.14818,1,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0080166,0.10227,0.076887,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00032916,0.1022,0.12254,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.02521,0.10173,0.14103,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.046474,0.10113,0.081062,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.037139,0.10095,0.096944,1,0
1,GO RESPONSE TO GONADOTROPIN,0.01829,0.10043,0.14583,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00094089,0.10014,0.10598,1,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.020166,0.099484,0.10662,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.011678,0.09859,0.11213,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010113,0.098322,0.12439,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.017315,0.098096,0.11025,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0024941,0.097052,0.1475,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.045155,0.096787,0.18742,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0024941,0.096276,0.10709,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0045438,0.096142,0.10507,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0050904,0.095342,0.17858,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.01829,0.094615,0.11641,1,0
1,GO STEROL METABOLIC PROCESS,0.01016,0.094473,0.10861,1,0
1,GO LYTIC VACUOLE ORGANIZATION,0.05063,0.094222,0.088693,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.032938,0.093554,0.09131,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00058763,0.093227,0.11519,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00029052,0.092707,0.123,1,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.037139,0.092424,0.075643,1,0
1,GO ALCOHOL METABOLIC PROCESS,0.0018256,0.092234,0.11698,1,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.066192,0.092099,0.084856,1,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.065005,0.092031,0.097815,1,0
1,GO PROTEIN DESTABILIZATION,0.016027,0.091976,0.10822,1,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.051111,0.09196,0.21145,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.025743,0.091153,0.1367,1,0
1,GO THIOESTER METABOLIC PROCESS,0.0013826,0.090875,0.1462,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.046031,0.09067,0.11915,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019523,0.090357,0.084241,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.017699,0.089867,0.19996,1,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0032501,0.089405,0.11069,1,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.053071,0.08919,0.089845,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.046474,0.088883,0.11526,1,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.024947,0.088529,0.11594,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0023321,0.088376,0.10387,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0050904,0.088259,0.10043,1,0
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.019735,0.087548,0.10717,1,0
1,GO REGULATION OF CHROMOSOME SEPARATION,0.01829,0.086248,0.066707,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.017699,0.085955,0.092146,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0068504,0.084977,0.090084,1,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.062114,0.084606,0.098627,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.060432,0.084352,0.093125,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.045155,0.084251,0.17485,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.040187,0.083969,0.074558,1,0
1,GO AMINE METABOLIC PROCESS,0.0070192,0.083708,0.086913,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.010279,0.083418,0.086227,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.027118,0.083248,0.095625,1,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.033271,0.082876,0.10035,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.016568,0.082358,0.086735,1,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.022209,0.082342,0.085437,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.034636,0.081722,0.14753,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.03902,0.081604,0.11732,1,0
1,GO PROSTAGLANDIN SECRETION,0.050154,0.081342,0.11326,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.039406,0.080711,0.14942,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.02521,0.080472,0.096493,1,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.056128,0.080296,0.10156,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0078263,0.079211,0.11567,1,0
1,GO VESICLE ORGANIZATION,0.015674,0.078401,0.086135,1,0
1,GO STEROID METABOLIC PROCESS,0.0088198,0.077803,0.09649,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.022209,0.077661,0.094604,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0015463,0.077519,0.10495,1,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.040582,0.076497,0.091731,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.027686,0.075599,0.15964,1,0
1,GO POSITIVE REGULATION OF SIGNALING,0.010041,0.07533,0.084592,1,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.014494,0.074933,0.12141,1,0
1,GO POSITIVE REGULATION OF BINDING,0.0066039,0.074645,0.096664,1,0
1,GO CYTOPLASMIC TRANSLATION,0.026013,0.07448,0.099896,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.010895,0.07382,0.089953,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.01849,0.073559,0.08616,1,0
1,GO REGULATION OF ENDOCYTOSIS,0.030994,0.073547,0.089644,1,0
1,GO MRNA EXPORT FROM NUCLEUS,0.01251,0.073299,0.079406,1,0
1,GO ACTIN NUCLEATION,0.013243,0.073151,0.086996,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0104,0.072894,0.091488,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.041383,0.072408,0.10254,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0022396,0.071534,0.12606,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0085105,0.070864,0.091944,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.017699,0.070401,0.085847,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.061549,0.06934,0.074279,1,0
1,GO SECRETION,0.046031,0.069154,0.072162,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.043444,0.068888,0.093936,1,0
1,GO T CELL LINEAGE COMMITMENT,0.057711,0.068559,0.11142,1,0
1,GO METAPHASE PLATE CONGRESSION,0.052575,0.06845,0.043834,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.055609,0.068263,0.077797,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0012177,0.067747,0.099789,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.016386,0.067147,0.084539,1,0
1,GO MEMBRANE ORGANIZATION,0.017699,0.067002,0.075239,1,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.02945,0.066952,0.069646,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0080166,0.066759,0.082226,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.018091,0.066753,0.082157,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.033948,0.066412,0.09944,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.05357,0.06539,0.078822,1,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.063258,0.064984,0.091671,1,0
1,GO EMBRYO DEVELOPMENT,0.0080166,0.064731,0.094005,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.036048,0.064498,0.09197,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0047798,0.061545,0.086199,1,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.016752,0.061374,0.078207,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.012367,0.060914,0.080336,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.056128,0.060689,0.075437,1,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.065005,0.060628,0.077573,1,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0043737,0.060104,0.095938,1,0
1,GO RNA CAPPING,0.027973,0.060062,0.064233,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.046921,0.059681,0.13234,1,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0057669,0.059444,0.11963,1,0
1,GO CHROMOSOME SEPARATION,0.052083,0.059261,0.049625,1,0
1,GO TRANSLATIONAL ELONGATION,0.043866,0.058566,0.078548,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.013546,0.05611,0.086207,1,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.066192,0.055829,0.079353,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.010895,0.055123,0.081167,1,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.052575,0.052694,0.074113,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.057179,0.05106,0.064801,1,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.066192,0.049853,0.061568,1,0
1,GO REGULATION OF CENTROSOME CYCLE,0.025743,0.048905,0.069433,1,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.026838,0.048413,0.05698,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.060432,0.047838,0.065888,1,0
1,GO SEQUESTERING OF CALCIUM ION,0.043444,0.04745,0.097014,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.038258,0.045987,0.04186,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.033271,0.045696,0.091232,1,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.036409,0.044809,0.081095,1,0
1,GO PROTEIN POLYMERIZATION,0.059879,0.042589,0.063644,1,0
1,GO HOMEOSTATIC PROCESS,0.044722,0.041962,0.061978,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.037882,0.041541,0.075944,1,0
1,GO IRON ION TRANSPORT,0.053071,0.035694,0.074598,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.056652,0.035069,0.058124,1,0
1,GO CARNITINE METABOLIC PROCESS,0.03068,0.030794,0.15669,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.047372,0.027693,0.051298,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.043444,0.022171,0.069692,1,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.057179,-0.02088,-0.17898,1,0
1,GO SINGLE FERTILIZATION,0.059879,-0.03577,-0.051411,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.019104,-0.041739,-0.08318,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.049681,-0.053049,-0.053254,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.023419,-0.053288,-0.06857,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.065596,-0.05372,-0.047756,1,0
1,GO CELL PROJECTION ORGANIZATION,0.055093,-0.055857,-0.043004,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.037509,-0.058178,-0.084533,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0137,-0.058698,-0.1145,1,0
1,GO SENSORY PERCEPTION,0.0044864,-0.060614,-0.076363,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.065596,-0.061089,-0.095475,1,0
1,GO HINDBRAIN MORPHOGENESIS,0.045155,-0.061589,-0.076393,1,0
1,GO DETECTION OF STIMULUS,0.02915,-0.062385,-0.05128,1,0
1,GO OOCYTE DIFFERENTIATION,0.042609,-0.063892,-0.084368,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.017894,-0.064599,-0.080678,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.042609,-0.065055,-0.036619,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.059331,-0.067648,-0.15209,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.057711,-0.067718,-0.0537,1,0
1,GO NEURON PROJECTION GUIDANCE,0.056128,-0.067892,-0.089796,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.064418,-0.068838,-0.072585,1,0
1,GO REGULATION OF TORC1 SIGNALING,0.062114,-0.068927,-0.06031,1,0
1,GO REGULATION OF NEURON MIGRATION,0.065005,-0.069491,-0.10875,1,0
1,GO CIRCADIAN RHYTHM,0.011678,-0.069955,-0.063246,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.036772,-0.073156,-0.056494,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.010522,-0.07354,-0.14153,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.03902,-0.073713,-0.12316,1,0
1,GO MEMBRANE DOCKING,0.03902,-0.073868,-0.051129,1,0
1,GO STRIATED MUSCLE CONTRACTION,0.015674,-0.074566,-0.085036,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.045155,-0.076047,-0.10754,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.037882,-0.076948,-0.07855,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.057711,-0.077023,-0.055445,1,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.060432,-0.079621,-0.062972,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.044722,-0.080419,-0.075273,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.041383,-0.080741,-0.088092,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.021509,-0.081592,-0.05992,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.015329,-0.082358,-0.062546,1,0
1,GO RESPONSE TO AMINE,0.019523,-0.083012,-0.10371,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.047372,-0.083205,-0.051167,1,0
1,GO TRANSPORT ALONG MICROTUBULE,0.049212,-0.08354,-0.063183,1,0
1,GO CELL CELL SIGNALING,0.00083767,-0.084678,-0.084968,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.020385,-0.085416,-0.071974,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.02128,-0.085487,-0.10614,1,0
1,GO REGULATION OF HORMONE LEVELS,0.0037016,-0.08621,-0.088293,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.020385,-0.087022,-0.084307,1,0
1,GO ACID SECRETION,0.007921,-0.087096,-0.092257,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.022209,-0.088289,-0.068227,1,0
1,GO ION TRANSPORT,0.0071918,-0.088579,-0.061573,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.065005,-0.088831,-0.072205,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.03006,-0.088849,-0.053051,1,0
1,GO NEUROGENESIS,0.0057669,-0.089172,-0.082085,1,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.028556,-0.089641,-0.086394,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.025743,-0.089848,-0.055906,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.0099244,-0.090131,-0.1121,1,0
1,GO EXPLORATION BEHAVIOR,0.055609,-0.090298,-0.14306,1,0
1,GO HEAT GENERATION,0.045591,-0.090607,-0.099096,1,0
1,GO CGMP MEDIATED SIGNALING,0.065596,-0.090629,-0.087075,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.0035605,-0.090764,-0.13385,1,0
1,GO DETECTION OF LIGHT STIMULUS,0.00086244,-0.09078,-0.11627,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.010522,-0.091057,-0.11022,1,0
1,GO AXON DEVELOPMENT,0.0078263,-0.091246,-0.10651,1,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.060432,-0.091261,-0.087274,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.013856,-0.091438,-0.064965,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.014172,-0.091472,-0.077092,1,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.0012177,-0.09199,-0.12233,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.062684,-0.092802,-0.056681,1,0
1,GO RESPONSE TO MONOSACCHARIDE,0.020385,-0.092851,-0.050219,1,0
1,GO MICROTUBULE BASED MOVEMENT,0.05357,-0.093973,-0.066322,1,0
1,GO REGULATION OF APPETITE,0.00046165,-0.094166,-0.12773,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.016568,-0.09459,-0.078616,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0019285,-0.094741,-0.11002,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.0027381,-0.095203,-0.10072,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.024947,-0.09604,-0.12987,1,0
1,GO REGULATION OF ANION TRANSPORT,0.02521,-0.096654,-0.072694,1,0
1,GO AXO DENDRITIC TRANSPORT,0.0052854,-0.097029,-0.11062,1,0
1,GO REGULATION OF HEART RATE,0.0024281,-0.097898,-0.13649,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00092737,-0.098134,-0.11302,1,0
1,GO AXONAL FASCICULATION,0.0104,-0.098796,-0.24727,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.049212,-0.098949,-0.080844,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.034984,-0.099034,-0.08308,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.031631,-0.099225,-0.12484,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.021509,-0.099829,-0.09052,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.017894,-0.10068,-0.092213,1,0
1,GO CELL MATURATION,0.0034243,-0.10194,-0.082895,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.043025,-0.1029,-0.13885,1,0
1,GO HEART PROCESS,0.0016575,-0.10329,-0.10385,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0012527,-0.10331,-0.1267,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.043025,-0.10332,-0.088381,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.016752,-0.10401,-0.075157,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.058247,-0.10424,-0.079208,1,0
1,GO HEAD DEVELOPMENT,0.0018508,-0.10462,-0.099039,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.017315,-0.10529,-0.10165,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0041031,-0.10537,-0.10905,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00090088,-0.1056,-0.084243,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.025743,-0.10584,-0.068179,1,0
1,GO PROTEIN DEPOLYMERIZATION,0.0024281,-0.10825,-0.093849,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.061549,-0.10927,-0.049261,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0099244,-0.10959,-0.11712,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0025277,-0.11046,-0.1203,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.047372,-0.11129,-0.06233,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.024687,-0.11139,-0.1041,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.018693,-0.11185,-0.1092,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.065596,-0.11241,-0.10221,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0090315,-0.11269,-0.1349,1,0
1,GO MEMBRANE FISSION,0.013093,-0.11271,-0.14127,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.036048,-0.11276,-0.089798,1,0
1,GO METAL ION TRANSPORT,0.0069343,-0.11293,-0.066279,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.017125,-0.11293,-0.087549,1,0
1,GO CHLORIDE TRANSPORT,0.0021798,-0.11454,-0.09476,1,0
1,GO PEPTIDE SECRETION,0.0056255,-0.11486,-0.07493,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.013546,-0.11494,-0.086577,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0077327,-0.11506,-0.092702,1,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0047798,-0.11515,-0.12469,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.016386,-0.11542,-0.12697,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0069343,-0.11566,-0.10378,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00068191,-0.11607,-0.10319,1,0
1,GO CELL PART MORPHOGENESIS,0.00094089,-0.11625,-0.11999,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.001955,-0.11628,-0.087655,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.0016347,-0.1164,-0.12894,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.030994,-0.11657,-0.10549,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.00072342,-0.11723,-0.10896,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.018693,-0.11758,-0.13646,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0071051,-0.11829,-0.091375,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.056128,-0.11838,-0.11335,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0012005,-0.11899,-0.11867,1,0
1,GO NEURON DIFFERENTIATION,0.00065224,-0.1191,-0.11366,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0023637,-0.11956,-0.17722,1,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.049681,-0.11972,-0.11702,1,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.042197,-0.12003,-0.1842,1,0
1,GO SEX DETERMINATION,0.062114,-0.12036,-0.094987,1,0
1,GO NEURON PROJECTION EXTENSION,0.0016575,-0.12058,-0.12575,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.016568,-0.12059,-0.15295,1,0
1,GO AXONAL TRANSPORT,0.0035146,-0.12096,-0.12491,1,0
1,GO MATING,0.0033799,-0.12105,-0.10838,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.011678,-0.1218,-0.19726,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.032278,-0.12233,-0.14789,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0010408,-0.12239,-0.15897,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0047798,-0.12283,-0.14676,1,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.03429,-0.12285,-0.094762,1,0
1,GO EATING BEHAVIOR,0.0025961,-0.12336,-0.11105,1,0
1,GO SNARE COMPLEX ASSEMBLY,0.030368,-0.12381,-0.10241,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00054518,-0.12388,-0.10501,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.001776,-0.12395,-0.11278,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.012798,-0.12399,-0.080607,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.001422,-0.12406,-0.087725,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0052197,-0.12475,-0.12055,1,0
1,GO REGULATION OF AXONOGENESIS,0.0040509,-0.12479,-0.12518,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0070192,-0.12493,-0.095034,1,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0086125,-0.12534,-0.12814,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.007921,-0.12544,-0.13071,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.00070238,-0.1258,-0.12054,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0013443,-0.12608,-0.10652,1,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.027686,-0.12638,-0.10755,1,0
1,GO MATING BEHAVIOR,0.0026663,-0.12729,-0.13743,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0062108,-0.12753,-0.11618,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.012087,-0.12895,-0.13666,1,0
1,GO REGULATION OF SYSTEM PROCESS,0.00063314,-0.1293,-0.10247,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.011678,-0.13015,-0.098726,1,0
1,GO DETECTION OF VISIBLE LIGHT,9.4959e-05,-0.13036,-0.14041,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.027401,-0.1311,-0.1084,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.0033361,-0.13115,-0.13047,1,0
1,GO SODIUM ION HOMEOSTASIS,0.031631,-0.13148,-0.10696,1,0
1,GO FOREBRAIN CELL MIGRATION,0.0039481,-0.13178,-0.14,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0028118,-0.13197,-0.11356,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0067673,-0.13325,-0.11081,1,0
1,GO CATION TRANSPORT,0.00061456,-0.13339,-0.091337,1,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.018898,-0.13368,-0.11377,1,0
1,GO FOREBRAIN DEVELOPMENT,0.00029511,-0.13373,-0.13554,1,0
1,GO REGULATION OF SECRETION,0.00040857,-0.13374,-0.098344,1,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.018091,-0.1345,-0.12949,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.014172,-0.13478,-0.1034,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00029511,-0.13489,-0.13039,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00036686,-0.1349,-0.13825,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0025277,-0.13568,-0.13696,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.012945,-0.13718,-0.13926,1,0
1,GO MICROTUBULE POLYMERIZATION,0.00012594,-0.13748,-0.15524,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.0011503,-0.13848,-0.086364,1,0
1,GO RESPONSE TO LEUCINE,0.0050904,-0.13932,-0.21342,1,0
1,GO NERVOUS SYSTEM PROCESS,6.8396e-06,-0.13937,-0.14155,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.016386,-0.13981,-0.090107,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0030436,-0.14038,-0.13099,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0017517,-0.14065,-0.095027,1,0
1,GO ORGANIC CATION TRANSPORT,0.0013443,-0.14083,-0.148,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,2.2015e-05,-0.1411,-0.16932,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00067188,-0.14114,-0.14368,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00098255,-0.14115,-0.20798,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.0024281,-0.1412,-0.15211,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00084997,-0.14156,-0.16292,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0098086,-0.142,-0.16076,1,0
1,GO HISTONE H4 K5 ACETYLATION,0.020166,-0.14205,-0.13191,1,0
1,GO ACROSOME ASSEMBLY,0.012798,-0.1426,-0.13044,1,0
1,GO CELL FATE SPECIFICATION,0.0030038,-0.14285,-0.1771,1,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.042609,-0.14286,-0.14783,1,0
1,GO NEURON DEVELOPMENT,0.00032916,-0.14328,-0.12241,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0029645,-0.14364,-0.12311,1,0
1,GO VISUAL BEHAVIOR,0.0018508,-0.14401,-0.10737,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.012798,-0.14408,-0.11688,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0071051,-0.14414,-0.11575,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0054872,-0.14428,-0.15255,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.032938,-0.14439,-0.12962,1,0
1,GO MEMBRANE REPOLARIZATION,0.0023957,-0.14452,-0.14143,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.033271,-0.14508,-0.074685,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.004156,-0.14538,-0.20867,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.0024609,-0.14593,-0.13797,1,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.063258,-0.14639,-0.11,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.055609,-0.14692,-0.17926,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.00032916,-0.14816,-0.10133,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0058389,-0.15008,-0.1042,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00019229,-0.15055,-0.16231,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0037985,-0.15085,-0.1668,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.028264,-0.15095,-0.10943,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.066192,-0.15121,-0.10506,1,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0071051,-0.1513,-0.12787,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.041383,-0.1514,-0.11205,1,0
1,GO REGULATION OF ION TRANSPORT,0.00027284,-0.15213,-0.11363,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0007901,-0.15311,-0.17036,1,0
1,GO RESPONSE TO AMPHETAMINE,0.0018006,-0.15351,-0.17562,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.003654,-0.15368,-0.17016,1,0
1,GO SODIUM ION TRANSPORT,0.00074504,-0.15404,-0.11435,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0031247,-0.15504,-0.20414,1,0
1,GO SECRETORY GRANULE ORGANIZATION,0.0074579,-0.15528,-0.10991,1,0
1,GO ADULT HEART DEVELOPMENT,0.062114,-0.15536,-0.11173,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00082553,-0.1554,-0.16915,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.00068191,-0.15604,-0.13535,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,4.8839e-05,-0.15616,-0.14576,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00067188,-0.15643,-0.12927,1,0
1,GO RELAXATION OF MUSCLE,0.02521,-0.15689,-0.13988,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00040857,-0.15703,-0.15958,1,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0037016,-0.15797,-0.12045,1,0
1,GO SECONDARY PALATE DEVELOPMENT,0.022209,-0.15863,-0.13672,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00084997,-0.15872,-0.17095,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00015583,-0.1593,-0.10855,1,0
1,GO COCHLEA DEVELOPMENT,0.0011341,-0.1593,-0.16417,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.016938,-0.1594,-0.15869,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.00087508,-0.15976,-0.12971,1,0
1,GO MITOCHONDRION LOCALIZATION,5.5127e-05,-0.15994,-0.1895,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.022446,-0.16062,-0.094486,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.0057669,-0.16142,-0.16264,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0053519,-0.16186,-0.13051,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0019819,-0.16211,-0.12599,1,0
1,GO COLLATERAL SPROUTING,0.016568,-0.16248,-0.14567,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0023957,-0.16268,-0.18942,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.015329,-0.16275,-0.16997,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00042128,-0.1628,-0.1803,1,0
1,GO RECEPTOR CLUSTERING,0.0023637,-0.16285,-0.16512,1,0
1,GO RESPONSE TO FOOD,2.8305e-05,-0.16325,-0.16511,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.008211,-0.16336,-0.16469,1,0
1,GO PALLIUM DEVELOPMENT,0.00031907,-0.16392,-0.13978,1,0
1,GO MALE SEX DETERMINATION,0.062684,-0.1647,-0.13356,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.018898,-0.16565,-0.13509,1,0
1,GO REGULATION OF ACROSOME REACTION,0.009139,-0.16579,-0.16242,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.028852,-0.16616,-0.23175,1,0
1,GO DEVELOPMENTAL MATURATION,3.3214e-05,-0.16663,-0.13975,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0028118,-0.16689,-0.16166,1,0
1,GO WALKING BEHAVIOR,0.00020835,-0.1674,-0.20237,1,0
1,GO FAT CELL PROLIFERATION,0.0044298,-0.16757,-0.18077,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.011151,-0.1677,-0.12594,1,0
1,GO MAINTENANCE OF CELL POLARITY,0.0094686,-0.16813,-0.13056,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.042609,-0.16824,-0.10693,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00052901,-0.16836,-0.14987,1,0
1,GO CELL JUNCTION MAINTENANCE,0.011151,-0.1684,-0.14146,1,0
1,GO COPULATION,0.035691,-0.1692,-0.11236,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.017894,-0.16924,-0.12057,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.0057669,-0.16971,-0.15192,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.0001179,-0.16996,-0.18111,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0001862,-0.17003,-0.16567,1,0
1,GO MEMORY,8.3013e-05,-0.17017,-0.16112,1,0
1,GO REPRODUCTIVE BEHAVIOR,9.6562e-05,-0.17025,-0.17492,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.0002117,-0.17029,-0.18107,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0032928,-0.17035,-0.15294,1,0
1,GO IMPORT INTO CELL,0.0012886,-0.17036,-0.11157,1,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.00041488,-0.17043,-0.1428,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.00098255,-0.17083,-0.15612,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0038977,-0.17183,-0.17633,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0062108,-0.17212,-0.17534,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.010769,-0.17224,-0.14045,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.0023009,-0.17306,-0.13868,1,0
1,GO REGULATION OF HEAT GENERATION,0.0033361,-0.17329,-0.18972,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.001568,-0.17342,-0.14385,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.053071,-0.17373,-0.11443,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.024173,-0.17397,-0.16086,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0072795,-0.17449,-0.1244,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00020178,-0.1745,-0.21237,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0011836,-0.17513,-0.1789,1,0
1,GO FEAR RESPONSE,0.00065224,-0.17566,-0.13738,1,0
1,GO PANCREAS DEVELOPMENT,0.019523,-0.17583,-0.10841,1,0
1,GO COGNITION,5.9056e-05,-0.17595,-0.14901,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00021511,-0.17637,-0.13086,1,0
1,GO EPITHELIAL CELL MATURATION,0.00035024,-0.17721,-0.23774,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.027686,-0.17768,-0.15184,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00094089,-0.17859,-0.15802,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.0001862,-0.1792,-0.2097,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.019735,-0.18132,-0.15498,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00061456,-0.18163,-0.17611,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.00012388,-0.18179,-0.16224,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00098255,-0.18217,-0.20404,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.018693,-0.18263,-0.17642,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,8.0256e-05,-0.18371,-0.19848,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.011022,-0.18381,-0.14025,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0032501,-0.18389,-0.1814,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004964,-0.18394,-0.18375,1,0
1,GO ACTION POTENTIAL,4.3946e-06,-0.1848,-0.21954,1,0
1,GO REGULATION OF HORMONE SECRETION,4.2271e-06,-0.18511,-0.17446,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00011986,-0.1854,-0.13928,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0021798,-0.18642,-0.16357,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0001803,-0.18672,-0.2094,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,8.5858e-05,-0.1868,-0.16935,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.5994e-06,-0.18691,-0.23064,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00065224,-0.18699,-0.12828,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0059852,-0.18706,-0.17713,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.024173,-0.18938,-0.1565,1,0
1,GO NEURON PROJECTION ARBORIZATION,0.01995,-0.19105,-0.15576,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00032408,-0.19114,-0.15679,1,0
1,GO HORMONE TRANSPORT,1.064e-06,-0.19138,-0.18776,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00011986,-0.1918,-0.17709,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.8124e-06,-0.19186,-0.20565,1,0
1,GO RESPONSE TO NICOTINE,0.00024045,-0.19284,-0.18069,1,0
1,GO STRIATUM DEVELOPMENT,0.00063314,-0.19295,-0.2023,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,3.8924e-05,-0.19296,-0.19613,1,0
1,GO REGULATION OF INSULIN SECRETION,2.0776e-06,-0.19303,-0.19869,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,1.3442e-05,-0.19407,-0.17887,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,7.105e-06,-0.19509,-0.17304,1,0
1,GO SPINAL CORD DEVELOPMENT,0.00024819,-0.19518,-0.17514,1,0
1,GO INTRACILIARY TRANSPORT,0.027686,-0.19537,-0.12322,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00011033,-0.19539,-0.23643,1,0
1,GO SENSORY PERCEPTION OF PAIN,9.086e-06,-0.19572,-0.18178,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,1.5014e-05,-0.19617,-0.18935,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.00044781,-0.19621,-0.1472,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0071051,-0.19775,-0.18353,1,0
1,GO CRANIAL NERVE DEVELOPMENT,0.0044298,-0.19779,-0.15247,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00070238,-0.19782,-0.20411,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010041,-0.19893,-0.13444,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.5576e-05,-0.20039,-0.17884,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00014362,-0.20059,-0.20594,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.7605e-06,-0.20124,-0.19429,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,2.1196e-06,-0.20139,-0.17142,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0054192,-0.20143,-0.1959,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00082553,-0.20254,-0.24309,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.6158e-05,-0.2027,-0.17229,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,3.3435e-06,-0.20366,-0.19417,1,0
1,GO DENDRITE MORPHOGENESIS,0.0001179,-0.20431,-0.184,1,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0062877,-0.20556,-0.12946,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,3.094e-05,-0.20581,-0.1647,1,0
1,GO BEHAVIOR,1.0004e-06,-0.20652,-0.18058,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,5.1446e-05,-0.20681,-0.20522,1,0
1,GO RESPONSE TO DOPAMINE,2.1807e-07,-0.2105,-0.2046,1,0
1,GO CARDIAC CONDUCTION,1.0958e-05,-0.21164,-0.19939,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00032916,-0.21202,-0.26984,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00023294,-0.21331,-0.16872,1,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0005056,-0.21342,-0.21577,1,0
1,GO ASSOCIATIVE LEARNING,5.2303e-06,-0.21366,-0.19369,1,0
1,GO DENDRITE DEVELOPMENT,8.1623e-05,-0.21391,-0.16992,1,0
1,GO HINDBRAIN DEVELOPMENT,5.6487e-06,-0.21433,-0.2002,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.011544,-0.21567,-0.19792,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00027284,-0.21586,-0.20727,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,3.5794e-07,-0.21649,-0.19105,1,0
1,GO TUBULIN DEACETYLATION,0.00011986,-0.21728,-0.23388,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00058763,-0.2182,-0.14316,1,0
1,GO ACROSOME REACTION,4.9361e-06,-0.219,-0.21086,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.051111,-0.22065,-0.12201,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.5412e-06,-0.22078,-0.24953,1,0
1,GO TELENCEPHALON REGIONALIZATION,0.016027,-0.22088,-0.2016,1,0
1,GO NEUROMUSCULAR PROCESS,2.8001e-06,-0.22127,-0.20423,1,0
1,GO VESICLE DOCKING,1.1588e-05,-0.22156,-0.17518,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0033799,-0.22286,-0.22859,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0020367,-0.22384,-0.19896,1,0
1,GO DIVALENT METAL ION EXPORT,0.0090315,-0.22654,-0.17892,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,7.1819e-07,-0.2273,-0.23505,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,5.8049e-05,-0.22777,-0.2101,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0019285,-0.2287,-0.19886,1,0
1,GO PARENTAL BEHAVIOR,0.001422,-0.22875,-0.2257,1,0
1,GO MITOCHONDRION DISTRIBUTION,4.4771e-05,-0.22916,-0.22966,1,0
1,GO SYNAPSE ORGANIZATION,3.9872e-06,-0.22919,-0.22231,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,4.1456e-06,-0.22954,-0.28515,1,0
1,GO INSULIN SECRETION,1.3468e-07,-0.22974,-0.22608,1,0
1,GO FEEDING BEHAVIOR,3.7282e-08,-0.23076,-0.22046,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0042636,-0.23102,-0.20687,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.7105e-06,-0.23181,-0.30709,1,0
1,GO REGULATION OF MICROTUBULE BINDING,1.536e-06,-0.2321,-0.26367,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00026858,-0.23305,-0.26412,1,0
1,GO MRNA SPLICE SITE SELECTION,0.00014839,-0.23317,-0.21591,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00047589,-0.23362,-0.29123,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00010152,-0.2337,-0.24656,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.00061456,-0.23413,-0.17353,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,1.6321e-06,-0.23434,-0.28847,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.3999e-08,-0.23488,-0.22372,1,0
1,GO SECRETORY GRANULE LOCALIZATION,2.4091e-05,-0.23551,-0.37764,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00038422,-0.23764,-0.22113,1,0
1,GO SIALYLATION,0.017315,-0.23927,-0.20164,1,0
1,GO SIGNAL RELEASE,1.0791e-07,-0.23937,-0.2015,1,0
1,GO RESPONSE TO POTASSIUM ION,0.00044781,-0.2395,-0.26205,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,1.3196e-05,-0.24018,-0.24832,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,2.8262e-08,-0.24042,-0.27005,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.011411,-0.24107,-0.22753,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.00054518,-0.24141,-0.19922,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,5.2538e-08,-0.24317,-0.23938,1,0
1,GO AMINO ACID TRANSPORT,4.2444e-07,-0.24393,-0.20904,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0028118,-0.24437,-0.24342,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.3442e-05,-0.24822,-0.2458,1,0
1,GO NEURON MIGRATION,1.4741e-05,-0.24832,-0.24388,1,0
1,GO AXONEME ASSEMBLY,0.00095459,-0.25035,-0.20313,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.7385e-05,-0.25072,-0.23139,1,0
1,GO METENCEPHALON DEVELOPMENT,3.4296e-07,-0.25119,-0.26037,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,3.628e-05,-0.2512,-0.20748,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,6.2993e-08,-0.25209,-0.27876,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0070192,-0.25269,-0.22588,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.00088789,-0.25511,-0.24163,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,7.2414e-06,-0.25511,-0.30695,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.016568,-0.25523,-0.18643,1,0
1,GO PRESYNAPSE ORGANIZATION,1.5293e-05,-0.25554,-0.27203,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.5412e-06,-0.25803,-0.22316,1,0
1,GO PEPTIDE HORMONE SECRETION,1.4677e-08,-0.2585,-0.25095,1,0
1,GO RESPONSE TO FORSKOLIN,0.0024609,-0.25978,-0.24165,1,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.047372,-0.26219,-0.17102,1,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0046018,-0.26238,-0.22088,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,7.9617e-06,-0.26335,-0.31715,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,1.0756e-05,-0.26352,-0.28546,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00031414,-0.26415,-0.31041,1,0
1,GO RESPONSE TO L GLUTAMATE,0.0035605,-0.2642,-0.24646,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.3806e-05,-0.26464,-0.25955,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0037985,-0.26561,-0.1988,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.0094686,-0.26612,-0.18612,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00048316,-0.26654,-0.26687,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5934e-07,-0.26718,-0.27431,1,0
1,GO RESPONSE TO COCAINE,1.9136e-07,-0.26811,-0.28649,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.3355e-07,-0.26931,-0.3054,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,1.0169e-05,-0.26942,-0.28123,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0048405,-0.27076,-0.25228,1,0
1,GO LEARNING,4.6202e-07,-0.27221,-0.24446,1,0
1,GO MAST CELL MIGRATION,0.0032501,-0.27277,-0.2558,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.0991e-06,-0.27417,-0.19786,1,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.022209,-0.27491,-0.16568,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00040235,-0.27704,-0.26314,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.5884e-05,-0.27714,-0.2604,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.1794e-07,-0.27823,-0.25747,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,5.9498e-07,-0.27837,-0.26887,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.9136e-07,-0.27844,-0.25731,1,0
1,GO TOXIN METABOLIC PROCESS,0.0085105,-0.27886,-0.17855,1,0
1,GO PROTEIN PALMITOYLATION,5.4356e-06,-0.27983,-0.21636,1,0
1,GO MEMBRANE DEPOLARIZATION,2.5868e-06,-0.28289,-0.24856,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,7.9617e-06,-0.2846,-0.27363,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.4699e-07,-0.28474,-0.28153,1,0
1,GO REGULATION OF EXOCYTOSIS,1.8142e-08,-0.28801,-0.24296,1,0
1,GO PROTEIN POLYGLUTAMYLATION,5.6487e-06,-0.29001,-0.26444,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.00072342,-0.29075,-0.18649,1,0
1,GO DENDRITIC TRANSPORT,9.4959e-05,-0.29286,-0.26425,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0032078,-0.29312,-0.26853,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.5674e-06,-0.2954,-0.3468,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,4.6881e-08,-0.29556,-0.28441,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,6.3569e-09,-0.29561,-0.34793,1,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0041031,-0.29562,-0.31985,1,0
1,GO SYNAPTIC VESICLE RECYCLING,3.0295e-08,-0.29689,-0.29682,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00010323,-0.29716,-0.26968,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.7385e-05,-0.29796,-0.23962,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.2253e-05,-0.2992,-0.27772,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.471e-07,-0.29976,-0.26879,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00011406,-0.29989,-0.27139,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.8723e-07,-0.30001,-0.26542,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,8.9166e-06,-0.30207,-0.31065,1,0
1,GO NEURON RECOGNITION,7.105e-06,-0.30255,-0.33622,1,0
1,GO RESPONSE TO LITHIUM ION,0.00011986,-0.30304,-0.28687,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,9.3381e-05,-0.30397,-0.32612,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,9.03e-05,-0.30399,-0.2582,1,0
1,GO NERVE DEVELOPMENT,2.3239e-05,-0.30489,-0.24807,1,0
1,GO SYNAPSE ASSEMBLY,5.3747e-08,-0.3073,-0.32249,1,0
1,GO POTASSIUM ION TRANSPORT,2.2926e-08,-0.30894,-0.26795,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.2505e-06,-0.30902,-0.28187,1,0
1,GO SYNAPTIC SIGNALING,2.7676e-09,-0.31034,-0.29423,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,3.2094e-09,-0.31249,-0.28348,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,2.3467e-08,-0.31303,-0.33746,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2482e-05,-0.31395,-0.26381,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,5.4982e-08,-0.31406,-0.33291,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,4.2487e-05,-0.31552,-0.36687,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,3.2057e-05,-0.31658,-0.31876,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,2.3239e-05,-0.31709,-0.25606,1,0
1,GO RESPONSE TO ACETYLCHOLINE,2.7452e-06,-0.31923,-0.30751,1,0
1,GO LOCOMOTORY BEHAVIOR,2.188e-08,-0.32007,-0.28433,1,0
1,GO NEUROTRANSMITTER UPTAKE,5.8262e-07,-0.32078,-0.28893,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00012388,-0.32123,-0.31287,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,7.105e-06,-0.3215,-0.32074,1,0
1,GO DIENCEPHALON DEVELOPMENT,1.9175e-06,-0.3218,-0.28184,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,1.4741e-05,-0.32396,-0.25714,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,6.4592e-06,-0.32657,-0.32032,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00020835,-0.33074,-0.25511,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00057029,-0.33111,-0.2661,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,7.105e-06,-0.33167,-0.28712,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.2444e-07,-0.33202,-0.31805,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.0322e-07,-0.33245,-0.33599,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,2.4452e-09,-0.33348,-0.31254,1,0
1,GO SEROTONIN SECRETION,0.0001179,-0.33502,-0.3209,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,2.856e-06,-0.33505,-0.36955,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.039795,-0.33584,-0.18533,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00020835,-0.3364,-0.2404,1,0
1,GO NEURON MATURATION,5.4982e-08,-0.33662,-0.32486,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00011406,-0.33879,-0.32341,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,9.4341e-06,-0.34005,-0.31003,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,6.5906e-08,-0.34173,-0.34518,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,1.1533e-09,-0.34257,-0.33755,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,4.1026e-05,-0.34267,-0.42505,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,4.5684e-06,-0.34344,-0.35688,1,0
1,GO FOREBRAIN REGIONALIZATION,7.105e-06,-0.34635,-0.32077,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.0781e-08,-0.34853,-0.30975,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,2.8305e-05,-0.34923,-0.32633,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.205e-09,-0.34945,-0.31205,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.5684e-06,-0.34979,-0.34218,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,7.8976e-09,-0.35156,-0.33982,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,9.9064e-10,-0.35171,-0.32956,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00027284,-0.35186,-0.29989,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00033432,-0.35189,-0.32077,1,0
1,GO REGULATION OF SYNAPSE MATURATION,5.5412e-06,-0.35197,-0.45896,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,9.6129e-06,-0.35379,-0.387,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,1.7154e-07,-0.35424,-0.31473,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.758e-05,-0.35429,-0.30449,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1245e-09,-0.35962,-0.36475,1,0
1,GO NOREPINEPHRINE SECRETION,9.8716e-08,-0.36585,-0.34323,1,0
1,GO NEUROTRANSMITTER REUPTAKE,5.4701e-07,-0.36888,-0.32603,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,3.0302e-06,-0.36897,-0.28796,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,1.9749e-05,-0.37248,-0.32407,1,0
1,GO CEREBELLAR CORTEX FORMATION,7.333e-07,-0.37357,-0.31079,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.8318e-07,-0.37508,-0.38409,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,7.969e-07,-0.37534,-0.28944,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.6823e-09,-0.37607,-0.39453,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,7.105e-06,-0.37654,-0.3834,1,0
1,GO OPTIC NERVE DEVELOPMENT,7.7586e-05,-0.37769,-0.31399,1,0
1,GO EXOCYTIC PROCESS,5.2359e-09,-0.37774,-0.32562,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.8701e-05,-0.37891,-0.32865,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.3442e-05,-0.38082,-0.40513,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.6514e-08,-0.38088,-0.35326,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.0422e-09,-0.38427,-0.33862,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,2.4837e-07,-0.38563,-0.41175,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,1.2434e-08,-0.38829,-0.39676,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.7154e-07,-0.38876,-0.43568,1,0
1,GO SPINAL CORD PATTERNING,6.337e-06,-0.3901,-0.37402,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,2.3853e-09,-0.39012,-0.35427,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.0546e-09,-0.3904,-0.35082,1,0
1,GO SUCKLING BEHAVIOR,9.0235e-07,-0.39257,-0.37182,1,0
1,GO RETINA LAYER FORMATION,6.0079e-05,-0.39476,-0.38707,1,0
1,GO GROOMING BEHAVIOR,4.7501e-09,-0.39846,-0.39097,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,6.8888e-05,-0.4075,-0.33682,1,0
1,GO SEROTONIN TRANSPORT,6.2046e-07,-0.4089,-0.39531,1,0
1,GO ADULT BEHAVIOR,1.8389e-10,-0.41455,-0.38062,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,2.3268e-09,-0.41567,-0.42574,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.5753e-08,-0.41614,-0.39326,1,0
1,GO RESPONSE TO INSECTICIDE,1.2886e-07,-0.4189,-0.40128,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.332e-06,-0.41935,-0.33215,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1.1588e-05,-0.42736,-0.33926,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00014599,-0.4328,-0.33903,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.0033e-09,-0.4335,-0.39572,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.1403e-10,-0.43391,-0.43575,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,9.5999e-07,-0.43528,-0.40924,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,6.3074e-11,-0.43581,-0.44226,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,5.2359e-09,-0.43732,-0.42981,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,4.9624e-10,-0.44188,-0.37941,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,3.5606e-08,-0.4421,-0.45314,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,1.2886e-07,-0.44269,-0.49226,1,0
1,GO DETECTION OF CALCIUM ION,1.7922e-07,-0.4431,-0.41882,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,5.0278e-07,-0.44355,-0.46198,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,2.8271e-07,-0.44441,-0.39712,1,0
1,GO REGULATION OF VESICLE FUSION,1.1307e-08,-0.44882,-0.43568,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.4148e-09,-0.44912,-0.4827,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,6.0565e-09,-0.45264,-0.52348,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.1338e-07,-0.4535,-0.41937,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,7.71e-09,-0.45741,-0.51336,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,1.5027e-08,-0.45938,-0.40564,1,0
1,GO CGMP METABOLIC PROCESS,3.5794e-07,-0.46001,-0.43352,1,0
1,GO GLIAL CELL FATE COMMITMENT,6.0079e-05,-0.46178,-0.42588,1,0
1,GO NOREPINEPHRINE TRANSPORT,2.6981e-08,-0.46312,-0.35644,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,1.8318e-07,-0.46363,-0.48031,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.9047e-09,-0.46858,-0.47412,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,7.0337e-07,-0.46896,-0.48658,1,0
1,GO POSTSYNAPSE ASSEMBLY,1.0861e-06,-0.4701,-0.45514,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,4.4148e-09,-0.4716,-0.53698,1,0
1,GO DOPAMINE METABOLIC PROCESS,3.0296e-10,-0.47343,-0.47151,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,4.1403e-10,-0.47651,-0.4376,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,8.7184e-11,-0.47832,-0.45554,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.3376e-10,-0.47851,-0.46764,1,0
1,GO NEURON FATE COMMITMENT,7.0522e-08,-0.47867,-0.4584,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,8.8389e-07,-0.48407,-0.45419,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,5.8856e-08,-0.49273,-0.43046,1,0
1,GO CATECHOLAMINE UPTAKE,6.5125e-09,-0.49448,-0.43107,1,0
1,GO SUBPALLIUM DEVELOPMENT,9.5999e-07,-0.49591,-0.40425,1,0
1,GO NEURONAL ACTION POTENTIAL,5.9116e-09,-0.50002,-0.4993,1,0
1,GO DENSE CORE GRANULE TRANSPORT,4.9872e-09,-0.50063,-0.67979,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.8318e-07,-0.50424,-0.53046,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,1.6457e-05,-0.50546,-0.44235,1,0
1,GO THALAMUS DEVELOPMENT,9.404e-07,-0.51246,-0.41259,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.6293e-09,-0.51525,-0.52753,1,0
1,GO NEUROTRANSMITTER TRANSPORT,3.7602e-11,-0.51758,-0.49524,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,8.0815e-10,-0.51936,-0.50191,1,0
1,GO GLUTAMATE SECRETION,1.0519e-10,-0.52462,-0.4864,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,6.8396e-06,-0.53228,-0.48554,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,2.9371e-11,-0.53547,-0.50698,1,0
1,GO SYNAPSE MATURATION,9.1205e-09,-0.5365,-0.61431,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.9872e-06,-0.55147,-0.51386,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.4112e-09,-0.56277,-0.48435,1,0
1,GO NEUROTRANSMITTER SECRETION,2.1678e-11,-0.5661,-0.54294,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,4.5233e-07,-0.56615,-0.51182,1,0
1,GO STARTLE RESPONSE,1.3761e-09,-0.56674,-0.51723,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,5.77e-09,-0.56997,-0.54479,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,4.1815e-08,-0.57716,-0.49263,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,3.8645e-11,-0.58038,-0.54675,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.7041e-11,-0.58492,-0.56235,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.2682e-10,-0.59112,-0.56973,1,0
1,GO VOCALIZATION BEHAVIOR,4.5822e-08,-0.59497,-0.60994,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.3066e-07,-0.59918,-0.57155,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,5.3647e-09,-0.59975,-0.51993,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.8301e-10,-0.60432,-0.58649,1,0
1,GO PROTEIN LOCALIZATION TO AXON,5.2538e-08,-0.60449,-0.65154,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,1.6884e-11,-0.60639,-0.58118,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,5.7536e-08,-0.61233,-0.60527,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.0072e-05,-0.6142,-0.43143,1,0
1,GO INNERVATION,2.6362e-08,-0.61674,-0.56308,1,0
1,GO DENDRITE EXTENSION,7.1121e-10,-0.61958,-0.52813,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.1375e-08,-0.6231,-0.60584,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,1.3376e-10,-0.6249,-0.69705,1,0
1,GO NEURON FATE SPECIFICATION,1.2733e-08,-0.62932,-0.63027,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.1794e-07,-0.63895,-0.54228,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,2.9078e-09,-0.64001,-0.61238,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.0766e-11,-0.64404,-0.62509,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.5529e-11,-0.64961,-0.62496,1,0
1,GO PREPULSE INHIBITION,1.1828e-09,-0.65234,-0.64822,1,0
1,GO AMINE TRANSPORT,1.5529e-11,-0.65494,-0.57055,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,1.1858e-08,-0.6568,-0.57941,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,1.725e-09,-0.65708,-0.63305,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.725e-09,-0.6571,-0.58107,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.9558e-07,-0.66177,-0.54847,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,7.8778e-10,-0.66342,-0.61976,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,5.6317e-09,-0.66898,-0.61561,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,3.019e-11,-0.67088,-0.63159,1,0
1,GO SYNAPTIC VESICLE PRIMING,2.1085e-11,-0.68056,-0.67895,1,0
1,GO REGULATION OF DENDRITE EXTENSION,3.8301e-10,-0.68324,-0.62717,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.3024e-10,-0.6903,-0.66251,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,5.2165e-11,-0.69516,-0.67503,1,0
1,GO MONOAMINE TRANSPORT,3.8645e-11,-0.70112,-0.59675,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.8573e-08,-0.72062,-0.64256,1,0
1,GO NEURON CELL CELL ADHESION,2.5893e-10,-0.73177,-0.77262,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.3752e-12,-0.74653,-0.72652,1,0
1,GO GANGLION DEVELOPMENT,5.6245e-08,-0.75821,-0.64618,1,0
1,GO SYNAPTIC VESICLE DOCKING,1.1706e-10,-0.76998,-0.74382,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.1245e-09,-0.77356,-0.76428,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,4.5922e-10,-0.78362,-0.80643,1,0
1,GO NOSE DEVELOPMENT,1.0212e-06,-0.7853,-0.57136,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,6.5125e-09,-0.79144,-0.75743,1,0
1,GO SYNAPTIC VESICLE MATURATION,2.2697e-09,-0.79173,-0.72714,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,1.9948e-11,-0.79555,-0.7798,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.3085e-09,-0.80141,-0.6825,1,0
1,GO DOPAMINE TRANSPORT,2.7041e-11,-0.8142,-0.73051,1,0
1,GO CATECHOLAMINE SECRETION,1.3133e-11,-0.84655,-0.74685,1,0
1,GO MECHANOSENSORY BEHAVIOR,1.2759e-09,-0.87562,-0.8245,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,3.5597e-11,-0.92741,-0.89234,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.9963e-12,-0.95116,-0.92792,1,0
1,GO REGULATION OF DOPAMINE SECRETION,1.736e-11,-0.97786,-0.88646,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.1415e-11,-1.0256,-0.97521,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.4686e-11,-1.1094,-1.0629,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.3088e-12,-1.4131,-1.3315,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.16285,0.26156,0.086555,0,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.087731,0.17393,0.12435,0,1
1,GO L SERINE METABOLIC PROCESS,0.27317,0.17389,0.044625,0,1
1,GO KERATINIZATION,0.1533,0.15891,0.10393,0,1
1,GO RESPONSE TO WATER,0.1313,0.15448,0.10818,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.077698,0.1541,0.095159,0,1
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.44994,0.15338,0.048287,0,1
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.14983,0.14856,0.11457,0,1
1,GO MESENCHYMAL CELL PROLIFERATION,0.073043,0.14607,0.13497,0,1
1,GO LYSINE METABOLIC PROCESS,0.32993,0.14424,0.1169,0,1
1,GO V D J RECOMBINATION,0.19557,0.14317,0.098641,0,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.14419,0.1423,0.095002,0,1
1,GO CYTOPLASM ORGANIZATION,0.21288,0.1421,0.14677,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.11002,0.14,0.16048,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.3739,0.13399,0.076186,0,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.10045,0.13395,0.048672,0,1
1,GO ER OVERLOAD RESPONSE,0.20409,0.13325,0.079313,0,1
1,GO BONE MATURATION,0.093918,0.13162,0.092237,0,1
1,GO PIRNA METABOLIC PROCESS,0.39606,0.13083,0.037167,0,1
1,GO DEVELOPMENTAL PIGMENTATION,0.066792,0.12963,0.083696,0,1
1,GO MAGNESIUM ION HOMEOSTASIS,0.13338,0.12722,0.16477,0,1
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.098784,0.12619,0.10576,0,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.073043,0.12617,0.082883,0,1
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.12029,0.12461,0.087047,0,1
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.16778,0.12136,0.11448,0,1
1,GO BROWN FAT CELL DIFFERENTIATION,0.1453,0.12017,0.075824,0,1
1,GO CELL AGGREGATION,0.30255,0.11991,0.079287,0,1
1,GO PANCREATIC JUICE SECRETION,0.077698,0.11974,0.12097,0,1
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.26095,0.11957,0.12035,0,1
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.073043,0.11924,0.10834,0,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.13338,0.11911,0.063888,0,1
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.31215,0.11867,0.083891,0,1
1,GO MESODERMAL CELL FATE COMMITMENT,0.47211,0.11844,0.020845,0,1
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.15802,0.11572,0.064,0,1
1,GO RESPONSE TO CORTICOSTERONE,0.19278,0.11535,0.080324,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.077698,0.11524,0.10964,0,1
1,GO ACTIN FILAMENT BASED TRANSPORT,0.13444,0.11336,0.10192,0,1
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.10214,0.11146,0.088589,0,1
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.10299,0.11125,0.10023,0,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.11553,0.1098,0.14507,0,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.099614,0.10876,0.059365,0,1
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.1914,0.10741,0.058266,0,1
1,GO RRNA CATABOLIC PROCESS,0.18595,0.10691,0.066961,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.075674,0.10381,0.10899,0,1
1,GO REGULATION OF HELICASE ACTIVITY,0.16904,0.10353,0.070614,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.080464,0.10244,0.075088,0,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.12224,0.10124,0.045329,0,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.079765,0.099803,0.055247,0,1
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.071119,0.098899,0.091775,0,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.18327,0.098082,0.067204,0,1
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.31215,0.097225,0.06322,0,1
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.13763,0.09688,0.067494,0,1
1,GO HISTONE H2A UBIQUITINATION,0.096327,0.096854,0.068246,0,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.21738,0.096513,0.055374,0,1
1,GO SNORNA METABOLIC PROCESS,0.14755,0.096395,0.045624,0,1
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.066792,0.096282,0.09881,0,1
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.2913,0.09511,0.053137,0,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.11647,0.094841,0.068051,0,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.082591,0.094661,0.098104,0,1
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.071756,0.09269,0.10156,0,1
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.14088,0.091181,0.07927,0,1
1,GO REGULATION OF CYTOKINESIS,0.092339,0.089906,0.045334,0,1
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.28033,0.089352,0.030666,0,1
1,GO GASTRIC ACID SECRETION,0.20699,0.0889,0.075505,0,1
1,GO HISTONE DEUBIQUITINATION,0.075009,0.088249,0.081658,0,1
1,GO BICARBONATE TRANSPORT,0.14419,0.087184,0.054511,0,1
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.082591,0.086643,0.043596,0,1
1,GO SPINDLE ORGANIZATION,0.18194,0.085585,0.035011,0,1
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.13656,0.085466,0.090669,0,1
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.11933,0.084526,0.071963,0,1
1,GO ACTIN FILAMENT BASED MOVEMENT,0.098784,0.084108,0.082054,0,1
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.13656,0.081172,0.064986,0,1
1,GO RESPONSE TO SALT,0.18194,0.081161,0.045924,0,1
1,GO POST EMBRYONIC DEVELOPMENT,0.26095,0.081055,0.063853,0,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.1453,0.080921,0.090085,0,1
1,GO NEPHRON MORPHOGENESIS,0.079765,0.080829,0.08785,0,1
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.22971,0.080621,0.048517,0,1
1,GO POSITIVE REGULATION OF NEURON DEATH,0.066792,0.080191,0.077147,0,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.11647,0.07849,0.097567,0,1
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.090011,0.077866,0.10763,0,1
1,GO SPHINGOID METABOLIC PROCESS,0.077698,0.075881,0.092028,0,1
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.094715,0.074979,0.063697,0,1
1,GO ESTROUS CYCLE,0.35886,0.073816,0.06675,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.6312,0.073207,-0.0115,0,1
1,GO REGULATION OF CELL DIFFERENTIATION,0.14088,0.073163,0.060528,0,1
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.1313,0.073121,0.052106,0,1
1,GO THYMUS DEVELOPMENT,0.21889,0.072982,0.070012,0,1
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.45972,0.071517,0.021775,0,1
1,GO MITOTIC NUCLEAR DIVISION,0.090011,0.071413,0.034556,0,1
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.14755,0.071151,0.06548,0,1
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.10912,0.071045,0.064894,0,1
1,GO MUSCLE HYPERTROPHY,0.09796,0.069929,0.078487,0,1
1,GO HISTONE H3 K14 ACETYLATION,0.16042,0.069724,0.044712,0,1
1,GO REGULATION OF MITOPHAGY,0.077698,0.068866,0.10477,0,1
1,GO GLUTAMINE METABOLIC PROCESS,0.29502,0.068688,0.032647,0,1
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.12029,0.068502,0.069512,0,1
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.10823,0.067816,0.087197,0,1
1,GO CELLULAR RESPONSE TO STEROL,0.08331,0.06776,0.11391,0,1
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.318,0.067706,0.022881,0,1
1,GO STRIATED MUSCLE ADAPTATION,0.71693,0.067704,0.024774,0,1
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.31409,0.067529,0.061585,0,1
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.32792,0.067267,0.039075,0,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.20699,0.066757,0.11074,0,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.59986,0.066143,0.026255,0,1
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.087731,0.066133,0.062149,0,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.16778,0.065686,0.036875,0,1
1,GO MRNA PROCESSING,0.11002,0.064618,0.049557,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25753,0.064592,0.031636,0,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.068006,0.064166,0.033316,0,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.091558,0.063194,0.024447,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.20409,0.0588,0.05583,0,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19838,0.058386,0.066202,0,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.12721,0.058101,0.055492,0,1
1,GO GMP METABOLIC PROCESS,0.38047,0.057093,0.047958,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.17669,0.056119,0.067457,0,1
1,GO SPINDLE ASSEMBLY,0.10823,0.055811,0.034221,0,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.36741,0.055751,0.058931,0,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.22658,0.055593,0.069917,0,1
1,GO METHYLATION,0.079765,0.054093,0.053865,0,1
1,GO MITOCHONDRIAL TRANSPORT,0.13027,0.053368,0.04295,0,1
1,GO HETEROCHROMATIN ORGANIZATION,0.36526,0.053061,0.027821,0,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25753,0.051797,0.024757,0,1
1,GO SEX DIFFERENTIATION,0.17156,0.051795,0.053963,0,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.1252,0.051235,0.024864,0,1
1,GO CHROMOSOME LOCALIZATION,0.13656,0.050659,0.03381,0,1
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.797,0.050575,0.030579,0,1
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.31215,0.050484,0.051297,0,1
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.18327,0.049892,0.058092,0,1
1,GO REGULATION OF DNA BINDING,0.36098,0.049623,0.033464,0,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.096327,0.049256,0.040406,0,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.44028,0.049226,0.031908,0,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.15098,0.049097,0.07358,0,1
1,GO POSITIVE REGULATION OF DNA REPAIR,0.22814,0.048869,0.03582,0,1
1,GO COVALENT CHROMATIN MODIFICATION,0.32592,0.04863,0.027387,0,1
1,GO RNA SPLICING,0.13979,0.04748,0.045819,0,1
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.11092,0.046712,0.045778,0,1
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.12029,0.046463,0.050461,0,1
1,GO DNA CATABOLIC PROCESS,0.1653,0.045972,0.036731,0,1
1,GO PHOTOPERIODISM,0.50776,0.044799,0.021147,0,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.178,0.044156,0.036991,0,1
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.12822,0.044064,0.054049,0,1
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.62545,0.043733,0.0081477,0,1
1,GO CHROMATIN REMODELING,0.45727,0.043307,0.0084553,0,1
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.22814,0.042293,0.046861,0,1
1,GO REGULATION OF GLUCONEOGENESIS,0.27317,0.040953,0.043934,0,1
1,GO CHROMATIN ORGANIZATION,0.45482,0.037202,0.015855,0,1
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.12822,0.035461,0.050773,0,1
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.23927,0.03542,0.041542,0,1
1,GO RETINA HOMEOSTASIS,0.33194,0.03269,0.027699,0,1
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.58585,0.030328,0.0096847,0,1
1,GO CHROMOSOME ORGANIZATION,0.09714,0.028176,0.034387,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE,0.22503,0.024985,0.030436,0,1
1,GO REGULATION OF HISTONE MODIFICATION,0.14869,0.024914,0.049693,0,1
1,GO REGULATION OF DEPHOSPHORYLATION,0.54208,0.024738,0.031571,0,1
1,GO RESPONSE TO LIGHT STIMULUS,0.53672,0.019281,0.025601,0,1
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0020646,0.44887,0.37856,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,2.2015e-05,0.44065,0.42759,0,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,2.4305e-07,0.422,0.40051,0,0
1,GO SKIN MORPHOGENESIS,3.2784e-06,0.37339,0.52901,0,0
1,GO HAIR FOLLICLE MATURATION,1.4454e-06,0.33468,0.35112,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00013451,0.29643,0.2517,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.15565,0.29291,0.17606,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00021857,0.28906,0.30936,0,0
1,GO RESPONSE TO HYPEROXIA,1.2534e-06,0.28488,0.32949,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0023637,0.28008,0.34048,0,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.2281e-06,0.28004,0.32667,0,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00010852,0.27874,0.38221,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0052854,0.26981,0.33617,0,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00049053,0.26859,0.30944,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.009139,0.25737,0.25522,0,0
1,GO NADPH REGENERATION,4.3236e-05,0.24631,0.25529,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0063654,0.23893,0.24889,0,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0002443,0.22539,0.28695,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,7.5001e-05,0.22415,0.26772,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.014332,0.20984,0.24609,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.46962,0.20917,0.0019893,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.096327,0.20366,0.14803,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.12029,0.19793,0.10575,0,0
1,GO MATERNAL PLACENTA DEVELOPMENT,0.0001179,0.19791,0.22636,0,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,1.3442e-05,0.19668,0.22912,0,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00067188,0.19547,0.21494,0,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00057029,0.19461,0.20451,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.099614,0.19271,0.098441,0,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00031414,0.19175,0.2112,0,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.001568,0.19077,0.25159,0,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00072342,0.18942,0.1803,0,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0012886,0.18704,0.14531,0,0
1,GO GLUTATHIONE METABOLIC PROCESS,4.8839e-05,0.18548,0.2175,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0074579,0.18484,0.18455,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.03068,0.18339,0.14865,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.13444,0.18317,0.10972,0,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.016752,0.17753,0.27687,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.06986,0.17539,0.18806,0,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,7.6657e-06,0.17525,0.22706,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.054582,0.17373,0.13341,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.010041,0.17255,0.18856,0,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0026663,0.17218,0.27187,0,0
1,GO REGULATION OF ODONTOGENESIS,0.016752,0.17137,0.15937,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.27495,0.17071,0.0987,0,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00096848,0.1702,0.2129,0,0
1,GO DECIDUALIZATION,0.0038977,0.17019,0.21529,0,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0092477,0.16971,0.20329,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00020835,0.16936,0.24751,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.094715,0.16892,0.15138,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.068619,0.16726,0.17129,0,0
1,GO NEURAL CREST FORMATION,0.14642,0.16693,0.12913,0,0
1,GO REGULATION OF GTP BINDING,0.0093576,0.16265,0.18627,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.28395,0.16115,0.11438,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0038977,0.15913,0.1611,0,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00042777,0.15749,0.20019,0,0
1,GO LIPID DIGESTION,0.13027,0.15726,0.093466,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.023668,0.15696,0.22757,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.11367,0.15513,0.10128,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.178,0.1535,0.10873,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.06986,0.15316,0.099614,0,0
1,GO HEAD MORPHOGENESIS,0.0067673,0.15174,0.19256,0,0
1,GO IMP METABOLIC PROCESS,0.19278,0.15092,0.064547,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.060988,0.15057,0.12148,0,0
1,GO COCHLEA MORPHOGENESIS,0.2114,0.15049,0.062364,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.27853,0.15001,0.087684,0,0
1,GO BODY MORPHOGENESIS,0.0086125,0.14925,0.15619,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11092,0.1487,0.14994,0,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.007921,0.14676,0.17074,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.1914,0.14213,0.076204,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.1533,0.14208,0.062317,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.27317,0.14149,0.068885,0,0
1,GO REGULATION OF BONE MINERALIZATION,0.0085105,0.14139,0.16761,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.0043184,0.14063,0.1834,0,0
1,GO OVULATION,0.039406,0.14056,0.13665,0,0
1,GO MICROVILLUS ORGANIZATION,0.11367,0.14004,0.091687,0,0
1,GO CELLULAR RESPONSE TO IRON ION,0.0039481,0.13868,0.23022,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.041383,0.13783,0.18165,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.44269,0.13744,0.034927,0,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00019541,0.13643,0.15553,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.99192,0.13575,-0.024048,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.085497,0.13527,0.091448,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.44994,0.13442,0.032789,0,0
1,GO RESPONSE TO INTERLEUKIN 4,2.0853e-05,0.13401,0.19786,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.035691,0.133,0.13462,0,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.20992,0.13298,0.098294,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.19979,0.1324,0.10476,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.43312,0.13221,0.077797,0,0
1,GO QUINONE METABOLIC PROCESS,0.1313,0.13152,0.059628,0,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0095807,0.13093,0.15567,0,0
1,GO DNA DEMETHYLATION,0.075009,0.12999,0.11067,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.096327,0.12807,0.09475,0,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0084096,0.1276,0.18608,0,0
1,GO HORMONE CATABOLIC PROCESS,0.17411,0.12651,0.095428,0,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0035146,0.12479,0.17931,0,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.012367,0.12348,0.10782,0,0
1,GO RESPONSE TO INACTIVITY,0.1453,0.12331,0.095196,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.093918,0.12196,0.11497,0,0
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.074349,0.1218,0.11624,0,0
1,GO PULMONARY VALVE MORPHOGENESIS,0.024947,0.12098,0.25457,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.0037498,0.12049,0.15949,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.077018,0.11867,0.14463,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0044298,0.11849,0.13543,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.071119,0.11845,0.096894,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.05063,0.11668,0.12978,0,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.041789,0.11603,0.1621,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.20554,0.11569,0.093268,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.096327,0.11532,0.060984,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.1793,0.11462,0.093689,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0052197,0.11436,0.13791,0,0
1,GO BIOMINERALIZATION,0.068619,0.11397,0.11142,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.15447,0.11372,0.10827,0,0
1,GO NUCLEOTIDE SALVAGE,0.1146,0.11239,0.13822,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.084763,0.11071,0.13414,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.039795,0.11058,0.10713,0,0
1,GO RESPONSE TO PARATHYROID HORMONE,0.13763,0.11048,0.10238,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.41899,0.10972,0.053391,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.19979,0.10952,0.12284,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.178,0.10919,0.065018,0,0
1,GO REGULATION OF BIOMINERALIZATION,0.01016,0.10908,0.157,0,0
1,GO GOLGI LOCALIZATION,0.074349,0.10871,0.1079,0,0
1,GO HISTAMINE SECRETION,0.28761,0.10829,0.085565,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.025743,0.10748,0.13644,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.68689,0.10732,0.0097558,0,0
1,GO RESPONSE TO ACIDIC PH,0.22503,0.10677,0.078858,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.022446,0.10598,0.14691,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.24416,0.10573,0.12615,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.14419,0.10502,0.082885,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.28945,0.10477,0.052153,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.10912,0.10403,0.14536,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.27853,0.10394,0.063574,0,0
1,GO BILE ACID METABOLIC PROCESS,0.31215,0.10328,0.045808,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.24089,0.1028,0.069833,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.36098,0.10178,0.049568,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.03068,0.1016,0.091483,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.27853,0.101,0.07328,0,0
1,GO MRNA MODIFICATION,0.10646,0.10009,0.097389,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.099614,0.099065,0.069427,0,0
1,GO LACTATE METABOLIC PROCESS,0.09796,0.09784,0.087404,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.084034,0.096526,0.12165,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.20122,0.096491,0.077936,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.14869,0.095129,0.075795,0,0
1,GO PROTEIN REFOLDING,0.26789,0.094864,0.055195,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.33194,0.094575,0.02597,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.50776,0.094402,0.072775,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.069238,0.094168,0.095424,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.3739,0.093937,-0.0010805,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.015674,0.093935,0.12876,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.01829,0.093736,0.15227,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.20699,0.093735,0.096111,0,0
1,GO FATTY ACID HOMEOSTASIS,0.10646,0.093589,0.089513,0,0
1,GO RRNA 3 END PROCESSING,0.074349,0.093575,0.059152,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.10646,0.093539,0.09474,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.40514,0.093283,0.071233,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.39156,0.09317,0.11441,0,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.03006,0.092524,0.10033,0,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.1313,0.092518,0.081298,0,0
1,GO KINETOCHORE ASSEMBLY,0.13979,0.092152,0.053699,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.27317,0.092145,0.10878,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.080464,0.091867,0.08122,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.40286,0.091762,0.041474,0,0
1,GO MESONEPHROS DEVELOPMENT,0.099614,0.091727,0.091665,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.12924,0.091071,0.21791,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0074579,0.091052,0.12171,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.11647,0.091009,0.23033,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.25753,0.090444,0.053946,0,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0013826,0.090398,0.12091,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.19697,0.090216,0.075703,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.10558,0.090176,0.092064,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.071119,0.090169,0.10293,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.1533,0.089967,0.073803,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.21587,0.089346,0.091364,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.011813,0.088939,0.14451,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.10129,0.088541,0.092593,0,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.076344,0.088418,0.10386,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.11002,0.088211,0.068752,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.078382,0.087786,0.050361,0,0
1,GO RESPONSE TO PH,0.090011,0.08776,0.095713,0,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.084763,0.087592,0.12873,0,0
1,GO MAST CELL ACTIVATION,0.30829,0.087386,0.068804,0,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.32195,0.086891,0.025704,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.14419,0.086839,0.079217,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.22503,0.086174,0.081388,0,0
1,GO SNORNA 3 END PROCESSING,0.20699,0.086105,0.043765,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.23286,0.086051,0.059543,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.5583,0.085901,0.01608,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.28395,0.085807,0.076528,0,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0031247,0.085661,0.1595,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.084034,0.085268,0.11328,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.20122,0.084779,0.082129,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.35463,0.08451,0.020566,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.31997,0.084501,0.038205,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.06986,0.084177,0.081174,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.077018,0.084176,0.081423,0,0
1,GO EXTRACELLULAR TRANSPORT,0.25753,0.084083,0.06549,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.25924,0.083765,0.066173,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.015501,0.083591,0.084394,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.013856,0.083332,0.1227,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.11933,0.083166,0.084092,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.37173,0.082928,0.052371,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.59424,0.08292,0.056472,0,0
1,GO LIPID EXPORT FROM CELL,0.071756,0.082839,0.084593,0,0
1,GO LIMB BUD FORMATION,0.45727,0.082379,0.13602,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.11647,0.081996,0.22835,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.033271,0.080964,0.11209,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.086981,0.080929,0.067139,0,0
1,GO ALDITOL METABOLIC PROCESS,0.015159,0.080885,0.13345,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.2114,0.08079,0.063349,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.1146,0.080771,0.065379,0,0
1,GO GLAND DEVELOPMENT,0.093918,0.080145,0.07963,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.22348,0.080066,0.1013,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.35886,0.079834,0.066308,0,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.10734,0.07914,0.099117,0,0
1,GO PROTEIN TRIMERIZATION,0.39381,0.078948,0.047547,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.12224,0.07786,0.081658,0,0
1,GO NAD METABOLIC PROCESS,0.68988,0.07769,0.021902,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.1873,0.077293,0.064248,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.2913,0.077182,0.079074,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.090011,0.07704,0.12703,0,0
1,GO ARACHIDONIC ACID SECRETION,0.16042,0.076982,0.064117,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10823,0.076092,0.091959,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.16042,0.076003,0.080965,0,0
1,GO SMOOTHENED SIGNALING PATHWAY,0.086237,0.075547,0.084589,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.35674,0.075342,0.1203,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.19003,0.075264,0.062715,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.14088,0.075096,0.031168,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.61687,0.074957,0.00084607,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.39606,0.074926,0.055613,0,0
1,GO RESPONSE TO ATP,0.016386,0.074905,0.090084,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.084763,0.074841,0.10828,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.20122,0.074602,0.066799,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.037139,0.074582,0.067467,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.1146,0.074437,0.14388,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.24745,0.074277,0.087403,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.19003,0.074135,0.065675,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.28213,0.074045,0.064135,0,0
1,GO SEGMENTATION,0.1873,0.073224,0.069198,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.095518,0.073146,0.07414,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.48468,0.073132,0.079825,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.47461,0.072728,0.071796,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.70486,0.072613,0.029551,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.070488,0.072581,0.13225,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.1914,0.072554,0.14705,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.032278,0.072551,0.11073,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.24745,0.072382,0.065034,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.12721,0.072269,0.078663,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.28395,0.072109,0.080115,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.43312,0.072105,0.036226,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.09796,0.072046,0.06887,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.010645,0.072004,0.091144,0,0
1,GO BONE MINERALIZATION,0.34008,0.071973,0.07858,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.36311,0.071939,0.049242,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.10558,0.071916,0.10114,0,0
1,GO GLIAL CELL DEVELOPMENT,0.40058,0.071784,0.045501,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.24911,0.071494,0.042006,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.28761,0.071243,0.016355,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.25753,0.071219,0.11547,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.59986,0.070905,0.021779,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.10045,0.070892,0.062741,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.19979,0.070778,0.15964,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.56103,0.070364,0.029891,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.56925,0.070242,0.061649,0,0
1,GO REPLICATION FORK PROCESSING,0.1914,0.069952,0.064774,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.63697,0.069894,0.066209,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0095807,0.069834,0.11702,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.41666,0.069243,0.067687,0,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.73822,0.069143,0.0067538,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.05357,0.069009,0.13966,0,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.11553,0.06881,0.095927,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.24745,0.068009,0.052217,0,0
1,GO HEART GROWTH,0.008211,0.067922,0.12687,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.082591,0.067635,0.089391,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.1873,0.067486,0.05438,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.090782,0.066593,0.11851,0,0
1,GO TAXIS,0.06986,0.066342,0.078813,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.14642,0.06631,0.058604,0,0
1,GO GDP METABOLIC PROCESS,0.90167,0.066218,-0.012962,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.25246,0.066186,0.071055,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.83158,0.066128,-0.016225,0,0
1,GO APPENDAGE DEVELOPMENT,0.084034,0.066094,0.094546,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.13027,0.065781,0.074342,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.19417,0.065585,0.076916,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.2458,0.065441,0.070355,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.2114,0.065373,0.064256,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.26095,0.065214,0.090718,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.84424,0.065194,0.034284,0,0
1,GO INTESTINAL ABSORPTION,0.49231,0.065194,0.059471,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.14755,0.06511,0.061111,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.18866,0.064285,0.07601,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.12224,0.064268,0.076155,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.35043,0.063901,0.038277,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.36098,0.06355,0.068943,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.86012,0.063298,0.01697,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.11933,0.062949,0.092892,0,0
1,GO FEMALE GAMETE GENERATION,0.18062,0.062744,0.039921,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.1653,0.062679,0.17229,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.58307,0.062576,0.038378,0,0
1,GO RENAL SYSTEM PROCESS,0.36956,0.062554,0.069465,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.55287,0.062416,0.034908,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.11367,0.062372,0.0741,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.043444,0.062229,0.077457,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.20265,0.062224,0.10442,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.59424,0.061974,0.054389,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.6691,0.06197,-0.045168,0,0
1,GO HISTAMINE TRANSPORT,0.65734,0.061956,0.029746,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.13549,0.06194,0.071361,0,0
1,GO AEROBIC RESPIRATION,0.10214,0.061935,0.048485,0,0
1,GO ECTODERM DEVELOPMENT,0.084034,0.06159,0.087805,0,0
1,GO REGULATION OF BONE REMODELING,0.13549,0.061042,0.08606,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.09796,0.061021,0.089535,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.19979,0.060534,0.084242,0,0
1,GO ORGAN INDUCTION,0.22195,0.060126,0.075428,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.30829,0.060015,0.037847,0,0
1,GO FILOPODIUM ASSEMBLY,0.98546,0.059998,0.0082447,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.41666,0.059964,0.047962,0,0
1,GO ENDOCYTOSIS,0.0053519,0.059936,0.10526,0,0
1,GO PHAGOSOME MATURATION,0.39381,0.059866,0.052423,0,0
1,GO ZINC ION HOMEOSTASIS,0.25753,0.059548,0.10055,0,0
1,GO ANIMAL ORGAN MATURATION,0.41203,0.059385,0.053952,0,0
1,GO NEGATIVE CHEMOTAXIS,0.28761,0.059291,0.059374,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.14419,0.059247,0.069388,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.079071,0.059173,0.10811,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.86012,0.058977,0.0060132,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.40286,0.058907,0.047713,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.64567,0.058605,0.031901,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.75664,0.058268,0.016007,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.56103,0.058226,0.040886,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.29689,0.058215,0.074112,0,0
1,GO CENTROSOME SEPARATION,0.16778,0.058065,0.039259,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.21738,0.057988,0.054056,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.081168,0.05797,0.090667,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.3442,0.05789,0.030063,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.45727,0.057832,0.04469,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.23445,0.057637,0.051713,0,0
1,GO REGULATION OF SENSORY PERCEPTION,0.21889,0.057552,0.04852,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.43789,0.057541,0.037155,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.14755,0.057185,0.016912,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.31021,0.056851,0.050234,0,0
1,GO RESPONSE TO IRON ION,0.51819,0.056611,0.039294,0,0
1,GO RESPONSE TO BMP,0.073694,0.05633,0.10093,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.15447,0.05623,0.025716,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.43789,0.056169,0.042408,0,0
1,GO ADAPTIVE THERMOGENESIS,0.27673,0.056055,0.054301,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.79075,0.055745,0.013572,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.2714,0.055614,0.061091,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.29689,0.055573,0.075593,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.021509,0.055489,0.1159,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.62545,0.055148,0.040307,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.32592,0.054949,0.044292,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.32792,0.054866,0.06065,0,0
1,GO KIDNEY MORPHOGENESIS,0.2458,0.054701,0.062111,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.22195,0.05463,0.107,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.24089,0.05452,0.033041,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.99192,0.054463,-0.023234,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.1453,0.054367,0.054706,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.12924,0.054285,0.11727,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.74741,0.054214,0.041455,0,0
1,GO RESPONSE TO ETHANOL,0.50258,0.054052,0.03624,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.59705,0.05392,0.015124,0,0
1,GO OVULATION CYCLE PROCESS,0.61402,0.053887,0.02548,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.090011,0.053753,0.072531,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.1146,0.053598,0.054544,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.16778,0.053411,0.07785,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.10045,0.053148,0.10332,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.070488,0.053085,0.086722,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.47211,0.052942,0.040697,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.52082,0.052816,0.047423,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.21288,0.052684,0.058271,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.89846,0.052655,0.00041435,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.6515,0.052192,0.038449,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.11933,0.052099,0.054909,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.17156,0.051969,0.057813,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.21437,0.051828,0.083401,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.95961,0.051816,-0.030545,0,0
1,GO RESPONSE TO AMYLOID BETA,0.54477,0.051639,0.043749,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.086981,0.051603,0.040459,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.23128,0.051551,0.053297,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.27673,0.051473,0.071833,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.15802,0.051448,0.062463,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.15802,0.051292,0.06292,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.22814,0.051186,0.050943,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.30066,0.051157,0.034624,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.081168,0.051132,0.07109,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.23128,0.050828,0.10752,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.11647,0.050806,0.082332,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.21889,0.050765,0.03797,0,0
1,GO RESPONSE TO MISFOLDED PROTEIN,0.051595,0.050708,0.1112,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.1252,0.050661,0.080177,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.02521,0.050486,0.059,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.47712,0.050301,0.064005,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.21288,0.050045,0.069317,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.30255,0.049908,0.064264,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.12924,0.049629,0.053204,0,0
1,GO ORGANELLE FISSION,0.20122,0.049552,0.018366,0,0
1,GO RENAL SODIUM EXCRETION,0.9693,0.049329,-0.0073941,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.21738,0.049242,0.066693,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.26267,0.049196,0.074035,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.30066,0.04912,0.060127,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.14755,0.049095,0.051243,0,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.074349,0.049052,0.060279,0,0
1,GO T CELL HOMEOSTASIS,0.17029,0.048993,0.076638,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.27853,0.048944,0.041039,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.51557,0.048776,0.032672,0,0
1,GO FUCOSE METABOLIC PROCESS,0.4355,0.048735,0.046965,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.2114,0.048712,0.050069,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.11553,0.048704,0.097393,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.2644,0.048613,0.072575,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.36526,0.048475,0.061917,0,0
1,GO OVULATION CYCLE,0.20265,0.048475,0.064606,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.088486,0.048372,0.07756,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.72299,0.04807,-0.030942,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.6312,0.047913,0.034789,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.078382,0.047559,0.11967,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.73822,0.047415,0.027288,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.12822,0.047323,0.060624,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.86649,0.047281,-0.01007,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.2913,0.046964,0.041587,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.67501,0.046767,-0.0055853,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.27495,0.046754,0.056088,0,0
1,GO WATER TRANSPORT,0.34213,0.046592,0.060693,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.28761,0.046567,0.061066,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.24911,0.046402,0.10206,0,0
1,GO CENTROSOME DUPLICATION,0.1533,0.046325,0.057724,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.50258,0.046086,0.050388,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.22042,0.04608,0.067577,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.53406,0.045943,0.027696,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.43075,0.045897,0.063231,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.45238,0.045636,0.057993,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4451,0.045556,0.024276,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.98546,0.045502,-0.023185,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.22814,0.045345,0.0094117,0,0
1,GO STEM CELL PROLIFERATION,0.38933,0.045309,0.041658,0,0
1,GO VITAMIN TRANSPORT,0.99515,0.045212,0.0051473,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.58864,0.044979,0.033957,0,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.3442,0.044899,0.032978,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.42133,0.044847,0.038348,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.30829,0.044761,0.067459,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.80012,0.044592,0.037904,0,0
1,GO SULFATE TRANSPORT,0.32592,0.044559,0.028216,0,0
1,GO MRNA METHYLATION,0.27853,0.044047,0.079934,0,0
1,GO LIPID DROPLET ORGANIZATION,0.21889,0.043908,0.057012,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.82211,0.043818,0.0012547,0,0
1,GO APPENDAGE MORPHOGENESIS,0.13656,0.043812,0.084951,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.18194,0.043785,0.03207,0,0
1,GO RESPONSE TO ZINC ION,0.6691,0.043457,0.034985,0,0
1,GO REPRODUCTION,0.21738,0.043457,0.042137,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.12029,0.04341,0.088392,0,0
1,GO BASE EXCISION REPAIR,0.1313,0.043274,0.037418,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.80012,0.042979,0.026858,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.81267,0.04285,0.01765,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.43789,0.042818,0.02663,0,0
1,GO GLYCOSYLATION,0.16407,0.042707,0.046727,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.069238,0.042644,0.056663,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.48976,0.042602,0.061191,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.64567,0.042526,0.035107,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.22195,0.042509,0.053096,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.67798,0.042461,0.020741,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.66616,0.042443,0.0030759,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.77519,0.042408,-0.044408,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.56376,0.042299,0.034035,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.13027,0.042261,0.060971,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.30255,0.041983,0.059012,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.2714,0.041944,0.060444,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.30446,0.04193,0.064951,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.16042,0.041427,0.05022,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.40514,0.041266,0.026624,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.86012,0.041081,0.0088936,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.71089,0.041016,0.014655,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.9693,0.040879,-0.0052716,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.68094,0.040722,0.001016,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.35674,0.040706,0.046845,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.59144,0.040661,0.024961,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.34008,0.040547,0.073955,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.27853,0.040452,0.04839,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.46962,0.040096,0.048258,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.28945,0.040065,0.038613,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.30446,0.040056,0.042754,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.572,0.040036,0.021741,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.33803,0.040008,0.037076,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.97253,0.039831,0.0056765,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.94348,0.039829,-0.030201,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.94348,0.039788,-0.013562,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.27853,0.039783,0.053662,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.20409,0.039587,0.043248,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.32792,0.039563,0.048573,0,0
1,GO POLYOL METABOLIC PROCESS,0.15565,0.039507,0.059879,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.55558,0.038958,0.021517,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.88565,0.038538,-0.0018314,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.87926,0.038473,-0.0051936,0,0
1,GO MISMATCH REPAIR,0.26267,0.038407,0.025028,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.1453,0.038078,0.049514,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.25246,0.038077,0.028696,0,0
1,GO MANNOSYLATION,0.80639,0.037979,0.014475,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.45972,0.037708,0.062545,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.53406,0.03766,0.029573,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.40514,0.037441,0.047556,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.19417,0.037195,0.057357,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.49487,0.036896,0.03037,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.081168,0.036868,0.063838,0,0
1,GO MITOCHONDRION ORGANIZATION,0.11647,0.036867,0.04139,0,0
1,GO REGULATION OF GROWTH,0.16778,0.036817,0.053464,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.29689,0.036731,0.10578,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.71693,0.036588,0.03297,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.59424,0.036484,0.019666,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.22814,0.035996,0.080869,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.10214,0.035981,0.10848,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.14755,0.035824,0.03188,0,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.34627,0.035529,0.028032,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.088486,0.035525,0.095092,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.14869,0.035201,0.068574,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.96607,0.035188,-0.0018803,0,0
1,GO SECONDARY METABOLIC PROCESS,0.41899,0.035188,0.027684,0,0
1,GO MEMBRANE BIOGENESIS,0.63408,0.035063,0.038183,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.44269,0.034777,-0.11108,0,0
1,GO CONVERGENT EXTENSION,0.22658,0.034496,0.0875,0,0
1,GO NADH METABOLIC PROCESS,0.87287,0.034475,-0.0098887,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.19417,0.034437,0.052786,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.50776,0.034337,0.02953,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.20122,0.034222,0.041836,0,0
1,GO RESPONSE TO COPPER ION,0.52874,0.0342,0.037683,0,0
1,GO MIDBRAIN DEVELOPMENT,0.10299,0.034111,0.086791,0,0
1,GO GROWTH,0.077018,0.034069,0.066449,0,0
1,GO METHIONINE METABOLIC PROCESS,0.31997,0.034007,0.033886,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.68988,0.03367,0.022203,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.59705,0.033523,0.030913,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.97899,0.033202,0.0084026,0,0
1,GO DIGESTIVE SYSTEM PROCESS,0.85376,0.033182,0.013044,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.59424,0.03316,0.036002,0,0
1,GO PROTEIN DENEDDYLATION,0.36741,0.033149,0.039855,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.99192,0.032703,-0.0098654,0,0
1,GO ORGANELLE ASSEMBLY,0.17283,0.032614,0.039924,0,0
1,GO EYE MORPHOGENESIS,0.44269,0.032564,0.042388,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.6312,0.032406,0.046417,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.178,0.032371,0.063874,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.69286,0.032119,0.018626,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.43312,0.032071,0.020119,0,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.2458,0.032024,0.07725,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.96284,0.03179,0.0057521,0,0
1,GO REGULATION OF EXCRETION,0.9113,0.031664,0.0069603,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.066792,0.031577,0.068492,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.74435,0.03145,0.039979,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.73822,0.031445,0.020573,0,0
1,GO DIOL METABOLIC PROCESS,0.81581,0.031329,0.0074449,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.46713,0.030917,0.034086,0,0
1,GO DEVELOPMENTAL GROWTH,0.55287,0.030849,0.0322,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.2714,0.030844,0.082568,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.28945,0.030815,0.054225,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.40286,0.030783,0.018906,0,0
1,GO REGULATION OF AXON GUIDANCE,0.39832,0.030541,0.036476,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.59705,0.030467,0.017849,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.23445,0.030363,0.067461,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.10214,0.030335,0.048358,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.28213,0.030299,0.065942,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.19278,0.030243,0.089221,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.90167,0.030054,0.0021002,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.36741,0.029992,0.047025,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.32592,0.029904,0.046902,0,0
1,GO CELL PROJECTION ASSEMBLY,0.23445,0.029456,0.054016,0,0
1,GO SISTER CHROMATID SEGREGATION,0.14755,0.029417,0.020814,0,0
1,GO REGULATION OF CELLULAR PH,0.40286,0.029132,0.032269,0,0
1,GO CHROMOSOME CONDENSATION,0.57752,0.029038,-0.004953,0,0
1,GO REGULATION OF CELL SIZE,0.70486,0.028971,0.01928,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.52345,0.028736,0.057064,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.23605,0.028674,0.06923,0,0
1,GO CELLULAR RESPONSE TO PH,0.97576,0.028663,0.0081045,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.26964,0.028652,0.039237,0,0
1,GO GLIOGENESIS,0.81267,0.028295,0.019179,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.97576,0.028272,-0.0013959,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.3871,0.028258,0.055543,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.40514,0.028194,0.078768,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.22658,0.028162,0.044025,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.45238,0.028024,0.042292,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47712,0.027873,-0.047464,0,0
1,GO AMINO ACID IMPORT,0.76899,0.027818,-0.0022738,0,0
1,GO COENZYME A METABOLIC PROCESS,0.7814,0.027785,0.024988,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.50258,0.02764,0.045276,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.90167,0.027575,0.0012687,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.77519,0.027445,-0.032579,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.2458,0.027313,0.027416,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.26614,0.027064,0.065193,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.50776,0.027004,0.020792,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.70185,0.026873,-0.025307,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.41666,0.026857,0.053408,0,0
1,GO RESPONSE TO FUNGUS,0.62258,0.026824,0.030549,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.22814,0.026736,0.053931,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.43312,0.026674,0.024502,0,0
1,GO HISTONE EXCHANGE,0.54477,0.026624,-0.0042309,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.25753,0.026621,0.063931,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.15447,0.026475,0.054849,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.59705,0.026359,0.021811,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.45727,0.025852,0.061963,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.71996,0.025823,0.0051092,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.14419,0.02581,0.11621,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.39381,0.025752,0.066614,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.28945,0.025743,0.049301,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.86331,0.025616,-0.021256,0,0
1,GO HISTONE H3 DEACETYLATION,0.44269,0.025526,0.044895,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.47963,0.025436,0.033532,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.1914,0.025412,0.073585,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.55287,0.025401,0.01467,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.33194,0.025367,0.087986,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.94671,0.025127,0.0026931,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.56103,0.025058,0.0051983,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.90488,0.025009,-0.044008,0,0
1,GO DEMETHYLATION,0.6055,0.024347,0.032951,0,0
1,GO CELLULAR RESPIRATION,0.28761,0.024296,0.0309,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.85376,0.0242,0.023346,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.59705,0.024196,0.028264,0,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.59424,0.024006,0.04294,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.22814,0.023941,0.062225,0,0
1,GO CELL GROWTH,0.64567,0.023924,0.029307,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.52609,0.023721,0.0043718,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.72603,0.023608,0.032272,0,0
1,GO ATP METABOLIC PROCESS,0.44269,0.023439,0.024375,0,0
1,GO DIET INDUCED THERMOGENESIS,0.95961,0.023424,0.0051484,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.25583,0.023363,0.084318,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.77209,0.023158,0.029434,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.10558,0.023079,0.062337,0,0
1,GO SCHWANN CELL DEVELOPMENT,0.64858,0.023053,0.03786,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.87606,0.022875,-0.034665,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.32592,0.022864,0.064218,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.57752,0.022817,0.039129,0,0
1,GO GONADOTROPIN SECRETION,0.26095,0.022792,0.076603,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.67501,0.022687,0.025547,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.60834,0.022603,0.030225,0,0
1,GO DNA REPLICATION,0.098784,0.022428,0.046956,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.46962,0.022268,0.049482,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.56376,0.022187,0.033481,0,0
1,GO RECEPTOR INTERNALIZATION,0.5394,0.022111,0.038626,0,0
1,GO CELLULAR HOMEOSTASIS,0.43075,0.021963,0.035548,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.26614,0.021735,0.048014,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.43075,0.021716,0.03786,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.85376,0.021709,-0.0098137,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.61117,0.021674,0.055701,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.7659,0.021647,-7.0731e-05,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.89526,0.021604,-0.010226,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.37608,0.021412,0.034544,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.68392,0.021241,0.0089513,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.69885,0.021206,-0.022613,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.28033,0.020907,0.052613,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.87287,0.020794,0.015407,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.55016,0.02059,-0.018864,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.82526,0.020546,0.021002,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.3442,0.020475,0.040332,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.60834,0.020355,0.024404,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.89526,0.020228,0.020324,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.19417,0.020173,0.077045,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.47963,0.020171,0.034156,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.60834,0.020124,0.036976,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.68689,0.019987,0.022717,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.76899,0.019773,0.0028098,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.28945,0.019731,0.044466,0,0
1,GO MYELIN MAINTENANCE,0.797,0.01956,0.039368,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.82842,0.019531,0.017008,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.40743,0.019327,0.036532,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.53672,0.019315,0.039301,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.45482,0.019304,-0.030208,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.67501,0.019196,-0.0031022,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.46713,0.019195,0.04644,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.70486,0.019101,0.021516,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.31604,0.018997,0.05696,0,0
1,GO REGULATION OF RNA SPLICING,0.62258,0.018956,0.01572,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.34835,0.018929,0.022927,0,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.55016,0.018857,0.038776,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.7814,0.018845,-0.010972,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.5314,0.018792,0.037502,0,0
1,GO LYMPH NODE DEVELOPMENT,0.50516,0.018704,0.066378,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.37173,0.01869,0.037883,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.54746,0.01852,0.031476,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.99515,0.018188,0.0058357,0,0
1,GO REGULATION OF TUBE SIZE,0.3739,0.01809,0.050633,0,0
1,GO RESPONSE TO CAMP,0.17283,0.017967,0.07724,0,0
1,GO NEURON PROJECTION REGENERATION,0.71693,0.017833,0.036965,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.59986,0.017771,-0.033114,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.10734,0.017651,0.034821,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.49231,0.017338,0.041866,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.96284,0.017316,0.014179,0,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.56103,0.017252,0.030375,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.80326,0.017226,0.035857,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.85694,0.017214,0.022658,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.72907,0.017137,-0.013405,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.42838,0.017123,0.03447,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.82526,0.017079,0.0088539,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.95316,0.017046,0.0052305,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.70486,0.016757,0.033976,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.70486,0.016724,0.022067,0,0
1,GO HISTONE H3 K27 METHYLATION,0.77209,0.016671,0.0071872,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.72603,0.01662,0.017111,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.86012,0.01661,0.0074239,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.51035,0.016556,0.03945,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.62832,0.016524,-0.015856,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.32792,0.016388,0.055891,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.33599,0.016344,0.051099,0,0
1,GO ION HOMEOSTASIS,0.47712,0.016042,0.037195,0,0
1,GO CARBOHYDRATE TRANSPORT,0.7659,0.015933,0.019275,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.66028,0.015754,-0.0020079,0,0
1,GO VASCULAR WOUND HEALING,0.75356,0.015492,0.026954,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.28213,0.015404,0.043801,0,0
1,GO TOR SIGNALING,0.49487,0.015397,0.031888,0,0
1,GO DIGESTION,0.95316,0.015204,-0.0060541,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.92738,0.015204,0.015346,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.60834,0.015054,-0.011601,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99838,0.014975,0.00033014,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.3871,0.014959,0.027789,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.8379,0.014852,-0.0092564,0,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.65442,0.014818,0.0071243,0,0
1,GO REGULATION OF PH,0.56925,0.014769,0.024996,0,0
1,GO DNA REPLICATION INITIATION,0.77829,0.014705,-0.027992,0,0
1,GO THYMIC T CELL SELECTION,0.28578,0.014702,0.076161,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.97576,0.014666,-0.0048651,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.99192,0.014645,0.0072992,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.54477,0.014524,0.0055265,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.58029,0.014412,0.023807,0,0
1,GO CELL JUNCTION ASSEMBLY,0.90488,0.014399,0.019371,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.9306,0.014382,0.012118,0,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.76281,0.014313,0.011851,0,0
1,GO APOPTOTIC DNA FRAGMENTATION,0.35674,0.014156,0.024106,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.38047,0.014144,0.045919,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.60834,0.014105,0.02449,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.88885,0.014054,0.0041558,0,0
1,GO MEIOTIC CELL CYCLE,0.96607,0.013921,-0.021479,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.89205,0.013888,-0.013968,0,0
1,GO G0 TO G1 TRANSITION,0.70185,0.013868,0.011447,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.46962,0.013833,0.038522,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.53672,0.013799,0.024217,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.31021,0.013682,0.062495,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.61687,0.01361,0.033264,0,0
1,GO CRISTAE FORMATION,0.5583,0.013452,0.047331,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.22971,0.013396,0.015533,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.30829,0.013316,0.11489,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.81896,0.013209,-0.017363,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.80326,0.013024,-0.017917,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.93382,0.013008,0.0038807,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.39832,0.012832,0.011568,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.16904,0.012661,0.053863,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.84741,0.012622,0.0054695,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.80326,0.012618,0.022011,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.12322,0.012413,0.037919,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.22195,0.012284,0.075058,0,0
1,GO SENSORY PERCEPTION OF TASTE,0.95639,0.01227,0.041841,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.88885,0.012059,-0.048925,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.68094,0.011872,-0.022789,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.22658,0.011757,0.11458,0,0
1,GO METAL ION HOMEOSTASIS,0.34835,0.01166,0.042417,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.78763,0.01155,0.02226,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.43075,0.011239,0.065384,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.58307,0.011186,-0.049213,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.14197,0.0111,0.052644,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.5314,0.01104,-0.024989,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.20409,0.011022,-0.065129,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.72299,0.010927,0.024549,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.58029,0.01067,-0.0085833,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.40973,0.010625,-0.038215,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.99192,0.010507,-0.0092984,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.74128,0.010343,0.02338,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.66616,0.01034,0.029435,0,0
1,GO RESPONSE TO LEAD ION,0.54746,0.010249,0.042207,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.98869,0.010067,0.0028469,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.23766,0.010008,-0.092979,0,0
1,GO EXIT FROM MITOSIS,0.97899,0.0099438,-0.0050862,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.94348,0.0098208,0.0031063,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.87926,0.0096185,-0.038858,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.92094,0.0094001,0.0010455,0,0
1,GO STRESS GRANULE ASSEMBLY,0.69586,0.0093243,0.018892,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.83474,0.0091954,0.025187,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.66321,0.0091053,-0.019596,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.72299,0.0090894,-0.018828,0,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.46218,0.0090282,0.033268,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.91451,0.0090014,0.010213,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.44994,0.0088947,0.020021,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.2714,0.0088843,0.14548,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.85376,0.0088415,-0.017699,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.34008,0.0088157,0.041129,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.43075,0.0087917,-0.029223,0,0
1,GO HEART TRABECULA FORMATION,0.73822,0.0086791,0.05826,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.57752,0.0085647,0.028581,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.77829,0.0084682,0.02078,0,0
1,GO TELOMERE CAPPING,0.73212,0.0083914,0.015654,0,0
1,GO MAGNESIUM ION TRANSPORT,0.82211,0.0083731,-0.01523,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.86968,0.0083074,-0.0015144,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.45972,0.0079786,0.034472,0,0
1,GO FEVER GENERATION,0.97576,0.0077718,-0.015154,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.94026,0.0076624,0.010541,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.70486,0.0073919,0.041553,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.86968,0.0073818,0.013348,0,0
1,GO STEROID CATABOLIC PROCESS,0.78763,0.0073403,0.023009,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.80012,0.00733,0.010599,0,0
1,GO OOCYTE MATURATION,0.60268,0.0071699,-0.041798,0,0
1,GO NOTCH SIGNALING PATHWAY,0.72299,0.0071229,-0.00039866,0,0
1,GO POSITIVE T CELL SELECTION,0.21587,0.0070259,0.089996,0,0
1,GO KINETOCHORE ORGANIZATION,0.61402,0.0069549,-0.022704,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.53672,0.0066334,-0.0070995,0,0
1,GO DEPHOSPHORYLATION,0.85694,0.0064472,0.021385,0,0
1,GO REGULATION OF MRNA PROCESSING,0.88565,0.0064019,0.0065773,0,0
1,GO AUTOPHAGIC CELL DEATH,0.58307,0.0062886,0.049028,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.80639,0.0061921,-0.011266,0,0
1,GO MYELIN ASSEMBLY,0.68689,0.0059437,0.052826,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.51819,0.0058557,0.036419,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.69885,0.0055994,-0.0055206,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.66616,0.0055753,0.04079,0,0
1,GO DNA PACKAGING,0.84107,0.0054882,-0.014456,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.9113,0.0054011,0.019777,0,0
1,GO MUSCLE SYSTEM PROCESS,0.5394,0.0053499,0.037298,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.99838,0.0052733,0.013469,0,0
1,GO OXIDATIVE DEMETHYLATION,0.81267,0.005011,-0.013473,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.62258,0.0049389,0.048383,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.58307,0.0048463,0.029434,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.87926,0.0047469,-0.00066981,0,0
1,GO LOCOMOTOR RHYTHM,0.87606,0.0047158,0.019809,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.89205,0.0046102,-0.011504,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.7659,0.0045358,0.019766,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.30446,0.0044298,0.046435,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.83158,0.0043959,-0.011627,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.86649,0.0043187,0.0028852,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.62832,0.0043096,0.0068396,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.80326,0.0042975,0.036896,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.66028,0.0041764,0.021202,0,0
1,GO RESPONSE TO COLD,0.73517,0.003932,-0.008139,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.37608,0.0038931,0.063635,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.64858,0.0035664,-0.0072197,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.69286,0.0034701,-0.037919,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.66028,0.0034673,-0.010248,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.77209,0.0033523,0.030506,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.86649,0.0032568,-0.0027058,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.36311,0.003219,-0.070759,0,0
1,GO SISTER CHROMATID COHESION,0.75664,0.0031694,-0.010325,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.54477,0.0031084,0.028816,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.82842,0.0030168,-0.023587,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.77829,0.002809,-0.042706,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.318,0.0027242,-0.044972,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.797,0.002705,0.00036032,0,0
1,GO LYSOSOME LOCALIZATION,0.35043,0.0026298,0.054576,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.67206,0.0024959,0.033565,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.41203,0.0024633,0.072218,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.85376,0.0022699,-0.0051091,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.99838,0.0019171,0.015347,0,0
1,GO MULTI ORGANISM PROCESS,0.59144,0.0018923,0.02334,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.70787,0.0018045,0.021528,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.37173,0.0017561,0.10364,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.40743,0.0016645,-0.045578,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.21288,0.0016644,-0.049623,0,0
1,GO RECOMBINATIONAL REPAIR,0.46962,0.0015428,0.025145,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.82842,0.0015402,0.023533,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.58585,0.0014913,0.028452,0,0
1,GO RESPONSE TO STARVATION,0.71391,0.0013799,0.0083967,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.44994,0.0012194,0.056979,0,0
1,GO RESPONSE TO LEPTIN,0.65442,0.0010894,0.042986,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.70787,0.0010834,-0.011197,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.58307,0.0010541,0.059063,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.93382,0.00086277,-0.012042,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.55558,0.00084126,0.034301,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.36311,0.00037504,0.019197,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.45727,0.0003318,0.042271,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.88885,0.00021694,0.018952,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.6691,2.7215e-05,-0.0233,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85694,-3.8261e-05,0.024241,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.99192,-6.8968e-05,0.0035344,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.39832,-0.00018445,-0.055692,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.43789,-0.00027461,0.049893,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.62832,-0.00052663,-0.013148,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.92094,-0.00054032,0.0092532,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.82842,-0.00055352,0.0093306,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.572,-0.00058121,-0.0010997,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.71089,-0.00072677,0.035941,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.39381,-0.00098367,0.049858,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.90809,-0.0010864,0.013352,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.73212,-0.0011035,-0.019565,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.38488,-0.0012098,0.058404,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.29877,-0.0016503,-0.053545,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.69286,-0.0017627,-0.026619,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.56376,-0.0017702,-0.02259,0,0
1,GO DNA REPLICATION CHECKPOINT,0.82526,-0.0019824,-0.0079779,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.5,-0.0022874,0.050887,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.35886,-0.0029645,0.033326,0,0
1,GO HISTONE H3 K4 METHYLATION,0.87287,-0.0029941,-0.033057,0,0
1,GO HISTONE H3 K9 METHYLATION,0.77829,-0.0029958,-0.00061708,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.91772,-0.0031109,-0.00078135,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.62258,-0.003195,0.033733,0,0
1,GO NUCLEOSOME ORGANIZATION,0.75972,-0.0032268,-0.009671,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.45238,-0.0034124,0.03207,0,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.24252,-0.0035308,-0.075419,0,0
1,GO WATER HOMEOSTASIS,0.80012,-0.0040865,-0.0070928,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.48976,-0.0041499,0.02873,0,0
1,GO REGULATION OF TOR SIGNALING,0.97899,-0.0042516,0.015081,0,0
1,GO ZINC ION TRANSPORT,0.54746,-0.004507,0.04924,0,0
1,GO FERTILIZATION,0.19417,-0.0045632,-0.035274,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.41434,-0.0046483,-0.029288,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.89205,-0.0047879,0.0037906,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.68392,-0.0049455,0.02794,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.37608,-0.0050049,0.041136,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.5394,-0.005036,-0.0094617,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.090782,-0.0050785,-0.060732,0,0
1,GO DOSAGE COMPENSATION,0.86012,-0.0050842,0.024841,0,0
1,GO SOMITOGENESIS,0.98869,-0.005126,0.017165,0,0
1,GO HEART VALVE FORMATION,0.63697,-0.0051496,0.042598,0,0
1,GO CHEMICAL HOMEOSTASIS,0.80012,-0.005234,0.020287,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.51819,-0.0053005,-0.043278,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.62258,-0.0053842,-0.003082,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.79387,-0.0054231,0.027055,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.96284,-0.0058427,0.011151,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.94671,-0.0059955,0.013772,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.58585,-0.0061151,-0.046862,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56376,-0.006217,-0.015209,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.96607,-0.0064264,0.0061695,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.80326,-0.0066513,-0.012997,0,0
1,GO HISTONE H2A ACETYLATION,0.7814,-0.0067681,0.002192,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.75972,-0.0068222,0.00017671,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.77209,-0.0070095,0.003734,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.75972,-0.0070387,0.030778,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.77829,-0.0071181,-0.0041742,0,0
1,GO SEXUAL REPRODUCTION,0.33599,-0.0076335,-0.019489,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.83158,-0.0076798,0.016312,0,0
1,GO VESICLE LOCALIZATION,0.92094,-0.0079681,0.017911,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.59424,-0.0083487,-0.030166,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.71693,-0.0084658,-0.0068603,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.82526,-0.0085204,0.0078516,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.84741,-0.0085563,0.007181,0,0
1,GO MICROTUBULE NUCLEATION,0.59986,-0.0085707,-0.013195,0,0
1,GO PROTEIN DEMETHYLATION,0.63986,-0.0087893,-0.017069,0,0
1,GO GLUCOSE IMPORT,0.90488,-0.0088482,0.018649,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.94348,-0.0089086,0.0038498,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.92094,-0.0089586,-0.028676,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.59705,-0.0093597,-0.029826,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.93382,-0.0093682,0.010152,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.39381,-0.0096187,-0.022246,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.85376,-0.0096622,-0.010508,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.32393,-0.0098225,0.15507,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.14869,-0.0098637,-0.050771,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.2714,-0.0099996,0.068004,0,0
1,GO PROTEIN MANNOSYLATION,0.43075,-0.010062,-0.030184,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.37827,-0.01008,-0.05659,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.75048,-0.01014,-0.026856,0,0
1,GO MEMBRANE FUSION,0.86331,-0.010214,0.0057713,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.79075,-0.010262,0.025646,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.52609,-0.010505,-0.044808,0,0
1,GO PHOSPHATE ION TRANSPORT,0.6691,-0.010542,-0.0010483,0,0
1,GO MICROTUBULE ANCHORING,0.99838,-0.010705,0.01897,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.62832,-0.010856,0.046256,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.90167,-0.010997,0.005387,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.85694,-0.011078,-0.0060975,0,0
1,GO NEURON DEATH,0.62832,-0.011178,0.002188,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.87606,-0.011218,-0.00042714,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.74741,-0.011399,-0.0024456,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.41666,-0.011523,-0.018916,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.87606,-0.011581,0.0074205,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.40058,-0.011631,-0.019094,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.50516,-0.011643,-0.011409,0,0
1,GO EAR MORPHOGENESIS,0.89526,-0.011663,-0.0080693,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.82211,-0.012021,0.020336,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.58864,-0.012239,-0.015887,0,0
1,GO UTERUS DEVELOPMENT,0.23445,-0.012446,-0.072671,0,0
1,GO HISTONE METHYLATION,0.54746,-0.012559,-0.021557,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.51035,-0.012627,-0.02132,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.95639,-0.012688,-0.018194,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.73212,-0.012706,-0.015862,0,0
1,GO EAR DEVELOPMENT,0.31215,-0.012819,-0.048202,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.31997,-0.012923,0.072077,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.80012,-0.01293,0.033526,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.52345,-0.013009,-0.021139,0,0
1,GO T CELL SELECTION,0.21889,-0.013363,0.091509,0,0
1,GO RESPONSE TO INTERLEUKIN 2,0.78763,-0.013559,0.033262,0,0
1,GO PROTEIN ACETYLATION,0.43312,-0.01357,-0.017945,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.86331,-0.0137,-0.011857,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.84107,-0.013853,0.0092231,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.41899,-0.013949,-0.020453,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.94348,-0.014159,0.010715,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.7659,-0.014161,0.031231,0,0
1,GO ALANINE TRANSPORT,0.60268,-0.014251,-0.02095,0,0
1,GO OOGENESIS,0.39606,-0.014726,-0.037006,0,0
1,GO GAMETE GENERATION,0.53672,-0.01474,-0.01404,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.70486,-0.014844,-0.012387,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.21587,-0.01485,-0.029823,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.51296,-0.015077,-0.038149,0,0
1,GO RESPONSE TO ETHER,0.78451,-0.015129,0.010362,0,0
1,GO CAMP METABOLIC PROCESS,0.96284,-0.015308,0.037428,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.65442,-0.015357,0.038726,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.6312,-0.015598,-0.0024536,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.91451,-0.015644,0.0054871,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.72299,-0.015681,-0.0068588,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.84424,-0.015798,-0.0051343,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.84741,-0.015819,0.0076866,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.59705,-0.016125,-0.012438,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.86331,-0.016154,0.0009836,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.51035,-0.016535,-0.013687,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.84107,-0.016789,-0.016169,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.49231,-0.016882,-0.0039676,0,0
1,GO ENSHEATHMENT OF NEURONS,0.797,-0.01722,0.024904,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.64276,-0.017271,-0.021288,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.38267,-0.017359,-0.013871,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.36956,-0.017371,-0.025459,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.74128,-0.017548,-0.0013836,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.35463,-0.017642,-0.03896,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.20409,-0.018161,-0.053389,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.59424,-0.018216,-0.029095,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.84107,-0.018298,0.011079,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.7814,-0.018406,0.013954,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.6055,-0.018496,-0.0095031,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.68689,-0.018518,0.030922,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.36098,-0.018796,-0.041916,0,0
1,GO INOSITOL METABOLIC PROCESS,0.3442,-0.018967,-0.054825,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.69286,-0.019076,0.0060473,0,0
1,GO ORGANELLE LOCALIZATION,0.50516,-0.019097,-0.0051717,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.62545,-0.019227,0.00046345,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.45482,-0.019365,0.039851,0,0
1,GO CELL MORPHOGENESIS,0.50516,-0.019632,-0.0084199,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.80012,-0.019945,0.022022,0,0
1,GO PROTEIN ACYLATION,0.081168,-0.020116,-0.037872,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.71391,-0.020329,0.038493,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.81896,-0.0204,-0.010249,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.94348,-0.020422,0.025907,0,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.21738,-0.020753,-0.041925,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.49231,-0.020788,-0.060552,0,0
1,GO CARTILAGE MORPHOGENESIS,0.75048,-0.020841,-0.012562,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.28578,-0.020936,-0.047294,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.64858,-0.021061,0.04503,0,0
1,GO PARTURITION,0.88885,-0.021101,-0.011453,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.85694,-0.021114,-0.003534,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.95961,-0.021118,0.014152,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.75048,-0.021214,-0.0032776,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.51557,-0.021252,-0.0026526,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.91772,-0.021716,0.0017743,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.84741,-0.021899,0.022569,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.68988,-0.022212,-0.020637,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.98546,-0.022671,0.032644,0,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.20992,-0.022947,-0.078116,0,0
1,GO L AMINO ACID TRANSPORT,0.14755,-0.023025,-0.049091,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.48722,-0.023053,-0.024871,0,0
1,GO MICROTUBULE BASED PROCESS,0.22348,-0.023084,-0.035883,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.52082,-0.023676,0.051308,0,0
1,GO RESPONSE TO REDOX STATE,0.86968,-0.024416,0.01855,0,0
1,GO MALE GAMETE GENERATION,0.38047,-0.024434,-0.023523,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.32393,-0.02455,-0.033681,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.68988,-0.024751,0.04385,0,0
1,GO CELL FATE COMMITMENT,0.17029,-0.024998,-0.054885,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.87926,-0.025133,0.0031567,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.49487,-0.025304,-0.035121,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.46962,-0.025307,0.058561,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.19697,-0.02538,-0.04823,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.89846,-0.025491,0.011441,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.81267,-0.02561,0.032298,0,0
1,GO RHYTHMIC PROCESS,0.12224,-0.025684,-0.030601,0,0
1,GO FORELIMB MORPHOGENESIS,0.72603,-0.025687,-0.018709,0,0
1,GO INNER EAR MORPHOGENESIS,0.65442,-0.025705,-0.02843,0,0
1,GO CELL RECOGNITION,0.33396,-0.025754,-0.023886,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.94348,-0.025775,0.01618,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.71089,-0.025973,0.023808,0,0
1,GO REGULATION OF CELL MATURATION,0.88885,-0.025975,-0.016842,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50516,-0.026272,-0.046328,0,0
1,GO PROTEIN METHYLATION,0.41434,-0.026283,-0.028624,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.1533,-0.026432,-0.046714,0,0
1,GO POLYOL CATABOLIC PROCESS,0.55287,-0.026564,-0.028766,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.6691,-0.026594,-0.03652,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.35253,-0.02662,-0.014999,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.59144,-0.026791,-0.030544,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.57476,-0.026804,-0.0085086,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.87926,-0.026907,0.0045563,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.12721,-0.027141,-0.062528,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.68988,-0.027149,0.008659,0,0
1,GO REGULATION OF GLIOGENESIS,0.39606,-0.027197,-0.025165,0,0
1,GO STEROID HORMONE SECRETION,0.83158,-0.027355,0.0087596,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.81581,-0.027366,-0.029246,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.21738,-0.027614,-0.026834,0,0
1,GO NUCLEOTIDE TRANSPORT,0.28945,-0.027651,-0.039696,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.90167,-0.028003,0.015053,0,0
1,GO MITOCHONDRIAL FUSION,0.84741,-0.028093,0.0014047,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.98869,-0.028144,0.015339,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.10912,-0.028451,-0.04064,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.56376,-0.028643,-0.0034833,0,0
1,GO REGULATION OF NEURON MATURATION,0.09714,-0.028645,-0.1781,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.86012,-0.028685,0.012798,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.65442,-0.028931,-0.005456,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.89526,-0.029124,0.0050753,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.29689,-0.02914,-0.068926,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.22503,-0.029148,-0.045005,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.44752,-0.029247,-0.048007,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.7814,-0.029264,0.011305,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.1793,-0.029292,-0.053027,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.59144,-0.029395,-0.019721,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.6312,-0.029495,-0.021601,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.86649,-0.029544,0.012197,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.45238,-0.029619,-0.013882,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.60834,-0.029856,0.00015831,0,0
1,GO MUSCLE CONTRACTION,0.89205,-0.03016,0.014492,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.36956,-0.0302,-0.050817,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.20409,-0.030215,-0.026851,0,0
1,GO NEURON APOPTOTIC PROCESS,0.15802,-0.031485,-0.032933,0,0
1,GO CELL CYCLE DNA REPLICATION,0.79075,-0.031499,-0.028303,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.82211,-0.031937,-0.0033446,0,0
1,GO RENAL WATER HOMEOSTASIS,0.59986,-0.032136,-0.0070843,0,0
1,GO RESPONSE TO EPINEPHRINE,0.99515,-0.032177,-0.00085447,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.21738,-0.032242,-0.04885,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.44752,-0.03233,-0.04834,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.94993,-0.032854,0.013683,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.41434,-0.032857,0.043607,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.73212,-0.033098,-0.036646,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.87606,-0.033207,0.014178,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.5314,-0.033563,-0.013589,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.21738,-0.033835,-0.053254,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.30066,-0.03413,-0.06309,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.53672,-0.03429,-0.011764,0,0
1,GO RESPONSE TO AXON INJURY,0.57476,-0.034557,-0.010544,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.46466,-0.034635,-0.0133,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.62258,-0.034883,0.071716,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.97253,-0.034889,0.0058341,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.45238,-0.035103,-0.021762,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.26095,-0.035185,-0.077816,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.37827,-0.035374,-0.029318,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15214,-0.035376,-0.053264,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.54746,-0.035449,-0.0010591,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.83158,-0.03572,-0.0039447,0,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.54746,-0.035767,0.059589,0,0
1,GO SOMITE DEVELOPMENT,0.63697,-0.035919,-0.011048,0,0
1,GO TRANSFERRIN TRANSPORT,0.23128,-0.035999,-0.039219,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.40743,-0.036137,-0.013476,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.178,-0.036212,-0.058536,0,0
1,GO METANEPHROS MORPHOGENESIS,0.48468,-0.036506,-0.025429,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.39606,-0.036744,-0.076344,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.62545,-0.036826,-0.02322,0,0
1,GO THYROID GLAND DEVELOPMENT,0.55016,-0.036834,-0.018665,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.2644,-0.03695,-0.038149,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.178,-0.037322,-0.059186,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.14088,-0.037379,-0.033817,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.61117,-0.037445,-0.015173,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.44752,-0.037559,-0.0022344,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.73517,-0.037882,0.00037121,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.3442,-0.037927,-0.11449,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.19417,-0.038131,-0.048426,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.40743,-0.038291,-0.056214,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.94348,-0.038514,0.010897,0,0
1,GO VASODILATION,0.32393,-0.038683,-0.070218,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.23766,-0.038693,-0.065071,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.87606,-0.038908,0.026398,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.99838,-0.039082,0.01747,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.19979,-0.039262,-0.074012,0,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.21437,-0.039503,-0.060692,0,0
1,GO NUCLEOSOME ASSEMBLY,0.58585,-0.039563,-0.042667,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.22042,-0.03968,-0.039859,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.56376,-0.039701,-0.03393,0,0
1,GO AXON EXTENSION,0.34835,-0.040026,-0.039184,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.11092,-0.040376,-0.095355,0,0
1,GO DNA STRAND ELONGATION,0.48976,-0.041163,-0.061202,0,0
1,GO INORGANIC ANION TRANSPORT,0.16285,-0.041282,-0.026015,0,0
1,GO PH REDUCTION,0.67501,-0.041485,-0.0097264,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.27853,-0.041523,-0.023502,0,0
1,GO MITOTIC DNA REPLICATION,0.61972,-0.041622,-0.044339,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.13338,-0.042321,-0.041845,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.69286,-0.042422,0.031338,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.077698,-0.042511,-0.05991,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.53672,-0.042699,-0.030131,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.1754,-0.042741,-0.055533,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.47461,-0.043099,-0.026752,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.79387,-0.04358,-0.008181,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.1533,-0.043708,-0.062543,0,0
1,GO ACTIN CROSSLINK FORMATION,0.21437,-0.043714,-0.09145,0,0
1,GO RESPONSE TO METAL ION,0.40058,-0.043755,-0.010396,0,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.11742,-0.043836,-0.070587,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.26267,-0.043879,-0.021105,0,0
1,GO REGULATION OF TRANSPORT,0.15447,-0.044297,-0.020096,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.21587,-0.044357,-0.075481,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.32195,-0.044473,-0.024655,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.064418,-0.04481,-0.06912,0,0
1,GO ENERGY HOMEOSTASIS,0.1313,-0.045437,-0.074594,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.80326,-0.045597,0.0064753,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.17029,-0.046025,-0.03546,0,0
1,GO ORGANIC ANION TRANSPORT,0.50516,-0.046316,-0.0073181,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.21587,-0.046704,-0.042719,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.2913,-0.047316,-0.039145,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.66321,-0.04736,-0.0087243,0,0
1,GO ATP TRANSPORT,0.50516,-0.04794,-0.018869,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2714,-0.04814,-0.037334,0,0
1,GO SPERM MOTILITY,0.20699,-0.048279,-0.05166,0,0
1,GO PHOTOTRANSDUCTION,0.17283,-0.048935,-0.05254,0,0
1,GO GERM CELL DEVELOPMENT,0.11275,-0.049145,-0.048142,0,0
1,GO PENILE ERECTION,0.29315,-0.049191,-0.076984,0,0
1,GO HISTONE H4 ACETYLATION,0.12029,-0.049521,-0.053067,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.18194,-0.049885,-0.042476,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.071756,-0.04992,-0.10071,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.1653,-0.050167,-0.027996,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.12029,-0.050464,-0.10205,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.20845,-0.050596,-0.030685,0,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.071119,-0.050679,-0.03924,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.26614,-0.050781,-0.039337,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.68988,-0.050838,-0.0025096,0,0
1,GO SHORT TERM MEMORY,0.67798,-0.050849,-0.025544,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.16778,-0.050864,-0.065342,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.63408,-0.051073,-0.025883,0,0
1,GO REGULATION OF FERTILIZATION,0.093918,-0.051154,-0.072865,0,0
1,GO CHROMATIN SILENCING,0.67798,-0.05225,-0.016639,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.23286,-0.05237,-0.088914,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.71693,-0.052449,-0.0055682,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.54208,-0.052701,-0.029783,0,0
1,GO ANION TRANSPORT,0.32393,-0.052774,-0.014418,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.16285,-0.052925,-0.04657,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.69885,-0.053066,-0.019046,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.47712,-0.053176,-0.050727,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.25583,-0.053294,-0.098288,0,0
1,GO MITOCHONDRIAL FISSION,0.30446,-0.053573,-0.033553,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.45482,-0.0536,-0.029702,0,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.22042,-0.053723,-0.028795,0,0
1,GO EXCRETION,0.29877,-0.053892,-0.029835,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.29689,-0.054072,-0.035457,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.94993,-0.054091,0.008743,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.27673,-0.05441,-0.040117,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.33194,-0.054654,-0.061482,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.15802,-0.054736,-0.027147,0,0
1,GO CALCIUM ION IMPORT,0.075009,-0.054931,-0.055985,0,0
1,GO CELL JUNCTION ORGANIZATION,0.11183,-0.055018,-0.042398,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.83158,-0.055527,0.0038664,0,0
1,GO NEUROBLAST PROLIFERATION,0.11275,-0.055564,-0.08393,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.28945,-0.055615,-0.026276,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.073043,-0.055673,-0.087098,0,0
1,GO HISTONE H3 K36 METHYLATION,0.69885,-0.0559,-0.019879,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.60268,-0.055905,-0.013393,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.64276,-0.057092,0.059174,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.84741,-0.057169,0.0093885,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.6312,-0.057202,-0.024243,0,0
1,GO AXIS SPECIFICATION,0.49231,-0.0574,-0.01804,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.09796,-0.057676,-0.13933,0,0
1,GO REGIONALIZATION,0.20409,-0.057712,-0.048064,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.081877,-0.058034,-0.075141,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.54208,-0.058382,-0.036652,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.34008,-0.058406,-0.036434,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.797,-0.059061,0.033419,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.13027,-0.059263,-0.052416,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.44752,-0.059314,-0.022499,0,0
1,GO NEURON REMODELING,0.45238,-0.059539,-0.044286,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.32592,-0.059764,-0.026812,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.33599,-0.060005,-0.029861,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.26095,-0.060028,-0.084018,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.28213,-0.060482,-0.038281,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.27317,-0.060974,-0.037443,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.19838,-0.060981,-0.019682,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.16407,-0.061126,-0.043751,0,0
1,GO BRAIN MORPHOGENESIS,0.16407,-0.061755,-0.075245,0,0
1,GO FUCOSYLATION,0.27853,-0.061779,-0.039779,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.20265,-0.061868,-0.032131,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.26964,-0.062102,-0.04708,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.073043,-0.062836,-0.099013,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.5394,-0.063043,-0.012011,0,0
1,GO PROTEIN KINASE C SIGNALING,0.25078,-0.063272,-0.061192,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.11742,-0.064466,-0.083901,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.1873,-0.064571,-0.030472,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.75356,-0.064591,-0.026395,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.11837,-0.064727,-0.070479,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.33396,-0.064921,-0.046006,0,0
1,GO RESPONSE TO CAFFEINE,0.52609,-0.064975,-0.023061,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.39381,-0.065182,-0.034028,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.23286,-0.065374,-0.045827,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.026013,-0.065454,-0.11061,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.51035,-0.065715,-0.034961,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.16285,-0.065897,-0.093591,0,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.093126,-0.065949,-0.04706,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.47211,-0.066084,-0.047307,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.23927,-0.066186,-0.036294,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.61117,-0.066617,-0.0092453,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.4451,-0.066808,-0.057154,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.16654,-0.067255,-0.12876,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.10823,-0.0673,-0.05969,0,0
1,GO TORC1 SIGNALING,0.22042,-0.067487,-0.02795,0,0
1,GO RESPONSE TO CALCIUM ION,0.17669,-0.067672,-0.036987,0,0
1,GO LIPOXYGENASE PATHWAY,0.90167,-0.068052,-0.014427,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.61402,-0.068251,-0.01868,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.24745,-0.068408,-0.07276,0,0
1,GO SPERM CAPACITATION,0.21587,-0.068625,-0.053699,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.16407,-0.068701,-0.096306,0,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.37827,-0.068738,-0.018411,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.84424,-0.069249,0.0034255,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.072397,-0.069592,-0.043797,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.12029,-0.069702,-0.065799,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.13444,-0.070021,-0.066619,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42133,-0.070114,-0.025422,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.11837,-0.070755,-0.042184,0,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.55558,-0.070771,-0.026282,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.31409,-0.070846,-0.026559,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.11275,-0.071201,-0.062817,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.084763,-0.072081,-0.075396,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.020385,-0.072424,-0.12974,0,0
1,GO ORGANIC ACID TRANSPORT,0.065005,-0.072432,-0.039945,0,0
1,GO MICROTUBULE SEVERING,0.15565,-0.073004,-0.064969,0,0
1,GO GENETIC IMPRINTING,0.46218,-0.073119,-0.019033,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0137,-0.073392,-0.10528,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.42367,-0.073493,-0.051049,0,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.10823,-0.074614,-0.087476,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.35463,-0.074951,-0.060691,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.20554,-0.075729,-0.079314,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.42133,-0.07608,-0.08186,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.1873,-0.076293,-0.052906,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.12721,-0.076998,-0.053847,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.55016,-0.077236,-0.021341,0,0
1,GO CILIUM ORGANIZATION,0.22348,-0.077423,-0.038983,0,0
1,GO LIPID TRANSLOCATION,0.22814,-0.077875,-0.052698,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.15683,-0.078396,-0.045151,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.25753,-0.079184,-0.043464,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.14088,-0.079333,-0.044763,0,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.12029,-0.079714,-0.0408,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.11742,-0.079953,-0.051471,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.44269,-0.080153,-0.058455,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.36311,-0.080359,-0.041449,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.21889,-0.080529,-0.065811,0,0
1,GO HISTONE H4 K16 ACETYLATION,0.24416,-0.080641,-0.047188,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.12029,-0.080806,-0.16416,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.10385,-0.080971,-0.033678,0,0
1,GO ORGANELLE FUSION,0.096327,-0.081078,-0.033483,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.34213,-0.081144,-0.024975,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.22814,-0.081684,-0.060373,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.036409,-0.081965,-0.059626,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.10912,-0.082412,-0.10559,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.67798,-0.082738,-0.021769,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.52082,-0.082949,-0.0222,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.18194,-0.083156,-0.045912,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.075674,-0.083276,-0.10499,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.34213,-0.083333,-0.036317,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.67206,-0.083615,-0.0095493,0,0
1,GO HAIR CELL DIFFERENTIATION,0.72299,-0.083636,-0.018753,0,0
1,GO DEVELOPMENTAL INDUCTION,0.18595,-0.083922,-0.055604,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.3739,-0.084204,-0.042266,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.085497,-0.084484,-0.074626,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.15098,-0.085219,-0.058934,0,0
1,GO LUNG CELL DIFFERENTIATION,0.14419,-0.085259,-0.11796,0,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.052575,-0.085473,-0.12744,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.48722,-0.08576,-0.025546,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.28761,-0.085983,-0.060694,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.16904,-0.087875,-0.047857,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.3442,-0.088432,-0.096218,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.20409,-0.08848,-0.063149,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.064418,-0.088513,-0.085185,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.11933,-0.089049,-0.058854,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.38267,-0.089095,-0.045353,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.42838,-0.089173,-0.029123,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.26267,-0.089548,-0.030886,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.10734,-0.090091,-0.062748,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.12029,-0.09046,-0.058823,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.1873,-0.090937,-0.078371,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.35253,-0.091964,-0.032513,0,0
1,GO RESPONSE TO GLUCAGON,0.05357,-0.093427,-0.074491,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.95316,-0.093684,0.040785,0,0
1,GO CILIUM MOVEMENT,0.21738,-0.093753,-0.054669,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.80012,-0.094006,-0.0050156,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.045155,-0.09409,-0.099933,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.23128,-0.094109,-0.04485,0,0
1,GO SPERMATID DIFFERENTIATION,0.18327,-0.096298,-0.048552,0,0
1,GO LONG TERM MEMORY,0.075009,-0.098149,-0.081462,0,0
1,GO RESPONSE TO PAIN,0.19557,-0.098281,-0.074879,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.089246,-0.098429,-0.067613,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.0053519,-0.10055,-0.13604,0,0
1,GO HEART FORMATION,0.14869,-0.10058,-0.098567,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.37173,-0.10102,-0.069718,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.12924,-0.10175,-0.17811,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.078382,-0.10224,-0.074529,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.01499,-0.10394,-0.12268,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.3442,-0.10444,-0.072505,0,0
1,GO PHAGOSOME ACIDIFICATION,0.17283,-0.10462,-0.054555,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.19838,-0.1051,-0.050358,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.61687,-0.10513,-0.04438,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11275,-0.10527,-0.051062,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.23286,-0.1068,-0.11657,0,0
1,GO DENDRITE SELF AVOIDANCE,0.18327,-0.10817,-0.080894,0,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.1387,-0.10939,-0.076456,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.20265,-0.10946,-0.087645,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.098784,-0.11035,-0.067837,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.18194,-0.11116,-0.077757,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.83158,-0.11119,0.026577,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15098,-0.11162,-0.1048,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.4355,-0.1133,-0.004376,0,0
1,GO HEART INDUCTION,0.29877,-0.1136,-0.088137,0,0
1,GO SLEEP,0.0077327,-0.11396,-0.12199,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.68094,-0.11547,0.013355,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.079071,-0.11609,-0.076608,0,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.24252,-0.11615,-0.068635,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.11933,-0.11625,-0.086943,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.071756,-0.11629,-0.10997,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.40286,-0.11746,-0.053958,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.24089,-0.11862,-0.074553,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.093126,-0.11914,-0.042559,0,0
1,GO CARDIAC CHAMBER FORMATION,0.079071,-0.1214,-0.15435,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.011022,-0.12171,-0.12323,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.007921,-0.12228,-0.11786,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.024947,-0.12337,-0.11205,0,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0010259,-0.12396,-0.12382,0,0
1,GO PROTEIN AUTOPROCESSING,0.081877,-0.12482,-0.077159,0,0
1,GO MALE MEIOSIS I,0.072397,-0.12512,-0.12316,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.001568,-0.12697,-0.11078,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.21288,-0.1297,-0.051328,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0021505,-0.12974,-0.15748,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.066192,-0.13082,-0.13058,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0023321,-0.13194,-0.1309,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.17156,-0.13237,-0.055602,0,0
1,GO REGULATION OF OOGENESIS,0.0059116,-0.1326,-0.098416,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.28761,-0.13368,-0.040904,0,0
1,GO SPERM AXONEME ASSEMBLY,0.077698,-0.13401,-0.10562,0,0
1,GO RHYTHMIC BEHAVIOR,0.0059852,-0.13455,-0.12467,0,0
1,GO CELL FATE DETERMINATION,0.040582,-0.13614,-0.11027,0,0
1,GO RESPONSE TO ALKALOID,9.3381e-05,-0.13758,-0.12755,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.3739,-0.13791,-0.049871,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.18866,-0.13843,-0.085453,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.30255,-0.14068,-0.13421,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.10129,-0.14311,-0.076142,0,0
1,GO REGULATION OF BEHAVIOR,0.0011503,-0.14346,-0.13058,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.1533,-0.14399,-0.10222,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.044722,-0.14424,-0.12132,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.067397,-0.14503,-0.11872,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.11647,-0.14631,-0.077597,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.081877,-0.15027,-0.15193,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0066851,-0.15076,-0.15299,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.08331,-0.15208,-0.14556,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.32393,-0.15504,-0.073906,0,0
1,GO N GLYCAN PROCESSING,0.25246,-0.15572,-0.069107,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.026838,-0.15573,-0.13744,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0050269,-0.1578,-0.20152,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.0098086,-0.15829,-0.12927,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.086981,-0.16011,-0.12042,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010852,-0.16178,-0.15814,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.082591,-0.16361,-0.13408,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00068191,-0.16478,-0.10996,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.006444,-0.16656,-0.18002,0,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.17283,-0.17113,-0.10023,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.029754,-0.17968,-0.13478,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.36526,-0.17974,-0.075868,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.40514,-0.1868,-0.075502,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.0004e-06,-0.18833,-0.24428,0,0
1,GO INCLUSION BODY ASSEMBLY,0.047827,-0.19097,-0.13428,0,0
1,GO GLYCINE TRANSPORT,0.081877,-0.19357,-0.15152,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.084763,-0.19717,-0.12783,0,0
1,GO SEGMENT SPECIFICATION,0.11183,-0.20751,-0.12532,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,8.4805e-07,-0.21172,-0.21159,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0031247,-0.21274,-0.18993,0,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,3.8161e-07,-0.21503,-0.21456,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.024687,-0.21575,-0.19592,0,0
1,GO RESPONSE TO CATECHOLAMINE,2.1196e-06,-0.21813,-0.18547,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.00095459,-0.21892,-0.21973,0,0
1,GO NEURAL RETINA DEVELOPMENT,8.9166e-06,-0.22608,-0.27739,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,4.1456e-06,-0.2318,-0.23034,0,0
1,GO CELL MIGRATION IN HINDBRAIN,0.00064263,-0.2335,-0.23206,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0028872,-0.23552,-0.25078,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,6.3249e-05,-0.23928,-0.2754,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,2.3239e-05,-0.24632,-0.26825,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00015331,-0.24845,-0.24779,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,9.4341e-06,-0.26037,-0.24308,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.00046165,-0.2647,-0.2365,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00044781,-0.27294,-0.29111,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,4.9228e-07,-0.27375,-0.27517,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.9613e-05,-0.27426,-0.27398,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,8.3066e-07,-0.28389,-0.30193,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,9.1829e-05,-0.28974,-0.24277,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,5.4356e-06,-0.3041,-0.26874,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,3.5022e-05,-0.30796,-0.35697,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,7.71e-09,-0.31038,-0.26797,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,2.4091e-05,-0.32183,-0.35385,0,0
1,GO HEART FIELD SPECIFICATION,0.012945,-0.33092,-0.2458,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,4.4285e-07,-0.3395,-0.31801,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,7.969e-07,-0.34767,-0.32554,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.091558,-0.34825,-0.11544,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,7.8124e-06,-0.36996,-0.2948,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,1.2032e-06,-0.37076,-0.32981,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,4.2271e-06,-0.37381,-0.38988,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,9.086e-06,-0.39175,-0.34,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,7.892e-08,-0.39193,-0.43978,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0038977,-0.39317,-0.32109,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00027716,-0.39697,-0.39712,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.3359e-07,-0.40255,-0.48009,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,1.9558e-07,-0.42318,-0.407,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,1.1245e-09,-0.42634,-0.42177,0,0
1,GO PITUITARY GLAND DEVELOPMENT,3.0905e-06,-0.42984,-0.34947,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,1.9563e-06,-0.43186,-0.5101,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0025617,-0.45054,-0.37693,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.00023294,-0.45678,-0.41328,0,0
1,GO REFLEX,5.0323e-06,-0.46168,-0.43356,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,1.0361e-05,-0.46799,-0.351,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,6.8885e-07,-0.53986,-0.44576,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.3853e-09,-0.54909,-0.45849,0,0
1,GO GROWTH HORMONE SECRETION,5.2359e-09,-0.65595,-0.55941,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.725e-09,-0.68475,-0.64982,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,3.2785e-11,-0.80399,-0.70269,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.0161e-09,-0.86773,-0.79269,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,6.4805e-11,-0.87798,-0.81446,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,3.5038e-07,-0.88953,-0.8277,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,2.2139e-09,-0.95479,-0.86699,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,7.6792e-10,-1.3366,-1.1237,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.9047e-09,0.90042,0.79773,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1479e-07,0.74415,0.6509,1,1
2,GO SYNAPSE MATURATION,2.0478e-05,0.58504,0.45558,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,5.8698e-06,0.57401,0.58923,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,4.2271e-06,0.55009,0.46604,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.0657e-06,0.52201,0.46141,1,1
2,GO RESPONSE TO L GLUTAMATE,6.5125e-09,0.51224,0.47959,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,9.086e-06,0.51064,0.45901,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,6.3359e-07,0.50738,0.47308,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,1.2534e-06,0.5047,0.45256,1,1
2,GO REGULATION OF SYNAPSE MATURATION,0.00018323,0.503,0.3842,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,1.1307e-08,0.48601,0.45743,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00010152,0.44349,0.37891,1,1
2,GO SECRETORY GRANULE LOCALIZATION,0.00014362,0.44291,0.35717,1,1
2,GO GLYCINE TRANSPORT,0.00043435,0.43133,0.38545,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,4.6202e-07,0.43075,0.36147,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,6.3249e-05,0.42938,0.46768,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00014599,0.42905,0.39061,1,1
2,GO DENSE CORE GRANULE TRANSPORT,0.00159,0.42061,0.33397,1,1
2,GO SYNAPTIC VESICLE MATURATION,5.2344e-05,0.41423,0.38759,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,2.9514e-07,0.41307,0.41768,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,3.2784e-06,0.4125,0.35792,1,1
2,GO POSTSYNAPSE ASSEMBLY,4.4771e-05,0.40969,0.40671,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,3.2784e-06,0.4041,0.35624,1,1
2,GO IMP METABOLIC PROCESS,1.536e-06,0.40254,0.44859,1,1
2,GO CYTOPLASMIC TRANSLATION,9.404e-07,0.39893,0.36419,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,6.4699e-07,0.39179,0.39216,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,6.5837e-06,0.39043,0.34689,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,4.9694e-05,0.38939,0.35656,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00032916,0.38668,0.37126,1,1
2,GO MATURATION OF LSU RRNA,8.8389e-07,0.38652,0.3909,1,1
2,GO MYOBLAST PROLIFERATION,1.4677e-08,0.38507,0.37598,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,7.0072e-05,0.38447,0.38879,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.7721e-08,0.38257,0.43305,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,6.5837e-06,0.382,0.4027,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,3.1312e-09,0.38153,0.34965,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.00010152,0.37492,0.32822,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00013673,0.37439,0.37997,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,1.5576e-05,0.37289,0.33802,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,1.5865e-05,0.37014,0.45107,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00049802,0.36926,0.34942,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.011678,0.36883,0.25188,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00010152,0.3683,0.31353,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,5.8698e-06,0.36054,0.35801,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,2.4371e-06,0.36025,0.3741,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.5604e-09,0.35748,0.36145,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0156e-07,0.357,0.41156,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00052901,0.35389,0.28467,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.0037016,0.35385,0.26704,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,2.5884e-05,0.3517,0.31226,1,1
2,GO SUCKLING BEHAVIOR,6.2169e-06,0.35022,0.36201,1,1
2,GO UV PROTECTION,6.2046e-07,0.34963,0.36518,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,1.5014e-05,0.34861,0.41655,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.1807e-07,0.3472,0.38489,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,5.7582e-06,0.34417,0.37054,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,1.7071e-05,0.34133,0.26315,1,1
2,GO TRANSLATIONAL INITIATION,1.3693e-05,0.34035,0.30956,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0046604,0.33834,0.25579,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00074504,0.33772,0.26812,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00019857,0.33749,0.33197,1,1
2,GO REGULATION OF MRNA BINDING,1.475e-06,0.33313,0.3257,1,1
2,GO L GLUTAMATE IMPORT,2.1621e-05,0.32968,0.26087,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00014599,0.32966,0.30042,1,1
2,GO CARDIAC CHAMBER FORMATION,0.0023957,0.32914,0.26457,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0010113,0.32663,0.30546,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0016347,0.32585,0.24286,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0010259,0.32399,0.38703,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00022208,0.32325,0.3364,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,2.3274e-07,0.31936,0.3624,1,1
2,GO OXYGEN TRANSPORT,0.026013,0.31879,0.27238,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.2416e-05,0.31605,0.28998,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.0781e-08,0.31254,0.30374,1,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.0031247,0.31033,0.27142,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,2.0853e-05,0.3099,0.33351,1,1
2,GO RIBOSOME ASSEMBLY,2.7452e-06,0.30751,0.3562,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.017894,0.30386,0.25557,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00058763,0.3037,0.29673,1,1
2,GO DENTATE GYRUS DEVELOPMENT,1.7071e-05,0.30211,0.40353,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00018323,0.30103,0.30966,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,1.3693e-05,0.30047,0.29085,1,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,4.3236e-05,0.30003,0.29706,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.8053e-06,0.29988,0.34385,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,1.3878e-06,0.29983,0.28476,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,2.5884e-05,0.29927,0.2681,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,4.1456e-06,0.29537,0.32714,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,1.4454e-06,0.29326,0.27473,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.00013232,0.29283,0.2533,1,1
2,GO PHAGOCYTOSIS RECOGNITION,2.7312e-05,0.29263,0.27376,1,1
2,GO NEUROTRANSMITTER REUPTAKE,8.3013e-05,0.29252,0.25848,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.2926e-08,0.292,0.35576,1,1
2,GO TELOMERASE RNA LOCALIZATION,1.155e-06,0.29126,0.32136,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,6.8888e-05,0.29093,0.2579,1,1
2,GO AMP METABOLIC PROCESS,0.00021857,0.29058,0.26157,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0052854,0.29027,0.20555,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0015463,0.28941,0.2459,1,1
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,8.2686e-06,0.28934,0.29276,1,1
2,GO GAS TRANSPORT,0.0062877,0.28887,0.24888,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.001442,0.28879,0.3108,1,1
2,GO PREPULSE INHIBITION,0.026561,0.28798,0.22147,1,1
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.00022565,0.28778,0.29675,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.4091e-05,0.28572,0.33657,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,3.2631e-05,0.28525,0.26551,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,2.5884e-05,0.28516,0.2968,1,1
2,GO MATURATION OF SSU RRNA,1.2954e-05,0.28439,0.31422,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,1.4741e-05,0.28375,0.29096,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,6.2175e-05,0.2827,0.26684,1,1
2,GO NEGATIVE CHEMOTAXIS,1.9044e-05,0.28218,0.30862,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,6.4341e-05,0.28197,0.25306,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.3693e-05,0.28089,0.31188,1,1
2,GO ADULT HEART DEVELOPMENT,5.2344e-05,0.28044,0.33287,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00014129,0.28,0.25565,1,1
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0070192,0.27885,0.26189,1,1
2,GO REGULATION OF VESICLE FUSION,0.00012388,0.27883,0.28155,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.1621e-05,0.27879,0.28461,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00013451,0.27794,0.28753,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0040509,0.27701,0.21806,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0003557,0.27689,0.22841,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00012388,0.27599,0.28174,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,8.0256e-05,0.27578,0.32418,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0012705,0.27335,0.24383,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00010152,0.27329,0.22305,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,1.2281e-06,0.27233,0.35748,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,2.2416e-05,0.26911,0.23776,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.0033799,0.26878,0.35226,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0001803,0.26716,0.32401,1,1
2,GO MATURATION OF 5 8S RRNA,5.3256e-05,0.2665,0.27335,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.063836,0.26625,0.17744,1,1
2,GO VIRAL TRANSLATION,4.4807e-06,0.26596,0.30568,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,1.1806e-05,0.26199,0.34223,1,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,6.9711e-06,0.26194,0.24633,1,1
2,GO DIVALENT METAL ION EXPORT,5.9056e-05,0.26156,0.32734,1,1
2,GO REGULATION OF RNA BINDING,4.7488e-06,0.25714,0.26105,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.9803e-06,0.25613,0.20491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00011406,0.25471,0.32893,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00011406,0.25243,0.23107,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.012087,0.25196,0.1945,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,3.628e-05,0.24874,0.28593,1,1
2,GO PROTEIN TRIMERIZATION,4.1751e-05,0.2486,0.25112,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0011668,0.24804,0.17493,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,1.7385e-05,0.248,0.3188,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.4592e-06,0.24729,0.30479,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.6761e-05,0.2459,0.23607,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0069343,0.24568,0.19953,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0001803,0.24492,0.26205,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00040857,0.24373,0.23948,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0030839,0.24365,0.3036,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.00012186,0.24364,0.24908,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.2487e-05,0.24246,0.23771,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0013633,0.24235,0.26231,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001862,0.24011,0.23921,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00026858,0.23994,0.2434,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,8.7316e-05,0.23969,0.26576,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0012005,0.23964,0.20913,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0037016,0.23951,0.19797,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00032916,0.23846,0.17685,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,9.9844e-05,0.23769,0.26937,1,1
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0098086,0.23758,0.18745,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00049802,0.23732,0.2311,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00016098,0.23656,0.25068,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00014599,0.23642,0.19933,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.0066851,0.2349,0.18619,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0033799,0.23419,0.22961,1,1
2,GO REGULATION OF NEURON MIGRATION,0.016752,0.23402,0.15912,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0025617,0.23311,0.21024,1,1
2,GO GTP METABOLIC PROCESS,1.5865e-05,0.23303,0.25118,1,1
2,GO REGULATION OF LYASE ACTIVITY,2.6386e-06,0.23241,0.24274,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.0070192,0.23227,0.19754,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0098086,0.22957,0.2459,1,1
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,9.9844e-05,0.22898,0.24981,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.00026024,0.22891,0.2047,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,3.2631e-05,0.22889,0.19397,1,1
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00082553,0.2283,0.23384,1,1
2,GO SIALYLATION,0.0018764,0.22827,0.31919,1,1
2,GO NEURON REMODELING,0.00099681,0.22782,0.21028,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,3.628e-05,0.22717,0.23483,1,1
2,GO NEURON PROJECTION ORGANIZATION,0.00016098,0.22659,0.21767,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.001071,0.22651,0.18815,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.02128,0.22552,0.19788,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0085105,0.2249,0.15102,1,1
2,GO MITOCHONDRIAL RNA PROCESSING,0.003166,0.22484,0.25964,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0005211,0.22264,0.25862,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.013546,0.22192,0.17286,1,1
2,GO NEUROTRANSMITTER UPTAKE,0.00016361,0.22189,0.21441,1,1
2,GO L SERINE METABOLIC PROCESS,0.017699,0.2218,0.20975,1,1
2,GO HEART VALVE FORMATION,0.0037016,0.2214,0.22137,1,1
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00018923,0.2213,0.19082,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0023009,0.22075,0.19578,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.027686,0.22019,0.17844,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00015583,0.21937,0.22321,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0024609,0.21889,0.24739,1,1
2,GO ARGININE METABOLIC PROCESS,0.00075607,0.21847,0.25736,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,1.4207e-05,0.21821,0.20213,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,9.086e-06,0.2179,0.24969,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,1.0557e-05,0.2178,0.23035,1,1
2,GO PEPTIDYL ARGININE METHYLATION,4.0314e-05,0.21778,0.22681,1,1
2,GO NAD METABOLIC PROCESS,2.1621e-05,0.21731,0.25861,1,1
2,GO TRNA MODIFICATION,1.2482e-05,0.2169,0.22901,1,1
2,GO GLUTAMATE SECRETION,0.0005789,0.21602,0.22028,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0015463,0.21554,0.31646,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0080166,0.21531,0.18125,1,1
2,GO PROTEIN OXIDATION,0.024687,0.21501,0.15555,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010497,0.21459,0.28275,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00065224,0.21459,0.21768,1,1
2,GO VIRAL GENE EXPRESSION,0.00027284,0.21417,0.22421,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00073415,0.21342,0.2168,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0053519,0.21277,0.1807,1,1
2,GO INNERVATION,0.036409,0.21203,0.20682,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00065224,0.21178,0.25064,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.016938,0.21143,0.22547,1,1
2,GO TRANSLATIONAL ELONGATION,6.7105e-06,0.21132,0.22018,1,1
2,GO SNORNA 3 END PROCESSING,0.00010497,0.21006,0.29692,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,7.2497e-05,0.20999,0.20405,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.017506,0.20985,0.13464,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,2.4837e-07,0.20969,0.22388,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0062877,0.20839,0.16833,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.011678,0.20784,0.15984,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.010895,0.207,0.21576,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0022396,0.2068,0.23321,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.018693,0.2064,0.14678,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00020178,0.20597,0.21259,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0020646,0.20575,0.19903,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.00081356,0.2057,0.1754,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,3.1494e-05,0.20554,0.24621,1,1
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015674,0.20483,0.18318,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0020929,0.20442,0.15952,1,1
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0042636,0.20442,0.20935,1,1
2,GO SYNAPTIC VESICLE PRIMING,0.0089251,0.20345,0.19905,1,1
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001235,0.20295,0.37701,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,2.5359e-06,0.20293,0.24734,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.024428,0.20285,0.16069,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.011678,0.20243,0.18368,1,1
2,GO CGMP METABOLIC PROCESS,0.0013633,0.20087,0.26875,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0034692,0.19956,0.16117,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0047198,0.19904,0.24007,1,1
2,GO RNA SURVEILLANCE,0.0024609,0.19891,0.15915,1,1
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0037016,0.19862,0.16396,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00086244,0.19832,0.20114,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,1.6158e-05,0.19815,0.23183,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,7.2497e-05,0.19807,0.1862,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00020178,0.19801,0.22131,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0039481,0.19774,0.16393,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.019104,0.19764,0.16923,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.017894,0.19667,0.198,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,6.7724e-05,0.19623,0.26214,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.206e-06,0.19608,0.18591,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.012227,0.1955,0.1593,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0078263,0.19518,0.18449,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0098086,0.19505,0.1401,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,3.9613e-05,0.19489,0.20315,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0013069,0.1946,0.18615,1,1
2,GO TRANSLATIONAL TERMINATION,0.00017176,0.19387,0.20645,1,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00023294,0.19338,0.18836,1,1
2,GO NEUROBLAST DIVISION,0.017894,0.19229,0.23398,1,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0094686,0.19214,0.17518,1,1
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00046165,0.19187,0.20319,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,3.4409e-05,0.1909,0.17132,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.00030449,0.19016,0.17062,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.012087,0.19003,0.19063,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,6.6578e-05,0.18989,0.26411,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032408,0.18927,0.23177,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00098255,0.18921,0.14376,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1.8701e-05,0.18911,0.23262,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0014022,0.18887,0.16692,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5865e-05,0.18861,0.19056,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0017277,0.18847,0.18105,1,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,4.1026e-05,0.18812,0.18603,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.000286,0.18796,0.20936,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,6.337e-06,0.18787,0.20308,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,2.8305e-05,0.18696,0.2083,1,1
2,GO RIBOSOME BIOGENESIS,4.2487e-05,0.18663,0.26364,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0019023,0.18637,0.16543,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0032928,0.18564,0.17966,1,1
2,GO SYNAPSE ORGANIZATION,0.0052854,0.18526,0.13892,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0015249,0.18518,0.17549,1,1
2,GO CGMP MEDIATED SIGNALING,0.0010259,0.18494,0.17521,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0047798,0.18485,0.17457,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.0028872,0.18433,0.18319,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,2.1621e-05,0.18398,0.1796,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00044781,0.18396,0.22082,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0030436,0.18282,0.14816,1,1
2,GO SHORT TERM MEMORY,0.0020929,0.18224,0.32308,1,1
2,GO NEURON RECOGNITION,0.0052854,0.18111,0.18995,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.001071,0.18073,0.23911,1,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.028264,0.18066,0.15634,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.024173,0.18039,0.13941,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001776,0.18002,0.16134,1,1
2,GO LONG TERM SYNAPTIC DEPRESSION,0.01251,0.17986,0.16195,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001442,0.17887,0.17342,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.00024045,0.17882,0.2133,1,1
2,GO AEROBIC RESPIRATION,0.00022565,0.17857,0.15721,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0056958,0.17785,0.16269,1,1
2,GO SNORNA METABOLIC PROCESS,0.00021857,0.17754,0.28823,1,1
2,GO AMINO ACID IMPORT,0.002631,0.17753,0.20013,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0027381,0.17733,0.15467,1,1
2,GO RRNA MODIFICATION,0.001422,0.17577,0.22967,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0020092,0.17322,0.18797,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00087508,0.17283,0.16845,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0020646,0.17238,0.23007,1,1
2,GO STRESS GRANULE ASSEMBLY,0.001568,0.17225,0.15311,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.047827,0.17218,0.12866,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00025215,0.1715,0.16168,1,1
2,GO MITOCHONDRION LOCALIZATION,0.00086244,0.17142,0.1538,1,1
2,GO MRNA MODIFICATION,6.8888e-05,0.17139,0.24291,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.0011836,0.1713,0.1736,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,4.3997e-05,0.17059,0.17291,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,5.3256e-05,0.17,0.19665,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0034692,0.16981,0.16935,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00024045,0.16971,0.24406,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0038478,0.16949,0.17198,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.052083,0.16905,0.13206,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.066192,0.16892,0.13413,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0018256,0.1686,0.18011,1,1
2,GO RRNA TRANSCRIPTION,2.2416e-05,0.16848,0.2083,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,6.7724e-05,0.1682,0.14583,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0041031,0.16814,0.18869,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.00058763,0.16799,0.15834,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0002117,0.16793,0.18452,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0010259,0.16668,0.19472,1,1
2,GO WALKING BEHAVIOR,1.7071e-05,0.16663,0.25021,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00052901,0.16611,0.14583,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0031247,0.16479,0.15617,1,1
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.012653,0.16456,0.13919,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,3.628e-05,0.16378,0.17565,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0019819,0.16368,0.12402,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.00015838,0.16285,0.15181,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00033432,0.16242,0.21104,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00013232,0.16213,0.15412,1,1
2,GO RRNA METABOLIC PROCESS,5.1446e-05,0.16205,0.24199,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,3.2057e-05,0.1616,0.23312,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.001483,0.16158,0.17584,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.0012705,0.16143,0.17759,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00017741,0.16141,0.17912,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0073682,0.1611,0.1508,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0033361,0.16042,0.18164,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.058787,0.15871,0.12185,1,1
2,GO ACIDIC AMINO ACID TRANSPORT,0.00064263,0.15852,0.16509,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0030038,0.15851,0.18027,1,1
2,GO DENDRITIC TRANSPORT,0.0045438,0.15769,0.19942,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0015249,0.15766,0.18509,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00016361,0.15742,0.13058,1,1
2,GO L AMINO ACID TRANSPORT,0.00014129,0.15739,0.22486,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.019312,0.15605,0.12578,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00044103,0.15566,0.15215,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0012005,0.15536,0.14043,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,3.8924e-05,0.1548,0.14781,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0050904,0.15474,0.14471,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.00011218,0.15471,0.13844,1,1
2,GO CRISTAE FORMATION,0.0021798,0.15445,0.20283,1,1
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.003607,0.15437,0.1571,1,1
2,GO GLUCOSE CATABOLIC PROCESS,0.0052854,0.15364,0.18941,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0012177,0.15317,0.13069,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0081133,0.15113,0.1581,1,1
2,GO RELAXATION OF MUSCLE,0.0050269,0.15081,0.15193,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,9.9844e-05,0.15036,0.19652,1,1
2,GO NADH METABOLIC PROCESS,0.00017457,0.14946,0.22397,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0029256,0.1494,0.16002,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.001422,0.14903,0.13656,1,1
2,GO RESPIRATORY SYSTEM PROCESS,0.00052901,0.14847,0.20819,1,1
2,GO MEMBRANE REPOLARIZATION,0.00098255,0.1481,0.1606,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.0048405,0.14783,0.15521,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00072342,0.14742,0.15044,1,1
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0059852,0.14724,0.12832,1,1
2,GO NUCLEOTIDE SALVAGE,0.009139,0.14715,0.23376,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00070238,0.1466,0.15264,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.012367,0.14638,0.14496,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.049681,0.14498,0.15044,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0066851,0.14474,0.15134,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.0071051,0.14471,0.15089,1,1
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.022209,0.1438,0.17565,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0052854,0.14355,0.18362,1,1
2,GO ONE CARBON METABOLIC PROCESS,0.0055559,0.14147,0.13433,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.038258,0.14111,0.11766,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0048405,0.14066,0.12362,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0089251,0.1403,0.13075,1,1
2,GO NCRNA PROCESSING,0.00010852,0.14002,0.20955,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00015331,0.13921,0.22722,1,1
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0032928,0.13848,0.16877,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0037985,0.13796,0.14359,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0065235,0.13796,0.15282,1,1
2,GO CELLULAR RESPIRATION,0.0005133,0.1376,0.13859,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00068191,0.13746,0.16535,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.051111,0.13727,0.15844,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.051111,0.13724,0.1409,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00070238,0.13707,0.16014,1,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0063654,0.13671,0.18647,1,1
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.025743,0.1361,0.12258,1,1
2,GO RNA POLYADENYLATION,0.0017277,0.13557,0.1224,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.015501,0.13534,0.099266,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00018923,0.13531,0.13708,1,1
2,GO NEURON PROJECTION EXTENSION,0.0080166,0.13512,0.12698,1,1
2,GO RNA CATABOLIC PROCESS,0.00071283,0.13442,0.13328,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00014599,0.13428,0.12807,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.3013e-05,0.13374,0.17173,1,1
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.023419,0.13365,0.11582,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013394,0.13347,0.11711,1,1
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.022209,0.13318,0.13328,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00091404,0.13279,0.15509,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.036409,0.1326,0.15436,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0023637,0.13241,0.15822,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.052575,0.13181,0.115,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.014332,0.13158,0.11902,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.039795,0.13147,0.16882,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0060595,0.13071,0.18321,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0019819,0.13047,0.12564,1,1
2,GO DNA REPLICATION INITIATION,0.0027747,0.13034,0.12515,1,1
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.035336,0.13028,0.12554,1,1
2,GO IMPORT INTO CELL,0.00025617,0.12911,0.15167,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0029256,0.12906,0.15119,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001235,0.12859,0.14052,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0013443,0.12852,0.12146,1,1
2,GO RNA 5 END PROCESSING,0.0016347,0.12803,0.20822,1,1
2,GO HEME METABOLIC PROCESS,0.028852,0.12782,0.14261,1,1
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0042095,0.12776,0.18875,1,1
2,GO COPPER ION HOMEOSTASIS,0.043444,0.12748,0.10537,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.00159,0.12746,0.13155,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0025617,0.12705,0.16466,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0028872,0.12673,0.13665,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.000662,0.12654,0.12694,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.01829,0.12652,0.13493,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.017506,0.12644,0.11081,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0058389,0.12629,0.13073,1,1
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.001422,0.12593,0.13192,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0049019,0.12556,0.13926,1,1
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00014599,0.12556,0.16328,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00020504,0.12531,0.14041,1,1
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.015501,0.12505,0.12645,1,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.014332,0.12434,0.14802,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0005133,0.12415,0.13715,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.062114,0.12355,0.106,1,1
2,GO AXON EXTENSION,0.008211,0.12322,0.13802,1,1
2,GO HYPOTONIC RESPONSE,0.028264,0.12272,0.13127,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00034485,0.1227,0.13968,1,1
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0037498,0.12238,0.15426,1,1
2,GO FOREBRAIN CELL MIGRATION,0.0083098,0.12237,0.14453,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.015501,0.12106,0.21298,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0080166,0.12022,0.16303,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.016752,0.11989,0.14062,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.002702,0.11968,0.12524,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.01251,0.11879,0.12066,1,1
2,GO ALDEHYDE CATABOLIC PROCESS,0.014332,0.11864,0.094376,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.02915,0.11793,0.15558,1,1
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0050904,0.11789,0.16175,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.032938,0.11765,0.11957,1,1
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00055343,0.11617,0.11588,1,1
2,GO MRNA METHYLATION,0.01016,0.11601,0.16515,1,1
2,GO REGULATION OF AXONOGENESIS,0.017125,0.1153,0.1331,1,1
2,GO PROTEIN TARGETING,0.00013016,0.11516,0.12305,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.014332,0.11502,0.10345,1,1
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.050154,0.11469,0.08844,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.049212,0.11332,0.10998,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.00086244,0.11258,0.11838,1,1
2,GO RRNA METHYLATION,0.0089251,0.11233,0.17455,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.0014624,0.11207,0.10983,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.056652,0.11206,0.089232,1,1
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.015501,0.11198,0.11348,1,1
2,GO MRNA METABOLIC PROCESS,0.00083767,0.11129,0.1039,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.05063,0.10928,0.085819,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.047372,0.10838,0.10907,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00061456,0.1082,0.10966,1,1
2,GO DEVELOPMENTAL CELL GROWTH,0.018091,0.10802,0.10393,1,1
2,GO NEUROMUSCULAR PROCESS,0.0094686,0.10706,0.1284,1,1
2,GO AMINO ACID TRANSPORT,0.00020178,0.10689,0.15658,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017315,0.10552,0.1254,1,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.001071,0.10534,0.13249,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.043866,0.10479,0.11672,1,1
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0019285,0.10458,0.11645,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0050904,0.10338,0.11241,1,1
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.057179,0.10222,0.079646,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.011544,0.10186,0.1032,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0076401,0.10112,0.1214,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.001704,0.10107,0.14112,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00030928,0.10011,0.10379,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0090315,0.099828,0.086748,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0039481,0.099347,0.12326,1,1
2,GO TRNA 5 END PROCESSING,0.0025617,0.099102,0.16351,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0023637,0.09899,0.11549,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.014658,0.098576,0.10373,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001235,0.096822,0.12739,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.010645,0.096013,0.12306,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.010041,0.095731,0.087258,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0010113,0.095097,0.089787,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,6.0079e-05,0.094692,0.13696,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.022686,0.094554,0.12347,1,1
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.010279,0.094137,0.13578,1,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0025617,0.094002,0.10309,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01829,0.093897,0.10655,1,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0044864,0.093412,0.15276,1,1
2,GO MIRNA METABOLIC PROCESS,0.016205,0.092975,0.099197,1,1
2,GO COCHLEA DEVELOPMENT,0.040187,0.092968,0.097606,1,1
2,GO DENDRITE DEVELOPMENT,0.055093,0.092096,0.097644,1,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0094686,0.091975,0.085293,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0062108,0.091787,0.086803,1,1
2,GO CARDIAC CONDUCTION,0.03006,0.091616,0.10899,1,1
2,GO CELLULAR RESPONSE TO PH,0.028556,0.089654,0.086785,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0067673,0.088888,0.14808,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.009139,0.088621,0.10931,1,1
2,GO ATP METABOLIC PROCESS,0.00072342,0.08862,0.10352,1,1
2,GO CELL RECOGNITION,0.0048405,0.088376,0.1049,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.011151,0.088318,0.1166,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0088198,0.087987,0.11219,1,1
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.011544,0.087903,0.13115,1,1
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.02915,0.087572,0.1105,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.055609,0.087268,0.072541,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.056652,0.087028,0.083585,1,1
2,GO REGULATION OF MRNA PROCESSING,0.043025,0.086797,0.068425,1,1
2,GO SNRNA PROCESSING,0.047827,0.085568,0.085866,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.020166,0.084128,0.12746,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0030436,0.083811,0.09318,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.043444,0.083387,0.07961,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0052854,0.082565,0.10093,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0020367,0.08019,0.10105,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0087156,0.080009,0.088786,1,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0090315,0.079687,0.10643,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.010279,0.077634,0.10855,1,1
2,GO PROTEIN NEDDYLATION,0.024173,0.076908,0.090326,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0021215,0.074556,0.11519,1,1
2,GO PHOSPHATE ION TRANSPORT,0.041383,0.073634,0.072994,1,1
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0014022,0.07192,0.11766,1,1
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.017699,0.071919,0.092564,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.022928,0.069693,0.076584,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.01829,0.068501,0.069755,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.056128,0.06738,0.071653,1,1
2,GO PROTEIN TETRAMERIZATION,0.0045438,0.067255,0.098046,1,1
2,GO REGULATION OF CELL SIZE,0.053071,0.066272,0.087243,1,1
2,GO SKELETAL MUSCLE CONTRACTION,0.026561,0.065419,0.12879,1,1
2,GO MRNA PROCESSING,0.028852,0.064901,0.069323,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.046921,0.063684,0.072094,1,1
2,GO REGULATION OF PROTEIN TARGETING,0.022209,0.062082,0.087333,1,1
2,GO RNA CAPPING,0.010522,0.058538,0.082266,1,1
2,GO RESPONSE TO HEAT,0.025743,0.054667,0.07904,1,1
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.016386,0.050861,0.078086,1,1
2,GO PROTEIN HOMOOLIGOMERIZATION,0.019104,0.045772,0.074334,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.011411,0.30695,0.22602,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0059852,0.29036,0.23739,1,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00061456,0.28197,0.36492,1,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0086125,0.28118,0.22025,1,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.016205,0.27098,0.27591,1,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00074504,0.26422,0.3148,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.037882,0.2609,0.25021,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.01585,0.24499,0.20691,1,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0020929,0.23777,0.20377,1,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00011406,0.23446,0.29007,1,0
2,GO ELASTIC FIBER ASSEMBLY,0.010895,0.21948,0.25731,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.032938,0.20637,0.26709,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.027401,0.19657,0.26618,1,0
2,GO LONG TERM MEMORY,0.00022208,0.1926,0.20871,1,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.01016,0.18964,0.17453,1,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00081356,0.18672,0.21516,1,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.065005,0.18652,0.13474,1,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.023173,0.18344,0.2322,1,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0068504,0.17483,0.18383,1,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0046604,0.17308,0.17561,1,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.0024281,0.17171,0.19944,1,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.0068504,0.17112,0.1921,1,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.037139,0.16932,0.15874,1,0
2,GO TRNA METHYLATION,8.1623e-05,0.16383,0.21537,1,0
2,GO LEARNING,0.0037985,0.16293,0.15688,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.023919,0.16282,0.14796,1,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.009139,0.16232,0.16122,1,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.020166,0.1613,0.19072,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.011678,0.15985,0.14098,1,0
2,GO AXONAL FASCICULATION,0.060432,0.15871,0.18496,1,0
2,GO REGULATION OF HIPPO SIGNALING,0.062684,0.15824,0.15291,1,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.004156,0.15751,0.24113,1,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.031953,0.15702,0.13448,1,0
2,GO COLLATERAL SPROUTING,0.0060595,0.15526,0.18228,1,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.033608,0.15476,0.12861,1,0
2,GO PROTEIN NITROSYLATION,0.013093,0.15265,0.15511,1,0
2,GO RESPONSE TO CAFFEINE,0.0032501,0.1517,0.16599,1,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.004156,0.15158,0.16995,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.010041,0.14936,0.12754,1,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0023321,0.14831,0.21575,1,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0016806,0.14671,0.16096,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.017506,0.14461,0.15665,1,0
2,GO TRNA PROCESSING,0.00016901,0.14065,0.18114,1,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02521,0.14059,0.19462,1,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0055559,0.13776,0.13228,1,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.024173,0.13742,0.18268,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.017506,0.13639,0.15905,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.014823,0.13441,0.19311,1,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.0078263,0.13043,0.15153,1,0
2,GO NEUROTRANSMITTER TRANSPORT,0.015501,0.12645,0.15033,1,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.011678,0.12407,0.16794,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.059331,0.12394,0.11733,1,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.056128,0.12319,0.13829,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.051111,0.11896,0.19705,1,0
2,GO RNA METHYLATION,0.0012005,0.11881,0.15199,1,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.020166,0.11852,0.14583,1,0
2,GO BONE GROWTH,0.035691,0.11758,0.15459,1,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.027118,0.11634,0.13903,1,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.025743,0.11623,0.11404,1,0
2,GO TRNA METABOLIC PROCESS,0.0012886,0.11603,0.14613,1,0
2,GO HEPARIN METABOLIC PROCESS,0.023919,0.11592,0.18574,1,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0047798,0.11534,0.13691,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.062684,0.11469,0.13598,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.011411,0.10963,0.128,1,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.060432,0.10913,0.11367,1,0
2,GO NEURAL CREST CELL MIGRATION,0.037139,0.10879,0.14032,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0050269,0.10829,0.15232,1,0
2,GO REGULATION OF AXON GUIDANCE,0.03902,0.10821,0.13874,1,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.014013,0.10787,0.21172,1,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0013443,0.1068,0.11807,1,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.03902,0.10669,0.11693,1,0
2,GO ASSOCIATIVE LEARNING,0.021053,0.10642,0.11353,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.012798,0.10605,0.1327,1,0
2,GO NEUROTRANSMITTER SECRETION,0.038258,0.10605,0.13615,1,0
2,GO CERAMIDE TRANSPORT,0.01016,0.10518,0.14209,1,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.040187,0.10428,0.13605,1,0
2,GO RESPONSE TO AMINE,0.015501,0.10384,0.11292,1,0
2,GO STRIATUM DEVELOPMENT,0.039406,0.10375,0.12731,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.032278,0.1036,0.17582,1,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.002702,0.10159,0.097691,1,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.037139,0.10123,0.11926,1,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.038258,0.1008,0.11989,1,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0104,0.099169,0.15379,1,0
2,GO ALANINE TRANSPORT,0.062114,0.09802,0.19549,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.049212,0.096942,0.12454,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0092477,0.096267,0.12104,1,0
2,GO NCRNA METABOLIC PROCESS,0.00049053,0.094966,0.176,1,0
2,GO SYNAPTIC SIGNALING,0.064418,0.094364,0.093217,1,0
2,GO RNA PROCESSING,0.00095459,0.092635,0.11827,1,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0057669,0.090352,0.12729,1,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.036409,0.09031,0.10157,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.058247,0.088616,0.11956,1,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.031631,0.088524,0.092948,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.033608,0.087929,0.12417,1,0
2,GO CELL PART MORPHOGENESIS,0.052083,0.087797,0.094365,1,0
2,GO RNA MODIFICATION,0.0020092,0.087018,0.14175,1,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.030368,0.08692,0.094582,1,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.03006,0.086851,0.11197,1,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0075485,0.084906,0.097314,1,0
2,GO MRNA 3 END PROCESSING,0.052083,0.084768,0.063555,1,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.022686,0.084306,0.097587,1,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.020385,0.084127,0.1024,1,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.03902,0.082672,0.16539,1,0
2,GO RNA 3 END PROCESSING,0.010522,0.082412,0.088477,1,0
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.050154,0.08202,0.080021,1,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.01499,0.081341,0.21395,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.063836,0.081125,0.1418,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.051595,0.08021,0.10252,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.060432,0.075008,0.077805,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.012798,0.074835,0.11635,1,0
2,GO NCRNA 3 END PROCESSING,0.01016,0.074817,0.12868,1,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.062684,0.074646,0.11272,1,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.043866,0.074636,0.082381,1,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.036409,0.074553,0.10441,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.030994,0.074193,0.090437,1,0
2,GO LIVER REGENERATION,0.024173,0.07353,0.097758,1,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.040981,0.072802,0.11973,1,0
2,GO NUCLEAR PORE ORGANIZATION,0.026286,0.072659,0.12726,1,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.036048,0.072419,0.12484,1,0
2,GO DETECTION OF VISIBLE LIGHT,0.053071,0.071603,0.25428,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.01849,0.071077,0.26412,1,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.027973,0.070812,0.10871,1,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.020605,0.070765,0.077725,1,0
2,GO TRNA TRANSPORT,0.006444,0.070225,0.13525,1,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.042197,0.070009,0.11103,1,0
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.028264,0.069455,0.073733,1,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.040582,0.069413,0.11549,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.02945,0.068626,0.068143,1,0
2,GO AXON DEVELOPMENT,0.03902,0.06861,0.10936,1,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0032078,0.066695,0.13736,1,0
2,GO BLASTOCYST FORMATION,0.066192,0.065837,0.060964,1,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.023173,0.065522,0.11732,1,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.020828,0.063346,0.14247,1,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.01829,0.062973,0.099779,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.036048,0.061984,0.063154,1,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.060432,0.060482,0.04415,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.030994,0.059939,0.080145,1,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.021053,0.059663,0.092244,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.01251,0.059619,0.15851,1,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.040187,0.059206,0.14374,1,0
2,GO RECEPTOR INTERNALIZATION,0.035691,0.058618,0.095963,1,0
2,GO NCRNA TRANSCRIPTION,0.0050269,0.058175,0.087912,1,0
2,GO RNA LOCALIZATION,0.013546,0.057912,0.09974,1,0
2,GO THIOESTER METABOLIC PROCESS,0.061549,0.057626,0.081979,1,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.043866,0.057094,0.069459,1,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.02945,0.056635,0.065104,1,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.065005,0.054387,0.085851,1,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.046921,0.053098,0.061396,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.019312,0.049969,0.091501,1,0
2,GO RNA SPLICING,0.052575,0.049902,0.062905,1,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.060432,0.049519,0.061165,1,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.011151,0.049074,0.083328,1,0
2,GO TELOMERE ORGANIZATION,0.049681,0.046731,0.071118,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.031953,0.046506,0.064481,1,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.049212,0.046357,0.072508,1,0
2,GO PROTEIN FOLDING,0.047372,0.045055,0.074267,1,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.040582,0.037168,0.12022,1,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.062114,0.036085,0.075424,1,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.014823,0.034792,0.10198,1,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.060988,0.028812,0.10275,1,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.056652,0.028439,0.06376,1,0
2,GO COGNITION,0.062684,0.026553,0.089103,1,0
2,GO AMINO ACID ACTIVATION,0.038258,0.023635,0.14106,1,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.063258,0.015883,0.085567,1,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.052083,-0.020264,-0.063472,1,0
2,GO SISTER CHROMATID SEGREGATION,0.057711,-0.02466,-0.041703,1,0
2,GO CELLULAR RESPONSE TO STARVATION,0.036772,-0.031136,-0.052728,1,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.025475,-0.033425,-0.033688,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.020828,-0.033577,-0.042551,1,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.056652,-0.033735,-0.039469,1,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.038258,-0.033975,-0.037155,1,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.065005,-0.035444,-0.04009,1,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.029754,-0.035668,-0.031726,1,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.035691,-0.036244,-0.048345,1,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.052575,-0.036777,-0.088173,1,0
2,GO CYTOSOLIC TRANSPORT,0.039406,-0.03911,-0.036671,1,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.062114,-0.039318,-0.031985,1,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.064418,-0.039675,-0.0278,1,0
2,GO CHROMATIN ORGANIZATION,0.053071,-0.039716,-0.035706,1,0
2,GO VESICLE LOCALIZATION,0.044292,-0.039739,-0.042293,1,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.03006,-0.040914,-0.044207,1,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.066192,-0.040915,-0.029615,1,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.011022,-0.041174,-0.044322,1,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.049681,-0.041488,-0.037247,1,0
2,GO DNA INTEGRITY CHECKPOINT,0.018898,-0.041895,-0.056199,1,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.062684,-0.042279,-0.044467,1,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.049681,-0.043277,-0.027169,1,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.048285,-0.043322,-0.038798,1,0
2,GO REGULATION OF APPETITE,0.047372,-0.043386,-0.0822,1,0
2,GO MITOTIC CELL CYCLE,0.062684,-0.043812,-0.028399,1,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.044722,-0.043887,-0.040904,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.012087,-0.043903,-0.039663,1,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.010769,-0.043952,-0.049793,1,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.051111,-0.044171,-0.047014,1,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.066192,-0.044584,-0.020712,1,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.036048,-0.045072,-0.045096,1,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.037139,-0.045372,-0.075792,1,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.013856,-0.046006,-0.040986,1,0
2,GO ERAD PATHWAY,0.043025,-0.046026,-0.039101,1,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.017699,-0.046235,-0.045905,1,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033948,-0.046239,-0.087563,1,0
2,GO REGULATION OF PHOSPHORYLATION,0.024687,-0.04627,-0.043069,1,0
2,GO ORGANELLE LOCALIZATION,0.0039481,-0.046527,-0.047967,1,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.048285,-0.046803,-0.084483,1,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.036048,-0.046883,-0.041855,1,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.044722,-0.04701,-0.085677,1,0
2,GO SPINDLE ASSEMBLY,0.042197,-0.047624,-0.044695,1,0
2,GO REGULATION OF HISTONE MODIFICATION,0.01995,-0.048046,-0.047655,1,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.026286,-0.048056,-0.049482,1,0
2,GO REGULATION OF CELL CYCLE,0.011151,-0.048142,-0.034252,1,0
2,GO CELL CYCLE,0.012087,-0.048214,-0.035457,1,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.059331,-0.048785,-0.075382,1,0
2,GO SINGLE FERTILIZATION,0.024687,-0.049354,-0.04909,1,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.028556,-0.049389,-0.084616,1,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.016752,-0.050036,-0.081391,1,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.039795,-0.050396,-0.036845,1,0
2,GO SYMBIOTIC PROCESS,0.045155,-0.050739,-0.046923,1,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.045591,-0.050831,-0.046448,1,0
2,GO MITOTIC NUCLEAR DIVISION,0.027401,-0.050947,-0.047504,1,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.056652,-0.051001,-0.064671,1,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.019735,-0.051345,-0.044693,1,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.011949,-0.051391,-0.059601,1,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.044722,-0.05142,-0.094144,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.050154,-0.051596,-0.060076,1,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.01995,-0.051838,-0.040465,1,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.059879,-0.051928,-0.038959,1,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.064418,-0.051986,-0.044541,1,0
2,GO ORGANELLE ASSEMBLY,0.0066039,-0.052209,-0.046478,1,0
2,GO HISTONE H3 K9 METHYLATION,0.02174,-0.052391,-0.076306,1,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.043444,-0.052734,-0.046813,1,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.036409,-0.052789,-0.09701,1,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.057711,-0.05293,-0.033005,1,0
2,GO OOGENESIS,0.048285,-0.0531,-0.070367,1,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.032607,-0.053185,-0.0608,1,0
2,GO LIPID MODIFICATION,0.027401,-0.053189,-0.055478,1,0
2,GO SPINDLE ORGANIZATION,0.058787,-0.053337,-0.039995,1,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.017894,-0.053599,-0.046285,1,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0084096,-0.05384,-0.099967,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.060432,-0.053882,-0.042924,1,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0047798,-0.054004,-0.046773,1,0
2,GO NON RECOMBINATIONAL REPAIR,0.0062108,-0.054041,-0.058759,1,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.030368,-0.054156,-0.050621,1,0
2,GO TOR SIGNALING,0.031953,-0.054663,-0.037946,1,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.011949,-0.054929,-0.058239,1,0
2,GO PEPTIDYL SERINE MODIFICATION,0.020385,-0.054961,-0.044019,1,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.065005,-0.054982,-0.0426,1,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0039992,-0.055346,-0.080375,1,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.019312,-0.055562,-0.049748,1,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.052575,-0.055661,-0.036334,1,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.039795,-0.055725,-0.070122,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0033799,-0.055734,-0.069521,1,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.037139,-0.055736,-0.048055,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.042609,-0.055879,-0.080761,1,0
2,GO CELL DIVISION,0.02915,-0.055911,-0.041234,1,0
2,GO LIPID METABOLIC PROCESS,0.045591,-0.055955,-0.04443,1,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.022446,-0.055962,-0.053734,1,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.020605,-0.056179,-0.039889,1,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.059879,-0.056224,-0.041827,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.057179,-0.056278,-0.042617,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.030368,-0.056647,-0.03553,1,0
2,GO NEGATIVE REGULATION OF GROWTH,0.054074,-0.056659,-0.039664,1,0
2,GO POSITIVE REGULATION OF SIGNALING,0.0048405,-0.057477,-0.059846,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.014494,-0.057595,-0.052321,1,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.051595,-0.057682,-0.058303,1,0
2,GO P BODY ASSEMBLY,0.033271,-0.058204,-0.053517,1,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.038258,-0.058254,-0.045779,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.013546,-0.05848,-0.11535,1,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.052575,-0.058602,-0.037167,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.025743,-0.058679,-0.059803,1,0
2,GO NUCLEUS ORGANIZATION,0.030994,-0.059064,-0.039068,1,0
2,GO PROTEIN CATABOLIC PROCESS,0.036409,-0.059251,-0.034166,1,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.053071,-0.059517,-0.033342,1,0
2,GO HISTONE H3 K9 MODIFICATION,0.016938,-0.059664,-0.076154,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.047372,-0.059835,-0.030936,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0088198,-0.059896,-0.062784,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.047827,-0.060295,-0.03892,1,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.024428,-0.060652,-0.049442,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.051111,-0.060677,-0.059268,1,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.050154,-0.061175,-0.048706,1,0
2,GO POSITIVE REGULATION OF GROWTH,0.050154,-0.061192,-0.04297,1,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.047827,-0.06121,-0.062856,1,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.014658,-0.061717,-0.062309,1,0
2,GO HISTONE H4 ACETYLATION,0.02915,-0.062092,-0.048641,1,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.055609,-0.062125,-0.038871,1,0
2,GO GLYCOSYLATION,0.024173,-0.062212,-0.072627,1,0
2,GO RESPONSE TO GROWTH FACTOR,0.026286,-0.062373,-0.062826,1,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.034636,-0.062479,-0.041638,1,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.040187,-0.062572,-0.052559,1,0
2,GO HISTONE UBIQUITINATION,0.004964,-0.062943,-0.071643,1,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.013394,-0.063131,-0.045396,1,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0059116,-0.063352,-0.067562,1,0
2,GO APOPTOTIC PROCESS,0.027118,-0.063374,-0.043478,1,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.048285,-0.063538,-0.12973,1,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.063836,-0.063565,-0.089856,1,0
2,GO MEMBRANE DOCKING,0.012945,-0.063623,-0.058333,1,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00042128,-0.063919,-0.065789,1,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.034636,-0.064492,-0.050981,1,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.035336,-0.064586,-0.050106,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.058247,-0.064622,-0.10985,1,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.02521,-0.064744,-0.064853,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.031953,-0.064845,-0.057441,1,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.065596,-0.065124,-0.04981,1,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.024173,-0.065295,-0.055998,1,0
2,GO REGULATION OF TOR SIGNALING,0.018898,-0.065596,-0.054709,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.050154,-0.065682,-0.041576,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0061347,-0.066055,-0.057307,1,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.033271,-0.066145,-0.060432,1,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.02521,-0.066276,-0.060279,1,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.032278,-0.066342,-0.095438,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.0086125,-0.066412,-0.11343,1,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.029754,-0.066545,-0.059635,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.040582,-0.066641,-0.075661,1,0
2,GO GOLGI VESICLE TRANSPORT,0.021973,-0.066987,-0.046983,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.043866,-0.06701,-0.06583,1,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.011813,-0.067124,-0.052978,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.016027,-0.067156,-0.052266,1,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.021053,-0.067265,-0.045494,1,0
2,GO LYSOSOME LOCALIZATION,0.021053,-0.067284,-0.091657,1,0
2,GO ACTIN FILAMENT BASED PROCESS,0.014658,-0.067452,-0.059508,1,0
2,GO BIOLOGICAL ADHESION,0.026286,-0.067583,-0.073306,1,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.016027,-0.067673,-0.042675,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.011544,-0.067814,-0.062602,1,0
2,GO SENSORY ORGAN DEVELOPMENT,0.033271,-0.067948,-0.053914,1,0
2,GO CELL AGING,0.049212,-0.068163,-0.068887,1,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.030368,-0.068202,-0.06187,1,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.012945,-0.068207,-0.066111,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0081133,-0.068251,-0.065069,1,0
2,GO FATTY ACID METABOLIC PROCESS,0.03902,-0.068378,-0.060474,1,0
2,GO ORGANELLE FISSION,0.0013069,-0.068392,-0.061332,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0034243,-0.068394,-0.063503,1,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.058787,-0.068408,-0.083212,1,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.026838,-0.068411,-0.075466,1,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.025743,-0.06863,-0.075182,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.052575,-0.068673,-0.05712,1,0
2,GO MACROAUTOPHAGY,0.0037016,-0.068691,-0.054021,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.039406,-0.068971,-0.055829,1,0
2,GO RESPONSE TO STEROID HORMONE,0.02174,-0.068972,-0.065617,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.026013,-0.069013,-0.040255,1,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0025961,-0.069089,-0.087441,1,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.00065224,-0.069094,-0.055988,1,0
2,GO CYTOKINESIS,0.0012705,-0.06912,-0.079402,1,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.040187,-0.06913,-0.055254,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.013243,-0.069166,-0.053206,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.047372,-0.06954,-0.042635,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.062684,-0.069701,-0.075835,1,0
2,GO MULTI ORGANISM PROCESS,0.0021798,-0.069781,-0.060422,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.056128,-0.069864,-0.054223,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0040509,-0.069879,-0.077544,1,0
2,GO EMBRYO DEVELOPMENT,0.0031247,-0.069892,-0.067764,1,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.0092477,-0.070104,-0.051183,1,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.02945,-0.07023,-0.065415,1,0
2,GO DETECTION OF STIMULUS,0.038258,-0.070246,-0.044137,1,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.057179,-0.070404,-0.036883,1,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.0086125,-0.070656,-0.066762,1,0
2,GO CELL CYCLE CHECKPOINT,0.0020367,-0.070838,-0.069177,1,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.013243,-0.070925,-0.04599,1,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.017894,-0.070973,-0.070689,1,0
2,GO THYMUS DEVELOPMENT,0.041383,-0.071011,-0.089818,1,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.00074504,-0.071081,-0.062298,1,0
2,GO HETEROCHROMATIN ORGANIZATION,0.010279,-0.071117,-0.061608,1,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00043435,-0.071157,-0.09309,1,0
2,GO RESPONSE TO KETONE,0.057711,-0.071163,-0.051912,1,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.012087,-0.071223,-0.084688,1,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.012367,-0.071452,-0.057505,1,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.018898,-0.071517,-0.064885,1,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.060432,-0.071539,-0.073671,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0020646,-0.071613,-0.052552,1,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.025475,-0.071749,-0.058953,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.029754,-0.071758,-0.10758,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.022686,-0.071807,-0.077179,1,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.041789,-0.072165,-0.073917,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0087156,-0.07235,-0.088591,1,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00090088,-0.0724,-0.058834,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.012367,-0.072417,-0.080018,1,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.052575,-0.072684,-0.075245,1,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.017894,-0.072865,-0.050353,1,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.054582,-0.073144,-0.063843,1,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.013856,-0.07315,-0.081364,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.065596,-0.073932,-0.06089,1,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.031953,-0.07398,-0.058857,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.024428,-0.074041,-0.11668,1,0
2,GO VESICLE ORGANIZATION,0.0032078,-0.074096,-0.07241,1,0
2,GO MESODERM DEVELOPMENT,0.062114,-0.074184,-0.054363,1,0
2,GO REGULATION OF VASOCONSTRICTION,0.020166,-0.074329,-0.074117,1,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.008211,-0.074395,-0.059534,1,0
2,GO RESPONSE TO BACTERIUM,0.024428,-0.074427,-0.08864,1,0
2,GO RESPONSE TO ANTIBIOTIC,0.036048,-0.074492,-0.076898,1,0
2,GO CYTOSKELETON ORGANIZATION,0.007921,-0.074591,-0.053081,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.013093,-0.074593,-0.066166,1,0
2,GO REGULATION OF CELL DEATH,0.01849,-0.074759,-0.050801,1,0
2,GO MUSCLE CELL DEVELOPMENT,0.012227,-0.074829,-0.073971,1,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.01016,-0.075059,-0.067533,1,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.018898,-0.075597,-0.10568,1,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.016205,-0.075735,-0.14602,1,0
2,GO SEXUAL REPRODUCTION,0.0007901,-0.075762,-0.070571,1,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.048285,-0.075791,-0.054873,1,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.062684,-0.076606,-0.056901,1,0
2,GO CIRCADIAN RHYTHM,0.0032928,-0.07665,-0.063953,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.059879,-0.07693,-0.09913,1,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0080166,-0.076978,-0.053347,1,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.016568,-0.077112,-0.068919,1,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.02915,-0.077127,-0.11305,1,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.03068,-0.077214,-0.075856,1,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00044103,-0.077223,-0.069555,1,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.040582,-0.077227,-0.077111,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.027973,-0.077308,-0.089124,1,0
2,GO RESPONSE TO METAL ION,0.045155,-0.077336,-0.04736,1,0
2,GO CELL MOTILITY,0.0095807,-0.077337,-0.069652,1,0
2,GO MEMBRANE FUSION,0.01016,-0.077359,-0.072542,1,0
2,GO ORGANELLE DISASSEMBLY,0.020385,-0.07738,-0.050299,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.039795,-0.077445,-0.072945,1,0
2,GO AGING,0.014823,-0.077715,-0.061554,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.038258,-0.078013,-0.074125,1,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.016027,-0.078053,-0.064885,1,0
2,GO PIGMENTATION,0.051595,-0.078155,-0.061135,1,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.013546,-0.078236,-0.10136,1,0
2,GO MUSCLE CELL DIFFERENTIATION,0.01995,-0.078437,-0.066814,1,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0065235,-0.078771,-0.06445,1,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.037882,-0.078782,-0.047232,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.0024941,-0.078815,-0.058815,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.013856,-0.078877,-0.080662,1,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.026561,-0.078965,-0.12137,1,0
2,GO TISSUE MORPHOGENESIS,0.0039481,-0.07897,-0.08357,1,0
2,GO ACTIN FILAMENT ORGANIZATION,0.0028872,-0.079058,-0.086128,1,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.033948,-0.079339,-0.048336,1,0
2,GO DNA DEALKYLATION,0.012087,-0.079357,-0.096597,1,0
2,GO APPENDAGE DEVELOPMENT,0.009139,-0.07947,-0.10105,1,0
2,GO THYMIC T CELL SELECTION,0.040187,-0.079595,-0.083794,1,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0065235,-0.079644,-0.082481,1,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.042609,-0.079685,-0.046969,1,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0099244,-0.079698,-0.075954,1,0
2,GO P38MAPK CASCADE,0.049212,-0.079728,-0.08511,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.022209,-0.079757,-0.058235,1,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0090315,-0.079927,-0.06237,1,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.037882,-0.079928,-0.09251,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.026561,-0.079944,-0.085616,1,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.034984,-0.080083,-0.040902,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.014013,-0.080244,-0.059861,1,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.022686,-0.08029,-0.072587,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.015674,-0.080376,-0.093851,1,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0021505,-0.08049,-0.10821,1,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0084096,-0.080583,-0.089008,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0089251,-0.080744,-0.08297,1,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.053071,-0.080777,-0.041723,1,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.01849,-0.080802,-0.091562,1,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0054192,-0.080816,-0.087189,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.000286,-0.080883,-0.1047,1,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.026838,-0.081297,-0.093674,1,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0055559,-0.081323,-0.061108,1,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.03902,-0.081418,-0.14439,1,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.066192,-0.081682,-0.07097,1,0
2,GO REGULATION OF CYTOKINESIS,0.017699,-0.081719,-0.067638,1,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.045155,-0.081745,-0.060382,1,0
2,GO GLUCOSE METABOLIC PROCESS,0.028264,-0.081789,-0.051031,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.066192,-0.08185,-0.10359,1,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.012653,-0.082075,-0.05625,1,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.03006,-0.082101,-0.067835,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.011151,-0.082287,-0.066278,1,0
2,GO SIGNAL RELEASE,0.05357,-0.082505,-0.045947,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0023009,-0.082579,-0.099456,1,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.043025,-0.08258,-0.042469,1,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0030038,-0.082931,-0.071346,1,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.014658,-0.08306,-0.10838,1,0
2,GO RESPONSE TO ALCOHOL,0.01499,-0.083199,-0.062811,1,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0067673,-0.083456,-0.070864,1,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.038637,-0.083501,-0.047395,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0048405,-0.083583,-0.090212,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.018693,-0.083604,-0.057211,1,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.027401,-0.083691,-0.065562,1,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.060988,-0.083864,-0.060499,1,0
2,GO APPENDAGE MORPHOGENESIS,0.0073682,-0.08393,-0.11779,1,0
2,GO FIBROBLAST MIGRATION,0.023173,-0.083947,-0.1076,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.004156,-0.084232,-0.084904,1,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00032408,-0.084249,-0.089615,1,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.049212,-0.084304,-0.049513,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00076726,-0.084563,-0.072566,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.010645,-0.084616,-0.086787,1,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.00025617,-0.084696,-0.17037,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.0037016,-0.08471,-0.091417,1,0
2,GO STEM CELL PROLIFERATION,0.0072795,-0.084794,-0.099813,1,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.01128,-0.085104,-0.057045,1,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0035605,-0.08512,-0.068427,1,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.039795,-0.085149,-0.10594,1,0
2,GO METAPHASE PLATE CONGRESSION,0.00022208,-0.0853,-0.10731,1,0
2,GO RESPONSE TO LIPID,0.044722,-0.085322,-0.051678,1,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0069343,-0.085424,-0.088086,1,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0048405,-0.085431,-0.081704,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.013093,-0.085511,-0.086311,1,0
2,GO MALE GAMETE GENERATION,0.00042777,-0.08566,-0.083743,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.010645,-0.08575,-0.065412,1,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00039622,-0.085808,-0.097761,1,0
2,GO REGULATION OF OSSIFICATION,0.020605,-0.085847,-0.089366,1,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00059648,-0.085972,-0.075852,1,0
2,GO GERM CELL DEVELOPMENT,0.0017277,-0.08611,-0.084982,1,0
2,GO REGULATION OF CELL DIVISION,0.0034243,-0.086324,-0.075312,1,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00016901,-0.086767,-0.10066,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.026561,-0.086834,-0.11401,1,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.052083,-0.086855,-0.1265,1,0
2,GO LIPID LOCALIZATION,0.015501,-0.086861,-0.07459,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.02174,-0.086967,-0.10584,1,0
2,GO PLATELET MORPHOGENESIS,0.018693,-0.087044,-0.1346,1,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00032916,-0.087074,-0.075711,1,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.013856,-0.087537,-0.096595,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.010279,-0.087723,-0.093428,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.044292,-0.087802,-0.094,1,0
2,GO RESPONSE TO BMP,0.0085105,-0.087976,-0.10516,1,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.029754,-0.088001,-0.096437,1,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0050269,-0.088039,-0.09024,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042609,-0.088185,-0.073002,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.050154,-0.08823,-0.069663,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0051547,-0.088393,-0.089164,1,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.056128,-0.088471,-0.090302,1,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0044298,-0.088483,-0.077267,1,0
2,GO POLYOL CATABOLIC PROCESS,0.0096941,-0.088485,-0.099429,1,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.009139,-0.088488,-0.08995,1,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.033608,-0.088541,-0.041596,1,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.0083098,-0.08867,-0.088844,1,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.0013069,-0.088715,-0.072457,1,0
2,GO LYMPHOCYTE COSTIMULATION,0.058247,-0.088719,-0.07146,1,0
2,GO METANEPHROS DEVELOPMENT,0.009139,-0.088731,-0.12234,1,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.028264,-0.088751,-0.063979,1,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.047827,-0.088751,-0.061776,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0047798,-0.088815,-0.093805,1,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.019735,-0.088928,-0.11692,1,0
2,GO REGULATION OF SECRETION,0.0077327,-0.088943,-0.067757,1,0
2,GO REGULATION OF PROTEOLYSIS,0.0053519,-0.089376,-0.074925,1,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0039481,-0.089411,-0.088965,1,0
2,GO SPROUTING ANGIOGENESIS,0.037882,-0.089538,-0.078749,1,0
2,GO REGULATION OF BLOOD PRESSURE,0.032938,-0.089637,-0.062503,1,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.035336,-0.089696,-0.095532,1,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.016205,-0.08976,-0.077789,1,0
2,GO PROTEIN AUTOUBIQUITINATION,0.0029256,-0.089806,-0.077266,1,0
2,GO TUBE DEVELOPMENT,0.0046018,-0.089977,-0.087696,1,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.047372,-0.090002,-0.066029,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0072795,-0.090136,-0.082086,1,0
2,GO ECTODERM DEVELOPMENT,0.0039481,-0.090163,-0.11596,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.013243,-0.09019,-0.08159,1,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.012945,-0.090222,-0.05852,1,0
2,GO MEIOTIC CELL CYCLE PROCESS,8.4424e-05,-0.090278,-0.0963,1,0
2,GO SECRETION,0.0058389,-0.090322,-0.06511,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0075485,-0.090396,-0.085344,1,0
2,GO ANIMAL ORGAN FORMATION,0.023419,-0.090402,-0.10376,1,0
2,GO EXOCYTOSIS,0.011813,-0.090568,-0.07068,1,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.029754,-0.091023,-0.060495,1,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.022928,-0.091031,-0.067073,1,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0038977,-0.091064,-0.080516,1,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.0085105,-0.091083,-0.076994,1,0
2,GO CELLULAR SENESCENCE,0.017506,-0.09111,-0.090069,1,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.044722,-0.091182,-0.10623,1,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.011678,-0.09127,-0.06076,1,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0089251,-0.091295,-0.056221,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.060432,-0.091321,-0.0728,1,0
2,GO CARDIAC CELL DEVELOPMENT,0.047372,-0.091333,-0.065582,1,0
2,GO TUBE MORPHOGENESIS,0.0072795,-0.091351,-0.089604,1,0
2,GO CRANIAL NERVE DEVELOPMENT,0.02521,-0.091355,-0.13792,1,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0069343,-0.091423,-0.10384,1,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.01995,-0.091453,-0.063513,1,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.065005,-0.091513,-0.059022,1,0
2,GO PINOCYTOSIS,0.045591,-0.09152,-0.098349,1,0
2,GO SPERM MOTILITY,0.0040509,-0.091554,-0.092543,1,0
2,GO HISTONE H2B UBIQUITINATION,0.0085105,-0.091583,-0.1061,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.045591,-0.09178,-0.065166,1,0
2,GO EPITHELIAL CELL PROLIFERATION,0.0052854,-0.091976,-0.11107,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.003607,-0.092028,-0.070974,1,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.00037835,-0.092034,-0.078508,1,0
2,GO REGULATION OF HEMOPOIESIS,0.0019285,-0.092047,-0.097028,1,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.02521,-0.092068,-0.052061,1,0
2,GO COPII COATED VESICLE BUDDING,0.0066851,-0.092105,-0.072414,1,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.057711,-0.092134,-0.17665,1,0
2,GO ERYTHROCYTE MATURATION,0.033271,-0.092223,-0.092363,1,0
2,GO NEGATIVE T CELL SELECTION,0.02915,-0.092469,-0.074515,1,0
2,GO VESICLE TARGETING,0.00080175,-0.092539,-0.10822,1,0
2,GO DOSAGE COMPENSATION,0.01829,-0.092616,-0.08957,1,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.014013,-0.09265,-0.093756,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.001118,-0.092729,-0.10312,1,0
2,GO RETINOL METABOLIC PROCESS,0.057711,-0.093017,-0.11576,1,0
2,GO REGULATION OF CELL MATURATION,0.0056958,-0.093026,-0.083623,1,0
2,GO B CELL HOMEOSTASIS,0.040981,-0.093046,-0.1023,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00047589,-0.093094,-0.077742,1,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00080175,-0.093294,-0.098335,1,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.062114,-0.093379,-0.12429,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.021053,-0.093389,-0.050153,1,0
2,GO CELL JUNCTION ASSEMBLY,0.016205,-0.093418,-0.07853,1,0
2,GO DEPHOSPHORYLATION,0.0021798,-0.093457,-0.061956,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.01829,-0.093648,-0.11969,1,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.049681,-0.093657,-0.075646,1,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0022095,-0.093813,-0.095682,1,0
2,GO RETINA HOMEOSTASIS,0.059331,-0.093886,-0.014752,1,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.043025,-0.093987,-0.14103,1,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.032278,-0.094141,-0.11735,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0072795,-0.094195,-0.092396,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0044298,-0.094207,-0.095613,1,0
2,GO GAMETE GENERATION,0.00017176,-0.094255,-0.086248,1,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.060988,-0.094497,-0.11579,1,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.024173,-0.094544,-0.065017,1,0
2,GO MAST CELL MIGRATION,0.057711,-0.094787,-0.1643,1,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.02521,-0.094995,-0.10185,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.023173,-0.095011,-0.079553,1,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.019312,-0.09527,-0.081549,1,0
2,GO PATTERN SPECIFICATION PROCESS,0.014494,-0.095437,-0.069333,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0045438,-0.095615,-0.070099,1,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.02945,-0.095726,-0.081488,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.024173,-0.09576,-0.071212,1,0
2,GO RESPONSE TO SALT STRESS,0.043025,-0.09582,-0.080095,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.001955,-0.096021,-0.078682,1,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.00074504,-0.096079,-0.093207,1,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.023919,-0.09667,-0.18677,1,0
2,GO GOLGI VESICLE BUDDING,0.0047798,-0.096789,-0.079325,1,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.020605,-0.096873,-0.080492,1,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.0066851,-0.097003,-0.10597,1,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.051111,-0.097153,-0.093323,1,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.0098086,-0.097336,-0.11479,1,0
2,GO RESPONSE TO ISCHEMIA,0.034984,-0.097403,-0.073845,1,0
2,GO PROTEIN POLYUBIQUITINATION,4.7172e-05,-0.097535,-0.09626,1,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0046018,-0.09759,-0.08674,1,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.011949,-0.097616,-0.072345,1,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.062684,-0.097666,-0.061484,1,0
2,GO PROTEIN MATURATION,0.0037985,-0.097912,-0.073314,1,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0031247,-0.097974,-0.083497,1,0
2,GO SEX DIFFERENTIATION,0.0081133,-0.098104,-0.071148,1,0
2,GO CELL FATE COMMITMENT,0.0062108,-0.098127,-0.088294,1,0
2,GO PROTEOLYSIS,0.00059648,-0.098222,-0.073947,1,0
2,GO LIPID EXPORT FROM CELL,0.01585,-0.098237,-0.11033,1,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0098086,-0.098557,-0.10669,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00053704,-0.098661,-0.094639,1,0
2,GO COLLECTING DUCT DEVELOPMENT,0.059331,-0.098692,-0.13667,1,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0068504,-0.098724,-0.086742,1,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0021505,-0.098915,-0.086603,1,0
2,GO FACE DEVELOPMENT,0.0071918,-0.09909,-0.11814,1,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.052083,-0.099097,-0.083315,1,0
2,GO GLAND MORPHOGENESIS,0.026286,-0.09924,-0.13328,1,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00068191,-0.099346,-0.11635,1,0
2,GO MEIOTIC CELL CYCLE,1.0557e-05,-0.09941,-0.10592,1,0
2,GO COAGULATION,0.0060595,-0.099544,-0.1017,1,0
2,GO VIRAL LATENCY,0.05063,-0.099555,-0.066025,1,0
2,GO REGULATION OF PH,0.00099681,-0.099562,-0.082681,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0099244,-0.099735,-0.094797,1,0
2,GO EXIT FROM MITOSIS,0.013243,-0.099811,-0.078363,1,0
2,GO CELL MATRIX ADHESION,0.012227,-0.10025,-0.10008,1,0
2,GO ERBB SIGNALING PATHWAY,0.0056958,-0.10031,-0.094039,1,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0018006,-0.10036,-0.085253,1,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0047198,-0.10051,-0.091508,1,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.045591,-0.10062,-0.11749,1,0
2,GO GRANULOCYTE MIGRATION,0.020385,-0.10065,-0.093922,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.006444,-0.10066,-0.11377,1,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.043866,-0.10068,-0.079308,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.00092737,-0.10071,-0.094907,1,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.00083767,-0.10078,-0.10116,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.038258,-0.1009,-0.094103,1,0
2,GO DEMETHYLATION,0.0137,-0.10095,-0.053688,1,0
2,GO MESODERM MORPHOGENESIS,0.027686,-0.101,-0.089927,1,0
2,GO CELL MATURATION,0.0013255,-0.10102,-0.093413,1,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0052197,-0.10104,-0.096325,1,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0012705,-0.10117,-0.1191,1,0
2,GO MAINTENANCE OF CELL NUMBER,0.0044298,-0.10125,-0.090333,1,0
2,GO CHROMOSOME LOCALIZATION,0.00017457,-0.10126,-0.10756,1,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.047827,-0.1013,-0.096829,1,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.00159,-0.10135,-0.10659,1,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0010408,-0.10137,-0.10359,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0013633,-0.10138,-0.082959,1,0
2,GO STEROID METABOLIC PROCESS,0.011151,-0.10142,-0.078451,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0074579,-0.10152,-0.054917,1,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.051111,-0.10165,-0.14159,1,0
2,GO RESPONSE TO FOOD,0.0029645,-0.10166,-0.12228,1,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.043866,-0.10194,-0.11596,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.01829,-0.10202,-0.14682,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.0062877,-0.10213,-0.070904,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.0025961,-0.10217,-0.070217,1,0
2,GO TISSUE MIGRATION,0.012087,-0.10219,-0.094257,1,0
2,GO MITOTIC CYTOKINESIS,0.00071283,-0.10222,-0.10566,1,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.020385,-0.10257,-0.093605,1,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.019735,-0.10257,-0.093929,1,0
2,GO REGULATION OF STEM CELL DIVISION,0.059879,-0.10259,-0.10767,1,0
2,GO REPLACEMENT OSSIFICATION,0.01995,-0.1026,-0.12879,1,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.047372,-0.10271,-0.095057,1,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.044722,-0.10284,-0.18565,1,0
2,GO FEMALE GAMETE GENERATION,0.020828,-0.10285,-0.059862,1,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.020605,-0.10306,-0.14022,1,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.032938,-0.10313,-0.10054,1,0
2,GO TUBE FORMATION,0.00041488,-0.10313,-0.11816,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.026286,-0.10337,-0.11456,1,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00038422,-0.10343,-0.087319,1,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.032278,-0.10347,-0.065883,1,0
2,GO REGULATION OF CELL ACTIVATION,0.003654,-0.10348,-0.098743,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0074579,-0.1035,-0.094851,1,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.057179,-0.10357,-0.13419,1,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.01585,-0.1036,-0.14109,1,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.040187,-0.1037,-0.1681,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.017315,-0.10381,-0.072641,1,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0066851,-0.10387,-0.10245,1,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0026663,-0.10392,-0.089144,1,0
2,GO ASTROCYTE ACTIVATION,0.032607,-0.10401,-0.093778,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.00070238,-0.10421,-0.10497,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0084096,-0.10425,-0.093384,1,0
2,GO ENDOSOMAL TRANSPORT,1.2253e-05,-0.10429,-0.09884,1,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.010522,-0.1043,-0.080216,1,0
2,GO HORMONE METABOLIC PROCESS,0.0095807,-0.10448,-0.097989,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0025961,-0.10455,-0.12344,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0028872,-0.10456,-0.10738,1,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.056128,-0.10458,-0.078445,1,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0016122,-0.1048,-0.11452,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.001704,-0.10484,-0.11102,1,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.031311,-0.10485,-0.074931,1,0
2,GO RENAL SYSTEM PROCESS,0.0023321,-0.10485,-0.11571,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0035605,-0.10488,-0.07987,1,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.0044298,-0.1053,-0.070226,1,0
2,GO SPECIFICATION OF SYMMETRY,0.00096848,-0.10555,-0.093974,1,0
2,GO REGULATION OF CELLULAR PH,0.00098255,-0.10563,-0.08544,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.037882,-0.1058,-0.12164,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.017506,-0.10582,-0.09797,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0053519,-0.10584,-0.10473,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.001776,-0.1059,-0.11869,1,0
2,GO PEPTIDE HORMONE SECRETION,0.025475,-0.10594,-0.073751,1,0
2,GO RESPONSE TO ACTIVITY,0.021973,-0.10598,-0.075288,1,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.0068504,-0.10611,-0.1215,1,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.027118,-0.10622,-0.10351,1,0
2,GO EMBRYONIC MORPHOGENESIS,0.00054518,-0.10643,-0.10406,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0066851,-0.10644,-0.10074,1,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.034636,-0.10675,-0.060894,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.0041031,-0.10678,-0.11155,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0046018,-0.10684,-0.12571,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0020092,-0.10685,-0.12569,1,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.040187,-0.10699,-0.11952,1,0
2,GO CARBOHYDRATE TRANSPORT,0.0025617,-0.10706,-0.078217,1,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.014823,-0.1073,-0.13305,1,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0029645,-0.10736,-0.077221,1,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0071918,-0.10749,-0.12169,1,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00088789,-0.10757,-0.098438,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.054582,-0.10759,-0.096015,1,0
2,GO V D J RECOMBINATION,0.0077327,-0.10784,-0.16565,1,0
2,GO SPINDLE LOCALIZATION,0.001568,-0.10785,-0.10574,1,0
2,GO MACROPHAGE DIFFERENTIATION,0.023668,-0.108,-0.11142,1,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0013633,-0.10818,-0.11867,1,0
2,GO PROTEIN MONOUBIQUITINATION,0.00015083,-0.10835,-0.086552,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0059116,-0.10861,-0.16285,1,0
2,GO RESPONSE TO WOUNDING,0.0047198,-0.10886,-0.10664,1,0
2,GO MATURE B CELL DIFFERENTIATION,0.066192,-0.1089,-0.12508,1,0
2,GO INOSITOL METABOLIC PROCESS,0.022928,-0.10897,-0.096078,1,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0042095,-0.10914,-0.086028,1,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.01829,-0.10928,-0.13795,1,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.0033361,-0.10942,-0.094175,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0065235,-0.1095,-0.10974,1,0
2,GO NEURONAL ACTION POTENTIAL,0.037509,-0.10975,-0.16198,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.040582,-0.11027,-0.060823,1,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,6.545e-05,-0.11031,-0.097665,1,0
2,GO POSTREPLICATION REPAIR,0.0005056,-0.11035,-0.085236,1,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.0020929,-0.11042,-0.079566,1,0
2,GO RESPONSE TO CADMIUM ION,0.031311,-0.11068,-0.10595,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.029754,-0.11075,-0.093446,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.037882,-0.11078,-0.11197,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00069207,-0.11092,-0.11349,1,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.001704,-0.111,-0.07744,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00038422,-0.11115,-0.07833,1,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00065224,-0.11152,-0.11855,1,0
2,GO CELL ACTIVATION,0.0038478,-0.11155,-0.096342,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0030436,-0.11163,-0.11988,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.00067188,-0.11166,-0.11042,1,0
2,GO RESPONSE TO COPPER ION,0.060432,-0.11175,-0.12484,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.066192,-0.11186,-0.10367,1,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.039795,-0.11188,-0.080757,1,0
2,GO REGULATION OF NUCLEAR DIVISION,0.00014599,-0.1119,-0.087358,1,0
2,GO RESPIRATORY BURST,0.016205,-0.11191,-0.14437,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.018693,-0.11196,-0.095031,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.004156,-0.1121,-0.11156,1,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.013093,-0.11226,-0.105,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.0032928,-0.11226,-0.13042,1,0
2,GO MUSCLE ADAPTATION,0.0037985,-0.11251,-0.095136,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.024687,-0.11255,-0.093389,1,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.016938,-0.11259,-0.096357,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.033271,-0.11276,-0.097252,1,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.004156,-0.11276,-0.12455,1,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.00058763,-0.11288,-0.14649,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0090315,-0.11297,-0.075858,1,0
2,GO REGULATION OF HORMONE LEVELS,0.001071,-0.11313,-0.096787,1,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.007921,-0.1132,-0.081836,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.0042636,-0.11331,-0.10225,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0040509,-0.11334,-0.19531,1,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0054872,-0.11344,-0.081042,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0050269,-0.11355,-0.10513,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.030994,-0.11366,-0.1012,1,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.017894,-0.11368,-0.11561,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.019312,-0.11375,-0.11908,1,0
2,GO MESENCHYME MORPHOGENESIS,0.0074579,-0.1138,-0.1261,1,0
2,GO HORMONE TRANSPORT,0.0030436,-0.11451,-0.097155,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.024947,-0.11479,-0.08072,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.050154,-0.11486,-0.13174,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00095459,-0.11487,-0.13296,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0018764,-0.11488,-0.094367,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.017315,-0.11495,-0.10202,1,0
2,GO VACUOLAR TRANSPORT,0.0034692,-0.1151,-0.080267,1,0
2,GO REPRODUCTION,6.0079e-05,-0.11512,-0.089705,1,0
2,GO RESPONSE TO ETHER,0.0044298,-0.11522,-0.10951,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.018091,-0.11524,-0.12618,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0073682,-0.11536,-0.096357,1,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.016938,-0.1155,-0.089128,1,0
2,GO POSITIVE CHEMOTAXIS,0.003607,-0.11556,-0.15004,1,0
2,GO GOLGI ORGANIZATION,7.0072e-05,-0.11558,-0.10512,1,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.010041,-0.11567,-0.086506,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011341,-0.11584,-0.091483,1,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0094686,-0.11591,-0.12878,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0025277,-0.11638,-0.090544,1,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0069343,-0.11638,-0.078704,1,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.063836,-0.11644,-0.068686,1,0
2,GO PEPTIDE SECRETION,0.0020929,-0.1165,-0.086037,1,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.018091,-0.11655,-0.19945,1,0
2,GO RNA DESTABILIZATION,0.057711,-0.11669,-0.051924,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0014022,-0.11672,-0.10214,1,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0023637,-0.11684,-0.13825,1,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0035146,-0.11692,-0.09479,1,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.001483,-0.11697,-0.12886,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0018006,-0.11697,-0.13112,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0039481,-0.11698,-0.12521,1,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.00049802,-0.11704,-0.10155,1,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062877,-0.11704,-0.10003,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0047798,-0.1171,-0.1291,1,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.016205,-0.11723,-0.13867,1,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.043025,-0.11734,-0.080705,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0090315,-0.11735,-0.12251,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.017894,-0.11744,-0.080022,1,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0070192,-0.11751,-0.098855,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.027401,-0.11754,-0.088615,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.023419,-0.11756,-0.086542,1,0
2,GO REGULATION OF PROTEIN IMPORT,0.060988,-0.11762,-0.057926,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.019312,-0.11766,-0.084688,1,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0023009,-0.1177,-0.096427,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0030436,-0.1178,-0.098698,1,0
2,GO INFLAMMATORY RESPONSE,0.0027747,-0.11785,-0.10491,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0088198,-0.11802,-0.1216,1,0
2,GO ETHER METABOLIC PROCESS,0.011022,-0.11811,-0.15441,1,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0049019,-0.11812,-0.090907,1,0
2,GO INTEGRIN ACTIVATION,0.057179,-0.11845,-0.08598,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.031311,-0.11849,-0.098247,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.01128,-0.11857,-0.093468,1,0
2,GO T CELL DIFFERENTIATION,0.00046872,-0.11863,-0.12419,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013633,-0.1187,-0.080507,1,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.011544,-0.11879,-0.093201,1,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0028118,-0.1188,-0.1103,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.045591,-0.11895,-0.070212,1,0
2,GO SPERMATID DIFFERENTIATION,0.003607,-0.11896,-0.10094,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0019023,-0.11898,-0.12056,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0038977,-0.11911,-0.13292,1,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.034984,-0.11913,-0.099108,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.020605,-0.11922,-0.10755,1,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0052197,-0.11932,-0.12038,1,0
2,GO MOLTING CYCLE,0.0074579,-0.11949,-0.11051,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0044864,-0.11971,-0.082777,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.01995,-0.11976,-0.057071,1,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.062684,-0.11977,-0.050797,1,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.0012886,-0.11979,-0.10967,1,0
2,GO EAR DEVELOPMENT,0.0032078,-0.11982,-0.098785,1,0
2,GO CARDIOCYTE DIFFERENTIATION,0.03429,-0.11987,-0.073477,1,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.0059116,-0.11995,-0.13783,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.013546,-0.12003,-0.089488,1,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.001118,-0.1201,-0.13187,1,0
2,GO NUCLEOTIDE TRANSPORT,0.018091,-0.12032,-0.072856,1,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00019857,-0.12032,-0.093477,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.016386,-0.12036,-0.15166,1,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0020929,-0.1204,-0.12107,1,0
2,GO CELL CELL ADHESION,0.00092737,-0.12047,-0.1158,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0098086,-0.12054,-0.12493,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.001955,-0.12061,-0.11856,1,0
2,GO T CELL ACTIVATION,0.00092737,-0.12079,-0.12127,1,0
2,GO DEFINITIVE HEMOPOIESIS,0.045155,-0.12087,-0.11602,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.017894,-0.12088,-0.11679,1,0
2,GO MYOTUBE CELL DEVELOPMENT,0.023419,-0.12099,-0.11315,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0022396,-0.12115,-0.10974,1,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.0016575,-0.12124,-0.10928,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0076401,-0.12126,-0.094378,1,0
2,GO MAMMARY GLAND DEVELOPMENT,0.0041031,-0.12127,-0.10884,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0053519,-0.12127,-0.13261,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0093576,-0.12137,-0.11154,1,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.035691,-0.1214,-0.090354,1,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.020828,-0.12146,-0.11004,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0094686,-0.12148,-0.14622,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00075607,-0.12163,-0.086918,1,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0042095,-0.12183,-0.14384,1,0
2,GO MYELOID CELL DIFFERENTIATION,0.00018323,-0.12192,-0.10768,1,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00010673,-0.12199,-0.095481,1,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0016347,-0.12216,-0.1261,1,0
2,GO TISSUE HOMEOSTASIS,6.7724e-05,-0.1223,-0.12707,1,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.020828,-0.12242,-0.16428,1,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00010497,-0.12252,-0.092278,1,0
2,GO MYOTUBE DIFFERENTIATION,0.0043737,-0.12263,-0.11328,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.007921,-0.12285,-0.11281,1,0
2,GO REGULATION OF DEFENSE RESPONSE,0.0005056,-0.12307,-0.11759,1,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.0024941,-0.12317,-0.085253,1,0
2,GO WOUND HEALING,0.0038977,-0.12321,-0.11729,1,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.1588e-05,-0.12327,-0.11166,1,0
2,GO PROTEIN DESTABILIZATION,0.00044781,-0.12333,-0.10998,1,0
2,GO INSULIN SECRETION,0.018693,-0.12337,-0.081144,1,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.9859e-05,-0.12339,-0.12111,1,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.0016122,-0.12349,-0.099974,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011813,-0.12358,-0.094876,1,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,5.5127e-05,-0.12361,-0.10406,1,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.027686,-0.12371,-0.13155,1,0
2,GO REGULATION OF CHEMOTAXIS,0.010895,-0.12376,-0.081434,1,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.0054872,-0.12379,-0.12071,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013546,-0.12381,-0.093352,1,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.023419,-0.12385,-0.11584,1,0
2,GO CENTRIOLE ASSEMBLY,0.00044103,-0.12394,-0.14081,1,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00061456,-0.12395,-0.11156,1,0
2,GO AMYLOID BETA CLEARANCE,0.03068,-0.12396,-0.097357,1,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.00065224,-0.12434,-0.14165,1,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.049681,-0.12434,-0.075449,1,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.0046604,-0.12447,-0.10053,1,0
2,GO PH REDUCTION,0.00069207,-0.12457,-0.11499,1,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00063314,-0.12461,-0.1232,1,0
2,GO PHOSPHOLIPID TRANSPORT,0.001442,-0.12478,-0.1247,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0074579,-0.12481,-0.12941,1,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00099681,-0.12489,-0.148,1,0
2,GO T CELL PROLIFERATION,0.0035146,-0.12501,-0.12134,1,0
2,GO LEUKOCYTE PROLIFERATION,0.0013633,-0.12506,-0.1218,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.009139,-0.1251,-0.12725,1,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.055093,-0.12524,-0.08942,1,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0025277,-0.12528,-0.090247,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.022686,-0.12538,-0.078283,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.00010152,-0.12559,-0.12967,1,0
2,GO ADAPTIVE THERMOGENESIS,0.0011503,-0.12561,-0.08896,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0069343,-0.12568,-0.1212,1,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0092477,-0.12572,-0.098346,1,0
2,GO REGULATION OF HORMONE SECRETION,0.0030839,-0.1258,-0.099579,1,0
2,GO CILIUM MOVEMENT,0.00027716,-0.12591,-0.12241,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0062108,-0.12596,-0.13694,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0085105,-0.12616,-0.10249,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0007901,-0.12617,-0.13801,1,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.016027,-0.12634,-0.07703,1,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0092477,-0.12641,-0.15058,1,0
2,GO OOCYTE DIFFERENTIATION,0.0058389,-0.12645,-0.11919,1,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.024173,-0.12658,-0.1109,1,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.0098086,-0.12667,-0.10508,1,0
2,GO EYE MORPHOGENESIS,0.012653,-0.12667,-0.085551,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0098086,-0.12676,-0.10762,1,0
2,GO DEFENSE RESPONSE,0.000662,-0.12681,-0.12232,1,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,7.5001e-05,-0.12686,-0.12202,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019312,-0.12696,-0.10102,1,0
2,GO REGULATION OF CELL SHAPE,0.0074579,-0.12709,-0.094566,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.001235,-0.12728,-0.11704,1,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.010041,-0.12736,-0.089132,1,0
2,GO REGIONALIZATION,0.0019285,-0.12759,-0.097892,1,0
2,GO RESPONSE TO ESTRADIOL,0.010769,-0.12767,-0.080923,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00026024,-0.1278,-0.14282,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.024173,-0.12783,-0.13687,1,0
2,GO MYOBLAST DIFFERENTIATION,0.001235,-0.12851,-0.15564,1,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.03068,-0.12857,-0.13231,1,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.0011668,-0.12864,-0.11056,1,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0066039,-0.12867,-0.13443,1,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.018898,-0.12868,-0.10399,1,0
2,GO NEPHRON MORPHOGENESIS,0.0028492,-0.12869,-0.13368,1,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.034984,-0.12871,-0.13153,1,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.014172,-0.12875,-0.11285,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.0011021,-0.12879,-0.10936,1,0
2,GO MICROTUBULE BUNDLE FORMATION,0.0027747,-0.12891,-0.12379,1,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.015159,-0.12894,-0.097041,1,0
2,GO FAT CELL PROLIFERATION,0.061549,-0.12913,-0.11112,1,0
2,GO TEMPERATURE HOMEOSTASIS,0.0026663,-0.12916,-0.074282,1,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.066192,-0.12919,-0.10558,1,0
2,GO REGULATION OF HAIR CYCLE,0.0060595,-0.12932,-0.14859,1,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.02521,-0.12948,-0.11458,1,0
2,GO ACUTE PHASE RESPONSE,0.0030839,-0.12954,-0.13956,1,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0037985,-0.12955,-0.10506,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.030994,-0.12968,-0.12809,1,0
2,GO RESPONSE TO CYTOKINE,0.0022396,-0.12979,-0.10938,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00041488,-0.12985,-0.14948,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00053704,-0.1299,-0.12397,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0011503,-0.13009,-0.1204,1,0
2,GO REGULATION OF PEPTIDE SECRETION,0.00029976,-0.1301,-0.10516,1,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.01016,-0.13024,-0.13943,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0031247,-0.13026,-0.12277,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.026286,-0.13031,-0.1075,1,0
2,GO B CELL PROLIFERATION,0.0066039,-0.13032,-0.12053,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.009139,-0.13036,-0.10261,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.032938,-0.13039,-0.15415,1,0
2,GO REGULATION OF PINOCYTOSIS,0.0043737,-0.1304,-0.14071,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0073682,-0.13049,-0.10468,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.00095459,-0.13056,-0.1121,1,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.041789,-0.13086,-0.084376,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0017517,-0.13099,-0.12495,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0029645,-0.13103,-0.11724,1,0
2,GO TRANSLESION SYNTHESIS,4.7999e-05,-0.13109,-0.11645,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0092477,-0.13132,-0.13914,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0047798,-0.13133,-0.14043,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.014658,-0.13144,-0.13161,1,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0068504,-0.13166,-0.11792,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.017894,-0.13169,-0.13731,1,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.039406,-0.13205,-0.092419,1,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00026438,-0.13217,-0.11599,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00012186,-0.13219,-0.093005,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.015329,-0.13222,-0.08093,1,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0054872,-0.13224,-0.10657,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0096941,-0.13228,-0.14077,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.065596,-0.13229,-0.1214,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00049802,-0.13234,-0.15071,1,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0069343,-0.13235,-0.079663,1,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.020385,-0.13239,-0.13806,1,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00099681,-0.13242,-0.12583,1,0
2,GO HISTONE MONOUBIQUITINATION,2.7452e-06,-0.13243,-0.13805,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00038422,-0.1326,-0.15211,1,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.020166,-0.13266,-0.12174,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0045438,-0.13289,-0.11794,1,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0012527,-0.1329,-0.097483,1,0
2,GO GLAND DEVELOPMENT,5.4184e-05,-0.1332,-0.13181,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0080166,-0.13344,-0.10844,1,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00013232,-0.13352,-0.11148,1,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.012087,-0.13355,-0.083281,1,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.033948,-0.13379,-0.072797,1,0
2,GO MULTICELLULAR ORGANISM AGING,0.00094089,-0.13382,-0.13328,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.01995,-0.13383,-0.13934,1,0
2,GO REGULATION OF CELL ADHESION,0.0011668,-0.13386,-0.12846,1,0
2,GO INNER EAR MORPHOGENESIS,0.001704,-0.13396,-0.1251,1,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.0032928,-0.13409,-0.14246,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.038258,-0.13411,-0.12184,1,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0052854,-0.13414,-0.14071,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.008211,-0.13427,-0.13905,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.023173,-0.13453,-0.13998,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.0043184,-0.13458,-0.11098,1,0
2,GO NOTCH SIGNALING PATHWAY,4.1456e-06,-0.13536,-0.16111,1,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.03068,-0.13537,-0.09318,1,0
2,GO INNATE IMMUNE RESPONSE,0.001955,-0.1354,-0.12968,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0046604,-0.13542,-0.10957,1,0
2,GO REGULATION OF CILIUM MOVEMENT,0.0052197,-0.13559,-0.12348,1,0
2,GO RESPONSE TO COLD,0.0015038,-0.13567,-0.15295,1,0
2,GO CELLULAR PIGMENTATION,0.00032408,-0.13571,-0.12917,1,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0021505,-0.13573,-0.13122,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.015501,-0.1359,-0.083271,1,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0037498,-0.13594,-0.17529,1,0
2,GO CYTOKINE PRODUCTION,0.00057029,-0.13596,-0.12854,1,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.020828,-0.13597,-0.11891,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.0018256,-0.13608,-0.12344,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.003654,-0.13609,-0.11489,1,0
2,GO KERATINOCYTE PROLIFERATION,0.0044298,-0.1361,-0.18898,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0081133,-0.1362,-0.11152,1,0
2,GO RESPONSE TO UV C,0.0020646,-0.13632,-0.15878,1,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0012886,-0.1365,-0.10511,1,0
2,GO CILIUM ORGANIZATION,0.00011218,-0.13654,-0.12756,1,0
2,GO ENDOTHELIAL CELL MIGRATION,0.0067673,-0.13655,-0.1105,1,0
2,GO LIPID STORAGE,0.047827,-0.13671,-0.071753,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0099244,-0.13671,-0.11879,1,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.021509,-0.13672,-0.092108,1,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00010673,-0.13676,-0.16396,1,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.015159,-0.13696,-0.11443,1,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0081133,-0.13699,-0.12289,1,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.019735,-0.13712,-0.24828,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.00042128,-0.13722,-0.13994,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0039992,-0.13741,-0.10681,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0029645,-0.1375,-0.10189,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.031953,-0.13761,-0.099925,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0018006,-0.13764,-0.13253,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.012087,-0.13769,-0.10434,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00025215,-0.13784,-0.15545,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.0012886,-0.13793,-0.13679,1,0
2,GO RESPONSE TO REDOX STATE,0.013856,-0.13802,-0.12036,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.019735,-0.13807,-0.12465,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00032408,-0.1381,-0.15428,1,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.063836,-0.13821,-0.15253,1,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.003607,-0.13847,-0.13117,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0017277,-0.13854,-0.11669,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.3236e-05,-0.13875,-0.14017,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0088198,-0.13877,-0.1246,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00019229,-0.13887,-0.13058,1,0
2,GO ENDOCRINE HORMONE SECRETION,0.00022927,-0.13927,-0.14703,1,0
2,GO HISTONE H2A UBIQUITINATION,0.00011406,-0.13946,-0.12519,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00034485,-0.1396,-0.13619,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.032938,-0.13961,-0.099808,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0104,-0.14011,-0.16145,1,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.0038478,-0.14012,-0.11228,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011022,-0.14018,-0.095485,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.065596,-0.14028,-0.10617,1,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00011033,-0.14043,-0.12358,1,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.00039622,-0.14058,-0.11863,1,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.052083,-0.1406,-0.097228,1,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00015331,-0.14061,-0.17358,1,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0032501,-0.14066,-0.16243,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0020929,-0.14071,-0.13779,1,0
2,GO B CELL ACTIVATION,0.00027284,-0.14074,-0.12212,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.012798,-0.14086,-0.10995,1,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00033955,-0.1409,-0.12742,1,0
2,GO PROTEIN KINASE B SIGNALING,0.00013016,-0.1412,-0.13245,1,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.018898,-0.14122,-0.12413,1,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.003166,-0.14142,-0.12166,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0052854,-0.1415,-0.10767,1,0
2,GO ENDOCRINE PROCESS,0.00060545,-0.14165,-0.14938,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.010895,-0.14165,-0.12112,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00046165,-0.14166,-0.11944,1,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.030368,-0.14171,-0.11711,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0037498,-0.14172,-0.16132,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0059852,-0.14183,-0.10732,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.00042777,-0.14187,-0.12803,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.0013443,-0.14203,-0.097593,1,0
2,GO SPERM AXONEME ASSEMBLY,0.0099244,-0.14205,-0.14675,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.004964,-0.14239,-0.12614,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00081356,-0.14249,-0.12602,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0059116,-0.14251,-0.12337,1,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,1.1789e-06,-0.14257,-0.1371,1,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.036048,-0.14268,-0.076907,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.014013,-0.14279,-0.14439,1,0
2,GO FAT CELL DIFFERENTIATION,4.0314e-05,-0.14283,-0.1469,1,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0028118,-0.14303,-0.14005,1,0
2,GO AXIS ELONGATION,0.061549,-0.14317,-0.14036,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0069343,-0.14331,-0.13236,1,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.3806e-05,-0.14345,-0.12492,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.00016098,-0.14351,-0.17083,1,0
2,GO ACTIN NUCLEATION,7.3739e-05,-0.14351,-0.12491,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.054582,-0.14359,-0.081104,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.7312e-05,-0.14361,-0.13852,1,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0051547,-0.14364,-0.19405,1,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,6.1119e-05,-0.14364,-0.12417,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0035605,-0.1437,-0.14167,1,0
2,GO EAR MORPHOGENESIS,0.00049053,-0.14388,-0.12743,1,0
2,GO LEUKOCYTE CHEMOTAXIS,0.0018764,-0.14392,-0.12467,1,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0054192,-0.14395,-0.12091,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,7.105e-06,-0.14407,-0.15146,1,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00054518,-0.14428,-0.12292,1,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0012886,-0.1445,-0.1454,1,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0011021,-0.14458,-0.14956,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.036772,-0.14471,-0.11939,1,0
2,GO ARTERY MORPHOGENESIS,0.0010113,-0.14474,-0.14226,1,0
2,GO HEAT GENERATION,0.043866,-0.14491,-0.13012,1,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0081133,-0.14491,-0.12118,1,0
2,GO CELL PROJECTION ASSEMBLY,1.5865e-05,-0.14496,-0.1146,1,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0032078,-0.14499,-0.096713,1,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00010852,-0.14508,-0.14255,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0012005,-0.14523,-0.12345,1,0
2,GO CYTOKINE SECRETION,0.0010113,-0.14535,-0.12359,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.030994,-0.14538,-0.065356,1,0
2,GO INTERACTION WITH HOST,0.00044103,-0.14546,-0.13764,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0093576,-0.1455,-0.1234,1,0
2,GO RESPONSE TO OXYGEN RADICAL,0.0028872,-0.14559,-0.10808,1,0
2,GO EXECUTION PHASE OF APOPTOSIS,1.0861e-06,-0.1457,-0.13091,1,0
2,GO RESPONSE TO INTERLEUKIN 2,0.012367,-0.14572,-0.119,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0018256,-0.14579,-0.13693,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001862,-0.14597,-0.11884,1,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00029511,-0.14598,-0.15518,1,0
2,GO SKELETAL MUSCLE ADAPTATION,0.056652,-0.14606,-0.086275,1,0
2,GO EPITHELIUM DEVELOPMENT,5.2445e-07,-0.14607,-0.16198,1,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0033799,-0.14612,-0.15534,1,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.010279,-0.14618,-0.18291,1,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.026838,-0.14624,-0.13437,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0056255,-0.14628,-0.11518,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.011151,-0.1464,-0.10174,1,0
2,GO IMMUNOGLOBULIN SECRETION,0.0104,-0.14641,-0.14928,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.0030038,-0.14653,-0.13199,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2344e-05,-0.14708,-0.16979,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0007901,-0.14734,-0.1105,1,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00094089,-0.14739,-0.17808,1,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.0074579,-0.14753,-0.11363,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0035146,-0.14793,-0.11397,1,0
2,GO RESPONSE TO DSRNA,0.012653,-0.14797,-0.09489,1,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0025277,-0.14798,-0.18415,1,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.003166,-0.14814,-0.12621,1,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,1.3948e-05,-0.14827,-0.15756,1,0
2,GO PHAGOSOME ACIDIFICATION,0.0056255,-0.14828,-0.11974,1,0
2,GO RIG I SIGNALING PATHWAY,0.0010558,-0.14834,-0.14232,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0029645,-0.14835,-0.15387,1,0
2,GO PEPTIDE CROSS LINKING,0.0053519,-0.14839,-0.17642,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00032408,-0.14866,-0.17778,1,0
2,GO VIRAL LIFE CYCLE,0.00094089,-0.14868,-0.12652,1,0
2,GO ANIMAL ORGAN MATURATION,0.022928,-0.14869,-0.10707,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.01849,-0.14892,-0.14231,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015249,-0.14902,-0.17684,1,0
2,GO REGULATION OF B CELL ACTIVATION,0.0007786,-0.14912,-0.13194,1,0
2,GO TELOMERE CAPPING,0.0023637,-0.14913,-0.096904,1,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0010558,-0.14918,-0.13789,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00019541,-0.14927,-0.11853,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.010041,-0.14931,-0.1409,1,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.0023009,-0.14933,-0.16077,1,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0040509,-0.14939,-0.12885,1,0
2,GO BONE RESORPTION,0.0007786,-0.1494,-0.15748,1,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066039,-0.14941,-0.11245,1,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0019023,-0.14943,-0.13406,1,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.031953,-0.14947,-0.13492,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.036772,-0.14961,-0.20092,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0005618,-0.14968,-0.15351,1,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0076401,-0.1497,-0.14897,1,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0092477,-0.14971,-0.17275,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00014129,-0.1498,-0.13409,1,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00038422,-0.14981,-0.14928,1,0
2,GO MALE SEX DIFFERENTIATION,4.7999e-05,-0.14989,-0.15111,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0046018,-0.1499,-0.11955,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00015838,-0.14994,-0.18882,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.004156,-0.14999,-0.16177,1,0
2,GO LEUKOCYTE MIGRATION,0.00067188,-0.15006,-0.12937,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0011836,-0.15014,-0.14729,1,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.042197,-0.15042,-0.1193,1,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0042636,-0.15056,-0.1384,1,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.021053,-0.15077,-0.16682,1,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,2.2015e-05,-0.15085,-0.14987,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.7312e-05,-0.15127,-0.13903,1,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00072342,-0.15148,-0.15363,1,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0058389,-0.15176,-0.17087,1,0
2,GO NEUTROPHIL HOMEOSTASIS,0.065596,-0.15189,-0.13265,1,0
2,GO PROTEIN PROCESSING,0.00015838,-0.15202,-0.13031,1,0
2,GO MONOCYTE CHEMOTAXIS,0.0053519,-0.15204,-0.15089,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.014332,-0.15205,-0.15828,1,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0094686,-0.15224,-0.10323,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0019285,-0.15225,-0.13907,1,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0030839,-0.15237,-0.11218,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0023009,-0.15261,-0.13548,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0018508,-0.15267,-0.145,1,0
2,GO EATING BEHAVIOR,0.01499,-0.15267,-0.090985,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0024609,-0.15278,-0.18562,1,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,2.4091e-05,-0.153,-0.18005,1,0
2,GO REGULATION OF SPINDLE ORGANIZATION,1.8363e-05,-0.15308,-0.13734,1,0
2,GO RESPONSE TO IRON ION,0.00067188,-0.15309,-0.17229,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016629,-0.1531,-0.16901,1,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00037257,-0.1531,-0.14573,1,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00029052,-0.15311,-0.1478,1,0
2,GO EPITHELIAL TUBE FORMATION,2.6386e-06,-0.15334,-0.16334,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0033799,-0.15337,-0.12687,1,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,1.8793e-06,-0.15337,-0.15128,1,0
2,GO GOLGI RIBBON FORMATION,0.0018764,-0.1535,-0.15122,1,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0044864,-0.15364,-0.19558,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0007786,-0.15371,-0.14981,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0011668,-0.15375,-0.13994,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00080175,-0.15382,-0.13463,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025961,-0.15391,-0.12308,1,0
2,GO KIDNEY MORPHOGENESIS,0.0005789,-0.154,-0.15538,1,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.017894,-0.15411,-0.1139,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0038478,-0.15435,-0.15738,1,0
2,GO DIOL METABOLIC PROCESS,0.041789,-0.15439,-0.10223,1,0
2,GO SECONDARY METABOLIC PROCESS,0.002631,-0.15473,-0.1421,1,0
2,GO MEMBRANE FISSION,0.0029256,-0.15478,-0.12614,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0023637,-0.15486,-0.11907,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0104,-0.15495,-0.14252,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.061549,-0.15528,-0.12175,1,0
2,GO DIENCEPHALON DEVELOPMENT,0.00071283,-0.15535,-0.18918,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0027381,-0.15551,-0.10949,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00019229,-0.15565,-0.17706,1,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,8.1361e-07,-0.1557,-0.14869,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.033608,-0.15591,-0.15033,1,0
2,GO DNA DEMETHYLATION,0.00033955,-0.1561,-0.14859,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00030928,-0.15616,-0.14879,1,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0088198,-0.15618,-0.18565,1,0
2,GO DIGESTION,6.0079e-05,-0.15632,-0.15989,1,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0071918,-0.15645,-0.1224,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00083767,-0.15651,-0.1313,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0030436,-0.15659,-0.15199,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.00017176,-0.15669,-0.15287,1,0
2,GO LUNG MORPHOGENESIS,0.0020367,-0.15702,-0.17951,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00084997,-0.15715,-0.16025,1,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.024428,-0.15719,-0.11179,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.0025277,-0.15748,-0.14074,1,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0069343,-0.15749,-0.13736,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.1623e-05,-0.15755,-0.20744,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00012804,-0.15759,-0.14431,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0022701,-0.15781,-0.12302,1,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.8701e-05,-0.15788,-0.16367,1,0
2,GO PIGMENT GRANULE LOCALIZATION,0.00076726,-0.15796,-0.15366,1,0
2,GO ENDOCYTIC RECYCLING,2.4972e-05,-0.15802,-0.14258,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0022396,-0.15808,-0.16231,1,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0024609,-0.15816,-0.1413,1,0
2,GO CELL KILLING,0.0016575,-0.15823,-0.15164,1,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0018006,-0.15834,-0.20269,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.008211,-0.15844,-0.15414,1,0
2,GO HISTAMINE TRANSPORT,0.018091,-0.15893,-0.19729,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,3.2631e-05,-0.15897,-0.1719,1,0
2,GO CHEMOKINE PRODUCTION,0.00094089,-0.15903,-0.15591,1,0
2,GO CELL CHEMOTAXIS,0.00029976,-0.15907,-0.14833,1,0
2,GO CELL JUNCTION MAINTENANCE,0.01016,-0.15931,-0.15057,1,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.040187,-0.15934,-0.15184,1,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.0029645,-0.1594,-0.1174,1,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0099244,-0.15944,-0.1067,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00025617,-0.15945,-0.17495,1,0
2,GO RESPONSE TO PROGESTERONE,0.00098255,-0.15951,-0.19263,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0035605,-0.15962,-0.16099,1,0
2,GO IMMUNE EFFECTOR PROCESS,0.00099681,-0.15971,-0.1317,1,0
2,GO LACTATE METABOLIC PROCESS,0.040981,-0.15972,-0.11167,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0032501,-0.15997,-0.22043,1,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,4.7999e-05,-0.16018,-0.15162,1,0
2,GO ENTRY INTO HOST,0.0020367,-0.16021,-0.17027,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,8.7316e-05,-0.16028,-0.16686,1,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,1.3948e-05,-0.16033,-0.14762,1,0
2,GO ETHANOL METABOLIC PROCESS,0.014658,-0.16051,-0.17827,1,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.043444,-0.16064,-0.10709,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.001955,-0.16081,-0.21692,1,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00030449,-0.16091,-0.16873,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0013443,-0.16133,-0.15956,1,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.0005618,-0.16158,-0.17015,1,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.019735,-0.16204,-0.10506,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030839,-0.16222,-0.19576,1,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0013069,-0.16223,-0.14275,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0050904,-0.16251,-0.16911,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0018006,-0.16254,-0.12057,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00036124,-0.16261,-0.15103,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0007786,-0.16286,-0.1745,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0030839,-0.16363,-0.13139,1,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.023173,-0.16364,-0.17738,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0137,-0.16406,-0.11432,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00025215,-0.16412,-0.18174,1,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.011544,-0.16418,-0.23223,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0070192,-0.16428,-0.16156,1,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,7.7586e-05,-0.16438,-0.17653,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,9.03e-05,-0.16462,-0.16641,1,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.01499,-0.16475,-0.18778,1,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0058389,-0.16487,-0.16883,1,0
2,GO EPIDERMIS MORPHOGENESIS,0.025475,-0.16489,-0.15528,1,0
2,GO MAST CELL MEDIATED IMMUNITY,0.00040857,-0.16504,-0.21452,1,0
2,GO REPLICATIVE SENESCENCE,0.028556,-0.16534,-0.13871,1,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.047372,-0.16542,-0.15527,1,0
2,GO NEURAL TUBE FORMATION,1.9175e-06,-0.16545,-0.17643,1,0
2,GO AORTA MORPHOGENESIS,0.0059852,-0.16549,-0.17426,1,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.016205,-0.16556,-0.13558,1,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.02915,-0.16563,-0.17497,1,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00044781,-0.16564,-0.16228,1,0
2,GO PROTEIN DEMANNOSYLATION,0.0099244,-0.16577,-0.12384,1,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.086e-06,-0.16589,-0.19598,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00046165,-0.16593,-0.15459,1,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.0037016,-0.16597,-0.12826,1,0
2,GO MYELOID CELL DEVELOPMENT,5.8049e-05,-0.16598,-0.13832,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00019229,-0.16635,-0.15145,1,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0059116,-0.16646,-0.11349,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.002702,-0.1665,-0.14058,1,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,9.819e-05,-0.16653,-0.14193,1,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0012177,-0.16665,-0.18834,1,0
2,GO FORELIMB MORPHOGENESIS,0.0096941,-0.16665,-0.15532,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010865,-0.16676,-0.18977,1,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0019023,-0.16681,-0.16029,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0021215,-0.16744,-0.15167,1,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0011503,-0.16782,-0.11665,1,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00074504,-0.16785,-0.14478,1,0
2,GO ALPHA BETA T CELL ACTIVATION,9.6129e-06,-0.16808,-0.18724,1,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.023419,-0.16844,-0.12479,1,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0032078,-0.16866,-0.1919,1,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0096941,-0.16883,-0.35428,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00016901,-0.16885,-0.14357,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00047589,-0.16889,-0.16299,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00041488,-0.16936,-0.15285,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.01829,-0.16938,-0.099228,1,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.028264,-0.16945,-0.16604,1,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.041383,-0.16951,-0.091822,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0017277,-0.16965,-0.12937,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,8.4424e-05,-0.16965,-0.15519,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00029052,-0.16985,-0.15821,1,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,8.7502e-06,-0.16987,-0.16093,1,0
2,GO ERYTHROCYTE DEVELOPMENT,0.00039018,-0.17004,-0.13278,1,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.011813,-0.17047,-0.12658,1,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,3.5461e-06,-0.17067,-0.15475,1,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.032278,-0.17072,-0.11517,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0077327,-0.17095,-0.19356,1,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.011813,-0.17149,-0.12809,1,0
2,GO REGULATION OF VASCULOGENESIS,0.014823,-0.17156,-0.17088,1,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.010522,-0.17157,-0.10019,1,0
2,GO APICAL PROTEIN LOCALIZATION,0.0010408,-0.17162,-0.14308,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00023294,-0.17196,-0.16013,1,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.032938,-0.17207,-0.11107,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013016,-0.17208,-0.13752,1,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00017176,-0.1725,-0.12495,1,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.054074,-0.17252,-0.098617,1,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,4.0314e-05,-0.17258,-0.13583,1,0
2,GO DEVELOPMENTAL INDUCTION,0.00040235,-0.17262,-0.18574,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.000662,-0.17269,-0.163,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,7.6283e-05,-0.17308,-0.17175,1,0
2,GO PEPTIDYL THREONINE MODIFICATION,5.8698e-06,-0.17325,-0.13057,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.055609,-0.17326,-0.13259,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0019819,-0.1733,-0.14332,1,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,5.6085e-05,-0.17339,-0.18304,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0026663,-0.17354,-0.1628,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.9044e-05,-0.17358,-0.15997,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,1.3196e-05,-0.1738,-0.16265,1,0
2,GO RENAL WATER HOMEOSTASIS,0.033608,-0.17385,-0.096704,1,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0011503,-0.17405,-0.15524,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0069343,-0.17422,-0.12188,1,0
2,GO REGULATION OF MYOBLAST FUSION,0.013093,-0.1743,-0.15317,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00015583,-0.17445,-0.2016,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0002117,-0.17458,-0.19759,1,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,7.0072e-05,-0.17477,-0.13019,1,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0021798,-0.17506,-0.22837,1,0
2,GO GERMINAL CENTER FORMATION,0.010895,-0.17508,-0.20849,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.4861e-06,-0.17522,-0.18265,1,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00049053,-0.17523,-0.23764,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0077327,-0.1753,-0.11003,1,0
2,GO BONE REMODELING,0.0034692,-0.17551,-0.13508,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0013069,-0.17558,-0.13368,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.004156,-0.1759,-0.10745,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037985,-0.17595,-0.17072,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.024428,-0.17606,-0.15929,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024045,-0.1764,-0.17988,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.021973,-0.17646,-0.12058,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.8911e-05,-0.17658,-0.2123,1,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.001955,-0.17727,-0.12921,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.001955,-0.17754,-0.14543,1,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.063258,-0.17759,-0.10986,1,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.018693,-0.17795,-0.12074,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0066851,-0.17827,-0.1856,1,0
2,GO INTRACILIARY TRANSPORT,0.0010259,-0.17834,-0.17177,1,0
2,GO TYPE I INTERFERON PRODUCTION,0.00086244,-0.17858,-0.14164,1,0
2,GO REGULATION OF ICOSANOID SECRETION,0.0025277,-0.17867,-0.1632,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,3.6924e-05,-0.17867,-0.14878,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00020178,-0.17872,-0.2461,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.5217e-06,-0.17878,-0.21482,1,0
2,GO DETECTION OF CALCIUM ION,0.039795,-0.17885,-0.16831,1,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00017176,-0.17939,-0.15451,1,0
2,GO REGULATION OF RUFFLE ASSEMBLY,1.4472e-05,-0.17942,-0.1705,1,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.0010408,-0.17951,-0.19718,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,9.4959e-05,-0.17956,-0.20032,1,0
2,GO EPITHELIAL CELL MATURATION,0.0038977,-0.17987,-0.16409,1,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.039795,-0.1799,-0.13872,1,0
2,GO REGULATION OF TELOMERE CAPPING,0.0054192,-0.18006,-0.10554,1,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.003607,-0.18015,-0.14081,1,0
2,GO AUTOPHAGOSOME MATURATION,0.00044781,-0.18021,-0.14076,1,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.021053,-0.18024,-0.14438,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0003557,-0.1803,-0.14905,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.0478e-05,-0.18031,-0.17975,1,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.003607,-0.18052,-0.16649,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,5.7059e-05,-0.18062,-0.20665,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.0022095,-0.18064,-0.16171,1,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0022396,-0.18097,-0.15331,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.002702,-0.18119,-0.21089,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0005056,-0.18128,-0.13988,1,0
2,GO SEX DETERMINATION,0.00014362,-0.18163,-0.23305,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.019104,-0.18169,-0.22289,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00055343,-0.18223,-0.14519,1,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0013826,-0.1823,-0.13962,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008211,-0.18242,-0.15253,1,0
2,GO REGULATION OF TISSUE REMODELING,0.0010259,-0.1825,-0.16234,1,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,3.2631e-05,-0.1825,-0.1286,1,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.05063,-0.18265,-0.15852,1,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.045155,-0.18273,-0.095909,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,6.4341e-05,-0.18277,-0.19546,1,0
2,GO ICOSANOID METABOLIC PROCESS,1.0958e-05,-0.1829,-0.22269,1,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0016575,-0.18291,-0.18271,1,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0044298,-0.18338,-0.14286,1,0
2,GO MYELOID CELL HOMEOSTASIS,5.6487e-06,-0.18343,-0.17132,1,0
2,GO RENAL TUBULE DEVELOPMENT,4.1751e-05,-0.18344,-0.19032,1,0
2,GO B CELL DIFFERENTIATION,1.9044e-05,-0.18346,-0.15515,1,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,1.7385e-05,-0.18349,-0.23014,1,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0098086,-0.18361,-0.20347,1,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060595,-0.18364,-0.18138,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.3442e-05,-0.18371,-0.20693,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0012886,-0.18405,-0.23342,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00047589,-0.18419,-0.14018,1,0
2,GO TISSUE REMODELING,0.00039622,-0.18464,-0.16586,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,1.6457e-05,-0.1847,-0.19295,1,0
2,GO RESPONSE TO VIRUS,0.00015583,-0.18471,-0.165,1,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.001442,-0.1848,-0.15533,1,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0039992,-0.18504,-0.16064,1,0
2,GO T CELL MEDIATED IMMUNITY,0.0016122,-0.18534,-0.18632,1,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.014013,-0.18552,-0.20103,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,2.0853e-05,-0.18565,-0.20346,1,0
2,GO CELLULAR RESPONSE TO VIRUS,4.2487e-05,-0.18571,-0.18416,1,0
2,GO SOMATIC STEM CELL DIVISION,0.053071,-0.186,-0.16849,1,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,1.0861e-06,-0.18609,-0.16676,1,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.00071283,-0.18618,-0.18932,1,0
2,GO MESONEPHROS DEVELOPMENT,8.5858e-05,-0.18629,-0.18396,1,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.0067673,-0.18637,-0.11794,1,0
2,GO REGULATION OF ACTIN NUCLEATION,7.6657e-06,-0.18639,-0.20082,1,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.012798,-0.18655,-0.11763,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.00032408,-0.18706,-0.18976,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,7.5001e-05,-0.18726,-0.2306,1,0
2,GO REGULATION OF NEURON MATURATION,0.011411,-0.18743,-0.14049,1,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.062684,-0.18779,-0.16145,1,0
2,GO NEPHRON DEVELOPMENT,2.3661e-05,-0.18797,-0.18328,1,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.758e-05,-0.18824,-0.16856,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00015583,-0.1886,-0.19864,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.008211,-0.18877,-0.15056,1,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00068191,-0.18887,-0.23202,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0045438,-0.18895,-0.15717,1,0
2,GO ETHANOL OXIDATION,0.065005,-0.18935,-0.18637,1,0
2,GO CENTROSOME SEPARATION,0.00020178,-0.18996,-0.19588,1,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0020092,-0.18998,-0.15858,1,0
2,GO ENDOSOME ORGANIZATION,7.969e-07,-0.19001,-0.16108,1,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.022446,-0.19028,-0.13519,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.022446,-0.19058,-0.13514,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4207e-05,-0.19063,-0.20993,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0027747,-0.19064,-0.1787,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.043444,-0.19086,-0.098441,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.4528e-05,-0.19105,-0.22116,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00015583,-0.19106,-0.20387,1,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00095459,-0.19117,-0.16399,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,4.6202e-07,-0.19135,-0.17158,1,0
2,GO GENETIC IMPRINTING,0.00053704,-0.1916,-0.16814,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0005789,-0.19162,-0.19053,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0066851,-0.19163,-0.15143,1,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.042609,-0.19201,-0.14216,1,0
2,GO PLATELET ACTIVATION,0.00022565,-0.19211,-0.15809,1,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.003166,-0.19234,-0.16553,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.00011406,-0.19263,-0.15508,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0032501,-0.19265,-0.15789,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,5.9056e-05,-0.19288,-0.19826,1,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.010522,-0.19292,-0.2103,1,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00019541,-0.1931,-0.21285,1,0
2,GO BONE CELL DEVELOPMENT,0.0005618,-0.19325,-0.14635,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.026838,-0.1934,-0.18803,1,0
2,GO REGULATION OF CELL KILLING,0.00011406,-0.19346,-0.21447,1,0
2,GO B CELL MEDIATED IMMUNITY,0.0021798,-0.19349,-0.15098,1,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00020504,-0.19372,-0.15291,1,0
2,GO CELLULAR DEFENSE RESPONSE,4.0657e-06,-0.19402,-0.23837,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,1.3693e-05,-0.19405,-0.21603,1,0
2,GO NEURON FATE COMMITMENT,0.0047798,-0.19429,-0.20991,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.0024941,-0.19432,-0.19625,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.4262e-06,-0.19433,-0.19112,1,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,1.8032e-05,-0.1944,-0.17609,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0054192,-0.19447,-0.13736,1,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.010645,-0.19467,-0.10855,1,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0046018,-0.19472,-0.14642,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.7172e-05,-0.19474,-0.16968,1,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,1.4741e-05,-0.19509,-0.1748,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,0.00015083,-0.19533,-0.17483,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00063314,-0.19538,-0.18802,1,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.0090315,-0.19548,-0.1576,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.011151,-0.19695,-0.12775,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,1.0861e-06,-0.19732,-0.19634,1,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00014362,-0.19737,-0.15591,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00046165,-0.19826,-0.19024,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1026e-05,-0.1985,-0.20162,1,0
2,GO INTERLEUKIN 8 PRODUCTION,0.00014599,-0.19857,-0.19771,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0061347,-0.19866,-0.20264,1,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0002443,-0.19871,-0.24011,1,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,1.7071e-05,-0.19879,-0.18618,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,1.0212e-06,-0.19892,-0.21868,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00033955,-0.19903,-0.1794,1,0
2,GO O GLYCAN PROCESSING,1.3693e-05,-0.19931,-0.26254,1,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00049802,-0.1998,-0.17292,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00024819,-0.19999,-0.1699,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0012705,-0.20004,-0.19991,1,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00062378,-0.2001,-0.16681,1,0
2,GO HEART FORMATION,0.0050269,-0.20017,-0.15445,1,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.004156,-0.20021,-0.18117,1,0
2,GO CENTROSOME DUPLICATION,1.471e-07,-0.20039,-0.20143,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.027401,-0.20062,-0.16165,1,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0052854,-0.20066,-0.14534,1,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.03902,-0.20075,-0.10681,1,0
2,GO B CELL APOPTOTIC PROCESS,0.00014129,-0.20085,-0.21628,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00017741,-0.20112,-0.28316,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0010113,-0.20117,-0.2441,1,0
2,GO MAST CELL ACTIVATION,0.00063314,-0.20127,-0.2007,1,0
2,GO INTERLEUKIN 6 PRODUCTION,5.1304e-06,-0.20137,-0.20343,1,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00037257,-0.20175,-0.21473,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.00012186,-0.2018,-0.22544,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00047589,-0.20182,-0.14687,1,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,1.5052e-06,-0.20213,-0.18473,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9859e-05,-0.20215,-0.18428,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.000662,-0.20242,-0.17908,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0012886,-0.2032,-0.19731,1,0
2,GO INTERLEUKIN 13 PRODUCTION,0.024947,-0.2034,-0.16274,1,0
2,GO VIRION ASSEMBLY,6.5906e-08,-0.20375,-0.18693,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.062684,-0.20386,-0.13355,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00029976,-0.2043,-0.20169,1,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.001955,-0.20434,-0.16468,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.00040857,-0.20463,-0.16602,1,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.023173,-0.20469,-0.13987,1,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.6085e-05,-0.2052,-0.19028,1,0
2,GO REGULATION OF COAGULATION,0.002631,-0.20526,-0.18741,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,1.0212e-06,-0.20537,-0.22464,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.2146e-06,-0.20561,-0.19785,1,0
2,GO RESPONSE TO INTERLEUKIN 6,4.2271e-06,-0.20565,-0.22392,1,0
2,GO REGULATION OF CHROMATIN BINDING,2.7804e-05,-0.20569,-0.20741,1,0
2,GO EPITHELIAL CELL DEVELOPMENT,2.0879e-07,-0.20593,-0.22691,1,0
2,GO PROSTANOID METABOLIC PROCESS,0.00023294,-0.20624,-0.26483,1,0
2,GO ZYMOGEN ACTIVATION,0.0039481,-0.20627,-0.19271,1,0
2,GO METANEPHROS MORPHOGENESIS,0.026561,-0.20629,-0.12618,1,0
2,GO RESPONSE TO INTERFERON GAMMA,0.0050904,-0.20654,-0.17737,1,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.002702,-0.20672,-0.24273,1,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,1.4076e-07,-0.20714,-0.20533,1,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.7071e-05,-0.20719,-0.19442,1,0
2,GO REGULATION OF CENTROSOME CYCLE,1.1034e-07,-0.20729,-0.1915,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00011596,-0.20744,-0.26313,1,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.0007786,-0.20764,-0.2166,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.0042095,-0.20775,-0.18622,1,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,9.6562e-05,-0.2078,-0.17607,1,0
2,GO VIRAL RELEASE FROM HOST CELL,2.1338e-07,-0.20789,-0.19901,1,0
2,GO MALE GENITALIA DEVELOPMENT,0.0096941,-0.20799,-0.16274,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0053519,-0.20805,-0.20498,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00019541,-0.20821,-0.23277,1,0
2,GO ERBB2 SIGNALING PATHWAY,5.9834e-06,-0.20857,-0.21357,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0013255,-0.20873,-0.19763,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,6.2175e-05,-0.20892,-0.17501,1,0
2,GO SENSORY PERCEPTION OF TASTE,1.1789e-06,-0.20908,-0.22509,1,0
2,GO BLOOD VESSEL REMODELING,0.0007901,-0.20983,-0.1768,1,0
2,GO ACTIVATED T CELL PROLIFERATION,7.6283e-05,-0.20987,-0.19303,1,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00049053,-0.20988,-0.17607,1,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00015083,-0.21016,-0.18102,1,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00076726,-0.21124,-0.13534,1,0
2,GO REGULATION OF HEAT GENERATION,0.037509,-0.21129,-0.16579,1,0
2,GO SUPEROXIDE ANION GENERATION,0.0012177,-0.2122,-0.20682,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00040235,-0.2125,-0.19274,1,0
2,GO INTERLEUKIN 12 PRODUCTION,8.4262e-06,-0.2128,-0.23451,1,0
2,GO RESPONSE TO INACTIVITY,0.0005789,-0.21377,-0.19245,1,0
2,GO NECROTIC CELL DEATH,1.6158e-05,-0.21405,-0.19944,1,0
2,GO GLOMERULUS DEVELOPMENT,6.0079e-05,-0.21414,-0.23525,1,0
2,GO MULTIVESICULAR BODY ORGANIZATION,1.1533e-09,-0.21432,-0.23527,1,0
2,GO OTIC VESICLE DEVELOPMENT,0.010895,-0.21435,-0.23949,1,0
2,GO ZYMOGEN INHIBITION,0.00017741,-0.21452,-0.2931,1,0
2,GO MICROVILLUS ASSEMBLY,0.0056255,-0.21465,-0.17465,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,6.2175e-05,-0.2147,-0.22532,1,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0062877,-0.21515,-0.16639,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.02174,-0.21517,-0.16996,1,0
2,GO PLATELET AGGREGATION,0.00011406,-0.21545,-0.21003,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0047798,-0.21564,-0.19907,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00057029,-0.21588,-0.21678,1,0
2,GO DEFENSE RESPONSE TO VIRUS,1.3948e-05,-0.21588,-0.2218,1,0
2,GO ENDOTHELIUM DEVELOPMENT,3.5022e-05,-0.21616,-0.17948,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,2.2824e-05,-0.21706,-0.17705,1,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.001483,-0.21797,-0.1465,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,5.3256e-05,-0.21801,-0.16253,1,0
2,GO REGULATION OF CENTROSOME DUPLICATION,1.2604e-07,-0.21893,-0.20833,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.018091,-0.21893,-0.23047,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.6579e-07,-0.21896,-0.25211,1,0
2,GO CYTOPLASM ORGANIZATION,0.0012705,-0.21944,-0.20299,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0071051,-0.21954,-0.11557,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.017125,-0.2197,-0.14999,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.01251,-0.21986,-0.18622,1,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.058247,-0.21997,-0.11937,1,0
2,GO ENDODERMAL CELL FATE COMMITMENT,8.5858e-05,-0.22044,-0.19946,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.6914e-06,-0.22049,-0.20719,1,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.021973,-0.22055,-0.20676,1,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,9.819e-05,-0.22057,-0.20174,1,0
2,GO MUSCLE CELL MIGRATION,2.9332e-05,-0.22061,-0.2184,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.8701e-05,-0.22071,-0.21585,1,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0007901,-0.22104,-0.22176,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00014362,-0.22119,-0.19301,1,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,4.1456e-06,-0.22148,-0.24099,1,0
2,GO SUBPALLIUM DEVELOPMENT,0.0068504,-0.22183,-0.16281,1,0
2,GO EOSINOPHIL CHEMOTAXIS,0.03429,-0.22197,-0.19379,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,5.0563e-05,-0.22213,-0.22241,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0069343,-0.22289,-0.18461,1,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0016122,-0.22313,-0.22003,1,0
2,GO REGULATION OF RECEPTOR BINDING,0.0039992,-0.22326,-0.18083,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00082553,-0.22347,-0.22511,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,9.086e-06,-0.22359,-0.2031,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0085105,-0.22386,-0.22781,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016629,-0.22399,-0.21728,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0005211,-0.22403,-0.19013,1,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0084096,-0.2242,-0.23412,1,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00013673,-0.22463,-0.19466,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.011949,-0.22513,-0.24342,1,0
2,GO REGULATION OF RESPIRATORY BURST,2.4972e-05,-0.2255,-0.21496,1,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.00075607,-0.22579,-0.18124,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.027401,-0.2261,-0.15195,1,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,7.8124e-06,-0.22632,-0.22312,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.8246e-05,-0.22635,-0.23647,1,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00019857,-0.22691,-0.25985,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0020929,-0.22707,-0.26958,1,0
2,GO INTERLEUKIN 10 PRODUCTION,9.9803e-06,-0.22716,-0.24752,1,0
2,GO REGULATION OF RESPONSE TO WOUNDING,6.1119e-05,-0.22719,-0.19383,1,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,3.2784e-06,-0.22761,-0.2416,1,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.033608,-0.22823,-0.17017,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00015838,-0.22859,-0.17837,1,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,9.9844e-05,-0.22876,-0.23811,1,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00023667,-0.22911,-0.19062,1,0
2,GO INTERFERON BETA PRODUCTION,0.00013232,-0.22914,-0.17754,1,0
2,GO VASCULAR WOUND HEALING,0.0035605,-0.22982,-0.20111,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00010323,-0.22997,-0.2545,1,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,2.6828e-05,-0.23013,-0.28348,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.3948e-05,-0.23013,-0.22695,1,0
2,GO VIRAL GENOME REPLICATION,7.8911e-05,-0.23073,-0.19882,1,0
2,GO CELL FATE SPECIFICATION,1.7071e-05,-0.23076,-0.21646,1,0
2,GO CYTOKINETIC PROCESS,8.6328e-08,-0.231,-0.21302,1,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00022565,-0.23169,-0.16637,1,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,6.8888e-05,-0.23185,-0.17737,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.013856,-0.23205,-0.24392,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00041488,-0.23248,-0.17179,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0062108,-0.23249,-0.19596,1,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00036124,-0.23291,-0.27659,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.2015e-05,-0.23368,-0.21923,1,0
2,GO SPERM CAPACITATION,7.9617e-06,-0.23418,-0.21352,1,0
2,GO RUFFLE ORGANIZATION,2.8886e-07,-0.23512,-0.18811,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.7316e-05,-0.23517,-0.19264,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.021053,-0.23539,-0.2478,1,0
2,GO ESCRT COMPLEX DISASSEMBLY,1.6994e-06,-0.23553,-0.27812,1,0
2,GO POSITIVE REGULATION OF COAGULATION,0.00013016,-0.23563,-0.23785,1,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00074504,-0.23637,-0.1814,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00039018,-0.23648,-0.21218,1,0
2,GO CARDIOBLAST DIFFERENTIATION,0.0062877,-0.23663,-0.18399,1,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0001862,-0.23673,-0.22336,1,0
2,GO REGULATION OF WOUND HEALING,2.4528e-05,-0.2371,-0.22695,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,4.5558e-05,-0.2383,-0.2747,1,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00038422,-0.23931,-0.2121,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.4699e-07,-0.23949,-0.24142,1,0
2,GO T CELL SELECTION,6.8888e-05,-0.24027,-0.17697,1,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.002702,-0.24101,-0.21006,1,0
2,GO RUFFLE ASSEMBLY,9.5999e-07,-0.24143,-0.17808,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00013451,-0.24162,-0.23463,1,0
2,GO PLACENTA DEVELOPMENT,2.4837e-07,-0.24187,-0.21236,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,1.2792e-06,-0.24196,-0.27141,1,0
2,GO PIGMENT ACCUMULATION,0.01251,-0.24211,-0.16819,1,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0015038,-0.24215,-0.18589,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0010259,-0.24233,-0.21003,1,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00075607,-0.24275,-0.19268,1,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.012367,-0.24286,-0.1514,1,0
2,GO MAGNESIUM ION TRANSPORT,2.5424e-05,-0.24299,-0.22029,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.011813,-0.24338,-0.20902,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.2487e-05,-0.24344,-0.21056,1,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00064263,-0.24369,-0.22796,1,0
2,GO N GLYCAN PROCESSING,0.010522,-0.2441,-0.18143,1,0
2,GO POSITIVE T CELL SELECTION,0.00011033,-0.24422,-0.19513,1,0
2,GO REGULATORY T CELL DIFFERENTIATION,2.9859e-05,-0.24463,-0.2905,1,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0052197,-0.24472,-0.15992,1,0
2,GO BILE ACID METABOLIC PROCESS,1.0424e-06,-0.24546,-0.24878,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00015331,-0.24565,-0.25679,1,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.015501,-0.2462,-0.16782,1,0
2,GO INTERLEUKIN 1 PRODUCTION,0.00015331,-0.24697,-0.21609,1,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,1.4207e-05,-0.24734,-0.21004,1,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.4407e-08,-0.24831,-0.26828,1,0
2,GO EOSINOPHIL MIGRATION,0.016205,-0.24846,-0.19948,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.7071e-05,-0.24862,-0.20069,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,9.6562e-05,-0.24908,-0.25138,1,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,2.2397e-08,-0.24941,-0.26024,1,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0015249,-0.25014,-0.34421,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.00043435,-0.25059,-0.24787,1,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.027973,-0.25066,-0.1385,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0011668,-0.25068,-0.23035,1,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,6.0991e-06,-0.25075,-0.19881,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,1.2716e-05,-0.25076,-0.24474,1,0
2,GO PANCREAS DEVELOPMENT,1.536e-06,-0.25138,-0.25548,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,8.5858e-05,-0.25191,-0.21685,1,0
2,GO MYOBLAST MIGRATION,0.012653,-0.25207,-0.2262,1,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,4.8416e-06,-0.2521,-0.24677,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0013069,-0.25222,-0.26637,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,2.7452e-06,-0.25272,-0.23321,1,0
2,GO REGULATION OF BONE REMODELING,0.00039018,-0.25273,-0.18659,1,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011151,-0.25281,-0.20968,1,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.8723e-07,-0.25292,-0.22814,1,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0011668,-0.25347,-0.20844,1,0
2,GO BROWN FAT CELL DIFFERENTIATION,1.8793e-06,-0.25352,-0.26581,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,7.5217e-06,-0.25361,-0.22643,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,2.4091e-05,-0.25436,-0.24636,1,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.014013,-0.2545,-0.20494,1,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.0861e-06,-0.25455,-0.23966,1,0
2,GO RETINAL METABOLIC PROCESS,0.033271,-0.25459,-0.20165,1,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00014839,-0.25494,-0.20443,1,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,5.5127e-05,-0.2557,-0.32629,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0010113,-0.25599,-0.24307,1,0
2,GO SPLEEN DEVELOPMENT,3.5038e-07,-0.25604,-0.21257,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.048285,-0.25616,-0.13297,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.5684e-06,-0.25768,-0.22889,1,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.010645,-0.25862,-0.2425,1,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.027686,-0.2593,-0.16945,1,0
2,GO MOTILE CILIUM ASSEMBLY,0.00091404,-0.25953,-0.25449,1,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.5868e-06,-0.26022,-0.2398,1,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.0065235,-0.2606,-0.30497,1,0
2,GO EPITHELIAL CELL DIFFERENTIATION,2.4586e-08,-0.26082,-0.24427,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.0074579,-0.26098,-0.23436,1,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0021215,-0.26165,-0.17464,1,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,2.6914e-06,-0.26166,-0.27287,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.01849,-0.26202,-0.18855,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.013093,-0.26204,-0.19792,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,7.6657e-06,-0.2623,-0.23612,1,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,5.0563e-05,-0.26258,-0.26031,1,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.0314e-05,-0.26286,-0.26939,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0057669,-0.26308,-0.21843,1,0
2,GO GANGLION DEVELOPMENT,0.014013,-0.26358,-0.18574,1,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0031247,-0.26403,-0.19068,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0016806,-0.26421,-0.27415,1,0
2,GO TOLERANCE INDUCTION,0.00095459,-0.2644,-0.32297,1,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,2.9332e-05,-0.26469,-0.23556,1,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.5674e-06,-0.26498,-0.23484,1,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0013443,-0.26556,-0.19071,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,1.439e-07,-0.26565,-0.29938,1,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,5.4184e-05,-0.266,-0.27945,1,0
2,GO AXONEME ASSEMBLY,2.1234e-05,-0.26656,-0.24191,1,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0024609,-0.26659,-0.23294,1,0
2,GO MYOFIBRIL ASSEMBLY,1.9044e-05,-0.26702,-0.19947,1,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,2.0364e-06,-0.26718,-0.32567,1,0
2,GO REGULATION OF SPINDLE ASSEMBLY,1.2058e-07,-0.2674,-0.23958,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.05357,-0.26772,-0.21411,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,8.0256e-05,-0.26793,-0.20903,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0025617,-0.26824,-0.20737,1,0
2,GO HOMOTYPIC CELL CELL ADHESION,8.7502e-06,-0.26833,-0.25755,1,0
2,GO PROTEIN ADP RIBOSYLATION,1.1086e-06,-0.26837,-0.24698,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,1.4472e-05,-0.26862,-0.23715,1,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.0205e-08,-0.26935,-0.29418,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.00055343,-0.26958,-0.20655,1,0
2,GO MICROVILLUS ORGANIZATION,0.00010323,-0.26992,-0.24949,1,0
2,GO RESPONSE TO INTERFERON BETA,0.0099244,-0.27058,-0.26533,1,0
2,GO EMBRYONIC HEMOPOIESIS,8.2686e-06,-0.27079,-0.26385,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00022208,-0.27101,-0.26326,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.00067188,-0.27129,-0.19213,1,0
2,GO ESTROUS CYCLE,0.0013255,-0.27217,-0.21303,1,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.024173,-0.27224,-0.17168,1,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00013451,-0.27252,-0.25972,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00011218,-0.27306,-0.23553,1,0
2,GO TRANSCYTOSIS,1.4454e-06,-0.27387,-0.22295,1,0
2,GO BRONCHUS DEVELOPMENT,0.0010408,-0.2741,-0.31484,1,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,2.342e-06,-0.27485,-0.26457,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00088789,-0.27555,-0.35989,1,0
2,GO GDP METABOLIC PROCESS,0.0011836,-0.27646,-0.20396,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,5.8049e-05,-0.27655,-0.22391,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.00013232,-0.27709,-0.26285,1,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,3.5646e-05,-0.27717,-0.20766,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,4.0678e-07,-0.27758,-0.25899,1,0
2,GO REGULATION OF PLATELET ACTIVATION,0.00061456,-0.27767,-0.25536,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,3.3214e-05,-0.2783,-0.23888,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.015159,-0.27869,-0.28246,1,0
2,GO MALE SEX DETERMINATION,1.3878e-06,-0.28009,-0.34727,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.3661e-05,-0.28103,-0.25572,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.015674,-0.2816,-0.18902,1,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001776,-0.28172,-0.27667,1,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00032408,-0.28276,-0.32611,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.5684e-06,-0.28301,-0.28424,1,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.3066e-07,-0.28337,-0.28797,1,0
2,GO ACTIN FILAMENT BASED TRANSPORT,2.4972e-05,-0.28377,-0.25556,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,2.3239e-05,-0.28401,-0.23097,1,0
2,GO SIGNAL PEPTIDE PROCESSING,3.8924e-05,-0.28414,-0.25028,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.9822e-07,-0.28581,-0.23715,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0012177,-0.2862,-0.23288,1,0
2,GO EXTRACELLULAR TRANSPORT,1.3878e-06,-0.28627,-0.28766,1,0
2,GO LIVER MORPHOGENESIS,0.00014362,-0.2871,-0.24146,1,0
2,GO LEFT RIGHT PATTERN FORMATION,9.4341e-06,-0.28821,-0.25951,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.2416e-05,-0.28836,-0.29945,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,2.8001e-06,-0.2887,-0.2699,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,5.2344e-05,-0.28875,-0.23687,1,0
2,GO SPINAL CORD PATTERNING,0.00013016,-0.28896,-0.2784,1,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,7.105e-06,-0.29087,-0.25139,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.8001e-06,-0.2914,-0.23643,1,0
2,GO RENAL ABSORPTION,0.00048316,-0.2919,-0.308,1,0
2,GO REGULATION OF CELL FATE COMMITMENT,6.6066e-07,-0.29198,-0.29995,1,0
2,GO FRUCTOSE METABOLIC PROCESS,0.0039992,-0.29254,-0.26278,1,0
2,GO CELL CELL JUNCTION ORGANIZATION,9.028e-08,-0.2927,-0.2498,1,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00044103,-0.29412,-0.2741,1,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,2.6914e-06,-0.29537,-0.28112,1,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0095807,-0.29555,-0.18427,1,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.00017457,-0.29625,-0.26402,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,2.2505e-06,-0.29633,-0.26017,1,0
2,GO REGULATION OF EXOSOMAL SECRETION,1.3468e-07,-0.2967,-0.26383,1,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.024687,-0.29735,-0.29289,1,0
2,GO NOTCH RECEPTOR PROCESSING,3.628e-05,-0.29767,-0.33728,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.00028155,-0.29823,-0.23963,1,0
2,GO SKIN DEVELOPMENT,2.188e-08,-0.29837,-0.28546,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,7.969e-07,-0.29859,-0.25644,1,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0023637,-0.29893,-0.30144,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,2.2697e-09,-0.29895,-0.27779,1,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00054518,-0.29966,-0.29092,1,0
2,GO LIPOXYGENASE PATHWAY,0.00054518,-0.30022,-0.30338,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,7.6283e-05,-0.30047,-0.32652,1,0
2,GO PRO B CELL DIFFERENTIATION,1.3693e-05,-0.30065,-0.26794,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.545e-05,-0.30066,-0.23908,1,0
2,GO EPIDERMIS DEVELOPMENT,2.5756e-08,-0.30126,-0.27493,1,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0013443,-0.30137,-0.2187,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,8.4805e-07,-0.30175,-0.33786,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0005056,-0.3018,-0.32202,1,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0044298,-0.30253,-0.26246,1,0
2,GO REGULATION OF INTEGRIN ACTIVATION,7.0337e-07,-0.30284,-0.27227,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00029976,-0.30306,-0.31253,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.8814e-05,-0.30329,-0.28456,1,0
2,GO BARBED END ACTIN FILAMENT CAPPING,9.5999e-07,-0.30366,-0.35139,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,9.0235e-07,-0.3042,-0.3507,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0018256,-0.30481,-0.31355,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,3.4409e-05,-0.30717,-0.3537,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,5.7059e-05,-0.30719,-0.31668,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0012886,-0.30915,-0.25138,1,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00036124,-0.30942,-0.2816,1,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00014362,-0.3095,-0.22659,1,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.0001803,-0.30955,-0.3323,1,0
2,GO VIRAL BUDDING,8.5043e-10,-0.31136,-0.28531,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,9.4407e-08,-0.31142,-0.30695,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.03006,-0.31163,-0.14641,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00049802,-0.31176,-0.31073,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013826,-0.31187,-0.24866,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,3.6924e-05,-0.31189,-0.26256,1,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00028155,-0.31306,-0.23584,1,0
2,GO OSTEOBLAST PROLIFERATION,1.3599e-06,-0.31357,-0.31449,1,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0054872,-0.31426,-0.23843,1,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0030436,-0.31456,-0.27878,1,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0021798,-0.31497,-0.28802,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00063314,-0.31508,-0.30243,1,0
2,GO CELL CELL JUNCTION ASSEMBLY,2.9602e-08,-0.31513,-0.26645,1,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00075607,-0.31561,-0.27593,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.5865e-05,-0.31623,-0.30096,1,0
2,GO WATER HOMEOSTASIS,4.1552e-07,-0.31703,-0.29063,1,0
2,GO T CELL LINEAGE COMMITMENT,6.1583e-08,-0.31772,-0.29401,1,0
2,GO ACTIN FILAMENT SEVERING,4.8839e-05,-0.31801,-0.34169,1,0
2,GO DETECTION OF OTHER ORGANISM,0.0001179,-0.31804,-0.31561,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.2169e-06,-0.31805,-0.27545,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.011678,-0.31836,-0.17335,1,0
2,GO SARCOMERE ORGANIZATION,4.0657e-06,-0.31849,-0.26758,1,0
2,GO LIPID TRANSLOCATION,1.536e-06,-0.31875,-0.27988,1,0
2,GO HETEROTYPIC CELL CELL ADHESION,1.0094e-07,-0.31971,-0.30609,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00021857,-0.31989,-0.30653,1,0
2,GO HAIR CELL DIFFERENTIATION,8.4262e-06,-0.32054,-0.25408,1,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0015249,-0.32062,-0.2878,1,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0089251,-0.32144,-0.28464,1,0
2,GO HISTAMINE SECRETION,0.00074504,-0.32421,-0.31,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,2.6914e-06,-0.32482,-0.30988,1,0
2,GO INTERFERON ALPHA PRODUCTION,1.4741e-05,-0.32528,-0.25362,1,0
2,GO HEPATOCYTE DIFFERENTIATION,1.8053e-06,-0.32531,-0.33907,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.1138e-06,-0.32589,-0.27605,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.9175e-06,-0.3264,-0.33912,1,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00025617,-0.3291,-0.24562,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,6.4699e-07,-0.32999,-0.27576,1,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,1.2441e-09,-0.33152,-0.34107,1,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,1.6457e-05,-0.33185,-0.33982,1,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00032408,-0.33258,-0.28536,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.019312,-0.3343,-0.31878,1,0
2,GO MITOTIC CYTOKINETIC PROCESS,8.9558e-11,-0.33538,-0.30879,1,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,4.8198e-07,-0.33584,-0.2988,1,0
2,GO ANOIKIS,1.8573e-08,-0.33675,-0.3343,1,0
2,GO RESPONSE TO WATER,2.2505e-06,-0.33721,-0.33684,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00012186,-0.33828,-0.3292,1,0
2,GO TRANSPOSITION,2.7078e-07,-0.34073,-0.37858,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.475e-06,-0.34105,-0.31418,1,0
2,GO GAP JUNCTION ASSEMBLY,1.5293e-05,-0.34141,-0.34988,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00074504,-0.34184,-0.24135,1,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2954e-05,-0.34244,-0.32237,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.0527e-08,-0.34343,-0.37101,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,7.0337e-07,-0.34391,-0.34242,1,0
2,GO TOXIN METABOLIC PROCESS,0.00013451,-0.34394,-0.29499,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0052197,-0.34435,-0.25742,1,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0002443,-0.34485,-0.31526,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,9.1829e-05,-0.34542,-0.27383,1,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00034485,-0.34794,-0.26692,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.6062e-07,-0.34914,-0.34491,1,0
2,GO REGULATION OF PLATELET AGGREGATION,1.3693e-05,-0.34946,-0.40319,1,0
2,GO REGULATION OF CELL FATE SPECIFICATION,7.2414e-06,-0.35032,-0.32884,1,0
2,GO LUNG EPITHELIUM DEVELOPMENT,7.4873e-07,-0.3521,-0.32988,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5756e-08,-0.35341,-0.39483,1,0
2,GO INTESTINAL ABSORPTION,1.8793e-06,-0.35342,-0.34886,1,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,9.9803e-06,-0.35442,-0.29652,1,0
2,GO DNA DEAMINATION,0.00055343,-0.3582,-0.29296,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.00076726,-0.35981,-0.34743,1,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.996e-06,-0.36063,-0.33873,1,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,3.7605e-06,-0.36272,-0.36218,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0012527,-0.36444,-0.33455,1,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0018508,-0.36517,-0.2383,1,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,6.2169e-06,-0.36858,-0.30639,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00025617,-0.37163,-0.38316,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0086125,-0.37211,-0.24969,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00026438,-0.37301,-0.34146,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0022396,-0.37734,-0.30412,1,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0012705,-0.37921,-0.31817,1,0
2,GO GLIAL CELL APOPTOTIC PROCESS,1.1375e-05,-0.38071,-0.37374,1,0
2,GO ADRENAL GLAND DEVELOPMENT,5.1304e-06,-0.38082,-0.31316,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5372e-07,-0.38231,-0.39724,1,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.9515e-10,-0.38352,-0.38639,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0038977,-0.384,-0.3674,1,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,5.1304e-06,-0.38443,-0.34005,1,0
2,GO INNER DYNEIN ARM ASSEMBLY,5.5864e-07,-0.38671,-0.44047,1,0
2,GO RETINA LAYER FORMATION,0.0010558,-0.38699,-0.2797,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.1361e-07,-0.38747,-0.32543,1,0
2,GO LYSINE METABOLIC PROCESS,2.6914e-06,-0.38755,-0.3506,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,1.1086e-06,-0.38909,-0.35317,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0016806,-0.39031,-0.37985,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3196e-05,-0.3914,-0.3278,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,7.1819e-07,-0.39157,-0.40554,1,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00070238,-0.39252,-0.32783,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,3.9822e-07,-0.39367,-0.38573,1,0
2,GO REGULATION OF TRANSPOSITION,2.9514e-07,-0.39546,-0.40634,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,4.4285e-07,-0.3958,-0.45957,1,0
2,GO REGULATION OF ANOIKIS,7.3772e-08,-0.39604,-0.40698,1,0
2,GO RESPONSE TO TYPE I INTERFERON,1.9393e-05,-0.39816,-0.39977,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,8.9047e-09,-0.40204,-0.37252,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.6457e-05,-0.40271,-0.36473,1,0
2,GO KERATINOCYTE DIFFERENTIATION,1.3761e-09,-0.4055,-0.40493,1,0
2,GO REGULATION OF RECEPTOR CLUSTERING,1.8701e-05,-0.40552,-0.38157,1,0
2,GO ENDOCARDIUM DEVELOPMENT,8.3066e-07,-0.4069,-0.37506,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,2.9859e-05,-0.40699,-0.35195,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,4.9872e-09,-0.41047,-0.37034,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,4.7501e-09,-0.41048,-0.38282,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0011836,-0.41121,-0.35384,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.2344e-05,-0.41297,-0.29001,1,0
2,GO POSITIVE REGULATION OF CELL MATURATION,1.5386e-08,-0.41678,-0.41304,1,0
2,GO PROGESTERONE METABOLIC PROCESS,7.8052e-07,-0.41683,-0.47458,1,0
2,GO RESPONSE TO INTERLEUKIN 18,2.4091e-05,-0.41894,-0.40331,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.9805e-09,-0.42254,-0.42249,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.4701e-07,-0.42255,-0.4212,1,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00068191,-0.42356,-0.3165,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.086e-06,-0.42802,-0.37313,1,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,6.5837e-06,-0.43244,-0.36039,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,1.3442e-05,-0.43263,-0.37546,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,1.5027e-08,-0.43289,-0.39429,1,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,6.1119e-05,-0.43339,-0.36422,1,0
2,GO RESPONSE TO FORSKOLIN,7.2414e-06,-0.43457,-0.33813,1,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,1.996e-06,-0.44135,-0.42513,1,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.001704,-0.44143,-0.40714,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.7693e-06,-0.44246,-0.45464,1,0
2,GO MUCUS SECRETION,0.00074504,-0.44257,-0.37628,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,6.0565e-09,-0.44343,-0.36966,1,0
2,GO MIDBODY ABSCISSION,1.5968e-11,-0.44451,-0.42021,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2441e-09,-0.44506,-0.42556,1,0
2,GO NEURON FATE SPECIFICATION,4.1026e-05,-0.44877,-0.36891,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,9.8716e-08,-0.44878,-0.43224,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.9078e-09,-0.44919,-0.5163,1,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,1.0861e-06,-0.45081,-0.41441,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,4.7488e-06,-0.45183,-0.41821,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,6.2169e-06,-0.46045,-0.40244,1,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,7.0522e-08,-0.46443,-0.42022,1,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.0979e-10,-0.46471,-0.40742,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.0527e-08,-0.46702,-0.438,1,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.538e-07,-0.4681,-0.37446,1,0
2,GO RESPONSE TO LITHIUM ION,1.9014e-08,-0.47564,-0.45252,1,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,9.1793e-10,-0.4779,-0.45774,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,4.9228e-07,-0.48007,-0.48484,1,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.2146e-06,-0.48054,-0.43784,1,0
2,GO LEYDIG CELL DIFFERENTIATION,1.996e-06,-0.48494,-0.45256,1,0
2,GO APICAL JUNCTION ASSEMBLY,1.2682e-10,-0.49821,-0.45867,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.6352e-05,-0.50021,-0.3405,1,0
2,GO KERATINOCYTE DEVELOPMENT,0.0003557,-0.50573,-0.3742,1,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,4.4787e-08,-0.50689,-0.43602,1,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,3.5794e-07,-0.51359,-0.46788,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,2.2416e-05,-0.51381,-0.38852,1,0
2,GO GLIAL CELL FATE COMMITMENT,3.2146e-06,-0.52865,-0.50477,1,0
2,GO NEGATIVE REGULATION OF ANOIKIS,4.0033e-09,-0.53432,-0.57623,1,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.9332e-05,-0.53483,-0.41031,1,0
2,GO KERATINIZATION,1.9064e-09,-0.54062,-0.49671,1,0
2,GO GAMMA DELTA T CELL ACTIVATION,3.247e-08,-0.55333,-0.45458,1,0
2,GO EPITHELIAL CELL CELL ADHESION,6.4192e-10,-0.57402,-0.62038,1,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,2.402e-08,-0.58399,-0.50907,1,0
2,GO REGULATION OF WATER LOSS VIA SKIN,5.1356e-08,-0.58761,-0.5342,1,0
2,GO CORNIFICATION,3.4553e-09,-0.59176,-0.55248,1,0
2,GO LUNG CELL DIFFERENTIATION,5.6317e-09,-0.59244,-0.56068,1,0
2,GO PSEUDOPODIUM ORGANIZATION,1.471e-07,-0.60853,-0.48464,1,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,9.6538e-08,-0.61605,-0.60441,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.6158e-05,-0.61807,-0.58181,1,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.0527e-08,-0.61984,-0.60439,1,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,2.457e-10,-0.65408,-0.6346,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.3647e-09,-0.67222,-0.66472,1,0
2,GO EPITHELIAL CELL MORPHOGENESIS,1.1533e-09,-0.68619,-0.6105,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,1.2434e-08,-0.70882,-0.58502,1,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,1.1398e-10,-0.7739,-0.73243,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.9371e-11,-0.77526,-0.72534,1,0
2,GO NOSE DEVELOPMENT,7.969e-07,-0.82284,-0.58609,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.628e-05,-0.82697,-0.69923,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,2.1085e-11,-0.84663,-0.88791,1,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,5.2165e-11,-0.86863,-0.79411,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.2631e-05,-1.015,-0.83732,1,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,5.0766e-11,-1.0561,-0.97646,1,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.077698,0.22361,0.14543,0,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.21587,0.21369,0.10653,0,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.39156,0.20523,0.049155,0,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.06986,0.20144,0.12134,0,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.06986,0.19348,0.1397,0,1
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.15921,0.17806,0.098415,0,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.11933,0.16565,0.090253,0,1
2,GO REGULATION OF DOPAMINE SECRETION,0.19557,0.15653,0.14571,0,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.24745,0.15653,0.10419,0,1
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.14197,0.15501,0.12347,0,1
2,GO BASIC AMINO ACID TRANSPORT,0.14869,0.15485,0.14456,0,1
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.075009,0.15453,0.11424,0,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.13338,0.15351,0.12594,0,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.1873,0.1501,0.10959,0,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.1387,0.14985,0.12374,0,1
2,GO MIDGUT DEVELOPMENT,0.43075,0.14692,0.069086,0,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.078382,0.14357,0.099751,0,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.30829,0.14342,0.11991,0,1
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.069238,0.14039,0.13033,0,1
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.071756,0.14034,0.16157,0,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.16407,0.13869,0.10692,0,1
2,GO TELENCEPHALON REGIONALIZATION,0.24911,0.13852,0.094224,0,1
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.073043,0.13678,0.094474,0,1
2,GO NAD BIOSYNTHETIC PROCESS,0.40058,0.13611,0.054405,0,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.078382,0.13308,0.10551,0,1
2,GO LIPID IMPORT INTO CELL,0.070488,0.13029,0.10225,0,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.068006,0.12974,0.11121,0,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.068619,0.12343,0.13274,0,1
2,GO RETINAL CONE CELL DIFFERENTIATION,0.39156,0.12076,0.16075,0,1
2,GO GLIAL CELL MIGRATION,0.077018,0.1138,0.10572,0,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.22042,0.11332,0.064996,0,1
2,GO PROSTAGLANDIN SECRETION,0.15921,0.11276,0.058881,0,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.14088,0.11246,0.052605,0,1
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.078382,0.11221,0.10239,0,1
2,GO SEQUESTERING OF METAL ION,0.17029,0.11066,0.051794,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.33599,0.10877,0.05644,0,1
2,GO PRESYNAPSE ORGANIZATION,0.13549,0.10667,0.089549,0,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.12126,0.10636,0.088476,0,1
2,GO REGULATION OF LIGASE ACTIVITY,0.12721,0.10444,0.084686,0,1
2,GO STRIATED MUSCLE CONTRACTION,0.067397,0.098869,0.078504,0,1
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.40743,0.098743,0.023104,0,1
2,GO CARDIAC MUSCLE CONTRACTION,0.10385,0.096832,0.079207,0,1
2,GO ZINC ION TRANSPORT,0.17411,0.095291,0.060882,0,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.074349,0.092738,0.10564,0,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.10558,0.092537,0.066635,0,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11183,0.090896,0.066985,0,1
2,GO THALAMUS DEVELOPMENT,0.49487,0.089983,0.050232,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.075674,0.08987,0.11237,0,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.1754,0.089818,0.080401,0,1
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.068619,0.086511,0.08421,0,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.27317,0.086361,0.06325,0,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.075009,0.083967,0.098536,0,1
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.067397,0.083452,0.11006,0,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.073043,0.0832,0.090625,0,1
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.34627,0.082921,0.040347,0,1
2,GO REGULATION OF CELL CYCLE ARREST,0.10299,0.082741,0.046415,0,1
2,GO ACETYL COA METABOLIC PROCESS,0.23766,0.081635,0.071027,0,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.099614,0.08017,0.071779,0,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.13763,0.077941,0.1718,0,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.094715,0.077249,0.089242,0,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.12126,0.076688,0.074784,0,1
2,GO NOREPINEPHRINE SECRETION,0.31997,0.075626,0.06504,0,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.12322,0.074751,0.093038,0,1
2,GO TUBULIN DEACETYLATION,0.16904,0.074112,0.10319,0,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.10129,0.071575,0.078201,0,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.20845,0.070613,0.046327,0,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.10214,0.068228,0.050524,0,1
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.086981,0.067582,0.072871,0,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12822,0.066391,0.10382,0,1
2,GO POSITIVE REGULATION OF RNA SPLICING,0.22971,0.065463,0.04216,0,1
2,GO MATING,0.47461,0.063802,0.029405,0,1
2,GO RESPONSE TO MISFOLDED PROTEIN,0.1914,0.062049,0.077579,0,1
2,GO APOPTOTIC DNA FRAGMENTATION,0.1533,0.061311,0.044253,0,1
2,GO COENZYME A METABOLIC PROCESS,0.072397,0.060609,0.084887,0,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.068006,0.056036,0.075976,0,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.06986,0.05451,0.052135,0,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.079765,0.053173,0.071785,0,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.39156,0.052616,0.037938,0,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.51296,0.051907,0.049248,0,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.08331,0.050723,0.069668,0,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.58585,0.048279,0.018504,0,1
2,GO REGULATION OF EXCRETION,0.1533,0.048128,0.081067,0,1
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.22814,0.044157,0.041007,0,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.040582,0.27696,0.23823,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.096327,0.25762,0.19818,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.00031907,0.23952,0.29175,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.014658,0.23295,0.22723,0,0
2,GO LEUKOCYTE AGGREGATION,0.090782,0.22251,0.11068,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0104,0.19808,0.23245,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.11837,0.19753,0.14643,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.12224,0.19641,0.12897,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.027973,0.18597,0.17282,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.056652,0.18324,0.10386,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.11367,0.17589,0.12561,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.066192,0.1688,0.19049,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.079071,0.16692,0.12461,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.047372,0.16512,0.11195,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.092339,0.15624,0.11297,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0020929,0.15594,0.15754,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00029052,0.15483,0.21379,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.12126,0.15443,0.10988,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.22814,0.15346,0.10799,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.029754,0.15278,0.16118,0,0
2,GO VOCALIZATION BEHAVIOR,0.10558,0.15187,0.18077,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0062877,0.15111,0.20162,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0095807,0.14383,0.1624,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.001704,0.1431,0.16975,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.073043,0.14214,0.11256,0,0
2,GO FIBRINOLYSIS,0.21288,0.1394,0.04938,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.025475,0.13777,0.15766,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.073694,0.13705,0.096776,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.2913,0.13442,0.075876,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.35463,0.12924,0.057815,0,0
2,GO CARTILAGE MORPHOGENESIS,0.19003,0.12912,0.10904,0,0
2,GO NADPH REGENERATION,0.26095,0.1276,0.061155,0,0
2,GO AORTA DEVELOPMENT,0.18595,0.12705,0.083068,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.011678,0.12697,0.15252,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.088486,0.12674,0.11532,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.012367,0.12651,0.14083,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.066792,0.12599,0.11955,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.068006,0.12487,0.12754,0,0
2,GO COCHLEA MORPHOGENESIS,0.093126,0.12474,0.10404,0,0
2,GO DENDRITE SELF AVOIDANCE,0.06986,0.124,0.13861,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.078382,0.12205,0.11485,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.02945,0.12091,0.12326,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.065596,0.12077,0.10888,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.22042,0.11931,0.096373,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.20265,0.11885,0.11453,0,0
2,GO PROTEIN DENEDDYLATION,0.0033799,0.11749,0.13084,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.1252,0.11742,0.099971,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.022209,0.11676,0.14695,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.14755,0.1164,0.1193,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.045591,0.11522,0.14214,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.090782,0.11517,0.11411,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0019023,0.11402,0.13442,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.33396,0.11221,0.082048,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.37173,0.11202,0.093345,0,0
2,GO ENAMEL MINERALIZATION,0.58029,0.11134,0.055643,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.014823,0.11054,0.25463,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.15802,0.11013,0.12909,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.020166,0.11011,0.11509,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.080464,0.1098,0.082649,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.0058389,0.10942,0.12169,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.30829,0.10923,0.06428,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13656,0.10908,0.15681,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.29502,0.10893,0.056125,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.20845,0.10807,0.091449,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.14642,0.10788,0.076454,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.09714,0.10758,0.13318,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.073694,0.10691,0.13058,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.074349,0.10649,0.12974,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20554,0.10646,0.13895,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.035336,0.10608,0.11037,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.11092,0.10523,0.095466,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.098784,0.10489,0.098588,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.098784,0.10411,0.087502,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.42838,0.10297,0.053931,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.55016,0.10295,0.05432,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.53406,0.10254,0.053776,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.5583,0.10164,0.047645,0,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.20409,0.1013,0.16281,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.19697,0.1013,0.12401,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.11742,0.099587,0.11466,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.20699,0.099034,0.092342,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.19838,0.098621,0.068786,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.070488,0.098471,0.093306,0,0
2,GO RRNA 3 END PROCESSING,0.05357,0.0983,0.10129,0,0
2,GO REPLICATION FORK PROCESSING,0.14642,0.098291,0.073303,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.3442,0.098132,0.052405,0,0
2,GO RESPONSE TO MANGANESE ION,0.12822,0.097398,0.082495,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.13549,0.096503,0.088688,0,0
2,GO RESPONSE TO AMYLOID BETA,0.0043737,0.095579,0.14471,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.031631,0.09532,0.12926,0,0
2,GO GROOMING BEHAVIOR,0.34213,0.09504,0.052166,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.45238,0.094818,0.050507,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.20265,0.09462,0.084588,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20409,0.094533,0.054792,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.20992,0.093762,0.10121,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.41434,0.09361,0.065517,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.20992,0.093149,0.075721,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.39606,0.093067,0.036064,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.21889,0.09284,0.085553,0,0
2,GO MEMBRANE DISASSEMBLY,0.09796,0.092775,0.090561,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.23927,0.092281,0.14688,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.51296,0.091986,0.054305,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.63408,0.091961,0.034622,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.33396,0.091474,0.068432,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.1754,0.091346,0.088486,0,0
2,GO BONE MORPHOGENESIS,0.32792,0.091344,0.047171,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.21288,0.091237,0.075482,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.45972,0.090688,0.042537,0,0
2,GO RESPONSE TO POTASSIUM ION,0.41434,0.090608,0.062705,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.13656,0.09035,0.18074,0,0
2,GO SYNAPSE ASSEMBLY,0.22503,0.089921,0.062281,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.17156,0.089881,0.11229,0,0
2,GO ALDITOL METABOLIC PROCESS,0.0078263,0.089859,0.16266,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.1533,0.089815,0.11075,0,0
2,GO PROTEIN KINASE A SIGNALING,0.5394,0.089582,0.020699,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.55016,0.089545,0.057241,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.30255,0.089143,0.08063,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.17411,0.088142,0.087223,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.087731,0.088141,0.096582,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.086237,0.088023,0.095648,0,0
2,GO MUSCLE FILAMENT SLIDING,0.23128,0.087957,0.077699,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.19278,0.087891,0.05462,0,0
2,GO ENDODERM FORMATION,0.16042,0.08767,0.082436,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.20409,0.087618,0.13454,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.02174,0.087465,0.10876,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.14088,0.086986,0.10761,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.20845,0.086327,0.031649,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.079071,0.086027,0.1064,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.12029,0.085453,0.11955,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.24745,0.08531,0.052295,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.06986,0.08485,0.097455,0,0
2,GO AXO DENDRITIC TRANSPORT,0.12822,0.084603,0.07313,0,0
2,GO CELL AGGREGATION,0.23128,0.084082,0.056611,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.33396,0.083539,0.06342,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.21587,0.083138,0.077366,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.37608,0.082193,0.096814,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.075009,0.082156,0.091696,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.34627,0.082079,0.096917,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.076344,0.081135,0.13412,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.09714,0.081081,0.1583,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.17283,0.080793,0.070884,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.32195,0.08065,0.072336,0,0
2,GO TRABECULA FORMATION,0.26614,0.080598,0.068349,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.52609,0.080516,0.05284,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.06986,0.080317,0.072577,0,0
2,GO NEURON PROJECTION GUIDANCE,0.069238,0.080216,0.10992,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.16654,0.079952,0.098234,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.67501,0.079223,0.030036,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.43789,0.07922,0.047108,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.12822,0.078824,0.10025,0,0
2,GO TOOTH MINERALIZATION,0.28033,0.07837,0.083985,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11647,0.078368,0.075177,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.68094,0.078245,0.032837,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.48215,0.077971,-0.0076283,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.066792,0.077467,0.10574,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.11092,0.077325,0.082372,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.15098,0.07726,0.071046,0,0
2,GO RESPONSE TO HYPEROXIA,0.30066,0.076794,0.069826,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.54208,0.076694,0.048229,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.043444,0.0766,0.19109,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.57752,0.07658,0.040825,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.12224,0.076447,0.066911,0,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.45238,0.076398,0.039705,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.06986,0.076357,0.082701,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.32592,0.076176,0.071196,0,0
2,GO PROTEASOME ASSEMBLY,0.092339,0.075677,0.082962,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.078382,0.075513,0.10456,0,0
2,GO BICARBONATE TRANSPORT,0.19278,0.075356,0.058638,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.20409,0.075174,0.081561,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.2913,0.0748,0.063459,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.36741,0.074757,0.060009,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.30637,0.074674,0.059742,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27317,0.074279,0.067387,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.046474,0.073958,0.064565,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.14755,0.073296,0.092279,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.11742,0.073284,0.18942,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.094715,0.073243,0.09138,0,0
2,GO DOPAMINE TRANSPORT,0.81581,0.072977,0.04873,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.19417,0.072813,0.10448,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.24911,0.072765,0.06842,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.11647,0.072598,0.059956,0,0
2,GO XENOBIOTIC TRANSPORT,0.19979,0.072306,0.071597,0,0
2,GO ENDODERM DEVELOPMENT,0.62832,0.072297,0.026255,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.090011,0.072097,0.052253,0,0
2,GO DENDRITE MORPHOGENESIS,0.10299,0.072039,0.09352,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.38488,0.072004,0.083376,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.10299,0.071874,0.10084,0,0
2,GO PIGMENT METABOLIC PROCESS,0.074349,0.071737,0.11734,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.33803,0.071673,0.043693,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.29315,0.071439,0.084029,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.26614,0.071435,0.055097,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.37173,0.070685,0.070391,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.13979,0.070644,0.072154,0,0
2,GO TRNA 5 LEADER REMOVAL,0.073694,0.070586,0.10238,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.25414,0.070443,0.085413,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.19003,0.070249,0.077139,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.10045,0.070088,0.099788,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.48722,0.06986,0.035397,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.40973,0.069682,0.074818,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.22195,0.069637,0.089726,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.1262,0.069447,0.14316,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.55287,0.069157,0.023452,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69885,0.069034,0.0066943,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.19278,0.068768,0.057063,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.15921,0.068711,0.087242,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.10558,0.068659,0.070123,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.019104,0.068499,0.067631,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.1653,0.068162,0.11854,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.084763,0.067906,0.076069,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.34627,0.067776,0.071704,0,0
2,GO MRNA SPLICE SITE SELECTION,0.54746,0.067739,0.028679,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.092339,0.067126,0.073088,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.10734,0.06691,0.11529,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.21288,0.066705,0.063497,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.34627,0.0666,0.04033,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.40058,0.066385,0.05997,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.10471,0.066201,0.0788,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,1,0.066141,-0.020448,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.46218,0.066138,0.051297,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.26267,0.066061,0.069335,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.1252,0.066024,0.1011,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.068006,0.065715,0.056917,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.71391,0.064972,0.038552,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.1387,0.064903,0.063832,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.19557,0.064794,0.092558,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.57476,0.064086,0.044327,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.28578,0.063728,0.062411,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.33396,0.063502,0.083604,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.4355,0.063369,0.058096,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.14419,0.063296,0.11018,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.35886,0.063243,0.068933,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.2913,0.062987,0.077607,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.017125,0.062851,0.14155,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.39606,0.062811,0.048579,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.22042,0.062137,0.043735,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.15214,0.062036,0.057157,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.26095,0.062003,0.085073,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32592,0.061924,0.068534,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.21738,0.061885,0.073244,0,0
2,GO RESPONSE TO VITAMIN A,0.36311,0.061865,0.048533,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.087731,0.061792,0.1037,0,0
2,GO LIMB BUD FORMATION,0.21288,0.061629,0.15224,0,0
2,GO METENCEPHALON DEVELOPMENT,0.098784,0.061454,0.082804,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.086981,0.061318,0.1118,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.11933,0.061306,0.064629,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.26095,0.061171,0.058128,0,0
2,GO PROTEIN DEMETHYLATION,0.32792,0.061083,0.055608,0,0
2,GO SEROTONIN TRANSPORT,0.15098,0.061022,0.10701,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.1453,0.060473,0.063815,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.079071,0.060461,0.071479,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.087731,0.060438,0.10075,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.35886,0.060218,0.05493,0,0
2,GO TOXIN TRANSPORT,0.14308,0.060048,0.067806,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.20845,0.060044,0.084996,0,0
2,GO OXIDATIVE DEMETHYLATION,0.1387,0.059933,0.054785,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.65442,0.059905,0.034452,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.14419,0.059824,0.1273,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.1914,0.059619,0.086748,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.44269,0.059132,0.072712,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.16163,0.059085,0.050072,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.48722,0.058999,0.042649,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11092,0.058924,0.072907,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.27673,0.058892,0.080988,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.318,0.058738,0.058494,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.81267,0.058513,-0.0026354,0,0
2,GO COPPER ION TRANSPORT,0.18866,0.058353,0.056563,0,0
2,GO MATING BEHAVIOR,0.18062,0.05832,0.078551,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.27673,0.058053,0.072245,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.15565,0.058015,0.060327,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.094715,0.057793,0.055322,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.1387,0.057747,0.090705,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.41434,0.057665,0.029484,0,0
2,GO DNA REPLICATION CHECKPOINT,0.3871,0.057091,0.04449,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.67501,0.056952,-0.035089,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.1313,0.056794,0.071938,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.18327,0.056769,0.082648,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.31215,0.056238,0.044502,0,0
2,GO RRNA CATABOLIC PROCESS,0.39606,0.056222,0.047502,0,0
2,GO PLASMINOGEN ACTIVATION,0.38047,0.056167,0.038049,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.079765,0.056066,0.06477,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.2458,0.055817,0.070893,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.49231,0.055373,0.077263,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.27853,0.055299,0.073898,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.076344,0.055262,0.073373,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.49231,0.05522,0.046395,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.23927,0.055163,0.040776,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.44028,0.05512,0.054532,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.10558,0.055099,0.062463,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.63408,0.055083,0.023771,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.59144,0.0548,0.025748,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.2114,0.054786,0.062666,0,0
2,GO STARTLE RESPONSE,0.75664,0.054741,0.042037,0,0
2,GO CELL CYCLE DNA REPLICATION,0.22658,0.054484,0.048294,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.25078,0.054394,0.074105,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.099614,0.054258,0.090185,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.2644,0.054197,0.054632,0,0
2,GO NUCLEUS LOCALIZATION,0.20845,0.053959,0.076116,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.14755,0.053943,0.077544,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.87287,0.0539,0.013557,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.68392,0.053887,0.021482,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.055609,0.053793,0.088972,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.75048,0.053736,0.035247,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.29877,0.053622,0.053569,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.68392,0.053583,0.042173,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36098,0.053482,0.036825,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0052854,0.053446,0.14689,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.085497,0.053332,0.087046,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.31409,0.053187,0.063739,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.74741,0.053187,-0.016825,0,0
2,GO FEEDING BEHAVIOR,0.18595,0.053156,0.058824,0,0
2,GO RNA STABILIZATION,0.14088,0.053111,0.062155,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.41434,0.052818,0.063801,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.54477,0.052781,0.034753,0,0
2,GO AXONAL TRANSPORT,0.19278,0.052725,0.073558,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.13763,0.052636,0.071695,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.066192,0.052591,0.09793,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.80639,0.052403,0.01218,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.31021,0.052329,0.085855,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.45727,0.052184,0.037804,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.30637,0.051984,0.094981,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.10299,0.05194,0.090226,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.11647,0.051772,0.073912,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.84424,0.051627,0.0063473,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.5394,0.051618,0.040574,0,0
2,GO ACTION POTENTIAL,0.26964,0.051452,0.060149,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.58864,0.051281,0.030941,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.072397,0.051061,0.079292,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1146,0.050985,0.09566,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16042,0.050876,0.065086,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.42133,0.050863,0.046896,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.40743,0.050859,0.053837,0,0
2,GO CATECHOLAMINE UPTAKE,0.38047,0.050848,0.089454,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.75972,0.050826,-0.002268,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10214,0.050815,0.071054,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.15214,0.050799,0.067441,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.23766,0.050671,0.056954,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.28761,0.050476,0.062225,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.61402,0.050433,0.038277,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.19979,0.050386,0.067571,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.20554,0.050372,0.066738,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.23128,0.05036,0.05312,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.41203,0.050359,0.036753,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.68689,0.05035,0.057508,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.14419,0.050044,0.083019,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.10823,0.049991,0.057957,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.32592,0.049977,0.055149,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.34627,0.049886,0.049575,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.48215,0.049797,0.062836,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.71996,0.049756,-0.041326,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.30066,0.04967,0.07358,0,0
2,GO RECEPTOR CLUSTERING,0.22814,0.049412,0.089749,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.89846,0.049406,0.0096719,0,0
2,GO VESICLE CARGO LOADING,0.42838,0.049378,0.040826,0,0
2,GO SNRNA METABOLIC PROCESS,0.25583,0.049124,0.063043,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.17283,0.049095,0.052567,0,0
2,GO HISTONE H3 K36 METHYLATION,0.97899,0.049069,0.0012987,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.13027,0.049051,0.098761,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.41434,0.049005,0.05662,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.18327,0.049001,0.083525,0,0
2,GO CELLULAR RESPONSE TO ATP,0.1262,0.048956,0.068579,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.18866,0.048857,0.064391,0,0
2,GO ODONTOGENESIS,0.38047,0.04883,0.051432,0,0
2,GO HEART PROCESS,0.26095,0.048705,0.051834,0,0
2,GO PROTEIN REFOLDING,0.93382,0.048674,0.028678,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.2114,0.048562,0.046571,0,0
2,GO MRNA CLEAVAGE,0.090011,0.048492,0.062627,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.19417,0.048471,0.072412,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.44269,0.048387,0.02972,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.084763,0.048364,0.10289,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.98222,0.048337,0.00093891,0,0
2,GO DE NOVO PROTEIN FOLDING,0.36956,0.048326,0.064807,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.93704,0.048301,0.0046325,0,0
2,GO ADULT BEHAVIOR,0.34835,0.048276,0.065098,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.1252,0.048194,0.095561,0,0
2,GO LACTATION,0.15802,0.048193,0.086377,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.45482,0.048068,0.03314,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.61972,0.048018,0.026561,0,0
2,GO BASE EXCISION REPAIR,0.086981,0.047871,0.063143,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.20699,0.047792,0.049278,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.63697,0.047701,0.031123,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.12822,0.04753,0.068792,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.15802,0.047305,0.062975,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.17669,0.047271,0.067736,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.10385,0.047039,0.090036,0,0
2,GO SODIUM ION TRANSPORT,0.60268,0.047022,0.026064,0,0
2,GO FEAR RESPONSE,0.87606,0.047019,-0.0036836,0,0
2,GO RESPONSE TO LEUCINE,0.87287,0.046975,0.025883,0,0
2,GO RESPONSE TO ATP,0.14642,0.046819,0.056318,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.36956,0.046746,0.068649,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.89846,0.046704,0.0088056,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.40286,0.046612,0.043678,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.62545,0.046605,0.069346,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.90809,0.046548,0.017909,0,0
2,GO WATER TRANSPORT,0.88885,0.046479,-0.00048324,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.66028,0.046296,0.036874,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.89526,0.046148,-0.0049846,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.51296,0.046069,0.039564,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.71693,0.046045,0.0066767,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.39832,0.045829,0.032013,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.80953,0.045764,0.02439,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.84107,0.045548,-0.047461,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.64276,0.045296,0.025669,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.26789,0.045205,0.053793,0,0
2,GO MICROTUBULE ANCHORING,0.90488,0.045078,-0.0068637,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.16904,0.045074,0.051913,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.51035,0.045014,0.021322,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.45238,0.044812,0.052601,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.1533,0.044707,0.063507,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.18461,0.044588,0.10425,0,0
2,GO GMP METABOLIC PROCESS,0.44752,0.044446,0.059941,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.21738,0.044374,0.077097,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.1146,0.043995,0.050991,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.31409,0.043714,0.07994,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.53672,0.043692,0.03037,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.30829,0.043554,0.048617,0,0
2,GO NUCLEAR EXPORT,0.10471,0.043523,0.057346,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16654,0.043464,0.047849,0,0
2,GO VAGINA DEVELOPMENT,0.29689,0.0434,0.10646,0,0
2,GO ANION HOMEOSTASIS,0.10823,0.04335,0.088847,0,0
2,GO PROTEIN HYDROXYLATION,0.5394,0.043284,0.028548,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.22348,0.043229,0.046819,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.62545,0.043113,0.023396,0,0
2,GO GLIAL CELL ACTIVATION,0.70787,0.042985,0.023323,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.28761,0.042896,0.067644,0,0
2,GO ORGANIC CATION TRANSPORT,0.24252,0.042871,0.059736,0,0
2,GO REGULATION OF DNA METHYLATION,0.6691,0.042775,-0.031357,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.44994,0.042577,0.055858,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.93704,0.042504,0.018129,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.14419,0.042479,0.080633,0,0
2,GO REGULATION OF HEART RATE,0.39381,0.042306,0.047904,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.099614,0.042151,0.073602,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.46218,0.042111,0.052898,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.50516,0.042047,0.037747,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.84424,0.04196,0.010397,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.08331,0.041952,0.062324,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.20265,0.041825,0.053106,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.17669,0.041756,0.071364,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.16904,0.041676,0.05748,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.23286,0.041643,0.048911,0,0
2,GO CELLULAR RESPONSE TO UV,0.45972,0.041592,0.030805,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.38488,0.041575,0.063411,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35463,0.041514,0.033028,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.071756,0.041413,0.062387,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.88245,0.04136,0.0018762,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.77519,0.041338,0.026218,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.084763,0.041267,0.077735,0,0
2,GO METAL ION TRANSPORT,0.16778,0.041032,0.051247,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.40743,0.040891,0.040203,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.28395,0.040745,0.057608,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.68392,0.040686,-0.0030662,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.34835,0.040671,0.056665,0,0
2,GO POTASSIUM ION TRANSPORT,0.11275,0.040534,0.076537,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.44269,0.040401,0.075845,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.95961,0.04037,-0.0050081,0,0
2,GO NUCLEAR TRANSPORT,0.096327,0.040352,0.047644,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.1653,0.040226,0.06584,0,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.58585,0.040135,0.036759,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.1793,0.03984,0.076604,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.68988,0.039738,0.03195,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.14755,0.039571,0.084367,0,0
2,GO ZINC ION HOMEOSTASIS,0.72603,0.039478,-0.034382,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.70185,0.039419,0.01193,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.13234,0.039415,0.068555,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.44752,0.039025,0.04909,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.26614,0.039009,0.068167,0,0
2,GO NEURON DEVELOPMENT,0.19697,0.038998,0.064131,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.22195,0.038986,0.07157,0,0
2,GO MEMBRANE DEPOLARIZATION,0.42133,0.038979,0.051269,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.80639,0.038976,0.01026,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.76281,0.03891,0.024012,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.37827,0.03875,0.038428,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.11647,0.038577,0.067211,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.17411,0.038561,0.047884,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.82526,0.038447,0.012568,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.25583,0.038328,0.052669,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.44994,0.038316,0.050578,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.71996,0.038309,0.038406,0,0
2,GO RESPONSE TO CALCIUM ION,0.26964,0.038267,0.056351,0,0
2,GO NEURON MATURATION,0.4451,0.038257,0.063747,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.79075,0.038178,-0.018716,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.65442,0.037917,0.017242,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.87926,0.037839,-0.029348,0,0
2,GO IRON ION HOMEOSTASIS,0.30255,0.037668,0.053713,0,0
2,GO RESPONSE TO THYROID HORMONE,0.77829,0.037625,0.0090865,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.34213,0.037617,0.063681,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.066792,0.037616,0.083423,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.71391,0.037431,0.02906,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.41666,0.037395,0.043623,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.34213,0.037387,0.10548,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.16654,0.037383,0.059043,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.37827,0.03712,0.04816,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.97253,0.037002,0.018136,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.82842,0.036973,0.026497,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.41203,0.036963,0.077941,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.25924,0.036836,0.046017,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.088486,0.03673,0.16073,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.50516,0.036702,0.047728,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.2114,0.036575,0.049678,0,0
2,GO PROTEIN STABILIZATION,0.5394,0.036437,0.027128,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.37173,0.036429,0.049367,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.27317,0.036367,0.052044,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.10646,0.036221,0.13059,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.23766,0.03621,0.045605,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.17411,0.036163,0.043269,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.37827,0.035659,0.042197,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.51819,0.035648,0.024135,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.48468,0.035613,0.053104,0,0
2,GO LOCOMOTORY BEHAVIOR,0.32993,0.035602,0.060696,0,0
2,GO PALLIUM DEVELOPMENT,0.4451,0.035527,0.046272,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.63697,0.035495,0.033757,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.90167,0.035478,0.015846,0,0
2,GO RESPONSE TO LEAD ION,0.36311,0.035381,0.05301,0,0
2,GO MUSCLE CONTRACTION,0.24252,0.035287,0.05002,0,0
2,GO HEART VALVE DEVELOPMENT,0.52609,0.035165,0.04421,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.1873,0.035149,0.063079,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.076344,0.034986,0.080015,0,0
2,GO MICROTUBULE POLYMERIZATION,0.10214,0.034876,0.079054,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.36098,0.034825,0.044901,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.91772,0.034785,0.015027,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.13656,0.03467,0.07692,0,0
2,GO REGULATION OF GENE SILENCING,0.33194,0.034664,0.042062,0,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.43789,0.034547,0.048993,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.19838,0.034539,0.060442,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.88885,0.034515,0.0027555,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.38488,0.034488,0.038583,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.6691,0.034361,0.02386,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.54208,0.034107,0.023687,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.20699,0.034045,0.045415,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.19003,0.034009,0.068217,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.62258,0.033918,0.033428,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.50258,0.033878,0.033666,0,0
2,GO REGULATION OF ION TRANSPORT,0.25924,0.033873,0.051238,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.50516,0.033689,0.036792,0,0
2,GO RENAL SODIUM EXCRETION,0.40743,0.033676,0.032422,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.72299,0.033656,0.016079,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.51819,0.033422,0.04119,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.86012,0.033363,0.011901,0,0
2,GO CHOLESTEROL EFFLUX,0.51296,0.03302,0.036359,0,0
2,GO CATION TRANSPORT,0.28578,0.032984,0.044574,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.9113,0.032894,0.0043852,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.19979,0.03286,0.093524,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.1914,0.0328,0.048975,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.5394,0.032768,0.036066,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.56376,0.032758,0.043493,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.53672,0.032684,0.03077,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.42838,0.032641,0.023375,0,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.12029,0.03259,0.10473,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.19417,0.032483,0.073639,0,0
2,GO ARTERY DEVELOPMENT,0.7814,0.032468,0.013444,0,0
2,GO NCRNA CATABOLIC PROCESS,0.21738,0.032361,0.065404,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.12322,0.032281,0.083332,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.1387,0.032233,0.052549,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.27495,0.032162,0.057785,0,0
2,GO BEHAVIOR,0.2913,0.032143,0.049767,0,0
2,GO NUCLEAR MIGRATION,0.51557,0.032107,0.049809,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.51296,0.031921,0.039624,0,0
2,GO MRNA TRANSPORT,0.17411,0.031762,0.063105,0,0
2,GO MITOCHONDRION ORGANIZATION,0.12421,0.031448,0.044027,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.65734,0.031391,0.0484,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.58307,0.031349,0.025663,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.93382,0.031263,0.01121,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.13763,0.03122,0.052505,0,0
2,GO NUCLEOSIDE SALVAGE,0.15447,0.031081,0.068356,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.84107,0.031043,0.0072375,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.38267,0.03099,0.042982,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.14197,0.030867,0.064722,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.36098,0.030648,0.047851,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.73822,0.030512,0.040465,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.19278,0.030433,0.042606,0,0
2,GO NEURON MIGRATION,0.33194,0.030377,0.068635,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.45972,0.030354,0.044768,0,0
2,GO CAMP METABOLIC PROCESS,0.45238,0.030055,0.051646,0,0
2,GO RESPONSE TO SALT,0.60268,0.030048,0.026387,0,0
2,GO DNA GEOMETRIC CHANGE,0.58029,0.029809,0.028296,0,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.81267,0.029762,0.011763,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.35043,0.029725,0.046032,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.49487,0.029676,0.028325,0,0
2,GO NADP METABOLIC PROCESS,0.80326,0.029648,0.0068733,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.94671,0.029533,0.017699,0,0
2,GO VITAMIN TRANSPORT,0.15921,0.029518,0.11433,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.74128,0.029381,0.026745,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.19417,0.029309,0.065135,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.5583,0.029269,-0.06169,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.98222,0.029176,0.0018237,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.47461,0.029161,0.025579,0,0
2,GO RESPONSE TO CAMP,0.13763,0.029122,0.070167,0,0
2,GO CELL GROWTH,0.68392,0.028949,0.025501,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.1533,0.028855,0.040422,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.72907,0.028828,0.012979,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.091558,0.0288,0.10316,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.2458,0.02845,0.041519,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.52345,0.028308,-0.026998,0,0
2,GO CATECHOLAMINE SECRETION,0.35886,0.028226,0.10511,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.23286,0.028158,0.061432,0,0
2,GO METHIONINE METABOLIC PROCESS,0.75048,0.027632,0.0053352,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.34835,0.027523,0.054715,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.99515,0.027195,-0.0045941,0,0
2,GO MITOCHONDRIAL FISSION,0.58029,0.027082,0.046766,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.17156,0.027081,0.046647,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.35043,0.027008,0.029329,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.77519,0.026928,0.040155,0,0
2,GO RNA INTERFERENCE,0.56925,0.026646,0.035951,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.40514,0.026574,0.051007,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.77519,0.026545,-0.024356,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.39832,0.026474,0.038684,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.65734,0.026466,0.025969,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.78451,0.026429,7.6618e-05,0,0
2,GO HISTONE DEUBIQUITINATION,0.44269,0.026318,0.030609,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.58864,0.026256,0.024677,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.34627,0.026197,0.044674,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.37173,0.026077,0.065101,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.50776,0.026008,0.03004,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.30637,0.025986,0.049326,0,0
2,GO NEURON DIFFERENTIATION,0.32195,0.025805,0.049367,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.62545,0.025798,0.026503,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.81896,0.025466,-0.016072,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.21587,0.025458,0.068928,0,0
2,GO METHYLATION,0.178,0.025457,0.044397,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.77209,0.025456,0.047354,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.9306,0.025414,-0.0049634,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.34835,0.025408,0.040551,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.62545,0.025286,0.037225,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.41899,0.025277,0.048838,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.5665,0.025267,0.030957,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.98222,0.02519,-0.0042444,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.99515,0.02506,-0.0002959,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.80639,0.025024,-0.0032477,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.89205,0.024833,-0.022189,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.24911,0.024751,0.053842,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.23766,0.024639,0.062182,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.51296,0.024367,0.027522,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.84741,0.024202,0.026962,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.48468,0.024188,0.02853,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.089246,0.024166,0.27608,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.33599,0.024125,0.051903,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.94026,0.024122,0.0074774,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.73517,0.024121,0.032478,0,0
2,GO PROTEIN PALMITOYLATION,0.7814,0.024059,-0.0064491,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.36098,0.023988,-0.036028,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.69286,0.023935,-0.048063,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.73822,0.023901,0.035662,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.71391,0.023842,0.03462,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.28578,0.023811,0.063437,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86968,0.023798,0.017403,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.63697,0.023653,-0.0024168,0,0
2,GO MITOTIC RECOMBINATION,0.42133,0.023548,0.036106,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.31604,0.023454,0.047465,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.60834,0.023411,-0.032484,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.91451,0.023359,0.017397,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.63986,0.023276,0.027424,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.40058,0.023108,0.030402,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.75356,0.023085,-0.00094541,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.6515,0.022522,-0.038838,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.92094,0.022514,0.0077578,0,0
2,GO NEUROBLAST PROLIFERATION,0.60834,0.022142,0.028992,0,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.30255,0.022131,0.09802,0,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.80953,0.022125,-0.0022266,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.6691,0.022027,0.021468,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.37173,0.022027,0.038898,0,0
2,GO PROTEIN IMPORT,0.572,0.02199,0.029821,0,0
2,GO CHROMOSOME CONDENSATION,0.67798,0.021951,0.019911,0,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.797,0.021795,0.031543,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.69586,0.021663,0.053822,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.36526,0.021564,0.043444,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51035,0.021501,0.04164,0,0
2,GO EXCRETION,0.10385,0.021445,0.073362,0,0
2,GO CHLORIDE TRANSPORT,0.51035,0.021339,0.02883,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.14755,0.021252,0.066637,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.71693,0.021221,0.012428,0,0
2,GO RESPONSE TO UV,0.7659,0.021014,0.012143,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.72907,0.020908,0.04829,0,0
2,GO DRUG CATABOLIC PROCESS,0.66616,0.020781,0.021204,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.74435,0.020763,0.043127,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.85376,0.020703,-0.0078903,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.42133,0.020636,0.048696,0,0
2,GO CHROMATIN SILENCING,0.97576,0.020609,0.010248,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.84107,0.020597,0.0043411,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.47963,0.020499,0.045713,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.78451,0.02039,-0.013423,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.70486,0.020237,0.022898,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.81581,0.020079,-0.0049502,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.075674,0.020033,0.085287,0,0
2,GO POLYOL METABOLIC PROCESS,0.39381,0.020027,0.039091,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.59986,0.020023,0.039513,0,0
2,GO MEMORY,0.19278,0.01992,0.066327,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.32792,0.019899,0.065204,0,0
2,GO ION TRANSPORT,0.50258,0.019889,0.029191,0,0
2,GO REGULATION OF EXOCYTOSIS,0.91451,0.019731,0.016903,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34008,0.019655,0.04088,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.44269,0.019605,0.085094,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.51557,0.019481,0.043611,0,0
2,GO ACROSOME REACTION,0.83474,0.01938,-0.0052609,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.53406,0.019366,0.025354,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.69586,0.019354,0.012101,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.35886,0.019274,0.050052,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.82842,0.018771,0.014827,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.36098,0.018723,0.048624,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.75664,0.018653,0.0097097,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.59144,0.018645,0.056016,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.99192,0.018351,0.00011196,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.27317,0.018323,0.042761,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.52609,0.018307,0.037233,0,0
2,GO DNA REPAIR,0.59144,0.018206,0.016226,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97576,0.018204,-0.0011312,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.2644,0.017952,0.04717,0,0
2,GO EXPLORATION BEHAVIOR,0.13444,0.017936,0.13915,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.6055,0.017872,0.069938,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.90488,0.01785,0.0093047,0,0
2,GO ENSHEATHMENT OF NEURONS,0.63986,0.017845,-0.0034045,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.39606,0.017725,0.086257,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.39156,0.017705,-0.06024,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.39156,0.017688,0.045384,0,0
2,GO REGULATION OF ACROSOME REACTION,0.64567,0.017656,0.038901,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.51035,0.017526,0.025799,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.77209,0.017054,0.0091974,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.9693,0.016937,0.0040401,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.5314,0.016824,0.046278,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.96284,0.016639,0.019122,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.45482,0.016579,-0.031755,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.81581,0.016509,0.0025988,0,0
2,GO NERVOUS SYSTEM PROCESS,0.45972,0.016416,0.034771,0,0
2,GO DEVELOPMENTAL GROWTH,0.86012,0.01623,0.017651,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.85376,0.016058,0.034859,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.19979,0.015896,0.054724,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.56376,0.015716,0.085011,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.40514,0.01569,0.058086,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.82842,0.015512,0.01796,0,0
2,GO MYELIN MAINTENANCE,0.74128,0.015255,0.035391,0,0
2,GO VASODILATION,0.45972,0.015113,0.033208,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.40743,0.015051,0.044119,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.65442,0.014996,0.024615,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.36098,0.014823,0.050266,0,0
2,GO RECOMBINATIONAL REPAIR,0.91451,0.014713,0.0055466,0,0
2,GO HEART TRABECULA FORMATION,0.76281,0.014498,-0.030767,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.97576,0.014278,0.0055728,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.2913,0.014244,0.041579,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.88245,0.01412,0.019998,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.83474,0.014098,0.012035,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.57752,0.014078,0.0036645,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.92094,0.013983,0.0032573,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.75664,0.01393,-0.015189,0,0
2,GO BONE DEVELOPMENT,0.94348,0.013918,0.002314,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.67798,0.013723,0.038058,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.99515,0.013663,-0.0074124,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.60268,0.01363,0.024409,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.45482,0.013517,0.070495,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.92094,0.013388,0.016502,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.76281,0.013216,-0.0091383,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.59986,0.013181,0.028912,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.81896,0.013109,-0.01005,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.92738,0.012997,0.1867,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.6515,0.012974,0.035267,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.30446,0.012953,0.050051,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.56376,0.01293,-0.020265,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.6515,0.012911,-0.020903,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.48976,0.012758,-0.042389,0,0
2,GO OVULATION CYCLE PROCESS,0.48976,0.012617,0.040368,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1,0.012326,0.01057,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.83474,0.012281,-0.002775,0,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.71693,0.012272,0.062706,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.76899,0.012128,0.024884,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.33194,0.012115,0.056502,0,0
2,GO DETOXIFICATION,0.87926,0.012076,-0.0026856,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.59424,0.01201,0.050016,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.55287,0.011752,0.030389,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.23605,0.011706,0.092249,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.8379,0.011619,-0.028285,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.62545,0.011456,0.032827,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.45972,0.011326,0.050444,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.99838,0.011292,-0.021213,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.087731,0.011141,0.10288,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.52609,0.011121,0.020821,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.88885,0.011106,0.017979,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.97576,0.01108,-0.010574,0,0
2,GO METAL ION HOMEOSTASIS,0.92738,0.010978,0.010069,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.44028,0.010905,-0.019487,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.99838,0.010875,0.016656,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.37608,0.010802,0.054681,0,0
2,GO REGULATION OF FERTILIZATION,0.80953,0.01078,0.009745,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.5,0.010752,0.029852,0,0
2,GO PROSTATE GLAND GROWTH,0.85694,0.010723,-0.072424,0,0
2,GO PENILE ERECTION,0.72299,0.010653,0.024176,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63697,0.010588,0.058233,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.62545,0.01055,0.030077,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.5583,0.010546,0.049284,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.95639,0.0105,-0.0081939,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.64858,0.010427,-0.0053508,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.75356,0.010332,0.031729,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.55558,0.01027,0.026114,0,0
2,GO NERVE DEVELOPMENT,0.87606,0.010211,-0.0062816,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.58307,0.010187,0.031406,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.75048,0.01008,-0.040775,0,0
2,GO REGULATION OF HEART GROWTH,0.55016,0.0099094,0.037499,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.38267,0.009685,0.053327,0,0
2,GO TORC1 SIGNALING,0.61972,0.0094343,0.033905,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.5314,0.0094082,-0.014969,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.9113,0.0093956,0.0060421,0,0
2,GO NEUROGENESIS,0.54208,0.0093757,0.034055,0,0
2,GO CELLULAR HOMEOSTASIS,0.40514,0.0093054,0.034747,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.71996,0.009151,0.02651,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.20554,0.0091243,0.069763,0,0
2,GO REGULATION OF DNA REPAIR,0.98869,0.0090827,0.0051962,0,0
2,GO ASYMMETRIC CELL DIVISION,0.83474,0.0090557,0.014585,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.97576,0.0090446,0.015774,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.64276,0.0089187,0.03159,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.73212,0.0086904,0.042565,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.34627,0.0083426,0.046252,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.74128,0.0083424,-0.026056,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.74741,0.0083367,0.020836,0,0
2,GO ION HOMEOSTASIS,0.75972,0.008326,0.021382,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.5,0.0082927,0.026399,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.68689,0.008256,0.031768,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.80326,0.0081565,0.00019261,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.7659,0.008153,0.014622,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.30637,0.0079656,-0.061197,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.27853,0.0079395,-0.053817,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.28945,0.0079375,0.030654,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.6691,0.0079258,-0.010076,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.69286,0.007923,-0.035351,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.178,0.0078937,-0.044629,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.83474,0.0078583,0.020929,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.93382,0.0078508,0.014708,0,0
2,GO RESPONSE TO DOPAMINE,0.23128,0.0078215,0.057132,0,0
2,GO DENDRITE EXTENSION,0.7814,0.007815,0.031964,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.49743,0.0078058,0.072701,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.39832,0.0076956,0.044593,0,0
2,GO CELL JUNCTION ORGANIZATION,0.89205,0.0073994,0.0088849,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.19557,0.0073451,0.24808,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.89526,0.007288,0.033074,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.47461,0.0072725,0.052244,0,0
2,GO MUSCLE SYSTEM PROCESS,0.54746,0.007167,0.032741,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.69286,0.0067849,-0.0093865,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.65734,0.0067686,0.023403,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.98222,0.0067464,0.01037,0,0
2,GO RESPONSE TO RETINOIC ACID,0.41434,0.0067176,-0.026472,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.43789,0.0066907,-0.042828,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.64567,0.0066695,0.042651,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.3871,0.0066448,0.046897,0,0
2,GO DRUG METABOLIC PROCESS,0.89526,0.0063539,0.0046235,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85059,0.0063508,-0.003061,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.58307,0.0063407,0.017958,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.98222,0.0060933,-0.0047819,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.90809,0.0058914,-0.0077875,0,0
2,GO CHROMATIN REMODELING,0.68392,0.0058551,-0.0052282,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.7659,0.0057558,0.018782,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.41434,0.0056112,0.053304,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.87287,0.0055639,0.017137,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.22814,0.0054508,0.062133,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.85694,0.0054148,-0.022317,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.97899,0.0053959,0.0046986,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.72603,0.0053938,0.0040144,0,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.89846,0.0053123,0.0033976,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.26614,0.0052836,0.045448,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.6515,0.0051573,-0.012819,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.78763,0.00503,0.019213,0,0
2,GO DNA RECOMBINATION,0.61972,0.0049107,-0.0080141,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.77829,0.0047453,-0.0062815,0,0
2,GO ORGANIC ACID TRANSPORT,0.27317,0.0047316,0.047351,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.25924,0.0047249,-0.062195,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.94671,0.0047069,0.00056326,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.88565,0.0047043,0.014809,0,0
2,GO DNA METABOLIC PROCESS,0.96284,0.0045794,0.0094463,0,0
2,GO MONOAMINE TRANSPORT,0.88245,0.0044828,0.031333,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.73212,0.0044408,-0.017871,0,0
2,GO INORGANIC ANION TRANSPORT,0.58307,0.0043809,0.021399,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.85376,0.0043396,0.025869,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.82211,0.0042206,0.026609,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.94348,0.0041954,-0.0018014,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.51035,0.0041863,-0.078794,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.68392,0.0040319,0.024321,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.74128,0.00389,0.0087618,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.75048,0.0038489,-0.0093519,0,0
2,GO ANIMAL ORGAN REGENERATION,0.9306,0.0038075,0.010488,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.83474,0.0037919,0.0074651,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.88245,0.0037826,0.01907,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.91451,0.0037276,0.017757,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.69286,0.0037253,0.017274,0,0
2,GO REGULATION OF OOGENESIS,0.71391,0.0036989,-0.014113,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.71693,0.00363,0.01891,0,0
2,GO CARTILAGE DEVELOPMENT,0.63986,0.0036156,-0.012344,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.65734,0.0035896,0.027875,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.69586,0.0034604,0.032123,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.59705,0.0034186,0.034204,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.44752,0.0033989,0.050288,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.96607,0.0033957,0.0090847,0,0
2,GO INTERACTION WITH SYMBIONT,0.58307,0.0033592,0.024623,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.52609,0.0033204,0.061339,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.31215,0.0032648,0.13663,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.21437,0.0032555,0.1203,0,0
2,GO CHROMATIN DISASSEMBLY,0.68988,0.0032551,0.059694,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.67501,0.0032533,0.031316,0,0
2,GO NEURON DEATH,0.34008,0.0031927,-0.015828,0,0
2,GO AMYLOID BETA FORMATION,0.78451,0.0031562,0.037063,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.96284,0.0030768,0.01112,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.75664,0.0029326,0.026222,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.62545,0.0029167,0.056846,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.31021,0.0028973,0.063942,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.58029,0.002853,0.06269,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.48468,0.0028358,-0.017655,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.84741,0.0028287,0.016016,0,0
2,GO FOREBRAIN REGIONALIZATION,0.84424,0.0027082,-0.0083323,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.41434,0.0026023,-0.026443,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.59705,0.0025959,-0.0077361,0,0
2,GO RESPONSE TO PROTOZOAN,0.77209,0.0025055,-0.017858,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.98869,0.0024763,0.012312,0,0
2,GO TRACHEA DEVELOPMENT,0.76899,0.0024328,-0.015558,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.75048,0.0023329,-0.003886,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.97253,0.0023211,0.014303,0,0
2,GO BODY FLUID SECRETION,0.92094,0.0023118,0.019038,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.45238,0.0023115,0.041792,0,0
2,GO OVULATION CYCLE,0.47712,0.0022718,0.044184,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.93704,0.0022578,0.0053909,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.98222,0.0021783,-0.0035112,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.52082,0.0020558,0.037117,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.97899,0.0019202,0.016295,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.90809,0.001915,0.014486,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.72907,0.0019024,-0.022692,0,0
2,GO REGULATION OF RNA SPLICING,0.87926,0.0017609,0.012402,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.77209,0.001534,0.037231,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.71089,0.0014603,0.0031176,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.5665,0.0014515,0.047789,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.52609,0.0012783,0.053518,0,0
2,GO T CELL HOMEOSTASIS,0.94348,0.0011311,0.0021052,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.85376,0.0009983,0.020018,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.31997,0.00097727,-0.035805,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.6691,0.00097416,0.042846,0,0
2,GO PORE COMPLEX ASSEMBLY,0.49231,0.00092911,0.035953,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.4451,0.00090029,0.045982,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.90809,0.00077832,0.019737,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.99192,0.00075369,0.0085369,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.92094,0.0007089,0.0099711,0,0
2,GO POSITIVE REGULATION OF BINDING,0.6312,0.0007039,0.0085769,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.84107,0.00068325,0.025941,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.66028,0.00067554,0.029904,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.46962,0.00065938,0.045624,0,0
2,GO REGULATION OF DNA BINDING,0.71996,0.00063716,-0.0018993,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.84424,0.00057234,-0.021392,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.96607,0.00052578,0.014184,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.73212,0.00040192,0.01501,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.87606,0.0003881,0.0028257,0,0
2,GO SYNCYTIUM FORMATION,0.64276,0.00034334,-0.020124,0,0
2,GO MISMATCH REPAIR,0.91451,0.00034034,0.0079069,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.50258,0.00018639,0.041989,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.97253,9.7396e-06,0.012376,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.82211,5.9318e-07,0.016445,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.73517,1.1992e-07,-0.0095617,0,0
2,GO IRON ION TRANSPORT,0.89205,-3.8151e-05,0.0066599,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.89846,-0.00019717,0.0069571,0,0
2,GO ENDOCYTOSIS,0.9113,-0.00024614,0.013245,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.62545,-0.00033777,0.021952,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.61687,-0.00042017,-0.0071643,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.21738,-0.0004792,0.10583,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.47963,-0.00050059,0.055467,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.66321,-0.00050746,0.033651,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.9306,-0.00054188,0.023702,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.59144,-0.00054328,0.028194,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.73822,-0.00062242,-0.0093833,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.67206,-0.00069713,-0.017257,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.97253,-0.0007389,0.015294,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.59144,-0.0007555,0.031527,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.32592,-0.00076334,-0.027014,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.73517,-0.00081043,-0.0040472,0,0
2,GO GROWTH,0.47461,-0.0008187,-0.003758,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.797,-0.00086571,0.00062405,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.92416,-0.00098744,0.018101,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.74741,-0.0010298,0.058196,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.41434,-0.0012577,0.039123,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.81896,-0.001291,0.020438,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.51296,-0.0013644,-0.0037794,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.93704,-0.0014472,0.0091094,0,0
2,GO CHROMOSOME SEPARATION,0.81267,-0.0014961,0.016868,0,0
2,GO REGULATION OF GROWTH,0.2714,-0.0015642,-0.014225,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.40286,-0.0016005,-0.016222,0,0
2,GO RESPONSE TO ESTROGEN,0.86012,-0.0016198,-0.0020215,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.99515,-0.0018784,0.018153,0,0
2,GO RESPONSE TO AMPHETAMINE,0.9306,-0.0019163,0.0029688,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.37827,-0.0019322,-0.049547,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.44752,-0.001941,0.047963,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.71996,-0.0021632,-0.0091708,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.71693,-0.0022137,-0.0060344,0,0
2,GO CELL CYCLE ARREST,0.75664,-0.0022627,0.0037696,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.58864,-0.0023649,-0.013749,0,0
2,GO THYROID GLAND DEVELOPMENT,0.3871,-0.0024086,-0.10674,0,0
2,GO PROSTATIC BUD FORMATION,0.72299,-0.0024811,-0.069672,0,0
2,GO SNRNA TRANSCRIPTION,0.61687,-0.0024919,0.025498,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.86331,-0.00266,0.0014563,0,0
2,GO SEGMENTATION,0.87606,-0.0027189,-0.0022992,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.98222,-0.0027409,0.027983,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.64276,-0.0028318,0.028021,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.45482,-0.0028885,-0.025357,0,0
2,GO CELL REDOX HOMEOSTASIS,0.71391,-0.0028905,0.017745,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.81267,-0.00291,0.0098301,0,0
2,GO HISTONE METHYLATION,0.83474,-0.0030807,0.0016013,0,0
2,GO PROTEIN ACETYLATION,0.55016,-0.0031298,-0.0074298,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.54477,-0.0031832,-0.041379,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.71996,-0.0032841,0.009089,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.81896,-0.0034475,-0.028538,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.797,-0.0034812,-0.00068113,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.51035,-0.0035258,0.038393,0,0
2,GO DNA STRAND ELONGATION,0.98222,-0.0035931,0.019787,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.50258,-0.0036035,-0.0062815,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.86968,-0.0036072,0.01143,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.74741,-0.0036836,0.025621,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.3871,-0.0036973,-0.024982,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.37827,-0.0040376,-0.015275,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.71996,-0.0041694,0.0064368,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.97253,-0.004171,0.0050321,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.5665,-0.0042993,-0.038053,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.41899,-0.0043104,-0.030982,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.797,-0.0043648,0.02371,0,0
2,GO BIOMINERALIZATION,0.39381,-0.0044445,-0.028956,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.60834,-0.0044525,-0.018391,0,0
2,GO BLASTOCYST GROWTH,0.95961,-0.0045103,0.0024782,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.66616,-0.0045859,0.0015264,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.90809,-0.0046619,0.024499,0,0
2,GO HISTONE EXCHANGE,0.86649,-0.0048008,0.0046146,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.5394,-0.0049617,-0.0098694,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.9693,-0.0049907,-0.0071504,0,0
2,GO G0 TO G1 TRANSITION,0.75664,-0.0050273,-0.0059924,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.89205,-0.0050397,0.00062374,0,0
2,GO IMPORT INTO NUCLEUS,0.63697,-0.0050665,-0.0032542,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.49743,-0.0050769,0.046307,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.71089,-0.0051074,-0.022084,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.96284,-0.0052673,0.0026093,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.99838,-0.0052742,0.01897,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.71391,-0.0053306,0.0051909,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.91772,-0.0053707,0.024157,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.83474,-0.0055542,0.013275,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.83474,-0.0055718,0.031139,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.53406,-0.0055835,-0.0045228,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.84741,-0.0056029,-0.019513,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.5394,-0.0057005,-0.013014,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.81267,-0.0057087,0.002921,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.44752,-0.0059489,-0.0090213,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.86331,-0.0060482,0.019349,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.99515,-0.0060936,0.0073751,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.52874,-0.0061012,0.058041,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.7814,-0.0061612,-0.0023127,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.48215,-0.0062511,-0.00048731,0,0
2,GO COMPLEMENT ACTIVATION,0.92738,-0.0062865,-0.021832,0,0
2,GO DNA LIGATION,0.74128,-0.0063184,-0.014794,0,0
2,GO TONGUE MORPHOGENESIS,0.56376,-0.0063555,-0.073777,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.3442,-0.0063732,-0.065624,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.39381,-0.0064977,-0.0048511,0,0
2,GO MAINTENANCE OF LOCATION,0.70486,-0.0065242,0.03378,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.89205,-0.006526,0.020952,0,0
2,GO CELL CELL SIGNALING,0.9306,-0.0065567,0.010174,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.92416,-0.0068609,0.0020308,0,0
2,GO OXIDATION REDUCTION PROCESS,0.51819,-0.0069491,0.028471,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.99515,-0.0069792,-0.01154,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.70787,-0.0072203,0.027779,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.30446,-0.0072881,-0.059631,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.67206,-0.0072909,-0.0046455,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.67206,-0.0073542,0.033471,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.65734,-0.0073594,-0.0084396,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.92738,-0.0074176,0.012959,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.71996,-0.0074346,0.026918,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.71996,-0.0074835,0.027406,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.31409,-0.0076155,-0.043632,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.80953,-0.0076354,0.010898,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.59424,-0.0076487,0.0027949,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.8379,-0.007712,-0.018225,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.80953,-0.0077458,0.016362,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.81896,-0.0078936,0.035634,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.572,-0.0078987,-0.0053891,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.52345,-0.0079852,-0.036312,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.95961,-0.0080961,0.025998,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.66616,-0.008191,-0.0045918,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.91772,-0.0082269,0.0096499,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.60268,-0.008233,0.038982,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.60268,-0.0082495,-0.013993,0,0
2,GO HAIR FOLLICLE MATURATION,0.41666,-0.0082621,-0.046224,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.72603,-0.0084263,0.0020007,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.6515,-0.0085551,0.034631,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.63697,-0.0085616,-0.0018157,0,0
2,GO FOREBRAIN DEVELOPMENT,0.80953,-0.0086626,0.0057599,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.67501,-0.0086824,-0.015515,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.50776,-0.0087926,-0.005831,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.98546,-0.0088259,0.0088589,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.88245,-0.0088626,0.020001,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.29877,-0.009008,-0.014545,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.80012,-0.0090213,0.014346,0,0
2,GO PROTEIN ACYLATION,0.572,-0.0090645,-0.004283,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.56376,-0.0091452,0.051213,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.37173,-0.0091646,0.073783,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.83474,-0.0091806,-0.0011677,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.37827,-0.0092397,-0.046744,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.33194,-0.0093132,-0.01174,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.9113,-0.0093633,-0.0074944,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.94993,-0.0093732,0.017775,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.29689,-0.0093968,-0.013958,0,0
2,GO CELL MORPHOGENESIS,0.67501,-0.0094223,0.031925,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.47712,-0.0094625,-0.012662,0,0
2,GO TERPENOID METABOLIC PROCESS,0.73517,-0.009505,-0.014926,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.40743,-0.0096167,-0.088873,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.73517,-0.0097897,-0.027375,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.93704,-0.01,0.012957,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.56103,-0.010036,-0.0048668,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.67501,-0.01007,0.034592,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.55016,-0.010194,-0.029132,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.38488,-0.01021,-0.074174,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.62545,-0.01024,0.028954,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.74128,-0.010431,0.0036243,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.96607,-0.010555,0.014085,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.9693,-0.010624,0.0056463,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.31021,-0.010694,-0.067038,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.99192,-0.010746,0.023469,0,0
2,GO MIDBRAIN DEVELOPMENT,0.37173,-0.010902,-0.028898,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.86012,-0.010922,-0.0081941,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.21288,-0.010935,-0.02324,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.63697,-0.010994,-0.021911,0,0
2,GO URETER DEVELOPMENT,0.38267,-0.010998,-0.11349,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9113,-0.01102,0.032876,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.95316,-0.011039,0.010223,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.50258,-0.011055,-0.038173,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.64276,-0.011106,-0.023224,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.44752,-0.011137,-0.0039988,0,0
2,GO BLASTODERM SEGMENTATION,0.17156,-0.011148,0.13313,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.38267,-0.011432,0.063581,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.67501,-0.011614,0.038636,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.25924,-0.01165,-0.024305,0,0
2,GO RESPONSE TO CHEMOKINE,0.79387,-0.011782,-0.0025907,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.71089,-0.011788,-0.037653,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.80953,-0.01183,-0.038328,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.3871,-0.011843,-0.035836,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.38488,-0.011875,-0.0055895,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.49487,-0.011891,-0.039805,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,1,-0.011903,0.0038798,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.96284,-0.011912,-0.012326,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.1533,-0.011953,-0.058651,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.95639,-0.011999,0.019665,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.97253,-0.012093,0.011398,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.98222,-0.012114,0.02065,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.79075,-0.012124,0.01333,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.6312,-0.012262,-0.031598,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.9693,-0.012294,0.012794,0,0
2,GO REGULATION OF T CELL MIGRATION,0.72299,-0.012346,-0.0044195,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.42838,-0.012485,-0.027991,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.87926,-0.012546,0.0060024,0,0
2,GO LIPID PHOSPHORYLATION,0.52082,-0.012616,-0.009999,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.98222,-0.01266,0.0033781,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.86968,-0.012672,0.015841,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.94993,-0.012688,0.013962,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.5394,-0.012701,-0.0285,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.2114,-0.012958,-0.074441,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.37827,-0.013353,-0.021433,0,0
2,GO MICROTUBULE NUCLEATION,0.92416,-0.013413,0.021724,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.78763,-0.013426,0.010676,0,0
2,GO DNA PACKAGING,0.45238,-0.013559,-0.011243,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.797,-0.013671,0.026794,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.71089,-0.013866,-0.018147,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.5394,-0.013928,-0.057804,0,0
2,GO TRABECULA MORPHOGENESIS,0.50258,-0.014045,-0.021,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.59424,-0.014117,-0.0011082,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.74435,-0.014157,0.03851,0,0
2,GO ANION TRANSPORT,0.99192,-0.014183,0.014147,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.5583,-0.014189,-0.057592,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.97576,-0.014195,0.01808,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.40286,-0.014319,-0.055896,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.40058,-0.014335,0.05171,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.56376,-0.014396,-0.0042063,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.82526,-0.014483,0.04831,0,0
2,GO INTRACELLULAR TRANSPORT,0.62258,-0.014485,0.0052272,0,0
2,GO RESPONSE TO RADIATION,0.57752,-0.01453,0.0073136,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.82211,-0.014596,-0.012481,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.62832,-0.014626,-0.02255,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.51819,-0.014686,-0.0054419,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.3739,-0.01478,-0.043498,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.66616,-0.014969,-0.0024122,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.35674,-0.015094,-0.041722,0,0
2,GO PROTEIN POLYMERIZATION,0.47211,-0.015107,-0.0063432,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.41899,-0.01513,0.059328,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.46466,-0.015142,-0.019499,0,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.75356,-0.01521,-0.002982,0,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.30255,-0.015215,-0.038778,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.71996,-0.015272,-0.028469,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.090011,-0.015375,-0.026666,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.70486,-0.015562,-0.0080062,0,0
2,GO HEART GROWTH,0.7814,-0.015563,0.0050874,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.87287,-0.015631,-0.018661,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.46713,-0.015725,-0.04006,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.91772,-0.015733,0.019859,0,0
2,GO DEVELOPMENTAL MATURATION,0.7659,-0.015771,0.0031575,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.52345,-0.015802,-0.019671,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.74435,-0.015818,0.0015203,0,0
2,GO REGULATION OF MYELINATION,0.87606,-0.015889,0.0116,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.35886,-0.016128,-0.017497,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.77829,-0.016258,0.039107,0,0
2,GO EXOCYTIC PROCESS,0.74741,-0.016319,0.012369,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.81267,-0.016321,0.0052902,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.5665,-0.016377,-0.013233,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.39156,-0.016389,-0.023452,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.5314,-0.016483,-0.00027208,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.59986,-0.016565,0.0024194,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.16407,-0.016566,-0.032865,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.51296,-0.016585,-0.020019,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.41203,-0.016591,0.041357,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.67798,-0.016749,-0.010336,0,0
2,GO PROTEIN SUMOYLATION,0.57752,-0.016756,-0.0026677,0,0
2,GO FIBROBLAST ACTIVATION,0.37608,-0.016832,-0.052542,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.57476,-0.016873,-0.027927,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.53672,-0.016985,-0.0058287,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.96607,-0.016999,0.018993,0,0
2,GO PEROXISOMAL TRANSPORT,0.94671,-0.017055,0.0072386,0,0
2,GO SOMITE DEVELOPMENT,0.36098,-0.017101,-0.028641,0,0
2,GO RESPONSE TO AXON INJURY,0.99838,-0.017159,0.011346,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.43789,-0.017159,-0.0067376,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.72907,-0.017301,0.026322,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.80012,-0.017338,0.011511,0,0
2,GO CELL CELL RECOGNITION,0.55287,-0.017455,-0.0092329,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.68392,-0.017475,-0.004226,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.68689,-0.017581,0.04838,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.87926,-0.017583,0.034305,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.59986,-0.017646,0.0030855,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.75356,-0.017649,-0.05202,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.66028,-0.017747,-0.012652,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.12126,-0.018012,-0.028249,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.99838,-0.018018,0.015925,0,0
2,GO REGULATION OF DNA REPLICATION,0.17029,-0.018275,-0.027803,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.76899,-0.018531,-0.00053258,0,0
2,GO NUCLEOSOME ORGANIZATION,0.84107,-0.018531,0.0027199,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.55287,-0.018546,0.025013,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.6312,-0.018593,0.0047878,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.15683,-0.018667,-0.088209,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.72299,-0.018729,-0.0098488,0,0
2,GO MYELIN ASSEMBLY,0.53672,-0.018861,0.05739,0,0
2,GO T CELL MIGRATION,0.86649,-0.018928,0.0036432,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.49487,-0.018933,-0.049271,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.98869,-0.01895,0.018311,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.8379,-0.019022,0.041318,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.2913,-0.0191,-0.027586,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.45482,-0.019372,-0.027618,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.10385,-0.019417,-0.086213,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.72603,-0.019553,-0.003653,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.77519,-0.019581,0.047323,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.53406,-0.01969,-0.027305,0,0
2,GO GENE SILENCING,0.46962,-0.019699,-0.0054219,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.2714,-0.019729,-0.078989,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.3739,-0.019807,-0.022171,0,0
2,GO RESPONSE TO GLUCAGON,0.80639,-0.019832,0.0094287,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.80012,-0.019849,0.012507,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.99192,-0.019857,0.011019,0,0
2,GO FOREGUT MORPHOGENESIS,0.59424,-0.01989,-0.040669,0,0
2,GO HIPPO SIGNALING,0.94348,-0.019933,0.0039638,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.21738,-0.019935,-0.022528,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.74741,-0.019983,-0.011307,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.66616,-0.020118,0.02661,0,0
2,GO STEM CELL DIVISION,0.75356,-0.020186,-0.0099354,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.49743,-0.020195,-0.0086722,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.61117,-0.020398,-0.053289,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.87606,-0.020431,-0.0040593,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.18461,-0.020436,-0.024415,0,0
2,GO REGULATION OF ORGAN GROWTH,0.94026,-0.020505,0.015558,0,0
2,GO CHOLESTEROL STORAGE,0.55558,-0.020512,0.055515,0,0
2,GO DNA CONFORMATION CHANGE,0.8379,-0.020656,0.004603,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.42367,-0.020661,-0.028506,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.71693,-0.020665,-0.014591,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.57476,-0.02068,-0.0086058,0,0
2,GO QUINONE METABOLIC PROCESS,0.095518,-0.020772,-0.12149,0,0
2,GO MACROMOLECULE DEACYLATION,0.75048,-0.02104,0.0051291,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.40286,-0.02108,-0.025432,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.90167,-0.021113,0.027897,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.43075,-0.021158,-0.0031437,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.86968,-0.021245,0.007632,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.62545,-0.021266,0.0035793,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.36741,-0.021417,-0.030048,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.70486,-0.021448,0.0043564,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.96284,-0.021551,-0.02012,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.92738,-0.021609,0.018979,0,0
2,GO CONVERGENT EXTENSION,0.95639,-0.021698,0.0075751,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.18866,-0.021755,-0.036383,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.61117,-0.021837,0.050586,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.19979,-0.021853,-0.018991,0,0
2,GO CALCIUM ION IMPORT,0.78451,-0.021854,0.031351,0,0
2,GO HEAD MORPHOGENESIS,0.19557,-0.021979,-0.064977,0,0
2,GO HISTONE H3 K4 METHYLATION,0.15214,-0.022029,-0.039291,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.2114,-0.022036,0.1063,0,0
2,GO PHOTOPERIODISM,0.35253,-0.022062,-0.033929,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25078,-0.022239,-0.010396,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.99838,-0.022265,0.003054,0,0
2,GO STEROL TRANSPORT,0.63408,-0.022462,-0.0038116,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.18866,-0.022527,-0.050005,0,0
2,GO BRAIN MORPHOGENESIS,0.82211,-0.02258,-0.0077414,0,0
2,GO RESPONSE TO DRUG,0.89205,-0.022591,0.016504,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.72603,-0.022609,0.00030682,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.6691,-0.022619,-0.0115,0,0
2,GO TISSUE REGENERATION,0.20699,-0.022619,-0.060566,0,0
2,GO PROTEIN METHYLATION,0.33396,-0.022649,-0.013666,0,0
2,GO RESPONSE TO STEROL,0.59424,-0.022693,-0.0026495,0,0
2,GO ORGANIC ANION TRANSPORT,0.92094,-0.022724,0.0096458,0,0
2,GO NEURON CELL CELL ADHESION,0.572,-0.022776,-0.045841,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.67501,-0.022947,-0.018796,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.71391,-0.02306,0.007252,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.52345,-0.023068,-0.0028128,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.36098,-0.023116,-0.018597,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.52609,-0.023218,-0.00019007,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.15921,-0.023239,-0.030892,0,0
2,GO HEART MORPHOGENESIS,0.22971,-0.023304,-0.034844,0,0
2,GO EMBRYO IMPLANTATION,0.46713,-0.023336,-0.037458,0,0
2,GO DNA CATABOLIC PROCESS,0.10823,-0.023532,-0.044501,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.69885,-0.023564,0.035028,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.59144,-0.023589,-0.0035974,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.35463,-0.023681,-0.069961,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.20845,-0.023764,-0.041532,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.35253,-0.023791,-0.052895,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.797,-0.023836,-0.018854,0,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.22503,-0.023872,-0.046801,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.68094,-0.023878,0.045437,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.55287,-0.02391,-0.024614,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.076344,-0.023944,-0.044191,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.44269,-0.024002,-0.044003,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.86649,-0.02402,0.0015569,0,0
2,GO DNA REPLICATION,0.77519,-0.024029,-0.0039187,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.61402,-0.0241,0.11151,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.35253,-0.024118,-0.018286,0,0
2,GO GROWTH HORMONE SECRETION,0.26789,-0.024343,-0.062049,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.64858,-0.024386,0.055079,0,0
2,GO NEURAL TUBE PATTERNING,0.21437,-0.024391,-0.063699,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.1873,-0.024515,-0.046309,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.75664,-0.024595,-0.0014888,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.22503,-0.024598,-0.021865,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.52082,-0.024634,-0.022743,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.86968,-0.024638,0.010094,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.46713,-0.024654,-0.00048282,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.68689,-0.024695,0.0066759,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.18062,-0.024772,-0.025509,0,0
2,GO AMINE METABOLIC PROCESS,0.1313,-0.024803,-0.049657,0,0
2,GO CELL PROJECTION ORGANIZATION,0.61972,-0.024804,-0.00065759,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.37173,-0.024989,-0.0083679,0,0
2,GO RESPONSE TO STARVATION,0.20409,-0.025043,-0.028103,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.80639,-0.025051,0.030512,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.68094,-0.025153,0.00010515,0,0
2,GO REGULATION OF BINDING,0.20845,-0.02525,-0.01843,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.34835,-0.025264,-0.019295,0,0
2,GO BONE MINERALIZATION,0.41899,-0.02547,-0.026709,0,0
2,GO RESPONSE TO COCAINE,0.92738,-0.025589,0.018097,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.34835,-0.025644,-0.024128,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.38267,-0.025673,-0.13342,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.34213,-0.025808,-0.060007,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.50776,-0.025817,-0.01421,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.27853,-0.025901,-0.017627,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.25078,-0.025941,-0.0068153,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.52609,-0.025997,-0.010154,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.36741,-0.026022,-0.033714,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.60834,-0.026059,0.042913,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.95961,-0.026097,0.024001,0,0
2,GO PODOSOME ASSEMBLY,0.40058,-0.026154,-0.041377,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.14088,-0.026232,-0.018558,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.55287,-0.026254,-0.0077822,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.72299,-0.026416,0.0088524,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.21288,-0.026481,-0.022288,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.68988,-0.026497,-0.0056593,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.73822,-0.026628,0.0061827,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.42602,-0.026661,-0.013103,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.67206,-0.026663,0.034117,0,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.56376,-0.026682,-0.053594,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.37608,-0.026695,-0.028024,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.14642,-0.02683,-0.089999,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.58585,-0.026835,-0.0056985,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.26267,-0.026836,-0.015163,0,0
2,GO CARNITINE SHUTTLE,0.62832,-0.026919,-0.0052681,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.34627,-0.026935,-0.016693,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.55558,-0.026958,-0.023535,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.85059,-0.026961,-0.011454,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.66321,-0.027099,0.0019768,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.32393,-0.027126,-0.023558,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.38267,-0.027171,-0.030727,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.086237,-0.027265,-0.057612,0,0
2,GO LYMPH NODE DEVELOPMENT,0.61687,-0.027294,-0.022805,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.90488,-0.027299,0.027264,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.35674,-0.027326,-0.020118,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.35674,-0.02737,-0.0094267,0,0
2,GO REGULATION OF URINE VOLUME,0.78451,-0.027492,0.00050637,0,0
2,GO HINDBRAIN DEVELOPMENT,0.58585,-0.027605,-0.007345,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.11647,-0.027631,-0.045995,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.81581,-0.027634,0.006759,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.35463,-0.027697,0.085771,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.15565,-0.027845,-0.034957,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.37608,-0.027855,-0.039212,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.19417,-0.027916,-0.025154,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.28578,-0.027921,-0.029117,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.90488,-0.027931,0.010838,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.31997,-0.028028,-0.0081872,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.57752,-0.028057,-0.020085,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.50258,-0.028058,-0.014303,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.70787,-0.028107,0.017471,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.66616,-0.028108,-0.027089,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.47211,-0.02814,-0.012075,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.89526,-0.028168,0.025787,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.11553,-0.028173,-0.080941,0,0
2,GO VISUAL BEHAVIOR,0.45238,-0.028358,-0.018776,0,0
2,GO MACROPHAGE ACTIVATION,0.66616,-0.028409,-0.0057055,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.82842,-0.028414,-0.0029243,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.40514,-0.028476,-0.0023828,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.36741,-0.028498,-0.018757,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.40973,-0.028525,-0.023493,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.89205,-0.028641,0.017893,0,0
2,GO STEM CELL DIFFERENTIATION,0.26964,-0.028679,-0.022878,0,0
2,GO CHEMICAL HOMEOSTASIS,0.50258,-0.028808,-0.0067579,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.52874,-0.028841,-0.009607,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.093918,-0.028857,-0.027829,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.97899,-0.028923,0.0026369,0,0
2,GO SENSORY PERCEPTION,0.39381,-0.028987,-0.015133,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.71089,-0.029021,0.0021493,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9306,-0.029096,0.022455,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.41203,-0.029099,-0.018218,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.2458,-0.029259,-0.065421,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.9113,-0.029304,0.026211,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.96607,-0.029328,0.014508,0,0
2,GO MACROPHAGE PROLIFERATION,0.9113,-0.029468,0.036259,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.74435,-0.029511,-0.0054234,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.81896,-0.029555,-0.037588,0,0
2,GO LIPID CATABOLIC PROCESS,0.48722,-0.029599,-0.010064,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.73212,-0.029669,0.046967,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.93704,-0.029772,-0.011138,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.73212,-0.029808,0.019537,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.31215,-0.029811,-0.023154,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.71089,-0.029819,0.0081329,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.99515,-0.029841,0.014322,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.77209,-0.029933,0.0066986,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.069238,-0.029963,-0.036345,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.52874,-0.029982,-0.013145,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.68094,-0.029994,-0.044399,0,0
2,GO NEURON APOPTOTIC PROCESS,0.13979,-0.03005,-0.030451,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.6515,-0.030061,-0.012552,0,0
2,GO LYMPHANGIOGENESIS,0.82842,-0.030097,-0.011679,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.39381,-0.030105,-0.031241,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.34835,-0.030112,-0.028649,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.76899,-0.030145,0.028306,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.22195,-0.03018,-0.014659,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.28578,-0.030228,-0.042758,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.11837,-0.030245,-0.023765,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.36741,-0.030266,-0.036371,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.25246,-0.030313,-0.03187,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.40514,-0.030387,-0.015617,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.72603,-0.030395,0.0093664,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.61402,-0.030435,-0.024869,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.25078,-0.030448,-0.022416,0,0
2,GO HEART DEVELOPMENT,0.098784,-0.030519,-0.043655,0,0
2,GO CELL CELL SIGNALING BY WNT,0.48722,-0.030526,-0.0085383,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.59986,-0.030659,-0.014538,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.28761,-0.030723,-0.01244,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.10823,-0.03076,-0.039329,0,0
2,GO RESPONSE TO FATTY ACID,0.69586,-0.030793,-0.0024305,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.75972,-0.030874,-0.050781,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.35043,-0.030899,-0.0074312,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.53406,-0.030965,-0.0057273,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.91772,-0.031041,-0.01107,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.11002,-0.031223,-0.019719,0,0
2,GO PEROXISOME ORGANIZATION,0.80012,-0.031266,0.0014952,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.42838,-0.031318,-0.057819,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.36526,-0.031333,-0.046227,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.41899,-0.031364,-0.019194,0,0
2,GO HISTONE H3 K27 METHYLATION,0.58864,-0.03142,-0.017658,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.33599,-0.031623,-0.032971,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.71996,-0.031711,-0.010017,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.53406,-0.031782,-0.015372,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.87926,-0.031838,0.0084771,0,0
2,GO MEMBRANE ORGANIZATION,0.13656,-0.031887,-0.021774,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.32993,-0.031966,-0.025196,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.5583,-0.031967,0.057316,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.37173,-0.03197,-0.023255,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.77519,-0.032131,-0.0051879,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.5583,-0.03214,-0.0048647,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.51035,-0.032237,0.03494,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.2458,-0.032343,-0.056436,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.19417,-0.032563,-0.020857,0,0
2,GO HEAD DEVELOPMENT,0.44028,-0.032651,-0.0087283,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.63408,-0.032821,-0.026702,0,0
2,GO CELL CYCLE PROCESS,0.13234,-0.032824,-0.020268,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.38488,-0.032849,-0.012061,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.98869,-0.033081,-0.0071612,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.65442,-0.033102,0.048421,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.70486,-0.033113,0.0030589,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96284,-0.033183,0.021224,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.41203,-0.033206,-0.053077,0,0
2,GO HISTONE DEACETYLATION,0.33599,-0.033422,-0.019043,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.11553,-0.033424,-0.033618,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.572,-0.03345,-0.039126,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.09714,-0.033491,-0.039056,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.14197,-0.033536,-0.06606,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.1387,-0.033572,-0.035315,0,0
2,GO RESPONSE TO X RAY,0.38267,-0.033653,-0.050022,0,0
2,GO REGULATION OF CELL AGING,0.3739,-0.033701,-0.038875,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.59144,-0.033763,-0.052094,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.59144,-0.033912,-0.0029634,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.74435,-0.033939,-0.0045189,0,0
2,GO MITOPHAGY,0.27495,-0.033994,-0.029145,0,0
2,GO FATTY ACID TRANSPORT,0.70486,-0.034029,-0.0014865,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.52082,-0.034302,-0.028057,0,0
2,GO REGULATION OF ODONTOGENESIS,0.65442,-0.034376,-0.041688,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.45238,-0.034386,-0.034024,0,0
2,GO STEROID ESTERIFICATION,0.88245,-0.034391,-0.023587,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.64276,-0.034402,-0.022452,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.89846,-0.034469,0.015819,0,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.25753,-0.034581,-0.049411,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.89846,-0.03465,0.012317,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.6055,-0.034745,-0.0064318,0,0
2,GO MESENCHYME DEVELOPMENT,0.3442,-0.03476,-0.030374,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.44752,-0.034811,-0.11089,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.19557,-0.034919,-0.040579,0,0
2,GO CHROMOSOME ORGANIZATION,0.11933,-0.034958,-0.021823,0,0
2,GO HOMEOSTATIC PROCESS,0.11183,-0.035008,-0.022205,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.18062,-0.035142,-0.028946,0,0
2,GO REGULATION OF AUTOPHAGY,0.10646,-0.035152,-0.019642,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.42602,-0.035253,-0.045734,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.40743,-0.035316,-0.0050016,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.64567,-0.035339,-0.0078961,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.65442,-0.03534,-0.0045318,0,0
2,GO VASCULATURE DEVELOPMENT,0.10823,-0.035382,-0.051243,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.52345,-0.035507,-0.01217,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.34008,-0.035539,-0.0113,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.1313,-0.035617,-0.034544,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10385,-0.035805,-0.026122,0,0
2,GO FERTILIZATION,0.073043,-0.035845,-0.030831,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.19697,-0.035891,-0.057256,0,0
2,GO CELL SUBSTRATE ADHESION,0.26095,-0.036005,-0.040776,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.51296,-0.036267,-0.0079951,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.52609,-0.036472,-0.014216,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.47211,-0.036479,-0.0068771,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.66028,-0.036488,0.02197,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.94026,-0.036531,-0.0097495,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.44269,-0.036566,-0.021983,0,0
2,GO VESICLE DOCKING,0.57752,-0.036641,-0.0090023,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.49743,-0.036674,-0.033664,0,0
2,GO VITAMIN METABOLIC PROCESS,0.84107,-0.036676,0.0099488,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.98222,-0.036717,0.017582,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.5,-0.036734,0.00092038,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.25924,-0.036753,-0.038008,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.56925,-0.036777,-0.0047411,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.44028,-0.036912,-0.012516,0,0
2,GO ORGAN GROWTH,0.31604,-0.037007,-0.02498,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.042609,-0.037063,-0.085391,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.11092,-0.037071,-0.022906,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.68988,-0.037093,-0.010111,0,0
2,GO HISTONE PHOSPHORYLATION,0.36741,-0.037099,-0.029842,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.1262,-0.037157,-0.027309,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.17156,-0.037205,-0.050645,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.89846,-0.037221,0.047323,0,0
2,GO SULFATION,0.26095,-0.037315,-0.081641,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.47712,-0.037355,-0.016301,0,0
2,GO SODIUM ION HOMEOSTASIS,0.15214,-0.037378,-0.049306,0,0
2,GO RESPONSE TO PH,0.44028,-0.037476,-0.0016022,0,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.28033,-0.037551,-0.061895,0,0
2,GO RECEPTOR RECYCLING,0.50516,-0.037665,-0.011489,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.81896,-0.037724,-0.0091347,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.29877,-0.037772,-0.041093,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.19417,-0.037783,-0.027213,0,0
2,GO MACROPHAGE CHEMOTAXIS,0.1533,-0.037798,-0.067757,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.75972,-0.037835,-0.013657,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.92738,-0.037929,0.025471,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.80639,-0.038004,0.030825,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.24911,-0.03821,-0.055942,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.93382,-0.038327,0.019661,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.62545,-0.038441,-0.022097,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.80012,-0.038581,0.0090773,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.44752,-0.038583,-0.0086582,0,0
2,GO VACUOLAR ACIDIFICATION,0.31997,-0.038592,-0.048685,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.36741,-0.038716,-0.017723,0,0
2,GO ORGANELLE INHERITANCE,0.34008,-0.038796,-0.018569,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.2114,-0.038825,-0.017115,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.081877,-0.039119,-0.0478,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.13027,-0.039199,-0.032064,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.90809,-0.039269,0.017381,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.23445,-0.039317,-0.049867,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.22971,-0.039416,-0.022286,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.58029,-0.039457,-0.0048023,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.42133,-0.039486,-0.027007,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.15921,-0.039499,-0.10032,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.20122,-0.039524,-0.035151,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.38047,-0.039571,-0.017326,0,0
2,GO ATP TRANSPORT,0.86012,-0.039604,0.012469,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.99515,-0.039769,0.010673,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.73212,-0.039771,-0.019011,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.28033,-0.039773,-0.044398,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.1387,-0.039875,-0.038701,0,0
2,GO REGENERATION,0.29877,-0.039901,-0.025413,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.2458,-0.040026,-0.050227,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.081877,-0.04005,-0.058183,0,0
2,GO ERK1 AND ERK2 CASCADE,0.318,-0.040083,-0.029041,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.31409,-0.040351,-0.016643,0,0
2,GO RHYTHMIC BEHAVIOR,0.31409,-0.040369,-0.029147,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.38267,-0.04038,-0.01825,0,0
2,GO MEMBRANE INVAGINATION,0.25078,-0.040443,-0.033846,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.80639,-0.040519,0.006206,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.59705,-0.040532,-0.0173,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.1653,-0.040591,-0.048874,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,1,-0.040673,0.016386,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.23605,-0.040705,-0.040291,0,0
2,GO NIK NF KAPPAB SIGNALING,0.20122,-0.040735,-0.051375,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.16163,-0.040822,0.10716,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.11647,-0.040871,-0.029497,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.35043,-0.04088,-0.020545,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.22971,-0.04101,-0.075934,0,0
2,GO HISTONE H2A ACETYLATION,0.23766,-0.04107,-0.042004,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.77829,-0.041201,0.075654,0,0
2,GO REGULATION OF TRANSPORT,0.1873,-0.041359,-0.018043,0,0
2,GO ARACHIDONIC ACID SECRETION,0.33194,-0.041467,-0.042166,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.34008,-0.041551,-0.0068642,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.067397,-0.041752,-0.05149,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.098784,-0.041845,-0.037512,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.72299,-0.041897,-0.014327,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.71996,-0.04194,-0.040692,0,0
2,GO MANNOSYLATION,0.16042,-0.041941,-0.055454,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.55558,-0.042131,-0.0097516,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.15098,-0.042208,-0.030895,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.41434,-0.04222,-0.02005,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.3739,-0.042276,-0.057141,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.086237,-0.042291,-0.074202,0,0
2,GO SULFATE TRANSPORT,0.24089,-0.042329,-0.012681,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.72603,-0.042536,-0.02489,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.61402,-0.042586,-0.013996,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.18866,-0.042596,-0.037705,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.45727,-0.042862,-0.036197,0,0
2,GO FUCOSYLATION,0.19979,-0.0429,-0.059741,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.98869,-0.042953,0.011743,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.61117,-0.04316,-0.0080317,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.085497,-0.043205,-0.03155,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.88245,-0.043208,0.013592,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.53406,-0.043263,-0.017596,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.25078,-0.043317,-0.037725,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.19417,-0.043426,-0.051385,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.31021,-0.043501,-0.027823,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.10299,-0.043564,-0.17751,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.6312,-0.043592,-0.011418,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.5394,-0.043666,-0.0015975,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.22348,-0.043685,-0.062861,0,0
2,GO RESPONSE TO INSULIN,0.073694,-0.043731,-0.03306,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.85376,-0.043737,0.0209,0,0
2,GO PROTEIN AUTOPROCESSING,0.20992,-0.043842,-0.041981,0,0
2,GO RHYTHMIC PROCESS,0.12029,-0.043947,-0.021408,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.15098,-0.043953,-0.035461,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.66321,-0.044047,0.044161,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74741,-0.044147,0.0096573,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.093918,-0.044148,-0.029583,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.15683,-0.044149,-0.034385,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.19003,-0.044175,-0.043625,0,0
2,GO ORGANELLE FUSION,0.22971,-0.0443,-0.021314,0,0
2,GO FIBROBLAST PROLIFERATION,0.99192,-0.044543,0.016354,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.98222,-0.044604,-0.013476,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.27673,-0.044606,-0.019738,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.71996,-0.044696,-0.015274,0,0
2,GO RESPONSE TO PEPTIDE,0.10299,-0.044704,-0.024406,0,0
2,GO REGULATION OF MAPK CASCADE,0.073043,-0.044721,-0.041177,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.10214,-0.044726,-0.025222,0,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.19697,-0.044772,-0.049093,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.080464,-0.04483,-0.037228,0,0
2,GO PLATELET DEGRANULATION,0.54746,-0.044834,-0.028212,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.41203,-0.044912,-0.013984,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.83158,-0.044947,0.020979,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.98222,-0.044974,0.0095253,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.20699,-0.045025,-0.053773,0,0
2,GO CHROMOSOME SEGREGATION,0.084034,-0.045025,-0.037736,0,0
2,GO STEROID CATABOLIC PROCESS,0.36311,-0.045293,-0.056217,0,0
2,GO PANCREATIC JUICE SECRETION,0.35886,-0.045345,-0.042342,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.94993,-0.045349,0.018751,0,0
2,GO INTERFERON GAMMA PRODUCTION,0.22814,-0.045403,-0.048048,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.37173,-0.045413,0.079069,0,0
2,GO OVULATION,0.42367,-0.045582,-0.044516,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.96284,-0.045602,0.031963,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.22042,-0.045642,-0.08892,0,0
2,GO SOMITOGENESIS,0.21288,-0.045769,-0.037988,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.17669,-0.045807,-0.034109,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.11275,-0.045856,-0.060776,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.75356,-0.045951,-0.0044742,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.74741,-0.04602,0.0025069,0,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.58029,-0.046035,-0.017744,0,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.23445,-0.046035,-0.031235,0,0
2,GO REGULATION OF GLIOGENESIS,0.11837,-0.046147,-0.052149,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.10646,-0.04617,-0.092883,0,0
2,GO SPINAL CORD DEVELOPMENT,0.38488,-0.046234,-0.032235,0,0
2,GO OSSIFICATION,0.15098,-0.046247,-0.05131,0,0
2,GO MYOBLAST FUSION,0.38933,-0.046257,-0.047156,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.5314,-0.046281,-0.018202,0,0
2,GO ALCOHOL METABOLIC PROCESS,0.33803,-0.046341,-0.018397,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.19838,-0.0464,-0.05894,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.082591,-0.046521,-0.030215,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.090011,-0.046572,-0.056267,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.17029,-0.046621,-0.039223,0,0
2,GO HISTONE H3 ACETYLATION,0.13763,-0.046655,-0.026631,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.89526,-0.04675,0.00078743,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.14642,-0.046933,-0.033239,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.16163,-0.046958,-0.060043,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.098784,-0.046959,-0.046797,0,0
2,GO REGULATION OF TUBE SIZE,0.075009,-0.046994,-0.052986,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.077018,-0.047089,-0.066119,0,0
2,GO ACID SECRETION,0.31997,-0.047091,-0.036564,0,0
2,GO TAXIS,0.34213,-0.04726,-0.015938,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.27853,-0.047264,-0.045515,0,0
2,GO T CELL APOPTOTIC PROCESS,0.32195,-0.047292,-0.055127,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.30066,-0.047382,-0.031159,0,0
2,GO PHAGOSOME MATURATION,0.30446,-0.047398,-0.029198,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.22814,-0.047441,-0.049308,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.54477,-0.047488,0.0004691,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.43789,-0.047506,-0.034729,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.17029,-0.047616,-0.092037,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.49231,-0.047649,-0.01423,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.10385,-0.047772,-0.03936,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.23286,-0.047844,-0.030854,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.1453,-0.047844,-0.086464,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.12721,-0.047845,-0.021487,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.12721,-0.047853,-0.021075,0,0
2,GO OOCYTE MATURATION,0.47963,-0.047858,-0.016332,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.84107,-0.047876,0.0036063,0,0
2,GO GLIOGENESIS,0.14419,-0.048029,-0.040395,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.49743,-0.048153,-0.022296,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.29502,-0.048283,-0.045228,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.56103,-0.048316,-0.025454,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.29315,-0.048449,-0.053404,0,0
2,GO REGULATION OF MITOPHAGY,0.13027,-0.048522,-0.05196,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.24745,-0.048556,-0.044192,0,0
2,GO MEMBRANE BIOGENESIS,0.43789,-0.048596,-0.035069,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.5314,-0.0486,-0.017985,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.39606,-0.048777,-0.015969,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.081877,-0.048838,-0.026076,0,0
2,GO STEROL HOMEOSTASIS,0.40286,-0.04912,-0.040128,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.46466,-0.049131,-0.010542,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.13027,-0.049157,-0.037296,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.071756,-0.049227,-0.029114,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.077698,-0.049251,-0.032914,0,0
2,GO CHONDROCYTE PROLIFERATION,0.70787,-0.049259,-0.027435,0,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.10734,-0.049274,-0.038775,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.44994,-0.049452,-0.10499,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.068619,-0.049586,-0.036905,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.074349,-0.049658,-0.044581,0,0
2,GO REGULATION OF ANION TRANSPORT,0.1387,-0.049753,-0.045604,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.20409,-0.049775,-0.018949,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.19278,-0.0498,-0.050758,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.15565,-0.049851,-0.037959,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.30637,-0.049861,-0.032065,0,0
2,GO SPERM EGG RECOGNITION,0.40743,-0.050144,-0.014319,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.51296,-0.050161,-0.045008,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.11367,-0.050187,-0.072401,0,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.55016,-0.050195,-0.013398,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.093126,-0.050197,-0.081618,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.20122,-0.050303,-0.021919,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.1252,-0.050344,-0.027098,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.91451,-0.050347,0.015243,0,0
2,GO GENITALIA DEVELOPMENT,0.26267,-0.050354,-0.043347,0,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.42133,-0.050475,-0.050477,0,0
2,GO NUCLEOSOME ASSEMBLY,0.35463,-0.05078,-0.027548,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.61117,-0.050782,-0.007331,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.093918,-0.050784,-0.048564,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.074349,-0.051013,-0.06159,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.23605,-0.051027,-0.037508,0,0
2,GO FEVER GENERATION,0.9113,-0.051045,-0.012519,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.10385,-0.051104,-0.070643,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.1914,-0.051178,-0.0182,0,0
2,GO PRIMARY MIRNA PROCESSING,0.3442,-0.051272,-0.039364,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.074349,-0.051275,-0.030666,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.071119,-0.051322,-0.063081,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.37827,-0.051365,-0.042956,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.1873,-0.051434,-0.018791,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.29877,-0.051536,-0.0042529,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.85376,-0.051553,0.013621,0,0
2,GO MANGANESE ION TRANSPORT,0.61687,-0.051577,-0.0042068,0,0
2,GO REGULATION OF PROTEIN BINDING,0.16407,-0.051638,-0.025641,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.12126,-0.051923,-0.041836,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.16778,-0.05199,-0.029063,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.32993,-0.051993,-0.059873,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.070488,-0.052017,-0.032389,0,0
2,GO LYMPHOCYTE MIGRATION,0.36526,-0.052017,-0.027293,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.22814,-0.052039,-0.037265,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.59424,-0.052055,-0.03827,0,0
2,GO FILOPODIUM ASSEMBLY,0.95961,-0.052073,0.014135,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.57752,-0.052097,-0.033685,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.21288,-0.052203,-0.036897,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.073043,-0.052351,-0.033326,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.10823,-0.052369,-0.082865,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.50516,-0.052374,-0.029614,0,0
2,GO BODY MORPHOGENESIS,0.10299,-0.052461,-0.0709,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.25246,-0.052495,-0.034083,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.52609,-0.05255,-0.040641,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.17283,-0.052664,-0.03648,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.43075,-0.052668,-0.0088836,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.12822,-0.052681,-0.042465,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.25246,-0.052689,-0.036007,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.41899,-0.052695,-0.010763,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.18194,-0.052696,-0.014845,0,0
2,GO SISTER CHROMATID COHESION,0.080464,-0.052734,-0.049553,0,0
2,GO FATTY ACID BETA OXIDATION,0.36956,-0.052789,-0.025908,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.32993,-0.052861,-0.023011,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.16904,-0.05294,-0.037311,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.12029,-0.052968,-0.04339,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.572,-0.053201,-0.013931,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.38267,-0.053219,-0.039269,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.4451,-0.053241,-0.0077244,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.09714,-0.053259,-0.039357,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.23927,-0.053307,-0.044017,0,0
2,GO RESPONSE TO ZINC ION,0.62258,-0.053334,-0.037969,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.19417,-0.053346,-0.070243,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.06986,-0.053486,-0.0433,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.13979,-0.053513,-0.044554,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.20554,-0.053605,-0.064276,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.068006,-0.053659,-0.12303,0,0
2,GO JNK CASCADE,0.079071,-0.053711,-0.035319,0,0
2,GO LIPID OXIDATION,0.23766,-0.053745,-0.038418,0,0
2,GO MICROTUBULE BASED PROCESS,0.13763,-0.053749,-0.029366,0,0
2,GO STEROID HORMONE SECRETION,0.16904,-0.053802,-0.094227,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.092339,-0.053835,-0.064463,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.25246,-0.053993,-0.071249,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.12721,-0.054026,-0.047992,0,0
2,GO CELLULAR EXTRAVASATION,0.23445,-0.054065,-0.033667,0,0
2,GO HYPEROSMOTIC RESPONSE,0.27495,-0.054084,-0.023679,0,0
2,GO CD40 SIGNALING PATHWAY,0.25414,-0.054086,-0.055561,0,0
2,GO VASCULOGENESIS,0.71391,-0.054448,-0.011809,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.11647,-0.054453,-0.032998,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.21738,-0.054482,-0.046997,0,0
2,GO RESPONSE TO ETHANOL,0.25414,-0.05457,-0.024802,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.54477,-0.054579,-0.015113,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.11183,-0.054675,-0.075205,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.81267,-0.054708,0.048709,0,0
2,GO HINDLIMB MORPHOGENESIS,0.26614,-0.054773,-0.062031,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.14755,-0.054777,-0.041268,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.19838,-0.054818,-0.069985,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.25414,-0.054863,-0.021037,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.3739,-0.055044,-0.027975,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.59986,-0.055072,-0.027175,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.45238,-0.055091,-0.032235,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.178,-0.055097,-0.018057,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.068619,-0.05513,-0.10418,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.23766,-0.055289,-0.035318,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.2644,-0.055301,-0.024509,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.6515,-0.055392,0.016047,0,0
2,GO TONGUE DEVELOPMENT,0.077698,-0.055397,-0.15188,0,0
2,GO REGULATION OF BEHAVIOR,0.62258,-0.055588,-0.0028173,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.44028,-0.055722,-0.034085,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.14869,-0.055764,-0.033518,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.47712,-0.055804,-0.0052778,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.61117,-0.055887,-0.026442,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21889,-0.055915,-0.077038,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.23128,-0.056051,-0.085873,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.34835,-0.056218,-0.074014,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.21437,-0.056286,-0.029287,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.27317,-0.056361,-0.023452,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.44994,-0.056462,-0.020562,0,0
2,GO GLUCOSE IMPORT,0.30066,-0.056495,-0.013207,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.13656,-0.056639,-0.044862,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.15921,-0.056696,-0.029252,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.19278,-0.056732,-0.019097,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.12029,-0.056757,-0.10459,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.11183,-0.056807,-0.047229,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.095518,-0.05684,-0.038677,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.14869,-0.057259,-0.032448,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13763,-0.057274,-0.075943,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.90488,-0.057417,0.0054062,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.11367,-0.057466,-0.031899,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.11275,-0.057471,-0.064676,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.22814,-0.057494,-0.046408,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.20554,-0.057516,-0.02988,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.45727,-0.057558,-0.039624,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.11275,-0.057587,-0.084872,0,0
2,GO MUSCLE CELL PROLIFERATION,0.21889,-0.057919,-0.043388,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.66028,-0.058073,-0.010254,0,0
2,GO RESPONSE TO INTERLEUKIN 15,0.1252,-0.058175,-0.083963,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.077018,-0.058193,-0.083934,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.081877,-0.058352,-0.050011,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.24745,-0.058498,-0.045077,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.45727,-0.058591,-0.057513,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.178,-0.058666,-0.030963,0,0
2,GO BLASTOCYST DEVELOPMENT,0.069238,-0.058763,-0.036174,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.15683,-0.058829,-0.06577,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.20992,-0.058855,-0.093695,0,0
2,GO GASTRULATION,0.4451,-0.058928,-0.021141,0,0
2,GO PERICARDIUM DEVELOPMENT,0.34835,-0.059068,-0.040907,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.31215,-0.059101,-0.025835,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.32792,-0.059132,-0.07162,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.26095,-0.059281,-0.088224,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.86012,-0.059395,0.0089277,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.95961,-0.05942,0.0055029,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.21587,-0.059441,-0.053047,0,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.17156,-0.059552,-0.031169,0,0
2,GO RESPONSE TO HORMONE,0.092339,-0.059629,-0.033082,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.12721,-0.059651,-0.064703,0,0
2,GO ENERGY HOMEOSTASIS,0.33194,-0.059659,-0.047097,0,0
2,GO STEROL METABOLIC PROCESS,0.42133,-0.059663,-0.015623,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.35886,-0.059977,-0.019947,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.11742,-0.06001,-0.056596,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.081877,-0.060183,-0.071314,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.77519,-0.06047,0.0033855,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.92738,-0.060684,0.012593,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.075674,-0.060748,-0.027143,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.09714,-0.06079,-0.059955,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.45482,-0.06092,-0.072358,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.09796,-0.060937,-0.068127,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.50516,-0.060946,-0.0058817,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.92094,-0.06095,-0.002697,0,0
2,GO BONE MATURATION,0.42133,-0.061045,-0.034223,0,0
2,GO PROTEIN MANNOSYLATION,0.16778,-0.061188,-0.046532,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.29877,-0.061204,-0.027847,0,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.10045,-0.06122,-0.037541,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.61972,-0.061407,-0.0062187,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.64567,-0.061514,0.010994,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.33803,-0.061565,-0.053223,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.47211,-0.062048,-0.037755,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.34008,-0.062091,-0.062945,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.25414,-0.062242,-0.038343,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.1262,-0.062535,-0.036195,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.20554,-0.062542,-0.036406,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.076344,-0.062822,-0.07802,0,0
2,GO RESPONSE TO TUMOR CELL,0.33396,-0.062868,-0.064705,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.75048,-0.062954,-0.012398,0,0
2,GO RESPONSE TO INTERLEUKIN 1,0.068006,-0.063,-0.064528,0,0
2,GO SELECTIVE AUTOPHAGY,0.13338,-0.06312,-0.039316,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.25583,-0.063403,-0.049605,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.12322,-0.063544,-0.0614,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.045155,-0.063612,-0.12102,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.09796,-0.063613,-0.030671,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.088486,-0.06409,-0.03728,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.9693,-0.064118,0.019508,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.19003,-0.064175,-0.052398,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.18866,-0.064181,-0.02054,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.079071,-0.064392,-0.177,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.54208,-0.064396,-0.0050192,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.28213,-0.064417,-0.046815,0,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.1653,-0.064484,-0.064456,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.14755,-0.064595,-0.06295,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.20992,-0.064653,-0.052228,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.99838,-0.064879,0.026431,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.26964,-0.064981,-0.036414,0,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.55287,-0.065262,0.067312,0,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.14419,-0.065417,-0.041262,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.26789,-0.065652,-0.11545,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.086237,-0.065687,-0.14696,0,0
2,GO PHOTOTRANSDUCTION,0.18595,-0.065734,0.14459,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.73822,-0.065793,0.0091488,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.13656,-0.065835,-0.054787,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.34213,-0.065915,-0.050857,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.057179,-0.066006,-0.080508,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.18327,-0.066022,-0.05043,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.18062,-0.066038,-0.093579,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.059331,-0.06604,-0.060106,0,0
2,GO MUSCLE HYPERTROPHY,0.090782,-0.066088,-0.056455,0,0
2,GO PHAGOCYTOSIS,0.26095,-0.066132,-0.037668,0,0
2,GO VACUOLE ORGANIZATION,0.069238,-0.06615,-0.040688,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.29502,-0.066164,-0.059428,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.17669,-0.066292,-0.071363,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.12029,-0.066434,-0.082978,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.73517,-0.066445,0.0094724,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21889,-0.066463,-0.077471,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.11933,-0.066586,-0.077283,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.29502,-0.066768,-0.018648,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.17669,-0.066938,-0.036583,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.6055,-0.066942,-0.014816,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.64858,-0.067009,-0.0061149,0,0
2,GO RESPONSE TO ALKALOID,0.22348,-0.067016,-0.030035,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.17029,-0.067182,-0.068845,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.071119,-0.067261,-0.049046,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.11933,-0.067295,-0.046043,0,0
2,GO LIPID DROPLET ORGANIZATION,0.068619,-0.067399,-0.064229,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.14308,-0.067434,-0.045574,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.13656,-0.067534,-0.11629,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.34627,-0.06764,-0.048597,0,0
2,GO GLIAL CELL PROLIFERATION,0.076344,-0.067696,-0.092643,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.27673,-0.067805,-0.050704,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.12721,-0.067837,-0.044049,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.22348,-0.067928,-0.04297,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.093126,-0.068001,-0.058045,0,0
2,GO REGULATION OF BONE DEVELOPMENT,0.52345,-0.068009,-0.013979,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.25583,-0.068019,-0.039927,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.15214,-0.068167,-0.08458,0,0
2,GO AXIS SPECIFICATION,0.21738,-0.06823,-0.031493,0,0
2,GO STRESS FIBER ASSEMBLY,0.19278,-0.068385,-0.038109,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.078382,-0.068403,-0.064636,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.10471,-0.068477,-0.082209,0,0
2,GO NEUTROPHIL MIGRATION,0.15565,-0.06855,-0.048049,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.13338,-0.068638,-0.036995,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.13338,-0.068697,-0.042904,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.11742,-0.068915,-0.048321,0,0
2,GO NEURAL CREST FORMATION,0.34008,-0.068934,-0.074213,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.64567,-0.069005,-0.017192,0,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.084034,-0.069156,-0.094323,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.97899,-0.069166,0.038597,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.86649,-0.06942,0.024814,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.11742,-0.069501,-0.091408,0,0
2,GO DNA MODIFICATION,0.076344,-0.069557,-0.038412,0,0
2,GO MRNA TRANSCRIPTION,0.26614,-0.069624,-0.032456,0,0
2,GO LYSOSOMAL TRANSPORT,0.11837,-0.069665,-0.043775,0,0
2,GO FUCOSE METABOLIC PROCESS,0.13027,-0.069799,-0.098087,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.092339,-0.069944,-0.075784,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.2114,-0.070029,-0.075988,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.22503,-0.070101,-0.015336,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.1653,-0.070343,-0.06011,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20122,-0.070563,-0.044893,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.72603,-0.070707,0.011571,0,0
2,GO FLUID TRANSPORT,0.12224,-0.070801,-0.07384,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.076344,-0.071032,-0.042785,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.51819,-0.071128,-0.053816,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.077698,-0.071147,-0.03246,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.34008,-0.071317,-0.043146,0,0
2,GO REGULATION OF LIPID STORAGE,0.12126,-0.071426,-0.046042,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40973,-0.071566,-0.081425,0,0
2,GO RESPONSE TO FUNGUS,0.12322,-0.071619,-0.052785,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.23286,-0.071738,-0.050617,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.18461,-0.072001,-0.069818,0,0
2,GO ACTIN CROSSLINK FORMATION,0.84741,-0.072073,0.059483,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10912,-0.072333,-0.029928,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.22503,-0.072334,-0.032139,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.13979,-0.072357,-0.062068,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.17411,-0.07247,-0.08984,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.49487,-0.072642,-0.067454,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.66616,-0.072914,-0.01083,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.45727,-0.073004,-0.058211,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.099614,-0.073098,-0.056341,0,0
2,GO T CELL CHEMOTAXIS,0.41666,-0.073191,-0.013159,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.33396,-0.073569,-0.11218,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.10558,-0.073584,-0.053252,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.086237,-0.073603,-0.062031,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.20122,-0.073613,-0.057208,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.12322,-0.073657,-0.039526,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.099614,-0.073672,-0.048589,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.25924,-0.073848,-0.040335,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.12126,-0.073876,-0.038885,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.51035,-0.074087,-0.03774,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.079765,-0.074184,-0.14403,0,0
2,GO RESPONSE TO NICOTINE,0.16163,-0.074188,-0.080398,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.14983,-0.074192,-0.038233,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.65442,-0.07431,0.0023461,0,0
2,GO LIPID HOMEOSTASIS,0.28033,-0.074381,-0.030841,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.051111,-0.074389,-0.090137,0,0
2,GO TRANSFERRIN TRANSPORT,0.12924,-0.074435,-0.043848,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.095518,-0.074497,-0.02679,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.1453,-0.074533,-0.024498,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.6691,-0.07481,0.01567,0,0
2,GO AMELOGENESIS,0.42133,-0.074891,-0.043567,0,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.16654,-0.074986,-0.06031,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.34008,-0.075013,-0.021803,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.1387,-0.075023,-0.038887,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.16163,-0.075051,-0.050745,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.42838,-0.075085,-0.057087,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.21437,-0.075089,-0.05267,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.24089,-0.075155,-0.026365,0,0
2,GO ACROSOME ASSEMBLY,0.86331,-0.07539,0.02212,0,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.086237,-0.075464,-0.051687,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.18062,-0.075471,-0.068274,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.46218,-0.075485,-0.024478,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.10471,-0.075668,-0.082302,0,0
2,GO RESPONSE TO PAIN,0.1653,-0.075683,-0.089295,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.36526,-0.075846,-0.016392,0,0
2,GO RESPONSE TO VITAMIN,0.13338,-0.075931,-0.06375,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.59144,-0.076023,0.0053949,0,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.14642,-0.076097,-0.063195,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.33396,-0.076289,-0.055226,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.091558,-0.076352,-0.052877,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.11183,-0.076411,-0.075469,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.28578,-0.076589,-0.054679,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.85059,-0.076723,0.030624,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.086981,-0.076724,-0.055729,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.21437,-0.076826,-0.031386,0,0
2,GO NEURON PROJECTION REGENERATION,0.6312,-0.076842,-0.0076628,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.59705,-0.076886,-0.0026791,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.12822,-0.076905,-0.032853,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.22348,-0.076997,-0.035388,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.069238,-0.077125,-0.075221,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.46962,-0.077262,-0.029786,0,0
2,GO RESPONSE TO TESTOSTERONE,0.16904,-0.077452,-0.054401,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.073043,-0.077499,-0.040062,0,0
2,GO KINETOCHORE ORGANIZATION,0.14088,-0.077551,-0.072281,0,0
2,GO RNA DECAPPING,0.072397,-0.077571,-0.041325,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.36741,-0.077987,-0.049365,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.079765,-0.078079,-0.071638,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.078382,-0.0781,-0.033005,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.65442,-0.078177,-0.0055762,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.77519,-0.078263,0.020997,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.23445,-0.078424,-0.041819,0,0
2,GO MACROPHAGE MIGRATION,0.086981,-0.078464,-0.080442,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.1453,-0.078684,-0.090833,0,0
2,GO SKIN MORPHOGENESIS,0.45727,-0.079008,-0.069264,0,0
2,GO DIET INDUCED THERMOGENESIS,0.53406,-0.079016,-0.010507,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.093918,-0.07925,-0.041967,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.14308,-0.079286,-0.10129,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.28761,-0.079483,-0.039907,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.077698,-0.079611,-0.070925,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.27853,-0.079936,-0.056652,0,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.58307,-0.080064,-0.034097,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.36311,-0.080072,-0.079989,0,0
2,GO GLIAL CELL DEVELOPMENT,0.13027,-0.080208,-0.039945,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.55287,-0.080529,-0.015435,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.065596,-0.080771,-0.060809,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.28761,-0.080937,-0.051052,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.23445,-0.081212,-0.049181,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.71089,-0.081411,-0.011917,0,0
2,GO AMINE CATABOLIC PROCESS,0.16778,-0.081453,-0.074839,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.14642,-0.081473,-0.099741,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.55016,-0.081729,-0.023009,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.15683,-0.081786,-0.06413,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.28945,-0.081968,-0.028665,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.12421,-0.082112,-0.061893,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.50516,-0.082409,-0.030964,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.46218,-0.082741,-0.029098,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.88565,-0.082847,0.025409,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.12924,-0.08307,-0.062215,0,0
2,GO GASTRIC ACID SECRETION,0.1453,-0.083161,-0.060726,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.40973,-0.083266,-0.04529,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.50258,-0.083344,-0.0090255,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.071756,-0.083423,-0.061312,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.25246,-0.083561,-0.053952,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.095518,-0.083693,-0.055144,0,0
2,GO HISTONE H4 DEACETYLATION,0.086237,-0.083778,-0.086179,0,0
2,GO REGULATION OF GASTRULATION,0.086237,-0.083788,-0.060346,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.071756,-0.084026,-0.085901,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.096327,-0.084083,-0.049494,0,0
2,GO KERATINOCYTE MIGRATION,0.19557,-0.084137,-0.042895,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.15565,-0.084365,-0.050538,0,0
2,GO REGULATION OF ERAD PATHWAY,0.079071,-0.084403,-0.027681,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.20122,-0.084593,-0.038668,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.32792,-0.084749,-0.06364,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.89205,-0.084763,0.0021679,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.077698,-0.084839,-0.061901,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.18062,-0.084916,-0.02669,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.98546,-0.08492,0.077565,0,0
2,GO ASTROCYTE DEVELOPMENT,0.38933,-0.084929,-0.034875,0,0
2,GO GENITALIA MORPHOGENESIS,0.88885,-0.085031,-0.010235,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.098784,-0.08508,-0.0759,0,0
2,GO PROTEIN KINASE C SIGNALING,0.15683,-0.085135,-0.05545,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.45972,-0.085145,-0.019814,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.075674,-0.085185,-0.053927,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.069238,-0.085616,-0.046845,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.10471,-0.085909,-0.13117,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.056128,-0.085921,-0.072116,0,0
2,GO AUTOPHAGIC CELL DEATH,0.05357,-0.085961,-0.089161,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.085497,-0.085974,-0.08458,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.017315,-0.086033,-0.096857,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.33599,-0.086174,-0.052783,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.28945,-0.086404,-0.05473,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.10045,-0.086641,-0.09016,0,0
2,GO COPULATION,0.086981,-0.086826,-0.089589,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0076401,-0.087095,-0.082864,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.15802,-0.087126,-0.057796,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.29315,-0.087162,-0.050514,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.17029,-0.087207,-0.056699,0,0
2,GO INCLUSION BODY ASSEMBLY,0.82211,-0.087364,0.035408,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.074349,-0.087392,-0.090522,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.09796,-0.087414,-0.064118,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.35253,-0.087906,-0.043737,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.075009,-0.087925,-0.13191,0,0
2,GO SLEEP,0.15921,-0.087932,-0.060459,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.015674,-0.087973,-0.121,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.025475,-0.088018,-0.080943,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.46466,-0.088027,-0.087439,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.28213,-0.088127,-0.050383,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.077018,-0.08815,-0.054802,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.6691,-0.08817,-0.01407,0,0
2,GO MITOCHONDRIAL FUSION,0.23766,-0.088236,-0.023094,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.56376,-0.088275,-0.033465,0,0
2,GO DNA METHYLATION,0.26095,-0.08838,-0.028914,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.19557,-0.088398,-0.0695,0,0
2,GO GOLGI LOCALIZATION,0.15098,-0.088409,-0.046438,0,0
2,GO TRNA CATABOLIC PROCESS,0.18866,-0.088422,-0.10274,0,0
2,GO KINETOCHORE ASSEMBLY,0.22503,-0.088484,-0.055003,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.178,-0.088693,-0.081061,0,0
2,GO NODAL SIGNALING PATHWAY,0.16042,-0.088792,-0.07872,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.18327,-0.088899,-0.035369,0,0
2,GO RESPONSE TO UV B,0.099614,-0.089042,-0.15248,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.090782,-0.089047,-0.059344,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.22503,-0.089095,-0.053833,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.16285,-0.089315,-0.036417,0,0
2,GO RESPONSE TO ACIDIC PH,0.35886,-0.089381,-0.041451,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.1914,-0.089482,-0.069331,0,0
2,GO REGULATION OF INSULIN SECRETION,0.093126,-0.089527,-0.049808,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.39156,-0.089549,-0.19892,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.30066,-0.089777,-0.052002,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.06986,-0.09,-0.078742,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.063836,-0.090574,-0.12544,0,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.25246,-0.090616,-0.10274,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.06986,-0.090666,-0.048661,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.5314,-0.090711,-0.028633,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.11837,-0.090769,-0.126,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.084763,-0.09077,-0.093516,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.12924,-0.091422,-0.089616,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.22195,-0.091802,-0.039411,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.30829,-0.091814,-0.035114,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.55287,-0.091966,-0.020317,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.21587,-0.092005,-0.082689,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.11837,-0.092141,-0.048239,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.30829,-0.092267,-0.037173,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.14755,-0.092346,-0.056479,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.086981,-0.092438,-0.081537,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.1653,-0.092557,-0.051801,0,0
2,GO AMINE TRANSPORT,0.46218,-0.092836,0.0037808,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.13549,-0.092877,-0.035126,0,0
2,GO PARENTAL BEHAVIOR,0.076344,-0.092887,-0.15255,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.32592,-0.093171,-0.037799,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.33803,-0.0932,-0.11713,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.13338,-0.093566,-0.065629,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.10299,-0.093617,-0.040528,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.076344,-0.093738,-0.059719,0,0
2,GO PIRNA METABOLIC PROCESS,0.098784,-0.094205,-0.10852,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.31604,-0.094408,-0.059192,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.1146,-0.094472,-0.068792,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.42133,-0.094649,-0.067867,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.40743,-0.094783,-0.047692,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.1252,-0.094802,-0.10338,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.58307,-0.094805,-0.056404,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.14419,-0.094819,-0.088888,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.18461,-0.09498,-0.055694,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21437,-0.095008,-0.10447,0,0
2,GO MITOTIC DNA REPLICATION,0.23445,-0.095239,-0.040779,0,0
2,GO BLEB ASSEMBLY,0.45727,-0.095335,-0.11244,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.071756,-0.095644,-0.057014,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.079765,-0.095769,-0.066432,0,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.36311,-0.09593,-0.086022,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.49487,-0.095975,-0.046058,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.081168,-0.096054,-0.185,0,0
2,GO HISTONE H3 DEACETYLATION,0.31997,-0.0961,-0.027687,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.34008,-0.096549,-0.044316,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.26095,-0.096642,-0.031586,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.13549,-0.096688,-0.061068,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.73822,-0.096798,0.0057314,0,0
2,GO RESPONSE TO EPINEPHRINE,0.55016,-0.096869,-0.040892,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.20699,-0.096989,-0.037994,0,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.021053,-0.097073,-0.16808,0,0
2,GO RESPONSE TO NUTRIENT,0.090782,-0.097393,-0.05277,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.09714,-0.097724,-0.06882,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.054074,-0.097897,-0.097244,0,0
2,GO SECRETION BY TISSUE,0.087731,-0.098338,-0.081071,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.079071,-0.098428,-0.07705,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.47712,-0.098512,-0.019951,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.22814,-0.098673,-0.10604,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.021973,-0.098762,-0.099886,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.17411,-0.09878,-0.051468,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.19003,-0.098814,-0.11091,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.15565,-0.099042,-0.07621,0,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.079765,-0.099249,-0.06158,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.27853,-0.09983,-0.074187,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.1793,-0.099923,-0.046096,0,0
2,GO RESPONSE TO GONADOTROPIN,0.12924,-0.099943,-0.073767,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.24911,-0.099951,-0.080187,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.1262,-0.099973,-0.13857,0,0
2,GO INTERLEUKIN 17 PRODUCTION,0.12029,-0.10079,-0.07875,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.11553,-0.10081,-0.063365,0,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.15802,-0.10092,-0.098544,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.33396,-0.1011,-0.079042,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.026013,-0.10169,-0.1249,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.29877,-0.10195,-0.077914,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.19697,-0.10201,-0.08802,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.17669,-0.10211,-0.056835,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.67798,-0.10235,-0.015242,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.075674,-0.10236,-0.054574,0,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.12822,-0.10266,-0.062438,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.32993,-0.10267,-0.036082,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.09796,-0.1031,-0.12147,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.21437,-0.10323,-0.10044,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.15683,-0.10388,-0.13843,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.29315,-0.10423,-0.041116,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.076344,-0.10426,-0.094819,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.18194,-0.10426,-0.070965,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.09796,-0.10433,-0.096287,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.48976,-0.10449,-0.00043987,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.13444,-0.10452,-0.06083,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.076344,-0.10464,-0.065274,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.67206,-0.10467,-0.028297,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.033948,-0.10473,-0.075569,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.22814,-0.10475,-0.069909,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.14642,-0.10552,-0.084951,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.30446,-0.10584,-0.051275,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.014013,-0.10586,-0.098081,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.09714,-0.10598,-0.092839,0,0
2,GO AMYLOID FIBRIL FORMATION,0.41203,-0.10608,-0.064704,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.082591,-0.1065,-0.062541,0,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.13979,-0.10667,-0.13101,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.40286,-0.1069,-0.062029,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.21288,-0.10705,-0.048463,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.10214,-0.10717,-0.063427,0,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.080464,-0.10746,-0.10426,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.085497,-0.10766,-0.09314,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.068006,-0.10781,-0.099404,0,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.25583,-0.10805,-0.12888,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.65442,-0.10912,-0.036722,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.082591,-0.10953,-0.057537,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.003654,-0.10958,-0.11751,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.13027,-0.11089,-0.1016,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.58029,-0.11099,-0.035918,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.067397,-0.11151,-0.085112,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.2644,-0.11278,-0.076127,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.14642,-0.11359,-0.043399,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.31997,-0.11382,-0.046417,0,0
2,GO EPIBOLY,0.35253,-0.11432,-0.056082,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.14088,-0.11456,-0.068343,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.009139,-0.11496,-0.122,0,0
2,GO NOTOCHORD DEVELOPMENT,0.12721,-0.11522,-0.1212,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.19838,-0.11539,-0.093667,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.078382,-0.11619,-0.070892,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.27673,-0.11621,-0.065842,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.3871,-0.11622,-0.043918,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.10299,-0.11706,-0.08334,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.035336,-0.11761,-0.07401,0,0
2,GO PLASMA MEMBRANE FUSION,0.077018,-0.1177,-0.13839,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13444,-0.11774,-0.083406,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.081877,-0.11844,-0.073746,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.079071,-0.11893,-0.11342,0,0
2,GO RESPONSE TO VITAMIN D,0.35253,-0.11911,-0.026888,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.19697,-0.11928,-0.07873,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.048285,-0.11944,-0.093396,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.080464,-0.11964,-0.11464,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.28395,-0.11994,-0.061895,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.3871,-0.12017,-0.046141,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0013255,-0.12049,-0.090181,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.1873,-0.12058,-0.070104,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.13763,-0.12092,-0.1435,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.23766,-0.12137,-0.077629,0,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.17411,-0.12149,-0.10514,0,0
2,GO TRACHEA MORPHOGENESIS,0.11002,-0.12152,-0.085076,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.45482,-0.12222,-0.10961,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.23927,-0.12229,-0.092226,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.11933,-0.12268,-0.12683,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.11275,-0.12284,-0.053426,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.38933,-0.12339,-0.037241,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.017506,-0.12407,-0.17606,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.11092,-0.12433,-0.13954,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.079071,-0.1246,-0.077398,0,0
2,GO DENDRITIC CELL MIGRATION,0.074349,-0.12558,-0.11304,0,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.10734,-0.12583,-0.15614,0,0
2,GO UTERUS DEVELOPMENT,0.18595,-0.12722,-0.059477,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.47211,-0.1274,-0.038095,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.14088,-0.12761,-0.097715,0,0
2,GO REGULATION OF GTP BINDING,0.43312,-0.12813,-0.038357,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.12822,-0.12924,-0.13404,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.00049053,-0.12929,-0.12862,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.23766,-0.12951,-0.023433,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.2458,-0.12969,-0.081217,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.10045,-0.1298,-0.08929,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.084034,-0.12981,-0.11175,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.15447,-0.12995,-0.086021,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.18461,-0.13018,-0.078043,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.15683,-0.13047,-0.080963,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.11837,-0.13084,-0.072492,0,0
2,GO TYPE 2 IMMUNE RESPONSE,0.10734,-0.13131,-0.12121,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.00030928,-0.13216,-0.11185,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0072795,-0.1322,-0.13974,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.25414,-0.13268,-0.059368,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.075674,-0.1331,-0.065959,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.1754,-0.13435,-0.12786,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.072397,-0.1345,-0.11613,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.081877,-0.13457,-0.13365,0,0
2,GO MICROTUBULE SEVERING,0.0074579,-0.13482,-0.13551,0,0
2,GO MALE MEIOSIS I,0.047827,-0.13614,-0.20205,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.20409,-0.13631,-0.10514,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.12421,-0.13634,-0.099066,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.2913,-0.13761,-0.07225,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.013243,-0.13783,-0.1219,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.049212,-0.13811,-0.12554,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.10646,-0.13816,-0.13423,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.093918,-0.13821,-0.091,0,0
2,GO FOAM CELL DIFFERENTIATION,0.10646,-0.13836,-0.087646,0,0
2,GO RESPONSE TO INSECTICIDE,0.27495,-0.13948,-0.071806,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.26267,-0.13997,-0.05848,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.35463,-0.1405,-0.071205,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.31021,-0.14346,-0.052689,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.073694,-0.14479,-0.087598,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.23766,-0.1451,-0.079293,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0022095,-0.14544,-0.13433,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.30446,-0.14625,-0.017683,0,0
2,GO CYTOLYSIS,0.077018,-0.14805,-0.1257,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0002443,-0.14812,-0.13718,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.079071,-0.14886,-0.11818,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.016938,-0.1489,-0.095465,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.12224,-0.14904,-0.094896,0,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.079765,-0.14948,-0.1346,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.077698,-0.14953,-0.12727,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.026286,-0.15033,-0.12502,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.14983,-0.15139,-0.075901,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.030994,-0.15149,-0.12898,0,0
2,GO PARTURITION,0.10129,-0.15234,-0.10501,0,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.072397,-0.1525,-0.12675,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.073043,-0.15263,-0.1224,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.070488,-0.15339,-0.08522,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.10045,-0.15339,-0.11016,0,0
2,GO SEROTONIN SECRETION,0.10045,-0.15456,-0.088129,0,0
2,GO T CELL EXTRAVASATION,0.081168,-0.15505,-0.14468,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.096327,-0.15733,-0.11878,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.39832,-0.15822,-0.04265,0,0
2,GO ORGAN INDUCTION,0.0062108,-0.15887,-0.15619,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0011341,-0.16072,-0.12832,0,0
2,GO LOCOMOTOR RHYTHM,0.094715,-0.16197,-0.079069,0,0
2,GO CARNITINE METABOLIC PROCESS,0.071756,-0.16204,-0.08552,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.22503,-0.16232,-0.063583,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.14755,-0.1627,-0.1117,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.09796,-0.16417,-0.11968,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.069238,-0.16437,-0.094283,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.12029,-0.16491,-0.1242,0,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.11367,-0.16632,-0.12409,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.001483,-0.16683,-0.10754,0,0
2,GO RENAL FILTRATION,0.1793,-0.16745,-0.079702,0,0
2,GO ER OVERLOAD RESPONSE,0.068619,-0.16839,-0.11774,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10558,-0.16912,-0.082104,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.068006,-0.1693,-0.08991,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.046921,-0.16931,-0.15733,0,0
2,GO NEPHRON TUBULE FORMATION,0.15683,-0.16954,-0.15921,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.070488,-0.17359,-0.11252,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.12126,-0.17941,-0.098864,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.35674,-0.18,-0.05637,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.017699,-0.18018,-0.17939,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0062877,-0.18185,-0.15606,0,0
2,GO BIOLOGICAL PHASE,0.1252,-0.18188,-0.15399,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047798,-0.1831,-0.20903,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.085497,-0.18718,-0.13435,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0083098,-0.18795,-0.27182,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0016806,-0.18807,-0.19398,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00027284,-0.18812,-0.16406,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.090782,-0.19095,-0.12621,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.11837,-0.19117,-0.080804,0,0
2,GO SEGMENT SPECIFICATION,0.0023957,-0.19163,-0.24458,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.11742,-0.19298,-0.1121,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,4.3997e-05,-0.19472,-0.19052,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.066792,-0.19676,-0.095986,0,0
2,GO HEART INDUCTION,0.080464,-0.19787,-0.11397,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.003166,-0.20035,-0.15768,0,0
2,GO RESPONSE TO LEPTIN,5.6085e-05,-0.2022,-0.24001,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.0012705,-0.20804,-0.18242,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.0019285,-0.20811,-0.21481,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0049019,-0.21038,-0.18734,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.01829,-0.21717,-0.18241,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0038478,-0.22551,-0.2063,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0012527,-0.22597,-0.19839,0,0
2,GO LIPID DIGESTION,0.00055343,-0.22795,-0.33057,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.00017176,-0.22831,-0.20563,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,4.0314e-05,-0.22962,-0.22536,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.068619,-0.23375,-0.1252,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.050154,-0.23598,-0.13273,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.013093,-0.2391,-0.16691,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.06986,-0.23928,-0.1547,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018923,-0.23951,-0.22015,0,0
2,GO CELL FATE DETERMINATION,4.7488e-06,-0.23963,-0.23819,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,7.8911e-05,-0.2418,-0.19278,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0012005,-0.2436,-0.17301,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.012653,-0.25281,-0.22746,0,0
2,GO HEART FIELD SPECIFICATION,0.0032078,-0.26507,-0.21918,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,3.0302e-06,-0.27364,-0.25977,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0012886,-0.27533,-0.21043,0,0
2,GO HORMONE CATABOLIC PROCESS,0.00017176,-0.27777,-0.25694,0,0
2,GO GONADOTROPIN SECRETION,4.0657e-06,-0.28275,-0.28788,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.00030449,-0.2849,-0.36083,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,5.5412e-06,-0.29098,-0.23178,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,1.7071e-05,-0.29112,-0.24707,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,2.2286e-07,-0.29925,-0.29386,0,0
2,GO DECIDUALIZATION,0.0018764,-0.30715,-0.23768,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,6.8348e-09,-0.30999,-0.29727,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.019104,-0.32069,-0.26258,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.0012527,-0.32374,-0.44726,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.00014362,-0.33564,-0.37518,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.00030449,-0.33565,-0.33878,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00021511,-0.34069,-0.26037,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0005789,-0.34758,-0.41776,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.010279,-0.35103,-0.29572,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,6.1119e-05,-0.35533,-0.25956,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.014332,-0.36203,-0.25275,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,1.155e-06,-0.38917,-0.35288,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,2.9859e-05,-0.4028,-0.3928,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.6986e-10,-0.40425,-0.34915,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.8419e-06,-0.40844,-0.38288,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,1.2281e-06,-0.41699,-0.42783,0,0
2,GO REFLEX,5.332e-06,-0.43574,-0.40474,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016629,-0.43762,-0.33063,0,0
2,GO PITUITARY GLAND DEVELOPMENT,6.3359e-07,-0.45893,-0.39885,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,5.9116e-09,-0.48088,-0.52212,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.9069e-08,-0.51143,-0.47322,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,3.0156e-07,-0.51543,-0.39435,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0043737,-0.53772,-0.32938,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,8.0712e-08,-0.54171,-0.45875,0,0
2,GO CARDIAC CELL FATE COMMITMENT,5.3562e-07,-0.57193,-0.47028,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.5451e-08,-0.63714,-0.54235,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,1.4334e-08,-0.65871,-0.58939,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,8.4877e-09,-0.73441,-0.60428,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,2.1234e-05,1.049,0.94726,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.5014e-05,0.88439,0.8484,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.2444e-07,0.7549,0.84069,1,1
3,GO HISTAMINE SECRETION,7.4854e-10,0.68516,0.6429,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00042128,0.67745,0.49261,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.1588e-05,0.66462,0.75274,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,3.7282e-08,0.63417,0.66156,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9309e-10,0.62784,0.58289,1,1
3,GO TOLERANCE INDUCTION,2.2505e-06,0.62759,0.52604,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.6514e-08,0.61034,0.54492,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.069e-09,0.60984,0.57463,1,1
3,GO HISTAMINE TRANSPORT,1.9905e-10,0.59743,0.60076,1,1
3,GO RESPONSE TO TYPE I INTERFERON,4.1552e-07,0.59233,0.5188,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.357e-07,0.57263,0.52751,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00098255,0.558,0.40109,1,1
3,GO DETECTION OF OTHER ORGANISM,1.7154e-07,0.55236,0.52498,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,6.5837e-06,0.54528,0.41352,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,3.3435e-06,0.54141,0.5254,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.2445e-07,0.53695,0.49695,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.819e-05,0.53469,0.47162,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.3196e-05,0.52869,0.43891,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.8161e-07,0.51833,0.49374,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00016901,0.51777,0.41288,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.7605e-06,0.51533,0.50213,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,1.7706e-05,0.51365,0.43494,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,2.2397e-08,0.51046,0.60356,1,1
3,GO MUCUS SECRETION,3.9613e-05,0.50716,0.48205,1,1
3,GO O GLYCAN PROCESSING,1.3376e-10,0.50623,0.49179,1,1
3,GO REGULATION OF PLATELET AGGREGATION,9.2321e-08,0.50519,0.49581,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00081356,0.50369,0.49591,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00010323,0.50341,0.41339,1,1
3,GO RENAL ABSORPTION,2.0776e-06,0.50196,0.46797,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0039481,0.49425,0.29509,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.8976e-09,0.48917,0.48949,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,1.8793e-06,0.48623,0.43498,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,1.5576e-05,0.47838,0.42708,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,1.5037e-07,0.47832,0.55729,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.5052e-06,0.47809,0.51218,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.0004e-06,0.47458,0.47119,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,3.3435e-06,0.47135,0.4555,1,1
3,GO RESPONSE TO INTERFERON BETA,7.5001e-05,0.46907,0.42064,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.1535e-07,0.46827,0.56686,1,1
3,GO REGULATION OF PLATELET ACTIVATION,1.7534e-07,0.46464,0.4173,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.2321e-08,0.45931,0.43359,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,1.0791e-07,0.45912,0.42231,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,5.6487e-06,0.45849,0.41819,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.6994e-06,0.45844,0.37123,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,2.3274e-07,0.4578,0.4091,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,5.4184e-05,0.452,0.43642,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,2.7e-09,0.45055,0.42708,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00015331,0.44722,0.3753,1,1
3,GO NEURONAL ACTION POTENTIAL,3.1004e-08,0.44608,0.4594,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00037835,0.44479,0.3697,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,1.6062e-07,0.44338,0.50991,1,1
3,GO LIPOXYGENASE PATHWAY,7.0072e-05,0.44305,0.40623,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.5052e-06,0.44298,0.39981,1,1
3,GO TOXIN METABOLIC PROCESS,1.0161e-09,0.44203,0.4758,1,1
3,GO GERMINAL CENTER FORMATION,9.404e-07,0.44155,0.44167,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,2.7452e-06,0.43898,0.45964,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.247e-08,0.43884,0.44731,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.8198e-07,0.43703,0.41707,1,1
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.8318e-07,0.43498,0.50449,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,2.8001e-06,0.43354,0.3791,1,1
3,GO REGULATION OF VASCULOGENESIS,2.8271e-07,0.43219,0.43127,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,7.6446e-07,0.42971,0.40084,1,1
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0005056,0.42888,0.37369,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.8262e-07,0.42706,0.40658,1,1
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,2.5868e-06,0.42587,0.47906,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,1.0094e-07,0.42191,0.43246,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.7385e-05,0.42053,0.39234,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,2.6981e-08,0.4202,0.40587,1,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,6.1119e-05,0.41728,0.37311,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,1.0212e-06,0.41716,0.40244,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.0014624,0.41694,0.34875,1,1
3,GO RESPONSE TO PAIN,1.3419e-09,0.41661,0.42497,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,2.6914e-06,0.41645,0.44717,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,5.0563e-05,0.41587,0.35925,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.6352e-05,0.41571,0.348,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.6158e-05,0.41475,0.35937,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.188e-08,0.41355,0.49177,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,5.9498e-07,0.41272,0.46165,1,1
3,GO DNA DEAMINATION,7.5001e-05,0.4127,0.3653,1,1
3,GO RESPONSE TO MAGNESIUM ION,6.6066e-07,0.41075,0.43186,1,1
3,GO INTESTINAL ABSORPTION,2.3467e-08,0.40957,0.46589,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.3239e-05,0.40829,0.34787,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.0429e-07,0.40823,0.36664,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,9.086e-06,0.4073,0.37936,1,1
3,GO REGULATION OF ANOIKIS,4.4787e-08,0.40653,0.45717,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2344e-05,0.40647,0.37569,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,2.0478e-05,0.40606,0.35906,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.7534e-07,0.40522,0.4342,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,1.9044e-05,0.40418,0.38382,1,1
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.0756e-05,0.4041,0.42006,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,3.0156e-07,0.40195,0.36733,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.3562e-07,0.3985,0.35187,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.2057e-05,0.39697,0.32163,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0002117,0.39679,0.36973,1,1
3,GO TYPE B PANCREATIC CELL PROLIFERATION,4.8416e-06,0.39509,0.42255,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,1.9175e-06,0.39486,0.45014,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,5.6085e-05,0.39423,0.37633,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,6.1119e-05,0.394,0.2984,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,2.5934e-07,0.39295,0.33905,1,1
3,GO GALACTOSE METABOLIC PROCESS,2.4528e-05,0.39257,0.3475,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,2.6828e-05,0.39191,0.37609,1,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.4807e-06,0.39149,0.37632,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00014839,0.39102,0.40271,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,2.0879e-07,0.39074,0.37405,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.971e-06,0.39047,0.43079,1,1
3,GO CELLULAR DEFENSE RESPONSE,1.6418e-07,0.39039,0.31907,1,1
3,GO ADHESION OF SYMBIONT TO HOST,1.155e-06,0.39039,0.43875,1,1
3,GO MICROVILLUS ORGANIZATION,1.6654e-06,0.38967,0.37536,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.3196e-05,0.38907,0.35831,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0022095,0.38836,0.34315,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,7.6446e-07,0.38699,0.36198,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,4.3997e-05,0.38594,0.39625,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,1.4163e-06,0.38496,0.34387,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00053704,0.38446,0.329,1,1
3,GO VITAMIN D METABOLIC PROCESS,1.2792e-06,0.38247,0.36403,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.5865e-05,0.38246,0.31887,1,1
3,GO RESPONSE TO COLD,2.5223e-10,0.38225,0.37821,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,6.8888e-05,0.38139,0.32262,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,1.2027e-05,0.38098,0.41403,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,3.9613e-05,0.37918,0.36227,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.0169e-05,0.37742,0.36895,1,1
3,GO REGULATION OF TISSUE REMODELING,3.9941e-08,0.37545,0.33997,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00024045,0.3744,0.34288,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.0429e-07,0.37407,0.42902,1,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00095459,0.37395,0.31225,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.0657e-06,0.37294,0.48898,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,4.1403e-10,0.37203,0.36378,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,1.8419e-06,0.37072,0.45327,1,1
3,GO RESPONSE TO DIETARY EXCESS,7.5451e-08,0.36936,0.39988,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.00010497,0.36886,0.3181,1,1
3,GO EOSINOPHIL MIGRATION,1.6158e-05,0.36854,0.36349,1,1
3,GO MATURE B CELL DIFFERENTIATION,3.6924e-05,0.36841,0.3152,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.9044e-05,0.36841,0.32832,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00029052,0.36704,0.36935,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.2027e-05,0.3667,0.38355,1,1
3,GO IMMUNOGLOBULIN SECRETION,4.9361e-06,0.3645,0.31072,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.00022208,0.36424,0.38892,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.3997e-05,0.36397,0.33643,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.3056e-06,0.36368,0.38324,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.8856e-08,0.36363,0.33456,1,1
3,GO EOSINOPHIL CHEMOTAXIS,7.5217e-06,0.36235,0.38618,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.1583e-08,0.36215,0.38815,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.0066039,0.35875,0.34673,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.4592e-06,0.35651,0.32249,1,1
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,2.0853e-05,0.35522,0.38947,1,1
3,GO REGULATION OF BONE REMODELING,2.6362e-08,0.35326,0.3617,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,2.4371e-06,0.35304,0.42498,1,1
3,GO SUPEROXIDE ANION GENERATION,9.6129e-06,0.35289,0.31851,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00031414,0.35279,0.31758,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.8363e-05,0.35267,0.32352,1,1
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.046031,0.35188,0.18157,1,1
3,GO LIPID TRANSLOCATION,1.7721e-08,0.35187,0.34136,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,3.8118e-09,0.35133,0.43818,1,1
3,GO KERATAN SULFATE CATABOLIC PROCESS,6.4341e-05,0.35062,0.33189,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,8.6579e-07,0.34987,0.31354,1,1
3,GO RELAXATION OF CARDIAC MUSCLE,4.3946e-06,0.34816,0.34981,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,9.0235e-07,0.34708,0.2971,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0046018,0.34673,0.2624,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.0323e-06,0.34656,0.357,1,1
3,GO PROTEIN DEGLYCOSYLATION,2.4371e-06,0.34623,0.29999,1,1
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00030928,0.34515,0.2949,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,9.5999e-07,0.34453,0.38305,1,1
3,GO RESPONSE TO EPINEPHRINE,7.9617e-06,0.34407,0.39324,1,1
3,GO B CELL APOPTOTIC PROCESS,1.9014e-08,0.34355,0.36811,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,9.086e-06,0.34296,0.28366,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,7.6283e-05,0.3421,0.31827,1,1
3,GO CORNIFICATION,8.5867e-06,0.34118,0.31106,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.7385e-05,0.34085,0.31803,1,1
3,GO MYELIN MAINTENANCE,3.094e-05,0.34076,0.38285,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.7706e-05,0.33971,0.34835,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,3.9102e-06,0.33967,0.40037,1,1
3,GO CERAMIDE CATABOLIC PROCESS,6.6578e-05,0.33902,0.34421,1,1
3,GO MEMBRANE RAFT ORGANIZATION,0.00061456,0.33836,0.3102,1,1
3,GO GAP JUNCTION ASSEMBLY,0.0001803,0.33673,0.29726,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.3878e-06,0.33615,0.28195,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2139e-09,0.33441,0.37601,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,9.2321e-08,0.3341,0.3079,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.719e-07,0.33403,0.30917,1,1
3,GO ZYMOGEN ACTIVATION,1.3196e-05,0.33357,0.33459,1,1
3,GO TISSUE REMODELING,6.6066e-07,0.3331,0.28378,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,1.3468e-07,0.33281,0.34768,1,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.8246e-05,0.33263,0.30128,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.1165e-05,0.33047,0.3491,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,1.9064e-09,0.33027,0.36656,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,1.0791e-07,0.33,0.35456,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0024281,0.32977,0.24238,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,7.8911e-05,0.32949,0.35259,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.0756e-05,0.32887,0.34674,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00017457,0.32878,0.35354,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00013673,0.32864,0.26281,1,1
3,GO INTERLEUKIN 10 PRODUCTION,6.8396e-06,0.32822,0.27209,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,5.7582e-06,0.32799,0.30147,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.064e-06,0.32649,0.33803,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00016629,0.32595,0.33769,1,1
3,GO RESPONSE TO INTERFERON GAMMA,1.0557e-05,0.32557,0.31556,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.0861e-06,0.32489,0.29687,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,8.1138e-06,0.32484,0.33018,1,1
3,GO KERATINIZATION,1.4454e-06,0.32446,0.30176,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00020504,0.32333,0.34569,1,1
3,GO BONE RESORPTION,7.892e-08,0.32301,0.30957,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0012886,0.32295,0.24725,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,6.1119e-05,0.3226,0.28448,1,1
3,GO RESPONSE TO MUSCLE STRETCH,2.1196e-06,0.32171,0.40633,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00047589,0.3217,0.30373,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00013016,0.32146,0.36001,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0001179,0.32131,0.24583,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.0395e-05,0.32112,0.30561,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,7.8911e-05,0.32085,0.34186,1,1
3,GO OPTIC NERVE DEVELOPMENT,2.3661e-05,0.32013,0.33534,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,1.4334e-08,0.31967,0.3296,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.00029052,0.31885,0.34544,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,7.6657e-06,0.31802,0.33169,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.5674e-06,0.31777,0.28786,1,1
3,GO REGULATION OF NEURON MATURATION,7.3803e-06,0.31607,0.28705,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5372e-07,0.31565,0.32256,1,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.0026663,0.31521,0.22735,1,1
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,6.2175e-05,0.31451,0.29536,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0062108,0.31436,0.24232,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.6321e-06,0.31387,0.28512,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.00011406,0.31385,0.31058,1,1
3,GO MAST CELL ACTIVATION,3.4296e-07,0.31332,0.3119,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00025215,0.3126,0.30568,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.4972e-05,0.31213,0.24302,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.4305e-07,0.31181,0.28493,1,1
3,GO RESPONSE TO WATER,2.3891e-06,0.31157,0.32443,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00013232,0.31117,0.28447,1,1
3,GO GLIAL CELL FATE COMMITMENT,0.0067673,0.31072,0.29051,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0025277,0.31046,0.25317,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00030449,0.31011,0.38482,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.014823,0.31004,0.22115,1,1
3,GO MAGNESIUM ION TRANSPORT,1.5372e-07,0.30951,0.322,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.4091e-05,0.30871,0.258,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.9332e-05,0.3085,0.30322,1,1
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00017176,0.30752,0.30383,1,1
3,GO MAST CELL MEDIATED IMMUNITY,7.105e-06,0.30743,0.28303,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,5.5412e-06,0.30723,0.27769,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,3.1479e-07,0.30722,0.31451,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.8032e-05,0.30689,0.26626,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,1.734e-06,0.30686,0.34773,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.2057e-05,0.30632,0.28417,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,4.0657e-06,0.30606,0.29804,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,3.2784e-06,0.3046,0.26084,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0012886,0.30439,0.31594,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.0657e-06,0.30399,0.31638,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.2733e-08,0.30384,0.31291,1,1
3,GO BONE REMODELING,3.2162e-07,0.30355,0.31041,1,1
3,GO REGULATION OF B CELL PROLIFERATION,2.7078e-07,0.30335,0.29718,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00053704,0.30211,0.31216,1,1
3,GO RESPONSE TO COPPER ION,3.3214e-05,0.30199,0.36097,1,1
3,GO N GLYCAN PROCESSING,4.7172e-05,0.30191,0.32526,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.00067188,0.30189,0.24884,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.4972e-05,0.30163,0.2455,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,5.0323e-06,0.30158,0.29691,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.011e-05,0.30157,0.3028,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.0478e-05,0.30142,0.24341,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.1456e-06,0.30061,0.28845,1,1
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0020646,0.30022,0.27657,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,8.8389e-07,0.30011,0.30385,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.5014e-05,0.29989,0.24414,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0020929,0.29969,0.27131,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0016575,0.29968,0.20985,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00013899,0.29821,0.3497,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.8924e-05,0.29813,0.26367,1,1
3,GO DETECTION OF BIOTIC STIMULUS,0.00013232,0.2979,0.28544,1,1
3,GO ANOIKIS,1.471e-07,0.29781,0.34798,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.4805e-07,0.29766,0.32758,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00030928,0.29748,0.2172,1,1
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.8305e-05,0.2973,0.28513,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0001179,0.29723,0.26625,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,3.2146e-06,0.29715,0.387,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.2253e-05,0.29714,0.28628,1,1
3,GO PLASMA MEMBRANE FUSION,6.8888e-05,0.29683,0.29465,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,5.9056e-05,0.29656,0.31383,1,1
3,GO MICROVILLUS ASSEMBLY,0.0010865,0.29644,0.25662,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0066039,0.29638,0.23693,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.4334e-08,0.29586,0.2919,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,5.2303e-06,0.295,0.35129,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,4.4771e-05,0.295,0.35955,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,2.188e-08,0.29485,0.33328,1,1
3,GO REGULATION OF CELL KILLING,8.7502e-06,0.29472,0.26822,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,1.9563e-06,0.29444,0.28303,1,1
3,GO INTERLEUKIN 12 PRODUCTION,1.1316e-06,0.29402,0.27754,1,1
3,GO ACTIN FILAMENT SEVERING,0.00080175,0.294,0.26977,1,1
3,GO STEROID HORMONE SECRETION,0.00011218,0.29341,0.26583,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.4409e-05,0.29309,0.24805,1,1
3,GO INDOLALKYLAMINE METABOLIC PROCESS,5.9498e-07,0.29309,0.36987,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00040857,0.29272,0.2446,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.0079e-05,0.29265,0.2562,1,1
3,GO T CELL EXTRAVASATION,0.0038478,0.29263,0.25681,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,8.8796e-05,0.29254,0.27791,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,1.7071e-05,0.29238,0.29115,1,1
3,GO B CELL PROLIFERATION,1.6654e-06,0.2916,0.2478,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.6782e-07,0.29131,0.33684,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00062378,0.29098,0.22826,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.6283e-05,0.29094,0.28944,1,1
3,GO SEQUESTERING OF ACTIN MONOMERS,0.0037016,0.29091,0.22746,1,1
3,GO CATECHOLAMINE UPTAKE,6.2175e-05,0.29035,0.30171,1,1
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.011678,0.28977,0.22095,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.5052e-06,0.28975,0.26839,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00014129,0.28975,0.31368,1,1
3,GO APICAL JUNCTION ASSEMBLY,5.3562e-07,0.28975,0.28498,1,1
3,GO ADRENAL GLAND DEVELOPMENT,1.4472e-05,0.28903,0.32768,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1.6654e-06,0.28878,0.42121,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,7.333e-07,0.28843,0.31636,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.5999e-07,0.28836,0.27969,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,1.1165e-05,0.28814,0.25289,1,1
3,GO LUNG ALVEOLUS DEVELOPMENT,5.8262e-07,0.28778,0.28423,1,1
3,GO OSTEOBLAST PROLIFERATION,4.3236e-05,0.2872,0.27044,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00018323,0.28713,0.27331,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0075485,0.28687,0.24621,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.8793e-06,0.28679,0.25402,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.8419e-06,0.28667,0.34152,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,3.9941e-08,0.28651,0.34173,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,4.3946e-06,0.2865,0.2564,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,1.2534e-06,0.28608,0.2862,1,1
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0020646,0.286,0.26041,1,1
3,GO REGULATION OF DENDRITE EXTENSION,2.5884e-05,0.28585,0.31127,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00037835,0.28584,0.23911,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,2.4305e-07,0.28567,0.30512,1,1
3,GO NOTCH RECEPTOR PROCESSING,0.00048316,0.28516,0.30013,1,1
3,GO VASODILATION,2.5868e-06,0.28473,0.2908,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00055343,0.2847,0.2464,1,1
3,GO FOAM CELL DIFFERENTIATION,1.9563e-06,0.2846,0.31627,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.01829,0.28432,0.22303,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.3693e-05,0.28426,0.27292,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,8.9166e-06,0.28423,0.33951,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0044298,0.28355,0.22528,1,1
3,GO BLOOD VESSEL REMODELING,5.4184e-05,0.28331,0.2478,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,3.6162e-06,0.28295,0.25414,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.00012186,0.28208,0.23976,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.3878e-06,0.28201,0.35875,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00012594,0.28159,0.22989,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,8.2543e-08,0.28144,0.26386,1,1
3,GO SENSORY PERCEPTION OF SMELL,3.357e-07,0.28135,0.27789,1,1
3,GO RESPONSE TO ACIDIC PH,0.00014599,0.28063,0.28592,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.913e-06,0.28026,0.26508,1,1
3,GO STEROID ESTERIFICATION,7.3739e-05,0.28021,0.41053,1,1
3,GO DOPAMINE TRANSPORT,1.1588e-05,0.2799,0.35477,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.00014839,0.27988,0.25065,1,1
3,GO REGULATION OF RESPIRATORY BURST,8.1361e-07,0.27987,0.32087,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,6.4592e-06,0.27981,0.26885,1,1
3,GO REGULATION OF ICOSANOID SECRETION,3.5606e-08,0.2798,0.2957,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,2.011e-05,0.27978,0.2248,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0005133,0.27972,0.24796,1,1
3,GO RESPONSE TO LITHIUM ION,7.4873e-07,0.27969,0.35018,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,3.9872e-06,0.27951,0.29484,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001803,0.27921,0.21472,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.9175e-06,0.27885,0.2717,1,1
3,GO TRANSPOSITION,1.9749e-05,0.27882,0.32132,1,1
3,GO REGULATION OF ACROSOME REACTION,0.00045468,0.2788,0.23381,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.2534e-06,0.2784,0.27668,1,1
3,GO LUNG CELL DIFFERENTIATION,9.6562e-05,0.27784,0.33389,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00075607,0.2778,0.22514,1,1
3,GO STEROL HOMEOSTASIS,3.5022e-05,0.2777,0.2208,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00098255,0.27765,0.23258,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,7.0337e-07,0.27753,0.273,1,1
3,GO HYALURONAN BIOSYNTHETIC PROCESS,9.086e-06,0.27704,0.26274,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.3435e-06,0.27692,0.2976,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0013255,0.27691,0.21852,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.1494e-05,0.27673,0.25801,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,6.337e-06,0.27668,0.27389,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,6.7724e-05,0.27648,0.2572,1,1
3,GO REGULATION OF COAGULATION,3.6924e-05,0.27645,0.27035,1,1
3,GO INTERLEUKIN 8 PRODUCTION,4.5558e-05,0.27639,0.23506,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00010852,0.27637,0.24619,1,1
3,GO REGULATION OF MYOBLAST FUSION,1.0361e-05,0.27622,0.30985,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,9.1829e-05,0.27587,0.24215,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0057669,0.27575,0.19513,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.3803e-06,0.27562,0.31661,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,4.31e-06,0.27561,0.23043,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011033,0.27539,0.22913,1,1
3,GO T CELL MEDIATED IMMUNITY,3.758e-05,0.27532,0.25463,1,1
3,GO CELL KILLING,2.206e-06,0.27522,0.24025,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.4091e-05,0.27518,0.22463,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.0657e-06,0.27492,0.28511,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0020929,0.27486,0.31911,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,3.8924e-05,0.27423,0.2531,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00054518,0.27319,0.22083,1,1
3,GO FUCOSE METABOLIC PROCESS,0.00020504,0.27294,0.23731,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0756e-05,0.27258,0.24315,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0092477,0.27254,0.22381,1,1
3,GO DETECTION OF CALCIUM ION,9.4341e-06,0.2725,0.34875,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0031247,0.27239,0.21012,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.9393e-05,0.27163,0.238,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00019229,0.27152,0.33291,1,1
3,GO PROTEIN DEMANNOSYLATION,2.0364e-06,0.27142,0.30334,1,1
3,GO GLYCOSYLATION,7.3476e-09,0.27123,0.26095,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,1.7071e-05,0.27111,0.26392,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.00039622,0.2711,0.27985,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0169e-05,0.27098,0.36629,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0053519,0.27043,0.21114,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.155e-06,0.27007,0.31105,1,1
3,GO POSITIVE REGULATION OF HEART RATE,7.105e-06,0.26971,0.28859,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00030928,0.26968,0.24363,1,1
3,GO DEFENSE RESPONSE TO VIRUS,3.094e-05,0.26953,0.23571,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0042636,0.26904,0.21303,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0395e-05,0.26904,0.26012,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.2015e-05,0.26839,0.23987,1,1
3,GO RESPONSE TO FORSKOLIN,0.0042095,0.26836,0.22368,1,1
3,GO REGULATION OF B CELL ACTIVATION,1.4454e-06,0.2676,0.23201,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00031907,0.26757,0.26684,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,3.2631e-05,0.2674,0.25178,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,5.2445e-07,0.26718,0.273,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,4.9228e-07,0.26697,0.22933,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.0021215,0.26666,0.27554,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,4.3236e-05,0.26631,0.31302,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,8.0256e-05,0.26598,0.34765,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00010852,0.26579,0.22981,1,1
3,GO DOPAMINE METABOLIC PROCESS,1.6654e-06,0.26561,0.29844,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,2.4091e-05,0.26547,0.26349,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,4.2487e-05,0.26544,0.27135,1,1
3,GO VIRAL GENOME REPLICATION,1.9044e-05,0.2654,0.22989,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.8793e-06,0.26509,0.25828,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.9617e-06,0.26505,0.29558,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.0557e-05,0.26453,0.20942,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00029511,0.26421,0.25891,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.2482e-05,0.26416,0.28293,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00030928,0.26394,0.24613,1,1
3,GO RESPONSE TO STEROL DEPLETION,6.2046e-07,0.26383,0.31659,1,1
3,GO ENTRY INTO HOST,0.00015583,0.26338,0.22693,1,1
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,8.4424e-05,0.26324,0.32242,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.000662,0.26244,0.23791,1,1
3,GO DIOL METABOLIC PROCESS,2.6386e-06,0.26165,0.28131,1,1
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.0958e-05,0.26149,0.27208,1,1
3,GO CHEMOKINE PRODUCTION,0.00011406,0.26147,0.21954,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.6162e-06,0.26137,0.2374,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.9749e-05,0.26136,0.2739,1,1
3,GO REGULATION OF CELL PROJECTION SIZE,0.000286,0.26109,0.26502,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,6.9711e-06,0.26078,0.26858,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,9.3381e-05,0.26031,0.24551,1,1
3,GO RESPIRATORY BURST,7.3739e-05,0.26025,0.24381,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,8.3013e-05,0.26007,0.28203,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0016122,0.26004,0.22171,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.011151,0.25973,0.21562,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,5.7051e-07,0.25918,0.24251,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,2.4091e-05,0.25901,0.22301,1,1
3,GO B CELL MEDIATED IMMUNITY,2.7804e-05,0.25879,0.26237,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,3.6162e-06,0.25874,0.31739,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.206e-06,0.25857,0.22416,1,1
3,GO B CELL HOMEOSTASIS,2.9859e-05,0.25829,0.22813,1,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,3.3806e-05,0.2582,0.24594,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00039018,0.25771,0.26087,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,3.3806e-05,0.25757,0.31819,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0047198,0.25718,0.16792,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,0.001955,0.25716,0.19593,1,1
3,GO INNATE IMMUNE RESPONSE,3.6877e-06,0.25679,0.21914,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,8.2686e-06,0.25657,0.22497,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,6.7461e-07,0.25641,0.23572,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,1.2253e-05,0.25623,0.22648,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.00036124,0.2562,0.2427,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.021509,0.25578,0.18804,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,5.7059e-05,0.25577,0.25815,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00013899,0.25547,0.22109,1,1
3,GO REGULATION OF CELL CELL ADHESION,6.7724e-05,0.25547,0.19194,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00012388,0.25501,0.25986,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,3.5646e-05,0.25471,0.32801,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,3.2631e-05,0.25451,0.21439,1,1
3,GO INTERLEUKIN 6 PRODUCTION,3.152e-06,0.25434,0.21638,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,2.9332e-05,0.25413,0.30933,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00012388,0.25408,0.23384,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0073682,0.25372,0.21842,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.2534e-06,0.25358,0.25103,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,3.8924e-05,0.2535,0.21191,1,1
3,GO MYOBLAST FUSION,3.3214e-05,0.25335,0.26277,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5359e-06,0.25324,0.26456,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0048405,0.25302,0.19566,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00032408,0.25225,0.20823,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.4771e-05,0.25213,0.24175,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0085105,0.2518,0.14415,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00024045,0.25162,0.18027,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2954e-05,0.25155,0.21421,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,3.9822e-07,0.25144,0.25793,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,2.342e-06,0.25141,0.24642,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00033955,0.25136,0.20148,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,1.3442e-05,0.25136,0.23135,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0022701,0.25136,0.21567,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,4.1456e-06,0.25126,0.22647,1,1
3,GO RESPONSE TO TUMOR CELL,0.00028155,0.25121,0.27844,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,7.4873e-07,0.25095,0.23508,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,9.6129e-06,0.2509,0.23618,1,1
3,GO AMYLOID FIBRIL FORMATION,0.00048316,0.25084,0.29434,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,1.4741e-05,0.25075,0.23688,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.0011836,0.25075,0.21484,1,1
3,GO PHAGOSOME ACIDIFICATION,1.3174e-07,0.25057,0.26624,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.00013232,0.25055,0.36228,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.8911e-05,0.25045,0.26871,1,1
3,GO HAIR CELL DIFFERENTIATION,8.1623e-05,0.2504,0.20769,1,1
3,GO RESPONSE TO GONADOTROPIN,4.8839e-05,0.24998,0.20835,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00010673,0.24987,0.27316,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00013899,0.24954,0.20818,1,1
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,1.7706e-05,0.2495,0.24651,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5865e-05,0.24944,0.24247,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00053704,0.24944,0.26158,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,8.1623e-05,0.24941,0.23501,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.024428,0.2494,0.23887,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0046604,0.24914,0.17879,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,1.2253e-05,0.24874,0.26877,1,1
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.057711,0.24868,0.2783,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00015583,0.24856,0.27893,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,1.155e-06,0.24844,0.28124,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0054192,0.24832,0.22233,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.4959e-05,0.24815,0.21802,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.7385e-05,0.24808,0.20947,1,1
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.063258,0.24761,0.16996,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,3.0295e-08,0.24745,0.23688,1,1
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.029754,0.24741,0.20429,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0085105,0.24646,0.22042,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.0905e-06,0.24637,0.22728,1,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.0059116,0.24628,0.25373,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.1274e-05,0.24606,0.19896,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.031311,0.24602,0.17881,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0011021,0.24583,0.22234,1,1
3,GO REGULATION OF TRANSPOSITION,0.00011596,0.24581,0.31686,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,8.4424e-05,0.24579,0.21343,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00010497,0.24573,0.2613,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00011596,0.24512,0.22192,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00033955,0.24511,0.26476,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.9941e-08,0.24502,0.30204,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0094686,0.24489,0.14903,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.021053,0.24488,0.14723,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.7605e-06,0.24487,0.20852,1,1
3,GO ETHER METABOLIC PROCESS,8.4262e-06,0.24466,0.23615,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,7.3803e-06,0.24427,0.26567,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00076726,0.24421,0.26313,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1375e-05,0.24395,0.22713,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00080175,0.24391,0.19863,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0005211,0.24362,0.26633,1,1
3,GO RESPONSE TO INTERLEUKIN 2,1.5865e-05,0.24361,0.23882,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00026858,0.24329,0.20589,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,2.5424e-05,0.24322,0.23324,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0034243,0.24312,0.202,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,1.0557e-05,0.24279,0.2197,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,7.8911e-05,0.24276,0.19494,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,6.0079e-05,0.24258,0.27502,1,1
3,GO RESPONSE TO PROTOZOAN,0.00040235,0.24256,0.20731,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.1361e-07,0.24249,0.24819,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00076726,0.24212,0.20162,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00054518,0.2419,0.28227,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00022208,0.24168,0.21401,1,1
3,GO CERAMIDE METABOLIC PROCESS,4.8198e-07,0.24168,0.22569,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,4.1552e-07,0.24129,0.22591,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.0099244,0.24126,0.19736,1,1
3,GO RESPONSE TO REDOX STATE,0.00073415,0.24099,0.21469,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00099681,0.24062,0.19893,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,5.9498e-07,0.24045,0.23021,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.1806e-05,0.24039,0.23053,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.00031907,0.24031,0.2104,1,1
3,GO RESPONSE TO THYROID HORMONE,0.0023321,0.24025,0.22888,1,1
3,GO NUCLEOTIDE SALVAGE,0.0050904,0.23993,0.16568,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00074504,0.23986,0.20164,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00029511,0.23978,0.23813,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0022701,0.23973,0.20385,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.0013443,0.23972,0.25946,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.002631,0.23964,0.19833,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.4873e-07,0.23938,0.24555,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,2.5868e-06,0.23907,0.21568,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.3056e-06,0.23899,0.24376,1,1
3,GO LEUKOCYTE PROLIFERATION,2.3661e-05,0.23888,0.19964,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00086244,0.2388,0.19515,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00040857,0.23848,0.20915,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,6.4592e-06,0.23836,0.22349,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00014129,0.23836,0.2467,1,1
3,GO AMYLOID BETA CLEARANCE,0.0011836,0.23834,0.18197,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00025617,0.23832,0.17073,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.342e-06,0.23829,0.22751,1,1
3,GO T CELL PROLIFERATION,8.5858e-05,0.23811,0.19412,1,1
3,GO TYPE I INTERFERON PRODUCTION,2.7804e-05,0.23802,0.20589,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.001071,0.23776,0.27854,1,1
3,GO ZYMOGEN INHIBITION,0.00032408,0.23737,0.24101,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,4.9694e-05,0.2373,0.21172,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.00029052,0.23726,0.22772,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,8.5867e-06,0.23708,0.25625,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.00027716,0.23689,0.18945,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.00026858,0.23686,0.19676,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.5022e-05,0.23684,0.20176,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00029052,0.23664,0.18616,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,3.2146e-06,0.23655,0.21893,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,1.7693e-06,0.23651,0.22354,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0016806,0.23617,0.32721,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.00063314,0.23616,0.19057,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,3.0395e-05,0.23606,0.26295,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0005211,0.2359,0.18889,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,9.6562e-05,0.23586,0.2065,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00024819,0.23584,0.17376,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,6.7105e-06,0.23577,0.21915,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0011341,0.23522,0.22982,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,6.4341e-05,0.23518,0.25087,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,1.0958e-05,0.23495,0.22328,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.2894e-09,0.23488,0.2535,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,3.5022e-05,0.23433,0.26092,1,1
3,GO WATER HOMEOSTASIS,1.1316e-06,0.23429,0.25954,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,6.3249e-05,0.23428,0.20076,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,3.8347e-06,0.23423,0.24707,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0054872,0.23421,0.14508,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,7.3803e-06,0.23419,0.23422,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00080175,0.23407,0.24898,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,1.9465e-08,0.23402,0.23958,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,6.1119e-05,0.23401,0.22774,1,1
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.033948,0.23398,0.17099,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00033955,0.23385,0.18926,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.0004e-06,0.23348,0.23013,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00026024,0.23307,0.25537,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,1.9175e-06,0.23276,0.2251,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00017457,0.2327,0.22336,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0022701,0.23251,0.17138,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0039481,0.23227,0.24943,1,1
3,GO RESPONSE TO VIRUS,3.6924e-05,0.23198,0.20285,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,3.1004e-08,0.23186,0.24211,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.1806e-05,0.23184,0.23861,1,1
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00049053,0.23183,0.20906,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,6.4592e-06,0.23153,0.19625,1,1
3,GO PHOSPHOLIPID TRANSPORT,1.5037e-07,0.23133,0.24994,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0361e-05,0.23095,0.22136,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,5.5127e-05,0.23093,0.32169,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.5558e-05,0.23079,0.18662,1,1
3,GO HEART TRABECULA FORMATION,0.0024281,0.23071,0.23586,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.1165e-05,0.23062,0.242,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00026024,0.23062,0.20604,1,1
3,GO KERATINOCYTE DIFFERENTIATION,2.6914e-06,0.23039,0.23749,1,1
3,GO DIGESTIVE SYSTEM PROCESS,2.2958e-06,0.23038,0.22065,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.00076726,0.23022,0.25651,1,1
3,GO LYTIC VACUOLE ORGANIZATION,3.4553e-09,0.23016,0.27709,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,3.8161e-07,0.23007,0.26833,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0023637,0.22982,0.24209,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0047198,0.2296,0.29559,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034636,0.22948,0.28892,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0001803,0.22946,0.25092,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.8793e-06,0.22903,0.22475,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.913e-06,0.22898,0.23997,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00010852,0.22894,0.20088,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3013e-05,0.22881,0.27936,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.010895,0.22864,0.21329,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.6129e-06,0.22864,0.23939,1,1
3,GO STEROID METABOLIC PROCESS,9.404e-07,0.22852,0.22288,1,1
3,GO REGULATION OF HEART RATE,5.6487e-06,0.22849,0.21882,1,1
3,GO MEMBRANE DEPOLARIZATION,4.4807e-06,0.22843,0.24352,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00070238,0.22817,0.21117,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,2.5868e-06,0.22802,0.2016,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,8.8282e-08,0.22778,0.22878,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.00015331,0.22767,0.18593,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0013255,0.22756,0.18414,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0021505,0.2275,0.25308,1,1
3,GO FUCOSYLATION,0.00016629,0.22743,0.19901,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.2445e-07,0.22727,0.21512,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.014494,0.22714,0.1694,1,1
3,GO CYTOKINE METABOLIC PROCESS,2.011e-05,0.22661,0.22591,1,1
3,GO RESPONSE TO INSECTICIDE,0.0025277,0.22659,0.25077,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,7.7166e-08,0.22634,0.23562,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,2.4371e-06,0.2262,0.25744,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00084997,0.22591,0.15646,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00014129,0.22584,0.27104,1,1
3,GO LIPID LOCALIZATION,4.4285e-07,0.22575,0.21084,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0020367,0.22549,0.16176,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00037257,0.22505,0.19479,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.8723e-07,0.22493,0.24429,1,1
3,GO REGULATION OF WOUND HEALING,6.9711e-06,0.22466,0.25698,1,1
3,GO IMMUNE EFFECTOR PROCESS,4.4807e-06,0.22446,0.21305,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00042777,0.22445,0.23852,1,1
3,GO PLATELET DEGRANULATION,9.3381e-05,0.22443,0.24482,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,8.5858e-05,0.22439,0.22256,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0001803,0.22436,0.18377,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.9175e-06,0.22435,0.21917,1,1
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.00061456,0.22411,0.25674,1,1
3,GO RESPONSE TO GROWTH HORMONE,7.2414e-06,0.22411,0.27133,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,2.4861e-06,0.22409,0.26441,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.4409e-05,0.22382,0.219,1,1
3,GO REGULATION OF MEMBRANE REPOLARIZATION,4.8839e-05,0.22363,0.22695,1,1
3,GO RESPONSE TO CAFFEINE,0.00091404,0.22357,0.17298,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.0027381,0.22351,0.19619,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.007921,0.22303,0.22892,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.3562e-07,0.22297,0.20633,1,1
3,GO HUMORAL IMMUNE RESPONSE,2.7452e-06,0.22296,0.21912,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0044864,0.22277,0.26423,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.8305e-05,0.22263,0.2121,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00010323,0.22261,0.27332,1,1
3,GO NECROTIC CELL DEATH,1.9175e-06,0.2226,0.24329,1,1
3,GO POSITIVE REGULATION OF HEART CONTRACTION,1.3325e-06,0.2226,0.26819,1,1
3,GO PROTEIN HYDROXYLATION,0.001568,0.22257,0.21446,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.6877e-06,0.22207,0.21847,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,5.6487e-06,0.22194,0.1965,1,1
3,GO ALANINE TRANSPORT,0.0019819,0.22166,0.18479,1,1
3,GO CYTOPLASM ORGANIZATION,0.00046165,0.22164,0.22002,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.206e-06,0.22159,0.21911,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00020178,0.22149,0.30217,1,1
3,GO VASCULAR WOUND HEALING,0.00016361,0.22131,0.29661,1,1
3,GO LEUKOCYTE MIGRATION,7.5217e-06,0.22121,0.20746,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.8856e-08,0.2211,0.24094,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00019541,0.22106,0.21008,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00023294,0.22095,0.25277,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0016806,0.22095,0.21277,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.6828e-05,0.22092,0.20817,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0019023,0.22088,0.16636,1,1
3,GO PLATELET ACTIVATION,0.00011406,0.22078,0.19797,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00013232,0.2207,0.24058,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.004156,0.22051,0.17448,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00019541,0.22047,0.26851,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8814e-05,0.22043,0.23798,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.3468e-07,0.2201,0.27824,1,1
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0059116,0.22005,0.21434,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00024045,0.21991,0.20062,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.000286,0.21971,0.22649,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,3.2631e-05,0.21934,0.22268,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,8.1138e-06,0.21928,0.28255,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00013673,0.21883,0.22247,1,1
3,GO INTERFERON ALPHA PRODUCTION,5.8698e-06,0.21882,0.24911,1,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.00044103,0.21872,0.26155,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0014624,0.21857,0.18582,1,1
3,GO ICOSANOID METABOLIC PROCESS,9.2585e-06,0.21835,0.2503,1,1
3,GO DEFENSE RESPONSE,2.342e-06,0.21824,0.19904,1,1
3,GO REGULATION OF ACTION POTENTIAL,0.00033955,0.21818,0.21286,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00019541,0.21816,0.20376,1,1
3,GO MANNOSYLATION,1.3325e-06,0.21807,0.24139,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00013673,0.21807,0.22837,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00055343,0.21798,0.22871,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.2143e-08,0.2179,0.23821,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,5.2445e-07,0.21786,0.21451,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00024045,0.21778,0.21432,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00029976,0.21778,0.1816,1,1
3,GO INTEGRIN ACTIVATION,3.4098e-06,0.21744,0.264,1,1
3,GO REGULATION OF POSITIVE CHEMOTAXIS,3.5022e-05,0.21738,0.23843,1,1
3,GO LEUKOCYTE CHEMOTAXIS,2.7804e-05,0.21726,0.18397,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00017741,0.2172,0.27659,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.3948e-05,0.21702,0.25921,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.0853e-05,0.21693,0.21793,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,4.2487e-05,0.21671,0.2406,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,5.8698e-06,0.21665,0.24926,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.0005056,0.21659,0.21041,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00012594,0.21652,0.17176,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0024941,0.2165,0.16698,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,3.6877e-06,0.21642,0.19893,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0001862,0.21642,0.1997,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,4.5684e-06,0.2163,0.21686,1,1
3,GO STEROL METABOLIC PROCESS,1.5052e-06,0.21609,0.20957,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00037257,0.21607,0.15105,1,1
3,GO PLATELET AGGREGATION,6.8888e-05,0.21562,0.23952,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.7999e-05,0.21509,0.20525,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0042095,0.21508,0.18899,1,1
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.012227,0.21505,0.23151,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00095459,0.21504,0.197,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,1.5865e-05,0.21503,0.2099,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.001483,0.21498,0.24247,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.00012594,0.21492,0.20919,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.758e-05,0.21488,0.20251,1,1
3,GO COPPER ION TRANSPORT,0.00032916,0.21481,0.21742,1,1
3,GO RESPONSE TO INTERLEUKIN 6,6.3249e-05,0.21474,0.2121,1,1
3,GO ENERGY HOMEOSTASIS,8.7316e-05,0.21453,0.22124,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,4.8839e-05,0.21426,0.29481,1,1
3,GO LIVER MORPHOGENESIS,2.0478e-05,0.21418,0.33244,1,1
3,GO CYTOKINE PRODUCTION,4.1751e-05,0.21392,0.187,1,1
3,GO SKIN DEVELOPMENT,4.7999e-05,0.21356,0.18914,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001955,0.21335,0.23552,1,1
3,GO EPIDERMIS DEVELOPMENT,3.1494e-05,0.21324,0.18705,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00023294,0.21283,0.16027,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.206e-06,0.21274,0.25746,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.00055343,0.21274,0.2025,1,1
3,GO SECRETION BY TISSUE,0.00023294,0.21272,0.19649,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.6828e-05,0.21254,0.23949,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,3.5646e-05,0.21241,0.24932,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00049053,0.21233,0.15274,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,6.545e-05,0.21208,0.21337,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,3.758e-05,0.21206,0.22336,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00026438,0.21185,0.25524,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.00044103,0.21175,0.20269,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.0169e-05,0.21171,0.24954,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0071918,0.2116,0.22945,1,1
3,GO NUCLEOTIDE TRANSPORT,2.0364e-06,0.21146,0.19951,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.0043737,0.21111,0.16922,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.5038e-07,0.21108,0.21407,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,5.332e-06,0.21094,0.21666,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,3.4409e-05,0.21081,0.22966,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,6.6578e-05,0.21074,0.19341,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,4.7488e-06,0.21057,0.22777,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.4701e-07,0.21051,0.21124,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,1.5576e-05,0.2104,0.29516,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00010323,0.2104,0.21108,1,1
3,GO CELL CHEMOTAXIS,3.094e-05,0.21032,0.18851,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.00014362,0.21023,0.16292,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,8.7502e-06,0.21012,0.20697,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.2057e-05,0.21006,0.21215,1,1
3,GO B CELL ACTIVATION,2.1621e-05,0.20995,0.17732,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00073415,0.2096,0.18805,1,1
3,GO BILE ACID METABOLIC PROCESS,1.7071e-05,0.2095,0.23172,1,1
3,GO ENDOCRINE PROCESS,1.3948e-05,0.20938,0.20344,1,1
3,GO CELL CELL ADHESION,0.00040235,0.20934,0.15687,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,2.9332e-05,0.20906,0.28081,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00013899,0.2088,0.19778,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,3.8246e-05,0.20865,0.27316,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.7582e-06,0.20811,0.20355,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.00027284,0.2081,0.20053,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0030436,0.20796,0.17694,1,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0093576,0.2079,0.16527,1,1
3,GO CARBOHYDRATE TRANSPORT,2.0429e-07,0.2079,0.19868,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059648,0.20786,0.18195,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010852,0.20781,0.18253,1,1
3,GO RESPONSE TO INACTIVITY,0.0026663,0.20771,0.22619,1,1
3,GO AMELOGENESIS,0.01585,0.20765,0.17926,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00021857,0.20765,0.20188,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00063314,0.20755,0.20741,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0049019,0.20741,0.17763,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0016575,0.20739,0.23504,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,9.2585e-06,0.20729,0.20902,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,9.2321e-08,0.20728,0.21505,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00069207,0.2071,0.20482,1,1
3,GO SPHINGOID METABOLIC PROCESS,7.8911e-05,0.20706,0.24222,1,1
3,GO STEROL TRANSPORT,8.7316e-05,0.20696,0.19743,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.0005133,0.20692,0.19806,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0051547,0.20687,0.13402,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.8796e-05,0.20663,0.20676,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,1.6158e-05,0.20658,0.20611,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00012594,0.2065,0.19999,1,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,9.6562e-05,0.206,0.25475,1,1
3,GO SIGNAL PEPTIDE PROCESSING,5.9834e-06,0.20591,0.27617,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,4.0314e-05,0.20585,0.2372,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.6761e-05,0.20585,0.20322,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00018923,0.20573,0.17401,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0050904,0.20563,0.16729,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00091404,0.20561,0.1979,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.0005056,0.20529,0.20486,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.002631,0.20529,0.18995,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00052901,0.20515,0.15462,1,1
3,GO TRANSCYTOSIS,0.00099681,0.20512,0.17304,1,1
3,GO NERVE DEVELOPMENT,0.0005211,0.2051,0.21458,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012186,0.20509,0.20472,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.4472e-05,0.20502,0.1923,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00019541,0.20488,0.30284,1,1
3,GO SKELETAL MUSCLE ADAPTATION,0.00084997,0.20485,0.19882,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00043435,0.20471,0.17377,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.3196e-05,0.20464,0.20592,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,1.6994e-06,0.20456,0.23889,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024609,0.20454,0.1475,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,2.342e-06,0.20439,0.22244,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,2.856e-06,0.20434,0.19387,1,1
3,GO CELLULAR RESPONSE TO STEROL,3.8246e-05,0.20432,0.22692,1,1
3,GO RESPONSE TO METAL ION,2.2286e-07,0.2042,0.18903,1,1
3,GO ORGANELLE MEMBRANE FUSION,2.0853e-05,0.20415,0.18346,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0013826,0.20407,0.19096,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,5.1304e-06,0.20398,0.2041,1,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.032607,0.20387,0.16486,1,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,4.2444e-07,0.20384,0.21736,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,9.6562e-05,0.20378,0.18918,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,9.8716e-08,0.2037,0.19276,1,1
3,GO ACROSOME REACTION,0.0058389,0.20346,0.1438,1,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0038977,0.20323,0.15626,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,3.0395e-05,0.20312,0.19518,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,4.5684e-06,0.20291,0.20643,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.0302e-06,0.20267,0.20016,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,4.6359e-05,0.20261,0.21263,1,1
3,GO ACTION POTENTIAL,1.2716e-05,0.20257,0.19794,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8049e-05,0.20196,0.19491,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.00025617,0.20194,0.15117,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.00013451,0.20189,0.19125,1,1
3,GO MEMBRANE FUSION,6.2169e-06,0.2018,0.18614,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.5022e-05,0.20174,0.18218,1,1
3,GO DIET INDUCED THERMOGENESIS,3.094e-05,0.20151,0.22877,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,1.0169e-05,0.20126,0.19691,1,1
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0078263,0.20095,0.17046,1,1
3,GO AMYLOID BETA FORMATION,0.00090088,0.20092,0.19761,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00044103,0.20087,0.22459,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.023919,0.20077,0.12386,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.000662,0.20065,0.20774,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0020929,0.20058,0.16646,1,1
3,GO GLOMERULUS DEVELOPMENT,0.002702,0.20057,0.19317,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.2585e-06,0.20044,0.19126,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0011341,0.2002,0.35572,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00068191,0.20013,0.15274,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.4959e-05,0.20011,0.19914,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.0429e-07,0.2,0.23379,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,1.5865e-05,0.1999,0.17622,1,1
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0048405,0.19946,0.24259,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0026663,0.19943,0.18436,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.9613e-05,0.19934,0.18194,1,1
3,GO REGULATION OF RESPONSE TO FOOD,0.0095807,0.19933,0.11661,1,1
3,GO REGULATION OF CELL ADHESION,0.00048316,0.19931,0.16568,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0056958,0.19918,0.13345,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0023637,0.19904,0.15874,1,1
3,GO RESPONSE TO FATTY ACID,0.00088789,0.19885,0.15428,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0012527,0.19882,0.21206,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00029976,0.19879,0.15571,1,1
3,GO DIGESTION,6.337e-06,0.19854,0.21568,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.2482e-05,0.19844,0.18223,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0104,0.19834,0.13089,1,1
3,GO METHIONINE METABOLIC PROCESS,0.000662,0.19833,0.17708,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.00020835,0.19825,0.22705,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.2954e-05,0.19806,0.20998,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00042777,0.19786,0.17764,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,3.0905e-06,0.19766,0.21146,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00013899,0.19759,0.17782,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.024687,0.19743,0.13265,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,8.1623e-05,0.19732,0.1779,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,5.9056e-05,0.1972,0.18999,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,2.0478e-05,0.19692,0.20483,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.0005211,0.19691,0.18027,1,1
3,GO INTERFERON BETA PRODUCTION,0.0027747,0.19663,0.15633,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.00071283,0.19653,0.23907,1,1
3,GO VACUOLAR ACIDIFICATION,5.4356e-06,0.19597,0.22926,1,1
3,GO RESPONSE TO CYTOKINE,3.8924e-05,0.19587,0.17235,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00036124,0.19548,0.17131,1,1
3,GO AMINE METABOLIC PROCESS,9.2321e-08,0.19535,0.19154,1,1
3,GO REGULATION OF BLOOD PRESSURE,1.2027e-05,0.19533,0.16881,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00024819,0.19527,0.15066,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015674,0.19524,0.14036,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.3948e-05,0.19524,0.20641,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0018764,0.19514,0.20562,1,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0038478,0.19508,0.18505,1,1
3,GO T CELL ACTIVATION,0.00021857,0.19506,0.15813,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0052854,0.19493,0.19525,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,7.2497e-05,0.19479,0.18833,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,5.3256e-05,0.19477,0.15858,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.9694e-05,0.19436,0.23174,1,1
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0018508,0.19431,0.23261,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,1.9393e-05,0.19416,0.18649,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0094686,0.19406,0.12482,1,1
3,GO SODIUM ION HOMEOSTASIS,0.00012594,0.19396,0.16949,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0005789,0.19395,0.17403,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,2.913e-06,0.19381,0.19487,1,1
3,GO INOSITOL METABOLIC PROCESS,0.00034485,0.19368,0.20199,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.062114,0.19364,0.12211,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.3806e-05,0.1936,0.20518,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,2.856e-06,0.19355,0.16868,1,1
3,GO RESPONSE TO BACTERIUM,3.628e-05,0.1935,0.17022,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0032928,0.19343,0.16207,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0002443,0.19321,0.14,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.1086e-06,0.1932,0.17558,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0011341,0.19312,0.16885,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00011218,0.19312,0.21186,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00069207,0.19306,0.18667,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.3256e-05,0.19304,0.16317,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00053704,0.19299,0.19293,1,1
3,GO REGULATION OF FERTILIZATION,4.8839e-05,0.19289,0.19279,1,1
3,GO MEMBRANE FISSION,0.014823,0.19288,0.15449,1,1
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.024173,0.1928,0.1731,1,1
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00049802,0.19268,0.18749,1,1
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010522,0.19265,0.15956,1,1
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0024941,0.19264,0.16967,1,1
3,GO MULTICELLULAR ORGANISM AGING,4.1751e-05,0.19253,0.18054,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0039992,0.19246,0.13375,1,1
3,GO LUNG EPITHELIUM DEVELOPMENT,0.00061456,0.1922,0.22364,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.004964,0.19219,0.20574,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.6654e-06,0.19194,0.19169,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0013069,0.1918,0.17489,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0047198,0.19168,0.15753,1,1
3,GO GRANULOCYTE MIGRATION,6.2175e-05,0.19144,0.1836,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.001118,0.19133,0.20176,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,7.4873e-07,0.19117,0.21411,1,1
3,GO RESPONSE TO AMPHETAMINE,0.006444,0.19113,0.17468,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00092737,0.19112,0.14912,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.011678,0.19098,0.15516,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.011022,0.19069,0.14712,1,1
3,GO RESPONSE TO PH,0.00010673,0.19056,0.19561,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.4959e-05,0.19046,0.20989,1,1
3,GO PHAGOSOME MATURATION,1.3948e-05,0.19041,0.21927,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,2.3239e-05,0.19014,0.19635,1,1
3,GO MUSCLE ADAPTATION,2.4972e-05,0.1901,0.19191,1,1
3,GO RENAL SYSTEM PROCESS,0.00032408,0.18978,0.17703,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0017277,0.18975,0.18242,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00037257,0.1897,0.14792,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0011021,0.18947,0.20099,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,1.5576e-05,0.18917,0.18639,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00018923,0.18913,0.21497,1,1
3,GO VIRAL LIFE CYCLE,0.00019857,0.189,0.15533,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0058389,0.18894,0.15519,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00096848,0.1889,0.17452,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,9.1829e-05,0.18889,0.2102,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.022209,0.18845,0.12622,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.5837e-06,0.18828,0.18412,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0053519,0.18828,0.13344,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0037016,0.1882,0.12691,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0019023,0.18782,0.1973,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.00035024,0.18764,0.16574,1,1
3,GO SENSORY PERCEPTION OF TASTE,1.4741e-05,0.18718,0.17237,1,1
3,GO REGULATION OF ANION TRANSPORT,3.8924e-05,0.18702,0.17076,1,1
3,GO AMINE TRANSPORT,9.3381e-05,0.18672,0.23631,1,1
3,GO CELL ACTIVATION,4.4771e-05,0.18648,0.17137,1,1
3,GO RESPONSE TO ISCHEMIA,9.3381e-05,0.18636,0.18934,1,1
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00044781,0.18604,0.23668,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.9711e-06,0.18597,0.18215,1,1
3,GO CHOLESTEROL STORAGE,0.001568,0.18594,0.20478,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0037985,0.18521,0.15517,1,1
3,GO RESPONSE TO CADMIUM ION,0.00099681,0.18519,0.19176,1,1
3,GO TRANSFERRIN TRANSPORT,2.4837e-07,0.18509,0.23032,1,1
3,GO ENDOTHELIUM DEVELOPMENT,0.0037985,0.18503,0.14976,1,1
3,GO NEUTROPHIL MIGRATION,6.8888e-05,0.18495,0.1708,1,1
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00015838,0.18495,0.18411,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00011986,0.18451,0.20504,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0022701,0.18441,0.17779,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.2631e-05,0.18439,0.22773,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.00015331,0.1843,0.16154,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.006444,0.1843,0.14548,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,2.2958e-06,0.18426,0.17953,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001568,0.18425,0.19555,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,7.3739e-05,0.18423,0.17964,1,1
3,GO CYTOKINE SECRETION,7.3803e-06,0.1842,0.21149,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0029256,0.18417,0.18792,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.4741e-05,0.18414,0.16463,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0048405,0.18408,0.1449,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00060545,0.18399,0.16869,1,1
3,GO INFLAMMATORY RESPONSE,9.2585e-06,0.18397,0.19074,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,3.2057e-05,0.18388,0.24491,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.0337e-07,0.18385,0.17239,1,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.016568,0.18381,0.13055,1,1
3,GO PARENTAL BEHAVIOR,0.065005,0.18376,0.13513,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00030449,0.18369,0.15393,1,1
3,GO MUSCLE HYPERTROPHY,8.7502e-06,0.18363,0.20521,1,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.0076401,0.18352,0.19198,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0042095,0.18335,0.14343,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00081356,0.18331,0.1684,1,1
3,GO PEPTIDE SECRETION,3.0811e-07,0.18328,0.19138,1,1
3,GO GDP METABOLIC PROCESS,0.0038478,0.18322,0.20328,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00091404,0.18318,0.15594,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00022565,0.18314,0.16168,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.9844e-05,0.18308,0.1716,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.004964,0.18305,0.16994,1,1
3,GO MYOTUBE DIFFERENTIATION,3.8924e-05,0.18293,0.19232,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00040235,0.18246,0.24389,1,1
3,GO B CELL DIFFERENTIATION,4.4771e-05,0.18241,0.16172,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001483,0.18236,0.23059,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,6.0079e-05,0.18217,0.2129,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0060595,0.18202,0.16709,1,1
3,GO RESPONSE TO NUTRIENT,0.00080175,0.18194,0.1487,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0016347,0.18187,0.16573,1,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0056958,0.18185,0.20535,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00063314,0.18181,0.18463,1,1
3,GO INTERACTION WITH HOST,0.00033432,0.18178,0.16307,1,1
3,GO EXOCYTOSIS,1.9175e-06,0.18176,0.18792,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.0256e-05,0.18163,0.19362,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.6994e-06,0.18153,0.19194,1,1
3,GO FATTY ACID CATABOLIC PROCESS,9.819e-05,0.18127,0.16468,1,1
3,GO LIPID EXPORT FROM CELL,0.00059648,0.18115,0.17806,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,4.8839e-05,0.18108,0.16859,1,1
3,GO T CELL MIGRATION,0.0063654,0.18091,0.14157,1,1
3,GO PROTEIN AUTOPROCESSING,3.8246e-05,0.18081,0.19361,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.00060545,0.18035,0.17372,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00029511,0.18029,0.12982,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010673,0.18016,0.1613,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0030038,0.18008,0.16575,1,1
3,GO TISSUE HOMEOSTASIS,3.9613e-05,0.18001,0.16332,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0083098,0.17994,0.14114,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.7172e-05,0.17988,0.16287,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.00010497,0.17966,0.19009,1,1
3,GO PROSTAGLANDIN SECRETION,0.0019285,0.1794,0.16605,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001483,0.17914,0.15557,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024045,0.17913,0.2671,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,6.8396e-06,0.17908,0.1632,1,1
3,GO CD40 SIGNALING PATHWAY,0.001442,0.17905,0.15556,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00033955,0.17904,0.16829,1,1
3,GO REGULATION OF PEPTIDE SECRETION,2.7078e-07,0.179,0.18622,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00087508,0.17875,0.16702,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.6657e-06,0.17873,0.23192,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,9.9844e-05,0.17853,0.19714,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.0314e-05,0.17849,0.17701,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00040235,0.17844,0.16237,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.064e-06,0.17844,0.19552,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00020178,0.17839,0.19218,1,1
3,GO POSITIVE REGULATION OF SECRETION,7.333e-07,0.1783,0.17977,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,7.3739e-05,0.17818,0.16077,1,1
3,GO FLUID TRANSPORT,0.00024045,0.17801,0.18616,1,1
3,GO LYMPHOCYTE MIGRATION,0.00041488,0.178,0.14983,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,2.913e-06,0.17798,0.20342,1,1
3,GO REGULATION OF DEFENSE RESPONSE,7.6657e-06,0.17764,0.17459,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0021215,0.17754,0.19249,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0005618,0.17695,0.18623,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0018764,0.1769,0.19319,1,1
3,GO LIPID STORAGE,6.4341e-05,0.17672,0.19211,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.0018508,0.17656,0.17061,1,1
3,GO NEURON MATURATION,0.0016122,0.17649,0.17456,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00010852,0.17648,0.24263,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00046165,0.1764,0.13424,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0024609,0.17612,0.19209,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0065235,0.17606,0.20557,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0058389,0.17605,0.13825,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00017176,0.17602,0.17206,1,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.049212,0.176,0.12422,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,8.8796e-05,0.17584,0.19383,1,1
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0013633,0.17582,0.14769,1,1
3,GO POSITIVE CHEMOTAXIS,0.00040235,0.17572,0.17342,1,1
3,GO MAINTENANCE OF CELL POLARITY,0.034984,0.17534,0.14359,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.0010558,0.1753,0.17553,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.010895,0.17508,0.15516,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.00075607,0.17506,0.15468,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0011503,0.175,0.18745,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00071283,0.17494,0.18002,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0005618,0.17492,0.17465,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.016752,0.17486,0.11566,1,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00065224,0.17458,0.1653,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0017517,0.17447,0.17331,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0087156,0.17447,0.15546,1,1
3,GO PIGMENT ACCUMULATION,0.056128,0.17441,0.12633,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.0017277,0.17441,0.25552,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.1552e-07,0.17428,0.21946,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0027747,0.17392,0.1601,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.006444,0.17389,0.12973,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092737,0.17376,0.192,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.00044103,0.17364,0.20221,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0029645,0.17363,0.16627,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.0016122,0.17358,0.14977,1,1
3,GO PH REDUCTION,2.8001e-06,0.17342,0.18304,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.015159,0.17324,0.11496,1,1
3,GO UBIQUINONE METABOLIC PROCESS,0.00015331,0.17317,0.17864,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0013443,0.17313,0.1455,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.00013016,0.17299,0.16046,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00011218,0.17296,0.20745,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0015038,0.17288,0.15566,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0030839,0.1727,0.1672,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,7.2497e-05,0.17267,0.16039,1,1
3,GO PROTEIN DESTABILIZATION,4.1026e-05,0.17266,0.16844,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00011406,0.17264,0.17605,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,5.4184e-05,0.1723,0.18653,1,1
3,GO TERPENOID METABOLIC PROCESS,0.0030436,0.1723,0.14515,1,1
3,GO PROTEIN PROCESSING,1.5674e-06,0.17209,0.20392,1,1
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.022446,0.17177,0.16543,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.066192,0.17176,0.14186,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,1.9175e-06,0.17157,0.16627,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.6162e-06,0.1714,0.16968,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001235,0.17137,0.14144,1,1
3,GO RESPONSE TO STEROL,0.00020504,0.17137,0.19252,1,1
3,GO PROTEIN TARGETING TO VACUOLE,0.00088789,0.17135,0.16562,1,1
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0051547,0.17131,0.16726,1,1
3,GO DETECTION OF STIMULUS,9.404e-07,0.17117,0.15161,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.00028155,0.17103,0.1601,1,1
3,GO CELLULAR RESPONSE TO DSRNA,0.0013443,0.17099,0.16559,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.010645,0.17099,0.15959,1,1
3,GO OUTER DYNEIN ARM ASSEMBLY,0.063258,0.1709,0.10473,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,2.5868e-06,0.17058,0.19013,1,1
3,GO RESPONSE TO FUNGUS,2.9332e-05,0.17039,0.17133,1,1
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.011151,0.17038,0.19478,1,1
3,GO COAGULATION,0.00092737,0.17037,0.15215,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0065235,0.17033,0.18328,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00010497,0.17022,0.19003,1,1
3,GO WOUND HEALING,0.0015463,0.17012,0.15537,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00090088,0.1701,0.13727,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.0005133,0.17003,0.1721,1,1
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0005133,0.16998,0.16159,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,1.6457e-05,0.16994,0.18276,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,6.3249e-05,0.16984,0.14589,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.001483,0.16981,0.15149,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00014599,0.16964,0.16652,1,1
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.038637,0.16962,0.11945,1,1
3,GO BICARBONATE TRANSPORT,0.00016901,0.16952,0.2059,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00068191,0.1695,0.1792,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0057669,0.16949,0.15244,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.003607,0.16947,0.12458,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.002702,0.16914,0.19784,1,1
3,GO RESPONSE TO INSULIN,2.8305e-05,0.16912,0.14665,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,6.545e-05,0.16907,0.20407,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.001483,0.16892,0.16542,1,1
3,GO PIGMENTATION,0.00021511,0.1689,0.13951,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.018693,0.16869,0.11389,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0016122,0.16865,0.15702,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.00032916,0.16859,0.14053,1,1
3,GO GLAND DEVELOPMENT,0.00095459,0.16814,0.12908,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,1.536e-06,0.16809,0.17854,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.015674,0.16804,0.14289,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0395e-05,0.16785,0.184,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.0002117,0.16771,0.17661,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00095459,0.16769,0.17401,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00076726,0.16759,0.15315,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.018898,0.16756,0.14534,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0022396,0.16748,0.1549,1,1
3,GO INSULIN SECRETION,7.2414e-06,0.16739,0.18429,1,1
3,GO VESICLE TARGETING,0.0019023,0.16726,0.13016,1,1
3,GO COPULATION,0.0063654,0.16725,0.15964,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0024609,0.16709,0.15244,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.00024819,0.16709,0.17404,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0032928,0.16707,0.18766,1,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0039481,0.16706,0.18712,1,1
3,GO RESPONSE TO CALCIUM ION,4.2487e-05,0.16704,0.17084,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,9.795e-06,0.16702,0.19711,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0022095,0.16677,0.16225,1,1
3,GO VESICLE ORGANIZATION,7.8911e-05,0.16665,0.14348,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0018764,0.16633,0.1526,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,4.6202e-07,0.16624,0.17932,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,3.5646e-05,0.16615,0.20292,1,1
3,GO ORGANIC ANION TRANSPORT,2.6914e-06,0.16605,0.16144,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0095807,0.16601,0.1587,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.7502e-06,0.16593,0.17441,1,1
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.4771e-05,0.16591,0.21621,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.0002443,0.16574,0.13705,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018898,0.16573,0.12512,1,1
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00039622,0.16571,0.18498,1,1
3,GO LIPID METABOLIC PROCESS,5.6487e-06,0.16551,0.15602,1,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.018091,0.16549,0.10706,1,1
3,GO DNA DEMETHYLATION,0.0080166,0.16548,0.13396,1,1
3,GO COPPER ION HOMEOSTASIS,0.00072342,0.16539,0.17905,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00023667,0.16538,0.15655,1,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.015159,0.16531,0.14456,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0015038,0.16527,0.17967,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.0071918,0.16503,0.12361,1,1
3,GO CARNITINE METABOLIC PROCESS,0.013856,0.16498,0.15397,1,1
3,GO LIPID HOMEOSTASIS,0.00013899,0.16497,0.16504,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,1.1789e-06,0.16496,0.15895,1,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.012087,0.16487,0.15035,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.002702,0.16485,0.17888,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0045438,0.1648,0.12016,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.3806e-05,0.16469,0.26859,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0022396,0.16466,0.16148,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,2.2015e-05,0.16455,0.18179,1,1
3,GO LIPID OXIDATION,0.00025215,0.16448,0.1545,1,1
3,GO SECRETION,1.6654e-06,0.16441,0.16465,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0020367,0.1643,0.11879,1,1
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00018323,0.16429,0.17311,1,1
3,GO REGULATION OF CELLULAR PH,2.9514e-07,0.16428,0.1765,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00053704,0.16428,0.14369,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00083767,0.16419,0.15167,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,7.2497e-05,0.16412,0.16228,1,1
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.0034692,0.16408,0.14007,1,1
3,GO CATECHOLAMINE SECRETION,0.00055343,0.16393,0.26029,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.00067188,0.16382,0.16244,1,1
3,GO SPERM CAPACITATION,0.00081356,0.16375,0.17234,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00013451,0.16375,0.15131,1,1
3,GO ALCOHOL METABOLIC PROCESS,8.0256e-05,0.16374,0.15512,1,1
3,GO RESPONSE TO IRON ION,0.00024045,0.16372,0.19431,1,1
3,GO ACUTE PHASE RESPONSE,9.9844e-05,0.16358,0.19772,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,1.5576e-05,0.16344,0.22561,1,1
3,GO LOCOMOTOR RHYTHM,0.014013,0.16329,0.14049,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00018923,0.16324,0.1697,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0044298,0.16321,0.16257,1,1
3,GO MACROPHAGE DIFFERENTIATION,0.018091,0.1632,0.12469,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.2784e-06,0.16315,0.18708,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00026438,0.16307,0.15772,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.004156,0.16294,0.2179,1,1
3,GO RESPONSE TO WOUNDING,0.0022095,0.1629,0.1471,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.4424e-05,0.16282,0.15497,1,1
3,GO TISSUE MIGRATION,0.0044298,0.16269,0.14267,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0024609,0.16268,0.12915,1,1
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00027284,0.16242,0.13312,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,6.7724e-05,0.16241,0.22572,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.0076401,0.16228,0.11981,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.001568,0.16227,0.17598,1,1
3,GO ANION TRANSPORT,3.4098e-06,0.16223,0.15091,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.0040509,0.16217,0.15023,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.017125,0.16207,0.14781,1,1
3,GO GLUCOSE METABOLIC PROCESS,6.8885e-07,0.16201,0.18137,1,1
3,GO REGULATION OF IMMUNE RESPONSE,9.1829e-05,0.162,0.15949,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0069343,0.16172,0.13525,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0002443,0.16162,0.21634,1,1
3,GO DEVELOPMENTAL INDUCTION,0.0027747,0.16152,0.15462,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00019541,0.16137,0.1717,1,1
3,GO RESPONSE TO PROGESTERONE,0.0029256,0.16114,0.16179,1,1
3,GO CHEMICAL HOMEOSTASIS,4.31e-06,0.16105,0.14743,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00067188,0.16103,0.22562,1,1
3,GO RESPONSE TO AMINE,0.035336,0.16099,0.10246,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.011022,0.16094,0.15061,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.6283e-05,0.16093,0.20084,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.001442,0.16086,0.1524,1,1
3,GO T CELL DIFFERENTIATION,0.00068191,0.16085,0.12683,1,1
3,GO LYSOSOME LOCALIZATION,0.00017457,0.16084,0.16584,1,1
3,GO PROTEIN MANNOSYLATION,0.00024045,0.16075,0.19012,1,1
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.025475,0.16028,0.10378,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.001704,0.16011,0.14354,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,1.536e-06,0.16006,0.177,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00049053,0.16002,0.17249,1,1
3,GO REGULATION OF PH,9.6538e-08,0.15978,0.18163,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00012594,0.15964,0.23168,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00091404,0.15953,0.14754,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.043025,0.15943,0.11937,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.060988,0.15942,0.13461,1,1
3,GO GLIAL CELL DEVELOPMENT,0.0013069,0.15929,0.15788,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00053704,0.159,0.19696,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.3997e-05,0.15898,0.18269,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,1.3948e-05,0.15884,0.17708,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0094686,0.15883,0.12675,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0057669,0.15881,0.16508,1,1
3,GO REGULATION OF HORMONE SECRETION,1.7071e-05,0.15866,0.16564,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00068191,0.15848,0.18106,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.6158e-05,0.15842,0.17781,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,1.5674e-06,0.15823,0.17197,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,6.1119e-05,0.15822,0.16246,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,1.7385e-05,0.15812,0.22521,1,1
3,GO CRANIAL NERVE DEVELOPMENT,0.0037985,0.15811,0.17633,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.5022e-05,0.15792,0.16088,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0060595,0.15789,0.14694,1,1
3,GO BIOLOGICAL ADHESION,0.0032928,0.15781,0.13211,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0053519,0.15756,0.14954,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016361,0.15752,0.1585,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,0.0033361,0.15738,0.15063,1,1
3,GO ENDOCRINE HORMONE SECRETION,6.4341e-05,0.15733,0.18873,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00020835,0.1573,0.19741,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.00029052,0.15709,0.14645,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.011411,0.15701,0.13963,1,1
3,GO ADAPTIVE THERMOGENESIS,9.404e-07,0.15689,0.18011,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.0002443,0.15664,0.15475,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,7.3803e-06,0.1565,0.15649,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001071,0.15637,0.17138,1,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0071918,0.15631,0.19419,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00027284,0.15615,0.15185,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0021798,0.15609,0.14278,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00029976,0.15588,0.18409,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0019023,0.15575,0.15921,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.1588e-05,0.1557,0.16174,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.00022565,0.15569,0.19909,1,1
3,GO MYELIN ASSEMBLY,0.0016575,0.1554,0.21727,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00049053,0.15486,0.17065,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.010645,0.15486,0.19092,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.01251,0.15466,0.15751,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.056128,0.15462,0.1531,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0062877,0.15455,0.15232,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0038478,0.15451,0.16958,1,1
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00037257,0.15431,0.15962,1,1
3,GO NEPHRON DEVELOPMENT,0.018693,0.15414,0.11477,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.0007901,0.1541,0.13531,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.01585,0.15407,0.11671,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,6.3249e-05,0.154,0.14327,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00068191,0.15395,0.15114,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010673,0.15393,0.18138,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0032078,0.15392,0.17176,1,1
3,GO DRUG METABOLIC PROCESS,0.00024819,0.15381,0.22315,1,1
3,GO ER OVERLOAD RESPONSE,0.0062877,0.15373,0.1704,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0005789,0.15372,0.17905,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.010041,0.15345,0.12761,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0084096,0.15345,0.13724,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0056958,0.15334,0.1342,1,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.010522,0.1533,0.15347,1,1
3,GO PHAGOCYTOSIS,0.0025961,0.15311,0.14029,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.001422,0.15304,0.13957,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0022095,0.15285,0.18522,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0058389,0.15284,0.14039,1,1
3,GO ION TRANSPORT,8.4262e-06,0.15277,0.14063,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.4163e-06,0.15274,0.18058,1,1
3,GO DETOXIFICATION,0.017125,0.15264,0.11225,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0058389,0.15263,0.1858,1,1
3,GO STEROID CATABOLIC PROCESS,0.0021505,0.15242,0.22449,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,6.545e-05,0.15242,0.17325,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.00032408,0.15237,0.13109,1,1
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016568,0.15234,0.2038,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.1588e-05,0.15233,0.14797,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00059648,0.15223,0.22322,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,9.9803e-06,0.15222,0.1805,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00011596,0.15198,0.19447,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.026561,0.15168,0.11118,1,1
3,GO REGULATION OF TUBE SIZE,0.00026858,0.15156,0.13587,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0032501,0.15152,0.13258,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0029645,0.15152,0.18939,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0031247,0.15128,0.12145,1,1
3,GO RESPONSE TO INTERLEUKIN 1,0.00026438,0.15113,0.12358,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.001704,0.15092,0.14458,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.05357,0.15087,0.081158,1,1
3,GO INORGANIC ANION TRANSPORT,1.5865e-05,0.15068,0.14389,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.057179,0.15059,0.14674,1,1
3,GO LIPID CATABOLIC PROCESS,1.8032e-05,0.15055,0.16524,1,1
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0046604,0.15041,0.14987,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0010259,0.15041,0.1605,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.0087156,0.1504,0.16311,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.00015583,0.15036,0.19043,1,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.057179,0.15035,0.10431,1,1
3,GO REGULATION OF LIPID TRANSPORT,0.00037257,0.1503,0.16037,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0005211,0.15003,0.17289,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.012087,0.15001,0.11552,1,1
3,GO REGULATION OF HORMONE LEVELS,1.6994e-06,0.14998,0.17432,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.0046018,0.14987,0.13196,1,1
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0043184,0.1498,0.15646,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,3.6162e-06,0.14955,0.22748,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0025617,0.14948,0.15538,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00010673,0.14939,0.14996,1,1
3,GO T CELL APOPTOTIC PROCESS,0.012798,0.14922,0.11976,1,1
3,GO METAL ION HOMEOSTASIS,8.0256e-05,0.14919,0.12526,1,1
3,GO SYNCYTIUM FORMATION,0.0005056,0.14897,0.19486,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0080166,0.14891,0.13996,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.043866,0.14886,0.11798,1,1
3,GO FATTY ACID METABOLIC PROCESS,2.4972e-05,0.14877,0.16499,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,6.1119e-05,0.14874,0.15368,1,1
3,GO PEROXISOMAL TRANSPORT,0.00029511,0.14869,0.1487,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.00012594,0.14865,0.19594,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0017517,0.14862,0.11898,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00095459,0.1484,0.11707,1,1
3,GO RETINOL METABOLIC PROCESS,0.0011836,0.14826,0.21046,1,1
3,GO REGULATION OF HEMOPOIESIS,0.0010558,0.14819,0.12014,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0018256,0.14814,0.18617,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00096848,0.14808,0.1431,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.03e-05,0.14798,0.18264,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,2.2416e-05,0.14794,0.13864,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.001071,0.14792,0.11104,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,9.819e-05,0.14784,0.1557,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0028118,0.14777,0.16806,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.014172,0.14774,0.11576,1,1
3,GO PLACENTA DEVELOPMENT,0.020605,0.14766,0.10811,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.017506,0.1476,0.12043,1,1
3,GO T CELL LINEAGE COMMITMENT,0.0019285,0.14754,0.15102,1,1
3,GO ZINC ION TRANSPORT,0.0020929,0.14725,0.12806,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00068191,0.1472,0.13774,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.5865e-05,0.14717,0.16844,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.016386,0.14714,0.14,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.01995,0.14685,0.25878,1,1
3,GO REGULATION OF APPETITE,0.0089251,0.14676,0.099572,1,1
3,GO FATTY ACID BETA OXIDATION,0.011151,0.14672,0.10992,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.0095807,0.14669,0.20353,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00026858,0.14669,0.17411,1,1
3,GO ESTROUS CYCLE,0.045591,0.14667,0.15131,1,1
3,GO CELLULAR RESPONSE TO STARVATION,3.5461e-06,0.14663,0.16775,1,1
3,GO MANGANESE ION TRANSPORT,0.0013443,0.14652,0.14733,1,1
3,GO XENOBIOTIC TRANSPORT,0.0032501,0.14611,0.15852,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.9803e-06,0.14575,0.17835,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0014022,0.14572,0.13979,1,1
3,GO FAT CELL DIFFERENTIATION,0.00034485,0.14555,0.16382,1,1
3,GO HEART TRABECULA MORPHOGENESIS,0.0071051,0.14548,0.14165,1,1
3,GO EPITHELIUM DEVELOPMENT,0.00073415,0.14546,0.12641,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00014129,0.14537,0.17123,1,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0028492,0.14536,0.16158,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0043184,0.14528,0.18299,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0028872,0.14524,0.1464,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.9393e-05,0.14516,0.13947,1,1
3,GO PROTEIN KINASE B SIGNALING,0.0042095,0.1451,0.12181,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,6.6578e-05,0.14509,0.17218,1,1
3,GO VACUOLE ORGANIZATION,1.0424e-06,0.145,0.17753,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.000286,0.14476,0.1441,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00019229,0.14473,0.14284,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.017699,0.14465,0.13001,1,1
3,GO REGULATION OF CHEMOTAXIS,0.00072342,0.14455,0.14077,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027686,0.14441,0.11255,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0033799,0.14441,0.13646,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,3.9613e-05,0.14389,0.15325,1,1
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0011021,0.14379,0.13098,1,1
3,GO HEPARIN METABOLIC PROCESS,0.064418,0.14371,0.12223,1,1
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00076726,0.14361,0.13179,1,1
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00094089,0.14357,0.15729,1,1
3,GO REGULATION OF SECRETION,5.5412e-06,0.14318,0.15342,1,1
3,GO ION HOMEOSTASIS,3.6924e-05,0.143,0.12939,1,1
3,GO ATP BIOSYNTHETIC PROCESS,0.037882,0.14283,0.12618,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.001568,0.14277,0.11232,1,1
3,GO GLUCOSE IMPORT,0.001422,0.14274,0.12185,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0059852,0.14273,0.1314,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,2.4091e-05,0.14265,0.15227,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.029754,0.14261,0.14313,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.8305e-05,0.14233,0.17483,1,1
3,GO REGULATION OF LIPID STORAGE,0.00092737,0.14222,0.15261,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.0012886,0.14216,0.1256,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00013232,0.14202,0.19106,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0030839,0.14184,0.11046,1,1
3,GO GOLGI VESICLE BUDDING,0.00041488,0.14182,0.12949,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.027973,0.14172,0.1228,1,1
3,GO GLIAL CELL ACTIVATION,0.0092477,0.14159,0.14023,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.003607,0.14155,0.13626,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.027686,0.14142,0.12299,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0007786,0.14134,0.14149,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0013069,0.14129,0.12922,1,1
3,GO ORGANELLE FUSION,5.6085e-05,0.14122,0.15033,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00038422,0.14098,0.15939,1,1
3,GO FATTY ACID TRANSPORT,0.00044103,0.14091,0.14462,1,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.043866,0.1408,0.13906,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.007921,0.14077,0.11513,1,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0030038,0.14057,0.14474,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0015463,0.1405,0.13203,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0083098,0.14045,0.12725,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00099681,0.14044,0.1266,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0002117,0.14035,0.16076,1,1
3,GO ACTIN NUCLEATION,0.00075607,0.14018,0.15611,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0005056,0.14001,0.13764,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0011836,0.13994,0.11872,1,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.016752,0.13989,0.11096,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.00090088,0.13973,0.13035,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.002631,0.13966,0.1541,1,1
3,GO IRON ION TRANSPORT,5.2303e-06,0.13963,0.17175,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0104,0.13915,0.14177,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.001776,0.13902,0.1355,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.9393e-05,0.13882,0.15576,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00040235,0.13867,0.16374,1,1
3,GO TEMPERATURE HOMEOSTASIS,1.7071e-05,0.13854,0.16088,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0087156,0.13852,0.17567,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00057029,0.13845,0.16783,1,1
3,GO NEGATIVE T CELL SELECTION,0.022686,0.13845,0.13543,1,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0058389,0.13843,0.14557,1,1
3,GO MACROPHAGE ACTIVATION,3.6924e-05,0.1384,0.21067,1,1
3,GO RESPONSE TO DSRNA,0.001235,0.13813,0.13166,1,1
3,GO REGULATION OF PROTEOLYSIS,0.00011596,0.1381,0.14292,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00022565,0.13801,0.12456,1,1
3,GO PROTEIN PALMITOYLATION,0.020605,0.13796,0.12475,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00062378,0.13795,0.13366,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.023173,0.13782,0.094217,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0016575,0.1378,0.15559,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.027401,0.13755,0.14988,1,1
3,GO MEMBRANE REPOLARIZATION,0.001568,0.13738,0.18003,1,1
3,GO LIPID DROPLET ORGANIZATION,5.7059e-05,0.13731,0.20798,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0067673,0.13716,0.11937,1,1
3,GO CHOLESTEROL EFFLUX,0.0046018,0.13704,0.13487,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,7.6657e-06,0.13698,0.16103,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,5.0323e-06,0.1369,0.15065,1,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.026013,0.13689,0.13364,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.000286,0.13684,0.1815,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,1.4472e-05,0.13678,0.13782,1,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0034243,0.13648,0.11626,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0012705,0.13624,0.15822,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0029645,0.13623,0.11548,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.00053704,0.13622,0.17768,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.058787,0.13621,0.11529,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.0010408,0.1362,0.11537,1,1
3,GO SODIUM ION TRANSPORT,9.6129e-06,0.1361,0.17138,1,1
3,GO LIPID IMPORT INTO CELL,0.016752,0.13571,0.14949,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00029976,0.1357,0.13127,1,1
3,GO SECONDARY PALATE DEVELOPMENT,0.012087,0.13561,0.14778,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.0012005,0.13556,0.12396,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.0014624,0.13548,0.11318,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.018693,0.13527,0.11704,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.023668,0.13522,0.16116,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0026663,0.13518,0.17382,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0003557,0.13516,0.15215,1,1
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00011218,0.13481,0.20946,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0028118,0.1348,0.11697,1,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00015583,0.13465,0.14459,1,1
3,GO POSITIVE T CELL SELECTION,0.0027381,0.13463,0.13077,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.030994,0.13443,0.11806,1,1
3,GO MUSCLE CELL DEVELOPMENT,0.0007901,0.13439,0.13836,1,1
3,GO RESPONSE TO DRUG,0.00060545,0.13435,0.1334,1,1
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.01995,0.13426,0.15962,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00016361,0.13421,0.15102,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,2.2824e-05,0.13408,0.17867,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,5.4356e-06,0.13402,0.15976,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00033432,0.13392,0.14488,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00013232,0.13387,0.13092,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00041488,0.13337,0.12112,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.00044103,0.1332,0.14932,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,7.2497e-05,0.13303,0.18343,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,4.7999e-05,0.13299,0.13028,1,1
3,GO CALCIUM ION IMPORT,0.003166,0.13299,0.11237,1,1
3,GO EXOCYTIC PROCESS,0.00068191,0.13291,0.17639,1,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0092477,0.13256,0.11667,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.2482e-05,0.13241,0.14153,1,1
3,GO RESPONSE TO STARVATION,1.3196e-05,0.13229,0.15444,1,1
3,GO RIG I SIGNALING PATHWAY,0.036048,0.13228,0.087743,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0050904,0.13218,0.15269,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0084096,0.13196,0.12327,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.010769,0.13187,0.12512,1,1
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0078263,0.13175,0.12295,1,1
3,GO COPII COATED VESICLE BUDDING,0.0016347,0.13161,0.11384,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00013451,0.13131,0.13995,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0024941,0.1311,0.15393,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00040235,0.13104,0.16274,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.002702,0.13095,0.11278,1,1
3,GO NEUROINFLAMMATORY RESPONSE,0.004964,0.13091,0.13238,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.0001803,0.13076,0.12765,1,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.023419,0.13059,0.12151,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,7.1274e-05,0.13051,0.13503,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00086244,0.13047,0.11036,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.018898,0.13035,0.16047,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0071918,0.13033,0.1324,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.00014839,0.13026,0.16317,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0073682,0.12991,0.12346,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00029511,0.12948,0.13541,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0010259,0.12935,0.11532,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0020367,0.12934,0.17533,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00080175,0.12929,0.111,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0073682,0.12926,0.1247,1,1
3,GO TRANSMEMBRANE TRANSPORT,1.2716e-05,0.12906,0.13006,1,1
3,GO HOMEOSTATIC PROCESS,6.7724e-05,0.12895,0.11764,1,1
3,GO DRUG CATABOLIC PROCESS,0.0075485,0.12894,0.17418,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00023667,0.12875,0.12155,1,1
3,GO MEMBRANE ORGANIZATION,0.00044781,0.12871,0.11164,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0005211,0.12865,0.13023,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0094686,0.12864,0.12659,1,1
3,GO NEUROTRANSMITTER REUPTAKE,0.050154,0.12846,0.12406,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.025475,0.12784,0.18655,1,1
3,GO SULFUR COMPOUND TRANSPORT,0.0005789,0.1278,0.1393,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0045438,0.12779,0.1109,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.0024281,0.12769,0.13425,1,1
3,GO RELAXATION OF MUSCLE,0.0057669,0.12766,0.15157,1,1
3,GO REGULATION OF PROTEIN MATURATION,0.025743,0.12753,0.10489,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.03006,0.12753,0.10751,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00036124,0.12733,0.12336,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017699,0.12728,0.15572,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0033361,0.12727,0.1356,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0088198,0.1271,0.12487,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056255,0.12658,0.13453,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,2.2015e-05,0.12657,0.13374,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.022209,0.12655,0.16972,1,1
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.034636,0.12653,0.1308,1,1
3,GO T CELL SELECTION,0.00055343,0.12647,0.13403,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.0012177,0.12619,0.12048,1,1
3,GO SINGLE FERTILIZATION,0.0031247,0.12592,0.089409,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.0051547,0.12591,0.12942,1,1
3,GO MUSCLE SYSTEM PROCESS,0.0025961,0.12578,0.10501,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0025961,0.12574,0.13172,1,1
3,GO RESPONSE TO KETONE,0.0034692,0.1256,0.11871,1,1
3,GO MESONEPHROS DEVELOPMENT,0.0046604,0.12534,0.1365,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00016098,0.12508,0.13434,1,1
3,GO CALCIUM MEDIATED SIGNALING,4.1026e-05,0.12504,0.11505,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.01499,0.12496,0.1113,1,1
3,GO RESPONSE TO STEROID HORMONE,0.0045438,0.12486,0.11214,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.00011406,0.12473,0.1156,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0072795,0.12473,0.14853,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00012594,0.12472,0.14434,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,4.6359e-05,0.12461,0.13686,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.015159,0.12461,0.10837,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,2.3661e-05,0.12447,0.13467,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.0066851,0.12442,0.12483,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.0015463,0.12441,0.1683,1,1
3,GO RESPONSE TO LIPID,0.0017277,0.12429,0.11881,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,1.1375e-05,0.12408,0.15073,1,1
3,GO EATING BEHAVIOR,0.00039018,0.12395,0.16231,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00010673,0.1239,0.13578,1,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.03006,0.12385,0.11845,1,1
3,GO RESPONSE TO TESTOSTERONE,0.0042636,0.12384,0.14799,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0059852,0.12381,0.15868,1,1
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014332,0.12371,0.097449,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0016806,0.12369,0.15572,1,1
3,GO ZINC ION HOMEOSTASIS,0.017315,0.12355,0.19005,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.3239e-05,0.12353,0.1421,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.013546,0.12346,0.093317,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.8347e-06,0.12331,0.152,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0030436,0.12328,0.15948,1,1
3,GO REGULATION OF LIPID LOCALIZATION,0.0005056,0.12327,0.14469,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0005211,0.12325,0.12709,1,1
3,GO PROTEIN MATURATION,8.2686e-06,0.1231,0.15855,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.000662,0.12275,0.11372,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.011022,0.12273,0.17354,1,1
3,GO FEAR RESPONSE,0.022446,0.12266,0.094398,1,1
3,GO REGULATION OF TOR SIGNALING,0.00029052,0.12258,0.12419,1,1
3,GO AUTOPHAGOSOME MATURATION,0.00090088,0.12255,0.1537,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0015463,0.12245,0.17029,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0010113,0.12235,0.11853,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.011813,0.12214,0.10843,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.017506,0.12213,0.10743,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00098255,0.12194,0.119,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00046872,0.12183,0.12207,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0070192,0.12183,0.13012,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.00020504,0.12175,0.11884,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.00031414,0.12154,0.11401,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0023957,0.12151,0.13352,1,1
3,GO NIK NF KAPPAB SIGNALING,0.0017517,0.12141,0.10832,1,1
3,GO CARDIAC CELL DEVELOPMENT,0.0035605,0.12116,0.12485,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.065596,0.1211,0.12411,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.027118,0.12105,0.15791,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0022095,0.12097,0.12341,1,1
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.036772,0.12096,0.12898,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.0002443,0.12079,0.15377,1,1
3,GO AMINE CATABOLIC PROCESS,0.0045438,0.12078,0.17187,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0062108,0.12062,0.10802,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,6.337e-06,0.12056,0.13607,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0023009,0.12024,0.1103,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.00031414,0.12022,0.13534,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,2.4861e-06,0.12017,0.1389,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.00096848,0.12015,0.12904,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.053071,0.12005,0.11315,1,1
3,GO PEROXISOME ORGANIZATION,0.0005133,0.12004,0.13754,1,1
3,GO RESPONSE TO HORMONE,0.0013826,0.12002,0.11279,1,1
3,GO AGING,0.00024819,0.11959,0.12307,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0022396,0.11945,0.11919,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.0014624,0.11915,0.13781,1,1
3,GO OXIDATION REDUCTION PROCESS,0.00011033,0.11899,0.12922,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.000662,0.11895,0.14412,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.012653,0.11876,0.11168,1,1
3,GO ACID SECRETION,0.001118,0.11872,0.12795,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0041031,0.11861,0.12749,1,1
3,GO CIRCADIAN RHYTHM,0.00029052,0.11847,0.12433,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0062108,0.11805,0.13451,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0021798,0.118,0.14137,1,1
3,GO REPLICATIVE SENESCENCE,0.049681,0.11795,0.1403,1,1
3,GO POSITIVE REGULATION OF MYELINATION,0.00053704,0.1179,0.14839,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0022701,0.11774,0.12345,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0017277,0.11768,0.13816,1,1
3,GO PROTEOLYSIS,0.00014362,0.11756,0.11703,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0020092,0.11737,0.12601,1,1
3,GO ENDOSOME ORGANIZATION,0.00047589,0.11727,0.13697,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.023668,0.11674,0.10219,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,8.3013e-05,0.11674,0.13082,1,1
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00012186,0.11667,0.11841,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0016122,0.11662,0.11558,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00022565,0.1166,0.1506,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,7.5001e-05,0.11643,0.15291,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0001803,0.11628,0.14373,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0065235,0.11624,0.14118,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0002443,0.11618,0.12447,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0073682,0.1161,0.11809,1,1
3,GO TRANSITION METAL ION TRANSPORT,7.5217e-06,0.11592,0.15319,1,1
3,GO POLYOL CATABOLIC PROCESS,0.0023957,0.11585,0.1407,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00032408,0.11557,0.1476,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0012527,0.11546,0.13162,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0024281,0.11542,0.14688,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.006444,0.11539,0.13111,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.02915,0.11536,0.090557,1,1
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.014332,0.11507,0.16857,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.062684,0.11489,0.093469,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0014624,0.1148,0.11672,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.028264,0.11472,0.10093,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00026438,0.11434,0.11781,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.011678,0.1142,0.13187,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8032e-05,0.11391,0.14345,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00054518,0.11369,0.15185,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.3239e-05,0.11366,0.14125,1,1
3,GO SARCOMERE ORGANIZATION,0.021973,0.11354,0.11676,1,1
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.055609,0.11353,0.13517,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0015249,0.11323,0.17475,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0067673,0.11304,0.11563,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.00010152,0.11246,0.15448,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.011813,0.11233,0.095979,1,1
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,9.9844e-05,0.1123,0.14923,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00099681,0.11215,0.10983,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0018764,0.11215,0.13336,1,1
3,GO KERATINOCYTE MIGRATION,0.0062877,0.11214,0.12233,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.039795,0.11183,0.13967,1,1
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.02128,0.11182,0.12316,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.0024281,0.11177,0.11847,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.8032e-05,0.11163,0.14187,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0047798,0.11155,0.12728,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.019735,0.11154,0.11121,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.051595,0.11133,0.10215,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00018323,0.11128,0.12025,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0022095,0.11098,0.18954,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0011836,0.11096,0.1065,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.001071,0.11052,0.18471,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0035605,0.11007,0.10602,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.02128,0.10976,0.11854,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0032501,0.10974,0.09969,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0035605,0.10968,0.11099,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0096941,0.10944,0.10587,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.013243,0.10931,0.096007,1,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0054192,0.10894,0.13706,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0028118,0.10881,0.12091,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0014022,0.10864,0.11783,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0071051,0.10844,0.10419,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00024045,0.10842,0.11311,1,1
3,GO THYMIC T CELL SELECTION,0.013243,0.10839,0.1072,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.039406,0.10832,0.071626,1,1
3,GO LIPID MODIFICATION,0.00042777,0.10826,0.1291,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0027381,0.10774,0.10529,1,1
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.040981,0.1074,0.12013,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.00084997,0.10709,0.11713,1,1
3,GO DENDRITE EXTENSION,0.0037985,0.10656,0.20058,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00040235,0.10654,0.13084,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.00073415,0.10647,0.13479,1,1
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.031311,0.10641,0.096006,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029511,0.10633,0.12675,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.0075485,0.1062,0.095838,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0022095,0.10599,0.12838,1,1
3,GO TRANSLESION SYNTHESIS,0.002702,0.10583,0.1019,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0018764,0.10574,0.11527,1,1
3,GO SENSORY PERCEPTION,0.0001862,0.10571,0.11048,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0087156,0.10524,0.10496,1,1
3,GO REGULATION OF MAPK CASCADE,0.0030839,0.10518,0.12021,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.004964,0.10372,0.10903,1,1
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0023637,0.10355,0.11304,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.003607,0.1034,0.10805,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.00046872,0.10296,0.11196,1,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.00036124,0.10296,0.14103,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.044722,0.10281,0.098119,1,1
3,GO RESPONSE TO ACTIVITY,0.0066039,0.1025,0.11323,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0092477,0.10231,0.090436,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.026013,0.10229,0.08834,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00088789,0.10188,0.1228,1,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.048285,0.10184,0.14697,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.031311,0.10158,0.1202,1,1
3,GO SELECTIVE AUTOPHAGY,0.0010408,0.10154,0.1318,1,1
3,GO ANIMAL ORGAN MATURATION,0.007921,0.10141,0.15378,1,1
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.021053,0.10101,0.1954,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.0071051,0.10098,0.099051,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00062378,0.10093,0.10903,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0037985,0.10088,0.1146,1,1
3,GO GOLGI ORGANIZATION,6.545e-05,0.10023,0.13308,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0054192,0.10007,0.13486,1,1
3,GO REGULATION OF AUTOPHAGY,0.00032916,0.10002,0.11213,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00082553,0.099304,0.11177,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00044781,0.099,0.13344,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.043025,0.098433,0.12089,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.020828,0.098125,0.11076,1,1
3,GO POLYOL METABOLIC PROCESS,0.0045438,0.098028,0.095621,1,1
3,GO NADP METABOLIC PROCESS,0.02945,0.097976,0.13548,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.016568,0.097722,0.12452,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.019104,0.097673,0.091066,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.020828,0.097595,0.082879,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.00034485,0.097586,0.11471,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0073682,0.09747,0.093927,1,1
3,GO RECEPTOR RECYCLING,0.017506,0.097405,0.11432,1,1
3,GO VIRAL RELEASE FROM HOST CELL,0.008211,0.097386,0.112,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038478,0.096588,0.1139,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00040857,0.09651,0.13231,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00080175,0.096127,0.10066,1,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.015159,0.096126,0.14851,1,1
3,GO REGULATION OF CELL DEATH,0.0043184,0.095849,0.093068,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0037985,0.09558,0.1195,1,1
3,GO DETECTION OF ABIOTIC STIMULUS,0.017506,0.095556,0.088478,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.001483,0.095357,0.094422,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.0023009,0.095213,0.11864,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0104,0.09521,0.12934,1,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.022928,0.09521,0.11087,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.01128,0.095151,0.12616,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.00088789,0.094033,0.10633,1,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0090315,0.093817,0.13625,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.026838,0.093801,0.13118,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00095459,0.093727,0.12302,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0002443,0.093243,0.13615,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.001568,0.093043,0.1041,1,1
3,GO GOLGI RIBBON FORMATION,0.02945,0.093012,0.12489,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.0062108,0.092898,0.15182,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.042197,0.092666,0.076038,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0075485,0.092155,0.10098,1,1
3,GO APOPTOTIC PROCESS,0.0017517,0.092064,0.097801,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00019229,0.091879,0.11447,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00031414,0.091419,0.17347,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.051595,0.091361,0.11476,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00073415,0.091243,0.10836,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.0010113,0.091232,0.10644,1,1
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.03006,0.090909,0.10477,1,1
3,GO MAINTENANCE OF LOCATION,0.0048405,0.090904,0.10087,1,1
3,GO SPLEEN DEVELOPMENT,0.042609,0.090874,0.085295,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0030436,0.090499,0.098399,1,1
3,GO ANIMAL ORGAN REGENERATION,0.01585,0.089937,0.10169,1,1
3,GO CELL CELL RECOGNITION,0.0014624,0.089924,0.12978,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.027118,0.089912,0.12124,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.001118,0.089672,0.1174,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.026013,0.089541,0.1104,1,1
3,GO RETINA HOMEOSTASIS,0.036048,0.089328,0.055531,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,6.2175e-05,0.088972,0.11842,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.023173,0.088655,0.12039,1,1
3,GO MUSCLE CELL PROLIFERATION,0.062684,0.08851,0.08344,1,1
3,GO TOR SIGNALING,0.00067188,0.088346,0.099767,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.040981,0.088223,0.12142,1,1
3,GO SYMBIOTIC PROCESS,0.011949,0.088046,0.074996,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.010769,0.08803,0.083592,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00068191,0.087934,0.11444,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.016938,0.086613,0.10425,1,1
3,GO RESPONSE TO ETHER,0.058247,0.086206,0.081711,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.052083,0.086109,0.065194,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0098086,0.086002,0.1147,1,1
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0095807,0.084979,0.11524,1,1
3,GO DNA CATABOLIC PROCESS,0.0018508,0.084736,0.099849,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.00086244,0.084307,0.11281,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.054582,0.083924,0.090005,1,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.052575,0.083696,0.10513,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.03068,0.083211,0.089824,1,1
3,GO EXCRETION,0.018898,0.083187,0.10454,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.040981,0.082688,0.084147,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.0037016,0.082447,0.10108,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0042636,0.082353,0.11787,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.024687,0.082084,0.15109,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.0017517,0.081784,0.092886,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.020166,0.081601,0.090773,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.024428,0.081179,0.10046,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.056652,0.079616,0.088124,1,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.033608,0.078684,0.073832,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0088198,0.077918,0.083638,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0040509,0.077781,0.094762,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.027401,0.076837,0.094936,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.01585,0.076788,0.083897,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0033361,0.076295,0.097967,1,1
3,GO ORGANELLE DISASSEMBLY,0.0012005,0.075735,0.10697,1,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0037016,0.075371,0.096981,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0024281,0.075295,0.088381,1,1
3,GO ATP METABOLIC PROCESS,0.0069343,0.075158,0.080847,1,1
3,GO POSTREPLICATION REPAIR,0.056652,0.075111,0.057833,1,1
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0033799,0.074942,0.1165,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.02915,0.074884,0.11845,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.015674,0.07454,0.12083,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.0024281,0.074343,0.1158,1,1
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.035336,0.073527,0.079616,1,1
3,GO REGULATION OF MITOPHAGY,0.03902,0.073461,0.10751,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.056652,0.073271,0.079445,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.041383,0.072655,0.079172,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.036048,0.071257,0.084856,1,1
3,GO CELLULAR IRON ION HOMEOSTASIS,0.044292,0.070676,0.09033,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.002631,0.068053,0.12299,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.0030839,0.067299,0.08853,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.0025961,0.067258,0.085994,1,1
3,GO FERTILIZATION,0.015159,0.065647,0.065574,1,1
3,GO MITOPHAGY,0.027118,0.065616,0.10635,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.041383,0.064412,0.072124,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.0033799,0.063322,0.10036,1,1
3,GO GOLGI VESICLE TRANSPORT,0.017506,0.063202,0.081963,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.042197,0.062703,0.10453,1,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.02945,0.062554,0.10211,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.034636,0.061607,0.073983,1,1
3,GO REGULATION OF CATABOLIC PROCESS,0.03006,0.055986,0.063688,1,1
3,GO THIOESTER METABOLIC PROCESS,0.0065235,0.048182,0.11458,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.026838,0.04687,0.072831,1,1
3,GO MACROAUTOPHAGY,0.0029256,0.042349,0.091596,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.031953,0.04179,0.063338,1,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0032501,0.47536,0.32283,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.065005,0.29533,0.15846,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.00028155,0.27331,0.31681,1,0
3,GO PROTEIN KINASE C SIGNALING,7.0072e-05,0.26618,0.27323,1,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0011503,0.26448,0.2472,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.003654,0.26357,0.32683,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0030038,0.23155,0.1864,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.012798,0.23022,0.19847,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.060988,0.21897,0.092541,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.012653,0.21765,0.31243,1,0
3,GO PLASMINOGEN ACTIVATION,0.0027381,0.21502,0.25589,1,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00096848,0.21036,0.23085,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.046921,0.20316,0.098398,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00023667,0.20212,0.19023,1,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.027118,0.20042,0.17294,1,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.001568,0.19952,0.21442,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.024687,0.19827,0.15044,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03429,0.19591,0.25324,1,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0029645,0.1954,0.40937,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.032938,0.19429,0.18392,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0011503,0.19115,0.17981,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.055609,0.19075,0.11474,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.038637,0.19049,0.10347,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0020092,0.18954,0.24696,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.020828,0.18898,0.14126,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.006444,0.18874,0.24316,1,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00083767,0.18336,0.25336,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.03902,0.18305,0.10432,1,0
3,GO EPIDERMIS MORPHOGENESIS,0.033608,0.18234,0.12309,1,0
3,GO MACROPHAGE PROLIFERATION,0.023419,0.18207,0.2052,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.014494,0.17946,0.18644,1,0
3,GO HYALURONAN METABOLIC PROCESS,0.001704,0.17926,0.14875,1,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.010895,0.1783,0.24772,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0018006,0.17748,0.17058,1,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0033361,0.17747,0.22415,1,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0034692,0.17706,0.20456,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.001118,0.17572,0.16271,1,0
3,GO MONOAMINE TRANSPORT,0.00016361,0.17536,0.2482,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0051547,0.17369,0.18114,1,0
3,GO PROSTANOID METABOLIC PROCESS,0.037882,0.17368,0.14521,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.015501,0.17166,0.14774,1,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.015329,0.17149,0.19794,1,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0047798,0.17067,0.22048,1,0
3,GO METANEPHROS MORPHOGENESIS,0.019735,0.16886,0.14189,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.031631,0.16821,0.11722,1,0
3,GO CAMP METABOLIC PROCESS,0.018898,0.16627,0.14379,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0077327,0.16611,0.15684,1,0
3,GO GLIAL CELL PROLIFERATION,0.0050269,0.16599,0.15721,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.040582,0.16595,0.1224,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.001422,0.16454,0.1775,1,0
3,GO DIENCEPHALON DEVELOPMENT,0.012227,0.16447,0.16466,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.031953,0.16408,0.17182,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.047827,0.16391,0.11293,1,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.050154,0.16387,0.15087,1,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0052197,0.16315,0.15314,1,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,1.0756e-05,0.16311,0.16076,1,0
3,GO ENDOCYTIC RECYCLING,0.00021511,0.16297,0.16073,1,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,5.5127e-05,0.16281,0.18923,1,0
3,GO INNERVATION,0.027401,0.16149,0.22795,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00045468,0.16018,0.1758,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,4.7172e-05,0.15925,0.16862,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.0050269,0.15835,0.26637,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.01849,0.15825,0.13451,1,0
3,GO PEPTIDE HORMONE SECRETION,3.628e-05,0.15805,0.17281,1,0
3,GO REGULATION OF BLOOD CIRCULATION,0.00011218,0.15749,0.15722,1,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.01829,0.15694,0.20404,1,0
3,GO DENDRITIC CELL MIGRATION,0.026286,0.15654,0.11182,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.016752,0.15623,0.2095,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0021215,0.15484,0.17084,1,0
3,GO STARTLE RESPONSE,0.03902,0.15361,0.13386,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.058247,0.15352,0.171,1,0
3,GO CELL MATRIX ADHESION,0.0054872,0.1531,0.14724,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0043184,0.15276,0.15464,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00015838,0.1527,0.18635,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0013255,0.1525,0.15409,1,0
3,GO HORMONE TRANSPORT,4.31e-06,0.15246,0.18076,1,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.022928,0.15111,0.12774,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.036409,0.15076,0.10706,1,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00094089,0.15072,0.16721,1,0
3,GO REGULATION OF FIBRINOLYSIS,0.0052854,0.14981,0.21415,1,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.0070192,0.14915,0.20971,1,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0035146,0.14915,0.16392,1,0
3,GO CIRCULATORY SYSTEM PROCESS,6.0079e-05,0.1481,0.14467,1,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.033608,0.14698,0.16415,1,0
3,GO REGULATION OF INSULIN SECRETION,7.0072e-05,0.14645,0.15771,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.052575,0.14636,0.14495,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.050154,0.14582,0.18875,1,0
3,GO CELLULAR PIGMENTATION,0.00054518,0.14575,0.14482,1,0
3,GO CHLORIDE TRANSPORT,2.5424e-05,0.14525,0.1504,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.026286,0.14507,0.15054,1,0
3,GO NOTCH SIGNALING PATHWAY,2.5424e-05,0.1449,0.18007,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0029645,0.14482,0.18809,1,0
3,GO MIDBODY ABSCISSION,8.7316e-05,0.14474,0.18944,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00075607,0.14379,0.17174,1,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.061549,0.14372,0.092853,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.027118,0.14345,0.12995,1,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.045591,0.14343,0.10832,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0137,0.14281,0.14875,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0023637,0.14223,0.16316,1,0
3,GO CELL JUNCTION ASSEMBLY,0.0071918,0.14182,0.11482,1,0
3,GO RETINAL METABOLIC PROCESS,0.037509,0.14142,0.23101,1,0
3,GO REGULATION OF OSSIFICATION,0.0023009,0.14086,0.14723,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0054192,0.13938,0.14463,1,0
3,GO EPITHELIAL CELL PROLIFERATION,0.0037985,0.13927,0.13389,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.001955,0.13834,0.1521,1,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.0021215,0.13826,0.16095,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.011411,0.13808,0.27971,1,0
3,GO HEART PROCESS,0.00022565,0.13771,0.14839,1,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.00032408,0.13763,0.14808,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.052575,0.13747,0.11722,1,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.0019023,0.1374,0.18694,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0071918,0.13684,0.13172,1,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.017506,0.13674,0.11122,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00013673,0.13656,0.17082,1,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.001704,0.13647,0.18047,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.027686,0.13646,0.18894,1,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0044298,0.13644,0.18209,1,0
3,GO COMPLEMENT ACTIVATION,0.0077327,0.13611,0.20646,1,0
3,GO MUSCLE CELL MIGRATION,0.0049019,0.13528,0.15829,1,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.019735,0.13445,0.13283,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0001803,0.13392,0.15597,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0084096,0.1338,0.17758,1,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.001568,0.13378,0.1612,1,0
3,GO CYTOLYSIS,0.059879,0.13372,0.13599,1,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.033271,0.13352,0.16238,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.022446,0.13347,0.13899,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031311,0.13342,0.10844,1,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0054872,0.1333,0.17321,1,0
3,GO CATION TRANSPORT,7.2497e-05,0.13301,0.1258,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0030839,0.13297,0.31277,1,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.012653,0.13297,0.14927,1,0
3,GO CELL REDOX HOMEOSTASIS,0.0005056,0.13283,0.14795,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.026561,0.13274,0.13741,1,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.037882,0.13267,0.17866,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.021973,0.13212,0.11002,1,0
3,GO MAMMARY GLAND DEVELOPMENT,0.014658,0.13159,0.11441,1,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.045591,0.13155,0.11543,1,0
3,GO SENSORY PERCEPTION OF PAIN,0.0012705,0.13117,0.13379,1,0
3,GO GLAND MORPHOGENESIS,0.021053,0.13045,0.14468,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0042636,0.1304,0.14943,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.031631,0.1303,0.15244,1,0
3,GO REGULATION OF ION TRANSPORT,0.00039018,0.13011,0.12317,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.037509,0.12979,0.14889,1,0
3,GO REGULATION OF TRANSPORT,0.000286,0.12974,0.10845,1,0
3,GO VIRION ASSEMBLY,0.0021215,0.1296,0.10684,1,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.011813,0.12889,0.12629,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.0020646,0.12849,0.18554,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.055093,0.12848,0.11407,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.024687,0.1273,0.11917,1,0
3,GO ORGANIC CATION TRANSPORT,0.0044864,0.12709,0.14479,1,0
3,GO METAL ION TRANSPORT,0.00014129,0.12702,0.12251,1,0
3,GO FATTY ACID HOMEOSTASIS,0.020166,0.12634,0.18516,1,0
3,GO CELL MOTILITY,0.0063654,0.12587,0.1098,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0017277,0.12583,0.15111,1,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.018898,0.12576,0.12358,1,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.033948,0.12521,0.10448,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0044864,0.12505,0.12208,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0052197,0.12477,0.14353,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0067673,0.1237,0.11128,1,0
3,GO KERATINOCYTE PROLIFERATION,0.01829,0.12348,0.1353,1,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00060545,0.12324,0.1192,1,0
3,GO REGULATION OF SYSTEM PROCESS,0.0019285,0.12299,0.11128,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0022701,0.12284,0.13491,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.022928,0.12254,0.099687,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.044722,0.12226,0.13164,1,0
3,GO RESPONSE TO BMP,0.023919,0.12208,0.10978,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0098086,0.12105,0.16303,1,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0081133,0.12069,0.12106,1,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.059879,0.12051,0.090765,1,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0019285,0.12044,0.10736,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.011151,0.12036,0.12202,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.049212,0.12024,0.085646,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.00045468,0.12016,0.10354,1,0
3,GO RESPONSE TO ALCOHOL,0.0032078,0.11968,0.11232,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.008211,0.11926,0.15144,1,0
3,GO PLATELET MORPHOGENESIS,0.030368,0.11914,0.13173,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.0137,0.11895,0.098232,1,0
3,GO RUFFLE ORGANIZATION,0.002631,0.11891,0.13221,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.012653,0.11876,0.1072,1,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.036772,0.11843,0.10838,1,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.015329,0.11838,0.12682,1,0
3,GO RESPONSE TO NICOTINE,0.051111,0.11829,0.098634,1,0
3,GO MEMBRANE HYPERPOLARIZATION,0.033608,0.11827,0.11043,1,0
3,GO RESPONSE TO PEPTIDE,0.00091404,0.11763,0.11402,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.001422,0.11746,0.1233,1,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0049019,0.11735,0.11317,1,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.062684,0.11732,0.18843,1,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0066851,0.11708,0.09593,1,0
3,GO SIGNAL RELEASE,6.4341e-05,0.11704,0.14482,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.063258,0.11693,0.085187,1,0
3,GO JNK CASCADE,0.0029256,0.11677,0.10996,1,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040981,0.11676,0.1298,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.012945,0.11648,0.13185,1,0
3,GO OSSIFICATION,0.0087156,0.11629,0.12031,1,0
3,GO FEEDING BEHAVIOR,0.016027,0.11567,0.097285,1,0
3,GO IMPORT INTO CELL,0.014823,0.11553,0.10185,1,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.00016901,0.11547,0.11873,1,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.033608,0.11531,0.13242,1,0
3,GO LOCOMOTORY BEHAVIOR,0.040582,0.11526,0.10397,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.012227,0.11474,0.11279,1,0
3,GO CARDIAC CONDUCTION,0.0014624,0.11452,0.15281,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.014494,0.1142,0.10929,1,0
3,GO REGULATION OF CELL MATURATION,0.0085105,0.11411,0.10942,1,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0104,0.11408,0.15312,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012367,0.11406,0.11514,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.007921,0.1135,0.11826,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.013546,0.11289,0.096657,1,0
3,GO RESPONSE TO CARBOHYDRATE,0.00090088,0.11233,0.11711,1,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.01016,0.11216,0.11025,1,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.063836,0.11212,0.10675,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.007921,0.11179,0.13146,1,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.0039481,0.11163,0.095668,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.014172,0.11161,0.095374,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.01585,0.11151,0.11935,1,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.039406,0.1109,0.078189,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.021973,0.11068,0.14189,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.036409,0.11065,0.09838,1,0
3,GO VIRAL BUDDING,0.00088789,0.11058,0.13557,1,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.010041,0.11004,0.10448,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0023637,0.10956,0.11981,1,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.048746,0.10936,0.13657,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.060432,0.10916,0.1693,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.02174,0.10914,0.093139,1,0
3,GO OOCYTE DIFFERENTIATION,0.0094686,0.10907,0.10368,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.016938,0.10896,0.11162,1,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0075485,0.10888,0.17369,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.030368,0.1085,0.21441,1,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.020166,0.10849,0.097074,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.02915,0.10829,0.098091,1,0
3,GO PRO B CELL DIFFERENTIATION,0.034636,0.10817,0.14016,1,0
3,GO MUSCLE CELL DIFFERENTIATION,0.0093576,0.10815,0.10057,1,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.01251,0.1081,0.087215,1,0
3,GO STRESS FIBER ASSEMBLY,0.05063,0.10801,0.10887,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.010769,0.10797,0.11963,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.010895,0.1079,0.11514,1,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0013443,0.10774,0.13564,1,0
3,GO DEVELOPMENTAL MATURATION,0.0095807,0.10756,0.10369,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.0021798,0.10751,0.11693,1,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.02521,0.10717,0.15742,1,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00091404,0.10705,0.12048,1,0
3,GO I KAPPAB PHOSPHORYLATION,0.036772,0.10665,0.11072,1,0
3,GO POTASSIUM ION TRANSPORT,0.0024609,0.1064,0.13191,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0053519,0.10634,0.10194,1,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0016122,0.10631,0.11496,1,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.00045468,0.10612,0.10828,1,0
3,GO PANCREAS DEVELOPMENT,0.050154,0.10607,0.10896,1,0
3,GO CELL MATURATION,0.00036686,0.10585,0.12406,1,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0014624,0.10577,0.10711,1,0
3,GO HORMONE METABOLIC PROCESS,0.00026858,0.10519,0.17144,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0029645,0.10495,0.11892,1,0
3,GO MOLTING CYCLE,0.021973,0.10489,0.091879,1,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.054074,0.10485,0.12615,1,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.026013,0.10474,0.13022,1,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.036409,0.10418,0.093006,1,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0018006,0.1038,0.12263,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.027686,0.10372,0.11145,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.01499,0.10365,0.10066,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.040582,0.10348,0.075934,1,0
3,GO REGULATION OF T CELL MIGRATION,0.0024941,0.1034,0.15955,1,0
3,GO AMINO ACID IMPORT,0.057711,0.10332,0.088789,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.026286,0.10319,0.10735,1,0
3,GO MACROPHAGE MIGRATION,0.012798,0.10318,0.10749,1,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.029754,0.10314,0.13003,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.031953,0.10313,0.14993,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.037509,0.10306,0.12243,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0043737,0.1027,0.098288,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.044722,0.10269,0.098264,1,0
3,GO ERBB SIGNALING PATHWAY,0.052083,0.10236,0.087558,1,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0060595,0.10225,0.10667,1,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0017517,0.10224,0.10574,1,0
3,GO NEGATIVE REGULATION OF GROWTH,0.0083098,0.10224,0.11009,1,0
3,GO VACUOLAR TRANSPORT,0.0007786,0.1016,0.12789,1,0
3,GO MALE SEX DIFFERENTIATION,0.013243,0.10121,0.10169,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.011544,0.10112,0.16903,1,0
3,GO REGULATION OF PROTEIN BINDING,0.0047198,0.1011,0.10951,1,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0025277,0.10062,0.098609,1,0
3,GO TUBE DEVELOPMENT,0.017506,0.10026,0.096918,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.017315,0.099564,0.081728,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.048746,0.099432,0.092947,1,0
3,GO ENSHEATHMENT OF NEURONS,0.01585,0.099399,0.10857,1,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.0034692,0.099348,0.10158,1,0
3,GO MUSCLE CONTRACTION,0.0065235,0.098133,0.09744,1,0
3,GO GROOMING BEHAVIOR,0.046474,0.097783,0.12008,1,0
3,GO ERK1 AND ERK2 CASCADE,0.045155,0.097593,0.11284,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0071918,0.097452,0.09377,1,0
3,GO EAR DEVELOPMENT,0.044292,0.096651,0.081643,1,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0096941,0.096582,0.10121,1,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.054074,0.096206,0.080809,1,0
3,GO RESPONSE TO GROWTH FACTOR,0.040187,0.095908,0.0851,1,0
3,GO ERAD PATHWAY,0.0052854,0.095812,0.10304,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.033608,0.095749,0.12599,1,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00094089,0.095442,0.16288,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0039992,0.095228,0.11132,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0048405,0.094818,0.099811,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0075485,0.094817,0.095089,1,0
3,GO PIGMENT CELL DIFFERENTIATION,0.054582,0.094641,0.094552,1,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.016752,0.094627,0.11137,1,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.0025277,0.094553,0.093792,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.035336,0.09453,0.12486,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.02521,0.094455,0.11195,1,0
3,GO REGULATION OF GROWTH,0.018898,0.094409,0.082453,1,0
3,GO TUBE MORPHOGENESIS,0.044722,0.094147,0.087444,1,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.010895,0.093848,0.094648,1,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046921,0.093496,0.10565,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.010895,0.093325,0.10815,1,0
3,GO RUFFLE ASSEMBLY,0.040187,0.093231,0.10103,1,0
3,GO RESPONSE TO MONOSACCHARIDE,0.00072342,0.093098,0.12078,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0075485,0.093038,0.11202,1,0
3,GO CELLULAR HOMEOSTASIS,0.0002443,0.092982,0.10518,1,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.032278,0.092836,0.093978,1,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0071051,0.092754,0.093901,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0018006,0.092706,0.11639,1,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.057711,0.092151,0.060837,1,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.016386,0.091825,0.11862,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0033361,0.091715,0.11155,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.014332,0.091671,0.11336,1,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.064418,0.09159,0.10344,1,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.042609,0.091462,0.084096,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.023668,0.091089,0.15388,1,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.065596,0.090879,0.1095,1,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.026561,0.090335,0.097582,1,0
3,GO TISSUE MORPHOGENESIS,0.040981,0.090258,0.074738,1,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.01128,0.090175,0.1042,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0056255,0.090109,0.10223,1,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.018091,0.089462,0.10277,1,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.0027747,0.089111,0.12289,1,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.003654,0.089005,0.092304,1,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00069207,0.088684,0.13042,1,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.065596,0.088473,0.076722,1,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0034692,0.088429,0.11081,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.004964,0.088387,0.11057,1,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.032938,0.088364,0.098364,1,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.029754,0.08777,0.11473,1,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0025961,0.087666,0.10902,1,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.02945,0.087388,0.076591,1,0
3,GO VITAMIN METABOLIC PROCESS,0.0092477,0.087015,0.11192,1,0
3,GO CARNITINE SHUTTLE,0.040187,0.086884,0.12902,1,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.054074,0.08666,0.070517,1,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.012653,0.086654,0.11403,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.019523,0.086229,0.10377,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0016347,0.085772,0.10661,1,0
3,GO REGULATION OF METAL ION TRANSPORT,0.02915,0.085764,0.07699,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.01585,0.085649,0.092508,1,0
3,GO MEMBRANE INVAGINATION,0.033271,0.085645,0.10516,1,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.016938,0.0856,0.12885,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.063258,0.085503,0.076024,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0078263,0.085173,0.12448,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.040582,0.085129,0.09639,1,0
3,GO CHEMOSENSORY BEHAVIOR,0.033608,0.084991,0.10003,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.023919,0.08497,0.089115,1,0
3,GO LYSOSOMAL TRANSPORT,0.0052197,0.084551,0.12419,1,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.038637,0.08448,0.1013,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0035605,0.084199,0.1143,1,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00031414,0.083988,0.10225,1,0
3,GO REGULATION OF EXOCYTOSIS,0.0016575,0.083976,0.13419,1,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.060432,0.083896,0.088967,1,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.033271,0.083874,0.12556,1,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.035336,0.083613,0.1255,1,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.02945,0.083448,0.085134,1,0
3,GO FIBROBLAST PROLIFERATION,0.012945,0.083388,0.1454,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.019312,0.083274,0.10407,1,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.047372,0.082964,0.080833,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.019104,0.082766,0.11975,1,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0042095,0.082542,0.094155,1,0
3,GO SOMITOGENESIS,0.0096941,0.082432,0.10077,1,0
3,GO CYTOKINETIC PROCESS,0.008211,0.08234,0.10825,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.063258,0.081939,0.076035,1,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.011949,0.081936,0.087343,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0087156,0.081917,0.13652,1,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.0056255,0.081735,0.12942,1,0
3,GO OSTEOCLAST DIFFERENTIATION,0.048285,0.081688,0.089062,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.023419,0.081649,0.082144,1,0
3,GO RHYTHMIC PROCESS,0.013243,0.081597,0.07939,1,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0033799,0.080977,0.094912,1,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.044722,0.08097,0.068443,1,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.02521,0.080499,0.082966,1,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.03429,0.07999,0.064273,1,0
3,GO PYRUVATE METABOLIC PROCESS,0.042609,0.07964,0.086459,1,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.046921,0.079448,0.085554,1,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.03429,0.079308,0.080943,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.047827,0.078846,0.11099,1,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.062684,0.078099,0.086177,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.014823,0.078067,0.10473,1,0
3,GO RESPONSE TO ESTRADIOL,0.054074,0.078005,0.075086,1,0
3,GO CELL CELL SIGNALING,0.042197,0.077578,0.069296,1,0
3,GO GLIOGENESIS,0.043866,0.077556,0.096003,1,0
3,GO NEURON DEATH,0.031311,0.07742,0.075983,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.043444,0.077375,0.076317,1,0
3,GO REGULATION OF PHOSPHORYLATION,0.0044298,0.07705,0.097479,1,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0059116,0.077026,0.10093,1,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.028556,0.076762,0.18829,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.014332,0.076753,0.12107,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0055559,0.076203,0.11391,1,0
3,GO DEPHOSPHORYLATION,0.013856,0.076009,0.07454,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.042197,0.075955,0.067443,1,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.040582,0.075883,0.089471,1,0
3,GO REPRODUCTION,0.010645,0.075848,0.078001,1,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.015674,0.075757,0.082758,1,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.032278,0.07558,0.083392,1,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.034984,0.075157,0.084388,1,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.048285,0.074893,0.082358,1,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.037509,0.074608,0.13695,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.021509,0.074547,0.082826,1,0
3,GO REGULATION OF PROTEIN FOLDING,0.046921,0.074136,0.084259,1,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0075485,0.073967,0.086965,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.015159,0.073938,0.076413,1,0
3,GO IRON ION HOMEOSTASIS,0.012087,0.073877,0.11245,1,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.051595,0.073764,0.069903,1,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.059879,0.073758,0.067805,1,0
3,GO ENDOSOMAL TRANSPORT,0.0099244,0.073524,0.079061,1,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.048746,0.073468,0.16608,1,0
3,GO PEPTIDYL SERINE MODIFICATION,0.023919,0.073376,0.073392,1,0
3,GO ESTROGEN METABOLIC PROCESS,0.054582,0.073302,0.11007,1,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.055093,0.073181,0.084491,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.02521,0.073049,0.092053,1,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.029754,0.072741,0.093452,1,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0095807,0.07221,0.089063,1,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.018898,0.072142,0.1145,1,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.033271,0.072117,0.12669,1,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.065596,0.072027,0.10825,1,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.027118,0.071884,0.078521,1,0
3,GO POSITIVE REGULATION OF GROWTH,0.058247,0.071406,0.070927,1,0
3,GO SPERM EGG RECOGNITION,0.010645,0.070678,0.089108,1,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.011813,0.070507,0.079523,1,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.047827,0.070471,0.06971,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.022686,0.070445,0.077254,1,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.020605,0.070353,0.089909,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.01016,0.070205,0.08343,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.058787,0.070195,0.056607,1,0
3,GO NERVOUS SYSTEM PROCESS,0.026561,0.069791,0.077037,1,0
3,GO MATING,0.016938,0.069399,0.099684,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.057179,0.069315,0.071921,1,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.057179,0.069239,0.10549,1,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.033948,0.069208,0.070226,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.023919,0.068835,0.12431,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.036409,0.068486,0.074669,1,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.051595,0.06831,0.092884,1,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.063836,0.068191,0.070879,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.024428,0.068184,0.15669,1,0
3,GO RESPONSE TO CHEMOKINE,0.0094686,0.068153,0.08031,1,0
3,GO KIDNEY MORPHOGENESIS,0.054582,0.06807,0.093595,1,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.049681,0.067459,0.074707,1,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.048746,0.067436,0.073061,1,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.054074,0.06676,0.064341,1,0
3,GO PROTEIN CATABOLIC PROCESS,0.0041031,0.066601,0.07919,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.038637,0.066485,0.11208,1,0
3,GO CELL GROWTH,0.065596,0.066213,0.07161,1,0
3,GO REGULATION OF PHAGOCYTOSIS,0.040187,0.065924,0.11306,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.015159,0.065696,0.092015,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.056128,0.065284,0.079238,1,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.012945,0.064276,0.0898,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0077327,0.063701,0.093466,1,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.02128,0.0633,0.085872,1,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.056652,0.063253,0.094256,1,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.060988,0.063181,0.059237,1,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.013243,0.062872,0.069761,1,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015329,0.062329,0.1543,1,0
3,GO MYOFIBRIL ASSEMBLY,0.03429,0.061939,0.10509,1,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.036772,0.061273,0.072431,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.043866,0.061228,0.071617,1,0
3,GO TISSUE REGENERATION,0.026013,0.061102,0.11831,1,0
3,GO OXIDATIVE PHOSPHORYLATION,0.035691,0.060668,0.078775,1,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.046031,0.059984,0.065853,1,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.023668,0.059816,0.079197,1,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015329,0.059187,0.073994,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.063836,0.059019,0.20358,1,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.056128,0.058396,0.12144,1,0
3,GO REGULATION OF BINDING,0.042197,0.057648,0.072989,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019312,0.057295,0.083014,1,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0137,0.056397,0.079163,1,0
3,GO ANION HOMEOSTASIS,0.043025,0.056241,0.10345,1,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.050154,0.056227,0.07971,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.042609,0.056129,0.080085,1,0
3,GO MULTI ORGANISM PROCESS,0.021973,0.056046,0.064572,1,0
3,GO BLASTOCYST DEVELOPMENT,0.011544,0.056017,0.071033,1,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.061549,0.054946,0.072346,1,0
3,GO HISTONE H2B UBIQUITINATION,0.049681,0.054147,0.084071,1,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.026561,0.054139,0.11511,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.03068,0.053802,0.077513,1,0
3,GO CYTOSOLIC TRANSPORT,0.015329,0.053791,0.081931,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0061347,0.05199,0.071899,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.041789,0.051858,0.08469,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.063258,0.050731,0.055131,1,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.033608,0.050001,0.095801,1,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.051595,0.049347,0.074434,1,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0062877,0.049052,0.094506,1,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0104,0.047443,0.071001,1,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.023419,0.046138,0.10393,1,0
3,GO VESICLE LOCALIZATION,0.056652,0.045553,0.065205,1,0
3,GO GLIAL CELL DIFFERENTIATION,0.050154,0.044793,0.098268,1,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.050154,0.044308,0.081497,1,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.032607,0.043842,0.12323,1,0
3,GO SEXUAL REPRODUCTION,0.044722,0.043502,0.053026,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.049212,0.043052,0.076269,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.039406,0.041412,0.10152,1,0
3,GO TRNA CATABOLIC PROCESS,0.054074,0.039333,0.16828,1,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.053071,0.038688,0.058823,1,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.057179,0.037678,0.047193,1,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.060432,0.035529,0.086834,1,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.056652,0.03122,0.049527,1,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0092477,0.029039,0.095195,1,0
3,GO REGULATION OF MACROAUTOPHAGY,0.038637,0.023626,0.073148,1,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.063258,0.0075491,0.070155,1,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.057179,-0.019916,-0.027721,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.059879,-0.031248,-0.044514,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.057179,-0.036741,-0.034409,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.065596,-0.037919,-0.036889,1,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.035336,-0.038992,-0.066762,1,0
3,GO TRANSPORT ALONG MICROTUBULE,0.065005,-0.043067,-0.050654,1,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.022686,-0.044293,-0.095906,1,0
3,GO DNA METABOLIC PROCESS,0.03429,-0.047992,-0.03162,1,0
3,GO MIRNA METABOLIC PROCESS,0.048285,-0.049332,-0.067469,1,0
3,GO NUCLEAR TRANSPORT,0.02915,-0.049381,-0.04439,1,0
3,GO HISTONE METHYLATION,0.058247,-0.049591,-0.053734,1,0
3,GO AXO DENDRITIC TRANSPORT,0.039406,-0.050631,-0.065925,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.053071,-0.053352,-0.040415,1,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.043444,-0.054481,-0.058265,1,0
3,GO RNA CATABOLIC PROCESS,0.057179,-0.054842,-0.071233,1,0
3,GO HISTONE UBIQUITINATION,0.061549,-0.055027,-0.043454,1,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024687,-0.055674,-0.053856,1,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.060988,-0.056944,-0.065215,1,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.019312,-0.057019,-0.090706,1,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.012945,-0.05741,-0.091064,1,0
3,GO RESPONSE TO UV,0.05357,-0.059432,-0.044278,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.063836,-0.060286,-0.071081,1,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.018091,-0.060457,-0.04878,1,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.066192,-0.061286,-0.052002,1,0
3,GO REGULATION OF RNA SPLICING,0.0054192,-0.061471,-0.071335,1,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0083098,-0.061909,-0.067621,1,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.019523,-0.062252,-0.036463,1,0
3,GO DNA REPAIR,0.0052854,-0.062489,-0.050475,1,0
3,GO HISTONE H3 K9 MODIFICATION,0.064418,-0.062723,-0.065083,1,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.01016,-0.06283,-0.05426,1,0
3,GO HISTONE H3 K9 METHYLATION,0.056652,-0.062931,-0.06918,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.02915,-0.062966,-0.073344,1,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.035691,-0.063274,-0.048146,1,0
3,GO CHROMOSOME ORGANIZATION,0.015674,-0.063758,-0.039369,1,0
3,GO REGULATION OF TELOMERE CAPPING,0.056128,-0.064244,-0.049538,1,0
3,GO HISTONE H4 DEACETYLATION,0.05357,-0.064368,-0.10641,1,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.059879,-0.064719,-0.031202,1,0
3,GO PROTEIN NEDDYLATION,0.01499,-0.065522,-0.088425,1,0
3,GO SNRNA TRANSCRIPTION,0.014494,-0.065888,-0.059225,1,0
3,GO REGULATION OF GENE SILENCING,0.010769,-0.066662,-0.070527,1,0
3,GO DNA REPLICATION,0.017315,-0.06737,-0.053401,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.037139,-0.067963,-0.068318,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.037882,-0.068416,-0.054256,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.021053,-0.068418,-0.092629,1,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.0092477,-0.068452,-0.054275,1,0
3,GO BASE EXCISION REPAIR,0.0052854,-0.069134,-0.073706,1,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0069343,-0.069239,-0.072449,1,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.0037498,-0.069497,-0.050824,1,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.026013,-0.069618,-0.13317,1,0
3,GO RNA POLYADENYLATION,0.011949,-0.069788,-0.080881,1,0
3,GO PEPTIDYL LYSINE METHYLATION,0.050154,-0.070082,-0.058016,1,0
3,GO DOUBLE STRAND BREAK REPAIR,0.0033361,-0.070198,-0.067521,1,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.036048,-0.07062,-0.056474,1,0
3,GO SISTER CHROMATID SEGREGATION,0.0080166,-0.070825,-0.063705,1,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.052083,-0.071226,-0.106,1,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.016752,-0.071469,-0.10599,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0055559,-0.07173,-0.065357,1,0
3,GO NEURON PROJECTION GUIDANCE,0.052575,-0.072065,-0.087386,1,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.012653,-0.072098,-0.055669,1,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.043866,-0.072348,-0.07883,1,0
3,GO SNRNA PROCESSING,0.040187,-0.072664,-0.083876,1,0
3,GO REGULATION OF RNA BINDING,0.03429,-0.073734,-0.096826,1,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0085105,-0.074029,-0.087659,1,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.019523,-0.074108,-0.057264,1,0
3,GO DNA CONFORMATION CHANGE,0.0063654,-0.074531,-0.063943,1,0
3,GO MRNA METABOLIC PROCESS,0.001071,-0.074737,-0.092005,1,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.027686,-0.074791,-0.046959,1,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.045591,-0.07529,-0.1242,1,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.035336,-0.075478,-0.073198,1,0
3,GO REGULATION OF LYASE ACTIVITY,0.060988,-0.075497,-0.081935,1,0
3,GO SPINDLE ASSEMBLY,0.011678,-0.075684,-0.051956,1,0
3,GO MICROTUBULE POLYMERIZATION,0.058787,-0.075838,-0.062775,1,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.040981,-0.075943,-0.03912,1,0
3,GO CHROMOSOME SEGREGATION,0.0059116,-0.076387,-0.061418,1,0
3,GO VIRAL GENE EXPRESSION,0.011022,-0.076628,-0.13296,1,0
3,GO TRNA PROCESSING,0.013546,-0.076821,-0.094881,1,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.023419,-0.07715,-0.10154,1,0
3,GO DNA PACKAGING,0.012367,-0.077181,-0.059724,1,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.02945,-0.077431,-0.069177,1,0
3,GO AXONAL TRANSPORT,0.028556,-0.077448,-0.077007,1,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052575,-0.077813,-0.074506,1,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0027747,-0.077871,-0.073481,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0040509,-0.077958,-0.071233,1,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.061549,-0.078417,-0.10287,1,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.053071,-0.078593,-0.082793,1,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.028264,-0.078644,-0.075823,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.053071,-0.079721,-0.071139,1,0
3,GO SNORNA METABOLIC PROCESS,0.029754,-0.080016,-0.12559,1,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0050904,-0.08057,-0.073746,1,0
3,GO DNA RECOMBINATION,0.01016,-0.080964,-0.053276,1,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.056652,-0.081051,-0.084443,1,0
3,GO MRNA CLEAVAGE,0.0072795,-0.081085,-0.074895,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0085105,-0.081493,-0.068968,1,0
3,GO TELOMERE ORGANIZATION,0.0011021,-0.081856,-0.080788,1,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.035336,-0.082056,-0.067478,1,0
3,GO CELL CYCLE DNA REPLICATION,0.0050904,-0.082471,-0.086348,1,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.014658,-0.082734,-0.075262,1,0
3,GO NCRNA TRANSCRIPTION,0.00058763,-0.083326,-0.085361,1,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.063258,-0.083726,-0.063562,1,0
3,GO RNA SURVEILLANCE,0.0030839,-0.084067,-0.13162,1,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0067673,-0.084105,-0.073132,1,0
3,GO VIRAL LATENCY,0.016027,-0.084587,-0.10665,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.054074,-0.084761,-0.063033,1,0
3,GO HISTONE H3 K27 METHYLATION,0.011411,-0.085333,-0.10638,1,0
3,GO MRNA PROCESSING,0.0003557,-0.085448,-0.096277,1,0
3,GO HISTONE H3 ACETYLATION,0.018091,-0.085658,-0.055208,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.006444,-0.085881,-0.096067,1,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.033271,-0.086042,-0.056405,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.048285,-0.08635,-0.050278,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0038478,-0.087104,-0.11059,1,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0037498,-0.087395,-0.17309,1,0
3,GO MITOCHONDRION LOCALIZATION,0.021053,-0.087797,-0.066632,1,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0032928,-0.088273,-0.072253,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0037498,-0.08891,-0.079296,1,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0013255,-0.089856,-0.084942,1,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0076401,-0.090016,-0.068201,1,0
3,GO NUCLEAR EXPORT,0.004964,-0.090116,-0.071276,1,0
3,GO CELLULAR RESPONSE TO UV,0.0092477,-0.090218,-0.073503,1,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.049212,-0.090341,-0.075642,1,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.05357,-0.090763,-0.08895,1,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.028556,-0.091054,-0.090174,1,0
3,GO CENTRIOLE ASSEMBLY,0.023173,-0.091351,-0.072246,1,0
3,GO RNA PROCESSING,0.00081356,-0.091705,-0.094703,1,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.035691,-0.092075,-0.086701,1,0
3,GO DNA GEOMETRIC CHANGE,0.0033361,-0.092891,-0.084581,1,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.049681,-0.093338,-0.056771,1,0
3,GO CHROMATIN REMODELING,0.0047798,-0.093521,-0.066031,1,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.047372,-0.093879,-0.098489,1,0
3,GO RRNA METABOLIC PROCESS,0.0060595,-0.093882,-0.12006,1,0
3,GO MICROTUBULE NUCLEATION,0.043444,-0.093924,-0.051078,1,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.014172,-0.093942,-0.087692,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016386,-0.093961,-0.12397,1,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.05063,-0.094527,-0.071965,1,0
3,GO SPINDLE LOCALIZATION,0.048746,-0.094593,-0.053035,1,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.021053,-0.094627,-0.085522,1,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.060432,-0.094721,-0.1679,1,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.024173,-0.094903,-0.076257,1,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.017315,-0.094985,-0.067381,1,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.031953,-0.095052,-0.094122,1,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.017506,-0.095288,-0.087178,1,0
3,GO RNA SPLICING,0.00015583,-0.09558,-0.10503,1,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.013394,-0.095787,-0.073212,1,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.01251,-0.096148,-0.11203,1,0
3,GO HISTONE H3 K9 ACETYLATION,0.001568,-0.096278,-0.13174,1,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.023173,-0.096346,-0.11643,1,0
3,GO SPINDLE ORGANIZATION,0.0043737,-0.096426,-0.063663,1,0
3,GO BONE MORPHOGENESIS,0.049681,-0.096441,-0.091969,1,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.03429,-0.096843,-0.10218,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.016752,-0.096916,-0.09323,1,0
3,GO CELLULAR RESPONSE TO X RAY,0.016027,-0.097378,-0.12706,1,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.020828,-0.097971,-0.10288,1,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.0037985,-0.098256,-0.094051,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.028264,-0.098845,-0.059578,1,0
3,GO SNRNA METABOLIC PROCESS,0.065596,-0.099002,-0.064179,1,0
3,GO MYOBLAST MIGRATION,0.059331,-0.099279,-0.18888,1,0
3,GO RNA METHYLATION,0.05063,-0.099362,-0.068986,1,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.014013,-0.099715,-0.074491,1,0
3,GO CHROMATIN SILENCING,0.003654,-0.099746,-0.10012,1,0
3,GO NCRNA METABOLIC PROCESS,0.019735,-0.10006,-0.086785,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.062684,-0.10032,-0.067329,1,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00019541,-0.10037,-0.11804,1,0
3,GO HISTONE H3 K14 ACETYLATION,0.056652,-0.10043,-0.061155,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029645,-0.10054,-0.091971,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0056255,-0.10105,-0.1386,1,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.058787,-0.10115,-0.078021,1,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.0037016,-0.10153,-0.12024,1,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.061549,-0.10177,-0.066505,1,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0054872,-0.10181,-0.069178,1,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0043737,-0.10199,-0.10497,1,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.0056958,-0.10202,-0.10193,1,0
3,GO G0 TO G1 TRANSITION,0.0021505,-0.10204,-0.10668,1,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.018693,-0.10208,-0.12443,1,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0080166,-0.10215,-0.074131,1,0
3,GO RNA CAPPING,0.0061347,-0.10262,-0.075159,1,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.053071,-0.10285,-0.10293,1,0
3,GO UV PROTECTION,0.042197,-0.1032,-0.12856,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.022928,-0.10329,-0.11022,1,0
3,GO OXIDATIVE DEMETHYLATION,0.012798,-0.10333,-0.075805,1,0
3,GO RECOMBINATIONAL REPAIR,0.00054518,-0.10346,-0.098258,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0022396,-0.10379,-0.1417,1,0
3,GO RNA 3 END PROCESSING,0.0013255,-0.10381,-0.089295,1,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.006444,-0.10406,-0.077508,1,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0023637,-0.10411,-0.0981,1,0
3,GO TRANSLATIONAL INITIATION,0.0065235,-0.10428,-0.16123,1,0
3,GO RIBOSOME ASSEMBLY,0.0083098,-0.10441,-0.17191,1,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.057179,-0.10442,-0.083051,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0098086,-0.1045,-0.13847,1,0
3,GO REGULATION OF DNA REPAIR,0.00026858,-0.10508,-0.089012,1,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.044722,-0.1051,-0.091093,1,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.052083,-0.10512,-0.11298,1,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.015501,-0.10518,-0.10615,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.03429,-0.10539,-0.13278,1,0
3,GO TRNA METHYLATION,0.055093,-0.1054,-0.080455,1,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.040582,-0.1058,-0.083464,1,0
3,GO TRNA MODIFICATION,0.013394,-0.10582,-0.10112,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.01829,-0.10628,-0.090486,1,0
3,GO NEURAL CREST CELL MIGRATION,0.055609,-0.1065,-0.10212,1,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0015463,-0.10723,-0.109,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0039992,-0.10784,-0.072094,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00020504,-0.10859,-0.10875,1,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0059116,-0.10953,-0.085402,1,0
3,GO NUCLEOSOME ORGANIZATION,0.0046018,-0.10953,-0.085711,1,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.0078263,-0.10961,-0.10629,1,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.028264,-0.11002,-0.10057,1,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00072342,-0.11121,-0.091242,1,0
3,GO SNORNA 3 END PROCESSING,0.014823,-0.11172,-0.14424,1,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.0011503,-0.11183,-0.095816,1,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0137,-0.11185,-0.10326,1,0
3,GO ERYTHROCYTE MATURATION,0.0093576,-0.11239,-0.1306,1,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.8924e-05,-0.11244,-0.11096,1,0
3,GO MRNA 3 END PROCESSING,0.0007901,-0.11251,-0.096838,1,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.03068,-0.11269,-0.092441,1,0
3,GO GLYCINE METABOLIC PROCESS,0.047827,-0.11277,-0.11439,1,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.030368,-0.1131,-0.088873,1,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.011813,-0.1136,-0.088378,1,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0017517,-0.1136,-0.10695,1,0
3,GO LYMPHANGIOGENESIS,0.0050904,-0.11541,-0.15625,1,0
3,GO RNA STABILIZATION,0.0021798,-0.11585,-0.092658,1,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.021053,-0.11633,-0.11296,1,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.014332,-0.11684,-0.10278,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.000662,-0.11717,-0.087656,1,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0021798,-0.11745,-0.12707,1,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.011151,-0.1175,-0.12364,1,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.00019857,-0.11755,-0.11817,1,0
3,GO MATURATION OF 5 8S RRNA,0.0070192,-0.11791,-0.13674,1,0
3,GO DNA STRAND ELONGATION,0.0045438,-0.11856,-0.10011,1,0
3,GO REGULATION OF NEURON MIGRATION,0.012227,-0.11908,-0.16044,1,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.016752,-0.11929,-0.16815,1,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.01251,-0.11933,-0.1426,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.064418,-0.11939,-0.070984,1,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.00044103,-0.11945,-0.099007,1,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0012886,-0.11972,-0.086516,1,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.017125,-0.11974,-0.10012,1,0
3,GO CYTOPLASMIC TRANSLATION,0.0018764,-0.12052,-0.18481,1,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.0088198,-0.12137,-0.17191,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00072342,-0.12146,-0.097274,1,0
3,GO ETHANOL CATABOLIC PROCESS,0.040582,-0.12154,-0.14522,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.0029645,-0.12173,-0.075203,1,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.006444,-0.12268,-0.094369,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.02174,-0.12322,-0.12387,1,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.021509,-0.12326,-0.13023,1,0
3,GO RESPIRATORY SYSTEM PROCESS,0.007921,-0.12336,-0.12555,1,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.00084997,-0.12382,-0.11472,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.011678,-0.12386,-0.088959,1,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00067188,-0.12393,-0.13453,1,0
3,GO DNA DEPENDENT DNA REPLICATION,0.00024819,-0.12426,-0.10497,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0071918,-0.12514,-0.11763,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029052,-0.12518,-0.10154,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,2.4972e-05,-0.12555,-0.12678,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0016806,-0.12564,-0.11271,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00019229,-0.12638,-0.13801,1,0
3,GO RNA LOCALIZATION,0.00016361,-0.12643,-0.10705,1,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00090088,-0.12656,-0.094701,1,0
3,GO CHROMOSOME SEPARATION,0.001568,-0.12675,-0.097434,1,0
3,GO MRNA TRANSPORT,0.00045468,-0.12758,-0.099328,1,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.064418,-0.12778,-0.10374,1,0
3,GO RIBOSOME BIOGENESIS,0.0030038,-0.12786,-0.14502,1,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.014823,-0.12818,-0.10753,1,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00072342,-0.1287,-0.10778,1,0
3,GO TRNA TRANSPORT,0.0013826,-0.12885,-0.12146,1,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.010769,-0.12906,-0.20107,1,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0047198,-0.12921,-0.143,1,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0066039,-0.12922,-0.11424,1,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0033361,-0.12949,-0.12446,1,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0012886,-0.12964,-0.12053,1,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00037835,-0.12991,-0.091044,1,0
3,GO DNA REPLICATION CHECKPOINT,0.0026663,-0.1302,-0.13971,1,0
3,GO MRNA EXPORT FROM NUCLEUS,8.8796e-05,-0.13041,-0.1173,1,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,5.3256e-05,-0.1305,-0.11518,1,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.039795,-0.13052,-0.11373,1,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0094686,-0.13065,-0.10757,1,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0016806,-0.13071,-0.085585,1,0
3,GO BLASTOCYST GROWTH,0.0062877,-0.13082,-0.10357,1,0
3,GO NCRNA PROCESSING,0.0034243,-0.13152,-0.1175,1,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.012227,-0.13163,-0.084988,1,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.026561,-0.13205,-0.10451,1,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.062684,-0.13241,-0.12548,1,0
3,GO PROSTATE GLAND GROWTH,0.0137,-0.1326,-0.19447,1,0
3,GO STRESS GRANULE ASSEMBLY,0.00020504,-0.13272,-0.15262,1,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.065596,-0.13298,-0.12334,1,0
3,GO REGULATION OF MRNA PROCESSING,0.00019229,-0.13371,-0.10834,1,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.015159,-0.13377,-0.15033,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.00024819,-0.13483,-0.11651,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0040509,-0.13501,-0.11696,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0013633,-0.13506,-0.11255,1,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.010769,-0.13522,-0.13375,1,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.020166,-0.13559,-0.12489,1,0
3,GO RRNA MODIFICATION,0.015674,-0.13561,-0.10664,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0037498,-0.1362,-0.14189,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,2.1234e-05,-0.13693,-0.12938,1,0
3,GO REPLICATION FORK PROCESSING,0.00038422,-0.13788,-0.16415,1,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.051111,-0.1387,-0.1119,1,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00083767,-0.13942,-0.1564,1,0
3,GO IMP METABOLIC PROCESS,0.044292,-0.13943,-0.14285,1,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0071918,-0.13953,-0.18821,1,0
3,GO PROTEIN DEMETHYLATION,0.007921,-0.13955,-0.12116,1,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.026838,-0.13976,-0.10564,1,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.0071918,-0.14026,-0.12206,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0059116,-0.14141,-0.11293,1,0
3,GO RRNA TRANSCRIPTION,0.0007901,-0.14159,-0.1445,1,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.056128,-0.14185,-0.13768,1,0
3,GO MEMBRANE DISASSEMBLY,0.0061347,-0.1419,-0.14141,1,0
3,GO MRNA METHYLATION,0.0023009,-0.14197,-0.13186,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE,8.0256e-05,-0.142,-0.11843,1,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00022208,-0.14207,-0.10745,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0053519,-0.14225,-0.11756,1,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.015159,-0.14248,-0.20391,1,0
3,GO RETROGRADE AXONAL TRANSPORT,0.00087508,-0.14256,-0.18187,1,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0024941,-0.14262,-0.10982,1,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.059331,-0.14267,-0.13214,1,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00048316,-0.14277,-0.1529,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.001483,-0.14291,-0.13017,1,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0052197,-0.14292,-0.13026,1,0
3,GO CHROMOSOME CONDENSATION,0.0039481,-0.14306,-0.10633,1,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00010852,-0.14344,-0.12247,1,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.024687,-0.14414,-0.13232,1,0
3,GO REGULATION OF HIPPO SIGNALING,0.016386,-0.14481,-0.14714,1,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0034243,-0.14483,-0.13795,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,1.6457e-05,-0.14541,-0.11784,1,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0047198,-0.14629,-0.11268,1,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0050904,-0.1463,-0.1141,1,0
3,GO GTP METABOLIC PROCESS,0.017506,-0.14757,-0.13345,1,0
3,GO HIPPO SIGNALING,0.014172,-0.14824,-0.15535,1,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0088198,-0.14871,-0.15618,1,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.0037498,-0.1495,-0.12354,1,0
3,GO KINETOCHORE ORGANIZATION,0.045591,-0.14952,-0.087862,1,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0023009,-0.14993,-0.18573,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,6.4341e-05,-0.14998,-0.16478,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0060595,-0.15012,-0.131,1,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.013856,-0.15027,-0.10499,1,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.0059852,-0.1506,-0.15017,1,0
3,GO MYOBLAST PROLIFERATION,0.001955,-0.15068,-0.1813,1,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00027284,-0.15103,-0.15073,1,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.001483,-0.15178,-0.13155,1,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.03902,-0.15202,-0.1015,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.045155,-0.15213,-0.15256,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,4.7999e-05,-0.1525,-0.14453,1,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0005211,-0.15291,-0.15268,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,8.4424e-05,-0.15291,-0.11901,1,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.002631,-0.15316,-0.17041,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.001071,-0.15414,-0.12107,1,0
3,GO RESPONSE TO L GLUTAMATE,0.043866,-0.15429,-0.15225,1,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.014013,-0.15491,-0.11898,1,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00027284,-0.15523,-0.10817,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.014172,-0.15848,-0.16644,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.011678,-0.15879,-0.19039,1,0
3,GO CARDIOBLAST DIFFERENTIATION,0.010769,-0.15935,-0.15977,1,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.024173,-0.15953,-0.092793,1,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00015838,-0.15974,-0.17847,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00039018,-0.16002,-0.14965,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,5.7059e-05,-0.16034,-0.13562,1,0
3,GO DNA REPLICATION INITIATION,6.337e-06,-0.16036,-0.1764,1,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.031953,-0.16072,-0.19057,1,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.041789,-0.16101,-0.15358,1,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.03902,-0.16123,-0.17014,1,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.023668,-0.16126,-0.20776,1,0
3,GO PSEUDOURIDINE SYNTHESIS,0.024687,-0.16148,-0.12661,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00027284,-0.16152,-0.12892,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00049053,-0.16257,-0.13588,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,3.758e-05,-0.16273,-0.13939,1,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0066851,-0.16369,-0.15732,1,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00159,-0.16376,-0.17379,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00068191,-0.16484,-0.18009,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0065235,-0.16495,-0.13509,1,0
3,GO HISTONE DEUBIQUITINATION,0.00029511,-0.16526,-0.12259,1,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00058763,-0.16556,-0.19079,1,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0029256,-0.16634,-0.21145,1,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.024428,-0.16666,-0.11263,1,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.0361e-05,-0.16733,-0.17016,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00016098,-0.1676,-0.13935,1,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0029256,-0.16773,-0.13374,1,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0049019,-0.16777,-0.12806,1,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0075485,-0.16788,-0.18299,1,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.0034243,-0.16899,-0.13479,1,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0012886,-0.1707,-0.12792,1,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00028155,-0.17086,-0.19117,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00022208,-0.1712,-0.1384,1,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,8.0256e-05,-0.17344,-0.21842,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00069207,-0.17356,-0.22473,1,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0044864,-0.17366,-0.14195,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,3.5022e-05,-0.1737,-0.15055,1,0
3,GO KINETOCHORE ASSEMBLY,0.062114,-0.17373,-0.091324,1,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.019104,-0.17382,-0.18554,1,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0075485,-0.17551,-0.13618,1,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0099244,-0.17567,-0.14228,1,0
3,GO V D J RECOMBINATION,0.0089251,-0.17758,-0.16339,1,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.035691,-0.17785,-0.12934,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0055559,-0.17854,-0.20932,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.014658,-0.18104,-0.2104,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,4.9361e-06,-0.18222,-0.1762,1,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.037509,-0.18333,-0.17215,1,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00036124,-0.18365,-0.22111,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0032928,-0.18391,-0.166,1,0
3,GO CHONDROCYTE PROLIFERATION,0.024173,-0.1843,-0.15923,1,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00031414,-0.18434,-0.21417,1,0
3,GO MRNA MODIFICATION,0.0019023,-0.18641,-0.14856,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.017894,-0.18801,-0.17153,1,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,7.0072e-05,-0.18902,-0.1918,1,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00096848,-0.18999,-0.17334,1,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00029511,-0.19091,-0.17538,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00057029,-0.19158,-0.26901,1,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0041031,-0.19195,-0.17925,1,0
3,GO MATURATION OF SSU RRNA,0.0005211,-0.19228,-0.19501,1,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00069207,-0.19263,-0.16299,1,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.049681,-0.19267,-0.13704,1,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00019229,-0.1941,-0.15026,1,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.021973,-0.19434,-0.19293,1,0
3,GO MATURATION OF LSU RRNA,0.0016806,-0.19444,-0.20809,1,0
3,GO MRNA SPLICE SITE SELECTION,0.00014129,-0.19529,-0.18869,1,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0060595,-0.19727,-0.17842,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00061456,-0.19863,-0.1893,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00058763,-0.19962,-0.20052,1,0
3,GO DENDRITE SELF AVOIDANCE,0.0075485,-0.20067,-0.18066,1,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00046872,-0.20077,-0.22352,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0047198,-0.20104,-0.16279,1,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.011022,-0.20298,-0.18252,1,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00020835,-0.20386,-0.16254,1,0
3,GO BONE GROWTH,0.017699,-0.20653,-0.14804,1,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.1494e-05,-0.20658,-0.20949,1,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.9859e-05,-0.20719,-0.16933,1,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0095807,-0.20813,-0.16203,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.016568,-0.20824,-0.15453,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.047372,-0.20908,-0.20097,1,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0061347,-0.20983,-0.17136,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.026561,-0.21225,-0.1468,1,0
3,GO DNA LIGATION,0.00087508,-0.2128,-0.15902,1,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.056652,-0.21348,-0.10932,1,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,1.0554e-07,-0.21483,-0.20489,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00029511,-0.21666,-0.2522,1,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0014624,-0.2174,-0.16529,1,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,4.6202e-07,-0.21868,-0.26137,1,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0040509,-0.22261,-0.22325,1,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0013255,-0.22313,-0.19462,1,0
3,GO TELOMERASE RNA LOCALIZATION,7.2497e-05,-0.22461,-0.22311,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,1.3948e-05,-0.22514,-0.21439,1,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0028872,-0.22616,-0.18656,1,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00070238,-0.22729,-0.20587,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0027381,-0.22744,-0.22348,1,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.001568,-0.22848,-0.22328,1,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.040981,-0.23215,-0.16691,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.016752,-0.23266,-0.22639,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,3.8246e-05,-0.23391,-0.24854,1,0
3,GO CELL PROLIFERATION IN FOREBRAIN,4.9694e-05,-0.2348,-0.23789,1,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.011151,-0.23548,-0.15712,1,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00021857,-0.23646,-0.17341,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,7.0337e-07,-0.23776,-0.20411,1,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.004156,-0.23976,-0.18839,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.028556,-0.23995,-0.19339,1,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,8.1623e-05,-0.24106,-0.18976,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.010895,-0.24125,-0.25792,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0081133,-0.24188,-0.19656,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0020092,-0.24318,-0.20826,1,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0070192,-0.24353,-0.15126,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.014494,-0.24362,-0.16215,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00046872,-0.24606,-0.28441,1,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,1.7693e-06,-0.24621,-0.22283,1,0
3,GO VIRAL TRANSLATION,0.000662,-0.24634,-0.21395,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.011022,-0.24668,-0.21166,1,0
3,GO NUCLEAR PORE ORGANIZATION,0.00032408,-0.24733,-0.19841,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.013243,-0.25006,-0.24703,1,0
3,GO ADULT HEART DEVELOPMENT,0.0007786,-0.25036,-0.23133,1,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.00013899,-0.25134,-0.19817,1,0
3,GO LATERAL MESODERM DEVELOPMENT,0.0005056,-0.25278,-0.25379,1,0
3,GO CENTRIOLE CENTRIOLE COHESION,6.545e-05,-0.2552,-0.22333,1,0
3,GO DENDRITIC TRANSPORT,0.0038977,-0.25651,-0.17775,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0013443,-0.25832,-0.23,1,0
3,GO LIMB BUD FORMATION,0.010522,-0.26204,-0.23407,1,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00074504,-0.26785,-0.28752,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0068504,-0.27312,-0.19274,1,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,1.3325e-06,-0.27696,-0.25089,1,0
3,GO CHROMATIN DISASSEMBLY,6.7105e-06,-0.27965,-0.23205,1,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,6.4341e-05,-0.28524,-0.31161,1,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00067188,-0.28676,-0.25255,1,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00039622,-0.29928,-0.22236,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.00026024,-0.30023,-0.27912,1,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0011341,-0.30113,-0.29519,1,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,2.5424e-05,-0.30159,-0.25028,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0056255,-0.30807,-0.24393,1,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00011033,-0.31226,-0.38035,1,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,2.3274e-07,-0.31511,-0.32097,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00015583,-0.38422,-0.31047,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,8.3013e-05,-0.39217,-0.35788,1,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00095459,-0.40761,-0.29414,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0012005,-0.40869,-0.39241,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0012527,-0.41909,-0.40064,1,0
3,GO CARDIAC CHAMBER FORMATION,7.6657e-06,-0.43445,-0.41226,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00022565,-0.43546,-0.36351,1,0
3,GO CARDIAC VENTRICLE FORMATION,1.3693e-05,-0.50299,-0.43098,1,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.14642,0.3096,0.14667,0,1
3,GO MECHANOSENSORY BEHAVIOR,0.16904,0.26792,0.15977,0,1
3,GO NEPHRIC DUCT MORPHOGENESIS,0.090011,0.24366,0.12392,0,1
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.25078,0.23225,0.11809,0,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.11933,0.21552,0.13371,0,1
3,GO PIRNA METABOLIC PROCESS,0.16778,0.17487,0.1188,0,1
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.075009,0.17389,0.12718,0,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.071119,0.17208,0.14046,0,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.074349,0.16779,0.11134,0,1
3,GO FEMALE GENITALIA DEVELOPMENT,0.11002,0.16603,0.074856,0,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.16654,0.15974,0.13833,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.080464,0.15594,0.10862,0,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.080464,0.15248,0.095135,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.1313,0.15183,0.078895,0,1
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.071119,0.15158,0.11387,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.074349,0.15027,0.098647,0,1
3,GO BONE CELL DEVELOPMENT,0.22195,0.14766,0.088018,0,1
3,GO RESPONSE TO MUSCLE ACTIVITY,0.11002,0.14625,0.10639,0,1
3,GO SYNAPSE MATURATION,0.29877,0.14586,0.10279,0,1
3,GO RESPONSE TO VITAMIN,0.09714,0.13704,0.093348,0,1
3,GO PODOSOME ASSEMBLY,0.20699,0.1367,0.085097,0,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.11742,0.13516,0.092991,0,1
3,GO REGULATION OF GTP BINDING,0.076344,0.13264,0.11331,0,1
3,GO LUNG MORPHOGENESIS,0.090782,0.13038,0.091084,0,1
3,GO REGULATION OF LIGASE ACTIVITY,0.10385,0.12929,0.077967,0,1
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.21738,0.12672,0.094187,0,1
3,GO NOREPINEPHRINE TRANSPORT,0.10385,0.12558,0.11089,0,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.19417,0.12139,0.077356,0,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.13979,0.12025,0.06194,0,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.084763,0.11852,0.098231,0,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.070488,0.11821,0.11216,0,1
3,GO THYROID HORMONE METABOLIC PROCESS,0.10912,0.11645,0.088344,0,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.18194,0.115,0.087538,0,1
3,GO VAGINA DEVELOPMENT,0.13979,0.1119,0.07577,0,1
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.13979,0.10975,0.091114,0,1
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.1146,0.10844,0.13729,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.56376,0.10559,0.021909,0,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.22503,0.1046,0.062053,0,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.077018,0.098849,0.088989,0,1
3,GO RESPONSE TO UV C,0.12224,0.098839,0.07385,0,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.098784,0.098216,0.079345,0,1
3,GO EMBRYONIC BODY MORPHOGENESIS,0.10214,0.097544,0.10482,0,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.15098,0.09394,0.069361,0,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.099614,0.091668,0.089115,0,1
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.25078,0.089442,0.054301,0,1
3,GO DNA DEALKYLATION,0.078382,0.087679,0.08131,0,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.19838,0.084241,0.094705,0,1
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.11092,0.082603,0.069229,0,1
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.31997,0.081289,0.044974,0,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.082591,0.080357,0.06958,0,1
3,GO HEPATOCYTE DIFFERENTIATION,0.089246,0.079818,0.096018,0,1
3,GO ASTROCYTE ACTIVATION,0.11183,0.079438,0.11294,0,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.070488,0.076633,0.078582,0,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.079765,0.075945,0.055203,0,1
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.16285,0.075015,0.050958,0,1
3,GO CARDIOLIPIN METABOLIC PROCESS,0.17411,0.074847,0.044294,0,1
3,GO T CELL DIFFERENTIATION IN THYMUS,0.13444,0.074825,0.06777,0,1
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.23128,0.074766,0.040079,0,1
3,GO SLEEP,0.072397,0.073714,0.090654,0,1
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.069238,0.073163,0.073413,0,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.10045,0.071139,0.11011,0,1
3,GO LACTATE METABOLIC PROCESS,0.069238,0.070368,0.12099,0,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.19417,0.070058,0.063319,0,1
3,GO RESPONSE TO ATP,0.077018,0.068549,0.084421,0,1
3,GO RESPONSE TO LEUCINE,0.17669,0.066032,0.10178,0,1
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.078382,0.065605,0.079239,0,1
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.15214,0.065079,0.069738,0,1
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.14755,0.064373,0.07484,0,1
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22503,0.063629,0.059153,0,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.29502,0.061391,0.035055,0,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.31604,0.059303,0.071072,0,1
3,GO MUSCLE FIBER DEVELOPMENT,0.45727,0.055475,0.044654,0,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.079071,0.051848,0.092226,0,1
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35463,0.046793,0.030154,0,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.4355,0.037082,0.025922,0,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.1262,0.036336,0.061089,0,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.54208,0.034602,0.015549,0,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.33599,0.024188,0.037707,0,1
3,GO REFLEX,1.3196e-05,0.44617,0.43944,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,3.758e-05,0.4015,0.40688,0,0
3,GO INTESTINAL LIPID ABSORPTION,1.9044e-05,0.37625,0.4885,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,2.0364e-06,0.36544,0.35715,0,0
3,GO LIPID DIGESTION,0.00041488,0.34305,0.37851,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,2.7312e-05,0.245,0.28899,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,3.2631e-05,0.24352,0.29063,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0025617,0.23715,0.18488,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0066039,0.23,0.19334,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.0712e-08,0.22951,0.31091,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00010852,0.21977,0.28337,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.0087156,0.21901,0.34788,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.013243,0.21585,0.23163,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.28761,0.2156,0.11664,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00028155,0.21517,0.18986,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.2631e-05,0.21308,0.29144,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,5.1446e-05,0.2114,0.2324,0,0
3,GO HEART INDUCTION,0.021973,0.20806,0.22671,0,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.072397,0.20223,0.16348,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.11553,0.19871,0.09935,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.012227,0.19519,0.18535,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.098784,0.19373,0.19771,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.13338,0.19346,0.10523,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.063836,0.19235,0.17072,0,0
3,GO NEURON CELL CELL ADHESION,0.13656,0.18878,0.15346,0,0
3,GO QUINONE METABOLIC PROCESS,0.0031247,0.18688,0.21869,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0050904,0.1849,0.13962,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.51557,0.18288,0.0696,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,4.3236e-05,0.1811,0.1982,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0137,0.18005,0.19418,0,0
3,GO RESPONSE TO LEPTIN,4.7172e-05,0.17997,0.2138,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,5.2344e-05,0.17888,0.23193,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.051595,0.17822,0.43376,0,0
3,GO BONE MINERALIZATION,0.0021215,0.17589,0.15551,0,0
3,GO PARTURITION,0.011678,0.17408,0.17073,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.10299,0.17292,0.13528,0,0
3,GO ANDROGEN METABOLIC PROCESS,3.8924e-05,0.1727,0.24396,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040582,0.1724,0.16424,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0017517,0.17232,0.2269,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.55558,0.17207,0.019757,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0027747,0.17186,0.16405,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0017517,0.17059,0.17425,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,3.758e-05,0.16959,0.18805,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.37827,0.16685,0.051021,0,0
3,GO GLYCINE TRANSPORT,0.14642,0.16554,0.1125,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.03006,0.16502,0.22143,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,5.6085e-05,0.16318,0.18385,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.28395,0.16283,0.068766,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,7.1274e-05,0.16272,0.19373,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.0044298,0.16227,0.22836,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.00031414,0.15998,0.18859,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.1262,0.15782,0.12841,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0026663,0.15774,0.14516,0,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0016347,0.15687,0.16174,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.001422,0.15666,0.13487,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.001422,0.15573,0.15079,0,0
3,GO BIOMINERALIZATION,0.00074504,0.15527,0.16069,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,5.2344e-05,0.15511,0.15099,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.079071,0.15507,0.12139,0,0
3,GO INCLUSION BODY ASSEMBLY,0.018898,0.15483,0.1792,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.013243,0.15436,0.19036,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.1793,0.15334,0.23233,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.026838,0.1511,0.2139,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.06986,0.15056,0.13478,0,0
3,GO RESPONSE TO AMYLOID BETA,0.048746,0.15052,0.11211,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.038637,0.15032,0.13232,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,5.6487e-06,0.1494,0.21119,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.049681,0.14924,0.172,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.15098,0.14917,0.085776,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00025617,0.14824,0.20144,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.25753,0.14732,0.1311,0,0
3,GO MALE SEX DETERMINATION,0.068619,0.14723,0.1135,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.087731,0.14692,0.15374,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.074349,0.14599,0.076925,0,0
3,GO MIDGUT DEVELOPMENT,0.082591,0.14501,0.14063,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.085497,0.14457,0.13128,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.70185,0.14449,0.024685,0,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.0027381,0.14343,0.11524,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.0098086,0.14319,0.10936,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.004964,0.14318,0.17055,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.52609,0.14289,0.062316,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.073694,0.14179,0.1295,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00094089,0.14135,0.2026,0,0
3,GO ENAMEL MINERALIZATION,0.23128,0.1413,0.11312,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.30637,0.1407,0.063678,0,0
3,GO ARACHIDONIC ACID SECRETION,0.0030839,0.14059,0.13995,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.11275,0.14031,0.088351,0,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0089251,0.13982,0.16735,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.077018,0.13961,0.14674,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.063258,0.13924,0.096656,0,0
3,GO VITAMIN TRANSPORT,0.00159,0.13893,0.15588,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0075485,0.13806,0.14871,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.020605,0.13713,0.17825,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.23445,0.137,0.094968,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.1262,0.13674,0.075002,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.0035146,0.13558,0.16466,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.024428,0.13535,0.11166,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.318,0.13528,0.070494,0,0
3,GO BLEB ASSEMBLY,0.11275,0.13527,0.18926,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.33396,0.13495,0.047709,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.35674,0.13476,0.091233,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.1252,0.13393,0.098405,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.26614,0.13357,0.054174,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.23766,0.13319,0.11165,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.0030436,0.13241,0.12228,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.074349,0.13231,0.14468,0,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.28761,0.13162,0.048567,0,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.17411,0.13074,0.079733,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.19697,0.13008,0.10746,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.024687,0.12979,0.16479,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0041031,0.12927,0.17318,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.001235,0.12917,0.14426,0,0
3,GO BLASTODERM SEGMENTATION,0.36956,0.12888,0.059688,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.59986,0.12768,0.022644,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.10912,0.12744,0.12395,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0054872,0.127,0.10712,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.10045,0.12605,0.18114,0,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.13338,0.12594,0.10146,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.046031,0.12544,0.1413,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.18866,0.12502,0.09258,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.065596,0.12488,0.15358,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00068191,0.12487,0.12399,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.020385,0.1245,0.13767,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.18866,0.12447,0.11202,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0069343,0.12429,0.12766,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.09796,0.12421,0.091777,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.1252,0.12397,0.089005,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.15683,0.12379,0.11601,0,0
3,GO SKIN MORPHOGENESIS,0.57752,0.12351,0.019792,0,0
3,GO PANCREATIC JUICE SECRETION,0.036772,0.12316,0.12242,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.1387,0.12297,0.1074,0,0
3,GO CELL AGGREGATION,0.35043,0.12288,0.049809,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0104,0.12219,0.1251,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.057179,0.12184,0.13385,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.09714,0.12147,0.18566,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.66028,0.12122,0.0079297,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.018693,0.1207,0.13905,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18461,0.12018,0.084968,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.00091404,0.11978,0.12399,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.20554,0.1192,0.084294,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.12721,0.11892,0.1012,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.043444,0.11891,0.15225,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.35043,0.11819,0.065757,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.011949,0.11816,0.11759,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.018091,0.11799,0.20775,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0001862,0.11767,0.1207,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.091558,0.11755,0.15811,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.017315,0.11744,0.14431,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.086237,0.11636,0.17593,0,0
3,GO GLIAL CELL MIGRATION,0.11002,0.11614,0.08214,0,0
3,GO CELL JUNCTION ORGANIZATION,0.095518,0.1161,0.072028,0,0
3,GO REGULATION OF VESICLE FUSION,0.067397,0.11581,0.14849,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.88245,0.11561,-0.019172,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.25078,0.11539,0.061249,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.21889,0.11475,0.088792,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.29689,0.11358,0.045754,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.21437,0.11325,0.16015,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.015329,0.11311,0.13159,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.13763,0.11301,0.20037,0,0
3,GO FIBROBLAST MIGRATION,0.14308,0.11291,0.082209,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.014658,0.11287,0.11011,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.15447,0.11242,0.10477,0,0
3,GO ORGANIC ACID TRANSPORT,0.00013016,0.11204,0.13097,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.041789,0.11198,0.12449,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.003654,0.11194,0.13684,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.030368,0.11169,0.10068,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.10912,0.11139,0.095527,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.49743,0.11136,0.058901,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,9.4959e-05,0.11076,0.15969,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.056128,0.11001,0.12011,0,0
3,GO CERAMIDE TRANSPORT,0.068006,0.10987,0.1176,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.095518,0.10973,0.088536,0,0
3,GO PREPULSE INHIBITION,0.48722,0.10953,0.056755,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.085497,0.10919,0.11861,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.073043,0.10911,0.12372,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.10558,0.10889,0.074984,0,0
3,GO GROWTH HORMONE SECRETION,0.10646,0.10887,0.14792,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.067397,0.10841,0.086058,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.040981,0.10798,0.18743,0,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.1754,0.10762,0.10168,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.22503,0.10746,0.063872,0,0
3,GO NOSE DEVELOPMENT,0.44269,0.10744,0.13933,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0026663,0.10733,0.11775,0,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,9.03e-05,0.10726,0.17104,0,0
3,GO CGMP MEDIATED SIGNALING,0.24089,0.10714,0.070256,0,0
3,GO ENDOCYTOSIS,0.012367,0.10669,0.096589,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.086981,0.10605,0.189,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.17156,0.10589,0.063513,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.062684,0.10521,0.10708,0,0
3,GO ORGAN INDUCTION,0.040187,0.10503,0.10321,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.99838,0.10502,-0.038333,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.45238,0.10424,0.027941,0,0
3,GO SEGMENT SPECIFICATION,0.16654,0.1042,0.11,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.37608,0.10409,0.063912,0,0
3,GO ACTIN FILAMENT BASED PROCESS,0.086237,0.10392,0.073393,0,0
3,GO CELL SUBSTRATE ADHESION,0.087731,0.10372,0.095118,0,0
3,GO OXYGEN TRANSPORT,0.41899,0.10346,0.03474,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.48215,0.10336,0.04686,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.1453,0.10331,0.078575,0,0
3,GO RESPONSE TO ETHANOL,0.0018764,0.10293,0.10686,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.16778,0.10252,0.10284,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.18062,0.10233,0.14244,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.09714,0.10116,0.09214,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0025277,0.10103,0.12576,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.09796,0.10092,0.1056,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.054074,0.10052,0.11675,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.17029,0.10048,0.10708,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.17411,0.10035,0.095084,0,0
3,GO RESPONSE TO ALKALOID,0.0028492,0.10022,0.1174,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.18327,0.099789,0.12198,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.29877,0.099627,0.11615,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.32592,0.099571,0.06019,0,0
3,GO PROTEIN OXIDATION,0.11933,0.099301,0.12426,0,0
3,GO RENAL WATER HOMEOSTASIS,0.13656,0.099077,0.076747,0,0
3,GO SEX DETERMINATION,0.13979,0.098858,0.06789,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.13027,0.098777,0.10834,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.071756,0.098648,0.096367,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.077018,0.098624,0.10905,0,0
3,GO HORMONE CATABOLIC PROCESS,0.052575,0.098556,0.14429,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.060988,0.098447,0.10874,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.25246,0.098184,0.10108,0,0
3,GO RESPONSE TO HYPEROXIA,0.37827,0.09803,0.04823,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.13338,0.098005,0.059466,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.027118,0.097951,0.10258,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.077018,0.097253,0.078522,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.018898,0.096854,0.11767,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.18062,0.096396,0.10829,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.17029,0.096314,0.065885,0,0
3,GO AORTA MORPHOGENESIS,0.12126,0.096303,0.08904,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.16163,0.096256,0.06624,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.68392,0.09623,-0.014332,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.19278,0.09607,0.094607,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.13656,0.095756,0.092581,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.038637,0.095603,0.093877,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.14983,0.095528,0.0754,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.12224,0.095278,0.10386,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.13763,0.095144,0.076364,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.071119,0.095069,0.10024,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.03429,0.094346,0.12127,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.018898,0.094066,0.14722,0,0
3,GO CELLULAR EXTRAVASATION,0.12822,0.093846,0.071823,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.084034,0.093687,0.074603,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.26789,0.093495,0.057327,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.19417,0.093425,0.10524,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.11275,0.09248,0.088351,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.19003,0.09247,0.18395,0,0
3,GO ASSOCIATIVE LEARNING,0.067397,0.092383,0.081514,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.055093,0.09233,0.1036,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.076344,0.092239,0.078672,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.44028,0.092192,0.051801,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.41899,0.092105,0.061688,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.12721,0.09193,0.082012,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.14088,0.091802,0.064315,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.3871,0.091612,0.041155,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.066792,0.0915,0.079669,0,0
3,GO PROTEIN LOCALIZATION TO AXON,0.092339,0.091269,0.19446,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.12126,0.091146,0.071478,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.011151,0.091093,0.1803,0,0
3,GO RESPONSE TO RETINOIC ACID,0.13979,0.091081,0.077534,0,0
3,GO EPIBOLY,0.10299,0.090799,0.11137,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.11092,0.090778,0.082593,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.49743,0.090409,0.015618,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20845,0.090247,0.06831,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.19417,0.090244,0.082408,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.14419,0.090157,0.05185,0,0
3,GO EPITHELIAL CELL MATURATION,0.10045,0.089985,0.11419,0,0
3,GO RESPONSE TO ZINC ION,0.019523,0.089752,0.15968,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.22042,0.089409,0.076127,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.41203,0.089103,0.095321,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.19417,0.089078,0.075012,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.093126,0.088303,0.10184,0,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.24911,0.088093,0.081719,0,0
3,GO SEROTONIN SECRETION,0.33194,0.087786,0.073851,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.54477,0.087765,0.060397,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.16042,0.087738,0.073868,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.067397,0.087641,0.11707,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.055609,0.087599,0.12244,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.30637,0.087497,0.043336,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.27673,0.086703,0.06412,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.09796,0.086528,0.082207,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.19417,0.086483,0.06602,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.10214,0.086362,0.085211,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.081877,0.086233,0.077008,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.092339,0.086131,0.068588,0,0
3,GO TONGUE MORPHOGENESIS,0.86968,0.086094,-0.047606,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.16285,0.086093,0.099377,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.041789,0.085673,0.089958,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.081877,0.085514,0.15411,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.53406,0.085464,0.064859,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.068619,0.085379,0.11956,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35253,0.085342,0.049049,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.54477,0.085337,0.057803,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.14755,0.085258,0.09983,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.14869,0.085159,0.098275,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.5314,0.085146,0.053749,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.034636,0.085128,0.099416,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.06986,0.08488,0.097177,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.45972,0.084856,0.052623,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.30637,0.084828,0.13166,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.18595,0.084825,0.047466,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.08331,0.084752,0.1016,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.093126,0.08474,0.080302,0,0
3,GO ARGININE METABOLIC PROCESS,0.16042,0.08464,0.11034,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1252,0.084346,0.081578,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.68392,0.084193,0.04624,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.11647,0.08391,0.074546,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.089246,0.083828,0.079149,0,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.10823,0.083581,0.13284,0,0
3,GO BODY MORPHOGENESIS,0.32792,0.083511,0.061385,0,0
3,GO MEMBRANE BIOGENESIS,0.31021,0.083396,0.064747,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.1453,0.083282,0.094732,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.1387,0.083218,0.071443,0,0
3,GO CGMP METABOLIC PROCESS,0.6515,0.083146,0.030889,0,0
3,GO REGULATION OF CELL SHAPE,0.09796,0.082671,0.082342,0,0
3,GO METANEPHROS DEVELOPMENT,0.14869,0.082648,0.081229,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.1146,0.082636,0.066493,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.28761,0.082347,0.052936,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.42602,0.082338,0.022737,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.12822,0.082309,0.072687,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.23766,0.082053,0.072685,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.11092,0.081964,0.079952,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.797,0.081867,-0.022639,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.6691,0.08186,0.017645,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.11367,0.081839,0.097736,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.069238,0.081758,0.070113,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.085497,0.081552,0.086142,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.41899,0.081485,0.054152,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.086237,0.081392,0.10317,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.019523,0.081136,0.098311,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.63697,0.081106,0.052909,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.15683,0.081047,0.069347,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.1387,0.080684,0.13435,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.51819,0.080603,0.04614,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.081168,0.080428,0.11247,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.36311,0.080387,0.081581,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.27317,0.080256,0.045094,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.1262,0.080094,0.07029,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.30066,0.07998,0.064913,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.014823,0.079961,0.096889,0,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.077698,0.079927,0.092327,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.062684,0.079711,0.11165,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.087731,0.079661,0.092954,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.13656,0.079438,0.06918,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.18461,0.079064,0.067413,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.70787,0.079037,0.018019,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.45727,0.07897,0.041183,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.070488,0.078707,0.079268,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.1914,0.07856,0.0955,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.20992,0.078438,0.034961,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.084034,0.077678,0.070121,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.36311,0.077385,0.052732,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18327,0.07735,0.067834,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.74128,0.077025,0.03884,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.10129,0.076954,0.063091,0,0
3,GO REGULATION OF HAIR CYCLE,0.093918,0.076873,0.085821,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.16654,0.076853,0.061947,0,0
3,GO VESICLE DOCKING,0.081168,0.076577,0.088046,0,0
3,GO FAT CELL PROLIFERATION,0.22042,0.076521,0.082444,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.80639,0.076496,-0.035551,0,0
3,GO GONADOTROPIN SECRETION,0.068619,0.076081,0.11937,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.017506,0.075928,0.091811,0,0
3,GO AXONEME ASSEMBLY,0.11183,0.07572,0.090987,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.093918,0.075542,0.089442,0,0
3,GO RENAL FILTRATION,0.24416,0.0755,0.13709,0,0
3,GO PERICARDIUM DEVELOPMENT,0.6312,0.075481,0.022958,0,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.11092,0.075404,0.064827,0,0
3,GO COLLATERAL SPROUTING,0.572,0.075336,0.031346,0,0
3,GO EMBRYO IMPLANTATION,0.48722,0.075299,0.049611,0,0
3,GO MAST CELL MIGRATION,0.95639,0.075263,0.0055799,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.14983,0.07515,0.084942,0,0
3,GO TRABECULA MORPHOGENESIS,0.28761,0.074817,0.050391,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.14419,0.074816,0.06921,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.23128,0.074679,0.10196,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.20409,0.074668,0.081084,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.22195,0.074637,0.054396,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.019312,0.074583,0.10724,0,0
3,GO RHYTHMIC BEHAVIOR,0.063836,0.074211,0.10337,0,0
3,GO GASTRULATION,0.18595,0.074128,0.06703,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.25924,0.074107,0.082263,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.092339,0.074001,0.098422,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.35886,0.073997,0.057693,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.58585,0.07382,0.044515,0,0
3,GO PSEUDOPODIUM ORGANIZATION,0.26095,0.073684,0.084572,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.19838,0.073567,0.059446,0,0
3,GO TRABECULA FORMATION,0.65442,0.073502,0.030852,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.21738,0.07341,0.071061,0,0
3,GO ETHANOL OXIDATION,0.25583,0.073296,0.10442,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.16904,0.073263,0.079267,0,0
3,GO ARTERY MORPHOGENESIS,0.178,0.073185,0.05729,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.099614,0.07307,0.08057,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.10558,0.073046,0.090326,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.1387,0.072923,0.058846,0,0
3,GO SPINAL CORD PATTERNING,0.30446,0.072853,0.095142,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.084034,0.072829,0.087425,0,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.098784,0.072746,0.061244,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.33599,0.072674,0.050522,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.022209,0.072493,0.098185,0,0
3,GO ALDITOL METABOLIC PROCESS,0.36741,0.072351,0.031424,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.16163,0.072323,0.053455,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.12322,0.072316,0.085536,0,0
3,GO COCHLEA DEVELOPMENT,0.64567,0.072204,0.011837,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.24089,0.072173,0.064327,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.61117,0.072134,0.035995,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.46962,0.072088,0.035633,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.17156,0.071956,0.055101,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.11002,0.071826,0.063543,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.086981,0.07182,0.07864,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.10734,0.071572,0.10155,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.178,0.07143,0.075661,0,0
3,GO VASCULATURE DEVELOPMENT,0.1313,0.071378,0.071854,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.1873,0.071342,0.093164,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.06986,0.071301,0.10629,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.15565,0.070968,0.073947,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.10734,0.070944,0.049674,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.27853,0.070942,0.049065,0,0
3,GO WATER TRANSPORT,0.036048,0.070908,0.11496,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.43789,0.070788,0.049908,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.09796,0.070666,0.079426,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.090782,0.070636,0.09746,0,0
3,GO RESPONSE TO AXON INJURY,0.14197,0.070502,0.093814,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.5,0.070478,0.024472,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.056128,0.070276,0.088521,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.32592,0.070169,0.067568,0,0
3,GO VASCULOGENESIS,0.60268,0.070141,0.031318,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.18461,0.070105,0.17259,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.32592,0.069928,0.068019,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.18461,0.069634,0.083917,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.032607,0.069527,0.09633,0,0
3,GO EPITHELIAL TUBE FORMATION,0.13549,0.069477,0.050652,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.22658,0.069418,0.073083,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.36098,0.069409,0.041917,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.035691,0.06939,0.08384,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.14419,0.069212,0.075822,0,0
3,GO EAR MORPHOGENESIS,0.21437,0.069008,0.043935,0,0
3,GO HYPOTONIC RESPONSE,0.47461,0.068727,0.0275,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.2714,0.068703,0.062505,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.22348,0.068688,0.068304,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.18866,0.068657,0.14074,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.36741,0.068426,0.049243,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.49487,0.068396,0.043339,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.45482,0.068149,0.066456,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.20845,0.067908,0.17923,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.7814,0.067717,0.027701,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.44994,0.067572,0.054043,0,0
3,GO SYNAPSE ASSEMBLY,0.32993,0.067271,0.054976,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.54746,0.067113,0.035919,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.079071,0.067096,0.076011,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.30637,0.067048,0.016518,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.27673,0.067011,0.048466,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.13979,0.066892,0.067433,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.13656,0.066874,0.059136,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83474,0.066858,0.037732,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.20699,0.066833,0.058552,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.16163,0.06681,0.060956,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.82526,0.066637,0.010734,0,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.068006,0.066634,0.10301,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.15098,0.066623,0.059494,0,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.37608,0.066575,0.10477,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.21437,0.066355,0.0947,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.23605,0.066271,0.070907,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.42367,0.066147,0.034907,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.2458,0.066136,0.044799,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.091558,0.066018,0.055436,0,0
3,GO RNA INTERFERENCE,0.87287,0.065916,-0.0044549,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.3739,0.065708,0.046809,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.14642,0.065443,0.10733,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.27853,0.065401,0.065119,0,0
3,GO NOTOCHORD DEVELOPMENT,0.63408,0.065326,0.010245,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.079071,0.065241,0.11109,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.33599,0.065206,0.053555,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.60834,0.065175,0.061201,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.19417,0.065114,0.051834,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.59986,0.065099,0.0298,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.10646,0.065044,0.12906,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.26789,0.065036,0.038034,0,0
3,GO FACE DEVELOPMENT,0.59144,0.064988,0.039478,0,0
3,GO SULFATE TRANSPORT,0.054074,0.064965,0.10189,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.51296,0.064833,-0.057122,0,0
3,GO ETHANOL METABOLIC PROCESS,0.61687,0.064697,0.021123,0,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.1146,0.064656,0.086179,0,0
3,GO CELL RECOGNITION,0.6312,0.064587,0.017935,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.178,0.064527,0.14913,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.075674,0.064373,0.069408,0,0
3,GO INNER EAR MORPHOGENESIS,0.19979,0.06437,0.057477,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.062684,0.064345,0.074954,0,0
3,GO NEURON REMODELING,0.20265,0.064202,0.08685,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.15098,0.064136,0.090626,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11183,0.06399,0.069145,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.39156,0.063847,0.044215,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.24252,0.063657,0.035372,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.63408,0.063472,0.020624,0,0
3,GO TAXIS,0.21437,0.063358,0.053035,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.3442,0.063357,0.069544,0,0
3,GO MITOCHONDRIAL FUSION,0.31021,0.063276,0.053298,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.094715,0.063158,0.055108,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.12721,0.06313,0.075461,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.0088198,0.062982,0.10591,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.13656,0.062936,0.053636,0,0
3,GO TUBE FORMATION,0.22042,0.062909,0.038833,0,0
3,GO T CELL HOMEOSTASIS,0.12224,0.062881,0.058573,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.39832,0.0628,0.049565,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.21288,0.062427,0.085416,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.23445,0.062227,0.059992,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.5314,0.062173,0.033425,0,0
3,GO ATP TRANSPORT,0.20265,0.062164,0.058548,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.36098,0.062102,0.047908,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.12126,0.062008,0.091441,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.85059,0.06187,0.01839,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.16163,0.061841,0.077095,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.5583,0.06181,0.045975,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.26789,0.061799,0.042114,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.14197,0.061749,0.063791,0,0
3,GO RETINA LAYER FORMATION,0.14642,0.061667,0.12901,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.13763,0.061569,0.083994,0,0
3,GO GROWTH,0.11742,0.061548,0.059326,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.26095,0.061442,0.044983,0,0
3,GO POSITIVE REGULATION OF BINDING,0.18595,0.061398,0.053561,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.19557,0.061362,0.072304,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.19697,0.061177,0.086936,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.088486,0.061151,0.091057,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.16904,0.06114,0.062684,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.36741,0.061134,0.042761,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.26964,0.06108,0.064936,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.49487,0.061051,0.053715,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.076344,0.060991,0.07818,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.52874,0.060969,0.028195,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.46218,0.060766,0.038822,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.13763,0.060585,0.064181,0,0
3,GO HEAD MORPHOGENESIS,0.73212,0.06051,0.01561,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.25078,0.060389,0.045129,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.25583,0.060281,0.061384,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13338,0.060112,0.061089,0,0
3,GO BEHAVIOR,0.1387,0.060103,0.062386,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.39832,0.060076,0.061983,0,0
3,GO RRNA CATABOLIC PROCESS,0.18327,0.059651,0.072878,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.3739,0.059434,0.057041,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.17411,0.059308,0.057837,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.10045,0.059244,0.079076,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.39156,0.058963,0.030878,0,0
3,GO AUTOPHAGIC CELL DEATH,0.318,0.058783,0.06167,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.079765,0.058766,0.08185,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.013093,0.058665,0.075675,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.078382,0.058645,0.068462,0,0
3,GO REGIONALIZATION,0.16042,0.058499,0.063932,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.23128,0.058488,0.065465,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.19003,0.058402,0.06283,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.37173,0.058285,0.044285,0,0
3,GO MEMORY,0.10385,0.058271,0.075564,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.045155,0.05822,0.091201,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.78451,0.058197,0.013136,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.34835,0.058143,0.047519,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.94993,0.0581,0.0052361,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.15683,0.057949,0.056064,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.58307,0.057938,0.020973,0,0
3,GO NADPH REGENERATION,0.3871,0.057861,0.052349,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.13656,0.057711,0.079246,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.572,0.057688,0.018593,0,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.21587,0.057593,0.052674,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.30255,0.057458,0.057941,0,0
3,GO EMBRYO DEVELOPMENT,0.29315,0.057418,0.036865,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.093126,0.057331,0.090574,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.51035,0.056894,0.029488,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.016386,0.056785,0.094459,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.19003,0.056743,0.078925,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.14869,0.056686,0.058923,0,0
3,GO RESPONSE TO FOOD,0.21437,0.05668,0.042059,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.19838,0.056616,0.11104,0,0
3,GO NOREPINEPHRINE SECRETION,0.2913,0.056586,0.073604,0,0
3,GO OOGENESIS,0.71693,0.05656,0.018202,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.41434,0.056559,0.042384,0,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.12322,0.056344,0.068315,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.38267,0.056172,0.035377,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.68988,0.055998,0.015647,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.98546,0.055912,-0.0081612,0,0
3,GO MYOBLAST DIFFERENTIATION,0.29315,0.055888,0.054267,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.24089,0.055865,0.050717,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.34835,0.055785,0.094041,0,0
3,GO CELL CELL SIGNALING BY WNT,0.28033,0.055609,0.044884,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11275,0.055202,0.052893,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.25924,0.05498,0.068634,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.071756,0.054957,0.058826,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.23286,0.054525,0.076725,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.89526,0.054299,0.011663,0,0
3,GO SPERM AXONEME ASSEMBLY,0.26267,0.054206,0.079651,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.27317,0.05416,0.071239,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.10823,0.054151,0.084464,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.085497,0.054053,0.063638,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.99192,0.05401,-0.017702,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.26267,0.053978,0.086946,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.072397,0.053975,0.090951,0,0
3,GO HINDBRAIN DEVELOPMENT,0.15802,0.053933,0.072037,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.82211,0.053808,0.007096,0,0
3,GO HEART DEVELOPMENT,0.51035,0.053669,0.032062,0,0
3,GO PROTEIN TRIMERIZATION,0.29877,0.053636,0.063303,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.797,0.053575,0.011758,0,0
3,GO MITOTIC DNA REPLICATION,0.49231,0.053492,0.043871,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.40058,0.053474,0.036033,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.092339,0.053449,0.060849,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.42133,0.053281,0.056235,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.049681,0.053269,0.15809,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.44269,0.053196,0.030774,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.091558,0.053048,0.074489,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.54208,0.053015,0.034424,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.14197,0.052984,0.06391,0,0
3,GO RESPONSE TO UV B,0.77519,0.05294,0.017151,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.33396,0.052927,0.061945,0,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.29877,0.052916,0.057442,0,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.16285,0.052885,0.06275,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.6055,0.052734,0.045321,0,0
3,GO NEPHRON MORPHOGENESIS,0.1533,0.05264,0.07181,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.15921,0.052617,0.065712,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.17411,0.052499,0.065673,0,0
3,GO RESPONSE TO ESTROGEN,0.48468,0.052373,0.036955,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.66321,0.052372,0.018731,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.11742,0.052296,0.073645,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.20265,0.052232,0.067145,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.12924,0.052194,0.057366,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.40514,0.052108,0.036088,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.41666,0.052004,0.046958,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.17156,0.051822,0.092077,0,0
3,GO REGULATION OF ODONTOGENESIS,0.42133,0.051739,0.093454,0,0
3,GO ADULT BEHAVIOR,0.19838,0.051205,0.082066,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.31997,0.05111,0.075817,0,0
3,GO PIGMENT METABOLIC PROCESS,0.41203,0.051063,0.037089,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.43312,0.051032,0.045504,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.84741,0.05097,0.014801,0,0
3,GO DEVELOPMENTAL GROWTH,0.56376,0.05096,0.02627,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.50516,0.05093,0.041147,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.21587,0.05087,0.054398,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.50258,0.050862,0.029916,0,0
3,GO SOMITE DEVELOPMENT,0.1754,0.050836,0.055162,0,0
3,GO HEART GROWTH,0.59986,0.050739,0.026555,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.59424,0.050721,0.020496,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.20409,0.050688,0.08129,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.1252,0.050679,0.047582,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.23286,0.050658,0.15777,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.12126,0.050509,0.08546,0,0
3,GO OVULATION,0.37173,0.050487,0.042087,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.1146,0.05035,0.072433,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.45482,0.050341,0.041734,0,0
3,GO DE NOVO PROTEIN FOLDING,0.075009,0.050328,0.083937,0,0
3,GO REGENERATION,0.11367,0.050326,0.072512,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.077018,0.050229,0.12987,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.22658,0.050047,0.079873,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.23286,0.050039,0.054014,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.74128,0.049767,0.008064,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.52082,0.04968,0.044132,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.55016,0.049671,0.039815,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.67798,0.049507,0.0090223,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.11647,0.049489,0.096896,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.39832,0.049376,0.040199,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.11553,0.049251,0.063089,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.36956,0.049102,0.040028,0,0
3,GO HEART FIELD SPECIFICATION,0.78763,0.049035,0.038992,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.073694,0.049014,0.06597,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.1873,0.049004,0.0651,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.070488,0.048925,0.072238,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.28213,0.048857,0.042425,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.11367,0.048786,0.057766,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.64276,0.048722,0.031599,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.076344,0.048664,0.095193,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.015159,0.048658,0.13529,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.38488,0.048522,0.045178,0,0
3,GO PROTEIN TETRAMERIZATION,0.40743,0.048158,0.032851,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.31997,0.048146,0.051637,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.52874,0.048048,0.041187,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.090782,0.04802,0.037899,0,0
3,GO P38MAPK CASCADE,0.21587,0.047847,0.081896,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.87606,0.04782,0.0022163,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.99192,0.04777,-0.0080536,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.25924,0.047726,0.070941,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32195,0.047695,0.040795,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.19003,0.047616,0.04572,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.15214,0.047551,0.071147,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.34835,0.047525,0.066424,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.96284,0.047329,-0.001156,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.3739,0.047306,0.048171,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.41203,0.047258,0.025443,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.096327,0.047129,0.086662,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.21288,0.047127,0.0859,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.34008,0.047126,0.056493,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.49743,0.046945,0.034257,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.10558,0.046892,0.089495,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.38047,0.046874,0.044127,0,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.14642,0.046848,0.063419,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.28945,0.046833,0.05289,0,0
3,GO PROTEIN STABILIZATION,0.069238,0.046809,0.06253,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26095,0.046718,0.054714,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.20845,0.046625,0.0494,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.25753,0.046612,0.061433,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.3442,0.046534,0.05258,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.17156,0.046533,0.051573,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.10299,0.046533,0.087612,0,0
3,GO RESPONSE TO COCAINE,0.080464,0.046411,0.091464,0,0
3,GO MESENCHYME DEVELOPMENT,0.64858,0.046383,0.019642,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.42602,0.046319,0.04564,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.43312,0.046308,0.051468,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.35674,0.046292,0.069561,0,0
3,GO TUBULIN DEACETYLATION,0.31215,0.046231,0.071006,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.18327,0.046178,0.051813,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.25078,0.046122,0.091301,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.1313,0.04611,0.10679,0,0
3,GO GMP METABOLIC PROCESS,0.30446,0.046088,0.060357,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.62545,0.045841,0.046114,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.42367,0.045785,0.072156,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.38933,0.045765,0.06093,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.095518,0.04567,0.053578,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.20554,0.045625,0.066015,0,0
3,GO CELLULAR RESPIRATION,0.12822,0.045607,0.064299,0,0
3,GO SPROUTING ANGIOGENESIS,0.66321,0.045459,0.029941,0,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.48468,0.045417,0.030897,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.10471,0.04529,0.069659,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.075009,0.045285,0.053988,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.14088,0.045151,0.062305,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.066792,0.045006,0.050941,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.13979,0.045005,0.049393,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.36098,0.044785,0.037182,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.1653,0.044759,0.052817,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.40286,0.044758,0.060688,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.67206,0.044757,0.040002,0,0
3,GO PROTEIN REFOLDING,0.32993,0.044735,0.058223,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.71693,0.044684,0.019517,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.28395,0.044679,0.049681,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.28761,0.044462,0.089917,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.81267,0.044426,0.037496,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.797,0.044353,-0.0048091,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.76281,0.04428,0.019572,0,0
3,GO SEGMENTATION,0.22348,0.044154,0.056875,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.12822,0.044094,0.04295,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.23286,0.044069,0.063437,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.23286,0.043855,0.092792,0,0
3,GO MESENCHYME MORPHOGENESIS,0.51557,0.043836,0.0321,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.1914,0.043773,0.077682,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.20409,0.043741,0.063852,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.61972,0.043602,0.024115,0,0
3,GO SYNAPSE ORGANIZATION,0.84107,0.043574,-0.0034679,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.67206,0.043567,0.026101,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.94026,0.043553,0.0051696,0,0
3,GO NEUROGENESIS,0.9113,0.043504,0.0093674,0,0
3,GO MITOCHONDRION ORGANIZATION,0.039406,0.04349,0.059039,0,0
3,GO BODY FLUID SECRETION,0.16407,0.043475,0.063933,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.12721,0.043441,0.063717,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.84741,0.043413,0.026873,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.47461,0.043358,0.090403,0,0
3,GO MESODERM MORPHOGENESIS,0.14088,0.043287,0.066851,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.19838,0.043263,0.0759,0,0
3,GO RESPONSE TO GLUCAGON,0.45972,0.043196,0.032286,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.94993,0.043175,0.013423,0,0
3,GO GASTRIC ACID SECRETION,0.16407,0.043154,0.069423,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.44028,0.043145,0.032122,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.088486,0.04314,0.040582,0,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.086237,0.043126,0.054026,0,0
3,GO SYNAPTIC SIGNALING,0.67501,0.04308,0.025656,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.51296,0.043069,0.044103,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.63986,0.042863,-0.027634,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.70185,0.042801,0.032052,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.32393,0.04276,0.061846,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.21889,0.042731,0.049071,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.079071,0.042726,0.081619,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.41434,0.042717,0.05139,0,0
3,GO RESPONSE TO POTASSIUM ION,0.89846,0.042687,-0.0077886,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.6055,0.042666,0.020319,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.66616,0.042644,0.037044,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.10385,0.042635,0.054795,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.32592,0.042524,0.068046,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.62545,0.042496,0.012124,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.25753,0.042405,0.059698,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.60268,0.042276,0.050909,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.58585,0.04208,0.024465,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.47211,0.042079,0.030046,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48468,0.042029,0.039077,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.69586,0.042006,0.029582,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.19697,0.041931,0.047037,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.84107,0.041828,0.019984,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10471,0.041805,0.060936,0,0
3,GO ORGANELLE INHERITANCE,0.19557,0.041783,0.056091,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.53406,0.041778,0.033867,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.18461,0.041669,0.044241,0,0
3,GO DNA MODIFICATION,0.28945,0.041642,0.035552,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.13656,0.041624,0.08083,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11837,0.041356,0.057407,0,0
3,GO MYELOID CELL DEVELOPMENT,0.29877,0.04131,0.058134,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.11742,0.041304,0.045717,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.16042,0.041284,0.088464,0,0
3,GO NEUROMUSCULAR PROCESS,0.41203,0.041103,0.042942,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.091558,0.040941,0.10875,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.73822,0.040743,-0.009311,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.46218,0.040702,0.034263,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.36526,0.040697,0.047369,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.35674,0.040444,0.044226,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.61687,0.040334,0.050067,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.35463,0.040332,0.065962,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.34627,0.040262,0.040026,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.26614,0.040261,0.11456,0,0
3,GO MALE GAMETE GENERATION,0.11367,0.040237,0.042234,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.75356,0.04021,0.026669,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.37608,0.040147,0.058595,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.23766,0.040147,0.085789,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.59144,0.040007,0.028505,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.92094,0.039964,0.012919,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.41203,0.039945,0.048328,0,0
3,GO CILIUM MOVEMENT,0.14197,0.039873,0.054161,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.2714,0.039791,0.078057,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.41203,0.039786,0.049442,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.23766,0.039672,0.10899,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.99838,0.039564,-0.0039888,0,0
3,GO RESPONSE TO CAMP,0.066792,0.039372,0.07969,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.40973,0.039247,0.056195,0,0
3,GO NEURON DEVELOPMENT,0.90809,0.039162,0.0017662,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.12822,0.039155,0.085326,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.19003,0.039052,0.048396,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.28213,0.038991,0.04668,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.46962,0.038819,0.030335,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.61402,0.038727,0.059135,0,0
3,GO PHOSPHATE ION TRANSPORT,0.18062,0.038713,0.0652,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.60268,0.038694,0.030731,0,0
3,GO HEAD DEVELOPMENT,0.63986,0.038692,0.024803,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.19838,0.03864,0.077972,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.99515,0.038521,-0.018989,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.25078,0.038318,0.073829,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.086981,0.038248,0.057448,0,0
3,GO LYMPH NODE DEVELOPMENT,0.076344,0.038177,0.092916,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.090011,0.038125,0.23366,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49743,0.038117,0.037305,0,0
3,GO SEX DIFFERENTIATION,0.081168,0.037984,0.065229,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.59986,0.037929,0.026341,0,0
3,GO SPERMATID DIFFERENTIATION,0.35674,0.037891,0.027532,0,0
3,GO OVULATION CYCLE,0.38488,0.037868,0.044789,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.318,0.037721,0.060612,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.71391,0.037714,0.036309,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.52874,0.037617,0.038281,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.35674,0.037389,0.039272,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.37173,0.03738,0.076937,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.35886,0.037377,0.052391,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.88565,0.037246,0.0058796,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.15098,0.037214,0.082183,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.26267,0.03709,0.068831,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.30829,0.037052,0.056034,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.85694,0.037049,-0.010793,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.11553,0.037048,0.050495,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.99192,0.037031,0.011439,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.70486,0.036816,-0.044114,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.16042,0.036744,0.037154,0,0
3,GO METENCEPHALON DEVELOPMENT,0.50516,0.036678,0.040347,0,0
3,GO NEURAL TUBE FORMATION,0.32195,0.036556,0.043857,0,0
3,GO ASTROCYTE DEVELOPMENT,0.23927,0.036544,0.089386,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.5,0.036536,0.046413,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.24745,0.036535,0.060391,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.15447,0.036501,0.071403,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.95316,0.036482,0.0014018,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.12224,0.036468,0.075298,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.19979,0.03643,0.096326,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.25078,0.036413,0.037049,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.37608,0.036396,0.12706,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.39606,0.036319,0.068125,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.23445,0.036287,0.068721,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.36311,0.036227,0.05285,0,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.15447,0.03622,0.062859,0,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.77519,0.036217,-0.0046259,0,0
3,GO NADH METABOLIC PROCESS,0.36741,0.036198,0.060899,0,0
3,GO REGULATION OF HEAT GENERATION,0.58585,0.036117,0.053722,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.09796,0.035983,0.074317,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.53672,0.035912,0.045195,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.62545,0.035871,0.031345,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31021,0.035825,0.067115,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.24745,0.035748,0.087723,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.23605,0.035704,0.063624,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.51296,0.035704,0.044985,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.16904,0.035645,0.051058,0,0
3,GO PHOTOPERIODISM,0.40973,0.035625,0.054609,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.12822,0.035605,0.072124,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.38933,0.035597,0.042503,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.18062,0.035543,0.048167,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.82526,0.035535,0.017207,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.44752,0.035526,0.066221,0,0
3,GO ECTODERM DEVELOPMENT,0.20409,0.035516,0.053404,0,0
3,GO ODONTOGENESIS,0.87606,0.035355,0.017744,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.16778,0.035212,0.05934,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.33396,0.035163,0.071548,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.21437,0.035117,0.057384,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.32592,0.034836,0.05687,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.19278,0.034797,0.044695,0,0
3,GO PHOTOTRANSDUCTION,0.15921,0.034676,0.022735,0,0
3,GO AXIS ELONGATION,0.70486,0.034325,0.0088022,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.72603,0.034298,0.014925,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.26964,0.034265,0.064118,0,0
3,GO GENITALIA DEVELOPMENT,0.14983,0.034195,0.06207,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.25924,0.034181,0.057987,0,0
3,GO RENAL SODIUM EXCRETION,0.09714,0.034015,0.095295,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.13656,0.03398,0.077528,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.73517,0.033949,0.029744,0,0
3,GO BONE MATURATION,0.99192,0.033919,0.0060292,0,0
3,GO REGULATION OF GLIOGENESIS,0.073694,0.03391,0.082719,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.39606,0.033845,0.062302,0,0
3,GO NEURON APOPTOTIC PROCESS,0.21437,0.03368,0.047073,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.24911,0.03366,0.046801,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.50258,0.033596,0.026487,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.36098,0.033591,0.043094,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.68988,0.033569,0.005702,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.2114,0.033524,0.041985,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.72299,0.033363,-0.0063854,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.11275,0.033261,0.10421,0,0
3,GO SPERM MOTILITY,0.32792,0.033212,0.042306,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.77209,0.033212,-0.017766,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.89205,0.033167,-0.012652,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.19278,0.033129,0.045749,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.57476,0.033104,0.015758,0,0
3,GO EYE MORPHOGENESIS,0.64567,0.033082,0.02396,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.43075,0.033062,0.038931,0,0
3,GO DEMETHYLATION,0.32393,0.033022,0.038929,0,0
3,GO SEROTONIN TRANSPORT,0.59144,0.033015,0.055266,0,0
3,GO GERM CELL DEVELOPMENT,0.30637,0.033011,0.030062,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.84741,0.032966,0.0016088,0,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.49231,0.032922,0.03046,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.572,0.032755,0.032157,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.7814,0.032707,-0.01511,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.48976,0.032609,0.027521,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.35253,0.032595,0.038109,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.46218,0.032533,0.065872,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.88245,0.032489,0.018581,0,0
3,GO ENDODERM DEVELOPMENT,0.41434,0.032475,0.049708,0,0
3,GO STRIATUM DEVELOPMENT,0.56925,0.032459,0.035327,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.42602,0.032434,0.070988,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.20554,0.032231,0.087218,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.3739,0.032193,0.076181,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.21288,0.032188,0.055512,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.29502,0.032168,0.044324,0,0
3,GO GANGLION DEVELOPMENT,0.40058,0.03212,0.12931,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.18062,0.031991,0.060518,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.97576,0.031988,0.010002,0,0
3,GO CELL PROJECTION ORGANIZATION,0.76899,0.031967,0.016001,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.2714,0.031909,0.046194,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.28033,0.031903,0.050749,0,0
3,GO AXIS SPECIFICATION,0.25246,0.031835,0.054034,0,0
3,GO AMINO ACID TRANSPORT,0.099614,0.031651,0.082247,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.87606,0.031508,-0.001297,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.16163,0.031284,0.067277,0,0
3,GO REGULATION OF CELL SIZE,0.9693,0.031237,0.0059629,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.069238,0.031171,0.051165,0,0
3,GO NEURON DIFFERENTIATION,0.80326,0.031149,-0.0024487,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.15921,0.031097,0.056015,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.86968,0.031062,-0.0071306,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.60268,0.031055,0.023578,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.5314,0.031049,0.026644,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.094715,0.030873,0.077276,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.09714,0.030826,0.051586,0,0
3,GO RESPONSE TO SALT,0.20409,0.030822,0.059381,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.66321,0.030673,0.02371,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.89846,0.030632,0.01629,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.34835,0.030495,0.067477,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.62545,0.0304,0.025068,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.2714,0.030396,0.036791,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.32792,0.030369,0.061531,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.4451,0.030317,0.086274,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.35674,0.03021,-0.093703,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.24089,0.030141,0.036615,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.76899,0.030127,0.016082,0,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.23766,0.030052,0.04759,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.6312,0.029908,0.025873,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.41203,0.029814,0.035853,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.92416,0.02973,0.0127,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.12924,0.029656,0.071354,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.61687,0.029623,0.035379,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.59986,0.029415,0.020088,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.67798,0.029366,-0.031654,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.59986,0.02927,0.033924,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.03006,0.029246,0.086704,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.38267,0.029178,0.030463,0,0
3,GO EXPLORATION BEHAVIOR,0.81267,0.029164,-0.042951,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.32592,0.02907,0.046257,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.36526,0.029069,0.038644,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.4451,0.028916,0.07136,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.5583,0.028786,0.0063945,0,0
3,GO GAMETE GENERATION,0.13979,0.028775,0.040949,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.44028,0.028588,0.065729,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.21288,0.028579,0.084325,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.43312,0.028391,0.041952,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.15565,0.028177,0.06098,0,0
3,GO AMP METABOLIC PROCESS,0.797,0.028109,-0.0076293,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.35463,0.028091,0.065773,0,0
3,GO HEAT GENERATION,0.47211,0.027991,0.045223,0,0
3,GO MIDBRAIN DEVELOPMENT,0.46466,0.027988,0.032923,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.59705,0.027909,0.018665,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.38047,0.027827,0.040545,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.77829,0.027757,0.014514,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.54208,0.027645,-0.077623,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.89846,0.027594,0.036152,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29877,0.027529,0.051352,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.51296,0.027524,0.041436,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.33803,0.027464,0.046762,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.86968,0.027448,0.037648,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.25753,0.027394,0.058454,0,0
3,GO AORTA DEVELOPMENT,0.79075,0.027211,-0.018584,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.28578,0.027208,0.055124,0,0
3,GO VISUAL BEHAVIOR,0.15214,0.027144,0.07343,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.23286,0.027134,0.030758,0,0
3,GO EXTRACELLULAR TRANSPORT,0.19697,0.027088,0.068425,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.14983,0.027088,0.041831,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.95961,0.027046,0.0040765,0,0
3,GO CELL FATE DETERMINATION,0.33396,0.027021,0.070364,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.86968,0.026914,0.0082241,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.67798,0.026863,-0.034473,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16285,0.026841,0.1131,0,0
3,GO COGNITION,0.85376,0.026805,0.013083,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.89205,0.026735,0.016545,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.32592,0.026711,0.053285,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.26789,0.026632,0.056365,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.63408,0.026472,0.04809,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.56376,0.026284,0.044365,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.72603,0.02628,0.033149,0,0
3,GO INTRACELLULAR TRANSPORT,0.075674,0.026128,0.04622,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.51819,0.025991,0.035677,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.70185,0.02598,0.023864,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.13338,0.025911,0.037799,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.22195,0.025897,0.071531,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.9306,0.025853,0.013879,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.56376,0.025592,0.037627,0,0
3,GO CYTOSKELETON ORGANIZATION,0.64567,0.02554,0.025633,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.65442,0.025414,0.0219,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.31215,0.025392,0.063949,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.38488,0.025317,-0.067156,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.68988,0.025166,0.014506,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.91451,0.02515,0.015443,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.45238,0.025067,0.039671,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.43312,0.024919,0.044954,0,0
3,GO CELL AGING,0.34627,0.024892,0.031874,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.92416,0.024878,-0.00093794,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.77829,0.024869,0.022748,0,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.99838,0.024834,0.0086388,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.98222,0.024819,0.0093421,0,0
3,GO COENZYME A METABOLIC PROCESS,0.35463,0.024781,0.058766,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.35253,0.024518,0.036506,0,0
3,GO CELL FATE SPECIFICATION,0.80639,0.024473,-0.0049402,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4355,0.024142,0.083806,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.14419,0.024136,0.10219,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.62545,0.02412,0.015693,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.37827,0.024019,0.05478,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.39381,0.024012,0.047744,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29502,0.024,0.039002,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.66321,0.023852,0.02291,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.37827,0.023798,0.031345,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.46713,0.023713,0.025999,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.47963,0.023683,0.025077,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.55016,0.023542,0.024569,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.72299,0.023522,0.024633,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.21288,0.02352,0.044277,0,0
3,GO FEMALE GAMETE GENERATION,0.89526,0.023503,0.0093232,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.75356,0.023433,0.019304,0,0
3,GO FIBROBLAST ACTIVATION,0.38267,0.023374,0.055501,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.51296,0.023297,0.10457,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.37173,0.023247,0.067605,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.23766,0.023247,0.05629,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.47461,0.023239,0.055508,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.3871,0.023185,0.030742,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13444,0.023073,0.062332,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.5314,0.023072,0.035415,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.69286,0.023003,0.015804,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.90488,0.022865,-0.0043621,0,0
3,GO MACROMOLECULE DEACYLATION,0.47712,0.022813,0.032942,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.48468,0.022666,0.037218,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.96284,0.022649,0.0073608,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.23286,0.022583,0.087055,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.81581,0.022526,-0.00054605,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.64567,0.02251,0.035031,0,0
3,GO RESPONSE TO INTERLEUKIN 7,0.3739,0.022451,0.055325,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.46962,0.022389,0.045025,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.42367,0.022365,0.023828,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.43312,0.022341,0.056796,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.71693,0.022184,0.021966,0,0
3,GO REGULATION OF PINOCYTOSIS,0.93382,0.022183,-0.0062591,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.83158,0.022096,-0.026689,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.37827,0.022085,0.042532,0,0
3,GO PROTEASOME ASSEMBLY,0.94993,0.022033,0.0072713,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.36526,0.021985,0.03175,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.24911,0.021843,0.042829,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.36526,0.021704,0.054213,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.81267,0.021525,0.023884,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.56376,0.021449,0.049691,0,0
3,GO HEME METABOLIC PROCESS,0.57752,0.021312,0.03913,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.54746,0.021237,-0.028771,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.31604,0.021228,-0.03375,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.79387,0.02106,0.011011,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.22503,0.021026,0.036424,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.44269,0.021004,0.076297,0,0
3,GO THYMUS DEVELOPMENT,0.57476,0.020997,0.030796,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.67501,0.020939,0.032719,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.1387,0.020901,0.052243,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.98869,0.020815,-0.0034063,0,0
3,GO ORGANELLE LOCALIZATION,0.28761,0.020626,0.032323,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.94026,0.020575,0.0018392,0,0
3,GO PRESYNAPSE ORGANIZATION,0.84424,0.020416,0.010025,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.1653,0.020385,0.06402,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.99192,0.02038,-0.0071278,0,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.73822,0.020313,-0.0045838,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.68988,0.020285,-0.038014,0,0
3,GO NUCLEOSIDE SALVAGE,0.38488,0.020113,0.030542,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.80639,0.020106,0.017622,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.46218,0.020087,0.041684,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.18595,0.020078,0.062172,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.68094,0.020016,0.023197,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.94671,0.01992,-0.0095878,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.26964,0.019911,0.040744,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.85694,0.019909,0.022335,0,0
3,GO HEART MORPHOGENESIS,0.86649,0.01985,0.0084973,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.45727,0.019605,0.05047,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.572,0.01959,-0.030998,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.66028,0.019507,-0.0040653,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.20699,0.019359,0.034715,0,0
3,GO CELL PROJECTION ASSEMBLY,0.50516,0.019295,0.029263,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.43312,0.019287,-0.039829,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.95316,0.0192,0.0053347,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.87287,0.019091,0.011374,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.32393,0.01908,0.091368,0,0
3,GO STEM CELL PROLIFERATION,0.87287,0.019067,0.016922,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.572,0.018838,0.040479,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.26614,0.018789,0.080355,0,0
3,GO RECEPTOR INTERNALIZATION,0.94993,0.018699,0.0068457,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.35043,0.018685,0.087032,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.4451,0.018677,0.042145,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.83474,0.018535,0.0091878,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.87606,0.018523,0.0063002,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.25078,0.01851,0.075712,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.75664,0.018471,0.014214,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.65442,0.018385,0.026009,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.27495,0.01837,0.06512,0,0
3,GO NEURON PROJECTION EXTENSION,0.68094,0.018338,-0.014693,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.36741,0.01829,0.058572,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59705,0.018054,0.015303,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.60268,0.018035,0.022028,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.88245,0.017882,-0.006535,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.86649,0.017803,0.0085507,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.20265,0.0178,0.068432,0,0
3,GO CELL MORPHOGENESIS,0.89846,0.017772,0.0049937,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.45238,0.017697,-0.0024558,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.47712,0.017677,0.044145,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.51035,0.017655,0.024976,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.96607,0.017623,-0.023919,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.32195,0.017622,0.051646,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.80326,0.017615,0.017502,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.38047,0.017538,0.042733,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.99515,0.017513,0.022405,0,0
3,GO RESPONSE TO RADIATION,0.61972,0.017392,0.019824,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.95639,0.017362,-0.026179,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.5394,0.017332,0.029813,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.90809,0.017308,0.0058886,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.77829,0.017178,-0.0138,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.56925,0.01711,0.04473,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.54208,0.017066,0.053049,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.72299,0.016855,0.024244,0,0
3,GO CELLULAR RESPONSE TO ATP,0.27853,0.016831,0.053759,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.92738,0.016709,0.0030405,0,0
3,GO PROTEIN POLYMERIZATION,0.82842,0.016668,0.021384,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.34627,0.016568,0.044011,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.50258,0.016449,0.049637,0,0
3,GO CELL FATE COMMITMENT,0.78451,0.016339,0.022088,0,0
3,GO ACTIN CROSSLINK FORMATION,0.99192,0.016314,-0.0028988,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.85059,0.016294,0.013664,0,0
3,GO MATING BEHAVIOR,0.3442,0.016288,0.047298,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.87926,0.016208,-0.0015637,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.42367,0.016078,0.086735,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.98222,0.016025,0.004901,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.48722,0.015758,0.025557,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.30829,0.015642,0.064431,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.98546,0.015548,-0.0040628,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.62258,0.015507,0.041537,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.93382,0.015492,0.0038247,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.8379,0.01543,0.01678,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.68988,0.015364,0.027864,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.26095,0.01524,0.071412,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.47211,0.015175,0.033837,0,0
3,GO MITOCHONDRIAL FISSION,0.52874,0.014989,0.044248,0,0
3,GO PINOCYTOSIS,0.64858,0.014753,0.015854,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.46466,0.014749,0.0734,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.72603,0.01474,0.020019,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.32592,0.01472,0.062031,0,0
3,GO CELLULAR SENESCENCE,0.47211,0.014689,0.028311,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.35253,0.01457,0.039611,0,0
3,GO ASYMMETRIC CELL DIVISION,0.25924,0.014487,0.086871,0,0
3,GO BIOLOGICAL PHASE,0.59986,0.014354,0.047711,0,0
3,GO NAD METABOLIC PROCESS,0.59144,0.014296,0.041646,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.82526,0.014283,0.0070318,0,0
3,GO GAS TRANSPORT,0.81267,0.013964,-0.00037597,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.95639,0.013954,0.0062512,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.94671,0.013859,0.020943,0,0
3,GO TOOTH MINERALIZATION,0.5665,0.013738,0.060849,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.75356,0.013736,0.011131,0,0
3,GO MEIOTIC CELL CYCLE,0.55558,0.013722,0.024477,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.9693,0.013667,0.011456,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.80326,0.013598,0.017023,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.63697,0.013557,0.052506,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.48215,0.013533,0.052473,0,0
3,GO PROTEIN FOLDING,0.12421,0.013529,0.066402,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.96607,0.013528,0.017578,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.62258,0.013447,0.019654,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.67206,0.013433,0.034412,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.46713,0.013315,0.048335,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.81581,0.013295,-0.016346,0,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.41899,0.013079,0.046575,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.46962,0.013048,0.06219,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1,0.012995,-0.0010944,0,0
3,GO T CELL CHEMOTAXIS,0.59986,0.012965,0.022155,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.73822,0.012774,0.024026,0,0
3,GO CARTILAGE DEVELOPMENT,0.51035,0.01265,0.038455,0,0
3,GO THALAMUS DEVELOPMENT,0.28395,0.01265,0.096431,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.98222,0.012552,0.0042366,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.1754,0.012522,0.090899,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.59986,0.012512,0.06351,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.92094,0.012481,-0.0093315,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.53406,0.012479,0.060659,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.6515,0.012478,-0.0055607,0,0
3,GO MESODERM DEVELOPMENT,0.90809,0.012411,0.0057828,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.63986,0.012332,0.045001,0,0
3,GO EXIT FROM MITOSIS,0.58307,0.012281,0.030367,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.71391,0.012129,-0.034352,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.39606,0.011918,-0.027369,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.75972,0.011884,-0.025779,0,0
3,GO ORGAN GROWTH,0.86012,0.011784,-0.0015913,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.11183,0.011773,0.062131,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.58307,0.01176,0.035049,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.84424,0.011669,0.018944,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.80639,0.011607,0.030279,0,0
3,GO CELL CYCLE ARREST,0.46218,0.011509,0.032511,0,0
3,GO URETER DEVELOPMENT,0.43312,0.011395,0.046343,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.8379,0.011289,0.0043303,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.88885,0.01128,0.0023547,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.83474,0.011221,0.01896,0,0
3,GO NEURON PROJECTION REGENERATION,0.86012,0.011212,0.0076292,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.36526,0.011117,-0.043427,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.15098,0.010995,0.069291,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.57752,0.010724,0.034101,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.64858,0.010655,0.045746,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.78763,0.010596,0.016622,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.56925,0.010552,-0.014979,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.39832,0.010408,-0.036427,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.31997,0.010296,0.10658,0,0
3,GO METHYLATION,0.30066,0.010142,-0.027554,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.40743,0.010141,0.11265,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.7659,0.010109,0.014485,0,0
3,GO HEART VALVE DEVELOPMENT,0.88885,0.0099179,0.014517,0,0
3,GO FIBRINOLYSIS,0.40058,0.0097181,0.052021,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.59986,0.0095324,0.028626,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.77209,0.0095263,0.056685,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.5394,0.0093738,0.045362,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.95639,0.0092528,-0.0055976,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.80639,0.0092297,0.044595,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.80953,0.0092254,0.0085766,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.80639,0.0092233,0.035982,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.94993,0.0092077,0.044541,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.6691,0.0091568,0.01699,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.63408,0.0091093,-0.01606,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.98222,0.0089205,0.011149,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.41899,0.0088933,-0.027843,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.46962,0.0088833,0.024619,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.78451,0.0088776,0.025286,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.3442,0.008877,0.10129,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.55558,0.008863,0.03748,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.42602,0.0087761,0.0378,0,0
3,GO MEMBRANE DOCKING,0.67798,0.0087669,0.023704,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.7659,0.0086774,0.023584,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.84424,0.0086279,0.010034,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.89846,0.0084878,0.0037929,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.83474,0.0084445,0.00067881,0,0
3,GO L AMINO ACID TRANSPORT,0.36956,0.0084087,0.038242,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.797,0.0083926,0.032972,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.27495,0.0083568,0.18918,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.97253,0.0083164,0.0020424,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.90809,0.0083129,0.0083,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.85376,0.0082119,-0.0085497,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.58307,0.0080784,0.019886,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.95639,0.0080623,0.0071349,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.21889,0.0079865,0.071516,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.74435,0.0079125,0.011158,0,0
3,GO STEM CELL DIVISION,0.71089,0.0079087,-0.013029,0,0
3,GO ARTERY DEVELOPMENT,0.75664,0.0078775,-0.016323,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.92738,0.0078607,0.0004546,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.59424,0.0076981,0.029402,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.13234,0.0076677,0.072954,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96284,0.0076671,0.0066699,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.53672,0.0076602,0.030071,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.59705,0.0076113,0.032501,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.86649,0.0075749,0.0123,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.51819,0.0075674,0.032084,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.77829,0.0075218,0.035817,0,0
3,GO FOREBRAIN DEVELOPMENT,0.61402,0.007506,-0.0060585,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.69586,0.0072924,0.016928,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.86968,0.0071273,0.01281,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.90167,0.0070023,-0.0016985,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.80326,0.0069714,0.0015272,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.61117,0.0068994,0.01946,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.75356,0.0068056,0.026635,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.73822,0.0066554,0.019625,0,0
3,GO MUSCLE FILAMENT SLIDING,0.43789,0.0065584,-0.046432,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.43312,0.006441,0.074836,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.70787,0.0062249,-0.012472,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.77209,0.0061864,0.018644,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.55287,0.0060711,-0.017321,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.39606,0.0059488,-0.020496,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.96284,0.0058973,-0.0088887,0,0
3,GO RESPONSE TO VITAMIN A,0.86331,0.0058753,0.0031699,0,0
3,GO PEPTIDE CROSS LINKING,0.30066,0.0057346,0.055116,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.71391,0.0056676,-0.0077551,0,0
3,GO RESPONSE TO DOPAMINE,0.65734,0.0056643,0.034427,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.90167,0.005546,-0.0032246,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.91772,0.0055324,0.023842,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.6055,0.005513,0.04448,0,0
3,GO NEGATIVE CHEMOTAXIS,0.59705,0.0054765,-0.040788,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.70486,0.0052001,0.022815,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.80012,0.0051558,0.0042641,0,0
3,GO SYNAPTIC VESICLE PRIMING,0.52345,0.0050987,0.099053,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.86649,0.0050817,0.012064,0,0
3,GO HISTONE H4 ACETYLATION,0.91772,0.0049689,0.0097705,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.39156,0.0049318,0.06463,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.63986,0.004851,-0.030014,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.78451,0.0047758,0.021862,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.93382,0.0047023,0.017507,0,0
3,GO REGULATION OF CELL AGING,0.55558,0.0046494,-0.018671,0,0
3,GO REGULATION OF CELL CYCLE,0.95639,0.0045685,0.0098072,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.99192,0.0044458,0.0050513,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.48976,0.0042782,0.050393,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.73212,0.0041729,0.025827,0,0
3,GO INTERACTION WITH SYMBIONT,0.84741,0.0038645,0.0021934,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.73212,0.0038224,-0.018608,0,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.71996,0.0038129,0.1338,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.30446,0.0036283,0.054733,0,0
3,GO LIPID PHOSPHORYLATION,0.61687,0.0035938,0.044287,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.59144,0.0034376,-0.015154,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.92094,0.0034132,-0.0016321,0,0
3,GO PROTEIN IMPORT,0.9113,0.00338,0.014878,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.94026,0.0033208,0.034884,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.70185,0.0033029,0.045433,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.45238,0.0032818,0.05005,0,0
3,GO RESPONSE TO VITAMIN D,0.86649,0.0032323,-0.017409,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.64276,0.0032127,-0.0067542,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.53672,0.0031049,-0.023468,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.82842,0.0030549,-0.0062884,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.96607,0.0030496,-0.029021,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.89846,0.003003,0.026063,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.58029,0.0028718,-0.014297,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.99192,0.0028235,0.015533,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.29315,0.002736,-0.037468,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.86012,0.0026668,-0.0070537,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.9693,0.0026455,-0.0010203,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.47461,0.0026453,-0.019433,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.71391,0.002575,0.012894,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.77519,0.0025622,-0.012372,0,0
3,GO MALE MEIOSIS I,0.24089,0.0024263,0.1343,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.75972,0.0024142,0.028016,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.52345,0.0022897,-0.027192,0,0
3,GO PENILE ERECTION,0.76281,0.0022569,-0.033365,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.50516,0.0021511,-0.029904,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.56376,0.0019381,0.042016,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.73822,0.0017264,0.024562,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.318,0.0017162,0.13859,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.85376,0.0016877,0.014666,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.73517,0.0016146,0.030952,0,0
3,GO TOXIN TRANSPORT,0.60268,0.001542,0.043786,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.72299,0.0015118,0.026934,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.80012,0.0015092,0.020443,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.68689,0.0014433,0.041381,0,0
3,GO CRISTAE FORMATION,0.572,0.0010472,0.047556,0,0
3,GO THYROID GLAND DEVELOPMENT,0.38488,0.00097331,-0.055487,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.39156,0.0009145,0.05922,0,0
3,GO AXONAL FASCICULATION,0.9306,0.00086958,-0.015582,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.75664,0.00085401,0.020767,0,0
3,GO REGULATION OF DNA BINDING,0.97899,0.00072055,0.015834,0,0
3,GO PROTEIN NITROSYLATION,0.48215,0.00067034,-0.076215,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.44269,0.00054738,0.055821,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.95639,0.00037058,-0.0072437,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.82526,0.0002064,0.0020193,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.74128,0.00012814,-0.009551,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.88885,-1.1424e-05,-0.013413,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.85694,-0.00010704,-0.005012,0,0
3,GO TRNA 5 LEADER REMOVAL,0.78451,-0.00011227,0.013113,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.39381,-0.00016903,0.054841,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.81267,-0.00022203,-0.016394,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.66616,-0.00034105,0.026812,0,0
3,GO RNA DESTABILIZATION,0.36311,-0.00035685,-0.029348,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.68689,-0.00044217,0.038269,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.77209,-0.0005587,-0.0050001,0,0
3,GO CONVERGENT EXTENSION,0.95961,-0.00059649,0.00283,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.92738,-0.00071946,0.0125,0,0
3,GO PROTEIN ACYLATION,0.61687,-0.00073588,-0.0034657,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.59705,-0.00079893,-0.003679,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.21587,-0.0010557,-0.078221,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.80012,-0.0014899,0.019465,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.54477,-0.0014952,0.037429,0,0
3,GO TORC1 SIGNALING,0.52345,-0.0015555,0.041702,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.81896,-0.0015699,0.028839,0,0
3,GO AEROBIC RESPIRATION,0.19979,-0.0015915,0.0618,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.572,-0.0016073,-0.073643,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.56925,-0.0017808,-0.020946,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.29689,-0.0018418,-0.059038,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.42838,-0.0019632,-0.024209,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.31409,-0.0020043,-0.012813,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.44028,-0.0022615,-0.024493,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.83158,-0.0022768,-0.0026613,0,0
3,GO PROTEIN TARGETING,0.93382,-0.0024082,0.0074285,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.28761,-0.0027449,-0.051899,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.5314,-0.002908,0.056263,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.71391,-0.0029338,0.002308,0,0
3,GO NCRNA CATABOLIC PROCESS,0.42838,-0.0032958,0.042498,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.70486,-0.0035383,-0.0080981,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.85059,-0.0037374,0.0026677,0,0
3,GO BRONCHUS DEVELOPMENT,0.51557,-0.0039585,0.10058,0,0
3,GO BLASTOCYST FORMATION,0.54208,-0.0041161,0.03342,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.75664,-0.0041208,-0.037519,0,0
3,GO REGULATION OF CELL DIVISION,0.89526,-0.0041242,0.01468,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.59424,-0.0042803,-0.0037981,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.74741,-0.004366,0.064607,0,0
3,GO ORGANELLE FISSION,0.42602,-0.0046733,-0.0049709,0,0
3,GO PROSTATIC BUD FORMATION,0.75048,-0.0048442,-0.06801,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.69885,-0.0049219,-0.020885,0,0
3,GO HISTONE MONOUBIQUITINATION,0.94026,-0.0051217,0.0059853,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.75664,-0.00517,0.0066844,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.76281,-0.0052242,-0.006457,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.85376,-0.0052658,0.057794,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.93704,-0.0054582,0.016394,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.95961,-0.0054656,0.0012549,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.82842,-0.0056644,0.0099872,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.32393,-0.0057183,0.069365,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.88885,-0.0058456,0.0064152,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.70185,-0.0059928,0.047263,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.99192,-0.0060667,0.0091414,0,0
3,GO GENETIC IMPRINTING,0.7814,-0.0060704,0.032355,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.32993,-0.0060705,-0.017773,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.797,-0.0060848,0.031721,0,0
3,GO SPECIFICATION OF SYMMETRY,0.39606,-0.006264,-0.021979,0,0
3,GO GOLGI LOCALIZATION,0.77209,-0.0064417,0.021727,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.47712,-0.0064787,-0.038897,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.34008,-0.0064931,-0.023331,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.5,-0.0064961,-0.023659,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.68689,-0.0065167,0.0066002,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.40286,-0.0065605,0.033354,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.63408,-0.0066432,0.019928,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.94993,-0.0067626,0.011953,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.68392,-0.0068874,-0.027771,0,0
3,GO LEARNING,0.64276,-0.0070792,-0.017095,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.49231,-0.0071817,0.06134,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.71089,-0.0072479,-0.017328,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.61972,-0.00725,0.0091859,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.22658,-0.007672,-0.048167,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.54208,-0.0080525,-0.0054748,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.62258,-0.0080871,-0.025285,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.72299,-0.0081438,0.03997,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.97576,-0.0082565,0.030148,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.61972,-0.0083907,0.06314,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.62545,-0.0085898,-0.014819,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.89526,-0.0087473,0.0068282,0,0
3,GO PROTEIN KINASE A SIGNALING,0.95961,-0.0087582,0.0023574,0,0
3,GO REGULATION OF EXCRETION,0.81267,-0.0088081,0.016971,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.59705,-0.009102,0.058842,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.59705,-0.0091221,-0.0019559,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.57476,-0.0091325,-0.022134,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.93704,-0.0092226,0.018431,0,0
3,GO CELL CYCLE,0.4451,-0.0093013,-0.0019974,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.94348,-0.0094473,0.025529,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.44269,-0.0095383,0.044414,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.88245,-0.0098984,0.0020449,0,0
3,GO DECIDUALIZATION,0.80012,-0.010006,-0.0086771,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.85059,-0.010126,0.017598,0,0
3,GO CILIUM ORGANIZATION,0.84107,-0.010207,0.0016587,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.56925,-0.010238,-0.015542,0,0
3,GO CELL PART MORPHOGENESIS,0.26614,-0.01026,-0.041985,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.51557,-0.010286,0.043239,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.46218,-0.010312,-0.019398,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.55287,-0.010508,0.045192,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.92094,-0.010521,-0.0060191,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.92738,-0.010624,0.03078,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.69885,-0.010655,-0.01458,0,0
3,GO CYTOKINESIS,0.44269,-0.01068,-0.0064464,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.54477,-0.010745,-0.013712,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.97253,-0.010814,0.029646,0,0
3,GO NEUROTRANSMITTER SECRETION,0.98869,-0.010896,0.045404,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.77519,-0.011326,0.0081663,0,0
3,GO MICROTUBULE ANCHORING,0.38933,-0.011569,-0.027496,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.58029,-0.011647,0.047006,0,0
3,GO ORGANELLE ASSEMBLY,0.7659,-0.011659,0.0037942,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.38047,-0.011667,-0.045188,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.69586,-0.011758,-0.0084918,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.33396,-0.011837,-0.012924,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.5394,-0.012003,-0.031908,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.86012,-0.012014,-0.0083833,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.39606,-0.012038,-0.021994,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.86331,-0.012161,0.0050145,0,0
3,GO ENDODERM FORMATION,0.68689,-0.012228,0.020099,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.78451,-0.012388,0.027472,0,0
3,GO MITOTIC CYTOKINESIS,0.73517,-0.012521,0.0017699,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.92738,-0.01255,0.022856,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.35253,-0.012634,-0.03388,0,0
3,GO IMPORT INTO NUCLEUS,0.65734,-0.012872,-0.0046911,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.36311,-0.013088,-0.021882,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.35043,-0.013149,-0.021505,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.20554,-0.013172,-0.049892,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.37173,-0.013336,-0.017661,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.75664,-0.013337,0.00033342,0,0
3,GO RESPONSE TO HEAT,0.89846,-0.01354,0.014526,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.80639,-0.013603,0.0092408,0,0
3,GO CENTROSOME SEPARATION,0.84107,-0.013615,0.040285,0,0
3,GO RESPONSE TO MANGANESE ION,0.75356,-0.013687,0.030619,0,0
3,GO AXON DEVELOPMENT,0.18327,-0.013763,-0.059548,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.35886,-0.013911,-0.040157,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.797,-0.014019,0.028416,0,0
3,GO HISTONE DEACETYLATION,1,-0.014044,0.014386,0,0
3,GO POSTSYNAPSE ORGANIZATION,0.23766,-0.01412,-0.066508,0,0
3,GO HISTONE H2A UBIQUITINATION,0.49231,-0.01421,-0.022386,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.89846,-0.014213,0.024264,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.3739,-0.014292,-0.042702,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.63986,-0.014376,-0.0013148,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4451,-0.014412,-0.042076,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.6691,-0.014533,0.037753,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.86012,-0.014624,-0.00791,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.99515,-0.014664,0.013651,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.43312,-0.014695,-0.012176,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.79387,-0.014695,-0.010993,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.3739,-0.014836,-0.033165,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.51819,-0.014979,-0.035199,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.66321,-0.015169,-0.013256,0,0
3,GO REGULATION OF MRNA BINDING,0.1313,-0.015217,-0.091008,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.86649,-0.015221,0.0082973,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.18062,-0.015306,-0.017361,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.65734,-0.015346,-0.010839,0,0
3,GO FORELIMB MORPHOGENESIS,0.4451,-0.015398,-0.049202,0,0
3,GO REGULATION OF DNA METHYLATION,0.7814,-0.015417,0.0043423,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.63408,-0.015522,-0.012147,0,0
3,GO GLUTAMATE SECRETION,0.83158,-0.015551,0.024966,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.83474,-0.015595,-0.022903,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.67206,-0.015617,0.04367,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.67206,-0.015659,-0.0019364,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.24089,-0.015765,-0.04825,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.81896,-0.015845,0.032195,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.73212,-0.015951,0.0083286,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.20409,-0.01604,-0.062272,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.64276,-0.016068,-0.014901,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.69286,-0.01608,-0.018267,0,0
3,GO HEART FORMATION,0.69586,-0.01642,-0.0063876,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.93704,-0.016509,-0.0082836,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.61972,-0.016535,-0.01268,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.85059,-0.016586,0.030265,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.98546,-0.016586,-0.0052935,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.13027,-0.016615,-0.030077,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.20265,-0.016642,-0.012702,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.1793,-0.016681,-0.030088,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.98546,-0.016787,0.021448,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.57752,-0.016796,0.03302,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.70486,-0.016883,0.045961,0,0
3,GO STEM CELL DIFFERENTIATION,0.73822,-0.017002,-0.0016639,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.62258,-0.017046,-0.010661,0,0
3,GO OVULATION CYCLE PROCESS,0.74741,-0.017112,0.026504,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.70185,-0.017246,0.028113,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.63986,-0.017311,-0.018543,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.39381,-0.017435,-0.008403,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.94993,-0.017508,0.014106,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.89205,-0.017594,0.012117,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.95961,-0.017634,0.024482,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.63697,-0.01798,-0.031657,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.55016,-0.018156,-0.026912,0,0
3,GO MISMATCH REPAIR,0.67206,-0.018193,-0.006203,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.83158,-0.018374,0.0015312,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.58864,-0.01858,-0.0079161,0,0
3,GO ANIMAL ORGAN FORMATION,0.53406,-0.018719,-0.027521,0,0
3,GO SIALYLATION,0.56376,-0.018723,0.058939,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.35674,-0.018781,-0.042099,0,0
3,GO SOMATIC STEM CELL DIVISION,0.22503,-0.018782,-0.094582,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.7659,-0.019074,0.0010646,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.78451,-0.01915,-0.017086,0,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.26614,-0.019308,-0.059192,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.50258,-0.019383,-0.020917,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.88245,-0.019389,-0.0012773,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.50776,-0.019831,-0.015425,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.68392,-0.01993,0.041619,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.6515,-0.019937,-0.00011207,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.80326,-0.019975,-0.0046057,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.40743,-0.019984,-0.017145,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.6515,-0.020256,0.034568,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.54208,-0.020256,-0.0081183,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.81896,-0.020497,-0.00011814,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.52609,-0.02056,-0.0042606,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.5,-0.020678,-0.038793,0,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.53406,-0.020834,0.11361,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.85376,-0.020913,0.0064709,0,0
3,GO MRNA TRANSCRIPTION,0.44994,-0.02106,-0.016557,0,0
3,GO APPENDAGE DEVELOPMENT,0.79075,-0.021073,-0.0012722,0,0
3,GO CELLULAR RESPONSE TO PH,0.84741,-0.021176,0.034233,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.75356,-0.021208,0.015729,0,0
3,GO REPLACEMENT OSSIFICATION,0.28395,-0.021215,-0.058249,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.74435,-0.021384,0.011718,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.57476,-0.021549,-0.0073461,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.22658,-0.021602,-0.038755,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.14419,-0.021618,-0.029094,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.52082,-0.021738,-0.034849,0,0
3,GO GENITALIA MORPHOGENESIS,0.797,-0.022329,-0.028234,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.52874,-0.022395,0.046857,0,0
3,GO BONE DEVELOPMENT,0.32195,-0.022443,-0.030924,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.60268,-0.022696,-0.012498,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.94026,-0.022924,0.0073288,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.36526,-0.023084,-0.071134,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.32393,-0.023121,-0.027746,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.28578,-0.023133,-0.026424,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.38488,-0.023145,-0.043135,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.70787,-0.023216,-0.010924,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.93382,-0.023331,0.0020805,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.26095,-0.023364,-0.027981,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.79387,-0.023365,0.010535,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.19979,-0.023409,-0.04507,0,0
3,GO REGULATION OF ERAD PATHWAY,0.81581,-0.023415,0.027519,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.73212,-0.023473,0.040363,0,0
3,GO NUCLEUS ORGANIZATION,0.69885,-0.023607,0.0054242,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.797,-0.023866,-0.053678,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.68988,-0.023895,0.026372,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.71996,-0.024064,-0.023518,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.49487,-0.024441,-0.0084248,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.075674,-0.024468,-0.09108,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.54746,-0.024492,-0.0062545,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.2913,-0.024744,-0.066411,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.90488,-0.024774,0.057944,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.35674,-0.024794,-0.017399,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.797,-0.024813,0.0077574,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.65734,-0.024902,-0.0085518,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.71089,-0.025002,0.0027781,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.86331,-0.025186,0.0099225,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.94026,-0.025305,0.023005,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.15447,-0.025315,-0.07505,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.7659,-0.025446,-0.015286,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.94026,-0.025489,0.032885,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.34008,-0.025553,-0.052322,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.31021,-0.02558,-0.050528,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.11553,-0.025686,-0.052371,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.98869,-0.025698,0.017334,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.38047,-0.025881,-0.026161,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.24745,-0.025978,-0.049447,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.99838,-0.025992,-0.01321,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.84741,-0.026174,-0.0075972,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.76281,-0.026207,-0.014039,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.69885,-0.026351,0.038376,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.63986,-0.026527,0.04175,0,0
3,GO CELL CYCLE PROCESS,0.15098,-0.026596,-0.015948,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.3871,-0.026778,-0.011269,0,0
3,GO ACROSOME ASSEMBLY,0.19979,-0.026792,-0.070639,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.86649,-0.026854,0.0064096,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.40286,-0.026899,-0.029754,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.15447,-0.026908,-0.015278,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.45972,-0.026926,-0.034381,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.75664,-0.02694,0.0092423,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.69885,-0.026982,0.0078031,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.12224,-0.027096,-0.063979,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.66616,-0.027179,-0.025241,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.26267,-0.02718,-0.034287,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.77829,-0.027222,-0.017324,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.4451,-0.027352,-0.020957,0,0
3,GO NCRNA 3 END PROCESSING,0.1914,-0.027503,-0.058153,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.40058,-0.027697,-0.023124,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.82526,-0.027701,0.0080671,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.87926,-0.027739,0.018458,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.66028,-0.027858,0.028495,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.37827,-0.02792,-0.032165,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.75048,-0.027924,-0.05772,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.92094,-0.028278,0.013191,0,0
3,GO CELL CYCLE CHECKPOINT,0.13338,-0.028335,-0.024469,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.55558,-0.028398,-0.0049287,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.1533,-0.028421,-0.024638,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.62832,-0.028802,-0.037928,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.25924,-0.028961,-0.019107,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.4451,-0.02906,-0.010733,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.57476,-0.029079,-0.002879,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59986,-0.029264,-0.0076854,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.30255,-0.029296,-0.054903,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.84424,-0.0297,0.04457,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.5314,-0.029723,-0.027718,0,0
3,GO APPENDAGE MORPHOGENESIS,0.51557,-0.029799,-0.022615,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.33803,-0.029822,-0.0099806,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.49487,-0.029936,-0.0068201,0,0
3,GO NEPHRON TUBULE FORMATION,0.42838,-0.030249,-0.072025,0,0
3,GO PROTEIN ACETYLATION,0.086981,-0.030285,-0.024116,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.36526,-0.030296,-0.033457,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.30255,-0.030316,-0.084575,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.096327,-0.030539,-0.029113,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.46962,-0.030556,-0.008924,0,0
3,GO REGULATION OF AXONOGENESIS,0.29315,-0.030574,-0.054531,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.2913,-0.030744,-0.057707,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.87926,-0.031099,0.071506,0,0
3,GO PORE COMPLEX ASSEMBLY,0.36311,-0.031312,-0.026147,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.58029,-0.031313,0.05175,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.87926,-0.031392,0.0047804,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.13338,-0.031437,-0.027199,0,0
3,GO REGULATION OF MYELINATION,0.19838,-0.031598,-0.041414,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.1453,-0.031691,-0.020991,0,0
3,GO DOSAGE COMPENSATION,0.31215,-0.031859,-0.033245,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.99838,-0.031895,0.079385,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.47712,-0.031968,-0.0038517,0,0
3,GO HISTONE H3 DEACETYLATION,0.5583,-0.032162,-0.014618,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.30637,-0.032186,-0.047431,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.80012,-0.032215,0.053017,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.19278,-0.032264,-0.01694,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.3871,-0.032392,-0.035305,0,0
3,GO FOREGUT MORPHOGENESIS,0.50776,-0.032413,-0.037785,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.51557,-0.032504,-0.013701,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.90488,-0.032555,0.012477,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19557,-0.032603,-0.075518,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.33599,-0.032885,0.00093964,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.97576,-0.033055,0.0027471,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.98546,-0.033157,0.032235,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.69286,-0.033198,0.0074508,0,0
3,GO RNA MODIFICATION,0.2644,-0.033284,-0.033245,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.29502,-0.033578,-0.030076,0,0
3,GO REGULATION OF ORGAN GROWTH,0.17156,-0.033783,-0.041336,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.46962,-0.033838,-0.046253,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.20122,-0.034097,-0.023801,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.56925,-0.034195,-0.013627,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.49231,-0.03431,-0.030076,0,0
3,GO SHORT TERM MEMORY,0.77209,-0.034316,-0.021557,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.1754,-0.034418,-0.034723,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.10471,-0.034471,-0.096014,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.11092,-0.034685,-0.069239,0,0
3,GO CELL DIVISION,0.09714,-0.034707,-0.027958,0,0
3,GO RECEPTOR CLUSTERING,0.31997,-0.034877,-0.055423,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.51819,-0.034934,-0.010858,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.1754,-0.035127,-0.046857,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.96607,-0.035227,0.0032146,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.5394,-0.03556,-0.022852,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.80012,-0.035597,-0.018838,0,0
3,GO LACTATION,0.77519,-0.035865,0.0095426,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.1262,-0.035917,-0.026849,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.56925,-0.036303,-0.023512,0,0
3,GO P BODY ASSEMBLY,0.18062,-0.036721,-0.034395,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.30829,-0.037114,-0.063653,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.73517,-0.037131,0.047501,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.57476,-0.037233,-0.012948,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.32792,-0.037272,-0.038958,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.38267,-0.037292,-0.032903,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.26614,-0.037481,-0.042015,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96284,-0.037774,0.031834,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.092339,-0.037854,-0.051386,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.61117,-0.037868,-0.045865,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.46466,-0.037875,-0.029154,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.90809,-0.037892,0.0056763,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.35253,-0.037956,-0.056076,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.37827,-0.037982,-0.013887,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.88245,-0.038136,-0.0053524,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.6055,-0.038203,-0.015509,0,0
3,GO LONG TERM MEMORY,0.80326,-0.038309,-0.0056674,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.041383,-0.038342,-0.084481,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.072397,-0.03835,-0.062653,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.39156,-0.038454,-0.033116,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.94671,-0.038852,0.009791,0,0
3,GO NEUROBLAST PROLIFERATION,0.32195,-0.03912,-0.035588,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.66616,-0.039225,-0.029628,0,0
3,GO REGULATION OF BEHAVIOR,0.70787,-0.039295,-0.0085235,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.26789,-0.039365,-0.034696,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.65734,-0.03956,0.020049,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.16285,-0.039585,-0.067869,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.94671,-0.039844,0.013542,0,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.68392,-0.039866,-0.013046,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.078382,-0.039972,-0.065958,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.23766,-0.039991,-0.046358,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.1453,-0.040204,-0.024269,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.41203,-0.040564,-0.035061,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.15921,-0.040633,-0.023945,0,0
3,GO RESPONSE TO LEAD ION,0.11933,-0.040924,-0.053379,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.8379,-0.041139,0.025263,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.31409,-0.041228,-0.033856,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.071119,-0.041274,-0.084113,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.12224,-0.041393,-0.018099,0,0
3,GO AMINO ACID ACTIVATION,0.74435,-0.041535,-0.0074138,0,0
3,GO MICROTUBULE BASED PROCESS,0.099614,-0.041558,-0.032934,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.58029,-0.041685,-0.031417,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.95316,-0.041713,0.006164,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.16285,-0.041729,-0.05968,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.23605,-0.042009,-0.022258,0,0
3,GO SUCKLING BEHAVIOR,0.34627,-0.042014,-0.060121,0,0
3,GO TRANSLATIONAL ELONGATION,0.078382,-0.042305,-0.057341,0,0
3,GO PROTEIN METHYLATION,0.24745,-0.042495,-0.031552,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.71391,-0.042509,-0.00076581,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.43075,-0.042522,-0.013569,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.30446,-0.042866,-0.046131,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.095518,-0.042932,-0.078405,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.84741,-0.043299,0.029095,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.50258,-0.043435,-0.027297,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.1252,-0.043477,-0.019221,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.079071,-0.043611,-0.040702,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.22042,-0.043659,-0.054252,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,1,-0.043966,0.0034652,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.45727,-0.044136,-0.079825,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.22195,-0.044196,-0.028441,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.84741,-0.044338,0.013246,0,0
3,GO REGULATION OF GASTRULATION,0.57752,-0.044536,-0.014744,0,0
3,GO NEURON FATE SPECIFICATION,0.92738,-0.044743,0.034318,0,0
3,GO DENDRITE MORPHOGENESIS,0.11933,-0.044764,-0.068121,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.45972,-0.044827,-0.042069,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.42602,-0.04499,-0.031496,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.87287,-0.045033,0.020127,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.15098,-0.045108,-0.05479,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.40514,-0.045206,-0.055082,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.28395,-0.045259,-0.074162,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.22195,-0.045313,-0.035227,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.34213,-0.045459,-0.045741,0,0
3,GO HISTONE EXCHANGE,0.12822,-0.045676,-0.053726,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.21587,-0.045693,-0.073402,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.071756,-0.045868,-0.095316,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.19003,-0.046133,-0.097042,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.68094,-0.046182,-0.011707,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.30829,-0.046299,-0.038769,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.13549,-0.046314,-0.090514,0,0
3,GO TRNA 5 END PROCESSING,0.5394,-0.04652,-0.022306,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43312,-0.046617,0.0064141,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.58029,-0.046618,-0.032769,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.10045,-0.046678,-0.080207,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.47712,-0.046692,-0.012361,0,0
3,GO GENE SILENCING,0.13763,-0.046692,-0.03158,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.48468,-0.046842,-0.024109,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.22658,-0.046954,-0.029532,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.46962,-0.047006,-0.0039322,0,0
3,GO AXON EXTENSION,0.082591,-0.047305,-0.073021,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.28761,-0.047307,-0.041301,0,0
3,GO MITOTIC CELL CYCLE,0.14419,-0.047362,-0.016882,0,0
3,GO RNA DECAPPING,0.1313,-0.047409,-0.0441,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.075674,-0.047619,-0.049112,0,0
3,GO METAPHASE PLATE CONGRESSION,0.17156,-0.047864,-0.023489,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.45972,-0.047869,-0.017982,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.56925,-0.048202,-0.032401,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.17669,-0.048304,-0.028039,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.1754,-0.048527,-0.039573,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.1754,-0.048804,-0.040637,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.90809,-0.04892,0.029863,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.95961,-0.048944,0.045285,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.091558,-0.04904,-0.03969,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.26614,-0.049193,-0.079602,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.14869,-0.04936,-0.11586,0,0
3,GO NEURON RECOGNITION,0.25583,-0.049705,-0.073549,0,0
3,GO CENTROSOME DUPLICATION,0.41203,-0.049839,-0.013221,0,0
3,GO HISTONE PHOSPHORYLATION,0.22971,-0.049879,-0.03708,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.16904,-0.050278,-0.065531,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.99515,-0.050616,0.01008,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.09714,-0.050652,-0.031502,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.85376,-0.050779,0.0042268,0,0
3,GO PROTEIN SUMOYLATION,0.077698,-0.050963,-0.034262,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.45238,-0.051072,-0.01485,0,0
3,GO CHROMATIN ORGANIZATION,0.071119,-0.051582,-0.031222,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.30829,-0.05175,-0.054079,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.57752,-0.051753,-0.02356,0,0
3,GO DENDRITE DEVELOPMENT,0.2714,-0.05187,-0.038135,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.075674,-0.051892,-0.0453,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.28761,-0.051985,-0.030508,0,0
3,GO REGULATION OF URINE VOLUME,0.40743,-0.052097,-0.026988,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.090011,-0.052114,-0.076998,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.26614,-0.052325,-0.018929,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.5314,-0.052409,-0.020866,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.32195,-0.052485,-0.03056,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.96284,-0.052659,-0.01997,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.94026,-0.052681,0.00012091,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.19003,-0.052997,-0.073208,0,0
3,GO HYPEROSMOTIC RESPONSE,0.5394,-0.053002,-0.012043,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.19979,-0.053308,-0.045467,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.18866,-0.053556,-0.040975,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.085497,-0.053748,-0.08284,0,0
3,GO RESPONSE TO SALT STRESS,0.19278,-0.05386,-0.061098,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.40514,-0.053914,-0.042607,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.38047,-0.054265,-0.033864,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.077698,-0.054623,-0.061163,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.25246,-0.054674,-0.070396,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.089246,-0.0548,-0.035336,0,0
3,GO FEVER GENERATION,0.45238,-0.054819,-0.039511,0,0
3,GO REGULATION OF CYTOKINESIS,0.13979,-0.055057,-0.025816,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.85059,-0.05512,0.02565,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.31604,-0.055343,-0.042591,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.75664,-0.055501,-0.001716,0,0
3,GO DNA METHYLATION,0.32592,-0.055589,-0.028782,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.28761,-0.05584,-0.072411,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.26095,-0.055872,-0.044605,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.60834,-0.056481,0.088006,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.15447,-0.056844,-0.073992,0,0
3,GO CHROMOSOME LOCALIZATION,0.093918,-0.05712,-0.032195,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.96607,-0.057123,0.0091823,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.49231,-0.057354,-0.021144,0,0
3,GO TRNA METABOLIC PROCESS,0.099614,-0.057372,-0.055178,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.94671,-0.057511,0.027584,0,0
3,GO TRACHEA MORPHOGENESIS,0.37608,-0.057825,-0.036098,0,0
3,GO HISTONE H3 K4 METHYLATION,0.074349,-0.058147,-0.06472,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.11183,-0.058213,-0.078788,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.5,-0.058449,-0.012618,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.10299,-0.058452,-0.046709,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.44028,-0.058538,-0.0477,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.48976,-0.058684,-0.026318,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.16778,-0.058726,-0.053836,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.1873,-0.058766,-0.081289,0,0
3,GO VESICLE CARGO LOADING,0.36956,-0.058799,-0.031139,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.26789,-0.059029,-0.042692,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.26095,-0.059173,-0.014751,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.10471,-0.059249,-0.14175,0,0
3,GO PRIMARY MIRNA PROCESSING,0.54208,-0.059261,-0.028456,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.15214,-0.059294,-0.049557,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.28578,-0.059477,-0.07466,0,0
3,GO HISTONE H2A ACETYLATION,0.5394,-0.059733,-0.019387,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.43312,-0.059741,-0.014594,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.31997,-0.059909,-0.037346,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.80326,-0.059944,-0.0053869,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.15447,-0.060039,-0.069747,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.14308,-0.06004,-0.064576,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.97576,-0.060208,0.034276,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.65442,-0.060258,-0.06939,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.070488,-0.060392,-0.085655,0,0
3,GO SEQUESTERING OF METAL ION,0.66321,-0.061149,-0.067293,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.55016,-0.061575,-0.0073082,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.28945,-0.061949,-0.036655,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.37608,-0.062244,-0.028758,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.2714,-0.06236,-0.053353,0,0
3,GO HAIR FOLLICLE MATURATION,0.54477,-0.062464,-0.024649,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.26614,-0.062536,-0.01772,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.1262,-0.062575,-0.10284,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.14755,-0.062694,-0.052427,0,0
3,GO FOREBRAIN CELL MIGRATION,0.24745,-0.063526,-0.052359,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.16778,-0.063641,-0.066808,0,0
3,GO OOCYTE MATURATION,0.64276,-0.064293,-0.01565,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.30255,-0.064403,-0.034135,0,0
3,GO INTRACILIARY TRANSPORT,0.31215,-0.064515,-0.04188,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.10558,-0.064576,-0.045332,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.48976,-0.064589,-0.042444,0,0
3,GO NEURAL TUBE PATTERNING,0.10734,-0.064807,-0.080819,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.84741,-0.06504,-0.014819,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.33194,-0.065205,-0.051746,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.10045,-0.065325,-0.044732,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.26614,-0.065627,-0.077215,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.55558,-0.066177,-0.043265,0,0
3,GO LIVER REGENERATION,0.1387,-0.066223,-0.061032,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.48976,-0.066305,-0.019883,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.20554,-0.066401,-0.040351,0,0
3,GO RESPONSE TO X RAY,0.23605,-0.066449,-0.064411,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.17029,-0.066682,-0.063333,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.22814,-0.067003,-0.094581,0,0
3,GO NUCLEUS LOCALIZATION,0.19417,-0.067605,-0.052051,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.080464,-0.06765,-0.048327,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.1252,-0.067677,-0.04745,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.090011,-0.06773,-0.071873,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.1262,-0.067872,-0.044247,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.14308,-0.068064,-0.050941,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.095518,-0.068095,-0.050659,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.28578,-0.068347,-0.043489,0,0
3,GO REGULATION OF OOGENESIS,0.20992,-0.068429,-0.033045,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.13338,-0.068446,-0.041166,0,0
3,GO PALLIUM DEVELOPMENT,0.11837,-0.068906,-0.040028,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.10734,-0.069183,-0.10903,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.30829,-0.069207,-0.0056666,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.090782,-0.069228,-0.078547,0,0
3,GO REGULATION OF DNA REPLICATION,0.12721,-0.06964,-0.031339,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.14983,-0.06967,-0.065408,0,0
3,GO TRANSLATIONAL TERMINATION,0.20992,-0.069833,-0.044765,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.34213,-0.06986,-0.065481,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.3871,-0.070115,-0.0073301,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.070488,-0.070142,-0.057505,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.23766,-0.070305,-0.04868,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.079765,-0.070344,-0.12404,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.10299,-0.070451,-0.041233,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.18062,-0.070465,-0.064585,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.28395,-0.070564,-0.043867,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.22042,-0.071018,-0.048672,0,0
3,GO SULFATION,0.10214,-0.071274,-0.086662,0,0
3,GO WALKING BEHAVIOR,0.086981,-0.071276,-0.070239,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.23766,-0.07161,-0.07833,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.10734,-0.071696,-0.08546,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.51557,-0.071941,-0.0058206,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.31604,-0.072568,-0.037116,0,0
3,GO L GLUTAMATE IMPORT,0.20992,-0.072714,-0.061751,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.52345,-0.073377,-0.030028,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.23286,-0.073457,-0.073168,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.36526,-0.07369,-0.043322,0,0
3,GO HISTONE H3 K36 METHYLATION,0.18327,-0.07381,-0.077549,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.26267,-0.073838,-0.043625,0,0
3,GO BRAIN MORPHOGENESIS,0.1754,-0.074193,-0.061764,0,0
3,GO TELOMERE CAPPING,0.076344,-0.07429,-0.037826,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.14419,-0.074437,-0.10074,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.28395,-0.074475,-0.047462,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.077018,-0.0747,-0.11095,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.12224,-0.074779,-0.07512,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.86968,-0.074927,0.01506,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.26267,-0.074953,-0.033189,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.50516,-0.075118,-0.049119,0,0
3,GO CELL JUNCTION MAINTENANCE,0.27853,-0.075202,-0.049668,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.069238,-0.075376,-0.063484,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.31604,-0.075456,-0.046413,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.073043,-0.075509,-0.14466,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.084763,-0.075604,-0.11044,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.084034,-0.07589,-0.076853,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.1914,-0.076041,-0.029335,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.10823,-0.076087,-0.08193,0,0
3,GO NUCLEOSOME ASSEMBLY,0.092339,-0.076101,-0.059968,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.30255,-0.076316,-0.049534,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.31409,-0.076663,-0.085656,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.45238,-0.076749,-0.024866,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.40058,-0.07697,-0.047365,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.15214,-0.077024,-0.056215,0,0
3,GO NUCLEAR MIGRATION,0.13234,-0.077028,-0.066827,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.2714,-0.077478,-0.030671,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.099614,-0.077951,-0.071362,0,0
3,GO PENTOSE METABOLIC PROCESS,0.47712,-0.078014,-0.032463,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.10385,-0.078594,-0.06161,0,0
3,GO NEURON PROJECTION ORGANIZATION,0.11183,-0.078715,-0.082564,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50258,-0.079158,-0.020364,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.020605,-0.079269,-0.053949,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.19838,-0.079405,-0.039604,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.572,-0.079515,-0.030489,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.74128,-0.079642,0.0087529,0,0
3,GO MITOTIC RECOMBINATION,0.080464,-0.07995,-0.081152,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.085497,-0.080025,-0.13301,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.077698,-0.080054,-0.076922,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.1533,-0.08028,-0.076233,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.30829,-0.080333,-0.10392,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.11933,-0.08059,-0.049605,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.20554,-0.080597,-0.026297,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.12924,-0.080662,-0.11278,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.14869,-0.080781,-0.075485,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.13656,-0.081557,-0.088895,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.25583,-0.082672,-0.080827,0,0
3,GO RNA 5 END PROCESSING,0.22814,-0.082758,-0.042129,0,0
3,GO SISTER CHROMATID COHESION,0.1146,-0.083548,-0.050592,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.099614,-0.083631,-0.067542,0,0
3,GO FOREBRAIN REGIONALIZATION,0.14869,-0.083736,-0.082546,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.27673,-0.083939,-0.00059677,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27673,-0.083958,-0.040977,0,0
3,GO COCHLEA MORPHOGENESIS,0.5665,-0.083965,-0.014587,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.092339,-0.084022,-0.10732,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.32195,-0.084044,-0.034778,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.098784,-0.084207,-0.081845,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.13338,-0.084284,-0.11565,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.62832,-0.084294,0.0019212,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.58307,-0.08435,-0.043297,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.17283,-0.084422,-0.046089,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.63986,-0.084449,-0.023285,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.3442,-0.084636,-0.035375,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.075009,-0.084885,-0.094526,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.52609,-0.085053,0.0025185,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.14419,-0.086025,-0.1008,0,0
3,GO MITOCHONDRION DISTRIBUTION,0.067397,-0.086372,-0.069149,0,0
3,GO PROTEIN DENEDDYLATION,0.093126,-0.087469,-0.069093,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.16778,-0.088416,-0.070374,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.11933,-0.088511,-0.048387,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.18595,-0.088792,-0.084274,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.071756,-0.08887,-0.108,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.30446,-0.090179,-0.066416,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.1453,-0.090458,-0.072277,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.15214,-0.090875,-0.055146,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.069238,-0.091676,-0.071414,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.027118,-0.092112,-0.082518,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.10471,-0.092343,-0.073886,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.48215,-0.09247,-0.05619,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.079765,-0.092658,-0.10981,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.15921,-0.092778,-0.11466,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.40973,-0.093268,-0.055535,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.069238,-0.093336,-0.062701,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.17156,-0.09336,-0.12337,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.079071,-0.09346,-0.11768,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.081168,-0.09348,-0.11024,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.44028,-0.093657,0.0073732,0,0
3,GO FILOPODIUM ASSEMBLY,0.23605,-0.093955,-0.034505,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.074349,-0.094011,-0.077963,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.18461,-0.094115,-0.063169,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.027686,-0.094293,-0.14374,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.35886,-0.094403,-0.040929,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.15683,-0.094664,-0.075712,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.21889,-0.094935,-0.078434,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.27853,-0.095304,-0.017935,0,0
3,GO LYSINE METABOLIC PROCESS,0.97576,-0.095408,-0.01135,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.11933,-0.095915,-0.076628,0,0
3,GO NEURON MIGRATION,0.094715,-0.096637,-0.074487,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.075674,-0.096694,-0.073586,0,0
3,GO RRNA METHYLATION,0.073043,-0.096905,-0.068305,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.16042,-0.096928,-0.12276,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.43312,-0.096983,-0.03714,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.94348,-0.097476,0.020963,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.14419,-0.097743,-0.05173,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.10823,-0.097964,-0.077846,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.084763,-0.098537,-0.077157,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.14088,-0.10036,-0.13139,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.09796,-0.10073,-0.075441,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.28033,-0.10163,-0.086677,0,0
3,GO MICROTUBULE SEVERING,0.11647,-0.10168,-0.083346,0,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.073043,-0.10239,-0.078042,0,0
3,GO SPINAL CORD DEVELOPMENT,0.20265,-0.10273,-0.054086,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.21738,-0.1031,-0.10655,0,0
3,GO NODAL SIGNALING PATHWAY,0.37173,-0.10421,-0.034124,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.079765,-0.10429,-0.068977,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.10045,-0.10439,-0.12087,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.45482,-0.1045,-0.033011,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.028556,-0.10483,-0.078822,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.22503,-0.10485,-0.042353,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.51035,-0.10515,-0.031375,0,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.062684,-0.1052,-0.081256,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.15921,-0.10608,-0.15705,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.19417,-0.10626,-0.14532,0,0
3,GO REGULATION OF AXON GUIDANCE,0.067397,-0.10664,-0.08377,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.12721,-0.10745,-0.069785,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.14755,-0.10746,-0.090218,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.14755,-0.1079,-0.11276,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.44269,-0.10794,-0.03729,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.098784,-0.10849,-0.089879,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.1914,-0.10891,-0.080178,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.06986,-0.11026,-0.14934,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.11367,-0.11128,-0.10246,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.29877,-0.11142,-0.077328,0,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.10385,-0.11217,-0.11087,0,0
3,GO NEURON FATE COMMITMENT,0.26614,-0.11325,-0.04096,0,0
3,GO VOCALIZATION BEHAVIOR,0.16163,-0.11334,-0.15125,0,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.6312,-0.11564,-0.036865,0,0
3,GO NEURAL CREST FORMATION,0.14419,-0.11565,-0.10525,0,0
3,GO REGULATION OF HEART GROWTH,0.09714,-0.11589,-0.062253,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.6515,-0.11677,0.023555,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.084034,-0.11698,-0.10908,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.08331,-0.11762,-0.077524,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.20265,-0.11888,-0.091352,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.08331,-0.12129,-0.15668,0,0
3,GO TONGUE DEVELOPMENT,0.22042,-0.12322,-0.090246,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.58029,-0.12493,-0.04035,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.23128,-0.12846,-0.079316,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.079765,-0.12846,-0.093078,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.10646,-0.13014,-0.082674,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.20554,-0.1321,-0.066455,0,0
3,GO TRACHEA DEVELOPMENT,0.1387,-0.13355,-0.081974,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.1754,-0.13448,-0.083372,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.024687,-0.13552,-0.095576,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.34213,-0.13572,-0.076625,0,0
3,GO NEUROBLAST DIVISION,0.54477,-0.13608,-0.038437,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.25246,-0.13674,-0.062341,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.067397,-0.1385,-0.10928,0,0
3,GO HINDLIMB MORPHOGENESIS,0.098784,-0.13924,-0.086378,0,0
3,GO DIVALENT METAL ION EXPORT,0.085497,-0.14194,-0.14249,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.071119,-0.14208,-0.14174,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.30255,-0.14333,-0.096376,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.089246,-0.1448,-0.12386,0,0
3,GO RRNA 3 END PROCESSING,0.098784,-0.14654,-0.066802,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.20265,-0.14654,-0.081205,0,0
3,GO UTERUS DEVELOPMENT,0.20845,-0.14665,-0.075705,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.18461,-0.14801,-0.16123,0,0
3,GO SECRETORY GRANULE LOCALIZATION,0.13979,-0.14813,-0.090168,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.27317,-0.1499,-0.064837,0,0
3,GO LEUKOCYTE AGGREGATION,0.36741,-0.15074,-0.10865,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.10471,-0.15282,-0.084212,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.12126,-0.1533,-0.1296,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.011151,-0.15342,-0.12723,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.092339,-0.15424,-0.098993,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.087731,-0.15501,-0.1024,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.068619,-0.15581,-0.13843,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.20845,-0.15967,-0.050632,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0016575,-0.16159,-0.18534,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.012227,-0.16268,-0.22532,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0095807,-0.16314,-0.14033,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.003607,-0.16467,-0.17151,0,0
3,GO CARTILAGE MORPHOGENESIS,0.019312,-0.16514,-0.20008,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.015501,-0.16584,-0.13733,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.027401,-0.16861,-0.12796,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.15565,-0.17398,-0.11172,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.10385,-0.17448,-0.11667,0,0
3,GO HEART VALVE FORMATION,0.17283,-0.18085,-0.11713,0,0
3,GO SYNAPTIC VESICLE MATURATION,0.17029,-0.18598,-0.07274,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.23128,-0.18764,-0.084305,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.027401,-0.18771,-0.14074,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.18595,-0.19057,-0.15,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0015463,-0.21612,-0.19341,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.2913,-0.22349,-0.10039,0,0
3,GO L SERINE METABOLIC PROCESS,0.074349,-0.23553,-0.16212,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00029976,-0.26906,-0.2685,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.10129,-0.29789,-0.15996,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.00022565,-0.37783,-0.33021,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.013243,0.20147,0.18596,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.016386,0.18082,0.1434,1,1
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.027973,0.16095,0.081438,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.057711,0.15341,0.1093,1,1
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.033948,0.14948,0.081229,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.043866,0.10291,0.074179,1,1
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.055093,-0.048599,-0.08226,1,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.056128,-0.051136,-0.16327,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.027118,-0.056385,-0.13813,1,0
4,GO METHIONINE METABOLIC PROCESS,0.031311,-0.056404,-0.13919,1,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.055609,-0.059297,-0.1147,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.041383,-0.062086,-0.1676,1,0
4,GO RNA 3 END PROCESSING,0.020605,-0.063087,-0.1497,1,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0052854,-0.064818,-0.18434,1,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.020166,-0.067272,-0.13535,1,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0088198,-0.068165,-0.11317,1,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0056958,-0.068546,-0.13926,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.028264,-0.068927,-0.14661,1,0
4,GO RNA CAPPING,0.044722,-0.069838,-0.10677,1,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.042609,-0.069862,-0.12766,1,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.017506,-0.071653,-0.12853,1,0
4,GO UBIQUINONE METABOLIC PROCESS,0.01251,-0.071705,-0.15788,1,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.0085105,-0.071972,-0.17534,1,0
4,GO TRNA METHYLATION,0.031631,-0.075442,-0.1617,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0065235,-0.077938,-0.18787,1,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.026838,-0.079919,-0.12039,1,0
4,GO RNA SPLICING,0.0059852,-0.080046,-0.1607,1,0
4,GO CHROMATIN SILENCING,0.017125,-0.080369,-0.15876,1,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.026561,-0.08143,-0.15098,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.021053,-0.081539,-0.21455,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0080166,-0.082919,-0.15413,1,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.0022396,-0.084312,-0.20693,1,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.016568,-0.084696,-0.11019,1,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.010769,-0.085127,-0.11795,1,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.057711,-0.085182,-0.1373,1,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.040981,-0.085215,-0.15031,1,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.057179,-0.08535,-0.13381,1,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0071918,-0.085412,-0.16634,1,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.016386,-0.086205,-0.12583,1,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.043444,-0.087537,-0.14687,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.012087,-0.087859,-0.12655,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.011411,-0.088924,-0.18574,1,0
4,GO BASE EXCISION REPAIR,0.033271,-0.089165,-0.12235,1,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.0084096,-0.089702,-0.16003,1,0
4,GO AEROBIC RESPIRATION,0.016205,-0.089777,-0.13682,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0016122,-0.089783,-0.1973,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.063836,-0.090615,-0.12763,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.017894,-0.090906,-0.14582,1,0
4,GO TRNA MODIFICATION,0.061549,-0.092405,-0.13323,1,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.012227,-0.092501,-0.16233,1,0
4,GO CRISTAE FORMATION,0.014494,-0.093069,-0.23355,1,0
4,GO NUCLEOSOME ORGANIZATION,0.010645,-0.093722,-0.14841,1,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00099681,-0.093928,-0.12732,1,0
4,GO REGULATION OF RNA SPLICING,0.00026024,-0.094503,-0.22008,1,0
4,GO SPINDLE ASSEMBLY,0.00026024,-0.094546,-0.217,1,0
4,GO MRNA PROCESSING,0.0025617,-0.0948,-0.17622,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0012005,-0.095545,-0.16989,1,0
4,GO SNRNA TRANSCRIPTION,0.0032501,-0.095562,-0.16415,1,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.0034243,-0.096264,-0.16911,1,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.061549,-0.097312,-0.22899,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.056128,-0.098574,-0.13446,1,0
4,GO RRNA METHYLATION,0.03068,-0.09864,-0.15758,1,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.00021857,-0.099084,-0.21603,1,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.001422,-0.099127,-0.19996,1,0
4,GO REGULATION OF MRNA BINDING,0.003166,-0.099477,-0.19238,1,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.054582,-0.099587,-0.26694,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.017506,-0.10049,-0.14792,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.040582,-0.10055,-0.11432,1,0
4,GO CHROMOSOME SEGREGATION,0.0038977,-0.10126,-0.16959,1,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.0033361,-0.10182,-0.13767,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.058247,-0.1025,-0.14346,1,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0020929,-0.10328,-0.22447,1,0
4,GO SPERM AXONEME ASSEMBLY,0.0104,-0.10334,-0.16363,1,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0015038,-0.10335,-0.22986,1,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.01499,-0.10347,-0.16139,1,0
4,GO RNA PROCESSING,0.0052854,-0.10376,-0.16081,1,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0067673,-0.10388,-0.25133,1,0
4,GO RNA METHYLATION,0.0068504,-0.10395,-0.1855,1,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.026838,-0.10454,-0.12611,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.048285,-0.10461,-0.1276,1,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0005133,-0.10589,-0.16743,1,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.054074,-0.10623,-0.11798,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0005211,-0.10624,-0.14499,1,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.013093,-0.10674,-0.1435,1,0
4,GO GROOMING BEHAVIOR,0.031631,-0.10792,-0.16151,1,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.0035146,-0.10863,-0.22192,1,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.032607,-0.10882,-0.21354,1,0
4,GO SISTER CHROMATID COHESION,0.010895,-0.10899,-0.16362,1,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0024281,-0.1093,-0.1537,1,0
4,GO METAPHASE PLATE CONGRESSION,0.019104,-0.10949,-0.1501,1,0
4,GO RECOMBINATIONAL REPAIR,0.0041031,-0.10975,-0.19594,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0025277,-0.10996,-0.16863,1,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0010259,-0.11003,-0.18743,1,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0020092,-0.11008,-0.17735,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0019285,-0.11089,-0.15919,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0041031,-0.11132,-0.20672,1,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.0005211,-0.11135,-0.17975,1,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.2824e-05,-0.11137,-0.21502,1,0
4,GO CENTROSOME DUPLICATION,0.00071283,-0.11143,-0.23466,1,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.021509,-0.11208,-0.15019,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0029256,-0.1121,-0.1839,1,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.002702,-0.11233,-0.21742,1,0
4,GO MEIOTIC CELL CYCLE,6.0079e-05,-0.11261,-0.20054,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0007901,-0.11303,-0.1717,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0052197,-0.11311,-0.16548,1,0
4,GO PEPTIDYL ARGININE METHYLATION,0.023919,-0.11317,-0.18257,1,0
4,GO REGULATION OF MRNA PROCESSING,0.0007786,-0.11334,-0.22356,1,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.039795,-0.11358,-0.14227,1,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.037882,-0.11397,-0.19482,1,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.011949,-0.11404,-0.12533,1,0
4,GO RNA MODIFICATION,0.002631,-0.11418,-0.18686,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.015501,-0.1143,-0.16228,1,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.00021511,-0.11443,-0.2151,1,0
4,GO G0 TO G1 TRANSITION,0.0020646,-0.1148,-0.21691,1,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.010769,-0.11495,-0.15765,1,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0005056,-0.11505,-0.29319,1,0
4,GO MRNA MODIFICATION,0.032938,-0.11625,-0.17101,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.00039622,-0.11639,-0.18599,1,0
4,GO RNA INTERFERENCE,0.0084096,-0.11683,-0.15509,1,0
4,GO PROTEIN MONOUBIQUITINATION,1.8363e-05,-0.11695,-0.24728,1,0
4,GO SISTER CHROMATID SEGREGATION,0.018091,-0.11716,-0.15556,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.021053,-0.11783,-0.15139,1,0
4,GO MRNA METABOLIC PROCESS,0.00055343,-0.11813,-0.15045,1,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.01016,-0.11825,-0.15994,1,0
4,GO SPINDLE ORGANIZATION,2.9859e-05,-0.1185,-0.24017,1,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.015159,-0.11852,-0.14707,1,0
4,GO DNA PACKAGING,0.003607,-0.11875,-0.17325,1,0
4,GO NEGATIVE T CELL SELECTION,0.00081356,-0.1189,-0.24422,1,0
4,GO POSTREPLICATION REPAIR,0.0001862,-0.11899,-0.17356,1,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0019285,-0.11916,-0.1784,1,0
4,GO CENTROSOME SEPARATION,0.024428,-0.11924,-0.17877,1,0
4,GO VIRAL TRANSLATION,0.026013,-0.11929,-0.16475,1,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.00041488,-0.11953,-0.21723,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0057669,-0.12012,-0.17255,1,0
4,GO AMIDE BIOSYNTHETIC PROCESS,7.3739e-05,-0.12057,-0.15944,1,0
4,GO RRNA TRANSCRIPTION,0.004156,-0.12094,-0.20913,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0029256,-0.12098,-0.17533,1,0
4,GO NCRNA TRANSCRIPTION,0.00159,-0.12107,-0.17804,1,0
4,GO RNA CATABOLIC PROCESS,0.000662,-0.12111,-0.12252,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.017506,-0.1212,-0.12853,1,0
4,GO REGULATION OF ATPASE ACTIVITY,0.00014129,-0.12133,-0.19426,1,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.0023321,-0.12153,-0.151,1,0
4,GO RESPONSE TO LITHIUM ION,0.0137,-0.12161,-0.23214,1,0
4,GO REGULATION OF DNA METHYLATION,0.013093,-0.1219,-0.238,1,0
4,GO MRNA 3 END PROCESSING,0.001955,-0.12218,-0.19393,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.054582,-0.12253,-0.093055,1,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0019285,-0.12253,-0.18935,1,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.001442,-0.12264,-0.16334,1,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.020828,-0.12264,-0.12872,1,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.00017457,-0.12268,-0.1975,1,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0019285,-0.12281,-0.14754,1,0
4,GO DNA GEOMETRIC CHANGE,0.0018764,-0.12337,-0.2,1,0
4,GO REPLICATION FORK PROCESSING,0.011411,-0.12349,-0.20258,1,0
4,GO DNA REPAIR,0.0002443,-0.12389,-0.20072,1,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0019819,-0.12396,-0.16671,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0093576,-0.124,-0.1865,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.5756e-08,-0.12412,-0.26509,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.010041,-0.12439,-0.17288,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00028155,-0.12485,-0.2089,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00083767,-0.12529,-0.16426,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,3.0395e-05,-0.12548,-0.21456,1,0
4,GO PHOTOTRANSDUCTION,5.0563e-05,-0.12592,-0.20909,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.8419e-06,-0.12607,-0.24789,1,0
4,GO DNA METABOLIC PROCESS,1.0169e-05,-0.12617,-0.21905,1,0
4,GO DNA CONFORMATION CHANGE,0.0020929,-0.12621,-0.1934,1,0
4,GO ORGANELLE FISSION,6.4341e-05,-0.12701,-0.21515,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.034984,-0.12719,-0.16139,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1.1375e-05,-0.12747,-0.23643,1,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0044298,-0.12766,-0.10877,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00038422,-0.12785,-0.17731,1,0
4,GO DETECTION OF VISIBLE LIGHT,3.4409e-05,-0.1279,-0.20401,1,0
4,GO MULTIVESICULAR BODY ORGANIZATION,0.00029976,-0.1282,-0.19721,1,0
4,GO RESPONSE TO ETHER,0.00042777,-0.1292,-0.20178,1,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.043025,-0.12928,-0.11298,1,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00062378,-0.12951,-0.20797,1,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,9.4341e-06,-0.13013,-0.18866,1,0
4,GO HISTONE H3 K9 ACETYLATION,6.6578e-05,-0.13018,-0.25153,1,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.013856,-0.13022,-0.17995,1,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.043444,-0.13044,-0.20145,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,1.1806e-05,-0.13049,-0.23141,1,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.01585,-0.13077,-0.14951,1,0
4,GO DNA MODIFICATION,1.1375e-05,-0.13108,-0.2201,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.039795,-0.13116,-0.13552,1,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.015159,-0.13117,-0.15102,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.040582,-0.13144,-0.12961,1,0
4,GO PROTEIN POLYGLUTAMYLATION,0.003654,-0.13184,-0.2198,1,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.016568,-0.13205,-0.17234,1,0
4,GO HISTONE H4 K16 ACETYLATION,0.056652,-0.13231,-0.1538,1,0
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.5677e-09,-0.13236,-0.2829,1,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,9.7991e-09,-0.13247,-0.2821,1,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0066851,-0.13263,-0.19927,1,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0092477,-0.1327,-0.20625,1,0
4,GO DNA REPLICATION CHECKPOINT,0.013546,-0.13301,-0.14412,1,0
4,GO SPERM EGG RECOGNITION,0.00039018,-0.13319,-0.15313,1,0
4,GO HISTONE H3 K27 METHYLATION,7.2497e-05,-0.1332,-0.26753,1,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,7.7586e-05,-0.13325,-0.20389,1,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.1121e-10,-0.13342,-0.27752,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,4.7172e-05,-0.13345,-0.2521,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.01016,-0.13366,-0.16355,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00010152,-0.13427,-0.19975,1,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.00030449,-0.13432,-0.22163,1,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.3325e-06,-0.13482,-0.16777,1,0
4,GO SINGLE STRAND BREAK REPAIR,0.058247,-0.13493,-0.17568,1,0
4,GO MIDBODY ABSCISSION,0.0056958,-0.13506,-0.16499,1,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.0018006,-0.13512,-0.15299,1,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0039481,-0.1354,-0.1709,1,0
4,GO METHYLATION,9.4341e-06,-0.13541,-0.22822,1,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.026561,-0.13556,-0.16903,1,0
4,GO DNA METHYLATION OR DEMETHYLATION,7.3739e-05,-0.13568,-0.23041,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.9044e-05,-0.13584,-0.25042,1,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,3.2162e-07,-0.13608,-0.28889,1,0
4,GO MRNA METHYLATION,0.011813,-0.13625,-0.22965,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,4.7963e-08,-0.13657,-0.22535,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,6.5837e-06,-0.13697,-0.13867,1,0
4,GO MANNOSYLATION,0.00045468,-0.13702,-0.2404,1,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00010852,-0.13711,-0.21045,1,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.057179,-0.13726,-0.1478,1,0
4,GO HISTONE MONOUBIQUITINATION,0.00032916,-0.1379,-0.23598,1,0
4,GO RNA POLYADENYLATION,6.1119e-05,-0.13807,-0.26368,1,0
4,GO RNA EXPORT FROM NUCLEUS,0.013243,-0.13834,-0.16544,1,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,1.2716e-05,-0.13844,-0.21659,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.0001862,-0.13879,-0.22722,1,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0016122,-0.13885,-0.21383,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,6.6578e-05,-0.13924,-0.23317,1,0
4,GO CHROMOSOME ORGANIZATION,4.3997e-05,-0.13935,-0.23429,1,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0021798,-0.13947,-0.19149,1,0
4,GO GENE SILENCING,4.2487e-05,-0.14008,-0.22729,1,0
4,GO PROTEIN ACYLATION,7.333e-07,-0.14025,-0.28214,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0038977,-0.14041,-0.16308,1,0
4,GO MITOCHONDRION LOCALIZATION,9.819e-05,-0.14044,-0.27804,1,0
4,GO TELOMERE CAPPING,0.00014839,-0.14057,-0.25482,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0023637,-0.14058,-0.18079,1,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.00070238,-0.14073,-0.19635,1,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00036686,-0.1409,-0.26173,1,0
4,GO HOMOLOGOUS RECOMBINATION,0.0095807,-0.14094,-0.15494,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,1.2032e-06,-0.14145,-0.25657,1,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0054872,-0.14183,-0.18422,1,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,8.3013e-05,-0.14218,-0.24465,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00049802,-0.14234,-0.1698,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.0037985,-0.14237,-0.18511,1,0
4,GO PORE COMPLEX ASSEMBLY,3.9613e-05,-0.14249,-0.26739,1,0
4,GO PEPTIDE METABOLIC PROCESS,6.4592e-06,-0.14278,-0.16942,1,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.0042636,-0.14301,-0.16756,1,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0081133,-0.14313,-0.19361,1,0
4,GO HISTONE UBIQUITINATION,6.2175e-05,-0.14339,-0.23896,1,0
4,GO REGULATION OF RNA BINDING,0.0017517,-0.14342,-0.19255,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00072342,-0.14399,-0.18787,1,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.0070192,-0.14402,-0.22308,1,0
4,GO RNA STABILIZATION,0.00036124,-0.1441,-0.22045,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00022927,-0.14463,-0.1858,1,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,6.5837e-06,-0.14472,-0.21101,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.001704,-0.14504,-0.2757,1,0
4,GO REGULATION OF TELOMERE CAPPING,7.3739e-05,-0.14515,-0.26851,1,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00039018,-0.14519,-0.1893,1,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,6.6578e-05,-0.1452,-0.20182,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00024819,-0.14581,-0.19021,1,0
4,GO MRNA SPLICE SITE SELECTION,0.0104,-0.14646,-0.18615,1,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0026663,-0.14693,-0.18452,1,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00049802,-0.14715,-0.21368,1,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,1.1034e-07,-0.14725,-0.25975,1,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,9.1829e-05,-0.1476,-0.25844,1,0
4,GO RNA LOCALIZATION,0.0012005,-0.14772,-0.19529,1,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0002117,-0.14775,-0.18971,1,0
4,GO DNA DEPENDENT DNA REPLICATION,0.014823,-0.14778,-0.16278,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00016098,-0.1478,-0.27156,1,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0013826,-0.14814,-0.25841,1,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0049019,-0.14828,-0.16127,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,3.2094e-09,-0.14829,-0.27922,1,0
4,GO PHAGOSOME ACIDIFICATION,0.0012177,-0.1483,-0.2076,1,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.0018256,-0.14859,-0.18623,1,0
4,GO NON RECOMBINATIONAL REPAIR,4.7488e-06,-0.14862,-0.25669,1,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0016122,-0.14889,-0.2342,1,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0021215,-0.14892,-0.16548,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0010408,-0.14926,-0.24845,1,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00016098,-0.14934,-0.17627,1,0
4,GO TELOMERE ORGANIZATION,0.0007901,-0.14935,-0.19194,1,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0030436,-0.14955,-0.22024,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.001071,-0.14991,-0.20004,1,0
4,GO MULTI ORGANISM LOCALIZATION,1.3056e-06,-0.15002,-0.25241,1,0
4,GO PROTEIN ACETYLATION,5.5127e-05,-0.15012,-0.26337,1,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00092737,-0.15023,-0.23383,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.011151,-0.15025,-0.15925,1,0
4,GO MIRNA METABOLIC PROCESS,0.00098255,-0.15027,-0.22463,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00017176,-0.15053,-0.23063,1,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,6.2175e-05,-0.15069,-0.27844,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0066851,-0.15078,-0.26182,1,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.0058389,-0.15079,-0.162,1,0
4,GO REGULATION OF HELICASE ACTIVITY,0.040582,-0.15083,-0.13095,1,0
4,GO TRANSLESION SYNTHESIS,0.00011033,-0.15086,-0.19412,1,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.00092737,-0.15128,-0.26992,1,0
4,GO MITOTIC NUCLEAR DIVISION,0.00049053,-0.15139,-0.21103,1,0
4,GO REGULATION OF FERTILIZATION,0.0002117,-0.15179,-0.22072,1,0
4,GO RESPONSE TO OXYGEN RADICAL,3.1494e-05,-0.15199,-0.20871,1,0
4,GO RESPONSE TO FOOD,0.0054192,-0.15229,-0.14476,1,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.01499,-0.15232,-0.21495,1,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,2.8814e-05,-0.15238,-0.19301,1,0
4,GO REGULATION OF DNA REPAIR,2.6352e-05,-0.15274,-0.2518,1,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0013826,-0.15279,-0.19075,1,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.0424e-06,-0.15296,-0.24739,1,0
4,GO DETECTION OF LIGHT STIMULUS,5.0323e-06,-0.15349,-0.22472,1,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0023637,-0.15362,-0.25194,1,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,7.6446e-07,-0.15369,-0.30251,1,0
4,GO VIRAL BUDDING,7.8911e-05,-0.1537,-0.20869,1,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0037498,-0.15377,-0.17764,1,0
4,GO ORGANELLE LOCALIZATION,9.658e-10,-0.15384,-0.3146,1,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00067188,-0.15394,-0.26825,1,0
4,GO REGULATION OF CILIUM MOVEMENT,0.00044781,-0.15404,-0.14997,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00070238,-0.15416,-0.2402,1,0
4,GO DNA RECOMBINATION,0.00020178,-0.1542,-0.21298,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.048746,-0.15446,-0.11383,1,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.0058389,-0.15493,-0.20037,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00011596,-0.15495,-0.17553,1,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,9.1829e-05,-0.1551,-0.31475,1,0
4,GO REGULATION OF ERAD PATHWAY,2.856e-06,-0.15514,-0.32332,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.017125,-0.1555,-0.15462,1,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011151,-0.15643,-0.20956,1,0
4,GO CHROMOSOME SEPARATION,0.0043737,-0.15663,-0.17671,1,0
4,GO CHROMOSOME LOCALIZATION,0.008211,-0.15671,-0.17062,1,0
4,GO CYTOKINESIS,1.7922e-07,-0.15682,-0.28813,1,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00031907,-0.15715,-0.1765,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,2.5066e-09,-0.15755,-0.25421,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.00015838,-0.15758,-0.25087,1,0
4,GO NUCLEAR EXPORT,9.3381e-05,-0.15771,-0.2285,1,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,5.6245e-08,-0.15778,-0.1832,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,1.0422e-09,-0.15793,-0.28196,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.004156,-0.15803,-0.20803,1,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.00099681,-0.15842,-0.22715,1,0
4,GO HISTONE H2B UBIQUITINATION,1.1806e-05,-0.15856,-0.26601,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,4.2784e-08,-0.15861,-0.29634,1,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,1.8723e-07,-0.15864,-0.2062,1,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00014129,-0.15894,-0.19701,1,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.0050269,-0.1593,-0.18291,1,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0030839,-0.15935,-0.17836,1,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.7693e-06,-0.15981,-0.23599,1,0
4,GO DNA CATABOLIC PROCESS,3.152e-06,-0.15985,-0.21692,1,0
4,GO NUCLEAR TRANSPORT,1.0861e-06,-0.15988,-0.25156,1,0
4,GO PEPTIDYL LYSINE MODIFICATION,3.758e-05,-0.15993,-0.2643,1,0
4,GO CHROMOSOME CONDENSATION,0.0051547,-0.15995,-0.17287,1,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0020646,-0.16014,-0.19713,1,0
4,GO CENTRIOLE ASSEMBLY,0.00040235,-0.16019,-0.26584,1,0
4,GO NUCLEUS ORGANIZATION,1.7693e-06,-0.16049,-0.27513,1,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00020504,-0.16049,-0.21715,1,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,1.0004e-06,-0.16055,-0.24049,1,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.9069e-08,-0.16062,-0.26565,1,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.030994,-0.16075,-0.15742,1,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00099681,-0.16084,-0.23075,1,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,1.2792e-06,-0.16088,-0.2562,1,0
4,GO MITOTIC RECOMBINATION,0.0003557,-0.1609,-0.24772,1,0
4,GO REGULATION OF CYTOKINESIS,2.3239e-05,-0.1612,-0.27323,1,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.052083,-0.16149,-0.11312,1,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,2.7312e-05,-0.16155,-0.22652,1,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.001704,-0.16169,-0.25752,1,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00044781,-0.16174,-0.21018,1,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0015249,-0.1619,-0.24835,1,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,2.4528e-05,-0.16215,-0.19266,1,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.01995,-0.16247,-0.20063,1,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.0014022,-0.1632,-0.21812,1,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.012087,-0.16327,-0.21138,1,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00064263,-0.16336,-0.17842,1,0
4,GO PH REDUCTION,1.6158e-05,-0.16337,-0.22079,1,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.000286,-0.1634,-0.25354,1,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,3.3214e-05,-0.16358,-0.25719,1,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.0043184,-0.16385,-0.21418,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00034485,-0.16391,-0.21053,1,0
4,GO CELL CYCLE PHASE TRANSITION,4.6578e-06,-0.16429,-0.23411,1,0
4,GO NUCLEOSIDE METABOLIC PROCESS,2.9332e-05,-0.16456,-0.20445,1,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,9.086e-06,-0.16477,-0.24207,1,0
4,GO OOCYTE MATURATION,0.00033955,-0.16487,-0.19789,1,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.00045468,-0.16488,-0.24962,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00086244,-0.16524,-0.23513,1,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.0005056,-0.16525,-0.26186,1,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,3.6361e-10,-0.16528,-0.26081,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.0395e-05,-0.16534,-0.22645,1,0
4,GO MITOTIC CYTOKINETIC PROCESS,0.00025617,-0.16536,-0.21698,1,0
4,GO CELL CYCLE,3.0295e-08,-0.16557,-0.27253,1,0
4,GO REGULATION OF CIRCADIAN RHYTHM,2.1624e-06,-0.16578,-0.28459,1,0
4,GO FEEDING BEHAVIOR,2.8001e-06,-0.16616,-0.26316,1,0
4,GO REGULATION OF CELL CYCLE,2.0546e-09,-0.1664,-0.28563,1,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00024045,-0.16662,-0.18647,1,0
4,GO CELL CYCLE PROCESS,2.3274e-07,-0.16677,-0.26159,1,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,8.0256e-05,-0.16688,-0.24792,1,0
4,GO CELL CYCLE CHECKPOINT,1.5052e-06,-0.16725,-0.26019,1,0
4,GO AMINE METABOLIC PROCESS,4.9228e-07,-0.16725,-0.20987,1,0
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.8301e-10,-0.1675,-0.3068,1,0
4,GO ATP METABOLIC PROCESS,1.6457e-05,-0.16751,-0.19676,1,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0033799,-0.16753,-0.22367,1,0
4,GO HISTONE H4 ACETYLATION,0.00054518,-0.16789,-0.24545,1,0
4,GO REGULATION OF CELL CYCLE PROCESS,3.357e-07,-0.16801,-0.25527,1,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.038258,-0.16806,-0.11948,1,0
4,GO PEPTIDYL LYSINE ACETYLATION,9.819e-05,-0.16812,-0.26207,1,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.010895,-0.16819,-0.15029,1,0
4,GO MICROTUBULE BASED PROCESS,3.247e-08,-0.16841,-0.28719,1,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00026438,-0.16874,-0.21823,1,0
4,GO REGULATION OF MITOTIC CELL CYCLE,5.02e-08,-0.16889,-0.26449,1,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,3.0905e-06,-0.16928,-0.30843,1,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,3.9822e-07,-0.16961,-0.27424,1,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00037257,-0.16967,-0.21415,1,0
4,GO MRNA CLEAVAGE,0.00025215,-0.1697,-0.22362,1,0
4,GO HISTONE H4 K5 ACETYLATION,0.0031247,-0.16986,-0.18953,1,0
4,GO MRNA TRANSPORT,0.00046165,-0.17006,-0.21703,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,6.1119e-05,-0.17011,-0.24016,1,0
4,GO GAMETE GENERATION,2.1064e-09,-0.17044,-0.26523,1,0
4,GO REGULATION OF AMINO ACID TRANSPORT,7.0072e-05,-0.17091,-0.28376,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,1.9064e-09,-0.17099,-0.24816,1,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,5.7059e-05,-0.17119,-0.22057,1,0
4,GO REGULATION OF CENTROSOME CYCLE,0.0023009,-0.17156,-0.20321,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0005618,-0.17165,-0.21427,1,0
4,GO TRNA TRANSPORT,0.0085105,-0.17168,-0.192,1,0
4,GO CEREBELLAR CORTEX FORMATION,0.001422,-0.17189,-0.26123,1,0
4,GO DNA BIOSYNTHETIC PROCESS,5.2445e-07,-0.17196,-0.25493,1,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,2.1807e-07,-0.17197,-0.31751,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE,1.4677e-08,-0.1721,-0.2825,1,0
4,GO HISTONE H3 ACETYLATION,1.4741e-05,-0.17212,-0.26853,1,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00029052,-0.17221,-0.23506,1,0
4,GO REGULATION OF DNA REPLICATION,5.4184e-05,-0.17229,-0.24589,1,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,1.536e-06,-0.17237,-0.25521,1,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00010497,-0.17258,-0.18838,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0018764,-0.17287,-0.18644,1,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001483,-0.1729,-0.21456,1,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.0343e-10,-0.17291,-0.3192,1,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0011021,-0.17297,-0.19602,1,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.00049802,-0.17302,-0.26003,1,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00023667,-0.17325,-0.22904,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,1.6654e-06,-0.17327,-0.26224,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.000662,-0.17334,-0.23894,1,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,2.8814e-05,-0.17339,-0.25712,1,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0032078,-0.17354,-0.17233,1,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,3.628e-05,-0.17366,-0.2365,1,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,6.4592e-06,-0.17367,-0.26381,1,0
4,GO REGULATION OF GENE SILENCING,5.1446e-05,-0.17378,-0.23598,1,0
4,GO CHROMATIN ORGANIZATION,2.971e-06,-0.17379,-0.27185,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.00031907,-0.17382,-0.16699,1,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,9.6562e-05,-0.17385,-0.19572,1,0
4,GO VIRION ASSEMBLY,3.152e-06,-0.17398,-0.21392,1,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00046165,-0.174,-0.19944,1,0
4,GO PHOTOPERIODISM,2.7312e-05,-0.17401,-0.25725,1,0
4,GO PROTEIN FOLDING,3.9872e-06,-0.17416,-0.25488,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,4.3997e-05,-0.1742,-0.22702,1,0
4,GO REGULATION OF NUCLEAR DIVISION,3.3435e-06,-0.17422,-0.23225,1,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00012804,-0.17431,-0.23094,1,0
4,GO TRANSFERRIN TRANSPORT,1.4472e-05,-0.17434,-0.26979,1,0
4,GO MITOTIC CELL CYCLE,8.3066e-07,-0.17468,-0.25543,1,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0029256,-0.17481,-0.18606,1,0
4,GO SEXUAL REPRODUCTION,2.8753e-10,-0.17482,-0.27234,1,0
4,GO VACUOLAR ACIDIFICATION,3.152e-06,-0.17544,-0.2757,1,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,4.5922e-10,-0.17561,-0.31641,1,0
4,GO DNA DEALKYLATION,4.5558e-05,-0.17569,-0.24813,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012945,-0.17608,-0.26601,1,0
4,GO WALKING BEHAVIOR,0.0013443,-0.17626,-0.24253,1,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,5.77e-09,-0.17672,-0.30284,1,0
4,GO DNA INTEGRITY CHECKPOINT,4.5233e-07,-0.17722,-0.2774,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,1.0241e-10,-0.17728,-0.28088,1,0
4,GO POSITIVE REGULATION OF CELL AGING,0.00048316,-0.17743,-0.19043,1,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.055093,-0.17753,-0.21909,1,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.4409e-05,-0.17759,-0.28318,1,0
4,GO POSITIVE THYMIC T CELL SELECTION,3.3214e-05,-0.17769,-0.27026,1,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.0019819,-0.17772,-0.25313,1,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.1806e-05,-0.17777,-0.28015,1,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0007901,-0.1778,-0.20298,1,0
4,GO DNA METHYLATION,0.00064263,-0.17788,-0.2226,1,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.010041,-0.17826,-0.24058,1,0
4,GO PROTEIN POLYUBIQUITINATION,6.205e-09,-0.17848,-0.28614,1,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,2.0853e-05,-0.17855,-0.22763,1,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,8.1361e-07,-0.1787,-0.23896,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.9361e-06,-0.17879,-0.23523,1,0
4,GO FOLIC ACID METABOLIC PROCESS,1.5865e-05,-0.17906,-0.28514,1,0
4,GO PROTEIN N LINKED GLYCOSYLATION,1.0004e-06,-0.17908,-0.29016,1,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.0085105,-0.17917,-0.22474,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001442,-0.17919,-0.26272,1,0
4,GO NUCLEAR PORE ORGANIZATION,0.050154,-0.17931,-0.17485,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.3435e-06,-0.17946,-0.2499,1,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00055343,-0.17948,-0.17718,1,0
4,GO INTRACELLULAR TRANSPORT,2.1543e-10,-0.17953,-0.28062,1,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,6.2565e-10,-0.17953,-0.31878,1,0
4,GO PROTEIN METHYLATION,0.00012594,-0.1797,-0.24776,1,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,3.2146e-06,-0.17972,-0.23189,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.4207e-05,-0.17973,-0.29621,1,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,7.3803e-06,-0.17979,-0.19379,1,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.1789e-06,-0.17999,-0.29874,1,0
4,GO PROTEIN TARGETING,1.8419e-06,-0.18013,-0.16424,1,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,5.9056e-05,-0.18022,-0.26526,1,0
4,GO NODAL SIGNALING PATHWAY,0.013394,-0.18057,-0.13436,1,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.0022095,-0.18074,-0.21762,1,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.0023321,-0.18081,-0.18385,1,0
4,GO ZINC ION TRANSPORT,1.4207e-05,-0.18106,-0.2659,1,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00044103,-0.18119,-0.21199,1,0
4,GO CHROMATIN REMODELING,0.00011218,-0.18123,-0.22404,1,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0033361,-0.18147,-0.2907,1,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,1.0169e-05,-0.1816,-0.24184,1,0
4,GO PIGMENT GRANULE LOCALIZATION,2.5884e-05,-0.18178,-0.26981,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,1.9044e-05,-0.18197,-0.21996,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.011813,-0.18198,-0.1497,1,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,4.8673e-09,-0.18199,-0.2602,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,8.4805e-07,-0.18211,-0.27893,1,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00018323,-0.18217,-0.31779,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.016205,-0.18224,-0.20044,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,2.4091e-05,-0.18232,-0.23373,1,0
4,GO COVALENT CHROMATIN MODIFICATION,6.4699e-07,-0.1824,-0.2868,1,0
4,GO CELL DIVISION,2.3784e-07,-0.18247,-0.26993,1,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00037835,-0.18256,-0.23496,1,0
4,GO PRIMARY MIRNA PROCESSING,0.00042128,-0.18256,-0.24973,1,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,5.6085e-05,-0.18264,-0.25332,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00069207,-0.18284,-0.22554,1,0
4,GO GOLGI LOCALIZATION,1.8363e-05,-0.18285,-0.2667,1,0
4,GO MEMBRANE DOCKING,2.1338e-07,-0.18303,-0.29918,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.05357,-0.18338,-0.19931,1,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,2.8262e-08,-0.18347,-0.28251,1,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0020929,-0.18351,-0.19485,1,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.011e-05,-0.18355,-0.21847,1,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0037498,-0.18359,-0.22268,1,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.3256e-05,-0.18359,-0.26467,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00013451,-0.18373,-0.2,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,2.9859e-05,-0.18391,-0.23874,1,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.00037257,-0.18445,-0.20342,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,1.7687e-09,-0.18446,-0.25549,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.00022565,-0.18457,-0.25307,1,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.001071,-0.18487,-0.20003,1,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,2.1234e-05,-0.18488,-0.22599,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,6.5125e-09,-0.18506,-0.27742,1,0
4,GO BLASTOCYST DEVELOPMENT,2.2286e-07,-0.18507,-0.22705,1,0
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,4.1025e-09,-0.18508,-0.24532,1,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0054192,-0.18515,-0.23317,1,0
4,GO DRUG CATABOLIC PROCESS,1.8701e-05,-0.18537,-0.22855,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,3.8347e-06,-0.18551,-0.22621,1,0
4,GO HISTONE H2A UBIQUITINATION,5.3256e-05,-0.18576,-0.24742,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,3.0296e-10,-0.18587,-0.29189,1,0
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,2.7668e-07,-0.18592,-0.27464,1,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00094089,-0.18637,-0.22399,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,3.9035e-08,-0.18639,-0.19988,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,5.8049e-05,-0.18643,-0.24213,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.9228e-07,-0.18657,-0.32132,1,0
4,GO REGULATION OF PROTEIN SUMOYLATION,1.9558e-07,-0.18669,-0.32213,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,6.4341e-05,-0.18672,-0.23918,1,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.00071283,-0.18716,-0.25657,1,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,3.1729e-08,-0.18717,-0.29358,1,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.7125e-10,-0.18729,-0.31764,1,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.2015e-05,-0.18733,-0.29401,1,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,1.3468e-07,-0.18738,-0.22759,1,0
4,GO MITOTIC CYTOKINESIS,2.8886e-07,-0.18745,-0.2815,1,0
4,GO BLASTOCYST FORMATION,7.8052e-07,-0.18763,-0.26308,1,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.2445e-07,-0.18781,-0.23615,1,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00029976,-0.18783,-0.22193,1,0
4,GO NUCLEOSIDE SALVAGE,0.0070192,-0.18785,-0.14539,1,0
4,GO REGULATION OF LIGASE ACTIVITY,0.00044103,-0.18809,-0.21451,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.034984,-0.18821,-0.12908,1,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.00040235,-0.18836,-0.23883,1,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.6352e-05,-0.1884,-0.23385,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.3239e-05,-0.18858,-0.24115,1,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00041488,-0.18863,-0.20904,1,0
4,GO ORGANELLE ASSEMBLY,5.3617e-10,-0.18885,-0.29083,1,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.055093,-0.18898,-0.22167,1,0
4,GO DNA REPLICATION,0.00025215,-0.18917,-0.21911,1,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,8.9166e-06,-0.18935,-0.24989,1,0
4,GO AXONAL TRANSPORT,7.6657e-06,-0.18936,-0.34321,1,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,1.2032e-06,-0.1894,-0.28495,1,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00022208,-0.18967,-0.20029,1,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.00014129,-0.18983,-0.25676,1,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,2.8814e-05,-0.1902,-0.23251,1,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.5052e-06,-0.19028,-0.26832,1,0
4,GO NIK NF KAPPAB SIGNALING,3.6435e-08,-0.1904,-0.282,1,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,3.5794e-07,-0.19042,-0.29077,1,0
4,GO PROTEIN HETEROOLIGOMERIZATION,3.628e-05,-0.19046,-0.25395,1,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,9.404e-07,-0.19064,-0.27527,1,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,4.5558e-05,-0.19065,-0.25881,1,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0037016,-0.1907,-0.23234,1,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.4472e-05,-0.19075,-0.30742,1,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,3.9822e-07,-0.19086,-0.27057,1,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.536e-06,-0.19102,-0.2473,1,0
4,GO REGULATION OF PH,2.2397e-08,-0.19122,-0.26815,1,0
4,GO CILIUM ORGANIZATION,5.3562e-07,-0.1914,-0.29014,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,2.4972e-05,-0.1915,-0.26567,1,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.0084096,-0.19151,-0.20052,1,0
4,GO CELLULAR RESPONSE TO HEAT,2.7452e-06,-0.19154,-0.28136,1,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,6.2169e-06,-0.19168,-0.29153,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00063314,-0.19177,-0.278,1,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,5.6487e-06,-0.1918,-0.25131,1,0
4,GO POLYAMINE METABOLIC PROCESS,0.00019541,-0.19189,-0.24054,1,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,5.2303e-06,-0.19191,-0.21664,1,0
4,GO BLASTOCYST GROWTH,0.0015038,-0.19199,-0.23349,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,6.8885e-07,-0.19233,-0.26088,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011341,-0.19234,-0.24427,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0013443,-0.19262,-0.29094,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.3468e-07,-0.19262,-0.23362,1,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,1.8723e-07,-0.19265,-0.28022,1,0
4,GO REGULATION OF PROTEIN FOLDING,1.1588e-05,-0.19302,-0.26791,1,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.004e-09,-0.19313,-0.31711,1,0
4,GO POLYOL CATABOLIC PROCESS,7.2414e-06,-0.19328,-0.3041,1,0
4,GO PROTEIN CATABOLIC PROCESS,8.2618e-11,-0.19334,-0.31997,1,0
4,GO ORGANELLE INHERITANCE,8.7502e-06,-0.19356,-0.24575,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.1479e-07,-0.19371,-0.31989,1,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.0022396,-0.19392,-0.25636,1,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,3.247e-08,-0.19432,-0.26766,1,0
4,GO TRANSPORT ALONG MICROTUBULE,2.4371e-06,-0.19444,-0.29814,1,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,1.2058e-07,-0.19479,-0.2529,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00017457,-0.19481,-0.2788,1,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.9905e-10,-0.19506,-0.33025,1,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0478e-05,-0.19525,-0.25163,1,0
4,GO THYMIC T CELL SELECTION,1.2716e-05,-0.19528,-0.24481,1,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2169e-06,-0.1953,-0.29616,1,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,2.2926e-08,-0.19556,-0.28382,1,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,2.65e-07,-0.19562,-0.25064,1,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,3.8246e-05,-0.19567,-0.25454,1,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,7.8124e-06,-0.19586,-0.24783,1,0
4,GO INTRACILIARY TRANSPORT,0.00070238,-0.19593,-0.23204,1,0
4,GO ERAD PATHWAY,3.4296e-07,-0.19594,-0.33339,1,0
4,GO RESPONSE TO LIGHT STIMULUS,3.7319e-10,-0.19594,-0.29427,1,0
4,GO MALE GAMETE GENERATION,1.4677e-08,-0.19606,-0.25075,1,0
4,GO ENDOCARDIUM DEVELOPMENT,0.0002443,-0.19607,-0.29036,1,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00046872,-0.19612,-0.28996,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,8.9047e-09,-0.19639,-0.28096,1,0
4,GO DIOL BIOSYNTHETIC PROCESS,0.00076726,-0.19665,-0.26157,1,0
4,GO P BODY ASSEMBLY,3.2631e-05,-0.19683,-0.28667,1,0
4,GO HISTONE METHYLATION,0.00015331,-0.19684,-0.25736,1,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00074504,-0.19689,-0.26397,1,0
4,GO OOGENESIS,3.7356e-07,-0.19692,-0.24722,1,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.2058e-07,-0.19702,-0.27706,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,3.1479e-07,-0.19711,-0.22049,1,0
4,GO SEQUESTERING OF METAL ION,5.1446e-05,-0.19717,-0.24501,1,0
4,GO SUCKLING BEHAVIOR,0.0085105,-0.19747,-0.27559,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.6907e-08,-0.19755,-0.27027,1,0
4,GO ORGANELLE DISASSEMBLY,3.9822e-07,-0.19758,-0.27307,1,0
4,GO DENSE CORE GRANULE TRANSPORT,0.0068504,-0.19777,-0.34613,1,0
4,GO RESPONSE TO RADIATION,5.3602e-11,-0.19795,-0.29985,1,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,9.086e-06,-0.19807,-0.24994,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0011021,-0.19825,-0.21101,1,0
4,GO AXO DENDRITIC TRANSPORT,2.6914e-06,-0.19848,-0.33981,1,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.00029511,-0.19863,-0.27333,1,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,1.3878e-06,-0.19897,-0.26498,1,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00084997,-0.19897,-0.24441,1,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.4893e-11,-0.19915,-0.32896,1,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.1535e-07,-0.19923,-0.26019,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,3.0156e-07,-0.19925,-0.2407,1,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,4.6578e-06,-0.19936,-0.24919,1,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00035024,-0.19944,-0.23479,1,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.2303e-06,-0.19956,-0.30153,1,0
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,3.2894e-09,-0.19994,-0.30925,1,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0019285,-0.2,-0.27951,1,0
4,GO PROTEIN MANNOSYLATION,0.00042777,-0.2001,-0.26196,1,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,7.0337e-07,-0.20021,-0.3223,1,0
4,GO RNA DECAPPING,3.6924e-05,-0.20034,-0.27631,1,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.00016098,-0.20039,-0.18923,1,0
4,GO HISTONE H4 DEACETYLATION,2.2958e-06,-0.20042,-0.29676,1,0
4,GO MICROTUBULE NUCLEATION,0.00074504,-0.20042,-0.31342,1,0
4,GO GERM CELL DEVELOPMENT,4.5822e-08,-0.20052,-0.25248,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0020092,-0.20057,-0.18193,1,0
4,GO REGULATION OF MRNA POLYADENYLATION,5.332e-06,-0.20073,-0.29891,1,0
4,GO AMP METABOLIC PROCESS,0.012798,-0.20081,-0.18929,1,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.5066e-09,-0.20095,-0.29444,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,4.3355e-07,-0.20101,-0.27192,1,0
4,GO GTP METABOLIC PROCESS,0.001955,-0.20102,-0.21798,1,0
4,GO HISTONE H2A ACETYLATION,0.0027747,-0.20102,-0.1714,1,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00065224,-0.20122,-0.20105,1,0
4,GO FAT CELL PROLIFERATION,0.0040509,-0.20136,-0.23345,1,0
4,GO POSITIVE REGULATION OF TRANSLATION,2.7078e-07,-0.20148,-0.25782,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1282e-07,-0.20204,-0.2516,1,0
4,GO MICROTUBULE BASED MOVEMENT,1.3174e-07,-0.20207,-0.2793,1,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,2.7614e-08,-0.20207,-0.29335,1,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,1.7154e-07,-0.20228,-0.26206,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION,2.801e-10,-0.20236,-0.33676,1,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,4.0033e-09,-0.2024,-0.30002,1,0
4,GO REGULATION OF CELLULAR PH,1.0094e-07,-0.20259,-0.26817,1,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00020504,-0.2026,-0.20816,1,0
4,GO ATP BIOSYNTHETIC PROCESS,0.0017277,-0.20268,-0.24927,1,0
4,GO HETEROCHROMATIN ORGANIZATION,5.4356e-06,-0.20272,-0.29456,1,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.3088e-12,-0.20309,-0.33243,1,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00031414,-0.20346,-0.22498,1,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.004156,-0.20354,-0.21853,1,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.0169e-05,-0.20384,-0.26212,1,0
4,GO DNA DEMETHYLATION,0.00022565,-0.20394,-0.25028,1,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.6202e-07,-0.2041,-0.34296,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00016361,-0.20422,-0.23995,1,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.5646e-05,-0.20459,-0.43488,1,0
4,GO REGULATION OF ACROSOME REACTION,0.0014624,-0.20467,-0.27952,1,0
4,GO RESPONSE TO NITRIC OXIDE,6.7411e-08,-0.20486,-0.26366,1,0
4,GO STEROID BIOSYNTHETIC PROCESS,5.9834e-06,-0.2049,-0.26398,1,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00099681,-0.20495,-0.23891,1,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0015463,-0.20496,-0.24667,1,0
4,GO ONE CARBON METABOLIC PROCESS,2.011e-05,-0.20514,-0.24225,1,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.9941e-08,-0.20524,-0.27946,1,0
4,GO SYMBIOTIC PROCESS,7.6205e-11,-0.20528,-0.27882,1,0
4,GO CELLULAR KETONE METABOLIC PROCESS,2.8262e-08,-0.20529,-0.26224,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.00039622,-0.2053,-0.2486,1,0
4,GO ENDOSOMAL TRANSPORT,1.5217e-09,-0.20535,-0.3329,1,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0033799,-0.20542,-0.16839,1,0
4,GO REGULATION OF CELL MATURATION,7.892e-08,-0.20552,-0.26389,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.9393e-05,-0.20556,-0.2456,1,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.029754,-0.20558,-0.16525,1,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,3.9717e-11,-0.20564,-0.33095,1,0
4,GO HISTONE H3 K4 METHYLATION,0.0018256,-0.2057,-0.2002,1,0
4,GO SENSORY PERCEPTION OF SMELL,2.5359e-06,-0.20607,-0.23957,1,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,3.5038e-07,-0.20637,-0.34274,1,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,3.8924e-05,-0.20654,-0.27529,1,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00030449,-0.20659,-0.22649,1,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.00019541,-0.20659,-0.23953,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0058389,-0.2067,-0.22026,1,0
4,GO VISUAL BEHAVIOR,1.471e-07,-0.20695,-0.32409,1,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.00016098,-0.20698,-0.19716,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,2.7804e-05,-0.20701,-0.26621,1,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.0007901,-0.20707,-0.25784,1,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,3.9309e-10,-0.20714,-0.32814,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,8.8389e-07,-0.20732,-0.2841,1,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,1.9989e-07,-0.20755,-0.27717,1,0
4,GO SINGLE FERTILIZATION,3.9064e-09,-0.20759,-0.26947,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00081356,-0.20761,-0.28027,1,0
4,GO GOLGI ORGANIZATION,7.5451e-08,-0.20767,-0.34564,1,0
4,GO MULTI ORGANISM PROCESS,3.1896e-11,-0.20772,-0.30189,1,0
4,GO OOCYTE DIFFERENTIATION,9.4959e-05,-0.2079,-0.21984,1,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,1.1034e-07,-0.20805,-0.27588,1,0
4,GO GOLGI VESICLE TRANSPORT,2.7286e-10,-0.20811,-0.34083,1,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.0004e-06,-0.20845,-0.28538,1,0
4,GO FEMALE GAMETE GENERATION,2.5066e-09,-0.20897,-0.27221,1,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,7.3476e-09,-0.20909,-0.26963,1,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0028118,-0.20912,-0.20466,1,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00010852,-0.20955,-0.21046,1,0
4,GO CILIUM MOVEMENT,2.538e-07,-0.20977,-0.24404,1,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,6.2175e-05,-0.20984,-0.28287,1,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.0044298,-0.20993,-0.20488,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.6782e-07,-0.21014,-0.31462,1,0
4,GO IMPORT INTO NUCLEUS,1.1307e-08,-0.21033,-0.28807,1,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,2.634e-09,-0.21049,-0.36396,1,0
4,GO TRANSITION METAL ION TRANSPORT,2.7e-09,-0.2105,-0.2765,1,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00013899,-0.21055,-0.23824,1,0
4,GO TRANSCYTOSIS,4.3946e-06,-0.21059,-0.34706,1,0
4,GO REGULATION OF DNA RECOMBINATION,9.2118e-07,-0.2107,-0.29136,1,0
4,GO PROTEIN SUMOYLATION,2.7804e-05,-0.21074,-0.27029,1,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,3.019e-11,-0.21079,-0.30557,1,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,2.7614e-08,-0.21084,-0.31745,1,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.3997e-05,-0.21098,-0.24688,1,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.0037498,-0.21101,-0.19638,1,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00023667,-0.21119,-0.24765,1,0
4,GO DOSAGE COMPENSATION,0.00014129,-0.2112,-0.27128,1,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.8885e-07,-0.21127,-0.24777,1,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,5.0563e-05,-0.21135,-0.28708,1,0
4,GO PROTEIN O LINKED GLYCOSYLATION,1.5753e-08,-0.21138,-0.35583,1,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0025617,-0.21151,-0.2459,1,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,3.3806e-05,-0.21165,-0.27431,1,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.6446e-07,-0.2117,-0.30261,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00028155,-0.21174,-0.27405,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8198e-07,-0.212,-0.35517,1,0
4,GO HISTONE H3 K14 ACETYLATION,7.1274e-05,-0.21201,-0.25757,1,0
4,GO SUBPALLIUM DEVELOPMENT,0.0017277,-0.21206,-0.33046,1,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.7804e-05,-0.21214,-0.26875,1,0
4,GO CELL REDOX HOMEOSTASIS,6.7724e-05,-0.21222,-0.19804,1,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,1.2733e-08,-0.21235,-0.35415,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.7909e-10,-0.21242,-0.33674,1,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,4.3236e-05,-0.21253,-0.42821,1,0
4,GO PEROXISOME ORGANIZATION,5.7051e-07,-0.21275,-0.25809,1,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,9.03e-05,-0.21283,-0.25302,1,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.1165e-05,-0.21288,-0.27963,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.0060595,-0.21311,-0.21882,1,0
4,GO GLYCOSYLATION,1.069e-09,-0.21313,-0.34435,1,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0015463,-0.21314,-0.26152,1,0
4,GO SPERMATID DIFFERENTIATION,7.4873e-07,-0.21316,-0.23221,1,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.00014362,-0.21316,-0.28392,1,0
4,GO REGULATION OF ACTIN NUCLEATION,1.1588e-05,-0.21319,-0.3007,1,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00030928,-0.2132,-0.20538,1,0
4,GO REGULATION OF HISTONE UBIQUITINATION,3.8347e-06,-0.21328,-0.25051,1,0
4,GO CELLULAR RESPONSE TO ATP,8.2864e-09,-0.21334,-0.30047,1,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.9859e-05,-0.21341,-0.30029,1,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.010041,-0.21351,-0.18447,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,5.0278e-07,-0.21379,-0.21772,1,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,2.5359e-06,-0.21385,-0.26451,1,0
4,GO PROTEIN IMPORT,1.7687e-09,-0.21421,-0.29856,1,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.0853e-05,-0.21437,-0.32278,1,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1.0202e-11,-0.21452,-0.34292,1,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00076726,-0.21457,-0.23469,1,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,5.8262e-07,-0.21458,-0.27821,1,0
4,GO NCRNA CATABOLIC PROCESS,4.2271e-06,-0.21461,-0.27532,1,0
4,GO REGULATION OF DNA BINDING,6.586e-10,-0.21499,-0.29114,1,0
4,GO EATING BEHAVIOR,4.7488e-06,-0.21509,-0.25283,1,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.5164e-08,-0.2151,-0.30448,1,0
4,GO OXIDATION REDUCTION PROCESS,5.1101e-09,-0.21519,-0.26655,1,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.2015e-05,-0.2152,-0.22615,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00014129,-0.2157,-0.30128,1,0
4,GO SPERM MOTILITY,4.2444e-07,-0.21575,-0.23526,1,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,2.2117e-10,-0.2158,-0.29725,1,0
4,GO GLUTAMATE METABOLIC PROCESS,2.342e-06,-0.21586,-0.26265,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,6.0991e-06,-0.21588,-0.30824,1,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.2926e-08,-0.21588,-0.31197,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,3.055e-09,-0.21599,-0.31738,1,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,1.0422e-09,-0.21604,-0.32866,1,0
4,GO MAINTENANCE OF CELL NUMBER,1.6907e-08,-0.21606,-0.33597,1,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,8.4262e-06,-0.21619,-0.25073,1,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0073682,-0.21624,-0.27646,1,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,9.2321e-08,-0.2163,-0.32769,1,0
4,GO SECRETORY GRANULE LOCALIZATION,0.00039018,-0.21635,-0.38292,1,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0023321,-0.21646,-0.23261,1,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,4.9361e-06,-0.21652,-0.30462,1,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.0019285,-0.21655,-0.20218,1,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.001776,-0.21676,-0.21644,1,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0001179,-0.2168,-0.30495,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,5.6245e-08,-0.21697,-0.27284,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.1316e-06,-0.21717,-0.28999,1,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,6.8348e-09,-0.21728,-0.35263,1,0
4,GO HISTONE PHOSPHORYLATION,1.5372e-07,-0.21736,-0.27353,1,0
4,GO EXECUTION PHASE OF APOPTOSIS,1.4677e-08,-0.21746,-0.28661,1,0
4,GO MACROAUTOPHAGY,1.5217e-09,-0.21752,-0.32402,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,1.1398e-10,-0.21756,-0.3013,1,0
4,GO HEMOGLOBIN METABOLIC PROCESS,8.8389e-07,-0.21762,-0.3517,1,0
4,GO LYSINE METABOLIC PROCESS,0.0065235,-0.21763,-0.21878,1,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,3.2057e-05,-0.21765,-0.26404,1,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0019819,-0.2177,-0.18974,1,0
4,GO CIRCADIAN RHYTHM,2.004e-09,-0.2178,-0.33137,1,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,6.2175e-05,-0.21789,-0.27565,1,0
4,GO NERVOUS SYSTEM PROCESS,6.3074e-11,-0.21797,-0.32565,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.3239e-05,-0.21798,-0.31163,1,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,2.4214e-11,-0.21821,-0.33975,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY,1.5217e-09,-0.21833,-0.28832,1,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.00043435,-0.21839,-0.24822,1,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,1.7309e-08,-0.21866,-0.31541,1,0
4,GO SPERM CAPACITATION,1.1165e-05,-0.2187,-0.24853,1,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,5.6594e-11,-0.2187,-0.29605,1,0
4,GO PROTEIN POLYMERIZATION,2.595e-12,-0.21872,-0.37909,1,0
4,GO MUSCLE FIBER DEVELOPMENT,5.2359e-09,-0.21881,-0.34173,1,0
4,GO ENDOSOME ORGANIZATION,1.2058e-07,-0.21887,-0.3023,1,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,4.719e-07,-0.21897,-0.29075,1,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,7.969e-07,-0.21915,-0.31702,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.034984,-0.2192,-0.1973,1,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0014624,-0.21927,-0.18064,1,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.5412e-06,-0.2193,-0.27072,1,0
4,GO DORSAL VENTRAL PATTERN FORMATION,1.1316e-06,-0.21937,-0.29829,1,0
4,GO MISMATCH REPAIR,3.2784e-06,-0.21938,-0.25778,1,0
4,GO MICROTUBULE BASED TRANSPORT,6.2046e-07,-0.21988,-0.30359,1,0
4,GO TOR SIGNALING,1.1245e-09,-0.21999,-0.3319,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.7282e-08,-0.22009,-0.28779,1,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,4.5684e-06,-0.22025,-0.28403,1,0
4,GO RESPONSE TO COCAINE,4.2271e-06,-0.22038,-0.30418,1,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.0678e-07,-0.22039,-0.31908,1,0
4,GO THIOESTER METABOLIC PROCESS,2.4371e-06,-0.22057,-0.26774,1,0
4,GO ORGANIC ACID CATABOLIC PROCESS,1.1533e-09,-0.22067,-0.29947,1,0
4,GO REGULATION OF CATABOLIC PROCESS,5.815e-11,-0.22092,-0.32547,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.6435e-08,-0.22093,-0.31584,1,0
4,GO GLYCINE METABOLIC PROCESS,0.0010259,-0.22123,-0.22379,1,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,2.1621e-05,-0.22137,-0.26647,1,0
4,GO REGULATION OF PROTEIN ACETYLATION,4.9694e-05,-0.22148,-0.25807,1,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0033361,-0.2215,-0.27314,1,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.0905e-06,-0.22155,-0.27702,1,0
4,GO DETECTION OF STIMULUS,7.2964e-10,-0.22161,-0.25834,1,0
4,GO PROTEOLYSIS,3.6667e-12,-0.22161,-0.3337,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00019857,-0.22164,-0.24768,1,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.2131e-09,-0.22174,-0.29862,1,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00011596,-0.22211,-0.29948,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.055e-09,-0.22228,-0.33832,1,0
4,GO PROTEIN TETRAMERIZATION,7.2964e-10,-0.22231,-0.29771,1,0
4,GO GLUTAMINE METABOLIC PROCESS,2.1621e-05,-0.22245,-0.27627,1,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.5427e-10,-0.22251,-0.31879,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.8142e-08,-0.22264,-0.28469,1,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,6.8888e-05,-0.22267,-0.21975,1,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00020504,-0.22267,-0.23609,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,6.4805e-11,-0.22276,-0.33882,1,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.0314e-05,-0.22311,-0.30143,1,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,9.5999e-07,-0.22321,-0.28154,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,1.6158e-05,-0.22323,-0.22289,1,0
4,GO SENSORY PERCEPTION,1.8881e-10,-0.2233,-0.28112,1,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,9.3415e-09,-0.22338,-0.28981,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,5.4724e-12,-0.22374,-0.35242,1,0
4,GO CELL CYCLE ARREST,9.3752e-12,-0.2238,-0.34529,1,0
4,GO INTERACTION WITH SYMBIONT,1.2328e-07,-0.22389,-0.27984,1,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,4.249e-10,-0.22397,-0.29523,1,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,2.004e-09,-0.22403,-0.34124,1,0
4,GO RESPONSE TO HEAT,8.6328e-08,-0.22406,-0.30242,1,0
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,6.4434e-08,-0.2241,-0.3254,1,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,3.9035e-08,-0.22423,-0.32411,1,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,2.4452e-09,-0.22427,-0.31153,1,0
4,GO CYTOSOLIC TRANSPORT,3.6293e-09,-0.22428,-0.38593,1,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0022701,-0.22435,-0.26607,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,4.7488e-06,-0.22445,-0.24465,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,2.2824e-05,-0.22451,-0.27668,1,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.7693e-06,-0.22459,-0.25738,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,8.3013e-05,-0.22499,-0.26715,1,0
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,1.4487e-10,-0.22504,-0.33955,1,0
4,GO FERTILIZATION,8.5043e-10,-0.22509,-0.27146,1,0
4,GO MULTICELLULAR ORGANISM AGING,6.6066e-07,-0.22526,-0.28928,1,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.0030839,-0.22527,-0.27449,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,3.1479e-07,-0.22529,-0.34,1,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,4.4771e-05,-0.22533,-0.34315,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.7721e-08,-0.22553,-0.3609,1,0
4,GO CYTOKINETIC PROCESS,1.996e-06,-0.22555,-0.29242,1,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,5.4701e-07,-0.2256,-0.34244,1,0
4,GO RESPONSE TO INTERLEUKIN 1,1.7687e-09,-0.22579,-0.28274,1,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.9014e-08,-0.22589,-0.27443,1,0
4,GO CD40 SIGNALING PATHWAY,9.795e-06,-0.22612,-0.30453,1,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,8.7316e-05,-0.22615,-0.21429,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0035605,-0.22622,-0.17916,1,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,5.6085e-05,-0.22623,-0.30119,1,0
4,GO REGULATION OF MACROAUTOPHAGY,2.3268e-09,-0.22635,-0.34049,1,0
4,GO EXIT FROM MITOSIS,4.7488e-06,-0.22638,-0.25215,1,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.5922e-10,-0.22669,-0.30788,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.0279e-11,-0.22673,-0.32809,1,0
4,GO REGULATION OF TOR SIGNALING,1.5604e-09,-0.22683,-0.34981,1,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0095807,-0.2269,-0.18848,1,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,5.6487e-06,-0.22692,-0.28921,1,0
4,GO THYMUS DEVELOPMENT,1.4454e-06,-0.2271,-0.29066,1,0
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,6.0759e-07,-0.22722,-0.3428,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,6.8396e-06,-0.22736,-0.28293,1,0
4,GO FATTY ACID BETA OXIDATION,2.5164e-08,-0.22755,-0.32447,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.5078e-11,-0.22764,-0.34411,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.77e-09,-0.22774,-0.33175,1,0
4,GO TETRAPYRROLE METABOLIC PROCESS,7.0522e-08,-0.22781,-0.29729,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.342e-06,-0.22786,-0.34495,1,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00010673,-0.22786,-0.24162,1,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,1.8701e-05,-0.22805,-0.29998,1,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,4.8673e-09,-0.22816,-0.31311,1,0
4,GO PROTEIN STABILIZATION,2.5066e-09,-0.22822,-0.30005,1,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,2.3268e-09,-0.22828,-0.29893,1,0
4,GO REGULATION OF TRANSPORT,2.9979e-12,-0.22842,-0.35784,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9078e-09,-0.22842,-0.30273,1,0
4,GO CELL AGING,6.4192e-10,-0.22855,-0.31396,1,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,1.6457e-05,-0.22863,-0.27794,1,0
4,GO DIOL METABOLIC PROCESS,0.0001862,-0.22866,-0.29282,1,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,2.8262e-08,-0.22867,-0.29907,1,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,6.3359e-07,-0.22873,-0.31581,1,0
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,3.3629e-10,-0.22931,-0.31622,1,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.006444,-0.22943,-0.31765,1,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,1.9465e-08,-0.2296,-0.28581,1,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,7.1819e-07,-0.22967,-0.3354,1,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0013443,-0.22967,-0.23739,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,4.0033e-09,-0.22971,-0.31925,1,0
4,GO RIG I SIGNALING PATHWAY,4.1552e-07,-0.22982,-0.31463,1,0
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,3.7605e-06,-0.22985,-0.30779,1,0
4,GO DIGESTION,2.2397e-08,-0.22995,-0.2755,1,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.8369e-09,-0.23018,-0.32966,1,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,2.1807e-07,-0.23029,-0.2742,1,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,6.4592e-06,-0.23045,-0.31555,1,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,1.5293e-05,-0.23059,-0.28584,1,0
4,GO HEME METABOLIC PROCESS,4.4807e-06,-0.23066,-0.32104,1,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,2.6828e-05,-0.23077,-0.28576,1,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,1.5372e-07,-0.23077,-0.30445,1,0
4,GO VIRAL RELEASE FROM HOST CELL,4.4787e-08,-0.23091,-0.30015,1,0
4,GO PEROXISOMAL TRANSPORT,5.4701e-07,-0.23092,-0.26769,1,0
4,GO SYNAPTIC VESICLE LOCALIZATION,1.2027e-05,-0.23093,-0.34113,1,0
4,GO RESPONSE TO PEPTIDOGLYCAN,1.7534e-07,-0.23132,-0.2918,1,0
4,GO DETOXIFICATION,8.8389e-07,-0.23132,-0.25732,1,0
4,GO RESPONSE TO IONIZING RADIATION,2.5893e-10,-0.2314,-0.32949,1,0
4,GO DENDRITE SELF AVOIDANCE,6.7724e-05,-0.23144,-0.31871,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,3.2162e-07,-0.23151,-0.29772,1,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00029511,-0.23187,-0.24731,1,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,3.8645e-11,-0.23195,-0.32132,1,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,4.3946e-06,-0.23196,-0.25941,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.7125e-10,-0.23215,-0.29719,1,0
4,GO HISTONE DEUBIQUITINATION,0.00016098,-0.23227,-0.29412,1,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.00088789,-0.23246,-0.25693,1,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.5674e-06,-0.23253,-0.33133,1,0
4,GO SEX DETERMINATION,3.8347e-06,-0.2326,-0.27246,1,0
4,GO LIVER REGENERATION,7.8976e-09,-0.23261,-0.30341,1,0
4,GO ENDODERMAL CELL FATE COMMITMENT,3.6924e-05,-0.23275,-0.25456,1,0
4,GO FC RECEPTOR SIGNALING PATHWAY,7.8778e-10,-0.23291,-0.33221,1,0
4,GO REPRODUCTION,1.5968e-11,-0.23293,-0.32037,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.9044e-05,-0.23321,-0.25969,1,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00016629,-0.23325,-0.2511,1,0
4,GO HINDBRAIN DEVELOPMENT,6.1583e-08,-0.2335,-0.33792,1,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.3769e-07,-0.2336,-0.28325,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,7.0671e-12,-0.23361,-0.34922,1,0
4,GO FOREBRAIN REGIONALIZATION,0.0013069,-0.23375,-0.24282,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.1196e-06,-0.23389,-0.29578,1,0
4,GO REGULATION OF CELL AGING,2.5164e-08,-0.23402,-0.31442,1,0
4,GO ACTIN NUCLEATION,5.02e-08,-0.23413,-0.30793,1,0
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.3133e-11,-0.23415,-0.3289,1,0
4,GO MICROTUBULE POLYMERIZATION,1.8419e-06,-0.23417,-0.34129,1,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.5604e-09,-0.23419,-0.34408,1,0
4,GO DIGESTIVE SYSTEM PROCESS,1.6407e-09,-0.23431,-0.3032,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00029976,-0.23433,-0.29526,1,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00012186,-0.23434,-0.29798,1,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.00025215,-0.2344,-0.24045,1,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.0027381,-0.23443,-0.36152,1,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.00013899,-0.23443,-0.26398,1,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00010673,-0.23451,-0.26871,1,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,2.0546e-09,-0.2348,-0.30041,1,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,2.3467e-08,-0.23493,-0.337,1,0
4,GO PIGMENT METABOLIC PROCESS,3.2859e-07,-0.23498,-0.29838,1,0
4,GO RESPONSE TO XENOBIOTIC STIMULUS,1.5372e-07,-0.2351,-0.24643,1,0
4,GO NEURAL TUBE PATTERNING,2.1375e-08,-0.23524,-0.34192,1,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00075607,-0.23547,-0.2799,1,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,8.0424e-11,-0.23547,-0.35584,1,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.026561,-0.2355,-0.2734,1,0
4,GO NUCLEOTIDE TRANSPORT,1.2328e-07,-0.23557,-0.328,1,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00034485,-0.23572,-0.26682,1,0
4,GO NADP METABOLIC PROCESS,4.6578e-06,-0.23582,-0.30468,1,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,2.7614e-08,-0.23582,-0.36623,1,0
4,GO CELLULAR RESPONSE TO UV,5.3747e-08,-0.23599,-0.31606,1,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,1.5014e-05,-0.23604,-0.3234,1,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,2.5756e-08,-0.23615,-0.30541,1,0
4,GO PYRUVATE METABOLIC PROCESS,2.7668e-07,-0.23619,-0.32463,1,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,7.9617e-06,-0.2362,-0.28174,1,0
4,GO CHROMATIN DISASSEMBLY,7.1274e-05,-0.23626,-0.30196,1,0
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,3.6586e-11,-0.23637,-0.31292,1,0
4,GO RHYTHMIC PROCESS,7.4177e-11,-0.23637,-0.34817,1,0
4,GO CELLULAR HOMEOSTASIS,7.0671e-12,-0.2364,-0.32362,1,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.9175e-06,-0.23648,-0.34737,1,0
4,GO STRESS GRANULE ASSEMBLY,0.00011596,-0.23663,-0.30017,1,0
4,GO CELL CELL SIGNALING,1.3888e-11,-0.23669,-0.35573,1,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.00017457,-0.23674,-0.25332,1,0
4,GO REPRODUCTIVE BEHAVIOR,9.8716e-08,-0.23692,-0.33033,1,0
4,GO DEPHOSPHORYLATION,4.0817e-11,-0.23715,-0.3485,1,0
4,GO CELL FATE SPECIFICATION,2.6828e-05,-0.23716,-0.25311,1,0
4,GO PROTEIN AUTOUBIQUITINATION,1.1533e-09,-0.23725,-0.31407,1,0
4,GO COPII COATED VESICLE BUDDING,3.2764e-10,-0.23751,-0.33136,1,0
4,GO RETINA HOMEOSTASIS,2.8925e-08,-0.23754,-0.21943,1,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,1.3039e-08,-0.23755,-0.29462,1,0
4,GO O GLYCAN PROCESSING,2.7078e-07,-0.23758,-0.37721,1,0
4,GO T CELL APOPTOTIC PROCESS,1.6782e-07,-0.23762,-0.30778,1,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,5.4701e-07,-0.2377,-0.29069,1,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00059648,-0.2377,-0.28506,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.725e-09,-0.23771,-0.31165,1,0
4,GO PROTEIN DEPHOSPHORYLATION,4.4302e-11,-0.23783,-0.34878,1,0
4,GO REGULATION OF INSULIN SECRETION,1.6907e-08,-0.23783,-0.33729,1,0
4,GO HOMEOSTATIC PROCESS,1.4092e-12,-0.23794,-0.33958,1,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0050269,-0.23815,-0.21325,1,0
4,GO CELLULAR RESPONSE TO RADIATION,1.7687e-09,-0.23822,-0.2984,1,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.0657e-06,-0.23831,-0.3291,1,0
4,GO EAR MORPHOGENESIS,1.1794e-07,-0.23843,-0.29912,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00060545,-0.23849,-0.298,1,0
4,GO REGULATION OF PROTEIN STABILITY,1.1245e-09,-0.23854,-0.30806,1,0
4,GO CELLULAR RESPONSE TO ALKALOID,8.4262e-06,-0.23864,-0.2519,1,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,9.5999e-07,-0.23864,-0.31717,1,0
4,GO BILE ACID METABOLIC PROCESS,1.0212e-06,-0.239,-0.29767,1,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,2.5164e-08,-0.23903,-0.28414,1,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,2.4837e-07,-0.23905,-0.34298,1,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00082553,-0.23909,-0.31986,1,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,2.4305e-07,-0.23922,-0.303,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.5822e-08,-0.23923,-0.31743,1,0
4,GO REGULATION OF MRNA 3 END PROCESSING,4.1552e-07,-0.23934,-0.31776,1,0
4,GO RESPONSE TO CHEMOKINE,1.9905e-10,-0.23937,-0.27738,1,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,9.2585e-06,-0.23955,-0.2716,1,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.8673e-09,-0.23962,-0.30099,1,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00015083,-0.23968,-0.25535,1,0
4,GO VESICLE LOCALIZATION,2.8573e-11,-0.24017,-0.36902,1,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,9.404e-07,-0.24019,-0.32476,1,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00011986,-0.2402,-0.26167,1,0
4,GO SPLEEN DEVELOPMENT,3.1729e-08,-0.24033,-0.31284,1,0
4,GO NEUROTRANSMITTER SECRETION,1.7071e-05,-0.24046,-0.32337,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,2.7041e-11,-0.2406,-0.36907,1,0
4,GO VITAMIN METABOLIC PROCESS,1.3085e-09,-0.24065,-0.30562,1,0
4,GO RESPONSE TO ABIOTIC STIMULUS,1.785e-11,-0.24065,-0.33056,1,0
4,GO CEREBRAL CORTEX DEVELOPMENT,2.1807e-07,-0.24116,-0.35262,1,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,2.2707e-10,-0.24119,-0.36438,1,0
4,GO GOLGI VESICLE BUDDING,6.4192e-10,-0.24128,-0.34174,1,0
4,GO RESPONSE TO AUDITORY STIMULUS,7.2497e-05,-0.24133,-0.37014,1,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00012594,-0.24139,-0.21147,1,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.9175e-06,-0.24154,-0.37601,1,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,1.155e-06,-0.24154,-0.33401,1,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.00038422,-0.2416,-0.31612,1,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,4.2271e-06,-0.2417,-0.30812,1,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.6062e-07,-0.24181,-0.27915,1,0
4,GO PROTEIN AUTOPROCESSING,5.6085e-05,-0.2419,-0.23488,1,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.7411e-08,-0.24201,-0.32479,1,0
4,GO PHOSPHATE ION TRANSPORT,3.2162e-07,-0.24201,-0.29758,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,4.0657e-06,-0.24211,-0.29339,1,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0046604,-0.24217,-0.25898,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,9.4157e-10,-0.24222,-0.35725,1,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.2143e-08,-0.24227,-0.32025,1,0
4,GO L AMINO ACID TRANSPORT,1.3671e-08,-0.24232,-0.36541,1,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,7.479e-12,-0.24233,-0.29125,1,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,7.71e-09,-0.24246,-0.31592,1,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,3.6361e-10,-0.24251,-0.27272,1,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,1.2328e-07,-0.24255,-0.33799,1,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,7.3803e-06,-0.24256,-0.26701,1,0
4,GO LYTIC VACUOLE ORGANIZATION,4.2784e-08,-0.24256,-0.36201,1,0
4,GO MITOCHONDRION DISTRIBUTION,1.6321e-06,-0.24263,-0.34956,1,0
4,GO REGULATION OF HISTONE METHYLATION,7.6657e-06,-0.24265,-0.29182,1,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.0012005,-0.24266,-0.25806,1,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,8.3013e-05,-0.24268,-0.30567,1,0
4,GO MIDBRAIN DEVELOPMENT,2.559e-11,-0.2429,-0.33415,1,0
4,GO PROTEIN HOMOTETRAMERIZATION,6.4192e-10,-0.24338,-0.30748,1,0
4,GO TRANSMEMBRANE TRANSPORT,1.736e-11,-0.24342,-0.32454,1,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.3661e-05,-0.24349,-0.26577,1,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0062877,-0.24366,-0.16887,1,0
4,GO DE NOVO PROTEIN FOLDING,0.00059648,-0.24367,-0.24199,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.3806e-05,-0.24374,-0.30306,1,0
4,GO DETECTION OF ABIOTIC STIMULUS,7.7166e-08,-0.24376,-0.29129,1,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00022927,-0.24381,-0.26489,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,9.5677e-09,-0.24385,-0.35617,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0026663,-0.244,-0.33949,1,0
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,4.2487e-05,-0.24403,-0.24225,1,0
4,GO FATTY ACID TRANSPORT,3.2764e-10,-0.24407,-0.34463,1,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,6.1119e-05,-0.24417,-0.25074,1,0
4,GO AMINE BIOSYNTHETIC PROCESS,5.3256e-05,-0.24424,-0.28639,1,0
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,3.192e-10,-0.24458,-0.3131,1,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,3.8924e-05,-0.24477,-0.28068,1,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,8.7502e-06,-0.2451,-0.24984,1,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.1751e-05,-0.24511,-0.32803,1,0
4,GO REGULATION OF MICROTUBULE BINDING,0.00090088,-0.24515,-0.30929,1,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,1.3442e-05,-0.24524,-0.33634,1,0
4,GO MACROMOLECULE DEACYLATION,2.0881e-08,-0.24534,-0.33229,1,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.0395e-05,-0.24541,-0.23528,1,0
4,GO PROTEIN DESTABILIZATION,8.2864e-09,-0.24543,-0.35479,1,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.003166,-0.24546,-0.25548,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,2.1595e-09,-0.24554,-0.32152,1,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,2.1234e-05,-0.24558,-0.21044,1,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,1.1828e-09,-0.2456,-0.32958,1,0
4,GO REGULATION OF SECRETION,4.6784e-11,-0.24565,-0.34994,1,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.8301e-10,-0.24569,-0.32773,1,0
4,GO HEAD DEVELOPMENT,9.4157e-10,-0.24571,-0.35719,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.2792e-06,-0.24577,-0.29915,1,0
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.9387e-10,-0.24586,-0.33049,1,0
4,GO REGULATION OF PEPTIDE TRANSPORT,2.1085e-11,-0.24591,-0.34726,1,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,4.6784e-11,-0.24599,-0.35421,1,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0010259,-0.2462,-0.28792,1,0
4,GO LIPOPROTEIN METABOLIC PROCESS,1.0241e-10,-0.2462,-0.3388,1,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.0004e-06,-0.2463,-0.29982,1,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,4.5239e-09,-0.24636,-0.30943,1,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00015583,-0.24668,-0.25561,1,0
4,GO VESICLE CARGO LOADING,1.2027e-05,-0.24672,-0.34418,1,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.5713e-07,-0.24691,-0.32605,1,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,1.1415e-11,-0.24704,-0.37957,1,0
4,GO PROTEIN DEPOLYMERIZATION,8.6937e-09,-0.24706,-0.39415,1,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,9.4157e-10,-0.24708,-0.38086,1,0
4,GO ADULT BEHAVIOR,6.8885e-07,-0.24714,-0.32859,1,0
4,GO KERATINIZATION,0.0012527,-0.24715,-0.22797,1,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00033955,-0.24723,-0.28099,1,0
4,GO CELL CELL RECOGNITION,5.8856e-08,-0.24734,-0.26257,1,0
4,GO CELL PROJECTION ASSEMBLY,1.2348e-10,-0.2474,-0.36138,1,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,2.5868e-06,-0.24745,-0.31387,1,0
4,GO DENDRITE EXTENSION,0.0015463,-0.24757,-0.25532,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.7582e-06,-0.24779,-0.31477,1,0
4,GO REGULATION OF HISTONE MODIFICATION,3.5606e-08,-0.24793,-0.3094,1,0
4,GO CELLULAR SENESCENCE,1.2143e-08,-0.24799,-0.30489,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,3.5022e-05,-0.24836,-0.31414,1,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,4.3549e-12,-0.24855,-0.35214,1,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.342e-06,-0.24856,-0.39697,1,0
4,GO CELLULAR OXIDANT DETOXIFICATION,7.71e-09,-0.24857,-0.26917,1,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,5.3602e-11,-0.24869,-0.35307,1,0
4,GO INTERLEUKIN 2 PRODUCTION,3.6293e-09,-0.24872,-0.34244,1,0
4,GO RESPONSE TO GAMMA RADIATION,1.1858e-08,-0.24878,-0.32529,1,0
4,GO HISTONE H3 K9 METHYLATION,5.8049e-05,-0.24878,-0.32291,1,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.7923e-10,-0.24878,-0.32961,1,0
4,GO VESICLE BUDDING FROM MEMBRANE,2.2707e-10,-0.24884,-0.34748,1,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,8.7502e-06,-0.24884,-0.32191,1,0
4,GO NEURON APOPTOTIC PROCESS,3.3629e-10,-0.2489,-0.34131,1,0
4,GO BRAIN MORPHOGENESIS,5.7051e-07,-0.24894,-0.33233,1,0
4,GO MATING BEHAVIOR,4.6202e-07,-0.249,-0.32033,1,0
4,GO SIGNAL RELEASE,5.2359e-09,-0.24909,-0.33057,1,0
4,GO HISTONE H3 K9 MODIFICATION,1.0557e-05,-0.24912,-0.31457,1,0
4,GO VACUOLAR TRANSPORT,2.457e-10,-0.2493,-0.37772,1,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,1.3769e-07,-0.24941,-0.35572,1,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.8001e-06,-0.24941,-0.29524,1,0
4,GO GLUCOSE METABOLIC PROCESS,7.1726e-09,-0.24943,-0.3492,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.012087,-0.24943,-0.20399,1,0
4,GO SODIUM ION HOMEOSTASIS,1.5037e-07,-0.24967,-0.29045,1,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.1245e-09,-0.24982,-0.28765,1,0
4,GO RESPONSE TO UV C,9.9844e-05,-0.24986,-0.28597,1,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,1.2534e-06,-0.24991,-0.28707,1,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0279e-08,-0.24997,-0.28485,1,0
4,GO PROTEIN NITROSYLATION,1.064e-06,-0.2501,-0.29092,1,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,4.0033e-09,-0.25014,-0.37975,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,7.1819e-07,-0.25016,-0.29249,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.9872e-06,-0.25022,-0.30183,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0011021,-0.25027,-0.23494,1,0
4,GO POSITIVE REGULATION OF TRANSPORT,1.5383e-12,-0.25035,-0.37263,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,3.1896e-11,-0.25036,-0.3247,1,0
4,GO ER OVERLOAD RESPONSE,0.00060545,-0.25037,-0.25547,1,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.00013016,-0.25045,-0.29186,1,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.9069e-08,-0.2505,-0.33908,1,0
4,GO RESPONSE TO UV,5.6317e-09,-0.25052,-0.32078,1,0
4,GO REGULATION OF CELLULAR LOCALIZATION,8.3747e-12,-0.25059,-0.36475,1,0
4,GO PEPTIDE HORMONE SECRETION,1.3769e-07,-0.25073,-0.32692,1,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,1.8323e-12,-0.25074,-0.39653,1,0
4,GO MALE SEX DETERMINATION,3.8924e-05,-0.25085,-0.27547,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.2434e-08,-0.25108,-0.31971,1,0
4,GO CARBOHYDRATE METABOLIC PROCESS,1.7442e-10,-0.25112,-0.34303,1,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,4.9069e-08,-0.25131,-0.34711,1,0
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,4.3606e-10,-0.25132,-0.36146,1,0
4,GO REGULATION OF CELL CYCLE ARREST,1.6782e-07,-0.25144,-0.28082,1,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,3.3806e-05,-0.25167,-0.31455,1,0
4,GO AUTOPHAGY OF MITOCHONDRION,8.6328e-08,-0.25173,-0.30926,1,0
4,GO LIPID EXPORT FROM CELL,5.6245e-08,-0.25174,-0.31275,1,0
4,GO AXONEME ASSEMBLY,4.1751e-05,-0.25177,-0.26927,1,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.332e-06,-0.25178,-0.34343,1,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.4873e-07,-0.25179,-0.35793,1,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.2886e-07,-0.25199,-0.36481,1,0
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,8.0898e-09,-0.25208,-0.3347,1,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,1.9948e-11,-0.25214,-0.36886,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.3639e-12,-0.25231,-0.32572,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.1807e-07,-0.25236,-0.31709,1,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,9.9705e-11,-0.25238,-0.30102,1,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,1.0422e-09,-0.25243,-0.33063,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0011836,-0.25249,-0.25171,1,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.4837e-07,-0.25257,-0.34261,1,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,1.1282e-07,-0.25257,-0.29377,1,0
4,GO LIPID BIOSYNTHETIC PROCESS,3.1098e-10,-0.25264,-0.3278,1,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.277e-11,-0.25268,-0.32876,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00013451,-0.2527,-0.2692,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.7172e-05,-0.25278,-0.24601,1,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,7.8778e-10,-0.25283,-0.34822,1,0
4,GO PROTEIN HOMOOLIGOMERIZATION,1.736e-11,-0.25284,-0.32518,1,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.3647e-09,-0.25287,-0.33805,1,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,1.0169e-05,-0.25298,-0.3405,1,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,6.1321e-12,-0.2531,-0.39459,1,0
4,GO NUCLEOTIDE PHOSPHORYLATION,2.1338e-07,-0.25316,-0.31735,1,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,7.0017e-09,-0.25326,-0.32133,1,0
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,7.6446e-07,-0.25352,-0.27447,1,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,6.0991e-06,-0.25356,-0.30979,1,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,3.6567e-07,-0.25362,-0.31337,1,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.0712e-08,-0.25367,-0.27216,1,0
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,1.8881e-10,-0.25369,-0.34381,1,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00010323,-0.25371,-0.33155,1,0
4,GO HEAT GENERATION,1.6321e-06,-0.25373,-0.2487,1,0
4,GO PENILE ERECTION,0.00011596,-0.25378,-0.26444,1,0
4,GO MYOTUBE CELL DEVELOPMENT,4.8198e-07,-0.25379,-0.28928,1,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,4.0817e-11,-0.25386,-0.35463,1,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,5.3562e-07,-0.25386,-0.3478,1,0
4,GO LEYDIG CELL DIFFERENTIATION,0.00035024,-0.25411,-0.39458,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,9.5999e-07,-0.25412,-0.26454,1,0
4,GO APOPTOTIC PROCESS,8.0609e-13,-0.25424,-0.35678,1,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0020092,-0.25428,-0.31714,1,0
4,GO MUSCLE CELL DIFFERENTIATION,5.6304e-12,-0.25429,-0.39533,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.011678,-0.25453,-0.35178,1,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,9.4157e-10,-0.25453,-0.33976,1,0
4,GO VIRAL LIFE CYCLE,1.2682e-10,-0.25459,-0.36526,1,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0062108,-0.25484,-0.24361,1,0
4,GO ERYTHROCYTE MATURATION,3.5038e-07,-0.25496,-0.37347,1,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,2.7452e-06,-0.25501,-0.34115,1,0
4,GO CHEMOSENSORY BEHAVIOR,3.2162e-07,-0.25502,-0.26449,1,0
4,GO IRON ION TRANSPORT,1.7687e-09,-0.25505,-0.30457,1,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,7.2202e-11,-0.25509,-0.31573,1,0
4,GO NEUROTRANSMITTER TRANSPORT,5.2303e-06,-0.25513,-0.32589,1,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.174e-11,-0.25515,-0.36259,1,0
4,GO RETINOL METABOLIC PROCESS,7.105e-06,-0.25518,-0.25963,1,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,3.0905e-06,-0.25522,-0.34319,1,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,5.1101e-09,-0.25523,-0.25552,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.7668e-07,-0.25524,-0.31273,1,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.0279e-08,-0.25535,-0.35377,1,0
4,GO PROSTAGLANDIN SECRETION,1.996e-06,-0.25536,-0.28581,1,0
4,GO CYTOSKELETON ORGANIZATION,3.7735e-12,-0.2554,-0.39542,1,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,1.7442e-10,-0.25541,-0.34979,1,0
4,GO IMMUNOGLOBULIN SECRETION,1.1282e-07,-0.25542,-0.35105,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,2.8886e-07,-0.25564,-0.34327,1,0
4,GO POSITIVE REGULATION OF SECRETION,6.8406e-11,-0.25609,-0.35045,1,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,3.1098e-10,-0.25623,-0.32769,1,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.00025215,-0.25624,-0.26461,1,0
4,GO HISTONE H3 DEACETYLATION,6.5906e-08,-0.25624,-0.34601,1,0
4,GO MACROPHAGE MIGRATION,3.6293e-09,-0.25634,-0.35904,1,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,1.6109e-10,-0.25634,-0.33872,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.2303e-06,-0.25634,-0.33986,1,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,5.6317e-09,-0.25635,-0.30504,1,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,1.1398e-10,-0.25636,-0.37666,1,0
4,GO NEURON DEATH,1.887e-11,-0.25644,-0.3722,1,0
4,GO ION TRANSPORT,7.9144e-12,-0.25664,-0.34379,1,0
4,GO MICROTUBULE BUNDLE FORMATION,1.7922e-07,-0.25675,-0.29974,1,0
4,GO ADULT HEART DEVELOPMENT,0.0029256,-0.25681,-0.26475,1,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,3.8924e-05,-0.25692,-0.28426,1,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,6.1583e-08,-0.25714,-0.33055,1,0
4,GO CELLULAR DEFENSE RESPONSE,7.7166e-08,-0.25726,-0.31196,1,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,6.5906e-08,-0.25731,-0.33187,1,0
4,GO INSULIN SECRETION,3.9035e-08,-0.25743,-0.33763,1,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.6129e-08,-0.25743,-0.36919,1,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,2.5893e-10,-0.25744,-0.35066,1,0
4,GO ETHER METABOLIC PROCESS,1.1086e-06,-0.25776,-0.32266,1,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,6.4434e-08,-0.25778,-0.39625,1,0
4,GO HUMORAL IMMUNE RESPONSE,4.249e-10,-0.25779,-0.34361,1,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,3.1494e-05,-0.25799,-0.31421,1,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,6.3569e-09,-0.25805,-0.26895,1,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.0279e-08,-0.25828,-0.34218,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.1312e-09,-0.25839,-0.38621,1,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,1.736e-11,-0.25846,-0.35909,1,0
4,GO GENETIC IMPRINTING,5.2303e-06,-0.25855,-0.30969,1,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,9.6562e-05,-0.2586,-0.2598,1,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.7442e-10,-0.25862,-0.38141,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,9.4407e-08,-0.25862,-0.3212,1,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.8142e-08,-0.25869,-0.37858,1,0
4,GO REGULATION OF T CELL CHEMOTAXIS,2.2505e-06,-0.25872,-0.26618,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,3.2785e-11,-0.2588,-0.35427,1,0
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.6782e-07,-0.25891,-0.28547,1,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.801e-10,-0.25893,-0.3133,1,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.6823e-09,-0.25896,-0.33072,1,0
4,GO CATION TRANSPORT,3.019e-11,-0.25898,-0.33892,1,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,9.4341e-06,-0.25902,-0.33932,1,0
4,GO RESPONSE TO MANGANESE ION,3.247e-08,-0.25909,-0.34915,1,0
4,GO REGULATION OF GLUCOSE IMPORT,3.1729e-08,-0.25929,-0.33885,1,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,4.5526e-11,-0.2593,-0.31683,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.0557e-05,-0.25932,-0.29795,1,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,8.6579e-07,-0.25943,-0.29877,1,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,1.6158e-05,-0.25945,-0.33363,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.030994,-0.25959,-0.21658,1,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,1.8573e-08,-0.2599,-0.34984,1,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.5461e-06,-0.25991,-0.34413,1,0
4,GO POLYOL BIOSYNTHETIC PROCESS,1.1579e-08,-0.25994,-0.32169,1,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.5016e-10,-0.26008,-0.35746,1,0
4,GO STARTLE RESPONSE,0.0013255,-0.26012,-0.26298,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,9.9064e-10,-0.26017,-0.34174,1,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,4.1815e-08,-0.26026,-0.2975,1,0
4,GO AMINO ACID TRANSPORT,9.8716e-08,-0.2604,-0.33168,1,0
4,GO INTERLEUKIN 10 PRODUCTION,1.6994e-06,-0.26044,-0.30248,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,2.2416e-05,-0.26054,-0.292,1,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,9.7068e-11,-0.26063,-0.34784,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5217e-09,-0.26076,-0.32914,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.7461e-07,-0.26093,-0.3646,1,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,3.9963e-12,-0.26101,-0.39069,1,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,1.1245e-09,-0.26105,-0.37816,1,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,1.7721e-08,-0.26109,-0.32933,1,0
4,GO MULTICELLULAR ORGANISM GROWTH,2.4893e-11,-0.2611,-0.40802,1,0
4,GO ANION TRANSPORT,1.2417e-11,-0.26123,-0.35018,1,0
4,GO CELL MATURATION,2.9515e-10,-0.26139,-0.33101,1,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.8673e-09,-0.26143,-0.37358,1,0
4,GO ACROSOME REACTION,3.6877e-06,-0.26153,-0.33426,1,0
4,GO GLUTAMATE SECRETION,6.2175e-05,-0.26155,-0.30826,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,5.3747e-08,-0.26162,-0.29848,1,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,2.3793e-12,-0.26162,-0.37667,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.1494e-05,-0.26171,-0.24368,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,1.8863e-12,-0.26179,-0.37128,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.3747e-12,-0.2618,-0.39571,1,0
4,GO INNER EAR MORPHOGENESIS,7.5451e-08,-0.26181,-0.3201,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0001179,-0.26211,-0.29194,1,0
4,GO REGULATION OF CELL DIVISION,6.4192e-10,-0.26213,-0.33977,1,0
4,GO UV DAMAGE EXCISION REPAIR,8.8389e-07,-0.26221,-0.3057,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,2.0437e-10,-0.26231,-0.33768,1,0
4,GO REGULATION OF NEURON MATURATION,6.4592e-06,-0.26246,-0.36342,1,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,1.1041e-08,-0.26249,-0.31499,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,8.0815e-10,-0.26258,-0.38996,1,0
4,GO ACTIN CROSSLINK FORMATION,4.9872e-09,-0.26265,-0.4732,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,4.2784e-08,-0.26269,-0.31251,1,0
4,GO CELLULAR ION HOMEOSTASIS,3.8833e-12,-0.26269,-0.3346,1,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.2023e-10,-0.26276,-0.35897,1,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.6407e-09,-0.26287,-0.33108,1,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.5934e-07,-0.26305,-0.3457,1,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,9.5677e-09,-0.26313,-0.30953,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,7.0072e-05,-0.26331,-0.22903,1,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,3.1479e-07,-0.26341,-0.32048,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,3.758e-05,-0.26343,-0.27705,1,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.6581e-10,-0.26344,-0.3372,1,0
4,GO REGULATION OF ANION TRANSPORT,3.9309e-10,-0.26347,-0.34134,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.1858e-08,-0.26356,-0.34747,1,0
4,GO ETHANOL OXIDATION,0.00030928,-0.26371,-0.37705,1,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,2.1543e-10,-0.26385,-0.33089,1,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,2.1624e-06,-0.26389,-0.29456,1,0
4,GO REGULATION OF ATP METABOLIC PROCESS,1.4677e-08,-0.26389,-0.31689,1,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.1375e-05,-0.26396,-0.36236,1,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,1.475e-06,-0.26408,-0.32743,1,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,6.9522e-13,-0.26413,-0.37618,1,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.9064e-09,-0.26416,-0.33671,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION,5.9602e-12,-0.26424,-0.35794,1,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,5.9498e-07,-0.2643,-0.34374,1,0
4,GO PALLIUM DEVELOPMENT,1.1086e-06,-0.26434,-0.31791,1,0
4,GO SARCOMERE ORGANIZATION,6.0759e-07,-0.26435,-0.30698,1,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.2328e-07,-0.26443,-0.31605,1,0
4,GO FATTY ACID CATABOLIC PROCESS,1.3039e-08,-0.26458,-0.32618,1,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,4.3549e-12,-0.26466,-0.39804,1,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.5461e-06,-0.26471,-0.2693,1,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.00016098,-0.26474,-0.27144,1,0
4,GO RUFFLE ASSEMBLY,1.3671e-08,-0.26476,-0.38018,1,0
4,GO CELLULAR LIPID METABOLIC PROCESS,1.174e-11,-0.26476,-0.34294,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00016361,-0.26484,-0.29839,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,8.3066e-07,-0.26493,-0.27202,1,0
4,GO VIRAL RNA GENOME REPLICATION,3.6567e-07,-0.26495,-0.32751,1,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,5.77e-09,-0.26497,-0.33176,1,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,2.7078e-07,-0.26509,-0.33814,1,0
4,GO RRNA CATABOLIC PROCESS,9.6129e-06,-0.26509,-0.28887,1,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00022927,-0.26511,-0.23271,1,0
4,GO METAL ION TRANSPORT,1.4282e-11,-0.26524,-0.34387,1,0
4,GO ZINC ION HOMEOSTASIS,0.0016806,-0.26526,-0.25738,1,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,6.586e-10,-0.26533,-0.2967,1,0
4,GO FOREBRAIN DEVELOPMENT,1.2733e-08,-0.26542,-0.35451,1,0
4,GO GANGLION DEVELOPMENT,0.020166,-0.26543,-0.2984,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,3.9941e-08,-0.26543,-0.3734,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,3.1494e-05,-0.26546,-0.25948,1,0
4,GO ADULT LOCOMOTORY BEHAVIOR,1.5052e-06,-0.26546,-0.32131,1,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.3228e-08,-0.26547,-0.37725,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00039622,-0.26548,-0.38671,1,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,4.1815e-08,-0.26562,-0.33345,1,0
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.5906e-08,-0.26567,-0.35496,1,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.0094e-07,-0.26576,-0.37526,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,8.4877e-09,-0.26593,-0.34603,1,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,3.0296e-10,-0.26607,-0.30871,1,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.4107e-10,-0.26608,-0.38605,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.0791e-07,-0.26631,-0.32967,1,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,1.5968e-11,-0.26635,-0.39529,1,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00024045,-0.26643,-0.29475,1,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,1.0519e-10,-0.26645,-0.36675,1,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,4.0678e-07,-0.26651,-0.29347,1,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,6.6717e-09,-0.26652,-0.35602,1,0
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.815e-11,-0.26665,-0.35269,1,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,2.6306e-11,-0.26668,-0.40288,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,1.3737e-10,-0.26672,-0.35169,1,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,2.8925e-08,-0.26675,-0.30053,1,0
4,GO RESPONSE TO MONOSACCHARIDE,6.6581e-11,-0.26678,-0.38207,1,0
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.4098e-06,-0.26681,-0.31363,1,0
4,GO ASSOCIATIVE LEARNING,6.895e-08,-0.26681,-0.34488,1,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,1.2534e-12,-0.26684,-0.40249,1,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,5.2253e-10,-0.2669,-0.38973,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,3.1757e-12,-0.26696,-0.38504,1,0
4,GO ECTODERM DEVELOPMENT,3.1312e-09,-0.26697,-0.31678,1,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,1.5372e-07,-0.26699,-0.33104,1,0
4,GO REGULATION OF MEMBRANE POTENTIAL,2.8925e-08,-0.26699,-0.34536,1,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,1.0792e-11,-0.26702,-0.38649,1,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.0657e-06,-0.26706,-0.34437,1,0
4,GO MICROTUBULE DEPOLYMERIZATION,1.0958e-05,-0.26706,-0.35574,1,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,1.451e-12,-0.26707,-0.38177,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,3.2162e-07,-0.2671,-0.34313,1,0
4,GO V D J RECOMBINATION,0.0046018,-0.26712,-0.218,1,0
4,GO ER NUCLEUS SIGNALING PATHWAY,5.1304e-06,-0.26713,-0.30986,1,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,4.4148e-09,-0.26716,-0.35217,1,0
4,GO SECRETION,1.942e-12,-0.26721,-0.37016,1,0
4,GO ORGANELLE FUSION,2.5756e-08,-0.2673,-0.35792,1,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.1793e-10,-0.2674,-0.37735,1,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,3.628e-05,-0.26749,-0.34305,1,0
4,GO HEPATOCYTE DIFFERENTIATION,1.8032e-05,-0.2675,-0.28681,1,0
4,GO COPII COATED VESICLE CARGO LOADING,3.6877e-06,-0.26771,-0.35715,1,0
4,GO VESICLE ORGANIZATION,1.642e-11,-0.26786,-0.38408,1,0
4,GO PROTEIN MATURATION,3.1032e-11,-0.26795,-0.3385,1,0
4,GO REGULATION OF PROTEIN IMPORT,1.8135e-09,-0.26802,-0.36569,1,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,1.451e-12,-0.26807,-0.40205,1,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,2.402e-08,-0.26808,-0.32324,1,0
4,GO ION HOMEOSTASIS,1.8863e-12,-0.26821,-0.34822,1,0
4,GO EPITHELIUM DEVELOPMENT,8.1414e-12,-0.2683,-0.38892,1,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,4.9694e-05,-0.26835,-0.32764,1,0
4,GO EAR DEVELOPMENT,9.5677e-09,-0.26838,-0.33646,1,0
4,GO DEMETHYLATION,7.4873e-07,-0.26847,-0.31014,1,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.5597e-11,-0.26847,-0.36894,1,0
4,GO FEAR RESPONSE,1.1579e-08,-0.26855,-0.30987,1,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,5.8049e-05,-0.26856,-0.30053,1,0
4,GO EMBRYONIC AXIS SPECIFICATION,1.3056e-06,-0.2687,-0.27386,1,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,3.4296e-07,-0.2687,-0.31171,1,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,9.1996e-11,-0.26878,-0.33804,1,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,5.4701e-07,-0.26912,-0.31721,1,0
4,GO PEPTIDE SECRETION,5.5078e-11,-0.26913,-0.3655,1,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,2.4091e-05,-0.26922,-0.35497,1,0
4,GO PATTERN SPECIFICATION PROCESS,6.586e-10,-0.26925,-0.34936,1,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,1.0527e-08,-0.26926,-0.34614,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00040857,-0.26944,-0.27213,1,0
4,GO RESPONSE TO INTERLEUKIN 7,1.5372e-07,-0.26948,-0.33866,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.815e-11,-0.26951,-0.37184,1,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,4.5233e-07,-0.26961,-0.29676,1,0
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.6792e-10,-0.26985,-0.35969,1,0
4,GO MACROPHAGE CHEMOTAXIS,1.5027e-08,-0.26997,-0.33397,1,0
4,GO FATTY ACID METABOLIC PROCESS,6.4805e-11,-0.27001,-0.3229,1,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,2.5695e-09,-0.27004,-0.3116,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00072342,-0.2701,-0.3118,1,0
4,GO REGULATION OF HORMONE LEVELS,1.6823e-09,-0.27017,-0.32044,1,0
4,GO POSITIVE REGULATION OF SIGNALING,6.3604e-13,-0.27024,-0.37798,1,0
4,GO RESPONSE TO DSRNA,1.3174e-07,-0.27042,-0.3445,1,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,1.5102e-11,-0.27044,-0.33485,1,0
4,GO LEFT RIGHT PATTERN FORMATION,1.8363e-05,-0.27046,-0.32169,1,0
4,GO ORGANIC ANION TRANSPORT,2.2286e-11,-0.27046,-0.35444,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,8.4871e-11,-0.27048,-0.3567,1,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.3435e-06,-0.27049,-0.314,1,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,4.3774e-08,-0.2705,-0.30506,1,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,4.4302e-11,-0.27053,-0.36364,1,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,1.785e-11,-0.27057,-0.36145,1,0
4,GO CERAMIDE BIOSYNTHETIC PROCESS,9.3415e-09,-0.27073,-0.37325,1,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0013255,-0.27106,-0.36514,1,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,4.4285e-07,-0.27111,-0.28403,1,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,7.598e-13,-0.27126,-0.38338,1,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.6581e-11,-0.27131,-0.33596,1,0
4,GO CALCIUM MEDIATED SIGNALING,1.0202e-11,-0.27153,-0.31389,1,0
4,GO LIMBIC SYSTEM DEVELOPMENT,9.8716e-08,-0.27155,-0.3321,1,0
4,GO L GLUTAMATE IMPORT,3.9941e-08,-0.27158,-0.34035,1,0
4,GO CELL FATE COMMITMENT,1.6823e-09,-0.27161,-0.32797,1,0
4,GO LIPID OXIDATION,1.1706e-10,-0.2717,-0.34133,1,0
4,GO MUSCLE TISSUE DEVELOPMENT,3.4634e-11,-0.2717,-0.37335,1,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,2.4837e-07,-0.27172,-0.31228,1,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,8.9558e-11,-0.27173,-0.34733,1,0
4,GO HORMONE TRANSPORT,2.2397e-08,-0.27177,-0.32575,1,0
4,GO RESPONSE TO PEPTIDE HORMONE,2.7494e-12,-0.27181,-0.3947,1,0
4,GO SPINAL CORD PATTERNING,0.00040235,-0.27194,-0.34933,1,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,5.8698e-06,-0.27194,-0.32857,1,0
4,GO EMBRYO DEVELOPMENT,4.8824e-12,-0.27199,-0.3845,1,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,8.0609e-13,-0.27201,-0.4001,1,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,6.1321e-12,-0.27204,-0.33788,1,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,7.3803e-06,-0.27207,-0.31912,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,1.2907e-12,-0.27213,-0.39476,1,0
4,GO RESPONSE TO PEPTIDE,8.8075e-13,-0.27223,-0.40641,1,0
4,GO RESPONSE TO TOXIC SUBSTANCE,1.4107e-10,-0.27232,-0.30288,1,0
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.7721e-08,-0.27242,-0.31716,1,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,1.9064e-09,-0.27245,-0.32605,1,0
4,GO RNA DESTABILIZATION,6.0991e-06,-0.27251,-0.33553,1,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00011406,-0.27255,-0.33444,1,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00026438,-0.27259,-0.33055,1,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1041e-08,-0.27268,-0.40682,1,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00029976,-0.27281,-0.32198,1,0
4,GO ANATOMICAL STRUCTURE MATURATION,1.174e-11,-0.27282,-0.36543,1,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,8.1361e-07,-0.2729,-0.38169,1,0
4,GO HEXOSE CATABOLIC PROCESS,1.8701e-05,-0.27292,-0.31765,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00028155,-0.27298,-0.34943,1,0
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,1.5027e-08,-0.27304,-0.3406,1,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,5.6451e-10,-0.27306,-0.38156,1,0
4,GO MANGANESE ION TRANSPORT,5.6487e-06,-0.27309,-0.27244,1,0
4,GO PEPTIDYL SERINE MODIFICATION,3.3639e-12,-0.27312,-0.40255,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.9989e-07,-0.27319,-0.3571,1,0
4,GO ADAPTATION OF SIGNALING PATHWAY,2.9514e-07,-0.27321,-0.32684,1,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,7.1613e-13,-0.27323,-0.38971,1,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,1.0792e-11,-0.27337,-0.39327,1,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.7494e-12,-0.2734,-0.39809,1,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,1.9905e-10,-0.2734,-0.36165,1,0
4,GO ANION TRANSMEMBRANE TRANSPORT,5.5078e-11,-0.27342,-0.35034,1,0
4,GO MONOSACCHARIDE METABOLIC PROCESS,2.634e-09,-0.27348,-0.34454,1,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,8.4871e-11,-0.27353,-0.38974,1,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0017517,-0.27354,-0.30679,1,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00027716,-0.27361,-0.33173,1,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,6.895e-08,-0.27382,-0.32165,1,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,2.9078e-09,-0.27386,-0.37563,1,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00099681,-0.27387,-0.24919,1,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,2.0478e-05,-0.27392,-0.35092,1,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,2.4586e-08,-0.27402,-0.36124,1,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,3.1004e-08,-0.27405,-0.3681,1,0
4,GO STEROL METABOLIC PROCESS,3.3713e-09,-0.27406,-0.33659,1,0
4,GO MUSCLE CELL FATE COMMITMENT,3.2146e-06,-0.27408,-0.31462,1,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,1.7922e-07,-0.27412,-0.31796,1,0
4,GO CIRCULATORY SYSTEM PROCESS,1.182e-12,-0.2742,-0.40521,1,0
4,GO T CELL SELECTION,5.3562e-07,-0.27423,-0.28868,1,0
4,GO NUCLEOTIDE SALVAGE,0.0011503,-0.27442,-0.25501,1,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.0422e-09,-0.27444,-0.35752,1,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.3888e-11,-0.27449,-0.33061,1,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,2.011e-05,-0.27452,-0.27207,1,0
4,GO REGULATION OF PROTEIN TARGETING,7.4854e-10,-0.27454,-0.34654,1,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,3.6162e-06,-0.27457,-0.32746,1,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,3.6667e-12,-0.27467,-0.36691,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4107e-10,-0.27478,-0.33158,1,0
4,GO ACTIVATION OF MAPK ACTIVITY,9.6219e-13,-0.27481,-0.42312,1,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,3.5794e-07,-0.27488,-0.2826,1,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.2775e-07,-0.27489,-0.39721,1,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,6.4592e-06,-0.27491,-0.33443,1,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4686e-11,-0.27492,-0.38104,1,0
4,GO REGULATION OF PEPTIDE SECRETION,7.4177e-11,-0.27498,-0.36055,1,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,7.71e-09,-0.27511,-0.34715,1,0
4,GO HINDBRAIN MORPHOGENESIS,3.8161e-07,-0.27516,-0.325,1,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.71e-09,-0.27523,-0.34279,1,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.8611e-12,-0.27532,-0.35736,1,0
4,GO PROTEIN KINASE A SIGNALING,1.7687e-09,-0.27533,-0.33512,1,0
4,GO RESPONSE TO CADMIUM ION,1.2716e-05,-0.27535,-0.3006,1,0
4,GO KERATINOCYTE DIFFERENTIATION,6.2046e-07,-0.27552,-0.33517,1,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00015083,-0.27554,-0.29453,1,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7602e-11,-0.27558,-0.37857,1,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,1.484e-09,-0.27561,-0.36353,1,0
4,GO COPPER ION TRANSPORT,2.7668e-07,-0.27563,-0.31247,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,6.4699e-07,-0.27563,-0.35201,1,0
4,GO RESPONSE TO OXIDATIVE STRESS,1.8863e-12,-0.27566,-0.36666,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.9822e-07,-0.2757,-0.40992,1,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,2.8262e-08,-0.27572,-0.32184,1,0
4,GO STEROID METABOLIC PROCESS,6.5125e-09,-0.27572,-0.3169,1,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,4.9228e-07,-0.27574,-0.32491,1,0
4,GO ION TRANSMEMBRANE TRANSPORT,2.4893e-11,-0.27578,-0.3459,1,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1.7534e-07,-0.27589,-0.37403,1,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,2.0398e-08,-0.27592,-0.33903,1,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.5223e-10,-0.27592,-0.38519,1,0
4,GO ENERGY HOMEOSTASIS,2.1338e-07,-0.2761,-0.41188,1,0
4,GO GLYCEROLIPID METABOLIC PROCESS,4.9403e-11,-0.27612,-0.34428,1,0
4,GO SPINDLE LOCALIZATION,1.996e-06,-0.27613,-0.31902,1,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,1.8863e-12,-0.27614,-0.4073,1,0
4,GO CELLULAR RESPONSE TO PH,1.8053e-06,-0.27618,-0.27438,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.2764e-10,-0.27626,-0.3364,1,0
4,GO CYTOPLASM ORGANIZATION,9.795e-06,-0.27632,-0.37908,1,0
4,GO MRNA TRANSCRIPTION,2.2824e-05,-0.27635,-0.3663,1,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.1188e-12,-0.27636,-0.38537,1,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.734e-06,-0.27654,-0.35866,1,0
4,GO DIET INDUCED THERMOGENESIS,6.2046e-07,-0.27668,-0.29217,1,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,1.3599e-06,-0.2767,-0.36376,1,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.0582e-12,-0.27671,-0.39722,1,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.7676e-09,-0.27672,-0.35565,1,0
4,GO REGULATION OF AUTOPHAGY,4.4302e-11,-0.2768,-0.36711,1,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,1.5968e-11,-0.27683,-0.35689,1,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,9.086e-06,-0.27684,-0.29143,1,0
4,GO RESPONSE TO INSULIN,1.4686e-11,-0.27698,-0.3891,1,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,1.1478e-12,-0.27699,-0.39709,1,0
4,GO MOTILE CILIUM ASSEMBLY,0.00011986,-0.27703,-0.32001,1,0
4,GO REGULATION OF CHROMATIN BINDING,7.8052e-07,-0.27706,-0.3561,1,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.6446e-07,-0.27712,-0.335,1,0
4,GO CHEMICAL HOMEOSTASIS,1.679e-12,-0.27717,-0.35379,1,0
4,GO RESPONSE TO CARBOHYDRATE,1.0493e-11,-0.27719,-0.39342,1,0
4,GO EPIDERMAL CELL DIFFERENTIATION,1.6062e-07,-0.27722,-0.33145,1,0
4,GO REGULATION OF HORMONE SECRETION,1.8573e-08,-0.27723,-0.32175,1,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,5.5412e-06,-0.27742,-0.3063,1,0
4,GO PURINE NUCLEOTIDE TRANSPORT,2.8886e-07,-0.27746,-0.3418,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,4.5684e-06,-0.2777,-0.32453,1,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,9.3381e-05,-0.27774,-0.31607,1,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.2321e-08,-0.27775,-0.40286,1,0
4,GO REGULATION OF DEFENSE RESPONSE,4.6784e-11,-0.27785,-0.34643,1,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,8.2903e-10,-0.27786,-0.39774,1,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0018508,-0.27791,-0.30156,1,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,5.2303e-06,-0.27794,-0.28948,1,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,1.4741e-05,-0.278,-0.29591,1,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,9.7991e-09,-0.27804,-0.34909,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.6129e-08,-0.27812,-0.30122,1,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,1.7534e-07,-0.27815,-0.40908,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING,9.2321e-08,-0.27817,-0.29885,1,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,4.6881e-08,-0.2782,-0.41684,1,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,4.7501e-09,-0.27821,-0.33158,1,0
4,GO REGULATION OF PROTEOLYSIS,2.7494e-12,-0.27826,-0.3756,1,0
4,GO GLUCOSE CATABOLIC PROCESS,0.0012886,-0.27829,-0.29659,1,0
4,GO HEART TRABECULA FORMATION,0.00010323,-0.27836,-0.3308,1,0
4,GO HORMONE METABOLIC PROCESS,2.3853e-09,-0.27838,-0.31107,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,1.5014e-05,-0.27844,-0.28913,1,0
4,GO POLYSACCHARIDE METABOLIC PROCESS,1.3761e-09,-0.27854,-0.37566,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,6.552e-13,-0.27858,-0.38763,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0016575,-0.27866,-0.27067,1,0
4,GO EPIDERMIS DEVELOPMENT,1.9546e-09,-0.27868,-0.36261,1,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.3274e-07,-0.27879,-0.32879,1,0
4,GO CELLULAR IRON ION HOMEOSTASIS,4.5922e-10,-0.2788,-0.31175,1,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,6.3074e-11,-0.27884,-0.35811,1,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,1.2172e-12,-0.27885,-0.38134,1,0
4,GO L SERINE METABOLIC PROCESS,0.012945,-0.27888,-0.22129,1,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,1.2131e-09,-0.27888,-0.3182,1,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,8.0898e-09,-0.27891,-0.34524,1,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00017457,-0.27891,-0.31179,1,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.8924e-05,-0.27894,-0.29092,1,0
4,GO MEMBRANE ORGANIZATION,2.1812e-12,-0.27896,-0.38266,1,0
4,GO PREPULSE INHIBITION,0.00033955,-0.279,-0.37573,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.1196e-06,-0.27909,-0.31138,1,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.9014e-08,-0.27912,-0.35846,1,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.8182e-13,-0.2793,-0.37613,1,0
4,GO G2 DNA DAMAGE CHECKPOINT,2.1338e-07,-0.27934,-0.33658,1,0
4,GO SENSORY ORGAN MORPHOGENESIS,1.725e-09,-0.27934,-0.35114,1,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,1.2131e-09,-0.27937,-0.3885,1,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,8.2618e-11,-0.27944,-0.33333,1,0
4,GO NEURAL NUCLEUS DEVELOPMENT,7.8052e-07,-0.27947,-0.33808,1,0
4,GO REGULATION OF GLUCONEOGENESIS,3.0295e-08,-0.27947,-0.35568,1,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,7.3739e-05,-0.27962,-0.26279,1,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,9.4407e-08,-0.2797,-0.34826,1,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,2.8305e-05,-0.27975,-0.30893,1,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.7614e-08,-0.27975,-0.34647,1,0
4,GO HEART FORMATION,1.9175e-06,-0.27981,-0.37263,1,0
4,GO HAIR CELL DIFFERENTIATION,3.5646e-05,-0.27993,-0.33696,1,0
4,GO SPECIFICATION OF SYMMETRY,3.4553e-09,-0.28002,-0.32761,1,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,8.2618e-11,-0.28003,-0.38038,1,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.6487e-06,-0.28006,-0.32103,1,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,3.152e-06,-0.28013,-0.34876,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.6001e-09,-0.28028,-0.30957,1,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,7.6283e-05,-0.28028,-0.2651,1,0
4,GO ALCOHOL METABOLIC PROCESS,1.1398e-10,-0.28033,-0.33905,1,0
4,GO EXTRACELLULAR TRANSPORT,1.3325e-06,-0.28045,-0.32529,1,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,2.3784e-07,-0.28047,-0.37928,1,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,7.5451e-08,-0.28052,-0.30093,1,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,4.5684e-06,-0.28059,-0.33296,1,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,5.6085e-05,-0.28076,-0.34863,1,0
4,GO CARBOHYDRATE TRANSPORT,1.2131e-09,-0.28078,-0.36026,1,0
4,GO DOPAMINE METABOLIC PROCESS,1.8701e-05,-0.28104,-0.31975,1,0
4,GO RESPONSE TO CORTICOSTERONE,9.5999e-07,-0.28105,-0.3483,1,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,2.5164e-08,-0.28106,-0.38982,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,2.2416e-05,-0.28122,-0.32152,1,0
4,GO SECRETORY GRANULE ORGANIZATION,2.6362e-08,-0.28124,-0.38527,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,4.3355e-07,-0.28134,-0.37568,1,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8793e-06,-0.2814,-0.2984,1,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,1.1535e-07,-0.28152,-0.36094,1,0
4,GO REGULATION OF CELL DEATH,8.8075e-13,-0.28154,-0.36526,1,0
4,GO REGULATION OF LYASE ACTIVITY,5.3747e-08,-0.28155,-0.32634,1,0
4,GO NEUROMUSCULAR PROCESS,1.5753e-08,-0.28156,-0.34331,1,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,7.2202e-11,-0.28159,-0.36631,1,0
4,GO REGULATION OF DEPHOSPHORYLATION,1.0519e-10,-0.2817,-0.37238,1,0
4,GO CHRONIC INFLAMMATORY RESPONSE,1.3948e-05,-0.28171,-0.34991,1,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,9.7991e-09,-0.28177,-0.31521,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1.3671e-08,-0.2819,-0.34349,1,0
4,GO REGULATION OF HEAT GENERATION,1.7706e-05,-0.28191,-0.27581,1,0
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.0235e-07,-0.28202,-0.3409,1,0
4,GO LIPID METABOLIC PROCESS,7.6937e-12,-0.28205,-0.34882,1,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.1041e-08,-0.28206,-0.32517,1,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,1.8323e-12,-0.28207,-0.40873,1,0
4,GO GRANULOCYTE MIGRATION,3.5427e-10,-0.28211,-0.36187,1,0
4,GO ACIDIC AMINO ACID TRANSPORT,2.1624e-06,-0.28215,-0.32408,1,0
4,GO ACID SECRETION,2.65e-07,-0.28222,-0.25778,1,0
4,GO TELENCEPHALON DEVELOPMENT,1.7721e-08,-0.28224,-0.35049,1,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00088789,-0.28231,-0.34125,1,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.0509e-11,-0.28235,-0.35585,1,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,2.3784e-07,-0.28241,-0.29713,1,0
4,GO OVULATION CYCLE PROCESS,2.801e-10,-0.28255,-0.39952,1,0
4,GO COGNITION,2.5223e-10,-0.28256,-0.37022,1,0
4,GO NEPHRON TUBULE FORMATION,0.0023637,-0.28257,-0.21652,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,2.0429e-07,-0.28273,-0.30777,1,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0005133,-0.28288,-0.37944,1,0
4,GO DRUG METABOLIC PROCESS,9.8716e-08,-0.28293,-0.29247,1,0
4,GO DNA DEAMINATION,0.009139,-0.28297,-0.28677,1,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.9905e-10,-0.28318,-0.37489,1,0
4,GO REGULATION OF BINDING,9.3425e-13,-0.28318,-0.37537,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.5359e-06,-0.28323,-0.39762,1,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,2.1812e-12,-0.28335,-0.41527,1,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,1.5277e-10,-0.28339,-0.37958,1,0
4,GO GLUCOSE IMPORT,1.5604e-09,-0.28339,-0.36086,1,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,1.9948e-11,-0.2834,-0.34913,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,3.9717e-11,-0.28341,-0.38232,1,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,9.3381e-05,-0.28356,-0.2973,1,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00033955,-0.28357,-0.30163,1,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,1.7309e-08,-0.28362,-0.31577,1,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,1.0036e-08,-0.28367,-0.34282,1,0
4,GO PIGMENTATION,1.2417e-11,-0.28369,-0.36686,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.2118e-07,-0.28371,-0.33778,1,0
4,GO REGULATION OF EXOCYTOSIS,2.0546e-09,-0.28381,-0.37302,1,0
4,GO ALPHA BETA T CELL PROLIFERATION,3.0905e-06,-0.28391,-0.39605,1,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,2.5695e-09,-0.28393,-0.31574,1,0
4,GO REGULATION OF TORC1 SIGNALING,4.4787e-08,-0.28398,-0.40335,1,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,1.4092e-12,-0.28412,-0.41396,1,0
4,GO GLIAL CELL FATE COMMITMENT,0.00076726,-0.28415,-0.32769,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,5.8856e-08,-0.28417,-0.33305,1,0
4,GO APICAL PROTEIN LOCALIZATION,0.00021857,-0.28418,-0.32045,1,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,2.6581e-10,-0.28422,-0.37712,1,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00072342,-0.28423,-0.21551,1,0
4,GO NOTCH SIGNALING PATHWAY,4.8359e-10,-0.28434,-0.41358,1,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,2.9859e-05,-0.28434,-0.27723,1,0
4,GO HISTONE DEACETYLATION,4.2784e-08,-0.28434,-0.34846,1,0
4,GO REGULATION OF PHOSPHORYLATION,6.7492e-13,-0.28435,-0.39436,1,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,2.5893e-10,-0.28436,-0.33796,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.4787e-08,-0.28442,-0.37207,1,0
4,GO EXPLORATION BEHAVIOR,2.6914e-06,-0.28447,-0.36776,1,0
4,GO REGULATION OF CELL PROJECTION SIZE,8.7316e-05,-0.28452,-0.31332,1,0
4,GO NEUROGENESIS,1.1097e-10,-0.28453,-0.3956,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,7.6446e-07,-0.28455,-0.35168,1,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,5.6487e-06,-0.28459,-0.37503,1,0
4,GO NECROTIC CELL DEATH,6.7411e-08,-0.28478,-0.34843,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9546e-09,-0.28483,-0.34624,1,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00029976,-0.28486,-0.27873,1,0
4,GO T CELL MEDIATED IMMUNITY,2.1807e-07,-0.28487,-0.35428,1,0
4,GO POSITIVE REGULATION OF CELL KILLING,4.6578e-06,-0.28489,-0.33939,1,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.8833e-12,-0.28502,-0.36977,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,2.1543e-10,-0.28503,-0.35252,1,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,8.0815e-10,-0.28506,-0.33744,1,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,5.332e-06,-0.28511,-0.40728,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,9.5999e-07,-0.28513,-0.31853,1,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,3.1896e-11,-0.28514,-0.37881,1,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,2.1064e-09,-0.28515,-0.45676,1,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,4.3774e-08,-0.28536,-0.39578,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,5.3747e-08,-0.28545,-0.31735,1,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,3.1312e-09,-0.28552,-0.36078,1,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,7.6792e-10,-0.28553,-0.33048,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.2785e-11,-0.28557,-0.36684,1,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,5.2165e-11,-0.28561,-0.36779,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,1.5968e-11,-0.28564,-0.34513,1,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.3039e-08,-0.28566,-0.36054,1,0
4,GO AGING,5.9602e-12,-0.2857,-0.36043,1,0
4,GO MITOCHONDRIAL FISSION,1.3056e-06,-0.28582,-0.35363,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,9.819e-05,-0.28594,-0.27259,1,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,4.2271e-06,-0.28594,-0.37271,1,0
4,GO REGULATION OF HYDROLASE ACTIVITY,6.9522e-13,-0.28596,-0.39988,1,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.451e-12,-0.28596,-0.37426,1,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.801e-10,-0.28598,-0.33966,1,0
4,GO BEHAVIOR,2.2707e-10,-0.28601,-0.37253,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,7.9617e-06,-0.28601,-0.31229,1,0
4,GO CELLULAR PIGMENTATION,1.9014e-08,-0.28604,-0.32055,1,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,3.1032e-11,-0.28616,-0.34625,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,6.5906e-08,-0.28639,-0.38002,1,0
4,GO TRANSITION METAL ION HOMEOSTASIS,9.9064e-10,-0.28641,-0.33099,1,0
4,GO ERYTHROCYTE DEVELOPMENT,6.8885e-07,-0.28652,-0.39756,1,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,4.249e-10,-0.28655,-0.32972,1,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,1.5383e-12,-0.28659,-0.36132,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,1.2172e-12,-0.28662,-0.40161,1,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.2441e-09,-0.28667,-0.35615,1,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,7.8052e-07,-0.28669,-0.27752,1,0
4,GO RESPONSE TO STARVATION,6.757e-10,-0.28691,-0.36707,1,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.6356e-09,-0.28698,-0.42291,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.0322e-07,-0.28708,-0.32042,1,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8369e-09,-0.28714,-0.3742,1,0
4,GO SULFUR COMPOUND TRANSPORT,1.6514e-08,-0.28722,-0.37859,1,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.9624e-10,-0.28724,-0.35865,1,0
4,GO MAINTENANCE OF LOCATION,2.6711e-12,-0.28732,-0.37688,1,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,9.1996e-11,-0.28733,-0.33476,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.6386e-06,-0.28739,-0.4052,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,5.0237e-12,-0.2874,-0.34739,1,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,9.1205e-09,-0.28742,-0.27438,1,0
4,GO MICROVILLUS ORGANIZATION,4.2271e-06,-0.28748,-0.41914,1,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,8.0256e-05,-0.28751,-0.28314,1,0
4,GO TONGUE DEVELOPMENT,0.00046872,-0.28752,-0.26306,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,2.1375e-08,-0.2876,-0.3773,1,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.0279e-08,-0.28761,-0.42702,1,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0015038,-0.28763,-0.32507,1,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.0905e-06,-0.28763,-0.34932,1,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,9.6538e-08,-0.28766,-0.31721,1,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.7687e-09,-0.28766,-0.37941,1,0
4,GO ACTIVATED T CELL PROLIFERATION,8.6937e-09,-0.2878,-0.37374,1,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,2.4091e-05,-0.28788,-0.30088,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE,5.9937e-13,-0.2881,-0.41778,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3769e-07,-0.28812,-0.40684,1,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00020504,-0.28813,-0.32255,1,0
4,GO INTERACTION WITH HOST,3.5597e-11,-0.28817,-0.39617,1,0
4,GO APOPTOTIC SIGNALING PATHWAY,4.3549e-12,-0.28825,-0.35721,1,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,7.8976e-09,-0.28835,-0.37669,1,0
4,GO PHAGOSOME MATURATION,5.4982e-08,-0.28857,-0.352,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.2416e-05,-0.2886,-0.35184,1,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,7.3476e-09,-0.28865,-0.31343,1,0
4,GO NEGATIVE REGULATION OF CELL AGING,1.0036e-08,-0.28867,-0.40039,1,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.9941e-08,-0.28867,-0.36878,1,0
4,GO VESICLE TARGETING,5.7923e-10,-0.28881,-0.36622,1,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.2585e-06,-0.28884,-0.32694,1,0
4,GO GOLGI TO VACUOLE TRANSPORT,3.7605e-06,-0.28884,-0.35653,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,2.8369e-09,-0.28911,-0.3405,1,0
4,GO RESPONSE TO INSECTICIDE,0.00031907,-0.28925,-0.30368,1,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,1.2733e-08,-0.28927,-0.31119,1,0
4,GO DEFENSE RESPONSE TO BACTERIUM,2.5066e-09,-0.28932,-0.31496,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00059648,-0.28933,-0.32355,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,8.0712e-08,-0.28943,-0.31584,1,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,9.3415e-09,-0.28944,-0.33469,1,0
4,GO NOSE DEVELOPMENT,0.044292,-0.28949,-0.23986,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00020178,-0.28949,-0.31077,1,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,1.5383e-12,-0.28953,-0.38362,1,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,1.6158e-05,-0.2896,-0.33746,1,0
4,GO TERPENOID METABOLIC PROCESS,2.2697e-09,-0.28966,-0.33296,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,2.5756e-08,-0.28974,-0.3084,1,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,6.8888e-05,-0.28974,-0.34504,1,0
4,GO EPITHELIAL CELL MATURATION,1.0004e-06,-0.28975,-0.3319,1,0
4,GO MUSCLE CONTRACTION,3.8833e-12,-0.28976,-0.3965,1,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,8.2864e-09,-0.28979,-0.39926,1,0
4,GO METAL ION HOMEOSTASIS,1.8863e-12,-0.28979,-0.35179,1,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,4.3082e-09,-0.28981,-0.34727,1,0
4,GO SEX DIFFERENTIATION,7.479e-12,-0.28997,-0.35008,1,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,4.2444e-07,-0.29004,-0.39653,1,0
4,GO SYNAPTIC SIGNALING,2.6362e-08,-0.29005,-0.35554,1,0
4,GO REGULATION OF CELL KILLING,2.65e-07,-0.29008,-0.34727,1,0
4,GO DEVELOPMENTAL INDUCTION,1.3769e-07,-0.29008,-0.35301,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00075607,-0.29011,-0.34455,1,0
4,GO SYNAPTIC VESICLE MATURATION,0.0005056,-0.29014,-0.37868,1,0
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,1.2907e-12,-0.29022,-0.40475,1,0
4,GO CELL VOLUME HOMEOSTASIS,2.2707e-10,-0.29025,-0.39873,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.5906e-08,-0.29043,-0.35411,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,2.7668e-07,-0.29045,-0.32847,1,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.5217e-06,-0.29054,-0.33302,1,0
4,GO REGULATION OF SYSTEM PROCESS,9.3752e-12,-0.29067,-0.38741,1,0
4,GO NEGATIVE REGULATION OF SIGNALING,6.3604e-13,-0.29071,-0.4047,1,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.9069e-08,-0.29075,-0.3379,1,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,1.069e-09,-0.29076,-0.32623,1,0
4,GO REGULATION OF SYMBIOTIC PROCESS,3.2894e-09,-0.29079,-0.3614,1,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,5.4821e-13,-0.29091,-0.39425,1,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,4.7963e-08,-0.29104,-0.35131,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,2.004e-09,-0.2911,-0.37638,1,0
4,GO REGULATION OF NECROTIC CELL DEATH,8.4805e-07,-0.29111,-0.3476,1,0
4,GO REGULATION OF GLIOGENESIS,4.4749e-10,-0.29113,-0.33804,1,0
4,GO VESICLE DOCKING,5.2303e-06,-0.29114,-0.34542,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.00016098,-0.29118,-0.31136,1,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,3.7735e-12,-0.29121,-0.39186,1,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,5.6487e-06,-0.29125,-0.34585,1,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,3.5629e-12,-0.29127,-0.38758,1,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,5.6451e-10,-0.29128,-0.39394,1,0
4,GO STEM CELL DIFFERENTIATION,1.1097e-10,-0.29133,-0.34441,1,0
4,GO EXOCYTOSIS,3.1757e-12,-0.29136,-0.39353,1,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.5037e-07,-0.29141,-0.3271,1,0
4,GO SPHINGOLIPID METABOLIC PROCESS,2.3853e-09,-0.29146,-0.38384,1,0
4,GO CATION TRANSMEMBRANE TRANSPORT,4.3109e-11,-0.29157,-0.3476,1,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.7125e-10,-0.2916,-0.35492,1,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.3661e-05,-0.29165,-0.34714,1,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,4.5922e-10,-0.29165,-0.34588,1,0
4,GO CELL PROJECTION ORGANIZATION,1.785e-11,-0.29169,-0.40003,1,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,1.6907e-08,-0.29181,-0.34599,1,0
4,GO REGULATION OF RUFFLE ASSEMBLY,3.1729e-08,-0.29187,-0.39986,1,0
4,GO RESPONSE TO DOPAMINE,2.0429e-07,-0.29203,-0.3234,1,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,6.545e-05,-0.29207,-0.38744,1,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00010152,-0.29214,-0.32183,1,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,6.1744e-13,-0.29219,-0.39379,1,0
4,GO LINOLEIC ACID METABOLIC PROCESS,9.4341e-06,-0.2922,-0.39815,1,0
4,GO CERAMIDE METABOLIC PROCESS,8.9487e-10,-0.29226,-0.38675,1,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,6.7492e-13,-0.29229,-0.45355,1,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,9.2321e-08,-0.29229,-0.38131,1,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.0582e-12,-0.29231,-0.37824,1,0
4,GO TRANSPOSITION,6.3249e-05,-0.29232,-0.32499,1,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,3.1032e-11,-0.29247,-0.35668,1,0
4,GO RESPONSE TO HORMONE,1.4092e-12,-0.29248,-0.39778,1,0
4,GO REGULATION OF CELL DIFFERENTIATION,6.9522e-13,-0.29259,-0.40939,1,0
4,GO MYOBLAST PROLIFERATION,2.8886e-07,-0.29263,-0.35024,1,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.6654e-06,-0.29263,-0.3397,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.7166e-08,-0.29267,-0.42564,1,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.2094e-09,-0.29272,-0.36278,1,0
4,GO REGULATION OF DOPAMINE SECRETION,0.0013255,-0.29287,-0.31745,1,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.155e-06,-0.29287,-0.29865,1,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,2.2912e-11,-0.29312,-0.41058,1,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.0004e-06,-0.29316,-0.39719,1,0
4,GO LIPID DROPLET ORGANIZATION,1.1794e-07,-0.29319,-0.33113,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.8301e-10,-0.29334,-0.37076,1,0
4,GO RESPONSE TO ISCHEMIA,1.3024e-10,-0.29339,-0.44292,1,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,1.3761e-09,-0.29348,-0.33047,1,0
4,GO RESPONSE TO FUNGUS,3.1479e-07,-0.2935,-0.271,1,0
4,GO PROTEIN PROCESSING,2.0509e-11,-0.29351,-0.37879,1,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,2.1375e-08,-0.29356,-0.44357,1,0
4,GO CELLULAR RESPONSE TO DRUG,3.8118e-09,-0.29357,-0.35571,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,1.2434e-08,-0.29361,-0.32512,1,0
4,GO NEURON RECOGNITION,1.0554e-07,-0.29363,-0.42368,1,0
4,GO ACTIVATION OF IMMUNE RESPONSE,1.9948e-11,-0.29366,-0.36678,1,0
4,GO RESPONSE TO ANTIBIOTIC,2.801e-10,-0.29386,-0.335,1,0
4,GO METENCEPHALON DEVELOPMENT,4.0678e-07,-0.29389,-0.32559,1,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,2.3793e-12,-0.29397,-0.41652,1,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,4.7963e-08,-0.29415,-0.36897,1,0
4,GO MUSCLE ORGAN DEVELOPMENT,4.4812e-12,-0.29418,-0.38821,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.9989e-07,-0.29436,-0.36831,1,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00035024,-0.29456,-0.27785,1,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,2.1196e-06,-0.29463,-0.33475,1,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.2286e-07,-0.29464,-0.34028,1,0
4,GO NEUTROPHIL MIGRATION,1.9064e-09,-0.29469,-0.34241,1,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.5684e-06,-0.29471,-0.38857,1,0
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.5277e-10,-0.29472,-0.34839,1,0
4,GO PROTEIN HYDROXYLATION,0.00011596,-0.29476,-0.36374,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.069e-09,-0.29479,-0.34004,1,0
4,GO SMOOTHENED SIGNALING PATHWAY,1.069e-09,-0.2948,-0.36419,1,0
4,GO INORGANIC ANION TRANSPORT,8.4871e-11,-0.2949,-0.33293,1,0
4,GO NEURON DIFFERENTIATION,2.801e-10,-0.29494,-0.39492,1,0
4,GO LOCOMOTORY BEHAVIOR,6.5125e-09,-0.29498,-0.38225,1,0
4,GO ISOPRENOID METABOLIC PROCESS,1.1307e-08,-0.29499,-0.29945,1,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,1.9175e-06,-0.29514,-0.40459,1,0
4,GO RETROGRADE AXONAL TRANSPORT,1.5293e-05,-0.29518,-0.40321,1,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.8723e-07,-0.29522,-0.37342,1,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,6.6774e-12,-0.29528,-0.3635,1,0
4,GO LEARNING,1.3671e-08,-0.29537,-0.37212,1,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.8753e-10,-0.29539,-0.35983,1,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,1.8318e-07,-0.29542,-0.34734,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.7125e-10,-0.29543,-0.35654,1,0
4,GO NEUTROPHIL CHEMOTAXIS,5.2359e-09,-0.29545,-0.33144,1,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.3312e-10,-0.2955,-0.38075,1,0
4,GO REGULATION OF RESPONSE TO STRESS,2.8299e-12,-0.29555,-0.35882,1,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.5027e-08,-0.2956,-0.33436,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00096848,-0.29564,-0.28078,1,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,3.3806e-05,-0.29581,-0.30287,1,0
4,GO RESPONSE TO UV B,4.2444e-07,-0.29588,-0.41798,1,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,9.2321e-08,-0.29606,-0.30815,1,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,4.249e-10,-0.29608,-0.35774,1,0
4,GO LIPID CATABOLIC PROCESS,2.1678e-11,-0.29609,-0.34923,1,0
4,GO I KAPPAB PHOSPHORYLATION,2.3268e-09,-0.29613,-0.3954,1,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.8149e-08,-0.29618,-0.38077,1,0
4,GO GLAND DEVELOPMENT,4.232e-12,-0.29633,-0.41645,1,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.2733e-08,-0.29637,-0.34903,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,1.0824e-12,-0.29639,-0.42375,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,2.7494e-12,-0.29644,-0.39277,1,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.6654e-06,-0.2965,-0.31426,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,8.0424e-11,-0.29651,-0.34182,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,4.6784e-11,-0.29653,-0.33904,1,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,6.0079e-05,-0.29664,-0.44231,1,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.6981e-08,-0.29665,-0.32801,1,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,8.4805e-07,-0.29673,-0.41492,1,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,2.8925e-08,-0.29682,-0.37672,1,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,3.1896e-11,-0.29682,-0.36058,1,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,6.3359e-07,-0.29684,-0.35261,1,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,2.0776e-06,-0.29689,-0.37453,1,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,2.4214e-11,-0.29692,-0.35949,1,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,1.2023e-10,-0.29692,-0.35127,1,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0025617,-0.29695,-0.25152,1,0
4,GO REGIONALIZATION,1.4471e-09,-0.29703,-0.34858,1,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.7051e-07,-0.2971,-0.40632,1,0
4,GO MEMBRANE DISASSEMBLY,1.3693e-05,-0.29712,-0.34512,1,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,3.5597e-11,-0.29737,-0.3643,1,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.0337e-07,-0.2974,-0.32348,1,0
4,GO RETINOIC ACID METABOLIC PROCESS,4.3946e-06,-0.29746,-0.28607,1,0
4,GO RECEPTOR METABOLIC PROCESS,1.1478e-12,-0.29753,-0.41401,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.4749e-10,-0.29759,-0.41284,1,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.5713e-07,-0.2976,-0.37012,1,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,2.9371e-11,-0.29768,-0.35372,1,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,3.6667e-12,-0.29772,-0.39097,1,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,7.598e-13,-0.29796,-0.40473,1,0
4,GO PLASMA MEMBRANE TUBULATION,7.8976e-09,-0.29803,-0.4725,1,0
4,GO AMINE CATABOLIC PROCESS,8.4415e-08,-0.29805,-0.34868,1,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,7.6446e-07,-0.29811,-0.39753,1,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,9.5999e-07,-0.29812,-0.30859,1,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,5.7923e-10,-0.29819,-0.36601,1,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,1.3999e-08,-0.29822,-0.26827,1,0
4,GO DEVELOPMENTAL CELL GROWTH,1.8881e-10,-0.29822,-0.43543,1,0
4,GO CORNIFICATION,0.001704,-0.29823,-0.25659,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,5.5078e-11,-0.29828,-0.34919,1,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.1807e-07,-0.29835,-0.41364,1,0
4,GO RESPONSE TO BIOTIC STIMULUS,1.9402e-11,-0.2984,-0.36291,1,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,3.9613e-05,-0.29844,-0.28458,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,2.8925e-08,-0.29847,-0.34458,1,0
4,GO MEMBRANE REPOLARIZATION,3.2784e-06,-0.2986,-0.36161,1,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.0437e-10,-0.29862,-0.4277,1,0
4,GO PROTEIN ADP RIBOSYLATION,5.3747e-08,-0.29863,-0.37492,1,0
4,GO REGULATION OF HEMOPOIESIS,3.2685e-12,-0.29867,-0.37862,1,0
4,GO NEGATIVE REGULATION OF BINDING,6.6774e-12,-0.29868,-0.37451,1,0
4,GO REGULATION OF STEM CELL PROLIFERATION,5.9432e-10,-0.29898,-0.39077,1,0
4,GO CELL GROWTH,1.2907e-12,-0.29902,-0.42378,1,0
4,GO TYPE I INTERFERON PRODUCTION,2.5066e-09,-0.29903,-0.38948,1,0
4,GO REGULATION OF METAL ION TRANSPORT,1.3685e-12,-0.29918,-0.38122,1,0
4,GO THALAMUS DEVELOPMENT,9.4959e-05,-0.29924,-0.31609,1,0
4,GO REGULATION OF IMMUNE RESPONSE,1.5102e-11,-0.29926,-0.37319,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,3.152e-06,-0.29935,-0.34833,1,0
4,GO NEURON CELLULAR HOMEOSTASIS,9.9803e-06,-0.29936,-0.34984,1,0
4,GO NAD METABOLIC PROCESS,5.0563e-05,-0.29939,-0.32575,1,0
4,GO FOREGUT MORPHOGENESIS,1.471e-07,-0.2995,-0.35312,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,4.2042e-09,-0.29951,-0.36939,1,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,3.5597e-11,-0.29954,-0.40608,1,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,1.9989e-07,-0.29972,-0.36495,1,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,9.7068e-11,-0.29982,-0.36075,1,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,8.5043e-10,-0.29982,-0.41751,1,0
4,GO RUFFLE ORGANIZATION,2.2139e-09,-0.29983,-0.38392,1,0
4,GO T CELL CHEMOTAXIS,7.0017e-09,-0.29991,-0.32569,1,0
4,GO FIBROBLAST ACTIVATION,9.7998e-07,-0.29991,-0.35858,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,2.9514e-07,-0.30002,-0.32708,1,0
4,GO MALE SEX DIFFERENTIATION,5.9602e-12,-0.30004,-0.3906,1,0
4,GO ACUTE PHASE RESPONSE,2.4586e-08,-0.30004,-0.31032,1,0
4,GO NAD BIOSYNTHETIC PROCESS,1.3056e-06,-0.30006,-0.34052,1,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,5.9834e-06,-0.3001,-0.40751,1,0
4,GO REGULATION OF CELL DEVELOPMENT,2.3554e-11,-0.30017,-0.40768,1,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,3.1098e-10,-0.3002,-0.34112,1,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.0002117,-0.30034,-0.42066,1,0
4,GO BROWN FAT CELL DIFFERENTIATION,2.8271e-07,-0.30035,-0.32138,1,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.1912e-13,-0.3004,-0.389,1,0
4,GO GRANULOCYTE CHEMOTAXIS,5.0922e-10,-0.30053,-0.35665,1,0
4,GO HEART DEVELOPMENT,1.0792e-11,-0.30054,-0.42183,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0001179,-0.30055,-0.28536,1,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,1.2032e-06,-0.30063,-0.32647,1,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,3.4634e-11,-0.30064,-0.43162,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.4494e-13,-0.30074,-0.40276,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,4.7488e-06,-0.30083,-0.32305,1,0
4,GO MATING,3.5412e-09,-0.30096,-0.32666,1,0
4,GO B CELL PROLIFERATION,8.2864e-09,-0.3011,-0.36375,1,0
4,GO INTERLEUKIN 12 PRODUCTION,8.4415e-08,-0.30113,-0.34404,1,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,7.6205e-11,-0.30123,-0.37681,1,0
4,GO PEPTIDE CROSS LINKING,1.2733e-08,-0.30126,-0.46237,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,5.3647e-09,-0.30135,-0.37154,1,0
4,GO SECONDARY METABOLIC PROCESS,5.6245e-08,-0.30141,-0.32603,1,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,1.7442e-10,-0.30157,-0.37429,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,9.2321e-08,-0.30157,-0.3428,1,0
4,GO CELLULAR RESPONSE TO STARVATION,3.9309e-10,-0.3016,-0.38379,1,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.2202e-11,-0.3016,-0.37956,1,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,2.0881e-08,-0.30162,-0.34706,1,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,1.2172e-12,-0.30164,-0.39249,1,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,1.5576e-05,-0.30189,-0.31437,1,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,2.6362e-08,-0.30217,-0.32438,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,7.598e-13,-0.30217,-0.41711,1,0
4,GO CELL CELL SIGNALING BY WNT,1.4092e-12,-0.30221,-0.40056,1,0
4,GO LYMPHOCYTE CHEMOTAXIS,6.8406e-11,-0.30232,-0.33632,1,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,2.4091e-05,-0.30241,-0.31673,1,0
4,GO MICROTUBULE ANCHORING,7.2129e-08,-0.30256,-0.38245,1,0
4,GO PEPTIDYL THREONINE MODIFICATION,2.1595e-09,-0.30264,-0.38376,1,0
4,GO RESPONSE TO REDOX STATE,0.0015038,-0.30272,-0.28077,1,0
4,GO TONGUE MORPHOGENESIS,0.03006,-0.30273,-0.17845,1,0
4,GO MESODERMAL CELL DIFFERENTIATION,7.8778e-10,-0.3028,-0.39704,1,0
4,GO DEVELOPMENTAL MATURATION,7.6205e-11,-0.30286,-0.37902,1,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,4.1403e-10,-0.30291,-0.3539,1,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.4076e-07,-0.30294,-0.37693,1,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.9487e-10,-0.30296,-0.34892,1,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.1389e-11,-0.30298,-0.40528,1,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.5223e-10,-0.30298,-0.32966,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,1.9387e-10,-0.30302,-0.41871,1,0
4,GO CELL KILLING,6.5906e-08,-0.30308,-0.31797,1,0
4,GO SPINAL CORD DEVELOPMENT,2.3784e-07,-0.30322,-0.34123,1,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.0804e-10,-0.30332,-0.3642,1,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00028155,-0.30344,-0.29445,1,0
4,GO RESPONSE TO L GLUTAMATE,0.00029052,-0.30352,-0.30137,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,1.4207e-05,-0.30358,-0.35584,1,0
4,GO REGULATION OF ICOSANOID SECRETION,7.6657e-06,-0.30359,-0.30987,1,0
4,GO MAINTENANCE OF LOCATION IN CELL,6.1321e-12,-0.30364,-0.36554,1,0
4,GO AXIS SPECIFICATION,6.2993e-08,-0.30377,-0.31455,1,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,6.8348e-09,-0.30383,-0.37108,1,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,8.7237e-10,-0.30392,-0.39331,1,0
4,GO NEGATIVE REGULATION OF CELL DEATH,2.1812e-12,-0.30396,-0.35256,1,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,5.8698e-06,-0.30401,-0.34711,1,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00057029,-0.30402,-0.27314,1,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.0156e-07,-0.30413,-0.36643,1,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.5217e-06,-0.30415,-0.40224,1,0
4,GO CELL PROLIFERATION IN HINDBRAIN,1.9175e-06,-0.30418,-0.33342,1,0
4,GO REGULATION OF MUSCLE ADAPTATION,4.3082e-09,-0.30427,-0.41899,1,0
4,GO RESPONSE TO VIRUS,9.4157e-10,-0.30429,-0.37454,1,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,5.0237e-12,-0.3043,-0.35342,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,2.1338e-07,-0.30443,-0.34752,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,5.6085e-05,-0.30446,-0.38071,1,0
4,GO FUCOSE METABOLIC PROCESS,7.892e-08,-0.30456,-0.34638,1,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.4967e-09,-0.30461,-0.3221,1,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,3.4516e-10,-0.30465,-0.40664,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,1.9948e-11,-0.30467,-0.3956,1,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,7.6937e-12,-0.30472,-0.413,1,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,6.3088e-12,-0.30479,-0.3548,1,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00076726,-0.30482,-0.32197,1,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,1.8573e-08,-0.30488,-0.34542,1,0
4,GO VASODILATION,6.8885e-07,-0.30509,-0.35071,1,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.7232e-13,-0.30511,-0.40247,1,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.1588e-05,-0.30511,-0.39083,1,0
4,GO RESPONSE TO INTERLEUKIN 12,4.3355e-07,-0.30513,-0.30257,1,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,9.7068e-11,-0.30514,-0.35005,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,4.4285e-07,-0.30515,-0.34853,1,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,1.1535e-07,-0.30523,-0.35433,1,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,7.5266e-09,-0.30523,-0.33033,1,0
4,GO LEUKOTRIENE METABOLIC PROCESS,1.1307e-08,-0.30523,-0.39269,1,0
4,GO CELLULAR RESPONSE TO DSRNA,1.0036e-08,-0.30525,-0.39411,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.188e-08,-0.30527,-0.32966,1,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.7998e-07,-0.30534,-0.29567,1,0
4,GO TUBE FORMATION,2.9515e-10,-0.30539,-0.3884,1,0
4,GO REGULATION OF GROWTH,1.3291e-12,-0.30544,-0.39706,1,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,6.4192e-10,-0.30548,-0.34349,1,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.9905e-10,-0.30551,-0.39916,1,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,1.679e-12,-0.30555,-0.39932,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.2165e-11,-0.30562,-0.38976,1,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,4.8662e-13,-0.30569,-0.40794,1,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.5277e-10,-0.30572,-0.37842,1,0
4,GO THYROID GLAND DEVELOPMENT,2.8305e-05,-0.30574,-0.33279,1,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,9.658e-10,-0.30574,-0.43903,1,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,1.5713e-07,-0.30575,-0.33881,1,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.793e-12,-0.30583,-0.38008,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,9.2118e-07,-0.30584,-0.35245,1,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,7.6937e-12,-0.30589,-0.41313,1,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,8.9558e-11,-0.30592,-0.39484,1,0
4,GO NEURONAL ACTION POTENTIAL,1.5293e-05,-0.30595,-0.35573,1,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,4.5526e-11,-0.30599,-0.44738,1,0
4,GO RESPONSE TO AMPHETAMINE,1.3599e-06,-0.30605,-0.31814,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.3647e-09,-0.30605,-0.39118,1,0
4,GO OSTEOBLAST DEVELOPMENT,9.4407e-08,-0.30605,-0.34785,1,0
4,GO RESPONSE TO METAL ION,3.5597e-11,-0.30612,-0.35902,1,0
4,GO TOXIN TRANSPORT,2.2697e-09,-0.30624,-0.38809,1,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,6.6774e-12,-0.30624,-0.32203,1,0
4,GO MESODERM DEVELOPMENT,1.642e-11,-0.3063,-0.36843,1,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,4.8198e-07,-0.30634,-0.34755,1,0
4,GO MUSCLE CELL DEVELOPMENT,3.3629e-10,-0.30635,-0.37632,1,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.9309e-10,-0.30641,-0.37362,1,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.3376e-10,-0.30653,-0.40103,1,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,2.2139e-09,-0.3066,-0.38008,1,0
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.2434e-08,-0.30661,-0.39348,1,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,8.7237e-10,-0.30661,-0.39122,1,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,1.0519e-10,-0.30687,-0.35329,1,0
4,GO LYSOSOMAL TRANSPORT,1.3376e-10,-0.30697,-0.42621,1,0
4,GO INTERLEUKIN 4 PRODUCTION,1.1034e-07,-0.30701,-0.3215,1,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.0817e-11,-0.30716,-0.38217,1,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.4749e-10,-0.30726,-0.35734,1,0
4,GO IMMUNE SYSTEM DEVELOPMENT,2.0582e-12,-0.30732,-0.37837,1,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.5576e-05,-0.30746,-0.29712,1,0
4,GO RESPONSE TO OXYGEN LEVELS,3.8645e-11,-0.30754,-0.35823,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00049053,-0.30759,-0.30403,1,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,8.5514e-13,-0.3076,-0.40546,1,0
4,GO RESPONSE TO AMINO ACID STARVATION,2.3274e-07,-0.30762,-0.35135,1,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.3435e-06,-0.30767,-0.35837,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.1912e-13,-0.30785,-0.40809,1,0
4,GO MAGNESIUM ION TRANSPORT,9.2585e-06,-0.30796,-0.33802,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1.536e-06,-0.30805,-0.36083,1,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,9.4499e-11,-0.3082,-0.34818,1,0
4,GO MYOTUBE DIFFERENTIATION,9.9185e-12,-0.30821,-0.4173,1,0
4,GO NADH METABOLIC PROCESS,0.00026024,-0.30826,-0.29253,1,0
4,GO ORGANELLE MEMBRANE FUSION,2.3268e-09,-0.30829,-0.40339,1,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,9.9705e-11,-0.30838,-0.34328,1,0
4,GO T HELPER CELL LINEAGE COMMITMENT,4.9361e-06,-0.30839,-0.30472,1,0
4,GO REGULATION OF BONE DEVELOPMENT,3.3713e-09,-0.30843,-0.39296,1,0
4,GO MUSCLE SYSTEM PROCESS,4.6112e-12,-0.30849,-0.404,1,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,5.3213e-13,-0.3086,-0.44532,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.8753e-10,-0.30865,-0.4161,1,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,3.6435e-08,-0.30868,-0.38489,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.9361e-06,-0.30869,-0.39707,1,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,9.1829e-05,-0.30872,-0.25642,1,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.6317e-09,-0.30873,-0.38511,1,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,6.6581e-11,-0.30881,-0.40959,1,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.6654e-06,-0.30883,-0.3467,1,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.1819e-07,-0.30891,-0.39782,1,0
4,GO REGULATION OF CALCIUM ION IMPORT,1.7687e-09,-0.30897,-0.3949,1,0
4,GO RECEPTOR RECYCLING,1.4487e-10,-0.30897,-0.38344,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0024941,-0.30919,-0.30028,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,1.3325e-06,-0.30924,-0.37245,1,0
4,GO IRON ION HOMEOSTASIS,2.4214e-11,-0.3093,-0.36287,1,0
4,GO MEMBRANE FUSION,1.6986e-10,-0.30951,-0.39364,1,0
4,GO NEURAL TUBE DEVELOPMENT,2.3933e-10,-0.30961,-0.40979,1,0
4,GO ETHANOL METABOLIC PROCESS,1.8419e-06,-0.30962,-0.35564,1,0
4,GO CARDIAC CELL DEVELOPMENT,5.4982e-08,-0.30963,-0.36851,1,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.5277e-10,-0.30964,-0.37382,1,0
4,GO RESPONSE TO NICOTINE,3.0302e-06,-0.30964,-0.2939,1,0
4,GO NEGATIVE REGULATION OF SECRETION,2.521e-12,-0.30974,-0.34217,1,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,2.7e-09,-0.30976,-0.38421,1,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.7602e-11,-0.30982,-0.38613,1,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00010323,-0.30984,-0.31857,1,0
4,GO RESPONSE TO ALCOHOL,2.1188e-12,-0.30989,-0.37379,1,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,7.2414e-06,-0.30995,-0.32602,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.1446e-05,-0.30995,-0.29458,1,0
4,GO MYELOID LEUKOCYTE MIGRATION,3.8645e-11,-0.30996,-0.38067,1,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.6792e-10,-0.30998,-0.36764,1,0
4,GO SOMITOGENESIS,1.5027e-08,-0.31003,-0.34793,1,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,1.2434e-08,-0.31007,-0.39907,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.634e-09,-0.31015,-0.37681,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.0527e-08,-0.31016,-0.39468,1,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.5277e-10,-0.31026,-0.33795,1,0
4,GO ETHER BIOSYNTHETIC PROCESS,9.9803e-06,-0.31029,-0.35829,1,0
4,GO SODIUM ION TRANSPORT,3.1098e-10,-0.31032,-0.34677,1,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,2.8573e-11,-0.31037,-0.40137,1,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.2859e-07,-0.31038,-0.357,1,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.1282e-07,-0.31046,-0.32481,1,0
4,GO INNATE IMMUNE RESPONSE,2.5223e-10,-0.31046,-0.37631,1,0
4,GO RESPONSE TO X RAY,1.1535e-07,-0.31061,-0.34755,1,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,6.4592e-06,-0.31066,-0.33241,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,5.4701e-07,-0.31068,-0.29512,1,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,6.6717e-09,-0.31076,-0.40441,1,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,1.6986e-10,-0.31079,-0.445,1,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.3039e-08,-0.31083,-0.37897,1,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,4.3997e-05,-0.31084,-0.29352,1,0
4,GO ACTIN FILAMENT BASED PROCESS,7.1613e-13,-0.31092,-0.46137,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,3.055e-09,-0.31094,-0.36947,1,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.00038422,-0.31096,-0.28435,1,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,8.2618e-11,-0.31097,-0.32814,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.2907e-12,-0.31103,-0.41858,1,0
4,GO SYNAPTIC VESICLE PRIMING,0.00159,-0.31105,-0.33785,1,0
4,GO RESPONSE TO OSMOTIC STRESS,2.801e-10,-0.31121,-0.3698,1,0
4,GO CGMP METABOLIC PROCESS,5.9056e-05,-0.31123,-0.35979,1,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.0493e-11,-0.31153,-0.42115,1,0
4,GO POLYOL METABOLIC PROCESS,8.0424e-11,-0.31162,-0.35848,1,0
4,GO ORGAN GROWTH,1.3505e-11,-0.31167,-0.41967,1,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.6158e-05,-0.31168,-0.36686,1,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,1.9402e-11,-0.3117,-0.40543,1,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.6981e-08,-0.31175,-0.37035,1,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.0202e-11,-0.31176,-0.39055,1,0
4,GO DETECTION OF CALCIUM ION,0.0055559,-0.31177,-0.25377,1,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.3376e-10,-0.31188,-0.38296,1,0
4,GO RESPONSE TO COPPER ION,0.00010152,-0.31191,-0.33137,1,0
4,GO PROSTAGLANDIN TRANSPORT,5.4701e-07,-0.31201,-0.33554,1,0
4,GO REGULATION OF ENDOCRINE PROCESS,3.7319e-10,-0.3121,-0.39391,1,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.7998e-07,-0.3121,-0.45421,1,0
4,GO CLATHRIN COAT ASSEMBLY,5.332e-06,-0.3122,-0.37626,1,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.1535e-07,-0.31225,-0.39222,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0019023,-0.31234,-0.27891,1,0
4,GO DEFENSE RESPONSE,1.887e-11,-0.31258,-0.37125,1,0
4,GO EPITHELIAL TUBE FORMATION,1.2441e-09,-0.31263,-0.37946,1,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,2.1338e-07,-0.31264,-0.39617,1,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.8833e-12,-0.31269,-0.3749,1,0
4,GO TUMOR NECROSIS FACTOR SECRETION,8.9487e-10,-0.31279,-0.34423,1,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,7.1726e-09,-0.31283,-0.45406,1,0
4,GO LIPID MODIFICATION,4.4812e-12,-0.31284,-0.38414,1,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.3765e-13,-0.31287,-0.43069,1,0
4,GO GROWTH,1.2907e-12,-0.31298,-0.40046,1,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.0361e-05,-0.31301,-0.35998,1,0
4,GO MOVEMENT IN HOST ENVIRONMENT,8.2618e-11,-0.31302,-0.42387,1,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.3948e-05,-0.31312,-0.28435,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,1.9563e-06,-0.31314,-0.3945,1,0
4,GO REGULATION OF ISOTYPE SWITCHING,3.9309e-10,-0.31326,-0.42139,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,7.8052e-07,-0.31328,-0.34329,1,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,5.4356e-06,-0.31334,-0.3641,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,8.5043e-10,-0.31338,-0.38787,1,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.3784e-07,-0.31343,-0.33361,1,0
4,GO NEURON DEVELOPMENT,1.7909e-10,-0.31346,-0.41132,1,0
4,GO NEPHRON MORPHOGENESIS,2.634e-09,-0.31359,-0.37534,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,9.4499e-11,-0.31365,-0.40299,1,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,1.2074e-11,-0.31368,-0.37105,1,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.4893e-11,-0.31369,-0.36856,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,4.7449e-12,-0.31374,-0.42537,1,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,2.3554e-11,-0.31377,-0.38955,1,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5968e-11,-0.31381,-0.36147,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,1.0241e-10,-0.31388,-0.36022,1,0
4,GO RESPONSE TO CYTOKINE,1.0493e-11,-0.31388,-0.39405,1,0
4,GO URETER DEVELOPMENT,3.5606e-08,-0.3139,-0.37335,1,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.7923e-10,-0.31397,-0.39993,1,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011668,-0.3141,-0.2928,1,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,3.5646e-05,-0.31415,-0.33604,1,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,9.404e-07,-0.31421,-0.34992,1,0
4,GO BICARBONATE TRANSPORT,1.0781e-08,-0.31423,-0.33175,1,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,1.5604e-09,-0.31427,-0.36931,1,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,6.3604e-13,-0.31429,-0.42478,1,0
4,GO POTASSIUM ION TRANSPORT,9.5677e-09,-0.3143,-0.33625,1,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.7687e-09,-0.31437,-0.36059,1,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.7676e-09,-0.31438,-0.40023,1,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.1356e-08,-0.3144,-0.35895,1,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,2.5756e-08,-0.31441,-0.36096,1,0
4,GO MEMBRANE FISSION,2.1338e-07,-0.31442,-0.40779,1,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.2397e-08,-0.31448,-0.40379,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,2.3554e-11,-0.31449,-0.41609,1,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.3113e-12,-0.31449,-0.39058,1,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.2202e-11,-0.3145,-0.38799,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,7.6792e-10,-0.31452,-0.42702,1,0
4,GO ADAPTIVE THERMOGENESIS,1.174e-11,-0.31454,-0.37955,1,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,2.6306e-11,-0.31454,-0.35599,1,0
4,GO STEROID ESTERIFICATION,2.2775e-07,-0.31468,-0.413,1,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,1.8881e-10,-0.31471,-0.37927,1,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,1.9563e-06,-0.31478,-0.39002,1,0
4,GO TEMPERATURE HOMEOSTASIS,5.4724e-12,-0.31483,-0.38356,1,0
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1041e-08,-0.31486,-0.39015,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.9478e-13,-0.31498,-0.40422,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,3.8161e-07,-0.315,-0.33848,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,4.3997e-05,-0.31502,-0.31002,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,3.1098e-10,-0.3151,-0.32833,1,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,3.3629e-10,-0.31513,-0.35168,1,0
4,GO NEUROTRANSMITTER UPTAKE,5.1356e-08,-0.31517,-0.3519,1,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,3.3713e-09,-0.31518,-0.4327,1,0
4,GO CALCIUM ION IMPORT,1.4334e-08,-0.31529,-0.36098,1,0
4,GO REGULATION OF B CELL PROLIFERATION,2.0398e-08,-0.31531,-0.38042,1,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,2.595e-12,-0.31533,-0.38888,1,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,2.5223e-10,-0.31539,-0.3826,1,0
4,GO CARBOHYDRATE HOMEOSTASIS,1.2131e-09,-0.3154,-0.35354,1,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,2.4214e-11,-0.31546,-0.40786,1,0
4,GO REGULATION OF CELL ACTIVATION,6.6774e-12,-0.31546,-0.40041,1,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.3468e-07,-0.31548,-0.38924,1,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,3.0856e-12,-0.31548,-0.45822,1,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,1.1034e-07,-0.31549,-0.32146,1,0
4,GO RESPIRATORY SYSTEM PROCESS,3.2162e-07,-0.31572,-0.3853,1,0
4,GO SKIN EPIDERMIS DEVELOPMENT,2.5893e-10,-0.31575,-0.40905,1,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.2397e-08,-0.31575,-0.35759,1,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,4.5822e-08,-0.31576,-0.36025,1,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.7536e-08,-0.31581,-0.36025,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.9309e-10,-0.31583,-0.32568,1,0
4,GO ERBB2 SIGNALING PATHWAY,1.3039e-08,-0.31595,-0.40697,1,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.1793e-10,-0.31599,-0.40488,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00034485,-0.316,-0.3587,1,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.152e-06,-0.316,-0.32634,1,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.6986e-10,-0.31605,-0.40305,1,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,4.0677e-13,-0.31611,-0.39869,1,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.0241e-10,-0.31616,-0.3866,1,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.9514e-07,-0.31617,-0.41726,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.055093,-0.31617,-0.19361,1,0
4,GO ORGANIC CATION TRANSPORT,6.8406e-11,-0.31621,-0.4053,1,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,1.0205e-12,-0.31633,-0.4318,1,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,6.7492e-13,-0.31641,-0.40479,1,0
4,GO ERYTHROCYTE HOMEOSTASIS,1.3737e-10,-0.31675,-0.39635,1,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.4686e-11,-0.31689,-0.36973,1,0
4,GO PROTEIN ACTIVATION CASCADE,3.6293e-09,-0.31695,-0.44655,1,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,1.0241e-10,-0.317,-0.41569,1,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,4.5233e-07,-0.31701,-0.30741,1,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.8416e-06,-0.31703,-0.29383,1,0
4,GO EPITHELIAL CELL FATE COMMITMENT,9.9844e-05,-0.31709,-0.37502,1,0
4,GO AUTOPHAGOSOME MATURATION,2.8369e-09,-0.31714,-0.34765,1,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,4.8359e-10,-0.31715,-0.37362,1,0
4,GO CELL RECOGNITION,2.0509e-11,-0.31721,-0.35887,1,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,6.3569e-09,-0.31729,-0.31245,1,0
4,GO REGULATION OF CELL FATE COMMITMENT,1.0004e-06,-0.31738,-0.31678,1,0
4,GO B CELL ACTIVATION,1.9402e-11,-0.31744,-0.40451,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,4.6202e-07,-0.31746,-0.38354,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,9.4157e-10,-0.31748,-0.34892,1,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,2.7e-09,-0.31749,-0.39589,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.559e-11,-0.3176,-0.39072,1,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,9.5999e-07,-0.31768,-0.28124,1,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,2.6828e-05,-0.31771,-0.35256,1,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,3.1032e-11,-0.31782,-0.43318,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,1.3085e-09,-0.31785,-0.36684,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.7909e-10,-0.31788,-0.36489,1,0
4,GO ENDOCRINE HORMONE SECRETION,3.2764e-10,-0.31793,-0.37291,1,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,3.8313e-13,-0.31805,-0.40751,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,9.0235e-07,-0.31809,-0.40281,1,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,6.3074e-11,-0.31811,-0.39218,1,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,9.6219e-13,-0.31817,-0.39455,1,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,1.5386e-08,-0.31822,-0.41092,1,0
4,GO EXOCYTIC PROCESS,1.0557e-05,-0.31823,-0.33079,1,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.4341e-06,-0.31838,-0.39268,1,0
4,GO VACUOLE ORGANIZATION,1.4487e-10,-0.31842,-0.39321,1,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.3554e-11,-0.31844,-0.38806,1,0
4,GO MUSCLE ORGAN MORPHOGENESIS,6.4192e-10,-0.31863,-0.4113,1,0
4,GO CELLULAR RESPONSE TO VIRUS,7.71e-09,-0.31864,-0.34624,1,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,3.6293e-09,-0.31869,-0.39128,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,4.8198e-07,-0.31875,-0.39432,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,9.658e-10,-0.31876,-0.4182,1,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.2434e-08,-0.31881,-0.37392,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.479e-12,-0.31881,-0.37038,1,0
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,4.3082e-09,-0.31885,-0.39358,1,0
4,GO PROSTANOID METABOLIC PROCESS,2.7452e-06,-0.3189,-0.34213,1,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0001803,-0.31899,-0.33303,1,0
4,GO OVULATION CYCLE,8.2618e-11,-0.31901,-0.41911,1,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,1.5102e-11,-0.31909,-0.38858,1,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.598e-13,-0.31912,-0.41769,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.3085e-09,-0.31922,-0.35218,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,2.8814e-05,-0.31923,-0.35062,1,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,9.9844e-05,-0.31926,-0.34587,1,0
4,GO MUSCLE FILAMENT SLIDING,5.6245e-08,-0.31933,-0.29835,1,0
4,GO SEROTONIN SECRETION,0.00052901,-0.31936,-0.24981,1,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.2444e-07,-0.31951,-0.40123,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,1.451e-12,-0.31956,-0.43243,1,0
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.7442e-10,-0.31971,-0.45317,1,0
4,GO DEVELOPMENTAL GROWTH,3.7735e-12,-0.31972,-0.41405,1,0
4,GO RESPONSE TO PROTOZOAN,4.7963e-08,-0.31976,-0.40965,1,0
4,GO RESPONSE TO BACTERIUM,1.2074e-11,-0.31977,-0.37073,1,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.3647e-09,-0.31978,-0.37756,1,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.9872e-09,-0.31994,-0.37326,1,0
4,GO REGULATION OF T CELL ACTIVATION,2.7797e-11,-0.32,-0.38492,1,0
4,GO CELL ACTIVATION,3.9963e-12,-0.32018,-0.39815,1,0
4,GO B CELL APOPTOTIC PROCESS,1.2253e-05,-0.32019,-0.35511,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,5.0135e-13,-0.32019,-0.42144,1,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.0322e-07,-0.32023,-0.4843,1,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,3.5412e-09,-0.3203,-0.39608,1,0
4,GO WATER HOMEOSTASIS,1.9546e-09,-0.32033,-0.39092,1,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0030839,-0.32037,-0.30448,1,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,5.2253e-10,-0.3204,-0.37129,1,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,5.2253e-10,-0.32041,-0.41261,1,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.1097e-10,-0.32043,-0.43134,1,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,9.8716e-08,-0.32047,-0.34996,1,0
4,GO LATERAL MESODERM DEVELOPMENT,1.3948e-05,-0.3205,-0.35363,1,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,1.7442e-10,-0.32056,-0.35698,1,0
4,GO TISSUE MORPHOGENESIS,8.1414e-12,-0.32058,-0.41061,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.6112e-12,-0.32059,-0.38514,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,3.8645e-11,-0.32062,-0.37776,1,0
4,GO LIPID LOCALIZATION,3.3639e-12,-0.32067,-0.39138,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,5.6245e-08,-0.32079,-0.43461,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.8318e-07,-0.32089,-0.36208,1,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,7.1726e-09,-0.32097,-0.36073,1,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00069207,-0.32114,-0.34203,1,0
4,GO ICOSANOID METABOLIC PROCESS,6.5125e-09,-0.32123,-0.33802,1,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,3.7735e-12,-0.32127,-0.38997,1,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,1.7442e-10,-0.32133,-0.35449,1,0
4,GO SELECTIVE AUTOPHAGY,2.5066e-09,-0.32141,-0.37118,1,0
4,GO TUBULIN DEACETYLATION,4.0657e-06,-0.32147,-0.40855,1,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,1.8793e-06,-0.32154,-0.38081,1,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00011406,-0.32157,-0.29029,1,0
4,GO SENSORY PERCEPTION OF PAIN,1.8881e-10,-0.32163,-0.34082,1,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,9.9064e-10,-0.32169,-0.40761,1,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,3.8313e-13,-0.32174,-0.46358,1,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,2.8299e-12,-0.32176,-0.43288,1,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,2.2453e-12,-0.32179,-0.38284,1,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.2094e-09,-0.32183,-0.37664,1,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.9624e-10,-0.32188,-0.37769,1,0
4,GO REGULATION OF BLOOD PRESSURE,8.1414e-12,-0.32193,-0.38893,1,0
4,GO POTASSIUM ION HOMEOSTASIS,7.0522e-08,-0.32195,-0.3495,1,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,1.8723e-07,-0.32195,-0.38761,1,0
4,GO ESTROGEN METABOLIC PROCESS,1.7922e-07,-0.32203,-0.29041,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.3468e-07,-0.32208,-0.39499,1,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.1165e-05,-0.32208,-0.34613,1,0
4,GO LYMPHOCYTE HOMEOSTASIS,4.1403e-10,-0.32218,-0.38032,1,0
4,GO CORTICOSTEROID HORMONE SECRETION,1.0958e-05,-0.32227,-0.33394,1,0
4,GO PLASMA MEMBRANE FUSION,4.2271e-06,-0.32234,-0.37414,1,0
4,GO REGULATION OF ION TRANSPORT,1.736e-11,-0.32238,-0.36093,1,0
4,GO FLUID TRANSPORT,3.3697e-11,-0.3224,-0.3868,1,0
4,GO REGULATION OF TRANSPOSITION,0.00013673,-0.32243,-0.33654,1,0
4,GO HISTAMINE SECRETION,0.0023009,-0.32246,-0.29627,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,1.3468e-07,-0.32247,-0.38497,1,0
4,GO SOMITE DEVELOPMENT,2.2286e-07,-0.32247,-0.32915,1,0
4,GO POSITIVE REGULATION OF BINDING,5.793e-12,-0.32261,-0.37289,1,0
4,GO ANIMAL ORGAN FORMATION,1.2759e-09,-0.32271,-0.38055,1,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.3697e-11,-0.32277,-0.39746,1,0
4,GO LYMPHOCYTE ACTIVATION,3.9963e-12,-0.32284,-0.39675,1,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,4.1815e-08,-0.32287,-0.34186,1,0
4,GO MOLTING CYCLE,6.4805e-11,-0.32298,-0.39405,1,0
4,GO ACTIN FILAMENT ORGANIZATION,8.5514e-13,-0.32311,-0.45772,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,3.1479e-07,-0.32312,-0.37807,1,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.0856e-12,-0.32317,-0.44969,1,0
4,GO APPENDAGE DEVELOPMENT,1.0519e-10,-0.32325,-0.42761,1,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,7.479e-12,-0.32334,-0.39682,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,1.8353e-11,-0.32343,-0.3779,1,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,4.2444e-07,-0.32345,-0.39643,1,0
4,GO T CELL CYTOKINE PRODUCTION,3.4553e-09,-0.3235,-0.35248,1,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.8262e-08,-0.32351,-0.38662,1,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.4528e-05,-0.32355,-0.32968,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,2.4214e-11,-0.32359,-0.39688,1,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,3.9941e-08,-0.32364,-0.32745,1,0
4,GO REGULATION OF T CELL MIGRATION,3.019e-11,-0.32365,-0.40168,1,0
4,GO RESPONSE TO AMINE,8.9047e-09,-0.32365,-0.33687,1,0
4,GO JNK CASCADE,5.9937e-13,-0.32389,-0.43273,1,0
4,GO BILE ACID AND BILE SALT TRANSPORT,1.155e-06,-0.32403,-0.39646,1,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,3.6361e-10,-0.32409,-0.39234,1,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,8.3747e-12,-0.32411,-0.37856,1,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,4.3549e-12,-0.32412,-0.39691,1,0
4,GO REGULATION OF EXOSOMAL SECRETION,1.2604e-07,-0.32416,-0.39536,1,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00023294,-0.32424,-0.37042,1,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.2286e-07,-0.32427,-0.39734,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,4.3082e-09,-0.32428,-0.40196,1,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,3.2894e-09,-0.3243,-0.39755,1,0
4,GO NATURAL KILLER CELL ACTIVATION,5.3647e-09,-0.32433,-0.37885,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.3948e-05,-0.32443,-0.31186,1,0
4,GO RESPONSE TO ESTRADIOL,6.4905e-12,-0.32445,-0.39281,1,0
4,GO DENDRITIC TRANSPORT,0.00013016,-0.32448,-0.37152,1,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,6.205e-09,-0.32448,-0.41995,1,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.2534e-06,-0.32451,-0.37908,1,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,1.9136e-07,-0.32454,-0.43854,1,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.00073415,-0.32462,-0.33459,1,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,5.02e-08,-0.32466,-0.37044,1,0
4,GO INTERLEUKIN 17 PRODUCTION,7.892e-08,-0.32466,-0.38489,1,0
4,GO LIPID PHOSPHORYLATION,6.3088e-12,-0.32467,-0.44369,1,0
4,GO REGULATION OF SENSORY PERCEPTION,4.7963e-08,-0.32478,-0.28189,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.4452e-09,-0.32481,-0.36283,1,0
4,GO RESPONSE TO ACTIVITY,5.5016e-10,-0.32488,-0.34852,1,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.996e-06,-0.32493,-0.35301,1,0
4,GO MYELOID CELL DIFFERENTIATION,2.3113e-12,-0.325,-0.41583,1,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,7.9144e-12,-0.32502,-0.36444,1,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,8.6579e-07,-0.32507,-0.35628,1,0
4,GO MYELOID LEUKOCYTE ACTIVATION,5.815e-11,-0.32509,-0.3887,1,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.0898e-09,-0.32525,-0.31321,1,0
4,GO STEROID CATABOLIC PROCESS,9.795e-06,-0.32531,-0.35021,1,0
4,GO SENSORY ORGAN DEVELOPMENT,5.3602e-11,-0.32534,-0.38696,1,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,1.0519e-10,-0.32561,-0.42068,1,0
4,GO ACYLGLYCEROL HOMEOSTASIS,1.7309e-08,-0.32566,-0.37322,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.5604e-09,-0.32567,-0.33472,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.6884e-11,-0.32568,-0.41436,1,0
4,GO PROGESTERONE METABOLIC PROCESS,0.001442,-0.32586,-0.34475,1,0
4,GO POSITIVE REGULATION OF CELL GROWTH,3.019e-11,-0.3259,-0.39246,1,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,2.9979e-12,-0.32592,-0.40934,1,0
4,GO REGULATION OF PROTEIN BINDING,7.3765e-13,-0.32595,-0.43547,1,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,2.3554e-11,-0.32605,-0.37575,1,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,8.4871e-11,-0.32606,-0.41806,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,5.3647e-09,-0.32606,-0.39037,1,0
4,GO APICAL JUNCTION ASSEMBLY,1.0781e-08,-0.32609,-0.43479,1,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,2.206e-06,-0.32628,-0.32428,1,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00035024,-0.32646,-0.33673,1,0
4,GO RESPONSE TO VITAMIN A,5.2538e-08,-0.32657,-0.3495,1,0
4,GO REGULATION OF FATTY ACID TRANSPORT,7.5266e-09,-0.32659,-0.38211,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.6304e-12,-0.32664,-0.43141,1,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.9602e-08,-0.32665,-0.36878,1,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,4.6202e-07,-0.32676,-0.38707,1,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,6.757e-10,-0.32694,-0.35145,1,0
4,GO THYMOCYTE APOPTOTIC PROCESS,4.7488e-06,-0.32703,-0.36544,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,3.462e-12,-0.32716,-0.38396,1,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0066851,-0.32739,-0.38329,1,0
4,GO EMBRYONIC MORPHOGENESIS,1.736e-11,-0.32743,-0.41274,1,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,7.0671e-12,-0.32744,-0.42492,1,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,1.4686e-11,-0.32749,-0.39962,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.8573e-11,-0.32765,-0.40185,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,7.5451e-08,-0.32768,-0.40216,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,6.3074e-11,-0.32771,-0.4222,1,0
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.5604e-09,-0.32788,-0.43153,1,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.6792e-10,-0.32794,-0.40378,1,0
4,GO CYTOKINE METABOLIC PROCESS,1.1099e-11,-0.32797,-0.42048,1,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.1535e-07,-0.32804,-0.34811,1,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.7286e-10,-0.32812,-0.38536,1,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,2.004e-09,-0.32812,-0.37812,1,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0033361,-0.32813,-0.36036,1,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,1.1579e-08,-0.32817,-0.42021,1,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,2.1064e-09,-0.32822,-0.40076,1,0
4,GO MESODERM MORPHOGENESIS,1.2023e-10,-0.32826,-0.41376,1,0
4,GO ENDOCYTIC RECYCLING,7.4177e-11,-0.32832,-0.44407,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.6109e-10,-0.32833,-0.39267,1,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.6112e-12,-0.32833,-0.38152,1,0
4,GO CYSTEINE METABOLIC PROCESS,0.00027284,-0.32853,-0.32884,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,5.9748e-11,-0.32857,-0.41605,1,0
4,GO REGULATION OF TUBE SIZE,9.6431e-12,-0.32859,-0.37494,1,0
4,GO DIENCEPHALON DEVELOPMENT,3.5794e-07,-0.32865,-0.36839,1,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,9.3415e-09,-0.32867,-0.38038,1,0
4,GO DENDRITIC CELL CHEMOTAXIS,3.2894e-09,-0.32867,-0.38212,1,0
4,GO REGULATION OF T CELL DIFFERENTIATION,4.9403e-11,-0.32868,-0.37284,1,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,7.8976e-09,-0.32875,-0.30411,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,7.2129e-08,-0.32875,-0.45708,1,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,9.4157e-10,-0.32876,-0.36023,1,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,4.9069e-08,-0.32881,-0.4012,1,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.0237e-12,-0.32884,-0.42662,1,0
4,GO ANIMAL ORGAN MORPHOGENESIS,6.9522e-13,-0.32927,-0.42131,1,0
4,GO PROSTATE GLAND GROWTH,4.9694e-05,-0.3293,-0.32389,1,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,8.9558e-11,-0.32933,-0.4616,1,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.2785e-11,-0.32934,-0.36742,1,0
4,GO REGULATION OF GASTRULATION,1.9905e-10,-0.32938,-0.46085,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,4.8076e-11,-0.3295,-0.36462,1,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,1.3196e-05,-0.3295,-0.38125,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.9926e-08,-0.32957,-0.42686,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,4.3236e-05,-0.32958,-0.35947,1,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1.7442e-10,-0.3296,-0.39132,1,0
4,GO VIRAL GENOME REPLICATION,1.0279e-08,-0.32962,-0.38896,1,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.1552e-07,-0.32962,-0.39043,1,0
4,GO RESPONSE TO MINERALOCORTICOID,1.9014e-08,-0.32984,-0.34184,1,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00062378,-0.32998,-0.27907,1,0
4,GO MYOFIBRIL ASSEMBLY,2.5695e-09,-0.33005,-0.37448,1,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,5.5078e-11,-0.33005,-0.38347,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.0983e-10,-0.33006,-0.39368,1,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.7922e-07,-0.33008,-0.4055,1,0
4,GO REGULATION OF NEURON DIFFERENTIATION,1.7909e-10,-0.33011,-0.42236,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8976e-09,-0.33011,-0.36938,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.5526e-11,-0.33013,-0.41572,1,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,8.5858e-05,-0.33016,-0.29745,1,0
4,GO MITOPHAGY,8.8282e-08,-0.33028,-0.3582,1,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,9.819e-05,-0.33034,-0.34262,1,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,5.1356e-08,-0.33036,-0.3603,1,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,6.4192e-10,-0.33039,-0.40116,1,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,9.3425e-13,-0.33048,-0.43822,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.2903e-10,-0.33048,-0.41327,1,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.1828e-09,-0.33052,-0.34289,1,0
4,GO RESPONSE TO GONADOTROPIN,1.4334e-08,-0.33052,-0.37213,1,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,3.0295e-08,-0.3306,-0.42967,1,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,2.5893e-10,-0.33071,-0.42109,1,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.6356e-09,-0.3308,-0.39874,1,0
4,GO ETHANOL CATABOLIC PROCESS,2.1196e-06,-0.33091,-0.32509,1,0
4,GO PROTEIN AUTOPHOSPHORYLATION,9.9094e-13,-0.33093,-0.46491,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,4.1815e-08,-0.33103,-0.34601,1,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,2.9805e-09,-0.33112,-0.37327,1,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,1.5674e-06,-0.33112,-0.32896,1,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.9926e-08,-0.33121,-0.42667,1,0
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.5604e-09,-0.33124,-0.43386,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,8.9558e-11,-0.33125,-0.40619,1,0
4,GO THYROID HORMONE METABOLIC PROCESS,4.5239e-09,-0.33127,-0.35037,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,3.247e-08,-0.33132,-0.37024,1,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,4.3997e-05,-0.33147,-0.33528,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9963e-12,-0.33148,-0.40926,1,0
4,GO CANONICAL WNT SIGNALING PATHWAY,1.8863e-12,-0.33148,-0.41366,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.3312e-10,-0.33155,-0.34877,1,0
4,GO FAT CELL DIFFERENTIATION,2.9127e-12,-0.33156,-0.43268,1,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,4.249e-10,-0.33157,-0.35601,1,0
4,GO NEURAL TUBE FORMATION,7.5266e-09,-0.33162,-0.39757,1,0
4,GO REGULATION OF LIPASE ACTIVITY,7.6205e-11,-0.33168,-0.35996,1,0
4,GO LYMPHOCYTE COSTIMULATION,1.0964e-09,-0.33173,-0.4023,1,0
4,GO MYOBLAST DIFFERENTIATION,7.8286e-11,-0.33174,-0.39892,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,1.1099e-11,-0.33184,-0.41152,1,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,1.6109e-10,-0.33187,-0.43089,1,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,1.4112e-09,-0.3319,-0.43365,1,0
4,GO DENTATE GYRUS DEVELOPMENT,0.00013673,-0.3319,-0.32457,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.719e-07,-0.33191,-0.35185,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,8.4415e-08,-0.33201,-0.39181,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,6.1744e-13,-0.33202,-0.42148,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.5514e-13,-0.33206,-0.44314,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.6581e-10,-0.33224,-0.38012,1,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,9.9064e-10,-0.33224,-0.369,1,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.3312e-10,-0.33224,-0.38289,1,0
4,GO DENDRITE DEVELOPMENT,7.8976e-09,-0.33236,-0.40725,1,0
4,GO REGULATION OF SODIUM ION TRANSPORT,1.5688e-10,-0.3324,-0.42202,1,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,1.4472e-05,-0.33243,-0.40036,1,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,9.1996e-11,-0.33243,-0.39385,1,0
4,GO POSITIVE REGULATION OF CELL DIVISION,1.5604e-09,-0.33244,-0.37697,1,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.8573e-08,-0.33264,-0.44874,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.892e-08,-0.33282,-0.3574,1,0
4,GO MYELOID CELL HOMEOSTASIS,9.1996e-11,-0.33283,-0.40597,1,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,2.634e-09,-0.33308,-0.41,1,0
4,GO AMINO SUGAR CATABOLIC PROCESS,4.3082e-09,-0.33309,-0.36981,1,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.6782e-07,-0.33309,-0.33132,1,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.1807e-07,-0.33312,-0.37486,1,0
4,GO SKIN DEVELOPMENT,1.0161e-09,-0.33315,-0.38983,1,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,5.4701e-07,-0.33315,-0.43395,1,0
4,GO CATECHOLAMINE SECRETION,6.7724e-05,-0.33326,-0.31814,1,0
4,GO CHLORIDE TRANSPORT,4.8076e-11,-0.33335,-0.35626,1,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0037016,-0.33337,-0.37821,1,0
4,GO LONG TERM SYNAPTIC DEPRESSION,3.0302e-06,-0.33353,-0.34954,1,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.232e-12,-0.33353,-0.37571,1,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,3.462e-12,-0.33354,-0.39188,1,0
4,GO REGULATION OF BLOOD CIRCULATION,4.6784e-11,-0.33377,-0.39548,1,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,6.8885e-07,-0.33385,-0.36103,1,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,3.8347e-06,-0.33393,-0.38273,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.5753e-08,-0.33393,-0.40306,1,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,1.9905e-10,-0.33401,-0.38196,1,0
4,GO LIPID IMPORT INTO CELL,3.0156e-07,-0.33406,-0.38241,1,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,3.9064e-09,-0.33418,-0.41572,1,0
4,GO EXCRETION,6.3074e-11,-0.33423,-0.37948,1,0
4,GO HEART PROCESS,3.8645e-11,-0.33426,-0.38933,1,0
4,GO NOREPINEPHRINE TRANSPORT,1.9563e-06,-0.33438,-0.36722,1,0
4,GO AMINE TRANSPORT,2.3661e-05,-0.33441,-0.29286,1,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,1.1316e-06,-0.33442,-0.33605,1,0
4,GO CYTOKINE PRODUCTION,1.0493e-11,-0.33445,-0.40536,1,0
4,GO REGULATION OF VESICLE FUSION,5.0323e-06,-0.33451,-0.42566,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,3.5018e-13,-0.33462,-0.45219,1,0
4,GO STRIATUM DEVELOPMENT,8.6328e-08,-0.33466,-0.40302,1,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,5.3186e-12,-0.33466,-0.4113,1,0
4,GO CEREBRAL CORTEX CELL MIGRATION,5.8262e-07,-0.33469,-0.38306,1,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.586e-10,-0.33481,-0.39174,1,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,3.6586e-11,-0.33483,-0.40929,1,0
4,GO IMMUNE EFFECTOR PROCESS,2.4214e-11,-0.33496,-0.39641,1,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.1815e-08,-0.335,-0.35289,1,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,3.0296e-10,-0.33501,-0.37354,1,0
4,GO CELL JUNCTION ORGANIZATION,2.2453e-12,-0.33505,-0.47552,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00020835,-0.33511,-0.32636,1,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.8198e-07,-0.33514,-0.46871,1,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,1.6994e-06,-0.33524,-0.406,1,0
4,GO POSITIVE REGULATION OF GROWTH,3.6667e-12,-0.33533,-0.41199,1,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,7.3772e-08,-0.33534,-0.41171,1,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,1.1794e-07,-0.33541,-0.41188,1,0
4,GO DEFENSE RESPONSE TO VIRUS,2.0881e-08,-0.33541,-0.39949,1,0
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.634e-09,-0.33542,-0.40473,1,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.004e-09,-0.33545,-0.41774,1,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,8.0424e-11,-0.3355,-0.3826,1,0
4,GO INTERFERON GAMMA PRODUCTION,4.1025e-09,-0.33552,-0.36561,1,0
4,GO SKELETAL SYSTEM DEVELOPMENT,8.5514e-13,-0.33552,-0.44535,1,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,7.5266e-09,-0.33552,-0.40655,1,0
4,GO ENTRY INTO HOST,5.3602e-11,-0.33561,-0.4617,1,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,7.6792e-10,-0.33571,-0.40551,1,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,7.1726e-09,-0.33576,-0.44538,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,1.439e-07,-0.33584,-0.36464,1,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,1.1245e-09,-0.33591,-0.39971,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4634e-11,-0.33594,-0.43862,1,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,9.028e-08,-0.33598,-0.38212,1,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,5.1652e-13,-0.33616,-0.43352,1,0
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,9.4407e-08,-0.33618,-0.4621,1,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,5.5078e-11,-0.33634,-0.392,1,0
4,GO RESPONSE TO STEROL DEPLETION,3.1479e-07,-0.33641,-0.38889,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,3.2785e-11,-0.33642,-0.43235,1,0
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.8369e-09,-0.33644,-0.4062,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2074e-11,-0.33644,-0.41976,1,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,6.6066e-07,-0.33654,-0.35057,1,0
4,GO AMMONIUM ION METABOLIC PROCESS,1.6761e-05,-0.33657,-0.3232,1,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.9834e-06,-0.33657,-0.41623,1,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,5.4701e-07,-0.33658,-0.34253,1,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,7.7166e-08,-0.3366,-0.35211,1,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,3.6586e-11,-0.33668,-0.39449,1,0
4,GO ENERGY RESERVE METABOLIC PROCESS,1.0964e-09,-0.33674,-0.38818,1,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,1.9948e-11,-0.33677,-0.44184,1,0
4,GO RESPONSE TO WATER,6.1119e-05,-0.33682,-0.34334,1,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,1.5838e-12,-0.33688,-0.44311,1,0
4,GO SEQUESTERING OF CALCIUM ION,7.2202e-11,-0.33691,-0.39185,1,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.9309e-10,-0.33696,-0.35914,1,0
4,GO LACTATION,3.3228e-08,-0.33704,-0.39344,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,5.7051e-07,-0.33706,-0.37087,1,0
4,GO MONONUCLEAR CELL MIGRATION,3.2094e-09,-0.3371,-0.36309,1,0
4,GO KIDNEY MORPHOGENESIS,5.2253e-10,-0.33722,-0.39572,1,0
4,GO DENDRITE MORPHOGENESIS,2.7614e-08,-0.33722,-0.41455,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,6.2169e-06,-0.33727,-0.4016,1,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.3933e-10,-0.3373,-0.40969,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.4871e-11,-0.33748,-0.36918,1,0
4,GO POSITIVE T CELL SELECTION,1.5994e-06,-0.33751,-0.29845,1,0
4,GO SMOOTH MUSCLE CONTRACTION,6.6774e-12,-0.33757,-0.39164,1,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.2434e-08,-0.33759,-0.39642,1,0
4,GO WHITE FAT CELL DIFFERENTIATION,8.7184e-11,-0.33761,-0.39537,1,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,3.9309e-10,-0.33777,-0.44385,1,0
4,GO AMINO SUGAR METABOLIC PROCESS,6.586e-10,-0.33785,-0.36503,1,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,1.9989e-07,-0.33789,-0.34267,1,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,3.1004e-08,-0.3379,-0.40659,1,0
4,GO STEROL HOMEOSTASIS,2.457e-10,-0.33794,-0.40301,1,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,1.2032e-06,-0.33798,-0.35504,1,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,3.8833e-12,-0.33805,-0.42224,1,0
4,GO CELLULAR RESPONSE TO X RAY,1.5713e-07,-0.33807,-0.35219,1,0
4,GO RESPONSE TO ACIDIC PH,7.6446e-07,-0.3381,-0.42784,1,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,1.1245e-09,-0.33814,-0.42111,1,0
4,GO T CELL DIFFERENTIATION,1.277e-11,-0.33821,-0.38753,1,0
4,GO REGULATION OF HISTONE DEACETYLATION,1.9558e-07,-0.33827,-0.37587,1,0
4,GO MESONEPHROS DEVELOPMENT,5.1101e-09,-0.33827,-0.39772,1,0
4,GO RESPONSE TO LIPID,9.3425e-13,-0.33831,-0.40163,1,0
4,GO POSITIVE REGULATION OF CELL DEATH,4.3184e-13,-0.33832,-0.41244,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,1.3419e-09,-0.33832,-0.40384,1,0
4,GO REGULATION OF MAPK CASCADE,6.7492e-13,-0.33833,-0.4325,1,0
4,GO REGULATION OF B CELL ACTIVATION,1.6109e-10,-0.33834,-0.39943,1,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,4.3355e-07,-0.33842,-0.39711,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,1.2131e-09,-0.33847,-0.37256,1,0
4,GO RESPONSE TO STEROID HORMONE,1.494e-12,-0.33861,-0.41275,1,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2348e-10,-0.33863,-0.39827,1,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,6.2993e-08,-0.33863,-0.46769,1,0
4,GO PROTEIN TRIMERIZATION,1.1794e-07,-0.33873,-0.34007,1,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,7.5266e-09,-0.33877,-0.40218,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00015083,-0.33884,-0.25842,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,2.457e-10,-0.33889,-0.38942,1,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.5223e-10,-0.33906,-0.42485,1,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.247e-08,-0.33913,-0.42846,1,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.0296e-10,-0.33922,-0.39291,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,1.069e-09,-0.33971,-0.42628,1,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,9.1146e-12,-0.33975,-0.38695,1,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.2046e-07,-0.33985,-0.39904,1,0
4,GO RECEPTOR INTERNALIZATION,3.6667e-12,-0.33987,-0.41572,1,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,3.7319e-10,-0.33988,-0.36117,1,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,2.1543e-10,-0.33989,-0.41571,1,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.0424e-11,-0.33993,-0.43532,1,0
4,GO COPPER ION HOMEOSTASIS,1.3671e-08,-0.33994,-0.39093,1,0
4,GO REGULATION OF ENDOCYTOSIS,2.3793e-12,-0.33996,-0.4382,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,2.1375e-08,-0.34005,-0.36368,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.069e-09,-0.34007,-0.36309,1,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.1726e-09,-0.34008,-0.45256,1,0
4,GO LOCALIZATION WITHIN MEMBRANE,9.658e-10,-0.3401,-0.41536,1,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,6.205e-09,-0.3401,-0.39886,1,0
4,GO REGENERATION,1.5383e-12,-0.3401,-0.41124,1,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,4.1403e-10,-0.34016,-0.34803,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.1085e-11,-0.34019,-0.42241,1,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,5.3747e-08,-0.3402,-0.38949,1,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,3.5038e-07,-0.34021,-0.37704,1,0
4,GO AUTOPHAGY OF NUCLEUS,5.9116e-09,-0.3404,-0.38822,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.2143e-08,-0.34042,-0.45176,1,0
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,7.3476e-09,-0.3405,-0.40974,1,0
4,GO MALE GENITALIA DEVELOPMENT,5.7536e-08,-0.34056,-0.38141,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4454e-06,-0.34068,-0.37572,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.4741e-05,-0.34081,-0.44232,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,6.8885e-07,-0.34081,-0.4046,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.2707e-10,-0.34082,-0.40204,1,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,1.3351e-08,-0.34082,-0.40316,1,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.1744e-13,-0.34083,-0.47849,1,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,2.9515e-10,-0.34091,-0.41314,1,0
4,GO REGULATION OF INTEGRIN ACTIVATION,1.6062e-07,-0.34094,-0.41741,1,0
4,GO PRO B CELL DIFFERENTIATION,7.892e-08,-0.34095,-0.43853,1,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,1.5838e-12,-0.34098,-0.40486,1,0
4,GO CELL CELL JUNCTION ASSEMBLY,2.3312e-10,-0.34105,-0.43939,1,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,8.5867e-06,-0.34109,-0.38759,1,0
4,GO RESPONSE TO FATTY ACID,6.3074e-11,-0.34112,-0.38615,1,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.0005133,-0.3412,-0.31323,1,0
4,GO LEUKOCYTE DIFFERENTIATION,2.1812e-12,-0.3412,-0.41432,1,0
4,GO ACROSOME ASSEMBLY,6.9711e-06,-0.34123,-0.32588,1,0
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,9.1205e-09,-0.34127,-0.40268,1,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.1858e-08,-0.34134,-0.38518,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.9487e-10,-0.34137,-0.42744,1,0
4,GO REGULATION OF VIRAL LIFE CYCLE,1.7309e-08,-0.3414,-0.40208,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,8.3013e-05,-0.3414,-0.38284,1,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.5893e-10,-0.34157,-0.3939,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.4157e-10,-0.34163,-0.41335,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,1.2328e-07,-0.34167,-0.41375,1,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,6.3604e-13,-0.3417,-0.4618,1,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,2.7e-09,-0.34171,-0.39288,1,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.3554e-11,-0.34172,-0.36832,1,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.4724e-12,-0.3418,-0.40811,1,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.3291e-12,-0.34183,-0.42896,1,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,9.4407e-08,-0.34187,-0.4162,1,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,5.0237e-12,-0.34192,-0.4428,1,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.479e-12,-0.34195,-0.3869,1,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,3.9717e-11,-0.34198,-0.43397,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,5.7051e-07,-0.34205,-0.34563,1,0
4,GO TORC1 SIGNALING,8.4415e-08,-0.34207,-0.38461,1,0
4,GO PRESYNAPSE ORGANIZATION,1.2604e-07,-0.34211,-0.39295,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.3737e-10,-0.34218,-0.40596,1,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,6.5906e-08,-0.3422,-0.36055,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.6001e-09,-0.34237,-0.44791,1,0
4,GO REGULATION OF CELL CELL ADHESION,3.0856e-12,-0.34244,-0.43511,1,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,8.0424e-11,-0.34255,-0.38057,1,0
4,GO CELL JUNCTION ASSEMBLY,2.3793e-12,-0.34257,-0.47563,1,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,9.9185e-12,-0.34264,-0.39195,1,0
4,GO REGULATION OF DENDRITE EXTENSION,0.0014624,-0.34265,-0.27249,1,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,2.3933e-10,-0.34286,-0.44611,1,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,1.2682e-10,-0.34292,-0.40631,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.6306e-11,-0.34306,-0.42387,1,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,7.0017e-09,-0.34309,-0.39584,1,0
4,GO RESPONSE TO DRUG,5.1691e-12,-0.34316,-0.4002,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00034485,-0.34331,-0.4354,1,0
4,GO BODY FLUID SECRETION,4.1948e-11,-0.34342,-0.3646,1,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,1.0241e-10,-0.34344,-0.39613,1,0
4,GO TISSUE HOMEOSTASIS,1.0493e-11,-0.34344,-0.37868,1,0
4,GO GLIAL CELL DIFFERENTIATION,1.2074e-11,-0.34348,-0.42496,1,0
4,GO REGULATION OF MITOPHAGY,2.538e-07,-0.34353,-0.37514,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.7442e-10,-0.34358,-0.44292,1,0
4,GO INTERLEUKIN 8 PRODUCTION,5.1101e-09,-0.3437,-0.42202,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.1552e-07,-0.3437,-0.44805,1,0
4,GO GENITALIA DEVELOPMENT,1.0493e-11,-0.34378,-0.39697,1,0
4,GO MEMORY,2.3554e-11,-0.34378,-0.41701,1,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,1.8863e-12,-0.34382,-0.44271,1,0
4,GO CELLULAR RESPONSE TO LIPID,1.2534e-12,-0.34402,-0.40645,1,0
4,GO IRON COORDINATION ENTITY TRANSPORT,6.0759e-07,-0.34405,-0.38161,1,0
4,GO REGULATION OF HEART GROWTH,1.9402e-11,-0.34409,-0.41452,1,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.7e-09,-0.34417,-0.53641,1,0
4,GO GOLGI RIBBON FORMATION,3.2859e-07,-0.3442,-0.43238,1,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,1.182e-12,-0.34421,-0.43071,1,0
4,GO CYTOKINE SECRETION,2.5893e-10,-0.34422,-0.35805,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.6109e-10,-0.34426,-0.36476,1,0
4,GO BASIC AMINO ACID TRANSPORT,1.9136e-07,-0.34432,-0.4789,1,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,5.4967e-09,-0.34432,-0.33403,1,0
4,GO ENSHEATHMENT OF NEURONS,3.2685e-12,-0.34435,-0.43392,1,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,1.7706e-05,-0.34441,-0.33411,1,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,7.5451e-08,-0.34463,-0.39081,1,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,4.5843e-13,-0.34479,-0.41603,1,0
4,GO PARENTAL BEHAVIOR,2.9332e-05,-0.34481,-0.35102,1,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,5.2359e-09,-0.34483,-0.41199,1,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,2.0853e-05,-0.34484,-0.47609,1,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.7286e-10,-0.34495,-0.43686,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,8.6937e-09,-0.34497,-0.40139,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,8.7184e-11,-0.34504,-0.41689,1,0
4,GO CARDIOCYTE DIFFERENTIATION,3.5427e-10,-0.34506,-0.40772,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,6.8396e-06,-0.34508,-0.37477,1,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,1.439e-07,-0.34515,-0.39346,1,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00024045,-0.34517,-0.33686,1,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.9064e-09,-0.34518,-0.42767,1,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.7797e-11,-0.34519,-0.40459,1,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,1.5027e-08,-0.34522,-0.37002,1,0
4,GO CELL PART MORPHOGENESIS,6.9323e-10,-0.34526,-0.42352,1,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,1.9948e-11,-0.34529,-0.43911,1,0
4,GO GLIOGENESIS,3.1757e-12,-0.34532,-0.42375,1,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,3.1032e-11,-0.34539,-0.43603,1,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,7.8976e-09,-0.34546,-0.36183,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,6.552e-13,-0.34553,-0.46137,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,2.9078e-09,-0.34554,-0.43826,1,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,4.0817e-11,-0.34555,-0.42632,1,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.7232e-13,-0.34557,-0.45376,1,0
4,GO T CELL PROLIFERATION,4.4749e-10,-0.34571,-0.37558,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,8.6145e-12,-0.34574,-0.40041,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.484e-09,-0.34574,-0.42515,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0424e-06,-0.34586,-0.36617,1,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.2716e-05,-0.34591,-0.41584,1,0
4,GO LEUKOCYTE CHEMOTAXIS,2.4214e-11,-0.34594,-0.3915,1,0
4,GO RESPONSE TO DIETARY EXCESS,6.6578e-05,-0.34604,-0.32675,1,0
4,GO IMPORT INTO CELL,8.4871e-11,-0.34604,-0.39188,1,0
4,GO TRANSMISSION OF NERVE IMPULSE,4.0678e-07,-0.34605,-0.36611,1,0
4,GO ERBB SIGNALING PATHWAY,4.3549e-12,-0.34612,-0.44163,1,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.758e-05,-0.34629,-0.36693,1,0
4,GO INFLAMMATORY RESPONSE,1.0202e-11,-0.34634,-0.39624,1,0
4,GO CARNITINE SHUTTLE,6.2993e-08,-0.34635,-0.42042,1,0
4,GO CGMP MEDIATED SIGNALING,7.8976e-09,-0.34636,-0.38977,1,0
4,GO DORSAL AORTA DEVELOPMENT,3.9102e-06,-0.3464,-0.47098,1,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00017457,-0.34649,-0.34755,1,0
4,GO SYNAPSE ASSEMBLY,1.6907e-08,-0.34651,-0.40602,1,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,1.8318e-07,-0.34664,-0.42299,1,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,8.3026e-13,-0.34665,-0.44913,1,0
4,GO LYSOSOME LOCALIZATION,4.8359e-10,-0.34676,-0.39521,1,0
4,GO REGULATION OF PROTEIN DEACETYLATION,1.1858e-08,-0.34693,-0.38947,1,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,1.1579e-08,-0.34699,-0.43569,1,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,2.7668e-07,-0.34703,-0.42352,1,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,3.7195e-09,-0.34708,-0.43626,1,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,4.1403e-10,-0.3471,-0.44053,1,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,1.4207e-05,-0.34714,-0.37338,1,0
4,GO REGULATION OF LIPID TRANSPORT,5.2165e-11,-0.34716,-0.37622,1,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,1.6109e-10,-0.34718,-0.4484,1,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,9.7998e-07,-0.34719,-0.3782,1,0
4,GO T CELL ACTIVATION,1.5968e-11,-0.34726,-0.40109,1,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.6293e-09,-0.34728,-0.40348,1,0
4,GO ACTION POTENTIAL,1.9465e-08,-0.34729,-0.3851,1,0
4,GO NEUROINFLAMMATORY RESPONSE,1.5102e-11,-0.34732,-0.40358,1,0
4,GO LEUKOCYTE PROLIFERATION,1.4877e-10,-0.34734,-0.39051,1,0
4,GO ACUTE INFLAMMATORY RESPONSE,6.9323e-10,-0.34744,-0.35866,1,0
4,GO ADRENAL GLAND DEVELOPMENT,3.4409e-05,-0.34745,-0.39613,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,1.996e-06,-0.34747,-0.40469,1,0
4,GO LEUKOCYTE CELL CELL ADHESION,1.5529e-11,-0.34752,-0.41259,1,0
4,GO EYE MORPHOGENESIS,9.4499e-11,-0.34756,-0.42162,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.3933e-10,-0.34764,-0.40722,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.7286e-10,-0.34765,-0.34763,1,0
4,GO KERATINOCYTE MIGRATION,2.7797e-11,-0.34767,-0.43382,1,0
4,GO FRUCTOSE METABOLIC PROCESS,0.0012886,-0.34782,-0.36415,1,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,8.5043e-10,-0.34788,-0.36234,1,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,3.3228e-08,-0.3481,-0.43005,1,0
4,GO FILOPODIUM ASSEMBLY,2.5223e-10,-0.34812,-0.47847,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.6245e-08,-0.34819,-0.39735,1,0
4,GO RETINAL METABOLIC PROCESS,0.00029052,-0.34821,-0.3594,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,3.4634e-11,-0.34833,-0.40766,1,0
4,GO REGULATION OF MAP KINASE ACTIVITY,1.2534e-12,-0.3485,-0.45339,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.2792e-06,-0.34852,-0.32194,1,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,7.2414e-06,-0.34865,-0.29351,1,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.0013826,-0.34869,-0.3143,1,0
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,9.1205e-09,-0.34904,-0.3754,1,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,1.9014e-08,-0.34906,-0.3875,1,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,2.011e-05,-0.3491,-0.38601,1,0
4,GO T CELL LINEAGE COMMITMENT,6.2169e-06,-0.34921,-0.29728,1,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,7.2964e-10,-0.34926,-0.47039,1,0
4,GO REGULATORY T CELL DIFFERENTIATION,1.4076e-07,-0.34936,-0.41573,1,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,4.5233e-07,-0.34938,-0.44469,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,3.2094e-09,-0.34947,-0.42364,1,0
4,GO MONOAMINE TRANSPORT,7.3803e-06,-0.34952,-0.33529,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,1.5217e-09,-0.34952,-0.47508,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,7.8261e-13,-0.34955,-0.44395,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,5.9834e-06,-0.34956,-0.35675,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,2.1595e-09,-0.34966,-0.47794,1,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,9.658e-10,-0.3497,-0.4277,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,3.9717e-11,-0.3498,-0.4371,1,0
4,GO RESPONSE TO TESTOSTERONE,1.3769e-07,-0.34999,-0.34389,1,0
4,GO PHAGOCYTOSIS RECOGNITION,2.5756e-08,-0.35001,-0.43983,1,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.9602e-08,-0.35003,-0.38834,1,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.6586e-11,-0.35004,-0.36785,1,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.3056e-06,-0.35012,-0.32613,1,0
4,GO REGULATION OF PINOCYTOSIS,2.1807e-07,-0.35023,-0.40583,1,0
4,GO ADIPOSE TISSUE DEVELOPMENT,1.6514e-08,-0.35029,-0.38753,1,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,1.0791e-07,-0.35036,-0.37887,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.8662e-13,-0.35043,-0.42903,1,0
4,GO REGULATION OF ORGAN GROWTH,1.736e-11,-0.35052,-0.4041,1,0
4,GO INOSITOL METABOLIC PROCESS,2.2958e-06,-0.3506,-0.36334,1,0
4,GO FIBROBLAST APOPTOTIC PROCESS,9.5677e-09,-0.35069,-0.42334,1,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.3468e-07,-0.35071,-0.37313,1,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0013826,-0.35078,-0.34866,1,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,9.7068e-11,-0.35084,-0.40765,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,3.7602e-11,-0.35124,-0.43908,1,0
4,GO LIPID HOMEOSTASIS,1.5102e-11,-0.35142,-0.38794,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,1.3737e-10,-0.35146,-0.46137,1,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,2.2286e-11,-0.35159,-0.43864,1,0
4,GO RESPONSE TO ACID CHEMICAL,1.5968e-11,-0.35169,-0.40438,1,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,2.4452e-09,-0.35184,-0.3792,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,3.0811e-07,-0.35188,-0.4116,1,0
4,GO MACROPHAGE DIFFERENTIATION,1.1415e-11,-0.35199,-0.44674,1,0
4,GO ANIMAL ORGAN REGENERATION,3.2764e-10,-0.35203,-0.36748,1,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,1.3761e-09,-0.35206,-0.37522,1,0
4,GO HISTONE H3 K36 METHYLATION,1.3948e-05,-0.35215,-0.35505,1,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,9.6562e-05,-0.35215,-0.40293,1,0
4,GO LYMPHOCYTE DIFFERENTIATION,6.4905e-12,-0.35222,-0.40053,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.6884e-11,-0.35228,-0.40728,1,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,2.0582e-12,-0.3523,-0.47397,1,0
4,GO POSITIVE REGULATION OF NEURON DEATH,2.9371e-11,-0.35238,-0.43708,1,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,1.0557e-05,-0.35243,-0.29831,1,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,6.0565e-09,-0.35249,-0.37837,1,0
4,GO PHOSPHOLIPID TRANSPORT,1.785e-11,-0.35257,-0.44524,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4076e-07,-0.3526,-0.39136,1,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.5822e-08,-0.35265,-0.38651,1,0
4,GO REGULATION OF LIPID LOCALIZATION,1.0792e-11,-0.35289,-0.38998,1,0
4,GO ENDOCRINE PROCESS,6.8406e-11,-0.35289,-0.40383,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,1.5102e-11,-0.3529,-0.42384,1,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,3.7195e-09,-0.35295,-0.39521,1,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.0343e-10,-0.35305,-0.37452,1,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00012388,-0.35325,-0.31495,1,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.1085e-11,-0.35327,-0.42534,1,0
4,GO CARDIAC CONDUCTION,3.7195e-09,-0.3533,-0.38643,1,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,9.1996e-11,-0.35337,-0.39838,1,0
4,GO REGULATION OF GTPASE ACTIVITY,9.3425e-13,-0.35345,-0.46839,1,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,7.2702e-12,-0.35348,-0.46672,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6001e-09,-0.35351,-0.4452,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,2.2775e-07,-0.35353,-0.37809,1,0
4,GO REGULATION OF TOLERANCE INDUCTION,8.1138e-06,-0.35353,-0.39331,1,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,4.719e-07,-0.35363,-0.36209,1,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.6407e-09,-0.35374,-0.41451,1,0
4,GO MAMMARY GLAND DEVELOPMENT,8.3747e-12,-0.35374,-0.45799,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION,1.9948e-11,-0.3538,-0.40165,1,0
4,GO INTRACELLULAR LIPID TRANSPORT,5.2253e-10,-0.35391,-0.432,1,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,1.3888e-11,-0.35403,-0.41861,1,0
4,GO CAMERA TYPE EYE DEVELOPMENT,1.736e-11,-0.35403,-0.42068,1,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,5.7582e-06,-0.35404,-0.37368,1,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,8.0712e-08,-0.35409,-0.38719,1,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,7.2414e-06,-0.35423,-0.38976,1,0
4,GO PLACENTA DEVELOPMENT,4.5922e-10,-0.35427,-0.40767,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2359e-09,-0.35431,-0.41317,1,0
4,GO SECRETION BY TISSUE,1.2733e-08,-0.35442,-0.34235,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,8.2543e-08,-0.35448,-0.41386,1,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,8.0898e-09,-0.35457,-0.37293,1,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2131e-09,-0.35462,-0.41916,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0071051,-0.35463,-0.3129,1,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,2.1234e-05,-0.35469,-0.35281,1,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00043435,-0.35472,-0.38585,1,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,6.552e-13,-0.35473,-0.46762,1,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,8.8389e-07,-0.35478,-0.40665,1,0
4,GO ALPHA BETA T CELL ACTIVATION,6.9323e-10,-0.35482,-0.39412,1,0
4,GO HYALURONAN METABOLIC PROCESS,8.9558e-11,-0.35487,-0.42525,1,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.1812e-12,-0.35489,-0.41211,1,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,6.1583e-08,-0.35491,-0.44798,1,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.8983e-07,-0.35491,-0.38108,1,0
4,GO GMP METABOLIC PROCESS,6.4699e-07,-0.35493,-0.33857,1,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,4.4749e-10,-0.35494,-0.4308,1,0
4,GO LIPOXYGENASE PATHWAY,0.00080175,-0.35512,-0.30523,1,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,5.3747e-08,-0.35512,-0.4033,1,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.1338e-07,-0.35522,-0.37256,1,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00036124,-0.35524,-0.33061,1,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.4634e-11,-0.3553,-0.39127,1,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.2784e-08,-0.3554,-0.43654,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.9078e-09,-0.35545,-0.42339,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.5037e-07,-0.35547,-0.42272,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,5.3617e-10,-0.35549,-0.41825,1,0
4,GO NEURON MIGRATION,8.0712e-08,-0.35561,-0.4025,1,0
4,GO CELL MORPHOGENESIS,1.5968e-11,-0.35564,-0.44908,1,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,1.0804e-10,-0.35566,-0.4,1,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.7449e-12,-0.35569,-0.43553,1,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.8824e-12,-0.35574,-0.40582,1,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.2912e-11,-0.35574,-0.40616,1,0
4,GO EPITHELIAL CELL DEVELOPMENT,6.6774e-12,-0.35578,-0.49046,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,9.4407e-08,-0.3558,-0.41426,1,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.2129e-08,-0.35591,-0.39271,1,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,4.0033e-09,-0.35591,-0.39869,1,0
4,GO PANCREAS DEVELOPMENT,1.2131e-09,-0.35603,-0.40952,1,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0493e-11,-0.35605,-0.45371,1,0
4,GO FOREBRAIN CELL MIGRATION,2.0881e-08,-0.35612,-0.39093,1,0
4,GO SYNAPSE ORGANIZATION,6.586e-10,-0.35613,-0.43396,1,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,7.2414e-06,-0.35615,-0.42222,1,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0011668,-0.3562,-0.35168,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.9748e-11,-0.35621,-0.44654,1,0
4,GO PINOCYTOSIS,1.3671e-08,-0.35625,-0.44116,1,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,2.8925e-08,-0.35629,-0.37933,1,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,3.1032e-11,-0.35631,-0.45382,1,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.462e-12,-0.35645,-0.42854,1,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,5.5078e-11,-0.35654,-0.42115,1,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.3355e-07,-0.35664,-0.389,1,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,6.3074e-11,-0.35665,-0.44779,1,0
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,3.6084e-13,-0.35682,-0.44332,1,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,8.2864e-09,-0.35693,-0.45583,1,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.6823e-09,-0.35694,-0.4041,1,0
4,GO STEROID HORMONE SECRETION,7.2129e-08,-0.35696,-0.37828,1,0
4,GO RESPONSE TO PROSTAGLANDIN E,4.5526e-11,-0.35703,-0.40361,1,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,2.3268e-09,-0.35736,-0.34829,1,0
4,GO REGULATION OF RECEPTOR RECYCLING,1.484e-09,-0.35738,-0.39284,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,1.1535e-07,-0.35743,-0.43148,1,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,2.402e-08,-0.35773,-0.4109,1,0
4,GO CALCINEURIN MEDIATED SIGNALING,3.7602e-11,-0.35801,-0.42363,1,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.1621e-05,-0.35807,-0.37188,1,0
4,GO RETINA LAYER FORMATION,3.8924e-05,-0.3581,-0.38327,1,0
4,GO STORE OPERATED CALCIUM ENTRY,1.5753e-08,-0.35811,-0.43105,1,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.7166e-08,-0.35816,-0.40857,1,0
4,GO PROGRAMMED NECROTIC CELL DEATH,7.71e-09,-0.35838,-0.3968,1,0
4,GO B CELL HOMEOSTASIS,1.0964e-09,-0.35843,-0.45232,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.6307e-12,-0.35861,-0.39875,1,0
4,GO SEGMENTATION,1.4487e-10,-0.35874,-0.38763,1,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.3133e-11,-0.35874,-0.39448,1,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.4701e-07,-0.35883,-0.34692,1,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.856e-06,-0.35895,-0.42452,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3085e-09,-0.35907,-0.40001,1,0
4,GO APPENDAGE MORPHOGENESIS,5.7923e-10,-0.35909,-0.43824,1,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,3.6435e-08,-0.35917,-0.42653,1,0
4,GO RESPONSE TO ESTROGEN,7.4177e-11,-0.3592,-0.42627,1,0
4,GO POST ANAL TAIL MORPHOGENESIS,1.0557e-05,-0.35929,-0.34299,1,0
4,GO NEGATIVE REGULATION OF GROWTH,6.1321e-12,-0.35952,-0.43456,1,0
4,GO INTERLEUKIN 13 PRODUCTION,6.4699e-07,-0.35962,-0.44145,1,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.9948e-11,-0.35966,-0.41984,1,0
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.0169e-05,-0.35972,-0.36169,1,0
4,GO RECEPTOR CLUSTERING,1.1245e-09,-0.35973,-0.46945,1,0
4,GO T HELPER 1 CELL DIFFERENTIATION,9.404e-07,-0.35981,-0.49098,1,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.3793e-12,-0.35995,-0.43056,1,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,1.182e-12,-0.36017,-0.47112,1,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,6.7461e-07,-0.36021,-0.36529,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.2538e-08,-0.36021,-0.38994,1,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.1004e-08,-0.36024,-0.44307,1,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.5164e-08,-0.36025,-0.4309,1,0
4,GO POSITIVE REGULATION OF MYELINATION,1.069e-09,-0.36037,-0.39169,1,0
4,GO EOSINOPHIL MIGRATION,4.9694e-05,-0.36037,-0.36832,1,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,7.2202e-11,-0.36039,-0.40767,1,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,3.1032e-11,-0.36039,-0.41408,1,0
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,3.2764e-10,-0.36042,-0.42288,1,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9989e-07,-0.36045,-0.39552,1,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,1.3085e-09,-0.36045,-0.42864,1,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,9.3415e-09,-0.36047,-0.39714,1,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,6.205e-09,-0.36056,-0.41268,1,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,6.586e-10,-0.36056,-0.45311,1,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0011836,-0.36078,-0.30741,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.7602e-11,-0.3609,-0.41018,1,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.9926e-08,-0.36099,-0.40243,1,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,1.5994e-06,-0.36112,-0.43995,1,0
4,GO STRIATED MUSCLE CONTRACTION,9.4157e-10,-0.36117,-0.38366,1,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.1948e-11,-0.36152,-0.41635,1,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.9332e-05,-0.36153,-0.33955,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.3599e-06,-0.36155,-0.40943,1,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,3.7319e-10,-0.36156,-0.46383,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.9834e-06,-0.36166,-0.39662,1,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.9989e-07,-0.3617,-0.38879,1,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,7.0671e-12,-0.36172,-0.39682,1,0
4,GO DIVALENT METAL ION EXPORT,4.7963e-08,-0.3618,-0.42766,1,0
4,GO AMINO ACID IMPORT,3.7282e-08,-0.36214,-0.41062,1,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,5.02e-08,-0.36216,-0.41933,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,6.6581e-11,-0.3623,-0.37855,1,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,3.7195e-09,-0.36242,-0.40584,1,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,1.2682e-10,-0.3625,-0.43212,1,0
4,GO RESPONSE TO VITAMIN D,3.1479e-07,-0.36263,-0.43137,1,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4305e-07,-0.36263,-0.41475,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.1032e-11,-0.36276,-0.44625,1,0
4,GO MUSCLE ADAPTATION,2.0983e-10,-0.36277,-0.43947,1,0
4,GO ZYMOGEN INHIBITION,1.8573e-08,-0.3629,-0.42355,1,0
4,GO REGULATION OF MAST CELL ACTIVATION,8.0712e-08,-0.36306,-0.3929,1,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0060595,-0.36306,-0.26514,1,0
4,GO ACTIVATION OF GTPASE ACTIVITY,5.793e-12,-0.3632,-0.46344,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.2685e-12,-0.36354,-0.44113,1,0
4,GO MONOCYTE CHEMOTAXIS,7.6446e-07,-0.36364,-0.3494,1,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5526e-11,-0.3637,-0.38589,1,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,2.3784e-07,-0.36374,-0.35114,1,0
4,GO RESPONSE TO COLD,1.9563e-06,-0.36381,-0.37153,1,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,2.3312e-10,-0.36382,-0.37112,1,0
4,GO POSITIVE REGULATION OF CELL MATURATION,9.4341e-06,-0.36392,-0.38644,1,0
4,GO SYNAPTIC VESICLE RECYCLING,1.4076e-07,-0.36398,-0.40222,1,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,4.1026e-05,-0.3641,-0.41493,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.5164e-08,-0.36411,-0.4591,1,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,2.8753e-10,-0.36419,-0.46501,1,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,1.8723e-07,-0.36434,-0.41628,1,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1.6062e-07,-0.36449,-0.41539,1,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0036e-08,-0.36461,-0.40487,1,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,3.8833e-12,-0.36474,-0.43412,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00030928,-0.36474,-0.31579,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.1099e-11,-0.36474,-0.38821,1,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.7693e-06,-0.36475,-0.34462,1,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,7.2702e-12,-0.36499,-0.47446,1,0
4,GO CATECHOLAMINE UPTAKE,2.0364e-06,-0.36502,-0.36282,1,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.9136e-07,-0.36522,-0.4361,1,0
4,GO VITAMIN D METABOLIC PROCESS,1.3468e-07,-0.36524,-0.42559,1,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.1729e-08,-0.36526,-0.42212,1,0
4,GO NEURON PROJECTION EXTENSION,5.0922e-10,-0.36527,-0.44716,1,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.2434e-08,-0.36542,-0.39633,1,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.1245e-09,-0.36543,-0.40718,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,8.1138e-06,-0.36543,-0.42742,1,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,1.7693e-06,-0.36544,-0.36406,1,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,4.7488e-06,-0.36545,-0.41739,1,0
4,GO RESPONSE TO CALCIUM ION,8.2618e-11,-0.36555,-0.40146,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,1.9136e-07,-0.36561,-0.41705,1,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,6.6717e-09,-0.3657,-0.41196,1,0
4,GO POSITIVE REGULATION OF JNK CASCADE,4.0677e-13,-0.3657,-0.46971,1,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,6.5906e-08,-0.3658,-0.34104,1,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,2.4491e-12,-0.36592,-0.45588,1,0
4,GO CELL CELL ADHESION,5.0135e-13,-0.36594,-0.45051,1,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,6.1119e-05,-0.36595,-0.35682,1,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.2344e-05,-0.36601,-0.3568,1,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.2954e-05,-0.36607,-0.38042,1,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.2118e-07,-0.36609,-0.37751,1,0
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,1.5713e-07,-0.36612,-0.40688,1,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,3.5412e-09,-0.3662,-0.40708,1,0
4,GO TRANSEPITHELIAL TRANSPORT,8.7184e-11,-0.36624,-0.38348,1,0
4,GO LIPOPROTEIN LOCALIZATION,1.2682e-10,-0.36625,-0.45976,1,0
4,GO FEMALE SEX DIFFERENTIATION,6.6581e-11,-0.36635,-0.3856,1,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,1.2482e-05,-0.36658,-0.38146,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.5629e-12,-0.3666,-0.53459,1,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,3.2146e-06,-0.3667,-0.3758,1,0
4,GO LEUKOCYTE HOMEOSTASIS,4.0817e-11,-0.36672,-0.41586,1,0
4,GO EMBRYONIC PATTERN SPECIFICATION,1.2143e-08,-0.36672,-0.35623,1,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.4371e-06,-0.36683,-0.39769,1,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,1.1789e-06,-0.36686,-0.43634,1,0
4,GO RESPONSE TO CAFFEINE,6.0991e-06,-0.36693,-0.31252,1,0
4,GO PROTEIN KINASE B SIGNALING,3.1757e-12,-0.36696,-0.42194,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.471e-07,-0.36709,-0.44222,1,0
4,GO RESPONSE TO INACTIVITY,2.3784e-07,-0.36712,-0.45981,1,0
4,GO ADAPTIVE IMMUNE RESPONSE,2.1543e-10,-0.36714,-0.41398,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,2.7797e-11,-0.36717,-0.48022,1,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,3.2057e-05,-0.36728,-0.41797,1,0
4,GO SENSORY SYSTEM DEVELOPMENT,8.1414e-12,-0.36728,-0.4241,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,8.4424e-05,-0.36738,-0.34032,1,0
4,GO HISTAMINE TRANSPORT,0.00022927,-0.36741,-0.33524,1,0
4,GO NEUROBLAST PROLIFERATION,2.5164e-08,-0.36741,-0.4096,1,0
4,GO RESPONSE TO PH,1.6109e-10,-0.36748,-0.45074,1,0
4,GO TRNA CATABOLIC PROCESS,1.1806e-05,-0.3676,-0.39836,1,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.5043e-10,-0.36773,-0.41723,1,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,8.7184e-11,-0.36775,-0.42935,1,0
4,GO AUTOPHAGOSOME ORGANIZATION,8.0424e-11,-0.36775,-0.41949,1,0
4,GO ENGULFMENT OF APOPTOTIC CELL,7.4177e-11,-0.36776,-0.45009,1,0
4,GO REGULATION OF URINE VOLUME,8.8611e-12,-0.36777,-0.4097,1,0
4,GO KETONE BIOSYNTHETIC PROCESS,8.4805e-07,-0.3678,-0.34364,1,0
4,GO PRESYNAPTIC ENDOCYTOSIS,1.7154e-07,-0.36788,-0.39996,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.8701e-05,-0.36791,-0.3418,1,0
4,GO REGULATION OF CELL FATE SPECIFICATION,5.9498e-07,-0.36804,-0.39479,1,0
4,GO XENOBIOTIC TRANSPORT,5.815e-11,-0.36805,-0.46232,1,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,1.069e-09,-0.36807,-0.44422,1,0
4,GO TISSUE REGENERATION,4.3606e-10,-0.36807,-0.39025,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,2.2926e-08,-0.36812,-0.42578,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00021857,-0.36815,-0.34758,1,0
4,GO PROTEIN TARGETING TO VACUOLE,1.2348e-10,-0.36828,-0.45461,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,9.7068e-11,-0.36828,-0.46992,1,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,8.4877e-09,-0.36832,-0.41806,1,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,9.4407e-08,-0.36832,-0.37263,1,0
4,GO CHEMOKINE PRODUCTION,1.3376e-10,-0.36836,-0.4151,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,6.4805e-11,-0.36839,-0.41896,1,0
4,GO LEFT RIGHT AXIS SPECIFICATION,8.9166e-06,-0.36851,-0.41381,1,0
4,GO CELL MOTILITY,4.1912e-13,-0.36864,-0.45267,1,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,5.8856e-08,-0.36866,-0.37408,1,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,4.8198e-07,-0.36866,-0.37158,1,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,3.7735e-12,-0.36869,-0.45274,1,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.4634e-11,-0.36874,-0.4347,1,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,5.0237e-12,-0.36875,-0.46784,1,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,1.1375e-05,-0.3688,-0.35225,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,6.1583e-08,-0.36894,-0.45201,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,3.6667e-12,-0.36894,-0.46226,1,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,5.5016e-10,-0.36908,-0.41464,1,0
4,GO ESTABLISHMENT OF CELL POLARITY,1.3737e-10,-0.36912,-0.43657,1,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.4773e-06,-0.36916,-0.41213,1,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,5.5016e-10,-0.36926,-0.47752,1,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00068191,-0.36932,-0.34938,1,0
4,GO AMYLOID BETA CLEARANCE,9.6431e-12,-0.36935,-0.46045,1,0
4,GO CELL CELL JUNCTION ORGANIZATION,6.4805e-11,-0.36946,-0.47444,1,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,1.0279e-08,-0.3695,-0.38884,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.249e-10,-0.36956,-0.40883,1,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,1.1086e-06,-0.36978,-0.33043,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,1.7693e-06,-0.37002,-0.39383,1,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,3.4098e-06,-0.37004,-0.39048,1,0
4,GO REGULATION OF VASCULAR PERMEABILITY,6.3088e-12,-0.37011,-0.52339,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.3133e-11,-0.37014,-0.45761,1,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.6784e-11,-0.37018,-0.42903,1,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,6.2046e-07,-0.37019,-0.3929,1,0
4,GO SPHINGOID METABOLIC PROCESS,6.5906e-08,-0.3702,-0.42737,1,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.8888e-05,-0.37032,-0.42353,1,0
4,GO AXON DEVELOPMENT,5.0922e-10,-0.37034,-0.43448,1,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,2.521e-12,-0.37036,-0.41295,1,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,1.051e-12,-0.3708,-0.49117,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.4821e-13,-0.37089,-0.44992,1,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9602e-12,-0.3709,-0.45959,1,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.7319e-10,-0.37104,-0.47946,1,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,6.8348e-09,-0.37109,-0.39605,1,0
4,GO FUCOSYLATION,2.4586e-08,-0.37111,-0.40587,1,0
4,GO RESPONSE TO KETONE,4.7449e-12,-0.37112,-0.40895,1,0
4,GO B CELL DIFFERENTIATION,1.0804e-10,-0.37116,-0.43413,1,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,2.4837e-07,-0.37128,-0.46854,1,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,1.7154e-07,-0.37131,-0.3932,1,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,6.6717e-09,-0.37148,-0.41694,1,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,3.8833e-12,-0.37154,-0.48025,1,0
4,GO SHORT TERM MEMORY,8.5858e-05,-0.37155,-0.368,1,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.3554e-11,-0.37168,-0.44355,1,0
4,GO SEROTONIN TRANSPORT,2.5359e-06,-0.37171,-0.36529,1,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,1.8723e-07,-0.37177,-0.35839,1,0
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,7.2414e-06,-0.37184,-0.29973,1,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,4.31e-06,-0.37188,-0.31508,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,2.2912e-11,-0.37207,-0.41056,1,0
4,GO COCHLEA DEVELOPMENT,4.1025e-09,-0.37217,-0.39004,1,0
4,GO REGULATION OF BODY FLUID LEVELS,7.1613e-13,-0.37234,-0.45038,1,0
4,GO SKELETAL MUSCLE ADAPTATION,5.8049e-05,-0.37234,-0.30191,1,0
4,GO POSITIVE CHEMOTAXIS,9.3752e-12,-0.37237,-0.44198,1,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.3351e-08,-0.37253,-0.41372,1,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,9.6538e-08,-0.37265,-0.38915,1,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.7797e-11,-0.37275,-0.45015,1,0
4,GO ASYMMETRIC CELL DIVISION,2.4452e-09,-0.37292,-0.43338,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.1533e-09,-0.37299,-0.44848,1,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,2.4972e-05,-0.37302,-0.35722,1,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.6158e-05,-0.37311,-0.46729,1,0
4,GO INTERLEUKIN 1 PRODUCTION,1.1828e-09,-0.37313,-0.44479,1,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.6407e-09,-0.37315,-0.4755,1,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,5.6487e-06,-0.37331,-0.35096,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.8301e-10,-0.37341,-0.41385,1,0
4,GO SNARE COMPLEX ASSEMBLY,3.2859e-07,-0.37402,-0.39458,1,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.8286e-11,-0.37403,-0.49182,1,0
4,GO REGULATION OF GLIAL CELL MIGRATION,8.0424e-11,-0.37405,-0.39176,1,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,2.1196e-06,-0.37406,-0.49353,1,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,8.2903e-10,-0.37408,-0.39866,1,0
4,GO TOXIN METABOLIC PROCESS,1.8701e-05,-0.37424,-0.35149,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,8.0898e-09,-0.37429,-0.42279,1,0
4,GO MAST CELL MIGRATION,8.2686e-06,-0.37432,-0.43773,1,0
4,GO INTERLEUKIN 6 PRODUCTION,6.4805e-11,-0.37445,-0.41718,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,5.7536e-08,-0.37448,-0.39999,1,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,2.3467e-08,-0.37454,-0.37603,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,4.9069e-08,-0.37455,-0.40219,1,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.0958e-05,-0.37462,-0.35118,1,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.1064e-09,-0.37469,-0.41563,1,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,7.0017e-09,-0.37474,-0.41707,1,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,9.3425e-13,-0.37475,-0.46695,1,0
4,GO REGULATION OF JUN KINASE ACTIVITY,2.595e-12,-0.37485,-0.47549,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.8814e-05,-0.37488,-0.37497,1,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.9624e-10,-0.37489,-0.45738,1,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,1.0804e-10,-0.37498,-0.39973,1,0
4,GO REGULATION OF CELL SIZE,6.3088e-12,-0.37502,-0.45942,1,0
4,GO STEROL TRANSPORT,1.2074e-11,-0.37521,-0.45091,1,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,2.6306e-11,-0.37531,-0.49623,1,0
4,GO CARNITINE METABOLIC PROCESS,2.6914e-06,-0.37541,-0.35114,1,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,3.3228e-08,-0.37554,-0.40921,1,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.2169e-06,-0.37573,-0.45046,1,0
4,GO SUPEROXIDE METABOLIC PROCESS,8.5043e-10,-0.37579,-0.35741,1,0
4,GO TUBE DEVELOPMENT,1.051e-12,-0.37603,-0.45989,1,0
4,GO RESPONSE TO DEXAMETHASONE,1.069e-09,-0.37605,-0.41584,1,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.0279e-08,-0.37607,-0.43272,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.5277e-10,-0.37629,-0.46735,1,0
4,GO SKELETAL MUSCLE CONTRACTION,1.0036e-08,-0.3763,-0.35855,1,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.0519e-10,-0.37641,-0.48266,1,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,4.1125e-12,-0.37643,-0.45311,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,3.9717e-11,-0.37649,-0.42332,1,0
4,GO NOREPINEPHRINE SECRETION,6.2175e-05,-0.37657,-0.32695,1,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.2434e-08,-0.37666,-0.46976,1,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,1.2023e-10,-0.37695,-0.40516,1,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,9.5999e-07,-0.377,-0.4467,1,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.7184e-11,-0.37706,-0.44625,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,1.3056e-06,-0.37708,-0.42999,1,0
4,GO HYPOTHALAMUS DEVELOPMENT,1.5037e-07,-0.37739,-0.38348,1,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,4.6578e-06,-0.37749,-0.41228,1,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,1.3737e-10,-0.37752,-0.38847,1,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,2.7494e-12,-0.37756,-0.48378,1,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,3.5038e-07,-0.3776,-0.44795,1,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,2.7668e-07,-0.3778,-0.40932,1,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1.1282e-07,-0.37793,-0.41448,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,3.9941e-08,-0.37818,-0.44943,1,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.1245e-09,-0.37819,-0.45685,1,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,3.055e-09,-0.37862,-0.52266,1,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,6.4434e-08,-0.37873,-0.41711,1,0
4,GO HYPOTONIC RESPONSE,2.4452e-09,-0.37877,-0.45786,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.2417e-11,-0.37878,-0.40896,1,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,2.2117e-10,-0.37882,-0.44236,1,0
4,GO HYPEROSMOTIC RESPONSE,2.3933e-10,-0.37888,-0.40471,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.4634e-11,-0.37912,-0.47464,1,0
4,GO RESPONSE TO MECHANICAL STIMULUS,5.0766e-11,-0.37916,-0.44803,1,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,1.8135e-09,-0.37931,-0.50372,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,9.6431e-12,-0.37941,-0.44436,1,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.8161e-07,-0.37953,-0.41273,1,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,3.8118e-09,-0.37953,-0.37533,1,0
4,GO HEART MORPHOGENESIS,1.5968e-11,-0.37956,-0.44206,1,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2926e-08,-0.37963,-0.44018,1,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,1.3419e-09,-0.37964,-0.44539,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.4967e-09,-0.37983,-0.37094,1,0
4,GO RESPONSE TO GROWTH FACTOR,1.9993e-12,-0.37991,-0.44808,1,0
4,GO MUSCLE HYPERTROPHY,4.8359e-10,-0.38002,-0.43945,1,0
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,5.6594e-11,-0.38003,-0.45477,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,9.9064e-10,-0.38045,-0.49896,1,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,3.8347e-06,-0.38046,-0.42023,1,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.6361e-10,-0.38052,-0.45589,1,0
4,GO MICROVILLUS ASSEMBLY,7.892e-08,-0.38052,-0.50531,1,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,3.9941e-08,-0.3806,-0.38233,1,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,2.634e-09,-0.38073,-0.44887,1,0
4,GO LONG TERM SYNAPTIC POTENTIATION,5.2165e-11,-0.38075,-0.45007,1,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.65e-07,-0.38079,-0.4359,1,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,4.1751e-05,-0.38083,-0.38917,1,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,3.8347e-06,-0.38083,-0.40935,1,0
4,GO REGULATION OF GONAD DEVELOPMENT,3.7319e-10,-0.38086,-0.41321,1,0
4,GO PROTEIN DEMETHYLATION,5.3562e-07,-0.38087,-0.3951,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,5.3747e-08,-0.38092,-0.48643,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.6145e-12,-0.38092,-0.42431,1,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,2.342e-06,-0.38093,-0.39968,1,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,6.1583e-08,-0.38097,-0.38944,1,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,1.2281e-06,-0.38112,-0.41938,1,0
4,GO HORMONE BIOSYNTHETIC PROCESS,1.155e-06,-0.38112,-0.33716,1,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,1.051e-12,-0.38116,-0.47738,1,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,1.5277e-10,-0.38117,-0.44237,1,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,1.2417e-11,-0.38122,-0.48202,1,0
4,GO LYMPHOCYTE MIGRATION,3.2685e-12,-0.38125,-0.41729,1,0
4,GO ANION HOMEOSTASIS,4.8076e-11,-0.38127,-0.42467,1,0
4,GO INTEGRIN ACTIVATION,5.2359e-09,-0.3814,-0.47155,1,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0033799,-0.38145,-0.24974,1,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,2.0546e-09,-0.38146,-0.405,1,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,3.6567e-07,-0.38169,-0.34748,1,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,1.6823e-09,-0.3817,-0.41509,1,0
4,GO RENAL WATER HOMEOSTASIS,2.6581e-10,-0.38184,-0.44827,1,0
4,GO FATTY ACID HOMEOSTASIS,1.2534e-06,-0.38199,-0.38825,1,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,2.5164e-08,-0.38216,-0.39463,1,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,9.2321e-08,-0.38217,-0.45145,1,0
4,GO COMPLEMENT ACTIVATION,2.801e-10,-0.38218,-0.48636,1,0
4,GO INTESTINAL ABSORPTION,4.6202e-07,-0.38229,-0.43503,1,0
4,GO REGULATION OF STEROL TRANSPORT,4.249e-10,-0.38231,-0.4021,1,0
4,GO SYNAPTIC VESICLE DOCKING,0.0019285,-0.38234,-0.35922,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,6.7461e-07,-0.38242,-0.35145,1,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,4.8673e-09,-0.38281,-0.42164,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.2117e-10,-0.38285,-0.46214,1,0
4,GO INTERMEMBRANE LIPID TRANSFER,2.2286e-11,-0.38285,-0.45879,1,0
4,GO REGULATION OF CELL MORPHOGENESIS,9.9185e-12,-0.38287,-0.46758,1,0
4,GO REGULATION OF SYNAPSE MATURATION,2.342e-06,-0.38287,-0.44901,1,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,1.3133e-11,-0.38301,-0.43723,1,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,1.0527e-08,-0.38303,-0.47207,1,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,2.342e-06,-0.38305,-0.42105,1,0
4,GO NEUROTRANSMITTER REUPTAKE,1.0791e-07,-0.38315,-0.37992,1,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.4112e-09,-0.38317,-0.47709,1,0
4,GO MACROPHAGE ACTIVATION,2.1085e-11,-0.38318,-0.43687,1,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,2.6914e-06,-0.38331,-0.44639,1,0
4,GO SCHWANN CELL DEVELOPMENT,2.1595e-09,-0.38351,-0.46254,1,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,8.9487e-10,-0.38356,-0.44343,1,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,4.9228e-07,-0.3836,-0.34387,1,0
4,GO REGULATION OF PROTEIN MATURATION,4.9403e-11,-0.38362,-0.43595,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2482e-05,-0.38371,-0.41093,1,0
4,GO RESPONSE TO INTERLEUKIN 15,2.9805e-09,-0.38392,-0.45841,1,0
4,GO CHOLESTEROL EFFLUX,3.4634e-11,-0.38393,-0.41533,1,0
4,GO BONE MORPHOGENESIS,3.3697e-11,-0.38397,-0.47941,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,3.7195e-09,-0.38398,-0.42396,1,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,3.628e-05,-0.38407,-0.44384,1,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.9805e-09,-0.38415,-0.42254,1,0
4,GO MYELOID CELL DEVELOPMENT,2.9078e-09,-0.38417,-0.4367,1,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,2.559e-11,-0.38418,-0.45324,1,0
4,GO INTERFERON ALPHA PRODUCTION,2.3268e-09,-0.38426,-0.41269,1,0
4,GO INTERFERON BETA PRODUCTION,1.9905e-10,-0.38445,-0.44266,1,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,1.6418e-07,-0.38448,-0.39821,1,0
4,GO MEMBRANE HYPERPOLARIZATION,1.9175e-06,-0.38461,-0.36901,1,0
4,GO REGULATION OF TUBULIN DEACETYLATION,1.3442e-05,-0.38462,-0.38225,1,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.3747e-08,-0.38462,-0.44247,1,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,3.1312e-09,-0.38479,-0.3943,1,0
4,GO CELL CHEMOTAXIS,6.1321e-12,-0.38481,-0.42613,1,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1.5217e-09,-0.38487,-0.5027,1,0
4,GO BONE RESORPTION,8.2903e-10,-0.385,-0.42913,1,0
4,GO DOPAMINE TRANSPORT,0.00020178,-0.3851,-0.32545,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,1.0964e-09,-0.38512,-0.4075,1,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.2162e-07,-0.38514,-0.47917,1,0
4,GO FORELIMB MORPHOGENESIS,2.6362e-08,-0.38536,-0.40789,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,9.9185e-12,-0.38552,-0.52669,1,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.7309e-08,-0.38575,-0.40789,1,0
4,GO REGULATION OF COLLATERAL SPROUTING,2.206e-06,-0.38575,-0.44847,1,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.5461e-06,-0.3858,-0.38177,1,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,1.0792e-11,-0.38609,-0.45782,1,0
4,GO LAMELLIPODIUM ASSEMBLY,8.7184e-11,-0.38612,-0.44475,1,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,3.247e-08,-0.38615,-0.3716,1,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,4.0657e-06,-0.38624,-0.35853,1,0
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,6.2046e-07,-0.3863,-0.41361,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00021857,-0.38648,-0.43897,1,0
4,GO T CELL MEDIATED CYTOTOXICITY,5.9056e-05,-0.38654,-0.42799,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.7286e-10,-0.38657,-0.41671,1,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,1.9465e-08,-0.38676,-0.38038,1,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,6.0205e-08,-0.3868,-0.4367,1,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,7.1274e-05,-0.38688,-0.3459,1,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,2.188e-08,-0.38704,-0.40255,1,0
4,GO REGULATION OF CHEMOTAXIS,4.7449e-12,-0.38714,-0.43084,1,0
4,GO RECEPTOR CATABOLIC PROCESS,4.1403e-10,-0.38716,-0.48804,1,0
4,GO OSTEOCLAST DIFFERENTIATION,3.6667e-12,-0.38716,-0.4429,1,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.4724e-12,-0.38717,-0.45897,1,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,3.8149e-08,-0.38721,-0.40724,1,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.4686e-11,-0.3873,-0.41682,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,2.8886e-07,-0.38731,-0.48619,1,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.2505e-06,-0.38756,-0.41495,1,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,1.7687e-09,-0.3877,-0.50532,1,0
4,GO REGULATION OF FATTY ACID OXIDATION,7.8976e-09,-0.38771,-0.39194,1,0
4,GO REGULATION OF HORMONE METABOLIC PROCESS,1.2058e-07,-0.38774,-0.46476,1,0
4,GO PROTEIN OXIDATION,3.9822e-07,-0.38785,-0.45287,1,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,2.6828e-05,-0.38799,-0.40241,1,0
4,GO REPLICATIVE SENESCENCE,1.4741e-05,-0.38801,-0.33896,1,0
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00014839,-0.38814,-0.36529,1,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,6.6717e-09,-0.38818,-0.51213,1,0
4,GO CELL JUNCTION DISASSEMBLY,5.3617e-10,-0.3883,-0.46629,1,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,7.1613e-13,-0.38834,-0.46581,1,0
4,GO ALANINE TRANSPORT,2.402e-08,-0.38843,-0.5148,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,7.2702e-12,-0.38856,-0.50328,1,0
4,GO EMBRYONIC HEMOPOIESIS,2.8262e-08,-0.38865,-0.43707,1,0
4,GO COAGULATION,1.5838e-12,-0.38894,-0.47462,1,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.7614e-08,-0.38901,-0.47382,1,0
4,GO RELAXATION OF MUSCLE,4.8198e-07,-0.38929,-0.37804,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.8824e-12,-0.38934,-0.50356,1,0
4,GO INTRACELLULAR MRNA LOCALIZATION,4.1552e-07,-0.38946,-0.41989,1,0
4,GO NEURAL CREST FORMATION,8.4262e-06,-0.38954,-0.35453,1,0
4,GO GLIAL CELL ACTIVATION,5.815e-11,-0.38966,-0.4214,1,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,3.4516e-10,-0.38977,-0.44042,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00020504,-0.38982,-0.44798,1,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.1579e-08,-0.38995,-0.4194,1,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,9.3415e-09,-0.38999,-0.45988,1,0
4,GO RESPONSE TO AXON INJURY,9.3752e-12,-0.39,-0.46345,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.1794e-07,-0.39003,-0.42286,1,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,1.734e-06,-0.39008,-0.41748,1,0
4,GO REGULATION OF FIBRINOLYSIS,4.9624e-10,-0.39012,-0.48409,1,0
4,GO OSSIFICATION,4.7449e-12,-0.39028,-0.45011,1,0
4,GO DENDRITIC CELL DIFFERENTIATION,3.5794e-07,-0.39034,-0.45495,1,0
4,GO HINDLIMB MORPHOGENESIS,9.7991e-09,-0.39054,-0.42863,1,0
4,GO CARDIAC CHAMBER FORMATION,1.2954e-05,-0.39082,-0.40346,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.2785e-11,-0.39091,-0.43637,1,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.5753e-08,-0.39092,-0.50126,1,0
4,GO CELL JUNCTION MAINTENANCE,2.1807e-07,-0.39093,-0.44116,1,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,1.182e-12,-0.39103,-0.51471,1,0
4,GO INTERLEUKIN 5 PRODUCTION,8.1361e-07,-0.3911,-0.43333,1,0
4,GO DENDRITIC CELL MIGRATION,5.9432e-10,-0.39116,-0.4301,1,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.0879e-07,-0.39118,-0.51366,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,1.4487e-10,-0.39146,-0.48762,1,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.5277e-10,-0.39156,-0.3729,1,0
4,GO NOTCH RECEPTOR PROCESSING,3.5646e-05,-0.39162,-0.38635,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.2784e-06,-0.3917,-0.37454,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00027716,-0.39188,-0.34413,1,0
4,GO ACTIN FILAMENT SEVERING,3.2162e-07,-0.39191,-0.49536,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,3.9941e-08,-0.39199,-0.35084,1,0
4,GO REGULATION OF CELL ADHESION,6.3604e-13,-0.39202,-0.48785,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.277e-11,-0.39213,-0.47828,1,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.1815e-08,-0.39219,-0.42896,1,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,3.247e-08,-0.39222,-0.421,1,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.4586e-08,-0.39223,-0.42792,1,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,1.5102e-11,-0.39242,-0.51675,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,9.1996e-11,-0.39249,-0.45939,1,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.6567e-07,-0.39281,-0.41814,1,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,7.3765e-13,-0.39291,-0.5116,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,6.1583e-08,-0.39292,-0.47684,1,0
4,GO T CELL DIFFERENTIATION IN THYMUS,3.019e-11,-0.39297,-0.3939,1,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,7.969e-07,-0.39304,-0.402,1,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,1.9546e-09,-0.39308,-0.40394,1,0
4,GO MAINTENANCE OF CELL POLARITY,4.4148e-09,-0.39311,-0.41287,1,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,3.1032e-11,-0.39318,-0.46517,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.536e-06,-0.39327,-0.49516,1,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.0853e-05,-0.39329,-0.40744,1,0
4,GO RESPONSE TO CORTICOSTEROID,4.7449e-12,-0.39336,-0.4167,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.3629e-10,-0.39336,-0.42653,1,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,6.5906e-08,-0.39337,-0.39532,1,0
4,GO GOLGI TO ENDOSOME TRANSPORT,7.4854e-10,-0.39358,-0.481,1,0
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,2.4452e-09,-0.39376,-0.45716,1,0
4,GO SCHWANN CELL DIFFERENTIATION,2.5893e-10,-0.39377,-0.4558,1,0
4,GO REGULATION OF AXONOGENESIS,1.6001e-09,-0.39389,-0.469,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,3.9064e-09,-0.3939,-0.41387,1,0
4,GO PROSTATE GLAND DEVELOPMENT,7.2964e-10,-0.39398,-0.47438,1,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,2.2286e-11,-0.39422,-0.46416,1,0
4,GO REGULATION OF STEM CELL DIVISION,2.5756e-08,-0.39423,-0.39504,1,0
4,GO NEURON MATURATION,5.7536e-08,-0.39425,-0.38117,1,0
4,GO PLATELET MORPHOGENESIS,2.8369e-09,-0.39431,-0.51265,1,0
4,GO RESPONSE TO MAGNESIUM ION,5.9498e-07,-0.39432,-0.49484,1,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.0322e-07,-0.39434,-0.46777,1,0
4,GO MITOCHONDRIAL DEPOLARIZATION,2.0429e-07,-0.39444,-0.37079,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.6407e-09,-0.39455,-0.45755,1,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,3.9035e-08,-0.3946,-0.48099,1,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9963e-12,-0.39464,-0.44846,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5277e-10,-0.39465,-0.50934,1,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,1.3024e-10,-0.39481,-0.43748,1,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.0033e-09,-0.39483,-0.41668,1,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,1.0519e-10,-0.39507,-0.45895,1,0
4,GO VAGINA DEVELOPMENT,2.2697e-09,-0.39514,-0.44109,1,0
4,GO CARTILAGE DEVELOPMENT,1.0792e-11,-0.39517,-0.48168,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,7.2964e-10,-0.39518,-0.43551,1,0
4,GO RENAL TUBULE DEVELOPMENT,1.0241e-10,-0.39529,-0.43762,1,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00033432,-0.39531,-0.28263,1,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.7602e-11,-0.39531,-0.44872,1,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.1729e-08,-0.39568,-0.38872,1,0
4,GO RESPONSE TO INTERLEUKIN 2,1.6514e-08,-0.3957,-0.43516,1,0
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,9.6538e-08,-0.39571,-0.37505,1,0
4,GO MAST CELL MEDIATED IMMUNITY,1.8142e-08,-0.39576,-0.42698,1,0
4,GO GLIAL CELL MIGRATION,5.6304e-12,-0.39581,-0.49672,1,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.1828e-09,-0.39584,-0.41133,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,5.3602e-11,-0.39601,-0.42917,1,0
4,GO COCHLEA MORPHOGENESIS,1.2434e-08,-0.39601,-0.41807,1,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,2.3891e-06,-0.39607,-0.34848,1,0
4,GO MITOTIC CELL CYCLE ARREST,1.0781e-08,-0.39611,-0.42205,1,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,2.65e-07,-0.39612,-0.38299,1,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.2414e-06,-0.39619,-0.438,1,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,5.815e-11,-0.39621,-0.47802,1,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,5.0237e-12,-0.39622,-0.43036,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00067188,-0.39629,-0.36672,1,0
4,GO BIOLOGICAL ADHESION,3.1054e-13,-0.3963,-0.48414,1,0
4,GO RESPIRATORY BURST,1.4112e-09,-0.39635,-0.41302,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.402e-08,-0.39663,-0.44372,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION,2.1812e-12,-0.39664,-0.47347,1,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.0527e-08,-0.3967,-0.42874,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,2.1338e-07,-0.3967,-0.45413,1,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,1.277e-11,-0.39676,-0.51214,1,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9064e-09,-0.39679,-0.41606,1,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,8.0898e-09,-0.39698,-0.4477,1,0
4,GO RESPONSE TO BMP,7.8286e-11,-0.39701,-0.45934,1,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2565e-10,-0.39702,-0.5155,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,9.9803e-06,-0.39703,-0.36224,1,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,6.4592e-06,-0.39709,-0.34393,1,0
4,GO ARTERY MORPHOGENESIS,3.5427e-10,-0.39713,-0.46847,1,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,2.188e-08,-0.39738,-0.38738,1,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,7.5266e-09,-0.39764,-0.45287,1,0
4,GO MEMBRANE DEPOLARIZATION,2.4586e-08,-0.39766,-0.41598,1,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.5604e-09,-0.39766,-0.47155,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.0279e-11,-0.39772,-0.4619,1,0
4,GO REGULATION OF LIPID STORAGE,2.1085e-11,-0.39776,-0.44102,1,0
4,GO LAMELLIPODIUM ORGANIZATION,3.019e-11,-0.39788,-0.45976,1,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.1398e-10,-0.39792,-0.46494,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.8389e-07,-0.39811,-0.39818,1,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,1.0791e-07,-0.39817,-0.41182,1,0
4,GO PIGMENT ACCUMULATION,1.0322e-07,-0.39823,-0.42668,1,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,1.5052e-06,-0.39835,-0.44561,1,0
4,GO OLIGODENDROCYTE DEVELOPMENT,9.2321e-08,-0.39837,-0.41225,1,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,1.4112e-09,-0.3987,-0.52479,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.9602e-12,-0.39878,-0.45873,1,0
4,GO CELLULAR RESPONSE TO FATTY ACID,2.5695e-09,-0.39884,-0.40826,1,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,6.4434e-08,-0.39914,-0.36603,1,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,1.3737e-10,-0.39923,-0.42449,1,0
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,2.9371e-11,-0.3993,-0.41944,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,4.8839e-05,-0.39937,-0.37875,1,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,2.1196e-06,-0.39938,-0.41125,1,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,9.1996e-11,-0.39945,-0.45538,1,0
4,GO STEM CELL DIVISION,1.1097e-10,-0.39961,-0.49176,1,0
4,GO GALACTOSE METABOLIC PROCESS,4.6578e-06,-0.39969,-0.44431,1,0
4,GO RESPONSE TO NUTRIENT,7.6205e-11,-0.3998,-0.40443,1,0
4,GO CARDIAC ATRIUM DEVELOPMENT,1.2434e-08,-0.39987,-0.4608,1,0
4,GO FIBRINOLYSIS,1.0161e-09,-0.39999,-0.54878,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,5.4701e-07,-0.39999,-0.35144,1,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.7614e-08,-0.40003,-0.45136,1,0
4,GO CHLORIDE ION HOMEOSTASIS,3.9064e-09,-0.40015,-0.48633,1,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.9717e-11,-0.40017,-0.48579,1,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,1.1535e-07,-0.40019,-0.42123,1,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.2958e-06,-0.40026,-0.41141,1,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.8881e-10,-0.40031,-0.48016,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,4.4302e-11,-0.4006,-0.43887,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.3948e-05,-0.40081,-0.3753,1,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,3.2146e-06,-0.40087,-0.46593,1,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,6.1583e-08,-0.40124,-0.45251,1,0
4,GO PARAXIAL MESODERM DEVELOPMENT,1.2886e-07,-0.40128,-0.42025,1,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,1.1415e-11,-0.40139,-0.4437,1,0
4,GO REGULATION OF VASOCONSTRICTION,4.1948e-11,-0.4015,-0.44897,1,0
4,GO REGULATION OF BONE REMODELING,2.7e-09,-0.40167,-0.45578,1,0
4,GO OSTEOBLAST DIFFERENTIATION,1.642e-11,-0.40174,-0.45049,1,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,6.2046e-07,-0.40194,-0.41219,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.4686e-11,-0.4021,-0.57323,1,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.887e-11,-0.4022,-0.45991,1,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.9175e-06,-0.40228,-0.38655,1,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.4516e-10,-0.4025,-0.45436,1,0
4,GO PROTEIN PALMITOYLATION,7.5451e-08,-0.40256,-0.39095,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.1415e-11,-0.40267,-0.46037,1,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.0033e-09,-0.40301,-0.42123,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,5.4724e-12,-0.40321,-0.58302,1,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.0033e-09,-0.4033,-0.51879,1,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.5037e-07,-0.40334,-0.46248,1,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,3.9064e-09,-0.40338,-0.5078,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,5.3617e-10,-0.4034,-0.52888,1,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,5.332e-06,-0.40346,-0.408,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.8299e-12,-0.40364,-0.49299,1,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.6418e-07,-0.40388,-0.41719,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.462e-12,-0.40401,-0.48857,1,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.8032e-05,-0.4041,-0.45641,1,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,1.5027e-08,-0.40437,-0.50116,1,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,4.5922e-10,-0.40441,-0.46796,1,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,5.4982e-08,-0.40452,-0.40667,1,0
4,GO EOSINOPHIL CHEMOTAXIS,0.00029052,-0.40461,-0.35455,1,0
4,GO EPIDERMIS MORPHOGENESIS,2.3853e-09,-0.40492,-0.47746,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.6361e-10,-0.405,-0.48015,1,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,3.9035e-08,-0.40501,-0.44915,1,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,1.7797e-12,-0.40508,-0.49734,1,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,1.4686e-11,-0.40519,-0.49439,1,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,7.0279e-11,-0.40562,-0.50871,1,0
4,GO CERAMIDE TRANSPORT,5.6451e-10,-0.40567,-0.45527,1,0
4,GO MYELIN ASSEMBLY,8.0712e-08,-0.40573,-0.49558,1,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,1.3671e-08,-0.40574,-0.42907,1,0
4,GO AMINOGLYCAN METABOLIC PROCESS,1.174e-11,-0.40578,-0.4507,1,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,2.9371e-11,-0.40587,-0.41878,1,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,1.6986e-10,-0.40607,-0.47445,1,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,3.4516e-10,-0.40611,-0.41373,1,0
4,GO ERK1 AND ERK2 CASCADE,9.9094e-13,-0.40615,-0.46391,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.6538e-08,-0.40621,-0.4799,1,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.2094e-09,-0.40624,-0.42841,1,0
4,GO PSEUDOPODIUM ORGANIZATION,8.5867e-06,-0.40641,-0.41785,1,0
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,8.0898e-09,-0.40653,-0.35905,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.634e-09,-0.40678,-0.41153,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.1312e-09,-0.40685,-0.41648,1,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,1.9563e-06,-0.40686,-0.4022,1,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,8.1414e-12,-0.40696,-0.43535,1,0
4,GO REGULATION OF MYELINATION,5.9432e-10,-0.40701,-0.39461,1,0
4,GO TUBE MORPHOGENESIS,1.1146e-12,-0.40703,-0.47769,1,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0084096,-0.40713,-0.30798,1,0
4,GO REGULATION OF PHAGOCYTOSIS,3.8833e-12,-0.40729,-0.46943,1,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,8.5043e-10,-0.40735,-0.45971,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,1.1588e-05,-0.40753,-0.39523,1,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.2057e-05,-0.40755,-0.36749,1,0
4,GO COLLATERAL SPROUTING,5.4982e-08,-0.40756,-0.48389,1,0
4,GO CARDIAC CHAMBER DEVELOPMENT,2.457e-10,-0.40757,-0.46291,1,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.0582e-12,-0.40763,-0.49503,1,0
4,GO ACTIVATION OF MAPKK ACTIVITY,3.1032e-11,-0.40766,-0.49098,1,0
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.8318e-07,-0.40797,-0.45976,1,0
4,GO STEM CELL PROLIFERATION,1.6823e-09,-0.40798,-0.41528,1,0
4,GO CYTOLYSIS,8.6579e-07,-0.40807,-0.43151,1,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,3.5461e-06,-0.40839,-0.3502,1,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.2604e-07,-0.40844,-0.44373,1,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,5.4982e-08,-0.40863,-0.50549,1,0
4,GO POSTSYNAPSE ORGANIZATION,3.9309e-10,-0.40885,-0.44246,1,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,3.0295e-08,-0.40889,-0.46377,1,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.2631e-05,-0.40891,-0.34317,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,4.1948e-11,-0.40912,-0.44772,1,0
4,GO SYNCYTIUM FORMATION,2.595e-12,-0.40913,-0.50382,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,2.0879e-07,-0.40936,-0.41358,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.247e-08,-0.4094,-0.46559,1,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,2.4972e-05,-0.40978,-0.41726,1,0
4,GO GLIAL CELL PROLIFERATION,2.5893e-10,-0.40986,-0.40869,1,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0015038,-0.40989,-0.32326,1,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.3793e-12,-0.41007,-0.48585,1,0
4,GO BONE DEVELOPMENT,1.2417e-11,-0.41015,-0.47813,1,0
4,GO DENDRITIC SPINE DEVELOPMENT,3.2764e-10,-0.41023,-0.45514,1,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,3.2162e-07,-0.41024,-0.41882,1,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.4487e-10,-0.41025,-0.43954,1,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.484e-09,-0.41043,-0.45328,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,3.4003e-08,-0.4105,-0.43072,1,0
4,GO REGULATION OF TISSUE REMODELING,1.3737e-10,-0.41055,-0.49359,1,0
4,GO RESPONSE TO SALT STRESS,7.1726e-09,-0.41071,-0.38272,1,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,2.7286e-10,-0.41073,-0.45094,1,0
4,GO CELLULAR RESPONSE TO VITAMIN D,7.6446e-07,-0.41074,-0.45262,1,0
4,GO PEPTIDE CATABOLIC PROCESS,1.1097e-10,-0.41081,-0.47801,1,0
4,GO LIPID STORAGE,4.7449e-12,-0.41085,-0.43234,1,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.658e-10,-0.41122,-0.39945,1,0
4,GO LONG TERM MEMORY,2.2707e-10,-0.41135,-0.47715,1,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2733e-08,-0.41142,-0.49972,1,0
4,GO OSTEOCLAST DEVELOPMENT,3.2764e-10,-0.41147,-0.5247,1,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,9.4341e-06,-0.4115,-0.37986,1,0
4,GO ASTROCYTE DIFFERENTIATION,1.0202e-11,-0.41198,-0.45078,1,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,4.7963e-08,-0.4121,-0.4239,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,3.6435e-08,-0.41212,-0.52367,1,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,7.2964e-10,-0.41243,-0.43861,1,0
4,GO REGULATION OF OSSIFICATION,2.9127e-12,-0.41249,-0.47413,1,0
4,GO TOLERANCE INDUCTION,4.5558e-05,-0.41264,-0.4626,1,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,1.4334e-08,-0.41266,-0.46895,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,2.3312e-10,-0.41271,-0.44352,1,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,6.0979e-10,-0.41273,-0.45249,1,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,1.0202e-11,-0.41279,-0.4538,1,0
4,GO LEUKOCYTE MIGRATION,3.2685e-12,-0.41295,-0.45094,1,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,1.2131e-09,-0.41306,-0.44875,1,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.9905e-10,-0.41306,-0.52097,1,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,1.1097e-10,-0.41312,-0.51987,1,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.1097e-10,-0.41316,-0.45862,1,0
4,GO REGULATION OF HIPPO SIGNALING,7.2414e-06,-0.41341,-0.45548,1,0
4,GO GASTRULATION,4.3109e-11,-0.41353,-0.47584,1,0
4,GO MUSCLE CELL MIGRATION,5.3617e-10,-0.41381,-0.49089,1,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,1.6418e-07,-0.4139,-0.43389,1,0
4,GO PIGMENT GRANULE ORGANIZATION,9.3415e-09,-0.4139,-0.39099,1,0
4,GO GANGLIOSIDE METABOLIC PROCESS,1.5386e-08,-0.41404,-0.46138,1,0
4,GO ASTROCYTE ACTIVATION,2.8925e-08,-0.41404,-0.41971,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.9465e-08,-0.41415,-0.41075,1,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.2042e-09,-0.41425,-0.49669,1,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,9.658e-10,-0.41435,-0.41412,1,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,1.0804e-10,-0.41449,-0.46057,1,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.6542e-10,-0.41461,-0.41709,1,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.7282e-08,-0.4147,-0.46198,1,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.4805e-11,-0.41494,-0.5297,1,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.5239e-09,-0.41499,-0.44286,1,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,2.9514e-07,-0.41502,-0.49993,1,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,3.2785e-11,-0.4151,-0.50911,1,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,1.6514e-08,-0.41514,-0.47247,1,0
4,GO RESPONSE TO THYROID HORMONE,3.6435e-08,-0.41544,-0.44702,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.3606e-10,-0.41545,-0.46127,1,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,5.1652e-13,-0.41561,-0.47947,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0014624,-0.41562,-0.3963,1,0
4,GO MOTOR NEURON AXON GUIDANCE,4.0868e-08,-0.41563,-0.4193,1,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,1.1579e-08,-0.41578,-0.42401,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,9.5999e-07,-0.41598,-0.45277,1,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.3769e-07,-0.41601,-0.43106,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.3784e-07,-0.41614,-0.53322,1,0
4,GO COLLECTING DUCT DEVELOPMENT,4.3774e-08,-0.41619,-0.52073,1,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,1.4487e-10,-0.41621,-0.47664,1,0
4,GO PIGMENT CELL DIFFERENTIATION,4.0817e-11,-0.41622,-0.42911,1,0
4,GO CARDIAC VENTRICLE FORMATION,2.3239e-05,-0.41624,-0.41892,1,0
4,GO CARDIOBLAST DIFFERENTIATION,3.2784e-06,-0.41627,-0.38105,1,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00015583,-0.41639,-0.40548,1,0
4,GO KERATAN SULFATE METABOLIC PROCESS,1.8353e-11,-0.41642,-0.49646,1,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,7.5451e-08,-0.41642,-0.3898,1,0
4,GO GENITALIA MORPHOGENESIS,4.6356e-09,-0.41653,-0.48745,1,0
4,GO UTERUS DEVELOPMENT,9.4407e-08,-0.41658,-0.4128,1,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,5.2303e-06,-0.41664,-0.40934,1,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.0314e-05,-0.41666,-0.38232,1,0
4,GO ANOIKIS,3.192e-10,-0.41676,-0.50047,1,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,1.6823e-09,-0.41678,-0.44462,1,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,9.4341e-06,-0.41685,-0.51465,1,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,9.3415e-09,-0.41704,-0.44962,1,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.2482e-05,-0.41704,-0.4582,1,0
4,GO MESENCHYME DEVELOPMENT,6.3088e-12,-0.41714,-0.45659,1,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.4812e-12,-0.41717,-0.47288,1,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,6.9522e-13,-0.41728,-0.51949,1,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,4.3946e-06,-0.41728,-0.41745,1,0
4,GO PEPTIDYL TYROSINE MODIFICATION,5.0135e-13,-0.41742,-0.48629,1,0
4,GO REGULATION OF ACTION POTENTIAL,5.4967e-09,-0.41745,-0.45317,1,0
4,GO GAS TRANSPORT,0.00036686,-0.41757,-0.29191,1,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,8.3026e-13,-0.41757,-0.51689,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.1245e-09,-0.41773,-0.45705,1,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,2.188e-08,-0.41778,-0.53165,1,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,5.2165e-11,-0.41793,-0.47004,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,2.5066e-09,-0.41809,-0.45236,1,0
4,GO REGULATION OF HEART RATE,1.471e-07,-0.41811,-0.36585,1,0
4,GO REGULATION OF WATER LOSS VIA SKIN,1.6158e-05,-0.41814,-0.38243,1,0
4,GO RESPONSE TO RETINOIC ACID,2.8299e-12,-0.41831,-0.47738,1,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,6.552e-13,-0.41876,-0.52273,1,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,1.3376e-10,-0.41878,-0.45723,1,0
4,GO LUNG CELL DIFFERENTIATION,2.2505e-06,-0.41896,-0.43433,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00061456,-0.41902,-0.42204,1,0
4,GO OSTEOBLAST PROLIFERATION,2.1064e-09,-0.41906,-0.52041,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS,9.404e-07,-0.4191,-0.45819,1,0
4,GO MECHANOSENSORY BEHAVIOR,0.0005133,-0.41922,-0.40787,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00022565,-0.41925,-0.41805,1,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,1.0781e-08,-0.41929,-0.47385,1,0
4,GO MUCUS SECRETION,0.0032928,-0.41941,-0.36019,1,0
4,GO COPULATION,3.7605e-06,-0.41943,-0.32952,1,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.3468e-07,-0.41953,-0.5212,1,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.3562e-07,-0.41954,-0.49726,1,0
4,GO TYPE 2 IMMUNE RESPONSE,8.9487e-10,-0.41955,-0.47296,1,0
4,GO POSITIVE REGULATION OF URINE VOLUME,1.7909e-10,-0.41962,-0.42668,1,0
4,GO REGULATION OF NEURON MIGRATION,1.1034e-07,-0.41966,-0.45663,1,0
4,GO DETECTION OF MECHANICAL STIMULUS,4.719e-07,-0.41977,-0.39151,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00021857,-0.41993,-0.46237,1,0
4,GO CELLULAR COMPONENT MAINTENANCE,1.9546e-09,-0.41993,-0.44497,1,0
4,GO PHAGOLYSOSOME ASSEMBLY,1.475e-06,-0.42014,-0.45777,1,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,6.6717e-09,-0.42026,-0.41925,1,0
4,GO AMYLOID BETA FORMATION,5.3602e-11,-0.42063,-0.46525,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,4.4807e-06,-0.42067,-0.38976,1,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.5233e-07,-0.42079,-0.42633,1,0
4,GO TAXIS,6.7492e-13,-0.42086,-0.4329,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,9.3415e-09,-0.42089,-0.46942,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.2912e-11,-0.42131,-0.47284,1,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.815e-11,-0.42139,-0.54779,1,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,2.2912e-11,-0.42147,-0.45989,1,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.1321e-12,-0.42197,-0.48763,1,0
4,GO PHOSPHOLIPID HOMEOSTASIS,3.357e-07,-0.42211,-0.38377,1,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,8.5858e-05,-0.4222,-0.39249,1,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,1.2281e-06,-0.42233,-0.40157,1,0
4,GO GLIAL CELL DEVELOPMENT,4.4302e-11,-0.42235,-0.45269,1,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,3.192e-10,-0.42237,-0.48921,1,0
4,GO HETEROTYPIC CELL CELL ADHESION,4.9624e-10,-0.42244,-0.44801,1,0
4,GO BONE CELL DEVELOPMENT,2.5066e-09,-0.42281,-0.48981,1,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.0519e-10,-0.42287,-0.46474,1,0
4,GO B CELL MEDIATED IMMUNITY,3.5597e-11,-0.42305,-0.46976,1,0
4,GO HEART TRABECULA MORPHOGENESIS,1.1535e-07,-0.42319,-0.44724,1,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,1.2733e-08,-0.42327,-0.44033,1,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.4207e-05,-0.42331,-0.40279,1,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,5.8182e-13,-0.42338,-0.50653,1,0
4,GO MAST CELL ACTIVATION,8.0898e-09,-0.42338,-0.42008,1,0
4,GO AXIS ELONGATION,1.7721e-08,-0.42347,-0.4303,1,0
4,GO CELLULAR EXTRAVASATION,4.5526e-11,-0.4235,-0.44337,1,0
4,GO RESPONSE TO PAIN,1.5604e-09,-0.42351,-0.42458,1,0
4,GO LOCOMOTOR RHYTHM,2.1196e-06,-0.42354,-0.466,1,0
4,GO ADHERENS JUNCTION ORGANIZATION,1.1307e-08,-0.42379,-0.49649,1,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.484e-09,-0.4239,-0.47271,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,4.3355e-07,-0.42392,-0.55184,1,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.4805e-11,-0.42402,-0.50513,1,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,2.3554e-11,-0.42405,-0.47586,1,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,2.0398e-08,-0.42414,-0.44606,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,9.9064e-10,-0.42415,-0.46274,1,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,1.182e-12,-0.42424,-0.50429,1,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.6667e-12,-0.42439,-0.47546,1,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,4.4812e-12,-0.42441,-0.50732,1,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.8353e-11,-0.42459,-0.46951,1,0
4,GO NEURON PROJECTION GUIDANCE,5.2253e-10,-0.42468,-0.45881,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,8.5867e-06,-0.42472,-0.4226,1,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.586e-10,-0.42487,-0.42034,1,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.2784e-08,-0.42492,-0.42532,1,0
4,GO CELLULAR RESPONSE TO ALCOHOL,1.8353e-11,-0.42506,-0.4498,1,0
4,GO POST EMBRYONIC DEVELOPMENT,1.4282e-11,-0.42518,-0.4758,1,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.9872e-09,-0.42525,-0.4428,1,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,4.4749e-10,-0.42528,-0.45201,1,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,5.8182e-13,-0.42534,-0.50842,1,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,2.6352e-05,-0.42536,-0.35707,1,0
4,GO PLASMINOGEN ACTIVATION,6.3569e-09,-0.42548,-0.49751,1,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,1.3056e-06,-0.42551,-0.42138,1,0
4,GO ROOF OF MOUTH DEVELOPMENT,1.4112e-09,-0.42582,-0.44105,1,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.494e-12,-0.42601,-0.49117,1,0
4,GO POSITIVE REGULATION OF COAGULATION,3.5427e-10,-0.42602,-0.47255,1,0
4,GO STRESS FIBER ASSEMBLY,3.7182e-13,-0.42605,-0.5699,1,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.3024e-10,-0.42664,-0.55394,1,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,1.2348e-10,-0.42686,-0.48104,1,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,6.4699e-07,-0.42703,-0.39849,1,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8001e-06,-0.42723,-0.47886,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.2058e-07,-0.42731,-0.4421,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,6.9522e-13,-0.42733,-0.51366,1,0
4,GO MITRAL VALVE DEVELOPMENT,5.3747e-08,-0.42743,-0.46749,1,0
4,GO RESPONSE TO WOUNDING,7.3765e-13,-0.42756,-0.49855,1,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8793e-06,-0.42773,-0.56028,1,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.8301e-10,-0.42792,-0.50077,1,0
4,GO T CELL MIGRATION,2.3554e-11,-0.42811,-0.4572,1,0
4,GO MUSCLE CELL PROLIFERATION,1.0824e-12,-0.4282,-0.46395,1,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.0792e-11,-0.42836,-0.47571,1,0
4,GO ARGININE METABOLIC PROCESS,1.2733e-08,-0.42862,-0.44609,1,0
4,GO ANIMAL ORGAN MATURATION,5.5078e-11,-0.42865,-0.47961,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.6112e-12,-0.4287,-0.50214,1,0
4,GO NEURON REMODELING,8.2864e-09,-0.42876,-0.4436,1,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,7.2964e-10,-0.42881,-0.47749,1,0
4,GO REGULATION OF HAIR CYCLE,1.0161e-09,-0.42885,-0.42962,1,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1.0519e-10,-0.42953,-0.47118,1,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,1.4454e-06,-0.42975,-0.42966,1,0
4,GO APOPTOTIC CELL CLEARANCE,3.3639e-12,-0.43007,-0.53985,1,0
4,GO DENDRITIC SPINE MORPHOGENESIS,7.3476e-09,-0.43013,-0.44348,1,0
4,GO RESPONSE TO HYDROPEROXIDE,3.1312e-09,-0.43027,-0.48401,1,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,1.5674e-06,-0.43041,-0.39751,1,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,6.2993e-08,-0.43051,-0.50891,1,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.0422e-09,-0.43051,-0.46905,1,0
4,GO OPTIC NERVE DEVELOPMENT,3.1479e-07,-0.43052,-0.45703,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,9.7068e-11,-0.43063,-0.45359,1,0
4,GO LUNG MORPHOGENESIS,7.4177e-11,-0.43068,-0.49853,1,0
4,GO MYELOID CELL APOPTOTIC PROCESS,5.6451e-10,-0.43083,-0.43411,1,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,1.4487e-10,-0.43096,-0.4602,1,0
4,GO FIBROBLAST MIGRATION,1.4877e-10,-0.43107,-0.48271,1,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,3.0856e-12,-0.43128,-0.49411,1,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,5.2538e-08,-0.4314,-0.47869,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,6.0205e-08,-0.43181,-0.4535,1,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1.4677e-08,-0.43188,-0.42341,1,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,2.801e-10,-0.43201,-0.4934,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,1.6907e-08,-0.43203,-0.47584,1,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,9.9185e-12,-0.43228,-0.49248,1,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,3.0156e-07,-0.43236,-0.54468,1,0
4,GO ARTERY DEVELOPMENT,6.8406e-11,-0.43237,-0.50922,1,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,2.0509e-11,-0.43243,-0.52515,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.5424e-05,-0.43272,-0.44601,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,9.1205e-09,-0.43275,-0.44753,1,0
4,GO BONE REMODELING,4.3109e-11,-0.43286,-0.49832,1,0
4,GO RESPONSE TO INTERLEUKIN 6,8.0815e-10,-0.43309,-0.46243,1,0
4,GO ACTIN FILAMENT BASED MOVEMENT,2.1085e-11,-0.43312,-0.45744,1,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.5934e-07,-0.43326,-0.3982,1,0
4,GO HEPARIN METABOLIC PROCESS,7.1819e-07,-0.43334,-0.43649,1,0
4,GO SULFATION,1.2143e-08,-0.43342,-0.39139,1,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.4192e-10,-0.4335,-0.57925,1,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,1.174e-11,-0.43354,-0.52969,1,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,1.4877e-10,-0.43363,-0.59463,1,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,3.4773e-06,-0.43392,-0.47805,1,0
4,GO AXON EXTENSION,3.5427e-10,-0.43431,-0.481,1,0
4,GO PROTEIN DEGLYCOSYLATION,1.5688e-10,-0.43436,-0.51973,1,0
4,GO RENAL VESICLE DEVELOPMENT,4.6356e-09,-0.43474,-0.45617,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.0279e-08,-0.43478,-0.48775,1,0
4,GO ENDOTHELIAL CELL PROLIFERATION,1.7286e-12,-0.43478,-0.5332,1,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,5.8856e-08,-0.4349,-0.43741,1,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,5.7536e-08,-0.4349,-0.45567,1,0
4,GO PHAGOCYTOSIS,1.5838e-12,-0.43492,-0.47376,1,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.8573e-08,-0.43492,-0.43331,1,0
4,GO SYNAPTIC MEMBRANE ADHESION,9.5999e-07,-0.4355,-0.4947,1,0
4,GO PROTEIN DEMANNOSYLATION,3.055e-09,-0.43556,-0.49789,1,0
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,7.2964e-10,-0.43558,-0.5008,1,0
4,GO RESPONSE TO ANGIOTENSIN,9.4157e-10,-0.43568,-0.47353,1,0
4,GO AORTA DEVELOPMENT,3.8118e-09,-0.4357,-0.52116,1,0
4,GO RENAL SYSTEM PROCESS,6.9522e-13,-0.43576,-0.52548,1,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,2.8305e-05,-0.43576,-0.38519,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0007786,-0.43592,-0.35354,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,2.4861e-06,-0.43623,-0.39667,1,0
4,GO VASCULATURE DEVELOPMENT,9.6219e-13,-0.4363,-0.51344,1,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,6.586e-10,-0.4364,-0.46739,1,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,5.3186e-12,-0.43652,-0.55,1,0
4,GO STRIATED MUSCLE ADAPTATION,2.9805e-09,-0.43655,-0.44278,1,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.00028155,-0.43657,-0.45011,1,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,8.6328e-08,-0.43664,-0.46056,1,0
4,GO REGULATION OF RESPIRATORY BURST,1.0527e-08,-0.43679,-0.41568,1,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,2.8373e-13,-0.43684,-0.52687,1,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,7.479e-12,-0.43685,-0.50479,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,4.6881e-08,-0.43714,-0.56282,1,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.8925e-08,-0.43747,-0.46956,1,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.8824e-12,-0.43747,-0.50622,1,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.8662e-13,-0.43749,-0.5213,1,0
4,GO AORTA MORPHOGENESIS,3.0811e-07,-0.43751,-0.45083,1,0
4,GO HEART VALVE FORMATION,8.6328e-08,-0.43759,-0.50952,1,0
4,GO FORMATION OF PRIMARY GERM LAYER,1.3133e-11,-0.43791,-0.52131,1,0
4,GO HYALURONAN BIOSYNTHETIC PROCESS,1.6129e-08,-0.43793,-0.48878,1,0
4,GO POSTSYNAPSE ASSEMBLY,1.3599e-06,-0.43815,-0.4991,1,0
4,GO BARBED END ACTIN FILAMENT CAPPING,9.6538e-08,-0.43835,-0.475,1,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,6.4192e-10,-0.43847,-0.49569,1,0
4,GO KERATINOCYTE PROLIFERATION,2.3268e-09,-0.43855,-0.48981,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,4.0343e-10,-0.43856,-0.56772,1,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,5.5412e-06,-0.43882,-0.48433,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.6129e-08,-0.43888,-0.44366,1,0
4,GO RESPONSE TO ACETYLCHOLINE,3.9035e-08,-0.43903,-0.43711,1,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,6.1321e-12,-0.43909,-0.50243,1,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,2.9371e-11,-0.43916,-0.43449,1,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,5.6085e-05,-0.4392,-0.38835,1,0
4,GO BLOOD VESSEL MORPHOGENESIS,9.6219e-13,-0.43923,-0.51928,1,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,4.1025e-09,-0.43936,-0.47608,1,0
4,GO MYOBLAST FUSION,5.6304e-12,-0.43936,-0.55051,1,0
4,GO RESPONSE TO TUMOR CELL,1.9465e-08,-0.43939,-0.46637,1,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,1.9014e-08,-0.43942,-0.43827,1,0
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.0343e-10,-0.43948,-0.475,1,0
4,GO REGULATION OF FIBROBLAST MIGRATION,1.9546e-09,-0.43965,-0.48228,1,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.182e-12,-0.43979,-0.52156,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,7.479e-12,-0.43984,-0.49606,1,0
4,GO RELAXATION OF CARDIAC MUSCLE,9.7998e-07,-0.43985,-0.45659,1,0
4,GO PLATELET ACTIVATION,2.4491e-12,-0.43989,-0.51948,1,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.7166e-08,-0.4399,-0.52812,1,0
4,GO CELLULAR RESPONSE TO KETONE,3.3697e-11,-0.44005,-0.43524,1,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,2.4305e-07,-0.44011,-0.39949,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.0509e-11,-0.44018,-0.5184,1,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,2.9805e-09,-0.44036,-0.57423,1,0
4,GO CELLULAR RESPONSE TO VITAMIN,1.2441e-09,-0.44049,-0.54719,1,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.9064e-09,-0.44064,-0.53378,1,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,2.5934e-07,-0.44081,-0.45837,1,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.3174e-07,-0.44088,-0.4509,1,0
4,GO REGULATION OF RECEPTOR CLUSTERING,1.8053e-06,-0.44101,-0.5094,1,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.2286e-11,-0.44117,-0.51546,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,5.6304e-12,-0.44122,-0.48943,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.7449e-12,-0.44125,-0.48533,1,0
4,GO SUPEROXIDE ANION GENERATION,1.9926e-08,-0.44141,-0.4375,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.9514e-07,-0.44144,-0.42935,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.7166e-08,-0.44149,-0.44611,1,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.8888e-05,-0.44153,-0.46544,1,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,1.2143e-08,-0.44155,-0.47962,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,3.3214e-05,-0.44167,-0.41302,1,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00010323,-0.44168,-0.44451,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.0804e-10,-0.44195,-0.57646,1,0
4,GO MEMBRANE INVAGINATION,8.8611e-12,-0.44201,-0.49139,1,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,6.3074e-11,-0.44203,-0.48075,1,0
4,GO RESPONSE TO IRON ION,2.2707e-10,-0.44209,-0.46132,1,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,1.0792e-11,-0.44218,-0.50758,1,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.2707e-10,-0.4424,-0.51686,1,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.4487e-10,-0.44242,-0.49176,1,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.004e-09,-0.44244,-0.43892,1,0
4,GO GAP JUNCTION ASSEMBLY,2.3268e-09,-0.44253,-0.57503,1,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,3.7319e-10,-0.44264,-0.50916,1,0
4,GO LIVER MORPHOGENESIS,7.5266e-09,-0.44311,-0.45532,1,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,4.3082e-09,-0.4432,-0.41189,1,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,2.9127e-12,-0.44349,-0.51185,1,0
4,GO OXYGEN TRANSPORT,0.0034692,-0.44357,-0.28195,1,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,1.1794e-07,-0.44365,-0.45419,1,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.7286e-10,-0.44369,-0.48537,1,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,2.2707e-10,-0.44387,-0.44646,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,3.462e-12,-0.44396,-0.48466,1,0
4,GO RESPONSE TO INTERFERON GAMMA,2.7676e-09,-0.44408,-0.49791,1,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,1.3351e-08,-0.44418,-0.49133,1,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.3268e-09,-0.44426,-0.52679,1,0
4,GO PROSTATE GLAND MORPHOGENESIS,2.9805e-09,-0.4444,-0.55884,1,0
4,GO FOAM CELL DIFFERENTIATION,2.3312e-10,-0.44458,-0.47406,1,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,1.3878e-06,-0.44467,-0.38947,1,0
4,GO TISSUE MIGRATION,6.7492e-13,-0.44477,-0.54646,1,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,4.249e-10,-0.44504,-0.51703,1,0
4,GO LENS FIBER CELL DEVELOPMENT,7.4177e-11,-0.44504,-0.52252,1,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,1.4107e-10,-0.44518,-0.53131,1,0
4,GO LUNG EPITHELIUM DEVELOPMENT,1.0036e-08,-0.44551,-0.46906,1,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.9127e-12,-0.44557,-0.49296,1,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,1.3174e-07,-0.44564,-0.49311,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.7154e-07,-0.44582,-0.51495,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.552e-13,-0.44589,-0.50617,1,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,1.182e-12,-0.44593,-0.49919,1,0
4,GO REGULATION OF HEART MORPHOGENESIS,2.402e-08,-0.44599,-0.43761,1,0
4,GO REGULATION OF ANOIKIS,1.2131e-09,-0.44607,-0.57037,1,0
4,GO SPROUTING ANGIOGENESIS,2.0509e-11,-0.44614,-0.51436,1,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,3.6586e-11,-0.44617,-0.46622,1,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.4677e-08,-0.44619,-0.51581,1,0
4,GO CHONDROCYTE DEVELOPMENT,4.4749e-10,-0.44632,-0.54952,1,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,3.8118e-09,-0.44681,-0.4831,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.2023e-10,-0.44708,-0.5297,1,0
4,GO SOMATIC STEM CELL DIVISION,2.4371e-06,-0.44757,-0.53312,1,0
4,GO CYCLOOXYGENASE PATHWAY,6.4699e-07,-0.44786,-0.45394,1,0
4,GO CRANIAL NERVE DEVELOPMENT,1.1307e-08,-0.44787,-0.45752,1,0
4,GO SERTOLI CELL DIFFERENTIATION,7.6205e-11,-0.44801,-0.49509,1,0
4,GO NEURONAL ION CHANNEL CLUSTERING,3.2631e-05,-0.44826,-0.45925,1,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.00092737,-0.44859,-0.40379,1,0
4,GO ANATOMICAL STRUCTURE REGRESSION,9.3415e-09,-0.44863,-0.56554,1,0
4,GO INNER DYNEIN ARM ASSEMBLY,4.7999e-05,-0.44882,-0.38378,1,0
4,GO RESPONSE TO PROGESTERONE,4.9403e-11,-0.44891,-0.4791,1,0
4,GO EPITHELIAL CELL PROLIFERATION,1.2907e-12,-0.44908,-0.47333,1,0
4,GO REGULATION OF B CELL DIFFERENTIATION,1.3351e-08,-0.44926,-0.4455,1,0
4,GO HEART VALVE DEVELOPMENT,2.1085e-11,-0.44926,-0.57162,1,0
4,GO P38MAPK CASCADE,1.4107e-10,-0.44929,-0.51124,1,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.3268e-09,-0.44947,-0.49089,1,0
4,GO NEURON PROJECTION ORGANIZATION,9.9064e-10,-0.44949,-0.46659,1,0
4,GO RESPONSE TO VITAMIN,5.3617e-10,-0.4499,-0.46567,1,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,1.6542e-10,-0.44996,-0.49359,1,0
4,GO WOUND HEALING,1.0824e-12,-0.45005,-0.51348,1,0
4,GO PROTEIN LOCALIZATION TO AXON,2.1234e-05,-0.45037,-0.48066,1,0
4,GO REPLACEMENT OSSIFICATION,1.5529e-11,-0.45044,-0.54887,1,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,1.3761e-09,-0.45054,-0.47724,1,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,8.6579e-07,-0.45079,-0.4794,1,0
4,GO COLLAGEN CATABOLIC PROCESS,2.6306e-11,-0.45094,-0.53723,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,2.457e-10,-0.45143,-0.52976,1,0
4,GO HYALURONAN CATABOLIC PROCESS,7.6792e-10,-0.45185,-0.54445,1,0
4,GO ENDOTHELIUM DEVELOPMENT,1.277e-11,-0.45203,-0.52906,1,0
4,GO ENDOTHELIAL CELL MIGRATION,6.7492e-13,-0.45249,-0.56356,1,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4686e-11,-0.45266,-0.52698,1,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,4.9624e-10,-0.45273,-0.53406,1,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1.0424e-06,-0.45291,-0.40901,1,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,3.9941e-08,-0.45308,-0.51811,1,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.6317e-09,-0.45341,-0.44922,1,0
4,GO SYNAPSE MATURATION,2.2505e-06,-0.4535,-0.47856,1,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.1678e-11,-0.45361,-0.49152,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.4177e-11,-0.45364,-0.49313,1,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.2618e-11,-0.45373,-0.51268,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,3.247e-08,-0.45387,-0.48492,1,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,2.559e-11,-0.45414,-0.51198,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.001422,-0.45421,-0.46411,1,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0011668,-0.45448,-0.33738,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.725e-09,-0.45468,-0.5045,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.5037e-07,-0.45479,-0.40504,1,0
4,GO DEFINITIVE HEMOPOIESIS,1.8594e-09,-0.4553,-0.51094,1,0
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.9948e-11,-0.45556,-0.49395,1,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,3.055e-09,-0.45583,-0.46197,1,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00020835,-0.45605,-0.38929,1,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.793e-12,-0.45606,-0.58369,1,0
4,GO ESTROUS CYCLE,5.1351e-07,-0.45607,-0.39129,1,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.3468e-07,-0.45613,-0.44996,1,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,1.9014e-08,-0.45617,-0.48617,1,0
4,GO METANEPHROS DEVELOPMENT,5.9748e-11,-0.45654,-0.45248,1,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,3.9941e-08,-0.45659,-0.51528,1,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,4.1456e-06,-0.45666,-0.43066,1,0
4,GO RESPONSE TO INTERFERON BETA,2.2416e-05,-0.45675,-0.52073,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.6435e-08,-0.4568,-0.45364,1,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,3.055e-09,-0.45687,-0.46341,1,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,2.8814e-05,-0.45692,-0.32333,1,0
4,GO REGULATION OF COAGULATION,3.1896e-11,-0.45711,-0.53281,1,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.5597e-11,-0.45721,-0.47485,1,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.0815e-10,-0.45726,-0.48888,1,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.4877e-10,-0.4574,-0.50256,1,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,1.5713e-07,-0.45752,-0.53686,1,0
4,GO CELLULAR RESPONSE TO NUTRIENT,1.2682e-10,-0.4578,-0.53208,1,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,6.6774e-12,-0.45784,-0.5246,1,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,1.1307e-08,-0.45791,-0.4815,1,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,2.0546e-09,-0.45795,-0.48189,1,0
4,GO GLYCINE TRANSPORT,1.7071e-05,-0.45818,-0.4488,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.8282e-08,-0.45823,-0.58985,1,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,2.7614e-08,-0.45834,-0.49319,1,0
4,GO LEUKOCYTE AGGREGATION,1.6321e-06,-0.45843,-0.51904,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,5.793e-12,-0.45854,-0.51041,1,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,9.7068e-11,-0.45885,-0.48602,1,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.4787e-08,-0.45942,-0.5257,1,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0279e-08,-0.45949,-0.4377,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,3.0295e-08,-0.45957,-0.44525,1,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,1.0205e-12,-0.45957,-0.52366,1,0
4,GO LENS FIBER CELL DIFFERENTIATION,2.7797e-11,-0.45967,-0.50121,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,5.793e-12,-0.45983,-0.56405,1,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,8.4262e-06,-0.46004,-0.46645,1,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.8886e-07,-0.46004,-0.56966,1,0
4,GO PLATELET DEGRANULATION,3.019e-11,-0.46012,-0.51247,1,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,2.9979e-12,-0.46032,-0.54993,1,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,4.1403e-10,-0.46047,-0.49547,1,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.2414e-06,-0.4607,-0.45649,1,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,5.2538e-08,-0.46084,-0.50021,1,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,2.4091e-05,-0.461,-0.46588,1,0
4,GO GDP METABOLIC PROCESS,1.8318e-07,-0.46113,-0.40326,1,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,9.6538e-08,-0.4612,-0.52075,1,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,3.7195e-09,-0.46124,-0.46127,1,0
4,GO NUCLEAR MIGRATION,1.3878e-06,-0.46138,-0.46784,1,0
4,GO ACTIVATION OF JNKK ACTIVITY,1.9546e-09,-0.46138,-0.50491,1,0
4,GO INTRACELLULAR STEROL TRANSPORT,6.0565e-09,-0.4614,-0.45753,1,0
4,GO GLIAL CELL APOPTOTIC PROCESS,1.9558e-07,-0.46145,-0.49822,1,0
4,GO ACTIN FILAMENT BASED TRANSPORT,1.2886e-07,-0.46167,-0.4445,1,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6001e-09,-0.46183,-0.58863,1,0
4,GO RENAL ABSORPTION,1.3468e-07,-0.46204,-0.56341,1,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,1.6418e-07,-0.46214,-0.45338,1,0
4,GO NEGATIVE REGULATION OF COAGULATION,7.6205e-11,-0.46257,-0.56499,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,3.6567e-07,-0.46367,-0.47744,1,0
4,GO MESENCHYME MORPHOGENESIS,1.2733e-08,-0.46383,-0.45377,1,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.2707e-10,-0.46386,-0.46555,1,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00048316,-0.46394,-0.35624,1,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.3671e-08,-0.46411,-0.51864,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.4982e-08,-0.46429,-0.43299,1,0
4,GO REGULATION OF CELL SHAPE,3.5629e-12,-0.46437,-0.51251,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.8814e-05,-0.46475,-0.40889,1,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,2.2139e-09,-0.46496,-0.45742,1,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.2907e-12,-0.46502,-0.56266,1,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,7.598e-13,-0.46505,-0.55943,1,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,7.6657e-06,-0.46557,-0.47005,1,0
4,GO TROPHOBLAST CELL MIGRATION,2.1807e-07,-0.4656,-0.45608,1,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,4.4302e-11,-0.46671,-0.48606,1,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.5386e-08,-0.46688,-0.53956,1,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.6514e-08,-0.46708,-0.4736,1,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,1.5753e-08,-0.4673,-0.50143,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.2434e-08,-0.46768,-0.52502,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,3.7319e-10,-0.46769,-0.49476,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,9.1996e-11,-0.46773,-0.49724,1,0
4,GO PLASMA MEMBRANE ORGANIZATION,2.2453e-12,-0.46789,-0.54446,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,1.494e-12,-0.46813,-0.58214,1,0
4,GO SECONDARY PALATE DEVELOPMENT,1.8594e-09,-0.46816,-0.49711,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,1.4334e-08,-0.46822,-0.52773,1,0
4,GO RESPONSE TO POTASSIUM ION,4.5558e-05,-0.46841,-0.36865,1,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.2441e-09,-0.4685,-0.45699,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,1.0161e-09,-0.46853,-0.45393,1,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,2.7797e-11,-0.46859,-0.49893,1,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,5.0766e-11,-0.46865,-0.46604,1,0
4,GO POSITIVE REGULATION OF HEART RATE,6.545e-05,-0.46887,-0.32238,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,3.2685e-12,-0.46889,-0.51236,1,0
4,GO REGULATION OF WOUND HEALING,5.793e-12,-0.47024,-0.52124,1,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,3.357e-07,-0.47038,-0.4643,1,0
4,GO ODONTOGENESIS,5.9602e-12,-0.4704,-0.51249,1,0
4,GO NEPHRON DEVELOPMENT,1.4686e-11,-0.47093,-0.50199,1,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.0861e-06,-0.47105,-0.49114,1,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,5.2253e-10,-0.47119,-0.48732,1,0
4,GO TRABECULA MORPHOGENESIS,5.0922e-10,-0.47146,-0.53081,1,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.5427e-10,-0.47146,-0.49009,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,1.5277e-10,-0.47155,-0.57127,1,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.1757e-12,-0.47204,-0.49886,1,0
4,GO HOMOTYPIC CELL CELL ADHESION,4.0817e-11,-0.47222,-0.54498,1,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2058e-07,-0.4723,-0.44961,1,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4677e-08,-0.47238,-0.54544,1,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,3.3713e-09,-0.47239,-0.48083,1,0
4,GO POSITIVE REGULATION OF WOUND HEALING,2.8753e-10,-0.4726,-0.51281,1,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,1.9546e-09,-0.47263,-0.4678,1,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,3.357e-07,-0.47269,-0.47215,1,0
4,GO VASCULOGENESIS,3.1757e-12,-0.4727,-0.55669,1,0
4,GO LYMPH VESSEL MORPHOGENESIS,1.2682e-10,-0.47295,-0.52761,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,9.4499e-11,-0.47303,-0.48091,1,0
4,GO SMOOTH MUSCLE CELL MIGRATION,6.8406e-11,-0.47311,-0.56442,1,0
4,GO ASTROCYTE DEVELOPMENT,2.2912e-11,-0.47325,-0.50512,1,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.1389e-11,-0.47381,-0.51465,1,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,2.0879e-07,-0.47386,-0.44426,1,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.2094e-09,-0.47398,-0.47423,1,0
4,GO MAMMARY GLAND MORPHOGENESIS,1.6884e-11,-0.47417,-0.5583,1,0
4,GO RESPONSE TO GROWTH HORMONE,3.2764e-10,-0.47449,-0.50884,1,0
4,GO HIPPO SIGNALING,9.4407e-08,-0.47449,-0.53021,1,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,6.0565e-09,-0.47456,-0.48847,1,0
4,GO METANEPHROS MORPHOGENESIS,2.2707e-10,-0.47459,-0.49807,1,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,9.4157e-10,-0.47467,-0.52969,1,0
4,GO NERVE DEVELOPMENT,2.3268e-09,-0.47471,-0.50032,1,0
4,GO MEMBRANE BIOGENESIS,2.559e-11,-0.47484,-0.54607,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,3.192e-10,-0.47486,-0.52225,1,0
4,GO CONVERGENT EXTENSION,8.0898e-09,-0.47502,-0.44841,1,0
4,GO TRACHEA DEVELOPMENT,8.0815e-10,-0.47507,-0.5191,1,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.232e-12,-0.47507,-0.49575,1,0
4,GO RESPONSE TO FORSKOLIN,2.0879e-07,-0.47511,-0.48455,1,0
4,GO REGULATION OF MEMBRANE INVAGINATION,6.4192e-10,-0.47514,-0.55482,1,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,2.5893e-10,-0.47534,-0.5012,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.8594e-09,-0.47539,-0.54319,1,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,6.2993e-08,-0.47558,-0.45065,1,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3467e-08,-0.47582,-0.57003,1,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.0278e-07,-0.47583,-0.46575,1,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,1.7286e-12,-0.47624,-0.53516,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.942e-12,-0.4765,-0.5471,1,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,4.7125e-10,-0.47654,-0.54249,1,0
4,GO FIBROBLAST PROLIFERATION,1.0493e-11,-0.47657,-0.48025,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.6145e-12,-0.47675,-0.50556,1,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.205e-09,-0.47679,-0.55412,1,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,9.9064e-10,-0.47685,-0.51935,1,0
4,GO MESENCHYMAL CELL PROLIFERATION,6.8348e-09,-0.47724,-0.52365,1,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.4677e-08,-0.47726,-0.5081,1,0
4,GO RESPONSE TO LEUCINE,2.7668e-07,-0.47737,-0.4457,1,0
4,GO DISACCHARIDE METABOLIC PROCESS,8.4877e-09,-0.47741,-0.46722,1,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.2397e-08,-0.47744,-0.5121,1,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.0422e-09,-0.47776,-0.50116,1,0
4,GO LUNG ALVEOLUS DEVELOPMENT,2.9078e-09,-0.47779,-0.53431,1,0
4,GO LIPID TRANSLOCATION,1.069e-09,-0.47783,-0.49408,1,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,2.8369e-09,-0.47794,-0.56395,1,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,3.1479e-07,-0.47795,-0.52571,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,3.628e-05,-0.47799,-0.36239,1,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,2.9979e-12,-0.47815,-0.5276,1,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.4112e-09,-0.47879,-0.47745,1,0
4,GO CELL SUBSTRATE ADHESION,3.9478e-13,-0.47882,-0.5901,1,0
4,GO PLATELET AGGREGATION,6.8406e-11,-0.47882,-0.5259,1,0
4,GO RESPONSE TO INTERFERON ALPHA,2.206e-06,-0.47909,-0.64981,1,0
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.6667e-12,-0.47917,-0.57688,1,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,2.4837e-07,-0.48053,-0.50536,1,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,4.1815e-08,-0.48063,-0.43953,1,0
4,GO MIDGUT DEVELOPMENT,2.3467e-08,-0.48065,-0.50331,1,0
4,GO ATRIAL SEPTUM DEVELOPMENT,8.8282e-08,-0.48092,-0.49987,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4805e-11,-0.481,-0.51054,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.9035e-08,-0.4811,-0.59221,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.6307e-12,-0.48137,-0.51116,1,0
4,GO NUCLEUS LOCALIZATION,2.3784e-07,-0.48151,-0.46169,1,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,4.4807e-06,-0.48194,-0.48121,1,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.8135e-09,-0.48292,-0.54158,1,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,3.5461e-06,-0.48333,-0.46672,1,0
4,GO TRACHEA MORPHOGENESIS,2.9515e-10,-0.48334,-0.52405,1,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,5.6245e-08,-0.4834,-0.50126,1,0
4,GO CELL MATRIX ADHESION,8.8075e-13,-0.48346,-0.59043,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.182e-12,-0.48356,-0.57821,1,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,3.6667e-12,-0.48374,-0.63089,1,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,3.2685e-12,-0.48391,-0.55504,1,0
4,GO REGULATION OF AMYLOID BETA FORMATION,1.4487e-10,-0.48395,-0.49402,1,0
4,GO CELLULAR RESPONSE TO STEROL,8.0815e-10,-0.48459,-0.49529,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00016901,-0.48496,-0.4227,1,0
4,GO TISSUE REMODELING,1.0202e-11,-0.48511,-0.53502,1,0
4,GO EMBRYONIC BODY MORPHOGENESIS,1.1828e-09,-0.48544,-0.52198,1,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.8645e-11,-0.48546,-0.58516,1,0
4,GO NOTOCHORD DEVELOPMENT,2.634e-09,-0.48549,-0.53883,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,6.1321e-12,-0.48586,-0.51151,1,0
4,GO ENDODERM DEVELOPMENT,1.6884e-11,-0.4859,-0.58639,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.7309e-08,-0.48636,-0.48823,1,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,3.5461e-06,-0.48645,-0.43619,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,3.9035e-08,-0.48661,-0.60141,1,0
4,GO UV PROTECTION,3.6435e-08,-0.48673,-0.46618,1,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,3.5412e-09,-0.4868,-0.52962,1,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,3.1004e-08,-0.48695,-0.56279,1,0
4,GO CAMP METABOLIC PROCESS,8.0424e-11,-0.48736,-0.52854,1,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,1.1579e-08,-0.4876,-0.54476,1,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.1101e-09,-0.48772,-0.57296,1,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,8.6145e-12,-0.48784,-0.50132,1,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.1858e-08,-0.4879,-0.5338,1,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.6877e-06,-0.488,-0.4951,1,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.4749e-10,-0.48809,-0.50002,1,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,7.8052e-07,-0.48816,-0.40387,1,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,1.734e-06,-0.48891,-0.52415,1,0
4,GO PROTEIN TARGETING TO LYSOSOME,5.7923e-10,-0.48905,-0.54282,1,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.634e-09,-0.49075,-0.48813,1,0
4,GO ENDODERM FORMATION,2.7041e-11,-0.49076,-0.61395,1,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,9.1205e-09,-0.4909,-0.56958,1,0
4,GO REGULATION OF RESPONSE TO WOUNDING,3.0856e-12,-0.49094,-0.50406,1,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.8793e-06,-0.49146,-0.57925,1,0
4,GO GASTRULATION WITH MOUTH FORMING SECOND,2.8925e-08,-0.49149,-0.483,1,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,5.1356e-08,-0.49206,-0.55918,1,0
4,GO EPITHELIAL CELL MORPHOGENESIS,1.3769e-07,-0.49221,-0.55147,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,1.942e-12,-0.49256,-0.52099,1,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.6907e-08,-0.49273,-0.42711,1,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,5.4724e-12,-0.49311,-0.5555,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00029511,-0.49317,-0.44365,1,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0013255,-0.49341,-0.32289,1,0
4,GO CHONDROCYTE DIFFERENTIATION,1.3505e-11,-0.4936,-0.54042,1,0
4,GO NEURON PROJECTION ARBORIZATION,4.0868e-08,-0.49394,-0.53095,1,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,1.0861e-06,-0.49398,-0.47173,1,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,2.9371e-11,-0.49423,-0.52488,1,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.1533e-09,-0.49443,-0.56758,1,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.2286e-07,-0.49457,-0.46109,1,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,5.9498e-07,-0.49461,-0.4583,1,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,2.1678e-11,-0.49464,-0.54947,1,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,1.736e-11,-0.49499,-0.51272,1,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,4.4787e-08,-0.4955,-0.44468,1,0
4,GO NEGATIVE REGULATION OF CELL KILLING,1.0756e-05,-0.49589,-0.55022,1,0
4,GO EMBRYO IMPLANTATION,2.2707e-10,-0.49631,-0.5018,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,3.3713e-09,-0.49632,-0.49145,1,0
4,GO CARDIAC SEPTUM DEVELOPMENT,5.5016e-10,-0.49641,-0.5194,1,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,2.0546e-09,-0.49643,-0.50991,1,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,3.1757e-12,-0.49649,-0.57495,1,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,9.4499e-11,-0.49665,-0.50613,1,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6109e-10,-0.49697,-0.49428,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.2912e-11,-0.49703,-0.6227,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.8359e-10,-0.49714,-0.53095,1,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,2.3467e-08,-0.49733,-0.43298,1,0
4,GO MATURE B CELL DIFFERENTIATION,2.188e-08,-0.49771,-0.52662,1,0
4,GO N GLYCAN PROCESSING,3.192e-10,-0.49782,-0.56688,1,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,2.3933e-10,-0.49783,-0.59167,1,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,2.5066e-09,-0.49789,-0.49123,1,0
4,GO LYMPHANGIOGENESIS,1.0781e-08,-0.49806,-0.48139,1,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,1.2792e-06,-0.4983,-0.54393,1,0
4,GO T CELL EXTRAVASATION,1.0781e-08,-0.49875,-0.54586,1,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,3.5606e-08,-0.49902,-0.47685,1,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,8.3747e-12,-0.49905,-0.57315,1,0
4,GO AMELOGENESIS,2.8573e-11,-0.49946,-0.55663,1,0
4,GO RESPONSE TO INTERLEUKIN 18,3.357e-07,-0.49968,-0.58166,1,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,9.9064e-10,-0.5,-0.49452,1,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,3.7195e-09,-0.50041,-0.56625,1,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,4.7172e-05,-0.5005,-0.48341,1,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,5.9602e-12,-0.50095,-0.53549,1,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,7.0671e-12,-0.50119,-0.59569,1,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,9.3752e-12,-0.50123,-0.61403,1,0
4,GO NEURAL CREST CELL DIFFERENTIATION,8.7184e-11,-0.5013,-0.48663,1,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,1.3999e-08,-0.50147,-0.53252,1,0
4,GO ENDODERMAL CELL DIFFERENTIATION,8.0424e-11,-0.50152,-0.64603,1,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.2434e-08,-0.50198,-0.45328,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.2348e-10,-0.50236,-0.51525,1,0
4,GO BLOOD VESSEL REMODELING,2.4491e-12,-0.50256,-0.60709,1,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,1.8881e-10,-0.50276,-0.5949,1,0
4,GO TRABECULA FORMATION,1.0804e-10,-0.50298,-0.54498,1,0
4,GO ADHERENS JUNCTION ASSEMBLY,1.6654e-06,-0.50308,-0.50815,1,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.4192e-10,-0.50341,-0.55281,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.357e-07,-0.50363,-0.4678,1,0
4,GO NEUROBLAST DIVISION,1.9926e-08,-0.50428,-0.54531,1,0
4,GO REGULATION OF MYOBLAST FUSION,3.2094e-09,-0.50444,-0.5048,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,4.5233e-07,-0.50465,-0.44436,1,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,3.9064e-09,-0.50467,-0.54879,1,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,1.2954e-05,-0.5048,-0.4473,1,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,5.5016e-10,-0.50503,-0.52245,1,0
4,GO CELLULAR RESPONSE TO CHOLESTEROL,3.5427e-10,-0.50544,-0.5226,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,1.1282e-07,-0.5055,-0.45982,1,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,3.6567e-07,-0.50604,-0.45776,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.1415e-11,-0.50728,-0.56222,1,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,3.4796e-08,-0.50762,-0.56746,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,3.055e-09,-0.50859,-0.59561,1,0
4,GO GAMMA DELTA T CELL ACTIVATION,4.3355e-07,-0.51013,-0.43583,1,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.1812e-12,-0.51054,-0.63328,1,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,3.2764e-10,-0.51184,-0.57928,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,1.0241e-10,-0.51196,-0.58415,1,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,2.6362e-08,-0.51206,-0.53068,1,0
4,GO AORTIC VALVE DEVELOPMENT,1.6109e-10,-0.51221,-0.60101,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,1.7922e-07,-0.51284,-0.54959,1,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,2.8262e-08,-0.51295,-0.48734,1,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.3671e-08,-0.51298,-0.48099,1,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,4.6784e-11,-0.51334,-0.49702,1,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.9948e-11,-0.51356,-0.54082,1,0
4,GO NEURON PROJECTION REGENERATION,2.4893e-11,-0.51365,-0.5266,1,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,3.8301e-10,-0.51377,-0.53183,1,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,1.8053e-06,-0.51384,-0.49088,1,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.7909e-10,-0.51397,-0.61142,1,0
4,GO ADHESION OF SYMBIONT TO HOST,2.5756e-08,-0.51426,-0.51368,1,0
4,GO RESPONSE TO MUSCLE STRETCH,0.00014839,-0.51426,-0.4153,1,0
4,GO DETECTION OF BIOTIC STIMULUS,5.3647e-09,-0.51442,-0.52494,1,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,2.9078e-09,-0.51468,-0.56068,1,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,4.6881e-08,-0.51497,-0.49318,1,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,8.6145e-12,-0.51551,-0.60049,1,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,1.1282e-07,-0.5159,-0.54566,1,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.4092e-12,-0.51617,-0.6017,1,0
4,GO EPITHELIAL CELL CELL ADHESION,1.2604e-07,-0.51622,-0.59726,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.6307e-12,-0.51628,-0.57215,1,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,1.7693e-06,-0.51639,-0.65292,1,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,9.4499e-11,-0.51642,-0.53678,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.4877e-10,-0.51711,-0.56087,1,0
4,GO PERICARDIUM DEVELOPMENT,7.7166e-08,-0.51717,-0.51183,1,0
4,GO GLAND MORPHOGENESIS,2.9979e-12,-0.51804,-0.57671,1,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.5102e-11,-0.51868,-0.5294,1,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,8.4877e-09,-0.51897,-0.4871,1,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.4163e-06,-0.51921,-0.40003,1,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.2094e-09,-0.51944,-0.51277,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,3.8161e-07,-0.5208,-0.50947,1,0
4,GO FOCAL ADHESION ASSEMBLY,3.1757e-12,-0.5211,-0.60687,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,1.4471e-09,-0.52129,-0.60273,1,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.1706e-10,-0.5216,-0.57992,1,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,1.996e-06,-0.52166,-0.58144,1,0
4,GO RESPONSE TO STEROL,7.8286e-11,-0.5219,-0.5217,1,0
4,GO NEGATIVE REGULATION OF ANOIKIS,4.5239e-09,-0.52204,-0.6411,1,0
4,GO T HELPER 2 CELL DIFFERENTIATION,6.6717e-09,-0.5225,-0.57068,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.1398e-10,-0.52277,-0.62422,1,0
4,GO COLLAGEN METABOLIC PROCESS,1.8323e-12,-0.5234,-0.60454,1,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,6.3088e-12,-0.52414,-0.61544,1,0
4,GO VOCALIZATION BEHAVIOR,5.4356e-06,-0.52422,-0.50239,1,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.3554e-11,-0.52435,-0.52267,1,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.0094e-07,-0.52481,-0.50803,1,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,3.192e-10,-0.5249,-0.58276,1,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,4.8673e-09,-0.52498,-0.56244,1,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,1.2328e-07,-0.52526,-0.48124,1,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.8389e-10,-0.5254,-0.55505,1,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,2.2117e-10,-0.52566,-0.53625,1,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,9.3415e-09,-0.52575,-0.58665,1,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,4.3355e-07,-0.52689,-0.64637,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,2.4586e-08,-0.5274,-0.54901,1,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.793e-12,-0.52749,-0.51042,1,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.4076e-07,-0.5278,-0.49466,1,0
4,GO RESPONSE TO TYPE I INTERFERON,1.9563e-06,-0.5279,-0.55001,1,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,1.5217e-09,-0.52866,-0.58195,1,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,4.6578e-06,-0.52891,-0.69106,1,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.6112e-12,-0.52916,-0.53494,1,0
4,GO FACE DEVELOPMENT,9.1996e-11,-0.52949,-0.5646,1,0
4,GO CORONARY VASCULATURE DEVELOPMENT,6.2565e-10,-0.52963,-0.51034,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.9035e-08,-0.52965,-0.48498,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.457e-10,-0.52988,-0.5256,1,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,7.6792e-10,-0.5302,-0.54845,1,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.4415e-08,-0.53033,-0.51167,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,7.8976e-09,-0.53066,-0.52748,1,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,1.3761e-09,-0.53072,-0.59195,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,8.4262e-06,-0.53073,-0.58834,1,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0005618,-0.53106,-0.36275,1,0
4,GO CHOLESTEROL STORAGE,4.7125e-10,-0.53108,-0.54923,1,0
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.402e-08,-0.53115,-0.55209,1,0
4,GO MACROPHAGE PROLIFERATION,4.4749e-10,-0.53187,-0.5811,1,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,4.1751e-05,-0.53203,-0.42163,1,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,4.5922e-10,-0.53237,-0.4942,1,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,4.8662e-13,-0.53266,-0.60467,1,0
4,GO INNERVATION,2.0429e-07,-0.533,-0.60622,1,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.6129e-08,-0.53353,-0.57695,1,0
4,GO REGULATION OF AXON GUIDANCE,7.6792e-10,-0.53445,-0.53061,1,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.4805e-11,-0.53562,-0.62149,1,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,1.9558e-07,-0.53565,-0.56007,1,0
4,GO BEHAVIORAL RESPONSE TO PAIN,2.3268e-09,-0.53569,-0.53805,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,8.1414e-12,-0.53583,-0.55951,1,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9432e-10,-0.53645,-0.51312,1,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.6986e-10,-0.53678,-0.54636,1,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.2764e-10,-0.53717,-0.49585,1,0
4,GO SERTOLI CELL DEVELOPMENT,1.8881e-10,-0.5373,-0.54287,1,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9136e-07,-0.53843,-0.61593,1,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,1.0493e-11,-0.53864,-0.60598,1,0
4,GO AXONAL FASCICULATION,2.402e-08,-0.53878,-0.51151,1,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,3.1098e-10,-0.5391,-0.50007,1,0
4,GO LYMPH VESSEL DEVELOPMENT,4.0343e-10,-0.53914,-0.58028,1,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.2286e-07,-0.53932,-0.47483,1,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.8573e-08,-0.53934,-0.60851,1,0
4,GO NEURAL CREST CELL MIGRATION,9.4499e-11,-0.54023,-0.5421,1,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,2.2926e-08,-0.54055,-0.67766,1,0
4,GO SEQUESTERING OF TRIGLYCERIDE,7.71e-09,-0.54056,-0.45798,1,0
4,GO RESPONSE TO EPINEPHRINE,2.6352e-05,-0.54062,-0.39411,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.7922e-07,-0.54064,-0.54169,1,0
4,GO GERMINAL CENTER FORMATION,5.4967e-09,-0.54065,-0.57665,1,0
4,GO ZYMOGEN ACTIVATION,1.4487e-10,-0.54177,-0.573,1,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.0804e-10,-0.54196,-0.57924,1,0
4,GO LAMELLIPODIUM MORPHOGENESIS,2.6362e-08,-0.54217,-0.52659,1,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,4.8839e-05,-0.54292,-0.48991,1,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,2.2286e-11,-0.54293,-0.6092,1,0
4,GO NEGATIVE CHEMOTAXIS,1.4877e-10,-0.54323,-0.58197,1,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.3468e-07,-0.54333,-0.46838,1,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,5.77e-09,-0.54367,-0.4966,1,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.0279e-08,-0.54435,-0.53912,1,0
4,GO BONE GROWTH,1.5217e-09,-0.54515,-0.55069,1,0
4,GO LIMB BUD FORMATION,5.332e-06,-0.54519,-0.51219,1,0
4,GO OLIGOPEPTIDE TRANSPORT,2.9602e-08,-0.54549,-0.50386,1,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,7.6792e-10,-0.54577,-0.52904,1,0
4,GO NEUTROPHIL HOMEOSTASIS,4.9624e-10,-0.54581,-0.63792,1,0
4,GO REGULATION OF CELL MATRIX ADHESION,6.3604e-13,-0.54622,-0.62858,1,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,1.1282e-07,-0.54635,-0.52583,1,0
4,GO REGULATION OF RECEPTOR BINDING,8.4871e-11,-0.5464,-0.61951,1,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.65e-07,-0.54658,-0.51962,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.1098e-10,-0.54733,-0.5535,1,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.004e-09,-0.54804,-0.56198,1,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,2.8573e-11,-0.54838,-0.60847,1,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,4.4812e-12,-0.54841,-0.55439,1,0
4,GO CERAMIDE CATABOLIC PROCESS,1.471e-07,-0.54945,-0.51171,1,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.5893e-10,-0.54987,-0.51803,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,1.2131e-09,-0.54987,-0.55325,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,3.9613e-05,-0.55071,-0.42292,1,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,6.9323e-10,-0.55131,-0.54077,1,0
4,GO CELLULAR RESPONSE TO ETHANOL,4.0868e-08,-0.55167,-0.45422,1,0
4,GO NEURON CELL CELL ADHESION,2.3239e-05,-0.55193,-0.47607,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,9.4407e-08,-0.55198,-0.50298,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,5.1101e-09,-0.5533,-0.51917,1,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,2.8925e-08,-0.55394,-0.57623,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.785e-11,-0.55448,-0.62407,1,0
4,GO OUTFLOW TRACT MORPHOGENESIS,7.4177e-11,-0.55469,-0.54618,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.5529e-11,-0.5549,-0.55917,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,3.055e-09,-0.55536,-0.71488,1,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,2.3274e-07,-0.55742,-0.50122,1,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,2.5893e-10,-0.55812,-0.59986,1,0
4,GO REGULATION OF VASCULOGENESIS,3.1479e-07,-0.55896,-0.53063,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.7125e-10,-0.55964,-0.64415,1,0
4,GO PROSTATIC BUD FORMATION,8.1361e-07,-0.5597,-0.53353,1,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5239e-09,-0.56116,-0.55884,1,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4112e-09,-0.56131,-0.73656,1,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,9.9705e-11,-0.56147,-0.6042,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,7.8778e-10,-0.56193,-0.52175,1,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,9.1793e-10,-0.56286,-0.64847,1,0
4,GO DENDRITIC SPINE MAINTENANCE,3.055e-09,-0.5632,-0.53889,1,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,6.1321e-12,-0.56388,-0.63884,1,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,3.7319e-10,-0.56404,-0.56778,1,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.0398e-08,-0.56491,-0.52959,1,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,9.1996e-11,-0.56503,-0.66021,1,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.785e-11,-0.56544,-0.65243,1,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,6.757e-10,-0.56587,-0.62333,1,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,6.0565e-09,-0.56678,-0.52453,1,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00034485,-0.56695,-0.63566,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,1.5713e-07,-0.5694,-0.51625,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,4.3355e-07,-0.56941,-0.53967,1,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,1.2023e-10,-0.56945,-0.58175,1,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.9993e-12,-0.56948,-0.6247,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,8.0898e-09,-0.57061,-0.58232,1,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,5.6451e-10,-0.57146,-0.68598,1,0
4,GO MEMBRANE RAFT ORGANIZATION,7.71e-09,-0.5715,-0.61911,1,0
4,GO GLYCOLIPID CATABOLIC PROCESS,1.6782e-07,-0.5718,-0.54445,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.5043e-10,-0.57226,-0.62073,1,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,1.5688e-10,-0.57246,-0.56515,1,0
4,GO EPIBOLY,4.6112e-12,-0.57274,-0.63036,1,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,2.4452e-09,-0.5731,-0.61385,1,0
4,GO CRANIAL NERVE MORPHOGENESIS,2.3312e-10,-0.57581,-0.58865,1,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.3468e-07,-0.5773,-0.64256,1,0
4,GO PODOSOME ASSEMBLY,2.1064e-09,-0.57757,-0.60405,1,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,4.4285e-07,-0.57803,-0.56974,1,0
4,GO CHONDROCYTE PROLIFERATION,4.1552e-07,-0.57827,-0.48628,1,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,6.3088e-12,-0.57861,-0.65075,1,0
4,GO REGULATION OF PLATELET AGGREGATION,2.7676e-09,-0.57997,-0.61201,1,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,5.1101e-09,-0.57999,-0.52498,1,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,6.2175e-05,-0.58001,-0.40257,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,5.9748e-11,-0.58012,-0.66268,1,0
4,GO PROTEIN KINASE C SIGNALING,9.6431e-12,-0.58032,-0.59733,1,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,1.1533e-09,-0.58045,-0.5441,1,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,3.4796e-08,-0.58092,-0.48261,1,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,8.8075e-13,-0.58158,-0.6078,1,0
4,GO DETECTION OF OTHER ORGANISM,2.5934e-07,-0.58371,-0.54008,1,0
4,GO REGULATION OF PLATELET ACTIVATION,3.4516e-10,-0.58414,-0.59076,1,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.232e-12,-0.58417,-0.59613,1,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.6711e-12,-0.58427,-0.70783,1,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,1.1794e-07,-0.58456,-0.58948,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.6219e-13,-0.58586,-0.69395,1,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.1543e-10,-0.58632,-0.59085,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,2.65e-07,-0.58647,-0.51084,1,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,6.7411e-08,-0.58648,-0.61595,1,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.1595e-09,-0.58682,-0.6073,1,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.9558e-07,-0.58826,-0.57369,1,0
4,GO KERATINOCYTE DEVELOPMENT,2.5424e-05,-0.5886,-0.44123,1,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,2.0398e-08,-0.58958,-0.59391,1,0
4,GO AMYLOID FIBRIL FORMATION,8.9558e-11,-0.58972,-0.62604,1,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,1.7154e-07,-0.58975,-0.53177,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.0766e-11,-0.59011,-0.63025,1,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.1398e-10,-0.59091,-0.63318,1,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,7.2964e-10,-0.59095,-0.65367,1,0
4,GO BRONCHUS DEVELOPMENT,4.5239e-09,-0.59134,-0.60312,1,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.3109e-11,-0.59137,-0.64867,1,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.5037e-07,-0.59265,-0.46671,1,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,2.2397e-08,-0.59277,-0.66711,1,0
4,GO BIOLOGICAL PHASE,2.3274e-07,-0.59343,-0.50676,1,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.3761e-09,-0.59356,-0.56996,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,1.439e-07,-0.59383,-0.55991,1,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.9905e-10,-0.59413,-0.63972,1,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.6828e-05,-0.59614,-0.50619,1,0
4,GO SIALYLATION,4.1815e-08,-0.59753,-0.54969,1,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.3737e-10,-0.5994,-0.60969,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,7.8778e-10,-0.6007,-0.63558,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.402e-08,-0.60101,-0.54737,1,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,3.6586e-11,-0.60104,-0.65811,1,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,3.5427e-10,-0.60106,-0.67924,1,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,6.2565e-10,-0.60498,-0.59789,1,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.4472e-05,-0.60569,-0.64376,1,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,5.77e-09,-0.60629,-0.68354,1,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,6.6717e-09,-0.60694,-0.56228,1,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,2.595e-12,-0.60866,-0.63469,1,0
4,GO VASCULAR WOUND HEALING,1.1579e-08,-0.60916,-0.53756,1,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.5695e-09,-0.61153,-0.60657,1,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,3.0395e-05,-0.61272,-0.45802,1,0
4,GO BLASTODERM SEGMENTATION,1.4471e-09,-0.61362,-0.58415,1,0
4,GO CELL CELL JUNCTION MAINTENANCE,5.3747e-08,-0.61427,-0.58135,1,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,2.1188e-12,-0.61451,-0.71903,1,0
4,GO BASEMENT MEMBRANE ORGANIZATION,1.2074e-11,-0.61536,-0.72851,1,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,3.0295e-08,-0.61683,-0.65224,1,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,7.2202e-11,-0.6187,-0.63711,1,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.2143e-08,-0.61882,-0.63244,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.7797e-12,-0.61902,-0.65783,1,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,6.4699e-07,-0.61976,-0.55878,1,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,6.6774e-12,-0.62013,-0.63824,1,0
4,GO PULMONARY VALVE DEVELOPMENT,5.3747e-08,-0.62055,-0.59021,1,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,4.8359e-10,-0.62492,-0.72745,1,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,2.6581e-10,-0.62506,-0.68049,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,5.1101e-09,-0.62518,-0.6007,1,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6407e-09,-0.62563,-0.63581,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.02e-08,-0.62568,-0.63152,1,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,5.2253e-10,-0.62919,-0.67334,1,0
4,GO ENDOTHELIAL CELL CHEMOTAXIS,3.0296e-10,-0.62932,-0.58367,1,0
4,GO GLOMERULUS DEVELOPMENT,7.9144e-12,-0.63129,-0.68154,1,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,1.4877e-10,-0.63235,-0.66791,1,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,1.2907e-12,-0.63323,-0.78837,1,0
4,GO REGULATION OF PODOSOME ASSEMBLY,1.4677e-08,-0.63408,-0.61888,1,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,3.0296e-10,-0.63465,-0.61331,1,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.3606e-10,-0.64033,-0.59253,1,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.0169e-05,-0.64585,-0.57733,1,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.9064e-09,-0.65012,-0.64739,1,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,1.9014e-08,-0.65222,-0.64524,1,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,3.1098e-10,-0.65481,-0.71954,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,2.4893e-11,-0.65571,-0.67729,1,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,9.1996e-11,-0.66033,-0.70693,1,0
4,GO HEMIDESMOSOME ASSEMBLY,5.8262e-07,-0.6608,-0.70015,1,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,8.4805e-07,-0.66207,-0.60759,1,0
4,GO TOOTH MINERALIZATION,4.6112e-12,-0.66941,-0.69708,1,0
4,GO SALIVARY GLAND DEVELOPMENT,1.3505e-11,-0.67355,-0.64487,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,1.3174e-07,-0.67486,-0.61554,1,0
4,GO BONE TRABECULA MORPHOGENESIS,2.1678e-11,-0.68162,-0.73932,1,0
4,GO FACIAL NERVE MORPHOGENESIS,1.2733e-08,-0.68561,-0.68996,1,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,6.4192e-10,-0.69013,-0.75924,1,0
4,GO BLEB ASSEMBLY,2.8262e-08,-0.69367,-0.74141,1,0
4,GO MYELIN MAINTENANCE,8.2903e-10,-0.69481,-0.67153,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.6306e-11,-0.69912,-0.69918,1,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,2.65e-07,-0.70271,-0.63243,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.5968e-11,-0.7031,-0.78538,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,2.0879e-07,-0.70636,-0.60452,1,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.3761e-09,-0.70639,-0.64618,1,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.3933e-10,-0.70901,-0.80497,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,9.658e-10,-0.71786,-0.64489,1,0
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,6.8348e-09,-0.72338,-0.77996,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00058763,-0.72749,-0.65166,1,0
4,GO ELASTIC FIBER ASSEMBLY,4.7501e-09,-0.72999,-0.75182,1,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.457e-10,-0.73544,-0.78022,1,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,2.3554e-11,-0.73674,-0.75318,1,0
4,GO ENAMEL MINERALIZATION,8.0424e-11,-0.74341,-0.73674,1,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,6.757e-10,-0.74382,-0.70321,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.6937e-12,-0.75687,-0.79359,1,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.642e-11,-0.75906,-0.87189,1,0
4,GO BASEMENT MEMBRANE ASSEMBLY,1.6109e-10,-0.78473,-0.81289,1,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.3761e-09,-0.79711,-0.79453,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0007786,-0.81566,-0.74571,1,0
4,GO RENAL FILTRATION,1.942e-12,-0.90119,-0.91222,1,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,1.6109e-10,-0.92192,-0.8781,1,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,5.2359e-09,-0.92456,-0.9192,1,0
4,GO TRANSLATIONAL TERMINATION,0.095518,0.089765,0.043565,0,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.1262,0.082453,0.039446,0,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.11647,0.079625,0.063059,0,1
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.11933,0.078527,0.054439,0,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.075674,0.07379,0.062839,0,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.1262,0.11164,0.074757,0,0
4,GO PROTEIN NEDDYLATION,0.090782,0.08306,0.068292,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.22042,0.080567,0.054304,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.094715,0.076908,0.051805,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.20699,0.058973,0.022287,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.12421,0.055188,0.042133,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.95639,0.05508,-0.047102,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.47211,0.052027,0.038698,0,0
4,GO MATURATION OF LSU RRNA,0.69286,0.051181,-0.033741,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.77209,0.047503,-0.0090435,0,0
4,GO PROTEASOME ASSEMBLY,0.087731,0.047007,0.04723,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.36098,0.046863,-0.093202,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.23605,0.045509,0.063001,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.572,0.045022,0.031458,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.71693,0.043044,-0.0032896,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.77519,0.037058,0.0083321,0,0
4,GO TRANSLATIONAL ELONGATION,0.40514,0.033516,0.0056757,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.41899,0.031717,0.0025575,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.81267,0.027494,-0.033548,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.92738,0.026711,-0.022734,0,0
4,GO PROTEIN DENEDDYLATION,0.74128,0.026312,-0.037209,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.97576,0.025098,-0.023497,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.89526,0.022741,-0.01256,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.94993,0.02272,-0.029282,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.63408,0.021156,0.018021,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.72603,0.019795,-0.049334,0,0
4,GO RIBOSOME ASSEMBLY,0.56103,0.016971,0.01515,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.67501,0.015027,-0.026113,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.98869,0.013592,-0.018754,0,0
4,GO TRNA 5 LEADER REMOVAL,0.69586,0.013225,-0.003158,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.61117,0.011726,-0.054017,0,0
4,GO TRANSLATIONAL INITIATION,0.70185,0.0098186,0.014507,0,0
4,GO SNORNA 3 END PROCESSING,0.46466,0.0070075,-0.073594,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.55287,0.0046444,-0.062487,0,0
4,GO MALE MEIOSIS I,0.5665,0.0046077,-0.10258,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.5665,0.0037647,-0.066063,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.4451,0.0023697,-0.053493,0,0
4,GO KINETOCHORE ORGANIZATION,0.45727,0.0019082,-0.064497,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.47461,-0.0016326,-0.094389,0,0
4,GO TRNA 5 END PROCESSING,0.96607,-0.0029232,-0.030181,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.39156,-0.0032955,-0.083175,0,0
4,GO REGULATION OF APPETITE,0.33803,-0.003461,-0.063043,0,0
4,GO CYTOPLASMIC TRANSLATION,0.7814,-0.0037295,-0.011159,0,0
4,GO RRNA 3 END PROCESSING,0.96607,-0.0050067,-0.021296,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5583,-0.0053787,-0.057636,0,0
4,GO NEURON FATE SPECIFICATION,0.53406,-0.0082968,-0.073537,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.19003,-0.0083375,-0.10878,0,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.61117,-0.0088046,-0.023888,0,0
4,GO AMINO ACID ACTIVATION,0.22348,-0.011436,-0.097678,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.23927,-0.012812,-0.10176,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.3739,-0.014333,-0.063491,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.31409,-0.015453,-0.099519,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.71996,-0.01609,-0.02114,0,0
4,GO HISTONE EXCHANGE,0.48722,-0.016294,-0.04163,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.42133,-0.018389,-0.040782,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.76281,-0.019601,-0.0698,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.318,-0.02236,-0.06269,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.79075,-0.022805,-0.037558,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.26964,-0.023156,-0.10205,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48468,-0.023992,-0.063004,0,0
4,GO NCRNA 3 END PROCESSING,0.46466,-0.024738,-0.056239,0,0
4,GO SNRNA PROCESSING,0.27495,-0.027346,-0.075874,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.064418,-0.028501,-0.13273,0,0
4,GO PIRNA METABOLIC PROCESS,0.49231,-0.028691,-0.074183,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.86649,-0.028919,-0.026214,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.17283,-0.029454,-0.079603,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.42602,-0.03197,-0.23246,0,0
4,GO RNA SURVEILLANCE,0.42838,-0.033115,-0.074918,0,0
4,GO SNORNA METABOLIC PROCESS,0.178,-0.033203,-0.12051,0,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.18327,-0.034036,-0.061187,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.55287,-0.036308,-0.050821,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.26267,-0.036877,-0.11289,0,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40743,-0.036975,-0.067759,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.99192,-0.037051,-0.029687,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.28945,-0.041118,-0.067235,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.28761,-0.042495,-0.12182,0,0
4,GO RNA 5 END PROCESSING,0.318,-0.042706,-0.087339,0,0
4,GO MYOBLAST MIGRATION,0.27495,-0.043568,-0.12329,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.45727,-0.044701,-0.072765,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.61402,-0.045393,-0.043156,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.40973,-0.045622,-0.047589,0,0
4,GO KINETOCHORE ASSEMBLY,0.30446,-0.046254,-0.076354,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.13549,-0.046301,-0.10574,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.16904,-0.047607,-0.13636,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.19417,-0.048729,-0.088771,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.22814,-0.050218,-0.062759,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.44994,-0.050253,-0.062492,0,0
4,GO TRNA PROCESSING,0.11367,-0.050405,-0.11148,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.1146,-0.051533,-0.093494,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.3739,-0.052923,-0.079665,0,0
4,GO RRNA MODIFICATION,0.12721,-0.054176,-0.12921,0,0
4,GO VIRAL GENE EXPRESSION,0.43789,-0.055015,-0.031378,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.1387,-0.055108,-0.12251,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.10214,-0.055304,-0.072655,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.52874,-0.05646,-0.018797,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.088486,-0.056714,-0.091723,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.46962,-0.056746,-0.056835,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.26964,-0.057091,-0.074907,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.14308,-0.058874,-0.088092,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1313,-0.06018,-0.078104,0,0
4,GO CELLULAR RESPIRATION,0.075674,-0.060722,-0.10014,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.29502,-0.062154,-0.11429,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.10823,-0.062986,-0.11431,0,0
4,GO RIBOSOME BIOGENESIS,0.30446,-0.063242,-0.080042,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.15802,-0.063548,-0.10241,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.074349,-0.063725,-0.11377,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.019523,-0.065601,-0.090328,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.1533,-0.067055,-0.10088,0,0
4,GO MATURATION OF SSU RRNA,0.18327,-0.067069,-0.10548,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.20265,-0.067506,-0.11695,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.16778,-0.06757,-0.055337,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.27853,-0.067661,-0.088776,0,0
4,GO TRNA METABOLIC PROCESS,0.075674,-0.067714,-0.12215,0,0
4,GO NCRNA PROCESSING,0.14755,-0.068036,-0.10914,0,0
4,GO SNRNA METABOLIC PROCESS,0.24252,-0.068629,-0.088113,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.045591,-0.069581,-0.14241,0,0
4,GO NUCLEOSOME ASSEMBLY,0.077018,-0.071031,-0.10885,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12029,-0.071267,-0.16563,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.032278,-0.073667,-0.15777,0,0
4,GO RRNA METABOLIC PROCESS,0.1252,-0.074736,-0.11018,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.20554,-0.075697,-0.098581,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.28945,-0.075889,-0.07212,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.061549,-0.076764,-0.1286,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.084763,-0.076882,-0.14258,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.33599,-0.076942,-0.23496,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.35886,-0.079006,-0.068876,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.098784,-0.079717,-0.099978,0,0
4,GO MATURATION OF 5 8S RRNA,0.31409,-0.080784,-0.082713,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.22042,-0.081018,-0.098652,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.11367,-0.082755,-0.11784,0,0
4,GO PENTOSE METABOLIC PROCESS,0.12126,-0.082821,-0.12058,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.01128,-0.083512,-0.17129,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.11742,-0.084308,-0.1309,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.10646,-0.084316,-0.1145,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.16904,-0.084459,-0.10369,0,0
4,GO LACTATE METABOLIC PROCESS,0.10558,-0.084514,-0.12786,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15565,-0.084679,-0.093176,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.14642,-0.084941,-0.094357,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0088198,-0.084971,-0.10041,0,0
4,GO VIRAL LATENCY,0.17669,-0.085269,-0.090198,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.19979,-0.087394,-0.1141,0,0
4,GO NCRNA METABOLIC PROCESS,0.070488,-0.087697,-0.12097,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.032607,-0.087724,-0.13627,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.0085105,-0.089135,-0.18282,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.20699,-0.092502,-0.085705,0,0
4,GO DNA REPLICATION INITIATION,0.14088,-0.093095,-0.089045,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.16654,-0.093192,-0.11774,0,0
4,GO IMP METABOLIC PROCESS,0.22503,-0.094596,-0.16781,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.10129,-0.097506,-0.10974,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.00099681,-0.097849,-0.23569,0,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.31215,-0.097855,-0.07649,0,0
4,GO CELL CYCLE DNA REPLICATION,0.094715,-0.098312,-0.12119,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.11837,-0.10233,-0.1191,0,0
4,GO MITOTIC DNA REPLICATION,0.073694,-0.10241,-0.16681,0,0
4,GO QUINONE METABOLIC PROCESS,0.010279,-0.10277,-0.17653,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.01016,-0.10307,-0.15303,0,0
4,GO REGULATION OF RESPONSE TO FOOD,0.093126,-0.10331,-0.081344,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.16285,-0.10451,-0.076,0,0
4,GO MITOCHONDRIAL FUSION,0.013243,-0.10647,-0.21196,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.14308,-0.10711,-0.0901,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0068504,-0.10747,-0.20345,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.19278,-0.10818,-0.12088,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.0065235,-0.10832,-0.15748,0,0
4,GO DNA LIGATION,0.087731,-0.10986,-0.10917,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.1146,-0.11153,-0.106,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.66321,-0.11333,-0.046307,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0054192,-0.11419,-0.17633,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.48976,-0.11623,-0.23486,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.0032501,-0.11787,-0.20337,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0073682,-0.1195,-0.17102,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.022686,-0.12037,-0.13672,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0017517,-0.12162,-0.14156,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.0067673,-0.12516,-0.16664,0,0
4,GO DNA STRAND ELONGATION,0.17283,-0.12594,-0.092449,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.0038977,-0.12649,-0.2077,0,0
4,GO NEURON FATE COMMITMENT,0.10823,-0.12677,-0.15908,0,0
4,GO SIGNAL PEPTIDE PROCESSING,0.13549,-0.12726,-0.12213,0,0
4,GO OXIDATIVE DEMETHYLATION,0.078382,-0.12739,-0.11754,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.080464,-0.12915,-0.1092,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0024281,-0.13073,-0.17469,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.11275,-0.13393,-0.16476,0,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00082553,-0.13564,-0.19844,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.00080175,-0.13869,-0.20121,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.20265,-0.13876,-0.11088,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0013826,-0.14038,-0.19035,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.0056255,-0.14142,-0.16494,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0012005,-0.14256,-0.20284,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0033361,-0.14287,-0.21659,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.030994,-0.14396,-0.18717,0,0
4,GO MITOCHONDRIAL TRANSPORT,6.9711e-06,-0.14482,-0.21306,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0013069,-0.1457,-0.16017,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0012005,-0.14695,-0.2468,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0018508,-0.14702,-0.25275,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.023919,-0.14829,-0.22972,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.026286,-0.15085,-0.20881,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0024609,-0.15187,-0.1978,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.031953,-0.15239,-0.13396,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.001235,-0.15241,-0.26469,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,5.4184e-05,-0.15277,-0.19299,0,0
4,GO MITOCHONDRION ORGANIZATION,1.0424e-06,-0.15301,-0.21455,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,5.2344e-05,-0.15371,-0.26607,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.068006,-0.15526,-0.12052,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.14308,-0.15536,-0.122,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00013451,-0.15793,-0.23906,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00082553,-0.16,-0.20195,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00069207,-0.16186,-0.25966,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0086125,-0.16212,-0.23166,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00010152,-0.16261,-0.26802,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,6.2046e-07,-0.1647,-0.26093,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.00028155,-0.16601,-0.24898,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,7.6283e-05,-0.16669,-0.20796,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,9.1829e-05,-0.16749,-0.18632,0,0
4,GO ALDITOL METABOLIC PROCESS,0.015501,-0.16842,-0.21822,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00016901,-0.16843,-0.16419,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00031414,-0.17102,-0.24897,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.012945,-0.17205,-0.26201,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,3.2859e-07,-0.17401,-0.2597,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,1.0861e-06,-0.17533,-0.28557,0,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0005789,-0.17579,-0.23746,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.9498e-07,-0.17936,-0.22537,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.00043435,-0.17988,-0.20893,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.0059116,-0.18076,-0.25637,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.021973,-0.18295,-0.26915,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.00040235,-0.18304,-0.20817,0,0
4,GO NADPH REGENERATION,0.00037835,-0.18383,-0.26432,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,4.1552e-07,-0.18525,-0.24368,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.0071051,-0.18533,-0.17814,0,0
4,GO SLEEP,5.6085e-05,-0.18677,-0.2291,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,7.8124e-06,-0.18692,-0.24999,0,0
4,GO RESPONSE TO SALT,0.00011986,-0.18762,-0.22228,0,0
4,GO RESPONSE TO ATP,1.8135e-09,-0.18784,-0.30013,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,8.2543e-08,-0.18798,-0.24394,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,7.3803e-06,-0.19187,-0.26121,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0019285,-0.1924,-0.25577,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,7.8124e-06,-0.19353,-0.27908,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.048285,-0.19363,-0.15814,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.042609,-0.19394,-0.3012,0,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,4.9361e-06,-0.1947,-0.28886,0,0
4,GO RESPONSE TO LEPTIN,6.3249e-05,-0.19533,-0.29296,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,2.8271e-07,-0.19555,-0.27274,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,1.3693e-05,-0.19712,-0.34164,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,3.2631e-05,-0.19773,-0.33986,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.023173,-0.19784,-0.20848,0,0
4,GO ACETYL COA METABOLIC PROCESS,7.9617e-06,-0.19791,-0.30173,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.027401,-0.19884,-0.14138,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,2.4371e-06,-0.19912,-0.32613,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0035605,-0.20034,-0.32088,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,1.6761e-05,-0.20035,-0.24419,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00032408,-0.2006,-0.26205,0,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00018323,-0.20245,-0.2628,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,3.758e-05,-0.20352,-0.25203,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0049019,-0.20367,-0.23515,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,1.6158e-05,-0.20603,-0.30682,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,6.0991e-06,-0.20662,-0.35451,0,0
4,GO NUCLEAR BODY ORGANIZATION,2.0478e-05,-0.20959,-0.32663,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.06986,-0.21234,-0.32565,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,8.7502e-06,-0.21363,-0.24433,0,0
4,GO PROTEIN REFOLDING,0.0039481,-0.21449,-0.2001,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00063314,-0.21533,-0.35551,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0013255,-0.2156,-0.34544,0,0
4,GO RESPONSE TO ALKALOID,3.5038e-07,-0.21708,-0.28158,0,0
4,GO COENZYME A METABOLIC PROCESS,0.00055343,-0.21772,-0.24247,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00048316,-0.21817,-0.24483,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,5.7059e-05,-0.21982,-0.24996,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,3.4773e-06,-0.22088,-0.30855,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,1.2482e-05,-0.22108,-0.29634,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00035024,-0.22218,-0.26008,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,6.7724e-05,-0.2229,-0.23305,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00049802,-0.22313,-0.23439,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,2.2505e-06,-0.22353,-0.34336,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00095459,-0.22388,-0.27894,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00010673,-0.22697,-0.2584,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.020385,-0.22932,-0.19462,0,0
4,GO SULFATE TRANSPORT,2.6352e-05,-0.23057,-0.26518,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.0001803,-0.23225,-0.34664,0,0
4,GO REGULATION OF OOGENESIS,1.064e-06,-0.23268,-0.25776,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0022095,-0.23335,-0.21264,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.0033799,-0.23369,-0.19625,0,0
4,GO FEVER GENERATION,2.6828e-05,-0.23408,-0.19229,0,0
4,GO ORGANIC ACID TRANSPORT,2.1543e-10,-0.23462,-0.33885,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,9.5677e-09,-0.23698,-0.31467,0,0
4,GO ARACHIDONIC ACID SECRETION,6.8396e-06,-0.2371,-0.29648,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.0026663,-0.2373,-0.23248,0,0
4,GO MICROTUBULE SEVERING,0.00010152,-0.23767,-0.2881,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.5386e-08,-0.23841,-0.31813,0,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,8.6579e-07,-0.23929,-0.27061,0,0
4,GO RHYTHMIC BEHAVIOR,1.0527e-08,-0.24045,-0.3561,0,0
4,GO COBALAMIN METABOLIC PROCESS,8.3066e-07,-0.24121,-0.28822,0,0
4,GO SEGMENT SPECIFICATION,0.0018764,-0.24233,-0.25262,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,8.1361e-07,-0.24239,-0.30133,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.4305e-07,-0.243,-0.42552,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,6.545e-05,-0.24333,-0.29109,0,0
4,GO ANDROGEN METABOLIC PROCESS,0.003166,-0.2439,-0.21742,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.00055343,-0.24451,-0.24905,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,7.3739e-05,-0.24473,-0.28161,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.2716e-05,-0.24528,-0.34381,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,5.4184e-05,-0.24613,-0.29898,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.022928,-0.24696,-0.18896,0,0
4,GO REGULATION OF PROTON TRANSPORT,1.3878e-06,-0.24702,-0.30417,0,0
4,GO REFLEX,0.0067673,-0.24718,-0.33644,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.00010673,-0.24779,-0.27683,0,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,2.7e-09,-0.24809,-0.28521,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,5.8049e-05,-0.24833,-0.30195,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0025277,-0.24877,-0.18175,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,6.205e-09,-0.2495,-0.34077,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00026024,-0.25022,-0.28101,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,5.332e-06,-0.25037,-0.32975,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,3.8924e-05,-0.25045,-0.26756,0,0
4,GO ORGAN INDUCTION,2.206e-06,-0.25086,-0.31551,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0015249,-0.25125,-0.25654,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.725e-09,-0.25141,-0.35098,0,0
4,GO AUTOPHAGIC CELL DEATH,3.9872e-06,-0.25239,-0.32003,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.031311,-0.25343,-0.20889,0,0
4,GO ATP TRANSPORT,1.9465e-08,-0.25356,-0.34478,0,0
4,GO ALCOHOL CATABOLIC PROCESS,4.5239e-09,-0.25386,-0.32857,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.003607,-0.25443,-0.23395,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,7.2414e-06,-0.25594,-0.27524,0,0
4,GO NEURAL RETINA DEVELOPMENT,3.2162e-07,-0.25665,-0.34756,0,0
4,GO LIPID DIGESTION,0.00022927,-0.25675,-0.3582,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,7.969e-07,-0.25734,-0.36913,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,8.3013e-05,-0.25745,-0.32832,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,4.1948e-11,-0.25824,-0.32498,0,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,6.757e-10,-0.259,-0.35392,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.064e-06,-0.26276,-0.31075,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.00059648,-0.26305,-0.22021,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.7963e-08,-0.26397,-0.42427,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,2.65e-07,-0.26574,-0.31423,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,2.6386e-06,-0.26594,-0.28107,0,0
4,GO RESPONSE TO GLUCAGON,8.9047e-09,-0.26605,-0.37913,0,0
4,GO GASTRIC ACID SECRETION,6.3249e-05,-0.26847,-0.2157,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.00069207,-0.26913,-0.29918,0,0
4,GO CELL FATE DETERMINATION,1.2716e-05,-0.26921,-0.321,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,4.31e-06,-0.27073,-0.33384,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,1.6994e-06,-0.27238,-0.3283,0,0
4,GO RESPONSE TO LEAD ION,2.8886e-07,-0.27288,-0.367,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,1.6307e-12,-0.27297,-0.3408,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,7.5217e-06,-0.27397,-0.31537,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0078263,-0.27429,-0.26152,0,0
4,GO RESPONSE TO INTERLEUKIN 4,4.4148e-09,-0.27753,-0.33737,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0020929,-0.27776,-0.25505,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,7.0337e-07,-0.27784,-0.28538,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,2.0853e-05,-0.27803,-0.27252,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,2.2926e-08,-0.27826,-0.3265,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00064263,-0.27871,-0.25771,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,1.6761e-05,-0.27923,-0.31378,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,4.2784e-08,-0.27954,-0.36037,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00017457,-0.27992,-0.30602,0,0
4,GO HEART GROWTH,8.3747e-12,-0.28285,-0.42696,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,3.5794e-07,-0.28293,-0.30608,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.9371e-11,-0.28527,-0.35486,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,1.9136e-07,-0.28612,-0.33598,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00099681,-0.28682,-0.32195,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,5.8856e-08,-0.28738,-0.35585,0,0
4,GO ENDOCYTOSIS,7.3765e-13,-0.28864,-0.43133,0,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,3.247e-08,-0.28881,-0.36074,0,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,2.2505e-06,-0.28921,-0.35366,0,0
4,GO PANCREATIC JUICE SECRETION,2.8925e-08,-0.28958,-0.34525,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,6.757e-10,-0.29039,-0.31546,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00159,-0.2921,-0.29157,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,3.2859e-07,-0.29323,-0.38056,0,0
4,GO T CELL HOMEOSTASIS,1.8142e-08,-0.29359,-0.30663,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,5.9116e-09,-0.29491,-0.38478,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00076726,-0.29588,-0.24789,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,4.3236e-05,-0.29639,-0.31513,0,0
4,GO RESPONSE TO ETHANOL,2.0509e-11,-0.2966,-0.3222,0,0
4,GO HEART FIELD SPECIFICATION,3.2631e-05,-0.29679,-0.41091,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,1.4207e-05,-0.30091,-0.31275,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0012886,-0.30131,-0.32086,0,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,3.462e-12,-0.30134,-0.34987,0,0
4,GO REGULATION OF BEHAVIOR,1.3468e-07,-0.3035,-0.31684,0,0
4,GO WATER TRANSPORT,1.2131e-09,-0.30457,-0.38196,0,0
4,GO REGULATION OF ODONTOGENESIS,3.357e-07,-0.30579,-0.37376,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,9.0235e-07,-0.30608,-0.31383,0,0
4,GO VITAMIN TRANSPORT,6.5906e-08,-0.30671,-0.34171,0,0
4,GO RESPONSE TO ZINC ION,3.0905e-06,-0.30684,-0.28958,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0018764,-0.30756,-0.30202,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00023667,-0.30787,-0.30831,0,0
4,GO RENAL SODIUM EXCRETION,1.3671e-08,-0.30816,-0.35167,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,2.6386e-06,-0.30901,-0.27787,0,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.8262e-08,-0.30953,-0.33687,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,8.9166e-06,-0.31009,-0.33932,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,2.4452e-09,-0.31211,-0.36942,0,0
4,GO RESPONSE TO CATECHOLAMINE,6.5906e-08,-0.31319,-0.33621,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.001442,-0.31505,-0.34491,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00010152,-0.31548,-0.36042,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.2482e-05,-0.31601,-0.38544,0,0
4,GO REGULATION OF EXCRETION,7.3772e-08,-0.3163,-0.35787,0,0
4,GO CELL AGGREGATION,3.357e-07,-0.31655,-0.36443,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,4.4302e-11,-0.31823,-0.36641,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,3.4098e-06,-0.32043,-0.43512,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,4.5822e-08,-0.32071,-0.4481,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,1.3039e-08,-0.32085,-0.33405,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0032078,-0.32091,-0.29049,0,0
4,GO RESPONSE TO CAMP,5.9748e-11,-0.32182,-0.38705,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.3236e-05,-0.32218,-0.44845,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,3.1098e-10,-0.32282,-0.36153,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,2.5868e-06,-0.32366,-0.39575,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,1.5027e-08,-0.32427,-0.40908,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,2.7078e-07,-0.32532,-0.36127,0,0
4,GO RESPONSE TO MISFOLDED PROTEIN,8.6937e-09,-0.32628,-0.4245,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,2.2505e-06,-0.32697,-0.33946,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,7.0279e-11,-0.32814,-0.40315,0,0
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,1.2482e-05,-0.3287,-0.32997,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00013899,-0.32906,-0.33327,0,0
4,GO OVULATION,2.5756e-08,-0.33145,-0.36622,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.1025e-09,-0.33161,-0.38264,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00054518,-0.33165,-0.35135,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.7411e-08,-0.33368,-0.35542,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.0478e-05,-0.33432,-0.31247,0,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,1.642e-11,-0.33482,-0.39219,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,6.7105e-06,-0.33693,-0.45667,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,1.4686e-11,-0.33804,-0.41408,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.8573e-11,-0.33945,-0.37359,0,0
4,GO CELLULAR RESPONSE TO CAMP,2.8753e-10,-0.33993,-0.37872,0,0
4,GO PITUITARY GLAND DEVELOPMENT,9.4959e-05,-0.34038,-0.34684,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,7.0072e-05,-0.34066,-0.35686,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,1.5217e-09,-0.34084,-0.38648,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0020929,-0.3409,-0.2672,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,1.2328e-07,-0.34115,-0.40536,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,6.0979e-10,-0.34433,-0.36563,0,0
4,GO SYNAPTIC VESICLE BUDDING,1.7922e-07,-0.34443,-0.40516,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.679e-12,-0.34505,-0.40767,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,9.086e-06,-0.34619,-0.44017,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,2.7e-09,-0.34703,-0.37603,0,0
4,GO INTESTINAL LIPID ABSORPTION,8.3013e-05,-0.3478,-0.42024,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,1.1533e-09,-0.3478,-0.3409,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,5.0278e-07,-0.34794,-0.32218,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,1.5604e-09,-0.35097,-0.46018,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0027747,-0.35099,-0.35009,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,3.8983e-07,-0.35335,-0.40376,0,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,5.1691e-12,-0.35676,-0.40089,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,1.6761e-05,-0.35681,-0.42333,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,1.2328e-07,-0.35729,-0.40205,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.4334e-08,-0.35978,-0.42599,0,0
4,GO GROWTH HORMONE SECRETION,0.00063314,-0.36038,-0.38533,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,4.5684e-06,-0.3615,-0.45057,0,0
4,GO PARTURITION,9.7991e-09,-0.36165,-0.38561,0,0
4,GO DEVELOPMENTAL PIGMENTATION,4.8076e-11,-0.36223,-0.3887,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,4.1456e-06,-0.36233,-0.39136,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.9941e-08,-0.36255,-0.43683,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,4.5822e-08,-0.36376,-0.35986,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.8753e-10,-0.36518,-0.37898,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,2.7078e-07,-0.3661,-0.38401,0,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,6.9323e-10,-0.36699,-0.44894,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00015331,-0.36882,-0.40712,0,0
4,GO HORMONE CATABOLIC PROCESS,2.9859e-05,-0.36945,-0.33177,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,9.6129e-06,-0.37021,-0.36116,0,0
4,GO GRANULOCYTE DIFFERENTIATION,9.2118e-07,-0.37098,-0.37149,0,0
4,GO C21 STEROID HORMONE METABOLIC PROCESS,8.1138e-06,-0.37113,-0.34577,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,5.2538e-08,-0.37211,-0.36873,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,7.6446e-07,-0.37316,-0.42855,0,0
4,GO RESPONSE TO PROSTAGLANDIN,2.6581e-10,-0.37339,-0.39955,0,0
4,GO LYMPH NODE DEVELOPMENT,2.4452e-09,-0.37363,-0.41376,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,8.6328e-08,-0.37446,-0.38457,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.0099244,-0.37599,-0.32034,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,3.9717e-11,-0.37627,-0.42044,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,4.0314e-05,-0.37637,-0.35681,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00032408,-0.37716,-0.31114,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,1.4334e-08,-0.37797,-0.50497,0,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,1.7687e-09,-0.379,-0.40318,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,6.895e-08,-0.38065,-0.41089,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,4.8198e-07,-0.38196,-0.38747,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,7.8124e-06,-0.38221,-0.28599,0,0
4,GO CELLULAR RESPONSE TO IRON ION,1.6129e-08,-0.38275,-0.43953,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,1.1086e-06,-0.38277,-0.41071,0,0
4,GO GONADOTROPIN SECRETION,6.4592e-06,-0.3841,-0.3509,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,3.6924e-05,-0.38841,-0.33899,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,3.4003e-08,-0.38918,-0.39802,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,1.5372e-07,-0.38933,-0.42122,0,0
4,GO CARDIAC MUSCLE CONTRACTION,3.2894e-09,-0.39012,-0.39204,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.5052e-06,-0.39504,-0.48653,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,4.4148e-09,-0.3997,-0.42347,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,2.8925e-08,-0.40111,-0.41866,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00010497,-0.40343,-0.40226,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4796e-08,-0.40632,-0.42123,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00034485,-0.40673,-0.30702,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,8.1138e-06,-0.40733,-0.39061,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,9.4407e-08,-0.40886,-0.46519,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,9.4341e-06,-0.409,-0.41843,0,0
4,GO BIOMINERALIZATION,5.0237e-12,-0.40972,-0.47257,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,5.9116e-09,-0.41057,-0.36097,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,3.8149e-08,-0.41098,-0.38327,0,0
4,GO MELANOCYTE DIFFERENTIATION,5.3617e-10,-0.41196,-0.42409,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,2.4837e-07,-0.41318,-0.45156,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,9.1793e-10,-0.41456,-0.50955,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,1.0781e-08,-0.41513,-0.49375,0,0
4,GO CARTILAGE MORPHOGENESIS,1.0861e-06,-0.41532,-0.50032,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,8.0898e-09,-0.4157,-0.44943,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00082553,-0.41631,-0.33209,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,1.0958e-05,-0.42422,-0.51157,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.7922e-07,-0.42501,-0.44679,0,0
4,GO INCLUSION BODY ASSEMBLY,3.0302e-06,-0.42818,-0.4425,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,3.1479e-07,-0.43349,-0.42127,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,7.6792e-10,-0.4351,-0.50145,0,0
4,GO RESPONSE TO AMYLOID BETA,2.3113e-12,-0.43577,-0.52693,0,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,5.3747e-08,-0.43772,-0.52993,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,1.4282e-11,-0.43783,-0.47985,0,0
4,GO REGULATION OF BIOMINERALIZATION,5.1691e-12,-0.43856,-0.47539,0,0
4,GO BONE MINERALIZATION,3.1896e-11,-0.43922,-0.45497,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,2.8271e-07,-0.44346,-0.44622,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,4.719e-07,-0.44392,-0.39221,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.2764e-10,-0.44452,-0.4577,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,2.0509e-11,-0.45001,-0.48409,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,1.4334e-08,-0.45133,-0.48904,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,7.892e-08,-0.45226,-0.46416,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,9.4499e-11,-0.45659,-0.52111,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,3.8983e-07,-0.45665,-0.53802,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,1.0792e-11,-0.45783,-0.54215,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.7602e-11,-0.45824,-0.50671,0,0
4,GO REGULATION OF BONE MINERALIZATION,2.2286e-11,-0.4597,-0.49207,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,1.8594e-09,-0.46358,-0.4573,0,0
4,GO REGULATION OF GTP BINDING,2.4586e-08,-0.46445,-0.45739,0,0
4,GO BONE MATURATION,5.2253e-10,-0.46505,-0.4699,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.5646e-05,-0.46904,-0.46308,0,0
4,GO HEART INDUCTION,0.00016901,-0.47288,-0.39752,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,1.2886e-07,-0.47826,-0.45714,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,1.1794e-07,-0.47937,-0.54775,0,0
4,GO HAIR FOLLICLE MATURATION,2.1375e-08,-0.47948,-0.4755,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,1.0527e-08,-0.47961,-0.47245,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,5.6451e-10,-0.48251,-0.50556,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,8.4871e-11,-0.48492,-0.44087,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.004e-09,-0.49471,-0.50947,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,8.6328e-08,-0.49927,-0.51204,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,3.9309e-10,-0.50222,-0.50521,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,9.2321e-08,-0.50834,-0.51348,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,1.2131e-09,-0.51637,-0.58152,0,0
4,GO DECIDUALIZATION,8.4805e-07,-0.51816,-0.47253,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,4.1026e-05,-0.52216,-0.4501,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,3.4553e-09,-0.5259,-0.64949,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.0337e-07,-0.52982,-0.47315,0,0
4,GO RESPONSE TO HYPEROXIA,1.0202e-11,-0.53898,-0.53523,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.6407e-09,-0.54233,-0.52584,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,9.5677e-09,-0.5427,-0.57719,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,1.9546e-09,-0.54805,-0.53675,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,9.1793e-10,-0.56624,-0.58839,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,1.5027e-08,-0.56719,-0.53349,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.9078e-09,-0.57588,-0.58278,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,2.0364e-06,-0.58056,-0.49228,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,2.011e-05,-0.58477,-0.46402,0,0
4,GO BODY MORPHOGENESIS,5.3602e-11,-0.58591,-0.5488,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,2.2697e-09,-0.59484,-0.54435,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,4.5239e-09,-0.60972,-0.54298,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,1.7071e-05,-0.61491,-0.45791,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,3.7356e-07,-0.62021,-0.56867,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,3.1312e-09,-0.62072,-0.59216,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,7.7166e-08,-0.64217,-0.62017,0,0
4,GO HEAD MORPHOGENESIS,1.3085e-09,-0.64363,-0.56331,0,0
4,GO SKIN MORPHOGENESIS,2.0437e-10,-0.65066,-0.78059,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,1.0493e-11,-0.81529,-0.81276,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,1.9402e-11,-0.83981,-0.87503,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,4.1552e-07,-0.84165,-0.71236,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,1.725e-09,-0.87335,-0.8265,0,0
5,GO REGULATION OF SYNAPSE MATURATION,1.2058e-07,0.70198,0.5774,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,5.3747e-08,0.67842,0.66523,1,1
5,GO ANATOMICAL STRUCTURE REGRESSION,8.1138e-06,0.6459,0.45322,1,1
5,GO SYNAPSE MATURATION,1.0212e-06,0.6354,0.518,1,1
5,GO VOCALIZATION BEHAVIOR,6.3569e-09,0.63364,0.64593,1,1
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.971e-06,0.62635,0.56414,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,2.6981e-08,0.62528,0.60866,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4796e-08,0.60796,0.66669,1,1
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,7.7166e-08,0.58956,0.57668,1,1
5,GO PREPULSE INHIBITION,2.538e-07,0.58051,0.53619,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.1316e-06,0.57101,0.56265,1,1
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.3082e-09,0.56851,0.56969,1,1
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.3948e-05,0.56806,0.53206,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.1858e-08,0.56405,0.56599,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,8.4805e-07,0.56033,0.47871,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,2.0398e-08,0.55601,0.53564,1,1
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.0161e-09,0.53392,0.57644,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,6.8885e-07,0.53305,0.5268,1,1
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.0781e-08,0.52165,0.50528,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,7.7166e-08,0.51595,0.52027,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,3.0811e-07,0.51515,0.4007,1,1
5,GO CARDIAC VENTRICLE FORMATION,5.1351e-07,0.5108,0.49726,1,1
5,GO POSTSYNAPSE ASSEMBLY,3.5606e-08,0.50113,0.52192,1,1
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,8.2543e-08,0.497,0.5087,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,5.9834e-06,0.49639,0.42927,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.9175e-06,0.49484,0.49743,1,1
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,8.2543e-08,0.49396,0.45716,1,1
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.6914e-06,0.4909,0.52184,1,1
5,GO NEURON CELL CELL ADHESION,9.8716e-08,0.48843,0.56227,1,1
5,GO FACIAL NERVE MORPHOGENESIS,1.8701e-05,0.48339,0.4248,1,1
5,GO RETINAL ROD CELL DIFFERENTIATION,5.4356e-06,0.48124,0.3906,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,8.6579e-07,0.47137,0.41774,1,1
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.4837e-07,0.46326,0.49962,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,3.8246e-05,0.45933,0.42296,1,1
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,5.0278e-07,0.45731,0.50785,1,1
5,GO SYNAPTIC VESICLE CLUSTERING,1.0424e-06,0.45711,0.54092,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,6.4434e-08,0.45616,0.42463,1,1
5,GO LIMB BUD FORMATION,4.9361e-06,0.45585,0.43239,1,1
5,GO NOSE DEVELOPMENT,5.2538e-08,0.45493,0.51699,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,9.4959e-05,0.4536,0.412,1,1
5,GO POSITIVE REGULATION OF NEURON MIGRATION,1.0958e-05,0.45133,0.40631,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.5277e-10,0.44781,0.45624,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.8673e-09,0.44439,0.41393,1,1
5,GO SOMATIC STEM CELL DIVISION,1.0958e-05,0.43758,0.41332,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.5359e-06,0.43565,0.4902,1,1
5,GO MALE SEX DETERMINATION,5.3747e-08,0.43412,0.409,1,1
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,2.1624e-06,0.43402,0.34848,1,1
5,GO SPINAL CORD PATTERNING,2.634e-09,0.43202,0.48458,1,1
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.9613e-05,0.43125,0.3666,1,1
5,GO REGULATION OF NEURON MIGRATION,1.4677e-08,0.43076,0.42084,1,1
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.0212e-06,0.4291,0.36555,1,1
5,GO CARDIAC CHAMBER FORMATION,9.7998e-07,0.42609,0.4351,1,1
5,GO THALAMUS DEVELOPMENT,2.6362e-08,0.42602,0.42686,1,1
5,GO FORELIMB MORPHOGENESIS,1.1579e-08,0.4252,0.39041,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.6761e-05,0.42307,0.36207,1,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,2.65e-07,0.42234,0.44347,1,1
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,3.9035e-08,0.42079,0.36377,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.5674e-06,0.42024,0.40335,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00011218,0.41959,0.31953,1,1
5,GO CELL PROLIFERATION IN HINDBRAIN,1.0004e-06,0.41933,0.36996,1,1
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.2604e-07,0.41896,0.4837,1,1
5,GO MICROTUBULE DEPOLYMERIZATION,1.8793e-06,0.41616,0.33508,1,1
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.1479e-07,0.41415,0.42599,1,1
5,GO REGULATION OF NEUROBLAST PROLIFERATION,1.1858e-08,0.41163,0.39283,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,4.5558e-05,0.41128,0.40868,1,1
5,GO CEREBELLAR CORTEX MORPHOGENESIS,5.3617e-10,0.41125,0.37833,1,1
5,GO NEURON FATE SPECIFICATION,5.3747e-08,0.41018,0.49006,1,1
5,GO INNER DYNEIN ARM ASSEMBLY,8.5858e-05,0.41001,0.41457,1,1
5,GO OTIC VESICLE DEVELOPMENT,9.4341e-06,0.40728,0.37008,1,1
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,4.8198e-07,0.40717,0.43223,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,3.1479e-07,0.40511,0.37623,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.6158e-05,0.40426,0.37318,1,1
5,GO HISTONE H3 K9 DEMETHYLATION,2.8262e-08,0.40341,0.37681,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.0017e-09,0.4032,0.44928,1,1
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,4.0678e-07,0.40253,0.38637,1,1
5,GO INNERVATION,5.4356e-06,0.40244,0.46223,1,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,5.9116e-09,0.40055,0.38455,1,1
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,7.5001e-05,0.39807,0.3636,1,1
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.1351e-07,0.39722,0.40078,1,1
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,2.0776e-06,0.39564,0.40351,1,1
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,7.8911e-05,0.39458,0.3447,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,4.31e-06,0.394,0.3252,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,0.00013673,0.39197,0.34367,1,1
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.2444e-07,0.39185,0.40106,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,1.9136e-07,0.38949,0.35679,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,0.00047589,0.38861,0.32219,1,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,9.3415e-09,0.38858,0.36812,1,1
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,2.5359e-06,0.388,0.39027,1,1
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0001803,0.38785,0.33976,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,4.4807e-06,0.38759,0.3406,1,1
5,GO HEART VALVE FORMATION,2.6386e-06,0.38702,0.46307,1,1
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.3997e-05,0.38428,0.38162,1,1
5,GO ACROSOME ASSEMBLY,1.5027e-08,0.38359,0.35484,1,1
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,3.152e-06,0.38286,0.35646,1,1
5,GO RESPONSE TO ACETYLCHOLINE,3.4796e-08,0.38083,0.39164,1,1
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.2958e-06,0.38057,0.41452,1,1
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,1.5293e-05,0.38029,0.31087,1,1
5,GO PARENTAL BEHAVIOR,1.8363e-05,0.37753,0.42789,1,1
5,GO NEURON FATE COMMITMENT,6.5906e-08,0.37658,0.39136,1,1
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.6994e-06,0.3753,0.48998,1,1
5,GO TONGUE MORPHOGENESIS,2.1234e-05,0.37502,0.38662,1,1
5,GO CRANIAL NERVE DEVELOPMENT,2.1624e-06,0.37464,0.31616,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021215,0.37389,0.2779,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00014129,0.37223,0.29001,1,1
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.7154e-07,0.37147,0.3442,1,1
5,GO CENTRIOLE CENTRIOLE COHESION,1.725e-09,0.3694,0.38992,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,4.1751e-05,0.36895,0.33593,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.1086e-06,0.36809,0.36745,1,1
5,GO CEREBELLAR CORTEX FORMATION,5.9116e-09,0.36773,0.36883,1,1
5,GO CORONARY VASCULATURE MORPHOGENESIS,4.2487e-05,0.36752,0.3422,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,3.9822e-07,0.36539,0.41412,1,1
5,GO NERVE DEVELOPMENT,7.333e-07,0.3651,0.35218,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,1.0791e-07,0.36463,0.4168,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,5.1351e-07,0.36338,0.32738,1,1
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0010408,0.3607,0.31734,1,1
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,1.4472e-05,0.36047,0.3274,1,1
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00091404,0.36004,0.3489,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.3066e-07,0.35788,0.38465,1,1
5,GO HISTONE H3 K36 METHYLATION,7.8778e-10,0.35622,0.38381,1,1
5,GO SYNAPTIC VESICLE DOCKING,0.00091404,0.35618,0.31304,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.00054518,0.35582,0.28128,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,1.7706e-05,0.3548,0.3905,1,1
5,GO TONGUE DEVELOPMENT,1.5014e-05,0.35436,0.33152,1,1
5,GO DIVALENT METAL ION EXPORT,3.2146e-06,0.35423,0.38268,1,1
5,GO HISTONE H3 K9 METHYLATION,4.7501e-09,0.3533,0.33368,1,1
5,GO MAST CELL MIGRATION,0.00015838,0.35311,0.38489,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,7.1274e-05,0.35025,0.35729,1,1
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,7.5217e-06,0.34939,0.29605,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,9.404e-07,0.34932,0.33219,1,1
5,GO LONG TERM SYNAPTIC DEPRESSION,1.2604e-07,0.34921,0.36825,1,1
5,GO HISTONE H3 K27 METHYLATION,6.4699e-07,0.34892,0.27534,1,1
5,GO PROTEIN LOCALIZATION TO AXON,8.3013e-05,0.34852,0.3955,1,1
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,2.8262e-08,0.34784,0.40658,1,1
5,GO TELENCEPHALON GLIAL CELL MIGRATION,3.7605e-06,0.34687,0.30785,1,1
5,GO FOREBRAIN REGIONALIZATION,8.4415e-08,0.34644,0.41171,1,1
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.015501,0.34548,0.1893,1,1
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.9558e-07,0.34499,0.35436,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.3355e-07,0.34487,0.42736,1,1
5,GO SPINAL CORD DEVELOPMENT,6.6581e-11,0.34477,0.37199,1,1
5,GO EMBRYONIC BRAIN DEVELOPMENT,3.4098e-06,0.34472,0.25387,1,1
5,GO SEX DETERMINATION,1.8318e-07,0.34425,0.32353,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0093576,0.34412,0.24271,1,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,6.2175e-05,0.34409,0.30254,1,1
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,5.6245e-08,0.34093,0.33106,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.6162e-06,0.34028,0.30483,1,1
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,8.6579e-07,0.34006,0.33793,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,1.7385e-05,0.33994,0.39004,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.0013633,0.33992,0.37824,1,1
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.8885e-07,0.33965,0.40118,1,1
5,GO RECEPTOR CLUSTERING,2.7668e-07,0.33857,0.30652,1,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0003557,0.33816,0.30029,1,1
5,GO ATRIAL SEPTUM DEVELOPMENT,3.1494e-05,0.33788,0.31003,1,1
5,GO NEURON CELLULAR HOMEOSTASIS,9.1829e-05,0.33747,0.29559,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,2.0776e-06,0.33643,0.40408,1,1
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00010497,0.33635,0.31994,1,1
5,GO CARDIAC MYOFIBRIL ASSEMBLY,1.6457e-05,0.33562,0.28292,1,1
5,GO SYNAPTIC VESICLE MATURATION,0.00015083,0.33518,0.35477,1,1
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,5.8262e-07,0.33498,0.34047,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00020178,0.33492,0.2664,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,3.4773e-06,0.3346,0.28421,1,1
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.001568,0.33392,0.35193,1,1
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,5.1356e-08,0.33365,0.3169,1,1
5,GO RESPONSE TO L GLUTAMATE,2.8814e-05,0.33364,0.32598,1,1
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.00065224,0.33263,0.27594,1,1
5,GO BRAIN MORPHOGENESIS,1.6514e-08,0.33209,0.32096,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.7668e-07,0.33156,0.30948,1,1
5,GO CEREBELLAR CORTEX DEVELOPMENT,6.586e-10,0.33139,0.35559,1,1
5,GO NEGATIVE REGULATION OF AXONOGENESIS,2.011e-05,0.32998,0.27665,1,1
5,GO LEFT RIGHT AXIS SPECIFICATION,6.4341e-05,0.32961,0.29537,1,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.7693e-06,0.32926,0.30082,1,1
5,GO NUCLEAR MIGRATION,2.7668e-07,0.32895,0.32585,1,1
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.2784e-08,0.32876,0.33932,1,1
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00029511,0.32875,0.2672,1,1
5,GO STARTLE RESPONSE,8.5867e-06,0.32843,0.35474,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,8.1138e-06,0.3282,0.34682,1,1
5,GO ACTIN FILAMENT BASED TRANSPORT,2.3784e-07,0.32757,0.34358,1,1
5,GO NEURON PROJECTION GUIDANCE,5.8856e-08,0.32725,0.31696,1,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,4.4749e-10,0.32723,0.37866,1,1
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,4.8198e-07,0.3263,0.3236,1,1
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,6.0565e-09,0.32489,0.29411,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.105e-06,0.32483,0.35901,1,1
5,GO NEURON PROJECTION ARBORIZATION,7.333e-07,0.32457,0.35071,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,4.0314e-05,0.32439,0.28555,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,7.8911e-05,0.3236,0.31523,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.5372e-07,0.3228,0.30919,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,1.734e-06,0.32273,0.29957,1,1
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00010152,0.32205,0.29222,1,1
5,GO CELL JUNCTION MAINTENANCE,1.5037e-07,0.32197,0.35252,1,1
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.3599e-06,0.32168,0.31875,1,1
5,GO NOREPINEPHRINE SECRETION,1.1165e-05,0.32118,0.32006,1,1
5,GO TELENCEPHALON REGIONALIZATION,1.3693e-05,0.32081,0.37468,1,1
5,GO NEUROBLAST PROLIFERATION,1.3671e-08,0.32031,0.33712,1,1
5,GO NUCLEUS LOCALIZATION,3.1479e-07,0.31934,0.30731,1,1
5,GO GANGLION DEVELOPMENT,0.00015583,0.31919,0.3286,1,1
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.719e-07,0.31903,0.30661,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00039622,0.31805,0.27719,1,1
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00021857,0.31805,0.27673,1,1
5,GO ESTROUS CYCLE,2.3239e-05,0.3179,0.27135,1,1
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00013232,0.31754,0.29676,1,1
5,GO CELL DIFFERENTIATION IN SPINAL CORD,2.7676e-09,0.31744,0.35054,1,1
5,GO NEURON MIGRATION,6.3569e-09,0.31715,0.35493,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.4285e-07,0.31688,0.34296,1,1
5,GO MYELIN MAINTENANCE,0.0014022,0.31622,0.27738,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,6.5837e-06,0.31591,0.32848,1,1
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,2.3891e-06,0.31582,0.32277,1,1
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00011406,0.31572,0.28023,1,1
5,GO METENCEPHALON DEVELOPMENT,1.1533e-09,0.31458,0.33858,1,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,3.5794e-07,0.31441,0.37845,1,1
5,GO MRNA SPLICE SITE SELECTION,3.5427e-10,0.31428,0.36948,1,1
5,GO INHIBITORY SYNAPSE ASSEMBLY,1.5014e-05,0.3141,0.39487,1,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00090088,0.314,0.23147,1,1
5,GO COCHLEA MORPHOGENESIS,2.5424e-05,0.31396,0.30522,1,1
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.4184e-05,0.31394,0.33,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,7.6283e-05,0.31312,0.28783,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00027716,0.31298,0.27779,1,1
5,GO NEURAL TUBE PATTERNING,5.1356e-08,0.3128,0.29194,1,1
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,3.055e-09,0.31244,0.32803,1,1
5,GO NEURON RECOGNITION,1.2482e-05,0.31064,0.30197,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,2.0364e-06,0.31051,0.41721,1,1
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0048405,0.30992,0.29411,1,1
5,GO CELL FATE SPECIFICATION,1.1579e-08,0.30964,0.31123,1,1
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,7.2497e-05,0.3096,0.30191,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.7316e-05,0.3087,0.27108,1,1
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,2.3467e-08,0.30857,0.30513,1,1
5,GO DENDRITIC SPINE MORPHOGENESIS,2.0879e-07,0.30831,0.32458,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.2697e-09,0.30754,0.31449,1,1
5,GO DORSAL VENTRAL AXIS SPECIFICATION,3.8246e-05,0.30749,0.30578,1,1
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,8.7502e-06,0.30697,0.31999,1,1
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.4409e-05,0.30596,0.34865,1,1
5,GO AXONAL FASCICULATION,0.00038422,0.3059,0.27616,1,1
5,GO REGULATION OF AXONOGENESIS,2.1338e-07,0.30589,0.30259,1,1
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,6.895e-08,0.30564,0.34422,1,1
5,GO NON MOTILE CILIUM ASSEMBLY,6.3359e-07,0.30491,0.26684,1,1
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.4972e-05,0.30487,0.2818,1,1
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,2.3467e-08,0.30478,0.32357,1,1
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0001179,0.30459,0.28551,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1282e-07,0.30407,0.36022,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.9558e-07,0.30404,0.28556,1,1
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,4.4807e-06,0.30401,0.30952,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,5.2538e-08,0.30361,0.31566,1,1
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,9.5999e-07,0.30306,0.322,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,4.5684e-06,0.30291,0.24642,1,1
5,GO HISTONE H3 K9 MODIFICATION,3.6293e-09,0.30284,0.30251,1,1
5,GO HIPPO SIGNALING,2.0478e-05,0.30267,0.27655,1,1
5,GO PROTEIN DEMETHYLATION,8.6937e-09,0.30205,0.30505,1,1
5,GO REGULATION OF DENDRITE MORPHOGENESIS,1.0036e-08,0.30166,0.31322,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,2.7312e-05,0.30104,0.23962,1,1
5,GO METANEPHROS MORPHOGENESIS,7.7586e-05,0.30083,0.25709,1,1
5,GO THYROID GLAND DEVELOPMENT,1.6654e-06,0.30078,0.30346,1,1
5,GO POSTSYNAPSE ORGANIZATION,7.5266e-09,0.3006,0.33732,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,5.0323e-06,0.30032,0.31824,1,1
5,GO CELL PROLIFERATION IN FOREBRAIN,1.9044e-05,0.2999,0.28403,1,1
5,GO CELLULAR COMPONENT MAINTENANCE,8.2543e-08,0.2998,0.28885,1,1
5,GO PROTEIN LOCALIZATION TO CILIUM,3.4796e-08,0.29967,0.31032,1,1
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,9.6562e-05,0.29962,0.28952,1,1
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.9035e-08,0.29932,0.31666,1,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,9.6562e-05,0.29883,0.34419,1,1
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.6782e-07,0.29848,0.28358,1,1
5,GO DENTATE GYRUS DEVELOPMENT,0.00019541,0.29809,0.36341,1,1
5,GO EPITHELIAL CELL MATURATION,3.5461e-06,0.29774,0.29839,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00011218,0.29719,0.28841,1,1
5,GO PHOTORECEPTOR CELL MAINTENANCE,3.247e-08,0.29698,0.27879,1,1
5,GO SIALYLATION,4.3997e-05,0.29622,0.31484,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00037257,0.29557,0.22055,1,1
5,GO HINDBRAIN DEVELOPMENT,1.069e-09,0.29544,0.29742,1,1
5,GO RESPONSE TO POTASSIUM ION,4.3236e-05,0.2954,0.32159,1,1
5,GO AXON DEVELOPMENT,1.0791e-07,0.29538,0.28371,1,1
5,GO REGULATION OF CILIUM ASSEMBLY,1.2733e-08,0.29535,0.27764,1,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0071051,0.29534,0.29065,1,1
5,GO EXCITATORY SYNAPSE ASSEMBLY,2.3891e-06,0.29525,0.37346,1,1
5,GO COLLECTING DUCT DEVELOPMENT,6.8396e-06,0.29472,0.37369,1,1
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.913e-06,0.29461,0.25389,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,5.2538e-08,0.29433,0.25967,1,1
5,GO DENDRITE MORPHOGENESIS,1.3039e-08,0.29355,0.31995,1,1
5,GO SYNAPSE ORGANIZATION,9.4407e-08,0.29326,0.2898,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.3774e-08,0.29284,0.28788,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.7154e-07,0.29245,0.30605,1,1
5,GO MYOBLAST MIGRATION,0.0065235,0.29233,0.21996,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0002117,0.29192,0.318,1,1
5,GO SPERMATID NUCLEUS DIFFERENTIATION,3.1004e-08,0.29189,0.29006,1,1
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.2993e-08,0.29175,0.2948,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.2032e-06,0.29154,0.2411,1,1
5,GO URETER DEVELOPMENT,0.00048316,0.29148,0.35015,1,1
5,GO NEURON MATURATION,2.538e-07,0.29096,0.28949,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.001422,0.29089,0.29713,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,6.2175e-05,0.29078,0.26258,1,1
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,1.5994e-06,0.29039,0.28872,1,1
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,1.3325e-06,0.29028,0.30955,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,1.0861e-06,0.29018,0.37621,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,7.1274e-05,0.29001,0.24175,1,1
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00049802,0.28996,0.35476,1,1
5,GO SYNAPSE ASSEMBLY,2.5934e-07,0.28992,0.30785,1,1
5,GO PRESYNAPSE ORGANIZATION,7.5217e-06,0.2898,0.28374,1,1
5,GO INTRACILIARY TRANSPORT,1.3769e-07,0.28939,0.31926,1,1
5,GO VENTRAL SPINAL CORD DEVELOPMENT,1.4677e-08,0.28875,0.31176,1,1
5,GO LEARNING,5.1356e-08,0.28868,0.28993,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.00016901,0.28859,0.2775,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,8.2864e-09,0.28848,0.3449,1,1
5,GO REGULATION OF CENTRIOLE REPLICATION,1.3878e-06,0.28786,0.28493,1,1
5,GO POST ANAL TAIL MORPHOGENESIS,6.7105e-06,0.28776,0.27104,1,1
5,GO AXONEME ASSEMBLY,3.0811e-07,0.28709,0.33481,1,1
5,GO NEPHRON TUBULE FORMATION,8.1623e-05,0.28706,0.29228,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0003557,0.28702,0.2616,1,1
5,GO ADULT HEART DEVELOPMENT,0.00036686,0.28653,0.235,1,1
5,GO PENILE ERECTION,0.00039622,0.28632,0.26081,1,1
5,GO RETINA LAYER FORMATION,0.00014839,0.28625,0.31194,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,4.31e-06,0.2861,0.30175,1,1
5,GO SEROTONIN TRANSPORT,0.0010259,0.28593,0.22565,1,1
5,GO NEURAL CREST FORMATION,0.00031414,0.28547,0.26257,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.2344e-05,0.28461,0.27596,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,7.6283e-05,0.28447,0.32725,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.01016,0.28415,0.22865,1,1
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.9989e-07,0.28393,0.2679,1,1
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.1858e-08,0.28373,0.30298,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0021798,0.28342,0.27922,1,1
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0044864,0.28281,0.24526,1,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,1.9563e-06,0.28267,0.29486,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0023637,0.28189,0.29508,1,1
5,GO MICROTUBULE ANCHORING,5.1351e-07,0.28084,0.2577,1,1
5,GO POTASSIUM ION HOMEOSTASIS,7.0337e-07,0.27996,0.29052,1,1
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,9.7991e-09,0.27992,0.31555,1,1
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.0017e-09,0.27977,0.30585,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00026438,0.27957,0.26139,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,5.4356e-06,0.27938,0.28464,1,1
5,GO RESPONSE TO VITAMIN A,0.00035024,0.27936,0.23363,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,1.7385e-05,0.2792,0.32555,1,1
5,GO ACTIN CROSSLINK FORMATION,2.8271e-07,0.27842,0.35384,1,1
5,GO RETROGRADE AXONAL TRANSPORT,1.3878e-06,0.27771,0.30504,1,1
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,8.5858e-05,0.27721,0.27052,1,1
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.0323e-06,0.27714,0.25041,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.00094089,0.27697,0.18325,1,1
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,1.536e-06,0.27589,0.33461,1,1
5,GO PANCREAS DEVELOPMENT,1.9558e-07,0.27574,0.30638,1,1
5,GO POSITIVE REGULATION OF AXONOGENESIS,1.1316e-06,0.27529,0.29182,1,1
5,GO MICROTUBULE BUNDLE FORMATION,1.9014e-08,0.27525,0.29584,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.0361e-05,0.27505,0.22107,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.044292,0.27471,0.18222,1,1
5,GO RESPONSE TO ELECTRICAL STIMULUS,2.0853e-05,0.27464,0.25998,1,1
5,GO DENDRITIC SPINE DEVELOPMENT,7.5451e-08,0.27458,0.29499,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,2.1624e-06,0.27451,0.30092,1,1
5,GO RESPONSE TO NICOTINE,9.4407e-08,0.27401,0.30638,1,1
5,GO INTRACILIARY RETROGRADE TRANSPORT,4.0657e-06,0.27391,0.34288,1,1
5,GO TUBE FORMATION,3.5038e-07,0.27322,0.22845,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.4837e-07,0.27295,0.27346,1,1
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00019229,0.27258,0.2376,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,0.00038422,0.27244,0.25134,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00019229,0.27238,0.21794,1,1
5,GO PROTEIN POLYGLUTAMYLATION,9.0235e-07,0.27222,0.29375,1,1
5,GO ADULT BEHAVIOR,2.0881e-08,0.27218,0.30588,1,1
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,2.9078e-09,0.27215,0.29627,1,1
5,GO REGULATION OF EXTENT OF CELL GROWTH,5.5864e-07,0.27206,0.29152,1,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,1.5994e-06,0.27155,0.22311,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,5.9116e-09,0.27093,0.29483,1,1
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0010558,0.27091,0.21596,1,1
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,2.0478e-05,0.27019,0.24344,1,1
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.7693e-06,0.27011,0.24767,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.6578e-06,0.26983,0.29676,1,1
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,1.475e-06,0.26977,0.2459,1,1
5,GO REGULATION OF HIPPO SIGNALING,0.001704,0.26957,0.22085,1,1
5,GO NEPHRON MORPHOGENESIS,3.3214e-05,0.26921,0.20947,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,4.1815e-08,0.26917,0.30725,1,1
5,GO REGULATION OF STEM CELL PROLIFERATION,1.5713e-07,0.26882,0.27186,1,1
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,2.4528e-05,0.26788,0.25521,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.00015331,0.26781,0.20648,1,1
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.1479e-07,0.26773,0.29236,1,1
5,GO CARDIAC ATRIUM DEVELOPMENT,1.9749e-05,0.26764,0.26172,1,1
5,GO REGULATION OF SYNAPTIC PLASTICITY,1.734e-06,0.26746,0.26622,1,1
5,GO CELL PART MORPHOGENESIS,4.9069e-08,0.26739,0.27364,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.2792e-06,0.26732,0.29736,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00022208,0.26723,0.22041,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,5.9056e-05,0.26709,0.26933,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,3.3228e-08,0.26707,0.25075,1,1
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,2.0879e-07,0.26699,0.31595,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.00035024,0.26653,0.28539,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,3.2094e-09,0.26614,0.27858,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0071051,0.26604,0.17607,1,1
5,GO ENDOCARDIUM DEVELOPMENT,7.8911e-05,0.26588,0.24831,1,1
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,4.7999e-05,0.26543,0.26536,1,1
5,GO REGULATION OF DENDRITE DEVELOPMENT,2.0398e-08,0.26526,0.28718,1,1
5,GO DENDRITE SELF AVOIDANCE,0.00098255,0.26465,0.22548,1,1
5,GO HISTONE H3 K9 TRIMETHYLATION,9.1205e-09,0.26437,0.29243,1,1
5,GO NEGATIVE REGULATION OF AXON EXTENSION,7.8124e-06,0.26437,0.28092,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,1.3999e-08,0.26426,0.29844,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,5.4967e-09,0.26412,0.30185,1,1
5,GO MITOCHONDRION DISTRIBUTION,3.2146e-06,0.26404,0.25603,1,1
5,GO DIENCEPHALON DEVELOPMENT,7.9617e-06,0.26387,0.26233,1,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.7411e-08,0.26335,0.28472,1,1
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.1234e-05,0.26306,0.29019,1,1
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,7.2414e-06,0.26305,0.29231,1,1
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0424e-06,0.26302,0.30324,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,6.5906e-08,0.26278,0.25458,1,1
5,GO APPENDAGE MORPHOGENESIS,6.6066e-07,0.26275,0.2575,1,1
5,GO HINDBRAIN MORPHOGENESIS,1.3039e-08,0.26262,0.27215,1,1
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.1751e-05,0.2624,0.2478,1,1
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,2.1624e-06,0.2624,0.27621,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00032916,0.26199,0.21431,1,1
5,GO REGULATION OF CYCLASE ACTIVITY,5.9834e-06,0.26148,0.24994,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,1.3196e-05,0.26131,0.23498,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,6.3359e-07,0.26117,0.24274,1,1
5,GO APICAL PROTEIN LOCALIZATION,1.3878e-06,0.26077,0.30876,1,1
5,GO MICROTUBULE POLYMERIZATION,9.9803e-06,0.26037,0.23441,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,3.0156e-07,0.26027,0.29746,1,1
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,3.0905e-06,0.26009,0.25472,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,9.3381e-05,0.2599,0.23566,1,1
5,GO HINDLIMB MORPHOGENESIS,0.00040235,0.25974,0.22629,1,1
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,1.064e-06,0.25952,0.25894,1,1
5,GO SYNAPTIC SIGNALING,1.5713e-07,0.25905,0.26413,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.5994e-06,0.25864,0.26801,1,1
5,GO GENETIC IMPRINTING,3.152e-06,0.25863,0.25362,1,1
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.000662,0.25849,0.22457,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,8.0712e-08,0.25845,0.29547,1,1
5,GO SMOOTHENED SIGNALING PATHWAY,1.5753e-08,0.25801,0.25433,1,1
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.00021857,0.25795,0.25199,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,7.2129e-08,0.25758,0.25323,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,1.4207e-05,0.25675,0.2807,1,1
5,GO FOREBRAIN CELL MIGRATION,2.8001e-06,0.25571,0.26354,1,1
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,8.6579e-07,0.25559,0.2476,1,1
5,GO REGULATION OF MICROTUBULE BINDING,0.00030928,0.25548,0.25085,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,3.9102e-06,0.25523,0.23021,1,1
5,GO CILIUM ORGANIZATION,2.3853e-09,0.25494,0.26285,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.5865e-05,0.25489,0.22142,1,1
5,GO EMBRYONIC DIGIT MORPHOGENESIS,1.3693e-05,0.25423,0.21155,1,1
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,2.3891e-06,0.25403,0.24039,1,1
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,9.086e-06,0.25394,0.23728,1,1
5,GO NOREPINEPHRINE TRANSPORT,9.3381e-05,0.25389,0.27306,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,2.2775e-07,0.25381,0.23077,1,1
5,GO DENDRITE DEVELOPMENT,1.3999e-08,0.2538,0.28751,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,2.9859e-05,0.25377,0.27488,1,1
5,GO NEURON PROJECTION ORGANIZATION,1.1086e-06,0.25363,0.27884,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.0069343,0.25352,0.24214,1,1
5,GO MESONEPHROS DEVELOPMENT,0.00044781,0.25349,0.19151,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,3.7195e-09,0.25347,0.28253,1,1
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00054518,0.25329,0.29453,1,1
5,GO POSITIVE REGULATION OF AXON EXTENSION,1.2482e-05,0.25297,0.25862,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0018006,0.25288,0.20498,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,5.2303e-06,0.25272,0.25487,1,1
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.025743,0.25262,0.21652,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.4356e-06,0.25223,0.23723,1,1
5,GO RESPONSE TO LEUCINE,0.00015583,0.25204,0.26885,1,1
5,GO REPLICATION FORK PROCESSING,3.2057e-05,0.25183,0.23849,1,1
5,GO IRON COORDINATION ENTITY TRANSPORT,4.0314e-05,0.25181,0.2557,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,1.0361e-05,0.25179,0.27155,1,1
5,GO CELLULAR RESPONSE TO VITAMIN D,0.00055343,0.25174,0.24879,1,1
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0011021,0.2516,0.24646,1,1
5,GO FOREBRAIN DEVELOPMENT,3.7195e-09,0.25158,0.26785,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.971e-06,0.25151,0.20984,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0016122,0.25144,0.24762,1,1
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00012804,0.25139,0.31522,1,1
5,GO PROTEIN PALMITOYLATION,1.6994e-06,0.25128,0.2674,1,1
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,1.1307e-08,0.25113,0.30138,1,1
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028118,0.25105,0.24803,1,1
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,3.4003e-08,0.25086,0.22483,1,1
5,GO HISTONE H4 DEACETYLATION,0.0001179,0.25073,0.20035,1,1
5,GO PEPTIDYL LYSINE TRIMETHYLATION,3.2162e-07,0.25052,0.22808,1,1
5,GO INNER EAR MORPHOGENESIS,1.9175e-06,0.25051,0.25584,1,1
5,GO NEURAL TUBE DEVELOPMENT,9.0235e-07,0.25045,0.21897,1,1
5,GO SEROTONIN SECRETION,0.002702,0.25017,0.24211,1,1
5,GO VENTRICULAR SYSTEM DEVELOPMENT,3.6293e-09,0.25014,0.29765,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,3.2057e-05,0.25011,0.24029,1,1
5,GO KINETOCHORE ORGANIZATION,0.00014362,0.24982,0.2309,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0018256,0.24952,0.2262,1,1
5,GO BASIC AMINO ACID TRANSPORT,0.022209,0.24935,0.14443,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.6062e-07,0.24922,0.28187,1,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1.9926e-08,0.24914,0.27796,1,1
5,GO COCHLEA DEVELOPMENT,9.2321e-08,0.24896,0.31911,1,1
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00018923,0.24892,0.18693,1,1
5,GO CELLULAR COMPONENT MORPHOGENESIS,6.1583e-08,0.24888,0.25919,1,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.1086e-06,0.24881,0.29958,1,1
5,GO STEM CELL DIVISION,0.00058763,0.24876,0.20412,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,2.1196e-06,0.2487,0.24526,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00020178,0.24835,0.29337,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.3747e-08,0.2482,0.23878,1,1
5,GO SPERM AXONEME ASSEMBLY,2.3661e-05,0.24816,0.25201,1,1
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.021973,0.24767,0.21184,1,1
5,GO STEM CELL PROLIFERATION,1.3325e-06,0.24742,0.23315,1,1
5,GO NEURON DIFFERENTIATION,1.8142e-08,0.24719,0.25076,1,1
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.00021857,0.24709,0.20664,1,1
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.7356e-07,0.24667,0.25633,1,1
5,GO SYNAPTIC VESICLE EXOCYTOSIS,1.2716e-05,0.24637,0.27782,1,1
5,GO NEUROTRANSMITTER SECRETION,6.9711e-06,0.24635,0.27753,1,1
5,GO SOMITE DEVELOPMENT,1.3878e-06,0.2462,0.22685,1,1
5,GO COLLATERAL SPROUTING,7.2497e-05,0.24606,0.27187,1,1
5,GO G0 TO G1 TRANSITION,1.4471e-09,0.24595,0.27865,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.011949,0.2458,0.22259,1,1
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0045438,0.245,0.25606,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0005211,0.24482,0.19715,1,1
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,5.8049e-05,0.24474,0.24648,1,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00025617,0.24431,0.20407,1,1
5,GO NEURON DEVELOPMENT,4.9069e-08,0.24426,0.2491,1,1
5,GO UTERUS DEVELOPMENT,0.00040857,0.24404,0.2355,1,1
5,GO KIDNEY MORPHOGENESIS,9.6129e-06,0.24388,0.2231,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.6062e-07,0.24388,0.24976,1,1
5,GO LATERAL VENTRICLE DEVELOPMENT,0.00013451,0.24372,0.28641,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.00049053,0.24356,0.34112,1,1
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.9624e-10,0.24353,0.28888,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.1316e-06,0.24309,0.22803,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,7.2497e-05,0.24264,0.25894,1,1
5,GO DOSAGE COMPENSATION,1.9563e-06,0.24256,0.23525,1,1
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.8305e-05,0.24219,0.26986,1,1
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,4.1456e-06,0.24191,0.26109,1,1
5,GO BONE MORPHOGENESIS,0.0040509,0.24189,0.16491,1,1
5,GO DORSAL VENTRAL PATTERN FORMATION,5.9116e-09,0.24172,0.29008,1,1
5,GO CONVERGENT EXTENSION,0.0005789,0.24166,0.20666,1,1
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00028155,0.24153,0.21954,1,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.064418,0.24141,0.24126,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,3.3435e-06,0.24074,0.26473,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,1.1789e-06,0.24074,0.24712,1,1
5,GO STRIATUM DEVELOPMENT,5.3256e-05,0.2405,0.25746,1,1
5,GO MOTILE CILIUM ASSEMBLY,0.00049802,0.24039,0.27865,1,1
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.4741e-05,0.24038,0.2322,1,1
5,GO EMBRYONIC ORGAN MORPHOGENESIS,2.4837e-07,0.24032,0.23188,1,1
5,GO PEPTIDYL LYSINE DIMETHYLATION,8.8389e-07,0.24028,0.23781,1,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,5.9056e-05,0.24024,0.22669,1,1
5,GO ENERGY HOMEOSTASIS,0.0007786,0.24013,0.1991,1,1
5,GO CORPUS CALLOSUM DEVELOPMENT,0.00013899,0.23994,0.29023,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,3.357e-07,0.2399,0.24881,1,1
5,GO SKELETAL SYSTEM MORPHOGENESIS,1.0361e-05,0.23978,0.19905,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00026438,0.23969,0.20982,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,2.011e-05,0.23936,0.24619,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00024045,0.2393,0.2482,1,1
5,GO NEGATIVE REGULATION OF DNA REPLICATION,4.3236e-05,0.23921,0.21468,1,1
5,GO REPRODUCTIVE BEHAVIOR,9.404e-07,0.23864,0.26906,1,1
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.1307e-08,0.23862,0.25759,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,2.7312e-05,0.23848,0.2284,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00013899,0.23843,0.30377,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.003607,0.23821,0.21245,1,1
5,GO SEGMENTATION,1.9393e-05,0.23816,0.19465,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,3.9102e-06,0.23809,0.26263,1,1
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.017699,0.23804,0.20471,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00083767,0.23791,0.24146,1,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,3.0395e-05,0.23787,0.27523,1,1
5,GO MITOTIC RECOMBINATION,0.00091404,0.23786,0.20387,1,1
5,GO SULFATION,0.00015838,0.23737,0.2156,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00023667,0.23719,0.21785,1,1
5,GO CENTRIOLE ASSEMBLY,4.4285e-07,0.23668,0.27393,1,1
5,GO MICROTUBULE BASED MOVEMENT,1.1307e-08,0.23662,0.23067,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,2.4528e-05,0.23655,0.26765,1,1
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0027381,0.23652,0.23096,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,8.6328e-08,0.23608,0.24476,1,1
5,GO EPITHELIAL TUBE FORMATION,8.3066e-07,0.23602,0.21531,1,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,2.4091e-05,0.23582,0.2377,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,2.1621e-05,0.23556,0.21034,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.4472e-05,0.2355,0.22311,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,1.8701e-05,0.23523,0.18363,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.2954e-05,0.23522,0.21562,1,1
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0007901,0.23517,0.28045,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,7.1274e-05,0.23517,0.2081,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,6.2046e-07,0.23514,0.20815,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00016361,0.23507,0.2301,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,3.152e-06,0.23489,0.2799,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,3.0905e-06,0.23486,0.29504,1,1
5,GO REGULATION OF CHROMATIN BINDING,5.1351e-07,0.23483,0.28996,1,1
5,GO INOSITOL METABOLIC PROCESS,0.00026024,0.23482,0.23041,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.3325e-06,0.2348,0.22655,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,2.6352e-05,0.23469,0.1824,1,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.000286,0.2346,0.25546,1,1
5,GO LOCOMOTORY BEHAVIOR,6.4699e-07,0.23413,0.2687,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.2058e-07,0.23391,0.22877,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,8.1361e-07,0.23389,0.24064,1,1
5,GO ORGANIC CATION TRANSPORT,0.00015083,0.23366,0.20247,1,1
5,GO NEUROGENESIS,4.3774e-08,0.2335,0.23474,1,1
5,GO TRANSPORT ALONG MICROTUBULE,4.2784e-08,0.23317,0.21975,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0007786,0.23313,0.22516,1,1
5,GO EXPLORATION BEHAVIOR,0.0068504,0.23303,0.192,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,7.333e-07,0.23292,0.26521,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.9332e-05,0.23289,0.24346,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,7.1274e-05,0.23278,0.22304,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.3239e-05,0.23259,0.24363,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,2.6914e-06,0.2324,0.22656,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,1.9014e-08,0.23227,0.22629,1,1
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00080175,0.23226,0.20058,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,1.3351e-08,0.23201,0.23608,1,1
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.1588e-05,0.23173,0.26721,1,1
5,GO HIPPOCAMPUS DEVELOPMENT,1.1789e-06,0.23172,0.23845,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,2.2958e-06,0.23171,0.21462,1,1
5,GO APPENDAGE DEVELOPMENT,1.8419e-06,0.23164,0.22551,1,1
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00015838,0.23154,0.23137,1,1
5,GO NEURON PROJECTION EXTENSION,1.734e-06,0.23137,0.25702,1,1
5,GO REGULATION OF RECEPTOR INTERNALIZATION,9.2321e-08,0.23116,0.24349,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.014658,0.23101,0.1785,1,1
5,GO ERYTHROCYTE MATURATION,3.5646e-05,0.23082,0.20629,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00011033,0.23073,0.19159,1,1
5,GO FAT CELL PROLIFERATION,0.012653,0.23063,0.17745,1,1
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00045468,0.23043,0.30153,1,1
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.0169e-05,0.23042,0.2733,1,1
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.7614e-08,0.22951,0.24491,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.033608,0.2295,0.21137,1,1
5,GO MIDGUT DEVELOPMENT,0.0071051,0.22945,0.20492,1,1
5,GO EMBRYONIC HEMOPOIESIS,5.7582e-06,0.22943,0.27343,1,1
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,1.4163e-06,0.22938,0.21544,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,6.8888e-05,0.22914,0.23911,1,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.0563e-05,0.22905,0.21643,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,1.155e-06,0.22904,0.27887,1,1
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,1.6158e-05,0.22903,0.26731,1,1
5,GO FUCOSYLATION,0.001955,0.22888,0.17993,1,1
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,1.7706e-05,0.22874,0.23825,1,1
5,GO HISTONE H4 K16 ACETYLATION,6.337e-06,0.22863,0.20679,1,1
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,1.1588e-05,0.22823,0.23928,1,1
5,GO MICROTUBULE BASED TRANSPORT,7.5451e-08,0.22808,0.22357,1,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.00031907,0.228,0.20142,1,1
5,GO RENAL VESICLE DEVELOPMENT,0.0012177,0.22782,0.21953,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,1.1316e-06,0.22743,0.20492,1,1
5,GO MUSCLE FIBER DEVELOPMENT,2.4091e-05,0.22723,0.2184,1,1
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.001704,0.2272,0.19577,1,1
5,GO PALLIUM DEVELOPMENT,2.9602e-08,0.22667,0.24685,1,1
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.001442,0.22652,0.18381,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0033361,0.2265,0.22406,1,1
5,GO REGULATION OF APPETITE,1.8032e-05,0.22634,0.19045,1,1
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,4.0868e-08,0.2263,0.2561,1,1
5,GO CEREBRAL CORTEX DEVELOPMENT,3.2094e-09,0.22623,0.27755,1,1
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,2.0776e-06,0.22621,0.22056,1,1
5,GO TRACHEA DEVELOPMENT,0.0066039,0.22615,0.19651,1,1
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.4334e-08,0.22606,0.20305,1,1
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00035024,0.22596,0.24835,1,1
5,GO HEAD DEVELOPMENT,5.4967e-09,0.22588,0.23929,1,1
5,GO SYNAPTIC VESICLE LOCALIZATION,2.5884e-05,0.22576,0.25726,1,1
5,GO SECONDARY PALATE DEVELOPMENT,0.00020835,0.22575,0.25925,1,1
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00034485,0.22563,0.19071,1,1
5,GO LUNG CELL DIFFERENTIATION,0.001483,0.22529,0.27176,1,1
5,GO EMBRYONIC EYE MORPHOGENESIS,2.5884e-05,0.22494,0.24818,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00086244,0.22484,0.24558,1,1
5,GO SEX DIFFERENTIATION,7.0337e-07,0.22433,0.18768,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00046872,0.22417,0.1827,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,7.8124e-06,0.22415,0.30142,1,1
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.0032078,0.22409,0.20812,1,1
5,GO KINETOCHORE ASSEMBLY,0.0010259,0.22395,0.19739,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0022396,0.22389,0.1665,1,1
5,GO TELENCEPHALON DEVELOPMENT,1.5753e-08,0.22359,0.25667,1,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,1.5293e-05,0.22347,0.2202,1,1
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0058389,0.2234,0.1804,1,1
5,GO L GLUTAMATE IMPORT,0.0038977,0.22336,0.15948,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,9.086e-06,0.22326,0.20773,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0068504,0.22323,0.17546,1,1
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.004964,0.223,0.16228,1,1
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,1.4741e-05,0.22262,0.21783,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,2.5934e-07,0.22257,0.1956,1,1
5,GO REGULATION OF HEAT GENERATION,6.3249e-05,0.22256,0.27411,1,1
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0005789,0.22233,0.23347,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00042777,0.22162,0.26743,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.206e-06,0.2215,0.23774,1,1
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.1588e-05,0.22139,0.24906,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,5.4701e-07,0.22124,0.22452,1,1
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0018256,0.2211,0.28067,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0013826,0.22107,0.22147,1,1
5,GO REGULATION OF HISTONE METHYLATION,3.7195e-09,0.22103,0.24867,1,1
5,GO MYOTUBE CELL DEVELOPMENT,1.3196e-05,0.22103,0.23253,1,1
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00059648,0.22098,0.24524,1,1
5,GO GENITALIA MORPHOGENESIS,0.009139,0.22028,0.2701,1,1
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.6457e-05,0.22004,0.19181,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.030994,0.21997,0.16613,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,7.0337e-07,0.21976,0.23164,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,9.819e-05,0.21941,0.24781,1,1
5,GO SUBSTANTIA NIGRA DEVELOPMENT,3.8347e-06,0.21924,0.21435,1,1
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.1456e-06,0.21909,0.22833,1,1
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0032928,0.21891,0.18181,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,0.00013232,0.21854,0.23391,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,1.2886e-07,0.21839,0.2067,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,5.2445e-07,0.21829,0.22652,1,1
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.00012594,0.21826,0.22011,1,1
5,GO EAR MORPHOGENESIS,9.6129e-06,0.21813,0.21761,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00017176,0.21809,0.21255,1,1
5,GO HISTONE H2A UBIQUITINATION,5.6245e-08,0.21808,0.24026,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,1.6418e-07,0.2178,0.21416,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,8.7502e-06,0.21775,0.23758,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.3661e-05,0.21755,0.22655,1,1
5,GO PRO B CELL DIFFERENTIATION,0.00016361,0.21731,0.26129,1,1
5,GO GLIAL CELL PROLIFERATION,0.00095459,0.21724,0.18005,1,1
5,GO REGULATION OF CELL DEVELOPMENT,2.538e-07,0.2171,0.21228,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,1.6158e-05,0.21706,0.23768,1,1
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.8594e-09,0.21694,0.25133,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,2.1196e-06,0.2168,0.27026,1,1
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,4.6359e-05,0.21673,0.26717,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.020385,0.21667,0.14063,1,1
5,GO LACTATE METABOLIC PROCESS,0.001568,0.21645,0.17144,1,1
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,4.0657e-06,0.21635,0.21724,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,1.8135e-09,0.21624,0.27082,1,1
5,GO NON RECOMBINATIONAL REPAIR,4.0314e-05,0.21604,0.16718,1,1
5,GO PEPTIDYL LYSINE METHYLATION,3.7195e-09,0.21588,0.24909,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,3.0156e-07,0.21583,0.2168,1,1
5,GO SPERMATID DIFFERENTIATION,2.9602e-08,0.21567,0.21246,1,1
5,GO CELL MORPHOGENESIS,7.1819e-07,0.21561,0.21769,1,1
5,GO REGULATION OF ORGANELLE ASSEMBLY,6.2993e-08,0.21555,0.2013,1,1
5,GO HISTONE H4 K5 ACETYLATION,8.5867e-06,0.2153,0.20374,1,1
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00019229,0.21527,0.2015,1,1
5,GO ECTODERM DEVELOPMENT,1.0361e-05,0.21525,0.19341,1,1
5,GO SINGLE STRAND BREAK REPAIR,4.7172e-05,0.21523,0.21156,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,4.1751e-05,0.215,0.25062,1,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,6.7105e-06,0.21488,0.24081,1,1
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00030449,0.21483,0.33675,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,2.856e-06,0.21445,0.22155,1,1
5,GO TUBULIN DEACETYLATION,0.00020504,0.21402,0.23817,1,1
5,GO MATING BEHAVIOR,3.1494e-05,0.21394,0.2372,1,1
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,4.1552e-07,0.21383,0.22263,1,1
5,GO SUBPALLIUM DEVELOPMENT,0.0041031,0.21364,0.21496,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00053704,0.21353,0.23151,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.9613e-05,0.21346,0.22055,1,1
5,GO CENTROMERE COMPLEX ASSEMBLY,0.00074504,0.21339,0.19463,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.013394,0.21333,0.15579,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,4.31e-06,0.21327,0.20641,1,1
5,GO MITOTIC SPINDLE ORGANIZATION,4.9694e-05,0.21319,0.18087,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,3.4296e-07,0.21311,0.22862,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,1.4454e-06,0.21306,0.20646,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,7.4873e-07,0.21306,0.23931,1,1
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,7.4873e-07,0.21297,0.21567,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.002631,0.21288,0.24517,1,1
5,GO STRESS GRANULE ASSEMBLY,0.00016629,0.21284,0.19608,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,8.7502e-06,0.21266,0.2419,1,1
5,GO CELL PROJECTION ORGANIZATION,4.0868e-08,0.21258,0.21923,1,1
5,GO EYE MORPHOGENESIS,9.5999e-07,0.21258,0.21472,1,1
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,2.2824e-05,0.21245,0.21002,1,1
5,GO DEVELOPMENTAL CELL GROWTH,3.4098e-06,0.21241,0.22595,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,9.5999e-07,0.21188,0.21532,1,1
5,GO OVULATION CYCLE PROCESS,6.7724e-05,0.21182,0.19659,1,1
5,GO REGULATION OF MICROTUBULE BASED PROCESS,1.8723e-07,0.2117,0.21557,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00092737,0.21136,0.19483,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00044781,0.21125,0.16575,1,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,8.4262e-06,0.21118,0.19941,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.00030449,0.21096,0.20361,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,7.6657e-06,0.21095,0.25961,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0059852,0.21095,0.17852,1,1
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00010673,0.21088,0.2318,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.2143e-08,0.21078,0.19811,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,0.0023637,0.21073,0.20583,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,8.3013e-05,0.21028,0.22249,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.00071283,0.21016,0.18279,1,1
5,GO LYSINE METABOLIC PROCESS,0.019312,0.21014,0.15967,1,1
5,GO LONG TERM MEMORY,0.00046872,0.20997,0.20743,1,1
5,GO EMBRYONIC MORPHOGENESIS,1.0361e-05,0.20973,0.1761,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00060545,0.2097,0.20753,1,1
5,GO MEMBRANE DISASSEMBLY,0.0077327,0.2095,0.17201,1,1
5,GO ENAMEL MINERALIZATION,0.03068,0.20933,0.17904,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,2.1624e-06,0.20915,0.2142,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,1.0861e-06,0.20915,0.21195,1,1
5,GO CELL JUNCTION ORGANIZATION,2.6914e-06,0.20911,0.21497,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.00028155,0.2088,0.21665,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0010259,0.20863,0.29865,1,1
5,GO CHROMATIN SILENCING AT TELOMERE,9.404e-07,0.2085,0.22267,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00026438,0.20814,0.23587,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,4.2271e-06,0.20792,0.20109,1,1
5,GO MALE SEX DIFFERENTIATION,3.2631e-05,0.2078,0.16724,1,1
5,GO FEMALE SEX DIFFERENTIATION,3.2784e-06,0.20771,0.20629,1,1
5,GO GAMETE GENERATION,1.1533e-09,0.20767,0.20649,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0013826,0.20748,0.19078,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.01849,0.20744,0.19798,1,1
5,GO CELL PROJECTION ASSEMBLY,2.1807e-07,0.20708,0.19475,1,1
5,GO BEHAVIOR,2.2775e-07,0.20683,0.2303,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,3.5022e-05,0.20682,0.22712,1,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.0043184,0.20678,0.23814,1,1
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.024428,0.2067,0.18542,1,1
5,GO MITOCHONDRION LOCALIZATION,5.0323e-06,0.20657,0.20997,1,1
5,GO NEUROTRANSMITTER TRANSPORT,1.8032e-05,0.20644,0.25655,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.012798,0.2063,0.1422,1,1
5,GO RESPONSE TO FOOD,1.2027e-05,0.20615,0.19041,1,1
5,GO V D J RECOMBINATION,2.9859e-05,0.20606,0.28287,1,1
5,GO HISTONE H3 K4 METHYLATION,4.0033e-09,0.20604,0.255,1,1
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.7071e-05,0.20597,0.23421,1,1
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0007786,0.20578,0.22114,1,1
5,GO NEURAL CREST CELL DIFFERENTIATION,0.0005056,0.20572,0.1959,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0023321,0.20556,0.16248,1,1
5,GO G2 DNA DAMAGE CHECKPOINT,4.7488e-06,0.20544,0.22234,1,1
5,GO LATERAL MESODERM DEVELOPMENT,0.0054872,0.20531,0.21826,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.00013232,0.20522,0.21847,1,1
5,GO RESPONSE TO STEROL,0.00055343,0.20499,0.18281,1,1
5,GO MEMBRANE HYPERPOLARIZATION,0.00049053,0.20499,0.25337,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.019104,0.20479,0.22996,1,1
5,GO PROTEIN ACYLATION,6.0565e-09,0.20472,0.20302,1,1
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.016027,0.20464,0.1511,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,6.2169e-06,0.20454,0.20208,1,1
5,GO NEURAL CREST CELL MIGRATION,0.00044781,0.20448,0.24421,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,2.6914e-06,0.20441,0.23732,1,1
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,5.8262e-07,0.20438,0.22208,1,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,2.206e-06,0.20431,0.25008,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.9393e-05,0.20424,0.20595,1,1
5,GO SCHWANN CELL DIFFERENTIATION,6.4341e-05,0.20416,0.2061,1,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0053519,0.20395,0.21597,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.0053519,0.20383,0.18814,1,1
5,GO PRESYNAPTIC ENDOCYTOSIS,6.0991e-06,0.20375,0.24153,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0002117,0.20373,0.18334,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,5.8698e-06,0.2037,0.22266,1,1
5,GO REGULATION OF TORC1 SIGNALING,9.8716e-08,0.20337,0.25495,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,3.8983e-07,0.20325,0.20202,1,1
5,GO POLYOL CATABOLIC PROCESS,0.00049802,0.20311,0.16056,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,5.4701e-07,0.20303,0.22563,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00029976,0.20302,0.27484,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,4.3946e-06,0.20284,0.23289,1,1
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,4.6202e-07,0.20277,0.2186,1,1
5,GO PATTERN SPECIFICATION PROCESS,4.6881e-08,0.20271,0.22742,1,1
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.040981,0.20268,0.12839,1,1
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00010673,0.20262,0.2074,1,1
5,GO CHONDROCYTE PROLIFERATION,0.017125,0.2026,0.16826,1,1
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,6.2175e-05,0.2026,0.20157,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.9859e-05,0.20245,0.19935,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,6.7105e-06,0.20229,0.24307,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,6.3569e-09,0.20215,0.19767,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,8.8282e-08,0.20214,0.22195,1,1
5,GO SCHWANN CELL DEVELOPMENT,0.00012594,0.20211,0.21769,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.206e-06,0.20207,0.2239,1,1
5,GO RECOMBINATIONAL REPAIR,1.7071e-05,0.20206,0.19177,1,1
5,GO DOPAMINE TRANSPORT,0.0024941,0.2018,0.27663,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00026438,0.20169,0.20873,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,6.895e-08,0.20166,0.22381,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00023667,0.20162,0.16627,1,1
5,GO MEMBRANE DOCKING,7.4873e-07,0.20157,0.18907,1,1
5,GO PROTEIN LOCALIZATION TO CHROMATIN,7.5217e-06,0.20153,0.19321,1,1
5,GO HETEROCHROMATIN ORGANIZATION,2.206e-06,0.20148,0.20085,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0010408,0.20143,0.16059,1,1
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,6.895e-08,0.20139,0.21746,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.00040857,0.20132,0.16525,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0066851,0.20118,0.19464,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00020835,0.20115,0.21675,1,1
5,GO NEGATIVE CHEMOTAXIS,0.010041,0.20109,0.20821,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0038478,0.20096,0.16043,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,8.7502e-06,0.20091,0.22525,1,1
5,GO CELLULAR RESPONSE TO X RAY,0.0005789,0.2008,0.14855,1,1
5,GO AXON EXTENSION,1.9563e-06,0.2007,0.2666,1,1
5,GO OVULATION CYCLE,9.03e-05,0.20068,0.1889,1,1
5,GO LYMPH VESSEL DEVELOPMENT,0.048285,0.20045,0.134,1,1
5,GO P BODY ASSEMBLY,5.8262e-07,0.20045,0.21676,1,1
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0071918,0.20043,0.15454,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,9.9803e-06,0.20031,0.18178,1,1
5,GO SENSORY ORGAN DEVELOPMENT,1.5713e-07,0.19981,0.21787,1,1
5,GO MALE GAMETE GENERATION,1.3761e-09,0.19979,0.20354,1,1
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0054872,0.19964,0.18009,1,1
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00088789,0.19953,0.17228,1,1
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00040235,0.19939,0.19628,1,1
5,GO COGNITION,1.5674e-06,0.19925,0.20671,1,1
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.05063,0.1991,0.16245,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.1588e-05,0.1991,0.18976,1,1
5,GO POST EMBRYONIC DEVELOPMENT,3.1494e-05,0.19908,0.20047,1,1
5,GO FEAR RESPONSE,0.00052901,0.19891,0.17167,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00032916,0.19881,0.19821,1,1
5,GO MALE MEIOTIC NUCLEAR DIVISION,8.4424e-05,0.19881,0.22063,1,1
5,GO ATP DEPENDENT CHROMATIN REMODELING,3.0302e-06,0.19875,0.21244,1,1
5,GO HEART FORMATION,0.0025277,0.19856,0.19973,1,1
5,GO MOLTING CYCLE,0.00014839,0.19851,0.1628,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.0081133,0.19832,0.14905,1,1
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0013826,0.19816,0.24501,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0074579,0.19815,0.16033,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,3.8347e-06,0.19807,0.2076,1,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,3.0395e-05,0.19805,0.21955,1,1
5,GO CENTROSOME DUPLICATION,1.9563e-06,0.19775,0.23552,1,1
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.9465e-08,0.19766,0.23639,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,6.0079e-05,0.19738,0.21366,1,1
5,GO NEUROMUSCULAR PROCESS,4.31e-06,0.19735,0.22652,1,1
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,3.0395e-05,0.19732,0.22874,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.00017176,0.19726,0.18914,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,6.3249e-05,0.19693,0.23736,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.9393e-05,0.19684,0.18944,1,1
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0049019,0.19683,0.17973,1,1
5,GO POSITIVE REGULATION OF RNA SPLICING,2.5424e-05,0.19632,0.17778,1,1
5,GO HISTONE H3 K14 ACETYLATION,1.3599e-06,0.19607,0.20385,1,1
5,GO REGULATION OF CELL CYCLE ARREST,4.4787e-08,0.19594,0.20408,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,2.2015e-05,0.19583,0.20649,1,1
5,GO AXIS ELONGATION,0.0028492,0.19582,0.18449,1,1
5,GO NEURAL TUBE FORMATION,5.0323e-06,0.19582,0.19964,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.9361e-06,0.19578,0.17957,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,3.3435e-06,0.19576,0.21993,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,0.00013673,0.1957,0.19532,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,3.4098e-06,0.19566,0.17434,1,1
5,GO MICROTUBULE BASED PROCESS,7.71e-09,0.19551,0.21841,1,1
5,GO GERM CELL DEVELOPMENT,2.1595e-09,0.19546,0.22254,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.020385,0.19537,0.14185,1,1
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.00058763,0.19522,0.20779,1,1
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,9.7998e-07,0.19494,0.2052,1,1
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0018764,0.19493,0.18281,1,1
5,GO MICROTUBULE NUCLEATION,0.00036124,0.19483,0.19656,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0067673,0.19483,0.2026,1,1
5,GO RESPONSE TO BMP,0.0011341,0.1948,0.16577,1,1
5,GO ENSHEATHMENT OF NEURONS,3.0395e-05,0.19475,0.17967,1,1
5,GO PROTEIN DEPOLYMERIZATION,4.6359e-05,0.19453,0.18715,1,1
5,GO PROSTATE GLAND GROWTH,0.016205,0.19442,0.19518,1,1
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.6202e-07,0.19404,0.21066,1,1
5,GO REGULATION OF CILIUM MOVEMENT,4.1456e-06,0.19403,0.22918,1,1
5,GO GLIAL CELL DEVELOPMENT,0.00042777,0.19389,0.16891,1,1
5,GO REGULATION OF CELL SIZE,2.5359e-06,0.19366,0.21862,1,1
5,GO ASSOCIATIVE LEARNING,1.9044e-05,0.1936,0.19458,1,1
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0002443,0.19359,0.21037,1,1
5,GO DNA REPLICATION CHECKPOINT,1.5293e-05,0.19334,0.21523,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.00039622,0.19333,0.13846,1,1
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,1.3693e-05,0.19331,0.18332,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0019023,0.19328,0.1607,1,1
5,GO PROTEIN ACETYLATION,2.188e-08,0.1932,0.19277,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00011406,0.19319,0.18795,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00096848,0.19311,0.19014,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,2.4972e-05,0.19303,0.22511,1,1
5,GO REGULATION OF MRNA PROCESSING,3.247e-08,0.19294,0.21943,1,1
5,GO REGIONALIZATION,2.5934e-07,0.19286,0.22054,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.0012527,0.19279,0.15072,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,7.6283e-05,0.19273,0.20369,1,1
5,GO PEPTIDE HORMONE SECRETION,9.7998e-07,0.19263,0.21695,1,1
5,GO SOMITOGENESIS,6.6578e-05,0.19262,0.17357,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00038422,0.1924,0.16879,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,2.011e-05,0.19239,0.19874,1,1
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00049053,0.19238,0.19704,1,1
5,GO CELL FATE COMMITMENT,1.7154e-07,0.19235,0.21244,1,1
5,GO SMOOTH MUSCLE CONTRACTION,0.0028492,0.19224,0.12985,1,1
5,GO DEMETHYLATION,3.3228e-08,0.19222,0.20357,1,1
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,2.3239e-05,0.19196,0.19722,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0013633,0.19187,0.1687,1,1
5,GO AXONAL TRANSPORT,2.3661e-05,0.19187,0.20956,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.0023321,0.19183,0.19844,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,2.8814e-05,0.19152,0.16934,1,1
5,GO HISTONE METHYLATION,8.9047e-09,0.19146,0.24056,1,1
5,GO SYNAPTIC VESICLE RECYCLING,9.795e-06,0.19137,0.23034,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,4.3082e-09,0.19106,0.23056,1,1
5,GO NUCLEOSOME ASSEMBLY,1.2027e-05,0.19076,0.21613,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.010279,0.19055,0.15281,1,1
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.000662,0.1905,0.14219,1,1
5,GO DEVELOPMENTAL GROWTH,5.5412e-06,0.19048,0.18311,1,1
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.00016361,0.19038,0.20417,1,1
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0024281,0.19033,0.17217,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00014129,0.19027,0.1679,1,1
5,GO REGULATION OF DNA REPAIR,1.7534e-07,0.19023,0.19339,1,1
5,GO GLAND DEVELOPMENT,0.00012594,0.1902,0.15444,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,1.996e-06,0.1902,0.17626,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.001568,0.19014,0.20429,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0137,0.19008,0.20801,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0027381,0.19005,0.1615,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0032501,0.19,0.17597,1,1
5,GO MAINTENANCE OF CELL NUMBER,4.9694e-05,0.18996,0.15444,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.3039e-08,0.18992,0.20017,1,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,6.8888e-05,0.18981,0.17856,1,1
5,GO TISSUE MORPHOGENESIS,0.0005056,0.18979,0.13259,1,1
5,GO SPECIFICATION OF SYMMETRY,4.0678e-07,0.1897,0.18719,1,1
5,GO RENAL TUBULE DEVELOPMENT,0.0023009,0.18961,0.15699,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,3.9822e-07,0.18928,0.17192,1,1
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,1.9044e-05,0.18898,0.19096,1,1
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0005056,0.1889,0.20482,1,1
5,GO DNA RECOMBINATION,6.8888e-05,0.1889,0.15966,1,1
5,GO RETINOIC ACID METABOLIC PROCESS,0.0007786,0.18881,0.2423,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.011678,0.18878,0.18675,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0061347,0.18859,0.16618,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.00069207,0.18853,0.18779,1,1
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00061456,0.18852,0.21076,1,1
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00011986,0.18844,0.19575,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,1.9393e-05,0.18842,0.20104,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.0023009,0.18833,0.20665,1,1
5,GO FILOPODIUM ASSEMBLY,0.00099681,0.1883,0.18396,1,1
5,GO REGULATION OF SISTER CHROMATID COHESION,2.3891e-06,0.18821,0.24215,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00012388,0.18816,0.16477,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,2.2015e-05,0.18814,0.1591,1,1
5,GO FUCOSE METABOLIC PROCESS,0.0022396,0.18812,0.17846,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.5239e-09,0.18801,0.19117,1,1
5,GO CHROMATIN SILENCING,9.1205e-09,0.18793,0.22773,1,1
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0095807,0.18785,0.15671,1,1
5,GO RESPONSE TO UV B,0.031311,0.18784,0.15334,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,5.6085e-05,0.1876,0.15837,1,1
5,GO DNA PACKAGING,1.9175e-06,0.18747,0.19979,1,1
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,1.5372e-07,0.18735,0.21301,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,2.4861e-06,0.18729,0.21031,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00041488,0.18727,0.15784,1,1
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00091404,0.18717,0.16076,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.0019819,0.18697,0.20237,1,1
5,GO EPIDERMIS MORPHOGENESIS,0.037509,0.18686,0.12631,1,1
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.0364e-06,0.18679,0.1983,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0038977,0.18667,0.12405,1,1
5,GO SEXUAL REPRODUCTION,2.4452e-09,0.18665,0.19398,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,1.0279e-08,0.18664,0.22687,1,1
5,GO EMBRYONIC PATTERN SPECIFICATION,2.2824e-05,0.18637,0.19822,1,1
5,GO DNA REPLICATION,4.31e-06,0.18637,0.19337,1,1
5,GO HISTONE H3 K4 TRIMETHYLATION,0.00019229,0.18636,0.18619,1,1
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.043444,0.18623,0.15862,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,2.2015e-05,0.18618,0.21905,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.001442,0.18601,0.19711,1,1
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00032916,0.18593,0.18995,1,1
5,GO GLAND MORPHOGENESIS,0.016938,0.18584,0.1482,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00039622,0.18578,0.26139,1,1
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.0027381,0.18544,0.1993,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0033361,0.18539,0.19164,1,1
5,GO HISTONE H4 ACETYLATION,2.9514e-07,0.18509,0.20107,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0028118,0.18501,0.14407,1,1
5,GO LYMPH VESSEL MORPHOGENESIS,0.012227,0.18489,0.16138,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,8.5867e-06,0.18482,0.17776,1,1
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.00032408,0.18471,0.16921,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.044722,0.18464,0.16239,1,1
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.00049053,0.18459,0.22167,1,1
5,GO REGULATION OF NEURON MATURATION,0.0060595,0.1844,0.17909,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,1.8053e-06,0.18432,0.19004,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00041488,0.18397,0.24205,1,1
5,GO MEIOTIC CHROMOSOME SEGREGATION,5.0563e-05,0.18392,0.1899,1,1
5,GO REGULATION OF AXON GUIDANCE,0.00015583,0.1839,0.23753,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00082553,0.18378,0.17827,1,1
5,GO REGULATION OF TRANSPOSITION,0.0046018,0.18375,0.20243,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,0.00059648,0.18362,0.16784,1,1
5,GO SPINDLE ORGANIZATION,1.7071e-05,0.18359,0.18178,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,0.00026024,0.18358,0.15123,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00017457,0.18354,0.18101,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00030928,0.1835,0.14232,1,1
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.013394,0.18344,0.13935,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.1806e-05,0.18286,0.20795,1,1
5,GO HISTONE DEACETYLATION,2.1234e-05,0.18275,0.1858,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,2.0398e-08,0.18275,0.19957,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,3.3806e-05,0.18268,0.15832,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00042777,0.18266,0.19677,1,1
5,GO REGULATION OF CELL DIVISION,4.0657e-06,0.18265,0.17487,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00017741,0.18263,0.26253,1,1
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00034485,0.18249,0.16725,1,1
5,GO CHROMOSOME LOCALIZATION,0.00019541,0.18234,0.14678,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,8.3013e-05,0.18212,0.17368,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014362,0.18196,0.26098,1,1
5,GO EMBRYO DEVELOPMENT,2.0364e-06,0.18182,0.16731,1,1
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,7.2414e-06,0.18181,0.22205,1,1
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.00073415,0.18165,0.23149,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.0020367,0.18158,0.16842,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00029052,0.18153,0.21118,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00065224,0.18149,0.15046,1,1
5,GO NEURON PROJECTION REGENERATION,0.0005618,0.18144,0.19849,1,1
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,4.1456e-06,0.18138,0.21121,1,1
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0054192,0.18134,0.17548,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0001862,0.18129,0.17095,1,1
5,GO GLIAL CELL DIFFERENTIATION,4.0314e-05,0.18123,0.18823,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,5.5127e-05,0.18114,0.16502,1,1
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,2.8886e-07,0.1811,0.20379,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00032916,0.18085,0.14399,1,1
5,GO CENTROSOME SEPARATION,0.0005618,0.18074,0.17226,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0059116,0.18067,0.14013,1,1
5,GO LIMBIC SYSTEM DEVELOPMENT,5.4356e-06,0.18065,0.20469,1,1
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.5604e-09,0.1803,0.23475,1,1
5,GO HISTONE H3 DEACETYLATION,2.2958e-06,0.1802,0.22413,1,1
5,GO EXTRACELLULAR TRANSPORT,0.0003557,0.18003,0.22326,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.5052e-06,0.17995,0.20961,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0001862,0.17994,0.1596,1,1
5,GO ACROSOME REACTION,0.00027284,0.17987,0.21459,1,1
5,GO REGULATION OF SPINDLE ASSEMBLY,0.0035146,0.1797,0.13556,1,1
5,GO MOTOR NEURON AXON GUIDANCE,0.0092477,0.17961,0.15623,1,1
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.8032e-05,0.17957,0.22338,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.048285,0.17952,0.14417,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,5.1446e-05,0.17941,0.19224,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,1.3196e-05,0.17931,0.15677,1,1
5,GO SPERM MOTILITY,2.0879e-07,0.17923,0.21316,1,1
5,GO PERICARDIUM DEVELOPMENT,0.024947,0.17909,0.15624,1,1
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00091404,0.17907,0.18721,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,4.0657e-06,0.17899,0.20934,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.001442,0.17873,0.1674,1,1
5,GO MONOAMINE TRANSPORT,6.6578e-05,0.17869,0.27727,1,1
5,GO MRNA EXPORT FROM NUCLEUS,0.00048316,0.1785,0.14055,1,1
5,GO PROTEIN KINASE C SIGNALING,0.00095459,0.17844,0.21396,1,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,2.011e-05,0.17829,0.17454,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00015331,0.17821,0.20372,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.036772,0.17816,0.13622,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.9069e-08,0.17785,0.17486,1,1
5,GO CHROMATIN DISASSEMBLY,0.00019229,0.17776,0.19464,1,1
5,GO RESPONSE TO COCAINE,1.8701e-05,0.17761,0.23486,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,3.4098e-06,0.1776,0.17959,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.9563e-06,0.17751,0.21,1,1
5,GO FERTILIZATION,5.2445e-07,0.17743,0.17484,1,1
5,GO MITRAL VALVE DEVELOPMENT,0.0025277,0.17723,0.20003,1,1
5,GO MISMATCH REPAIR,1.996e-06,0.177,0.19921,1,1
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.5865e-05,0.17699,0.1838,1,1
5,GO REPRODUCTION,6.7461e-07,0.17687,0.15893,1,1
5,GO REGULATION OF DNA RECOMBINATION,0.00047589,0.17676,0.14954,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00088789,0.17671,0.19283,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.0001862,0.17666,0.19885,1,1
5,GO ODONTOGENESIS,0.024428,0.17664,0.13253,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0010865,0.17663,0.14538,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0002117,0.17659,0.16045,1,1
5,GO RESPONSE TO DOPAMINE,8.1138e-06,0.17641,0.19974,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.00022927,0.1763,0.16949,1,1
5,GO MATING,3.758e-05,0.1761,0.18504,1,1
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00010673,0.17602,0.17866,1,1
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.2416e-05,0.17599,0.19301,1,1
5,GO REGULATION OF HORMONE SECRETION,1.5293e-05,0.17593,0.18082,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,1.3351e-08,0.17585,0.17948,1,1
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00055343,0.17575,0.22556,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00025617,0.17566,0.14313,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.0059116,0.17561,0.20866,1,1
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.015159,0.17557,0.14545,1,1
5,GO DOUBLE STRAND BREAK REPAIR,3.5022e-05,0.17555,0.17157,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.007921,0.17549,0.16654,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,8.4424e-05,0.17544,0.16528,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00071283,0.17541,0.26045,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.001235,0.17535,0.20794,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00045468,0.17531,0.18186,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00012594,0.17507,0.29868,1,1
5,GO PROSTATIC BUD FORMATION,0.028556,0.17501,0.22086,1,1
5,GO LIPID TRANSLOCATION,0.0023637,0.17498,0.18496,1,1
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,1.4741e-05,0.17492,0.16686,1,1
5,GO HEART VALVE DEVELOPMENT,0.0062108,0.17476,0.15486,1,1
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00059648,0.17454,0.14958,1,1
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0017517,0.1745,0.17514,1,1
5,GO HAIR CELL DIFFERENTIATION,0.001704,0.1744,0.23212,1,1
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0020646,0.17436,0.18809,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.00081356,0.17431,0.20342,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.010522,0.17425,0.12802,1,1
5,GO EAR DEVELOPMENT,4.9361e-06,0.17424,0.21939,1,1
5,GO AXIS SPECIFICATION,1.1588e-05,0.17407,0.19586,1,1
5,GO AXO DENDRITIC TRANSPORT,3.628e-05,0.17402,0.19642,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,6.4592e-06,0.17379,0.20479,1,1
5,GO NUCLEOSOME ORGANIZATION,4.6578e-06,0.17378,0.19357,1,1
5,GO INTRACELLULAR MRNA LOCALIZATION,0.0037498,0.17362,0.15542,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0027747,0.1734,0.15772,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00087508,0.17333,0.12866,1,1
5,GO MEIOSIS I CELL CYCLE PROCESS,2.1234e-05,0.17333,0.19032,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00012388,0.17299,0.14402,1,1
5,GO REGULATION OF MRNA POLYADENYLATION,1.1588e-05,0.17298,0.19348,1,1
5,GO REGULATION OF LYASE ACTIVITY,0.00016098,0.1729,0.19286,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,2.4528e-05,0.17281,0.17431,1,1
5,GO CILIUM MOVEMENT,4.5233e-07,0.17276,0.22429,1,1
5,GO REGULATION OF INSULIN SECRETION,4.4807e-06,0.17265,0.20693,1,1
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,3.5022e-05,0.1726,0.19445,1,1
5,GO REGULATION OF SPINDLE CHECKPOINT,8.5858e-05,0.1725,0.22431,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00098255,0.17246,0.14438,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0010259,0.17242,0.2428,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,3.3806e-05,0.17239,0.15833,1,1
5,GO RECEPTOR INTERNALIZATION,0.00064263,0.17219,0.14376,1,1
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0047198,0.17219,0.14648,1,1
5,GO GROOMING BEHAVIOR,0.0027381,0.17191,0.19986,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00015838,0.17188,0.23723,1,1
5,GO ARTERY MORPHOGENESIS,0.057179,0.17188,0.10118,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.00037257,0.17172,0.22609,1,1
5,GO MESENCHYME DEVELOPMENT,0.001704,0.17155,0.14644,1,1
5,GO PROTEIN AUTOUBIQUITINATION,3.2631e-05,0.17151,0.15615,1,1
5,GO HEART MORPHOGENESIS,8.0256e-05,0.17141,0.17896,1,1
5,GO RENAL FILTRATION,0.01499,0.1714,0.27126,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.2344e-05,0.17119,0.16586,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0001862,0.17112,0.1479,1,1
5,GO CELL CELL SIGNALING,3.4773e-06,0.17094,0.1692,1,1
5,GO GDP METABOLIC PROCESS,0.0012005,0.17082,0.21988,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.2686e-06,0.17077,0.15264,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0063654,0.17068,0.15611,1,1
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.00033955,0.17068,0.1827,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.0089251,0.17063,0.17875,1,1
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.0007901,0.17059,0.14543,1,1
5,GO CEREBRAL CORTEX CELL MIGRATION,3.758e-05,0.17057,0.23805,1,1
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00021511,0.1703,0.1482,1,1
5,GO REGULATION OF CHROMOSOME SEGREGATION,7.2497e-05,0.17011,0.1794,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00042128,0.1701,0.12975,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.010895,0.16994,0.17651,1,1
5,GO CYTOKINESIS,1.2954e-05,0.16993,0.16265,1,1
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0011668,0.16942,0.21035,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0044864,0.16921,0.16681,1,1
5,GO SINGLE FERTILIZATION,1.3325e-06,0.16914,0.17078,1,1
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,1.1282e-07,0.16913,0.20491,1,1
5,GO PROSTATE GLAND DEVELOPMENT,0.023173,0.16908,0.13262,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.2416e-05,0.16903,0.17069,1,1
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.060988,0.16896,0.13024,1,1
5,GO THYMUS DEVELOPMENT,1.155e-06,0.16893,0.22401,1,1
5,GO PROTEIN METHYLATION,3.7282e-08,0.16879,0.21731,1,1
5,GO CARDIAC CHAMBER DEVELOPMENT,0.004156,0.16865,0.13207,1,1
5,GO FOREGUT MORPHOGENESIS,0.00036686,0.16862,0.22326,1,1
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,1.536e-06,0.16848,0.21891,1,1
5,GO DNA INTEGRITY CHECKPOINT,8.4805e-07,0.16837,0.19311,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,3.8983e-07,0.16827,0.19306,1,1
5,GO HISTONE UBIQUITINATION,1.5052e-06,0.16801,0.17759,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.0044864,0.16792,0.12856,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.00032408,0.16791,0.13872,1,1
5,GO HISTONE EXCHANGE,0.00084997,0.16789,0.15823,1,1
5,GO NEGATIVE REGULATION OF TOR SIGNALING,5.2303e-06,0.16787,0.20655,1,1
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0035605,0.16785,0.16929,1,1
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,4.0678e-07,0.16782,0.1899,1,1
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00029976,0.16781,0.18727,1,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.016752,0.16761,0.13319,1,1
5,GO ADHERENS JUNCTION ORGANIZATION,0.00071283,0.16758,0.19885,1,1
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0073682,0.16741,0.19163,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0023637,0.16737,0.15799,1,1
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1.0004e-06,0.16736,0.18571,1,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00016629,0.16718,0.15504,1,1
5,GO SPERM CAPACITATION,0.0020092,0.1671,0.16659,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,8.3066e-07,0.16709,0.18599,1,1
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00073415,0.16708,0.18033,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00088789,0.16702,0.12741,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0024941,0.16695,0.16236,1,1
5,GO CELL CYCLE ARREST,5.2303e-06,0.16668,0.16175,1,1
5,GO DNA CONFORMATION CHANGE,1.0958e-05,0.16667,0.17888,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,6.4434e-08,0.16656,0.22166,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0001179,0.16645,0.14462,1,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0010865,0.1663,0.13312,1,1
5,GO MULTI ORGANISM PROCESS,2.3784e-07,0.16618,0.16092,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.000662,0.16604,0.13606,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.4356e-06,0.166,0.19443,1,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,4.31e-06,0.16579,0.19453,1,1
5,GO GLIOGENESIS,5.5127e-05,0.16577,0.17237,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.0033361,0.16575,0.17475,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.011151,0.16568,0.16255,1,1
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00044781,0.16561,0.18986,1,1
5,GO LUNG MORPHOGENESIS,0.017699,0.16541,0.1378,1,1
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0007901,0.16522,0.16671,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.006444,0.16519,0.1369,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00048316,0.16518,0.15826,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0021798,0.16501,0.2169,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.0557e-05,0.16499,0.21818,1,1
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0031247,0.16488,0.12389,1,1
5,GO REGULATION OF SYSTEM PROCESS,6.2175e-05,0.1648,0.16812,1,1
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.00020504,0.16477,0.18974,1,1
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0069343,0.16476,0.12846,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00020835,0.16475,0.18157,1,1
5,GO SISTER CHROMATID COHESION,9.6129e-06,0.1645,0.19852,1,1
5,GO PROTEIN TARGETING TO VACUOLE,0.058787,0.16449,0.1029,1,1
5,GO HEAT GENERATION,0.00039018,0.16445,0.19413,1,1
5,GO MEMORY,1.9393e-05,0.16445,0.19727,1,1
5,GO DEVELOPMENTAL INDUCTION,0.001776,0.16438,0.17272,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.0034243,0.16433,0.16402,1,1
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0017277,0.16429,0.14472,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0022396,0.1641,0.17854,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00018323,0.16406,0.1811,1,1
5,GO ENDOTHELIUM DEVELOPMENT,0.0028492,0.16405,0.16027,1,1
5,GO COVALENT CHROMATIN MODIFICATION,8.2903e-10,0.16398,0.21554,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.012087,0.16385,0.15125,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.049681,0.16369,0.15618,1,1
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0007786,0.16362,0.19506,1,1
5,GO HORMONE TRANSPORT,2.2416e-05,0.16358,0.17549,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00012594,0.16357,0.14337,1,1
5,GO REGULATION OF HEART MORPHOGENESIS,0.0066039,0.16351,0.17727,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0051547,0.16347,0.19605,1,1
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,7.1274e-05,0.16344,0.14961,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00036124,0.1634,0.14685,1,1
5,GO CATECHOLAMINE SECRETION,0.00017457,0.16336,0.3108,1,1
5,GO OOGENESIS,1.3174e-07,0.16323,0.20389,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0011021,0.1632,0.19303,1,1
5,GO POTASSIUM ION TRANSPORT,1.7706e-05,0.16311,0.20936,1,1
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0005618,0.16308,0.1739,1,1
5,GO REGULATION OF DNA REPLICATION,8.5867e-06,0.16298,0.1734,1,1
5,GO REGULATION OF CHROMATIN ORGANIZATION,1.2143e-08,0.16295,0.19746,1,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,3.628e-05,0.16292,0.16752,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0013069,0.1629,0.16567,1,1
5,GO REGULATION OF GTPASE ACTIVITY,0.00019229,0.16289,0.14356,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.051595,0.16272,0.13811,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,7.8124e-06,0.16271,0.16113,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00010673,0.16264,0.18918,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.034636,0.16245,0.14836,1,1
5,GO DNA DEPENDENT DNA REPLICATION,1.0756e-05,0.16236,0.18984,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0020367,0.16234,0.12168,1,1
5,GO DEVELOPMENTAL MATURATION,1.6994e-06,0.16218,0.19087,1,1
5,GO CYTOSKELETON ORGANIZATION,4.5684e-06,0.16215,0.16351,1,1
5,GO REGULATION OF EXOCYTOSIS,5.0563e-05,0.16214,0.18304,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.1304e-06,0.16214,0.15831,1,1
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0023637,0.16188,0.17974,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.006444,0.16186,0.1611,1,1
5,GO MRNA PROCESSING,0.00014362,0.16178,0.1446,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00033955,0.16178,0.14855,1,1
5,GO GLIAL CELL MIGRATION,0.049681,0.16173,0.10677,1,1
5,GO REGULATION OF MYELINATION,0.00049053,0.16154,0.16175,1,1
5,GO HISTONE DEUBIQUITINATION,9.9844e-05,0.16141,0.18271,1,1
5,GO REGULATION OF HELICASE ACTIVITY,0.0017517,0.16122,0.17488,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0023957,0.16114,0.14827,1,1
5,GO REGULATION OF CYTOKINESIS,4.3946e-06,0.16107,0.19664,1,1
5,GO TOOTH MINERALIZATION,0.0096941,0.16099,0.19897,1,1
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.009139,0.16095,0.21235,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.003607,0.16073,0.16132,1,1
5,GO POSITIVE REGULATION OF MRNA PROCESSING,7.1274e-05,0.16062,0.16597,1,1
5,GO CHROMATIN ORGANIZATION,1.5217e-09,0.1606,0.21485,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,3.8246e-05,0.16046,0.18619,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0065235,0.16035,0.18548,1,1
5,GO GOLGI LOCALIZATION,0.013093,0.16031,0.097091,1,1
5,GO TORC1 SIGNALING,1.6994e-06,0.16026,0.21252,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00015583,0.16007,0.16593,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00049802,0.16001,0.14853,1,1
5,GO ORGANELLE LOCALIZATION,8.4262e-06,0.15989,0.14638,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,3.5646e-05,0.15979,0.20383,1,1
5,GO REGULATION OF HISTONE MODIFICATION,9.4407e-08,0.15975,0.18864,1,1
5,GO CHROMATIN REMODELING,8.1361e-07,0.15973,0.19674,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00068191,0.15973,0.18313,1,1
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.000662,0.15968,0.16248,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.03068,0.15968,0.17165,1,1
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.001776,0.15944,0.14278,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0012705,0.15939,0.12426,1,1
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.6158e-05,0.15936,0.17828,1,1
5,GO NUCLEAR CHROMOSOME SEGREGATION,6.5837e-06,0.15925,0.1765,1,1
5,GO INTERSTRAND CROSS LINK REPAIR,7.5217e-06,0.15917,0.19745,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.00061456,0.15915,0.17341,1,1
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,1.0004e-06,0.15915,0.17444,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,1.4207e-05,0.15896,0.17746,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.011813,0.15884,0.13634,1,1
5,GO MIDBRAIN DEVELOPMENT,1.1375e-05,0.15877,0.15879,1,1
5,GO HISTONE H3 K9 ACETYLATION,2.8305e-05,0.15845,0.18358,1,1
5,GO EMBRYONIC AXIS SPECIFICATION,3.7605e-06,0.15834,0.2275,1,1
5,GO TUBE MORPHOGENESIS,0.0061347,0.15811,0.11855,1,1
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,5.7582e-06,0.15795,0.18354,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0037498,0.15793,0.14438,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0023009,0.15771,0.13564,1,1
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0050904,0.15769,0.13812,1,1
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00017741,0.15726,0.18376,1,1
5,GO MEIOTIC SPINDLE ORGANIZATION,0.00011406,0.1571,0.21099,1,1
5,GO NERVOUS SYSTEM PROCESS,2.5359e-06,0.15703,0.16994,1,1
5,GO CHROMOSOME SEGREGATION,1.0958e-05,0.157,0.17685,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.012087,0.15695,0.20139,1,1
5,GO REGULATION OF CHROMOSOME ORGANIZATION,2.2958e-06,0.15685,0.16202,1,1
5,GO REGULATION OF MITOPHAGY,0.00074504,0.15675,0.15496,1,1
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00054518,0.15673,0.19458,1,1
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.0023321,0.15673,0.23615,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.0016122,0.15663,0.14144,1,1
5,GO MEMBRANE BIOGENESIS,0.0011836,0.15655,0.21419,1,1
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00011986,0.1565,0.15762,1,1
5,GO CELL CYCLE CHECKPOINT,5.1351e-07,0.15649,0.19361,1,1
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0070192,0.15649,0.19071,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0031247,0.15643,0.15347,1,1
5,GO REGULATION OF MEMBRANE PERMEABILITY,3.9613e-05,0.15637,0.15304,1,1
5,GO MITOTIC CYTOKINESIS,0.0019285,0.15632,0.11902,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,5.2344e-05,0.15627,0.17212,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.00029976,0.15624,0.13823,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00021857,0.15623,0.17181,1,1
5,GO GROWTH,4.8839e-05,0.15622,0.14361,1,1
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,2.0853e-05,0.15619,0.21174,1,1
5,GO SPINDLE LOCALIZATION,0.00041488,0.15598,0.15385,1,1
5,GO RNA POLYADENYLATION,0.0051547,0.15598,0.12526,1,1
5,GO REGULATION OF HAIR CYCLE,0.0018006,0.15588,0.15416,1,1
5,GO REGULATION OF RNA SPLICING,2.5756e-08,0.15584,0.20427,1,1
5,GO DNA GEOMETRIC CHANGE,0.00020178,0.15581,0.15875,1,1
5,GO VASCULOGENESIS,0.0095807,0.15569,0.16084,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0010408,0.15563,0.16187,1,1
5,GO SECRETORY GRANULE ORGANIZATION,0.0012705,0.15539,0.16319,1,1
5,GO MITOTIC SPINDLE ASSEMBLY,0.00065224,0.15513,0.15162,1,1
5,GO EPITHELIUM DEVELOPMENT,0.0020929,0.15512,0.1209,1,1
5,GO REGULATION OF SPINDLE ORGANIZATION,0.0011836,0.15507,0.14073,1,1
5,GO REGULATION OF CELL CYCLE CHECKPOINT,4.4771e-05,0.15502,0.20221,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.022209,0.15495,0.15981,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.015501,0.15479,0.14591,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00033432,0.15478,0.18391,1,1
5,GO OUTFLOW TRACT MORPHOGENESIS,0.011813,0.15475,0.16321,1,1
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00037257,0.15446,0.16316,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.01585,0.15445,0.12486,1,1
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0075485,0.15444,0.22403,1,1
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0018006,0.15444,0.16929,1,1
5,GO TRANSPOSITION,0.003607,0.15437,0.199,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8305e-05,0.15418,0.19072,1,1
5,GO NEURON APOPTOTIC PROCESS,9.6129e-06,0.15417,0.15708,1,1
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0058389,0.15396,0.14345,1,1
5,GO DNA REPAIR,4.6359e-05,0.15393,0.14777,1,1
5,GO AORTA MORPHOGENESIS,0.065005,0.15386,0.12265,1,1
5,GO INSULIN SECRETION,7.3803e-06,0.15384,0.20549,1,1
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.011949,0.15383,0.14445,1,1
5,GO DETECTION OF VISIBLE LIGHT,8.5867e-06,0.15376,0.13336,1,1
5,GO REGULATION OF ACTION POTENTIAL,0.0063654,0.15373,0.1622,1,1
5,GO CIRCADIAN RHYTHM,1.1789e-06,0.15365,0.17559,1,1
5,GO GMP METABOLIC PROCESS,0.0023321,0.15356,0.15178,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.0012177,0.15354,0.14936,1,1
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.4184e-05,0.15347,0.20756,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0085105,0.15345,0.14561,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.031631,0.15338,0.1328,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,3.3214e-05,0.15318,0.16635,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0024941,0.15314,0.12275,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0096941,0.15312,0.14409,1,1
5,GO LACTATION,0.010769,0.15304,0.12279,1,1
5,GO REPLACEMENT OSSIFICATION,0.025743,0.15299,0.1291,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0017517,0.15291,0.13438,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00057029,0.15283,0.18279,1,1
5,GO REGULATION OF CENTROSOME CYCLE,1.9393e-05,0.15269,0.19043,1,1
5,GO REGULATION OF MRNA 3 END PROCESSING,0.0001179,0.15262,0.16541,1,1
5,GO TELOMERE CAPPING,0.00021511,0.15262,0.14695,1,1
5,GO EXIT FROM MITOSIS,0.0010259,0.15247,0.14255,1,1
5,GO METAPHASE PLATE CONGRESSION,0.00083767,0.15239,0.13117,1,1
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0063654,0.15234,0.18082,1,1
5,GO TUBE DEVELOPMENT,0.0047798,0.15231,0.119,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0046604,0.15217,0.13483,1,1
5,GO MITOTIC CELL CYCLE CHECKPOINT,2.3274e-07,0.15211,0.19588,1,1
5,GO SODIUM ION TRANSPORT,0.00044103,0.15205,0.14738,1,1
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,4.3997e-05,0.15203,0.17774,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0088198,0.152,0.15777,1,1
5,GO DNA STRAND ELONGATION,0.00032916,0.15183,0.17989,1,1
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.001235,0.15182,0.17713,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0104,0.15181,0.20219,1,1
5,GO NEUROTRANSMITTER UPTAKE,0.0037016,0.15179,0.15715,1,1
5,GO CHONDROCYTE DEVELOPMENT,0.0058389,0.15176,0.17582,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0024609,0.15173,0.20104,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0034243,0.15151,0.14905,1,1
5,GO HISTONE H2A ACETYLATION,4.3997e-05,0.15132,0.18369,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0052854,0.15099,0.18503,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.00099681,0.15098,0.15224,1,1
5,GO RNA SPLICING,0.00012594,0.15064,0.14162,1,1
5,GO UV PROTECTION,0.0062877,0.15059,0.17367,1,1
5,GO REGULATION OF DNA BINDING,2.7452e-06,0.15047,0.16172,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0032078,0.15045,0.12151,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.051595,0.15039,0.098108,1,1
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0045438,0.15034,0.15924,1,1
5,GO CELL CYCLE PROCESS,5.8698e-06,0.15033,0.14944,1,1
5,GO EATING BEHAVIOR,0.00014839,0.15033,0.16742,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.022928,0.15022,0.11849,1,1
5,GO SISTER CHROMATID SEGREGATION,7.5001e-05,0.15008,0.16542,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,0.00094089,0.14994,0.15557,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,6.7724e-05,0.14994,0.15868,1,1
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0005133,0.14994,0.18613,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.0035146,0.14983,0.12012,1,1
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0034692,0.14982,0.13618,1,1
5,GO VESICLE DOCKING,0.0025961,0.14971,0.13859,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0071051,0.14963,0.12509,1,1
5,GO FEEDING BEHAVIOR,0.00010673,0.14961,0.18348,1,1
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.00033955,0.14951,0.12846,1,1
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.046474,0.14938,0.086321,1,1
5,GO GOLGI RIBBON FORMATION,0.00038422,0.14934,0.19975,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015501,0.14926,0.15596,1,1
5,GO CELLULAR RESPONSE TO UV,5.4184e-05,0.14922,0.15652,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,2.3239e-05,0.1492,0.14556,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0063654,0.14919,0.12726,1,1
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0056255,0.14896,0.13336,1,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00015583,0.14892,0.14545,1,1
5,GO JNK CASCADE,0.004156,0.1489,0.10636,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.035691,0.14885,0.11413,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,9.3381e-05,0.14882,0.18602,1,1
5,GO POSITIVE REGULATION OF DNA REPLICATION,4.1026e-05,0.14864,0.1585,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0002443,0.14856,0.15305,1,1
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0053519,0.14854,0.22134,1,1
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0030839,0.1485,0.14989,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,2.4305e-07,0.14847,0.16507,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,3.4296e-07,0.14844,0.16581,1,1
5,GO SIGNAL RELEASE,2.9859e-05,0.14842,0.16115,1,1
5,GO ORGANELLE ASSEMBLY,3.8983e-07,0.14841,0.16044,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,6.3249e-05,0.1484,0.1783,1,1
5,GO MRNA METHYLATION,0.0034243,0.14836,0.1575,1,1
5,GO REGULATION OF CELL CYCLE PROCESS,4.1456e-06,0.14816,0.14881,1,1
5,GO CHROMOSOME ORGANIZATION,8.8282e-08,0.1481,0.18081,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00014129,0.14796,0.15193,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,1.2886e-07,0.14787,0.16212,1,1
5,GO REGULATION OF FEEDING BEHAVIOR,0.0018508,0.14778,0.17477,1,1
5,GO ORGANELLE FISSION,1.0958e-05,0.14765,0.15304,1,1
5,GO VISUAL BEHAVIOR,0.00023667,0.14761,0.15094,1,1
5,GO RRNA CATABOLIC PROCESS,0.0052854,0.14759,0.14088,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00011406,0.14741,0.16329,1,1
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,2.1621e-05,0.14739,0.15714,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.032278,0.14734,0.16874,1,1
5,GO RHYTHMIC PROCESS,3.5038e-07,0.14729,0.18144,1,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0054192,0.14722,0.15987,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0039481,0.14716,0.13606,1,1
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.00017176,0.14712,0.1773,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.0085105,0.14702,0.1415,1,1
5,GO CLATHRIN COAT ASSEMBLY,0.03902,0.14699,0.12373,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00084997,0.14696,0.13639,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.0051547,0.14695,0.14792,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,4.7999e-05,0.14685,0.18175,1,1
5,GO ROOF OF MOUTH DEVELOPMENT,0.00018923,0.14684,0.18601,1,1
5,GO HEART DEVELOPMENT,0.00029511,0.14678,0.14447,1,1
5,GO MEIOTIC CELL CYCLE,3.0302e-06,0.14675,0.17874,1,1
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,4.4771e-05,0.14666,0.1797,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.628e-05,0.14655,0.15137,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.00062378,0.14648,0.1765,1,1
5,GO ANIMAL ORGAN MATURATION,0.00026438,0.14648,0.19729,1,1
5,GO CHROMOSOME CONDENSATION,0.00046872,0.14639,0.16931,1,1
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,6.337e-06,0.14634,0.16345,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,0.14634,0.14155,1,1
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0035146,0.14599,0.14622,1,1
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,1.0557e-05,0.14591,0.14073,1,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.5127e-05,0.14579,0.17119,1,1
5,GO ANOIKIS,0.0099244,0.14577,0.15518,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.0066039,0.14574,0.17004,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.00022208,0.14547,0.17732,1,1
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00067188,0.14547,0.15501,1,1
5,GO BONE DEVELOPMENT,0.011813,0.14511,0.11454,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.05063,0.14502,0.10047,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0027747,0.14494,0.14388,1,1
5,GO CELL DIVISION,5.2303e-06,0.14466,0.16305,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0089251,0.14463,0.12373,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0018764,0.14459,0.15267,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00086244,0.14456,0.13582,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.00072342,0.14449,0.14159,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,7.6657e-06,0.14427,0.13956,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.011544,0.14408,0.12559,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0024281,0.14401,0.18408,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0075485,0.14395,0.11447,1,1
5,GO LIPID PHOSPHORYLATION,1.2954e-05,0.14395,0.17064,1,1
5,GO NEGATIVE REGULATION OF CELL AGING,0.033271,0.14381,0.12502,1,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,9.9803e-06,0.1436,0.15381,1,1
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.024428,0.14348,0.10877,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,1.9044e-05,0.14344,0.15553,1,1
5,GO HOMOLOGOUS RECOMBINATION,0.0015463,0.14337,0.171,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0015038,0.14337,0.1434,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.036772,0.14328,0.11962,1,1
5,GO REGULATION OF SENSORY PERCEPTION,0.00071283,0.14325,0.13398,1,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.01128,0.14306,0.12354,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047198,0.14301,0.18847,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0095807,0.14294,0.13598,1,1
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.040187,0.14288,0.18714,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.004156,0.14285,0.16198,1,1
5,GO REGULATION OF HORMONE LEVELS,0.00071283,0.14276,0.12761,1,1
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0046604,0.14268,0.077702,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020092,0.14268,0.17282,1,1
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.001955,0.14267,0.15414,1,1
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,3.2057e-05,0.14266,0.15402,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.021973,0.14256,0.13976,1,1
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.0137,0.14231,0.10393,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0005618,0.1423,0.13627,1,1
5,GO MITOTIC NUCLEAR DIVISION,7.5001e-05,0.14208,0.15715,1,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00017457,0.14192,0.1454,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0044298,0.1419,0.13988,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0016806,0.14187,0.1807,1,1
5,GO MRNA TRANSPORT,0.00053704,0.14179,0.12962,1,1
5,GO RNA EXPORT FROM NUCLEUS,0.0071918,0.14173,0.11101,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.020828,0.14171,0.12356,1,1
5,GO MUSCLE CELL DIFFERENTIATION,0.0012527,0.14171,0.12866,1,1
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00044781,0.14169,0.1445,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0020367,0.14153,0.13407,1,1
5,GO REGULATION OF CELL CYCLE,8.1361e-07,0.1414,0.1502,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00025215,0.1414,0.15115,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00068191,0.14104,0.17567,1,1
5,GO HYPEROSMOTIC RESPONSE,0.00016098,0.14103,0.18789,1,1
5,GO DNA METHYLATION OR DEMETHYLATION,4.2487e-05,0.14094,0.13643,1,1
5,GO VIRAL RNA GENOME REPLICATION,0.014172,0.14089,0.11245,1,1
5,GO HISTONE PHOSPHORYLATION,0.00086244,0.14069,0.13566,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0030436,0.14066,0.13417,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0040509,0.14064,0.1196,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00064263,0.14057,0.12687,1,1
5,GO MRNA 3 END PROCESSING,0.00048316,0.14051,0.14446,1,1
5,GO NUCLEAR EXPORT,0.0033361,0.1405,0.11437,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,1.5865e-05,0.14048,0.14864,1,1
5,GO REGULATION OF CHROMOSOME SEPARATION,0.0011341,0.14042,0.1566,1,1
5,GO NEGATIVE REGULATION OF RNA SPLICING,1.1806e-05,0.14042,0.16754,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,8.9166e-06,0.14037,0.14866,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.033271,0.14035,0.11469,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.019104,0.14029,0.13925,1,1
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00011596,0.14026,0.1356,1,1
5,GO CHROMOSOME SEPARATION,0.00052901,0.14024,0.16835,1,1
5,GO RNA DESTABILIZATION,0.0005056,0.14017,0.15745,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.010769,0.14004,0.10154,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.001422,0.13995,0.19765,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.0058389,0.13994,0.10944,1,1
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.000662,0.13992,0.20584,1,1
5,GO CELL CYCLE DNA REPLICATION,4.2487e-05,0.13992,0.18743,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0024281,0.13988,0.1646,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00011033,0.13964,0.14623,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.016938,0.13953,0.10179,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0012886,0.13952,0.12424,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,1.734e-06,0.13948,0.15946,1,1
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,1.3056e-06,0.13928,0.1782,1,1
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00073415,0.1392,0.19702,1,1
5,GO PEPTIDYL SERINE MODIFICATION,8.4424e-05,0.1388,0.13934,1,1
5,GO SPINDLE ASSEMBLY,0.00012804,0.13877,0.15869,1,1
5,GO MYELIN ASSEMBLY,0.024947,0.13855,0.1537,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00014839,0.13831,0.14874,1,1
5,GO RENAL WATER HOMEOSTASIS,0.00084997,0.1382,0.21075,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0055559,0.13818,0.13538,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.043866,0.1381,0.085183,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,8.8796e-05,0.13774,0.14447,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.038258,0.13768,0.17367,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.00036124,0.13764,0.16623,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.00065224,0.13743,0.11927,1,1
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00092737,0.13733,0.15468,1,1
5,GO RENAL SYSTEM PROCESS,0.0025961,0.13725,0.16092,1,1
5,GO PROTEIN DEPHOSPHORYLATION,2.011e-05,0.13721,0.13727,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0062108,0.13719,0.11284,1,1
5,GO DETECTION OF LIGHT STIMULUS,8.5858e-05,0.13703,0.10807,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.0047798,0.13682,0.10066,1,1
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0024281,0.13667,0.11675,1,1
5,GO POSITIVE REGULATION OF GROWTH,3.1494e-05,0.13662,0.15873,1,1
5,GO UV DAMAGE EXCISION REPAIR,0.0015463,0.13661,0.15728,1,1
5,GO CORONARY VASCULATURE DEVELOPMENT,0.024947,0.1366,0.14197,1,1
5,GO FEMALE GAMETE GENERATION,1.475e-06,0.13655,0.162,1,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00074504,0.13655,0.10887,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.0028492,0.13651,0.20877,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.02174,0.13622,0.16753,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0037016,0.13617,0.1497,1,1
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.010279,0.13612,0.096388,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,1.5293e-05,0.13588,0.15362,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0028118,0.13584,0.14117,1,1
5,GO EPITHELIAL CELL PROLIFERATION,0.016568,0.13583,0.10993,1,1
5,GO HISTONE H3 ACETYLATION,6.2169e-06,0.13583,0.16143,1,1
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,8.1138e-06,0.13582,0.1647,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00017176,0.13579,0.1218,1,1
5,GO LENS FIBER CELL DEVELOPMENT,0.013856,0.13568,0.16939,1,1
5,GO REGULATION OF TELOMERE CAPPING,0.0095807,0.13562,0.11966,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011411,0.13559,0.12644,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.028264,0.13559,0.11463,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0018764,0.13555,0.1371,1,1
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0013633,0.13553,0.082309,1,1
5,GO FAT CELL DIFFERENTIATION,0.009139,0.13544,0.1152,1,1
5,GO ONE CARBON METABOLIC PROCESS,0.033608,0.13527,0.097964,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00015838,0.13521,0.15418,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.026013,0.13521,0.10846,1,1
5,GO ENDOCYTIC RECYCLING,0.0062877,0.13517,0.12448,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00092737,0.13509,0.12389,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE,4.9228e-07,0.13509,0.15502,1,1
5,GO DNA LIGATION,0.040187,0.13505,0.098703,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00036686,0.13491,0.10873,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,4.7963e-08,0.13484,0.18071,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.057711,0.13477,0.088322,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,2.0364e-06,0.13476,0.16678,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00046165,0.13466,0.21821,1,1
5,GO POSITIVE REGULATION OF HEART GROWTH,0.035691,0.13461,0.10393,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00034485,0.13457,0.13467,1,1
5,GO GOLGI ORGANIZATION,0.0098086,0.13453,0.091104,1,1
5,GO NUCLEUS ORGANIZATION,0.001483,0.13435,0.11481,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.016752,0.13434,0.10832,1,1
5,GO SODIUM ION HOMEOSTASIS,0.00068191,0.13428,0.16576,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0098086,0.13424,0.13296,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,1.0958e-05,0.13418,0.14481,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.010279,0.13415,0.097215,1,1
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0085105,0.13413,0.11861,1,1
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.000286,0.13413,0.11877,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00024819,0.1341,0.11234,1,1
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.023419,0.13407,0.094952,1,1
5,GO REGULATION OF GROWTH,0.00013451,0.13405,0.13315,1,1
5,GO MEIOTIC CELL CYCLE PROCESS,2.1234e-05,0.13403,0.1685,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.024947,0.13402,0.15918,1,1
5,GO CELL CYCLE,3.152e-06,0.134,0.14633,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.00019229,0.13393,0.11537,1,1
5,GO RESPIRATORY SYSTEM PROCESS,0.0075485,0.13381,0.14265,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.039406,0.13365,0.082387,1,1
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,1.3442e-05,0.1336,0.18754,1,1
5,GO NUCLEOTIDE PHOSPHORYLATION,0.010041,0.13356,0.10821,1,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00033432,0.13354,0.11066,1,1
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.628e-05,0.13341,0.13391,1,1
5,GO OOCYTE DIFFERENTIATION,0.015329,0.13332,0.10779,1,1
5,GO MULTICELLULAR ORGANISM AGING,0.0075485,0.13331,0.12031,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.001422,0.13316,0.14794,1,1
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.036048,0.13306,0.10465,1,1
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.00037257,0.13305,0.14256,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.001568,0.13302,0.15053,1,1
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0050269,0.13298,0.092276,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.001235,0.13296,0.13317,1,1
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.058247,0.13292,0.13478,1,1
5,GO ERYTHROCYTE DEVELOPMENT,0.022209,0.13291,0.10945,1,1
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0021215,0.13286,0.14946,1,1
5,GO ASYMMETRIC CELL DIVISION,0.011411,0.13276,0.17164,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0035605,0.13262,0.10795,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011021,0.13239,0.1546,1,1
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0060595,0.13232,0.10113,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,4.3946e-06,0.13212,0.16945,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00049802,0.13208,0.14545,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0051547,0.132,0.11561,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00023667,0.132,0.13268,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.02521,0.13199,0.13903,1,1
5,GO ERROR PRONE TRANSLESION SYNTHESIS,1.0361e-05,0.1319,0.18014,1,1
5,GO REGULATION OF CENTROSOME DUPLICATION,0.00020504,0.13179,0.18054,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0016806,0.13172,0.16608,1,1
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00088789,0.1315,0.11548,1,1
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0030839,0.13145,0.12813,1,1
5,GO CELLULAR RESPONSE TO STARVATION,0.00042128,0.13144,0.13516,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0075485,0.13142,0.10971,1,1
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00028155,0.13135,0.12011,1,1
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00018923,0.13133,0.14231,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,0.017506,0.13128,0.10451,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,8.0256e-05,0.13113,0.14305,1,1
5,GO VESICLE LOCALIZATION,0.001118,0.13109,0.11623,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.018693,0.13108,0.13237,1,1
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0027747,0.13084,0.128,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0054192,0.13077,0.10278,1,1
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0076401,0.13069,0.12425,1,1
5,GO PROTEIN MONOUBIQUITINATION,0.00027716,0.13059,0.14042,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0072795,0.13025,0.10684,1,1
5,GO LYSOSOMAL TRANSPORT,0.0060595,0.13019,0.1164,1,1
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00016361,0.13006,0.16589,1,1
5,GO APOPTOTIC DNA FRAGMENTATION,5.3256e-05,0.12999,0.139,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0059116,0.12994,0.13939,1,1
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.0991e-06,0.12989,0.14684,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0039481,0.12987,0.10523,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.001118,0.12986,0.11408,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00159,0.1298,0.10698,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00025617,0.12955,0.13814,1,1
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,1.5027e-08,0.12945,0.18415,1,1
5,GO DEPHOSPHORYLATION,2.9859e-05,0.12935,0.13347,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.0015038,0.12931,0.10836,1,1
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.03006,0.12919,0.1335,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,7.7586e-05,0.12915,0.12749,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0043184,0.12914,0.12534,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0044298,0.12902,0.17966,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.021053,0.12891,0.10363,1,1
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,7.7586e-05,0.12888,0.17188,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00012388,0.12886,0.14878,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.01829,0.1288,0.10919,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.8049e-05,0.12873,0.13454,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.037139,0.12872,0.10772,1,1
5,GO MITOTIC CELL CYCLE,0.00015838,0.12865,0.13121,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.011411,0.12855,0.10595,1,1
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.01995,0.12849,0.10635,1,1
5,GO OXIDATIVE DEMETHYLATION,0.0061347,0.12848,0.09826,1,1
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.004156,0.12844,0.16816,1,1
5,GO CELL MATURATION,1.2482e-05,0.12833,0.16692,1,1
5,GO RESPONSE TO LIGHT STIMULUS,8.7502e-06,0.12832,0.13756,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00024819,0.12817,0.11343,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00023667,0.12797,0.10796,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.00026858,0.12728,0.12986,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.008211,0.12724,0.096437,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.0003557,0.12709,0.1173,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00040857,0.12701,0.1261,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.0039992,0.12676,0.09948,1,1
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00067188,0.12665,0.18123,1,1
5,GO RESPONSE TO AMINO ACID STARVATION,0.00099681,0.12662,0.15003,1,1
5,GO REGULATION OF MITOTIC CELL CYCLE,5.8049e-05,0.12651,0.12713,1,1
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0021505,0.12637,0.11758,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00029976,0.12637,0.16221,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0059852,0.12636,0.11379,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.001776,0.12627,0.14228,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.033608,0.12626,0.1265,1,1
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00033955,0.1262,0.11948,1,1
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00039018,0.12609,0.15942,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.027401,0.12602,0.11502,1,1
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.064418,0.12598,0.097353,1,1
5,GO POSITIVE REGULATION OF MITOPHAGY,0.0075485,0.12566,0.12846,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0043184,0.12547,0.14024,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,3.4773e-06,0.12546,0.13714,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.014332,0.12544,0.10328,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00032408,0.12538,0.13668,1,1
5,GO CARDIAC CONDUCTION,0.0013255,0.12512,0.18118,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0032928,0.12507,0.11014,1,1
5,GO DNA METABOLIC PROCESS,7.8911e-05,0.125,0.12744,1,1
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.010041,0.1249,0.12871,1,1
5,GO CELL CYCLE PHASE TRANSITION,0.00059648,0.1249,0.11611,1,1
5,GO REGULATION OF PROTEIN SUMOYLATION,0.00013899,0.12489,0.15734,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,0.0013069,0.1246,0.13556,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,0.0061347,0.12457,0.15717,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.010041,0.12442,0.095044,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00099681,0.1244,0.14812,1,1
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.001422,0.12439,0.15867,1,1
5,GO RESPONSE TO UV,4.3997e-05,0.12429,0.14895,1,1
5,GO METANEPHROS DEVELOPMENT,0.017894,0.12426,0.12543,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0024609,0.12423,0.1481,1,1
5,GO REGULATION OF CELL MATURATION,0.0090315,0.12423,0.097742,1,1
5,GO CALCIUM ION IMPORT,0.011678,0.12422,0.1184,1,1
5,GO REGULATION OF GLIOGENESIS,3.4409e-05,0.12413,0.18092,1,1
5,GO NUCLEAR TRANSPORT,0.0024609,0.12412,0.11003,1,1
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.3381e-05,0.12384,0.1302,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.027686,0.12373,0.12299,1,1
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0074579,0.12363,0.12844,1,1
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0093576,0.12359,0.13909,1,1
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.0020092,0.12358,0.10709,1,1
5,GO OOCYTE MATURATION,0.045591,0.12338,0.12323,1,1
5,GO GLUCOSE IMPORT,0.0013069,0.12334,0.13057,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.058787,0.12326,0.10449,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.017315,0.12323,0.087267,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.024947,0.12295,0.12007,1,1
5,GO MACROMOLECULE DEACYLATION,5.5127e-05,0.12294,0.15826,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.031631,0.1227,0.12277,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,3.5646e-05,0.12258,0.17266,1,1
5,GO HISTONE MONOUBIQUITINATION,3.8246e-05,0.1225,0.16547,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,1.0361e-05,0.12237,0.14567,1,1
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.01585,0.12232,0.14722,1,1
5,GO ADAPTATION OF SIGNALING PATHWAY,0.043444,0.1222,0.099134,1,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.016386,0.1222,0.097374,1,1
5,GO PIRNA METABOLIC PROCESS,0.022446,0.12219,0.11149,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.037882,0.12213,0.080494,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0025617,0.12209,0.13255,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0025277,0.1219,0.10886,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0033799,0.12179,0.11159,1,1
5,GO CHEMOSENSORY BEHAVIOR,0.013394,0.12162,0.12083,1,1
5,GO METHYLATION,0.00015083,0.12157,0.13526,1,1
5,GO NUCLEOTIDE EXCISION REPAIR,0.024428,0.12145,0.077807,1,1
5,GO POSTREPLICATION REPAIR,0.0029256,0.12143,0.095583,1,1
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.040981,0.12119,0.13244,1,1
5,GO EXCRETION,0.0030436,0.12091,0.13649,1,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.7312e-05,0.12084,0.18198,1,1
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02915,0.12071,0.07405,1,1
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.046031,0.1207,0.10621,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.01128,0.12061,0.098432,1,1
5,GO PLACENTA DEVELOPMENT,0.022928,0.12058,0.10984,1,1
5,GO IMPORT INTO CELL,0.0052854,0.12054,0.13099,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.013394,0.12051,0.091879,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0037498,0.12047,0.10918,1,1
5,GO DNA REPLICATION INITIATION,0.00044103,0.12045,0.16709,1,1
5,GO CARBOHYDRATE PHOSPHORYLATION,0.013394,0.12009,0.13309,1,1
5,GO NEURON DEATH,0.00017741,0.12004,0.13289,1,1
5,GO PROTEIN SUMOYLATION,4.6359e-05,0.11999,0.15244,1,1
5,GO CHLORIDE TRANSPORT,0.00090088,0.11979,0.13433,1,1
5,GO RESPONSE TO IRON ION,0.019104,0.11975,0.13282,1,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.0024941,0.11969,0.10578,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.00080175,0.11968,0.11673,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0056958,0.11967,0.0965,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.013546,0.11958,0.10616,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0099244,0.11944,0.098114,1,1
5,GO CYTOSOLIC TRANSPORT,0.0033799,0.11937,0.11672,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.0074579,0.11936,0.092192,1,1
5,GO REGULATION OF TOR SIGNALING,6.3249e-05,0.11923,0.15649,1,1
5,GO IMPORT INTO NUCLEUS,0.0062877,0.1191,0.097311,1,1
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0089251,0.11887,0.093689,1,1
5,GO ESCRT COMPLEX DISASSEMBLY,0.02174,0.11883,0.12046,1,1
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.6924e-05,0.11872,0.13892,1,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0080166,0.11856,0.090859,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.001442,0.11854,0.1382,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.028556,0.11844,0.097418,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.038637,0.11842,0.13814,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00013899,0.1183,0.15621,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.0003557,0.11825,0.12792,1,1
5,GO ENDOSOMAL TRANSPORT,0.0067673,0.11788,0.097287,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.051595,0.11783,0.098054,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,3.4773e-06,0.11777,0.16294,1,1
5,GO NCRNA TRANSCRIPTION,0.01499,0.11776,0.086061,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.022686,0.11761,0.11479,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.031631,0.11739,0.078499,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00021857,0.11734,0.11808,1,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.00096848,0.1173,0.1328,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00018323,0.11717,0.12401,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,0.0005618,0.1171,0.11284,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0098086,0.11707,0.13779,1,1
5,GO ORGAN GROWTH,0.0057669,0.11699,0.10705,1,1
5,GO HEART PROCESS,0.0098086,0.11654,0.12142,1,1
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.03429,0.11639,0.069236,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.030368,0.11625,0.10477,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.045155,0.11608,0.085076,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.022209,0.11601,0.088336,1,1
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.011022,0.11599,0.096914,1,1
5,GO REGULATION OF SECRETION,0.00032916,0.11578,0.12944,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.021053,0.11559,0.085157,1,1
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.016752,0.11557,0.092161,1,1
5,GO CARDIAC CELL DEVELOPMENT,0.013093,0.11549,0.11302,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.047372,0.11532,0.10598,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.0067673,0.1153,0.089374,1,1
5,GO REGULATION OF DNA METABOLIC PROCESS,5.7059e-05,0.1153,0.13129,1,1
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.035336,0.11521,0.10704,1,1
5,GO PHOTOPERIODISM,4.7172e-05,0.11506,0.18326,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.023419,0.11493,0.10338,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0010113,0.11492,0.14563,1,1
5,GO REGULATION OF TRANSPORT,0.00083767,0.11491,0.10971,1,1
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.036409,0.11466,0.12267,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0018006,0.11457,0.14821,1,1
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0057669,0.11447,0.10852,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0040509,0.11446,0.10656,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0005133,0.1142,0.13515,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.0056255,0.11416,0.10115,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.049681,0.11414,0.081708,1,1
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00059648,0.11403,0.16353,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.0023321,0.11399,0.11286,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.016386,0.11394,0.11571,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.01128,0.11393,0.091381,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0039481,0.11392,0.10378,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075485,0.11378,0.15624,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.058247,0.11373,0.15027,1,1
5,GO REGULATION OF CELL AGING,0.015674,0.11369,0.11471,1,1
5,GO DNA DEALKYLATION,0.0038977,0.11351,0.13352,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.015329,0.1134,0.13117,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.00064263,0.11336,0.14632,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0020929,0.1131,0.10296,1,1
5,GO STRESS FIBER ASSEMBLY,0.032938,0.11309,0.11416,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.055609,0.11301,0.071859,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.0059116,0.11296,0.12239,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,0.00070238,0.11295,0.13707,1,1
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.01829,0.11291,0.06799,1,1
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0071918,0.11283,0.11173,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,8.1623e-05,0.11273,0.16558,1,1
5,GO SNRNA TRANSCRIPTION,0.0047798,0.11273,0.095586,1,1
5,GO RETINA HOMEOSTASIS,0.00019541,0.11265,0.1291,1,1
5,GO SKELETAL MUSCLE ADAPTATION,0.029754,0.11264,0.134,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.001568,0.11242,0.10111,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.03006,0.1124,0.12893,1,1
5,GO PEPTIDE SECRETION,0.0025277,0.11227,0.1119,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0025961,0.1121,0.13432,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0041031,0.11204,0.12115,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.024947,0.11202,0.12288,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00049053,0.11198,0.12296,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,2.2824e-05,0.11194,0.15514,1,1
5,GO MESODERM DEVELOPMENT,0.0034692,0.1119,0.10825,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.016752,0.11178,0.11411,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.041789,0.11174,0.10509,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011151,0.11171,0.10066,1,1
5,GO PROTEIN LOCALIZATION TO MEMBRANE,6.8888e-05,0.1116,0.09997,1,1
5,GO RNA 3 END PROCESSING,0.036409,0.11157,0.084678,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0016806,0.11153,0.12157,1,1
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.0958e-05,0.11146,0.13935,1,1
5,GO PIGMENTATION,0.023173,0.11132,0.091464,1,1
5,GO CELL MOTILITY,0.017506,0.11109,0.098995,1,1
5,GO RNA DECAPPING,0.035336,0.11106,0.08999,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.016938,0.11102,0.14903,1,1
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.0080166,0.111,0.11574,1,1
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.026838,0.11095,0.085109,1,1
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.049212,0.11094,0.13995,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.053071,0.11087,0.076535,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.019735,0.11077,0.097833,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00090088,0.11054,0.13474,1,1
5,GO RNA LOCALIZATION,0.025475,0.11054,0.082261,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00159,0.11052,0.10458,1,1
5,GO DNA METHYLATION,0.0005211,0.11049,0.13332,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00041488,0.1104,0.14019,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.017506,0.11028,0.28002,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.0039481,0.11026,0.098311,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.041383,0.1102,0.11991,1,1
5,GO RESPONSE TO RADIATION,0.00016629,0.11014,0.11378,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011813,0.11001,0.098046,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,0.0030839,0.10996,0.11486,1,1
5,GO DNA CATABOLIC PROCESS,8.5858e-05,0.10991,0.13305,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.0021798,0.10991,0.11418,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.023173,0.10983,0.19173,1,1
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0084096,0.1097,0.17356,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.016027,0.10954,0.12449,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00098255,0.10949,0.13842,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.0010113,0.10947,0.11914,1,1
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0066039,0.10943,0.14784,1,1
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0037985,0.10936,0.17043,1,1
5,GO MITOCHONDRIAL FISSION,0.044722,0.10914,0.075803,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0012705,0.10909,0.12162,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0056255,0.10891,0.096006,1,1
5,GO REGULATION OF BINDING,0.0025617,0.10889,0.10696,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0022396,0.10885,0.14303,1,1
5,GO STEM CELL DIFFERENTIATION,0.001955,0.10878,0.10586,1,1
5,GO RESPONSE TO STARVATION,0.00061456,0.1085,0.13057,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.017315,0.1085,0.092673,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0023009,0.10835,0.12707,1,1
5,GO SENSORY PERCEPTION,0.00014599,0.10835,0.12452,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.011949,0.10826,0.10946,1,1
5,GO ANIMAL ORGAN FORMATION,0.0047798,0.10805,0.14596,1,1
5,GO REGULATION OF NUCLEAR DIVISION,8.3013e-05,0.10805,0.13679,1,1
5,GO REGULATION OF BLOOD CIRCULATION,0.0055559,0.108,0.1311,1,1
5,GO DNA DEMETHYLATION,0.0024941,0.10777,0.15238,1,1
5,GO REGULATION OF PEPTIDE SECRETION,0.0032501,0.10763,0.10918,1,1
5,GO SKIN DEVELOPMENT,0.033271,0.1075,0.098407,1,1
5,GO INTRACELLULAR TRANSPORT,0.0070192,0.10746,0.079682,1,1
5,GO CARDIOCYTE DIFFERENTIATION,0.049212,0.10726,0.084482,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,6.1119e-05,0.10722,0.22081,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00015083,0.10712,0.12735,1,1
5,GO VACUOLAR TRANSPORT,0.014013,0.10708,0.095466,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.0019819,0.10704,0.11377,1,1
5,GO NOTCH SIGNALING PATHWAY,0.0063654,0.10693,0.12176,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0084096,0.10689,0.092563,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.016938,0.10686,0.099412,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.002631,0.10673,0.097254,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063314,0.10673,0.11222,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.0066851,0.1067,0.10518,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00041488,0.10649,0.18999,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.014172,0.10635,0.093254,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.023668,0.10592,0.090917,1,1
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0037985,0.10591,0.11517,1,1
5,GO RESPONSE TO AXON INJURY,0.0090315,0.10582,0.12848,1,1
5,GO TAXIS,0.0016122,0.10577,0.13068,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0075485,0.10574,0.080121,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.020166,0.10567,0.090079,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0030038,0.10561,0.098939,1,1
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.0013255,0.10558,0.12903,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0098086,0.10547,0.090999,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.042197,0.10535,0.077342,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0137,0.10533,0.11309,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00075607,0.10532,0.14188,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0019285,0.10502,0.10229,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.004156,0.105,0.10495,1,1
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0081133,0.10498,0.096002,1,1
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,1.2954e-05,0.10497,0.15559,1,1
5,GO MYOBLAST DIFFERENTIATION,0.031953,0.10497,0.085652,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.018693,0.10483,0.09899,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.043866,0.10483,0.11003,1,1
5,GO CELL CELL ADHESION,0.056652,0.10476,0.088565,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0019285,0.10473,0.1166,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.0055559,0.1047,0.11015,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0034243,0.10464,0.14331,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.046031,0.10461,0.089028,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0012705,0.10459,0.10883,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0066851,0.10453,0.10603,1,1
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.037509,0.10445,0.11895,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.010895,0.10441,0.1566,1,1
5,GO LIPID DROPLET ORGANIZATION,0.0034692,0.10425,0.13531,1,1
5,GO PEPTIDYL THREONINE MODIFICATION,0.00015838,0.10418,0.13852,1,1
5,GO RESPONSE TO SALT STRESS,0.028264,0.10414,0.10911,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.028264,0.10402,0.073443,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0018764,0.10402,0.10646,1,1
5,GO CELLULAR RESPONSE TO RADIATION,0.00034485,0.10392,0.10535,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.01849,0.10382,0.1214,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.013546,0.10341,0.081052,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.03006,0.10298,0.082682,1,1
5,GO CELL GROWTH,0.00025215,0.10288,0.13782,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035691,0.10277,0.076928,1,1
5,GO TOR SIGNALING,0.00020835,0.10254,0.13193,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.038637,0.10243,0.19687,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.006444,0.10226,0.10095,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.002631,0.10224,0.10711,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.012367,0.10219,0.094519,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0019023,0.10213,0.11305,1,1
5,GO BIOLOGICAL ADHESION,0.055093,0.10194,0.090275,1,1
5,GO CAMP METABOLIC PROCESS,0.035691,0.10172,0.13506,1,1
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.02174,0.10168,0.10739,1,1
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.012227,0.10162,0.071416,1,1
5,GO DNA MODIFICATION,0.00033432,0.10158,0.10842,1,1
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.028852,0.10155,0.1082,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.008211,0.10135,0.1006,1,1
5,GO EXOCYTIC PROCESS,0.056128,0.10133,0.10568,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0054872,0.10127,0.11355,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0098086,0.10109,0.088332,1,1
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.026286,0.10088,0.078704,1,1
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0083098,0.10087,0.093921,1,1
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.030994,0.10069,0.075262,1,1
5,GO EPIDERMIS DEVELOPMENT,0.028556,0.10056,0.09669,1,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.018693,0.10038,0.098471,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001118,0.10034,0.11656,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.018091,0.1003,0.12416,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.049681,0.10025,0.10389,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,0.0013255,0.10018,0.10966,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.034984,0.10017,0.069402,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0089251,0.099601,0.097017,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.027401,0.099509,0.15453,1,1
5,GO REGULATION OF HISTONE UBIQUITINATION,0.018091,0.099436,0.094595,1,1
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0039481,0.099341,0.078383,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0062877,0.099119,0.1217,1,1
5,GO RESPONSE TO X RAY,0.062114,0.098972,0.07558,1,1
5,GO REGULATION OF CELL SHAPE,0.019523,0.098572,0.11362,1,1
5,GO CIRCULATORY SYSTEM PROCESS,0.020385,0.098539,0.095576,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0086125,0.098269,0.082165,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0012886,0.098145,0.1118,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.019104,0.097889,0.11668,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.042197,0.097725,0.10105,1,1
5,GO METAL ION TRANSPORT,0.0021798,0.097647,0.11007,1,1
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.013546,0.097627,0.12832,1,1
5,GO RESPONSE TO ETHER,0.058247,0.097386,0.095959,1,1
5,GO HOMEOSTATIC PROCESS,0.01995,0.097271,0.072422,1,1
5,GO PHOTOTRANSDUCTION,0.0033799,0.097126,0.069932,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE,0.051111,0.097062,0.082316,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0088198,0.097047,0.093432,1,1
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.034984,0.096986,0.091257,1,1
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.018091,0.09697,0.10269,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0067673,0.096927,0.11002,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0084096,0.096794,0.12133,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0028118,0.096635,0.094029,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,0.00091404,0.096226,0.10591,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0038478,0.096037,0.16998,1,1
5,GO CATION TRANSPORT,0.0021798,0.095985,0.11169,1,1
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0010113,0.09598,0.1015,1,1
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0038977,0.095956,0.11101,1,1
5,GO LIPID MODIFICATION,0.018898,0.095799,0.089226,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0031247,0.095685,0.12725,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.027401,0.095525,0.08338,1,1
5,GO BILE ACID METABOLIC PROCESS,0.022209,0.094945,0.11046,1,1
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.001955,0.094796,0.097021,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00022565,0.094628,0.11807,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.038258,0.094297,0.10845,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.012087,0.0942,0.096911,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.011151,0.094133,0.099443,1,1
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00070238,0.094066,0.10674,1,1
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.058787,0.093867,0.11392,1,1
5,GO POLYOL METABOLIC PROCESS,0.057179,0.093645,0.083815,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046921,0.093592,0.10163,1,1
5,GO POSITIVE REGULATION OF BINDING,0.0081133,0.093569,0.091686,1,1
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.01499,0.093295,0.077321,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.003607,0.093245,0.098105,1,1
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.063258,0.093187,0.076201,1,1
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.063258,0.093076,0.099062,1,1
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.003166,0.092997,0.12079,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.063836,0.092977,0.069769,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.009139,0.092956,0.10483,1,1
5,GO SPINDLE MIDZONE ASSEMBLY,0.0096941,0.092904,0.14629,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.032607,0.092877,0.076717,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.0080166,0.092794,0.097099,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.023668,0.092758,0.092376,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.039406,0.092699,0.098501,1,1
5,GO REGULATION OF ION TRANSPORT,0.003607,0.092528,0.11531,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0019819,0.092379,0.095515,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.05063,0.092153,0.093441,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0042636,0.092139,0.10262,1,1
5,GO ENDOCRINE HORMONE SECRETION,0.056652,0.091962,0.074417,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.034636,0.091961,0.15308,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0013255,0.091929,0.10785,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.036409,0.091444,0.068804,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.010041,0.091439,0.1179,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.027973,0.091429,0.093318,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.0020929,0.091398,0.11671,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.024428,0.091296,0.086237,1,1
5,GO CELL RECOGNITION,0.0059852,0.09125,0.12037,1,1
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.029754,0.091024,0.07767,1,1
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.016386,0.090862,0.079182,1,1
5,GO BASE EXCISION REPAIR,0.0024281,0.090806,0.10592,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0086125,0.090607,0.10122,1,1
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.015501,0.090458,0.13244,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.025475,0.090293,0.10997,1,1
5,GO MUSCLE SYSTEM PROCESS,0.064418,0.089861,0.076333,1,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00026858,0.089758,0.13443,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,0.013093,0.089699,0.088121,1,1
5,GO MRNA METABOLIC PROCESS,0.01499,0.089444,0.079491,1,1
5,GO RESPONSE TO ESTRADIOL,0.0083098,0.089237,0.11179,1,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.016752,0.089207,0.11018,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.041383,0.089052,0.073167,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.02128,0.088795,0.083624,1,1
5,GO GENE SILENCING,0.00016098,0.088763,0.12574,1,1
5,GO ADAPTIVE THERMOGENESIS,0.046031,0.088711,0.078962,1,1
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0016347,0.088481,0.13099,1,1
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.031953,0.08844,0.07864,1,1
5,GO REGULATION OF ORGAN GROWTH,0.01849,0.088073,0.09639,1,1
5,GO RESPONSE TO PROSTAGLANDIN E,0.024428,0.087813,0.11341,1,1
5,GO NEGATIVE REGULATION OF GROWTH,0.025743,0.087387,0.091028,1,1
5,GO PROTEIN POLYMERIZATION,0.0025277,0.086967,0.11652,1,1
5,GO RESPONSE TO ACTIVITY,0.011813,0.086834,0.097147,1,1
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.01849,0.086808,0.13443,1,1
5,GO RESPONSE TO INSULIN,0.027118,0.08656,0.085629,1,1
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.03902,0.086545,0.068885,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.033948,0.086533,0.091425,1,1
5,GO CHEMICAL HOMEOSTASIS,0.03429,0.086488,0.07538,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.029754,0.086473,0.06846,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.021509,0.086446,0.079213,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00046872,0.086424,0.13096,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0038977,0.086303,0.087945,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.046921,0.086025,0.07911,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0022396,0.085745,0.11832,1,1
5,GO TRANSLESION SYNTHESIS,0.0098086,0.085744,0.094159,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.031953,0.085708,0.10528,1,1
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0098086,0.085662,0.10355,1,1
5,GO INORGANIC ANION TRANSPORT,0.015159,0.085655,0.088628,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0014624,0.085307,0.11671,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.007921,0.08529,0.10974,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.020605,0.08484,0.10409,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0050269,0.084817,0.11195,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.037882,0.084644,0.076496,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0070192,0.084535,0.10284,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.0019819,0.08427,0.14692,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.011544,0.084098,0.1057,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0054192,0.084086,0.089448,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.02915,0.083732,0.10003,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.012798,0.083566,0.12534,1,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.060432,0.083003,0.080081,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.015674,0.082947,0.095211,1,1
5,GO ION TRANSPORT,0.0062877,0.082862,0.0966,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.010279,0.082702,0.094322,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.024947,0.082688,0.13102,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0071051,0.082651,0.092107,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.044292,0.082495,0.11244,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.059879,0.082447,0.07439,1,1
5,GO TISSUE HOMEOSTASIS,0.058247,0.082301,0.073629,1,1
5,GO POSITIVE REGULATION OF SECRETION,0.0137,0.081645,0.09256,1,1
5,GO MEMBRANE ORGANIZATION,0.016205,0.081227,0.086257,1,1
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.05357,0.081054,0.10793,1,1
5,GO SPLEEN DEVELOPMENT,0.035336,0.080767,0.096212,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.034984,0.080078,0.078034,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.027686,0.08007,0.078155,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.01585,0.079807,0.082496,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.035691,0.07979,0.10465,1,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.063836,0.079764,0.07141,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.052575,0.07933,0.073973,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0066851,0.078636,0.11119,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0092477,0.078613,0.11195,1,1
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.045155,0.078382,0.095577,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.051111,0.0783,0.070582,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.053071,0.078184,0.11012,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.051111,0.078133,0.075731,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.034636,0.077823,0.061359,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0077327,0.077566,0.096545,1,1
5,GO APOPTOTIC PROCESS,0.047827,0.077379,0.066525,1,1
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020385,0.077378,0.068415,1,1
5,GO MUSCLE CONTRACTION,0.060988,0.07728,0.077488,1,1
5,GO DNA BIOSYNTHETIC PROCESS,0.037882,0.076991,0.065345,1,1
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.046031,0.076985,0.10389,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.01585,0.076907,0.097406,1,1
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.020166,0.076822,0.074984,1,1
5,GO PROTEIN STABILIZATION,0.058787,0.076424,0.064629,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.040981,0.07596,0.076149,1,1
5,GO CELLULAR RESPONSE TO PH,0.059879,0.075902,0.07083,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.016205,0.075848,0.082763,1,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.003166,0.075741,0.093263,1,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.057711,0.075473,0.081328,1,1
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0032078,0.075359,0.13257,1,1
5,GO TELOMERE ORGANIZATION,0.047372,0.075168,0.081593,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.034984,0.075097,0.072075,1,1
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.026013,0.074991,0.077723,1,1
5,GO REGULATION OF MACROAUTOPHAGY,0.0066851,0.07486,0.088631,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.036772,0.074532,0.070243,1,1
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.007921,0.074379,0.087354,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0019819,0.074313,0.096212,1,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.026013,0.074101,0.083912,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.054074,0.073081,0.077095,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.062684,0.072952,0.066931,1,1
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.003607,0.072143,0.097026,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.012653,0.07207,0.087874,1,1
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.020385,0.072066,0.13877,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.020605,0.071816,0.069272,1,1
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.0070192,0.07137,0.10049,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.062114,0.071349,0.10358,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.02128,0.071192,0.066623,1,1
5,GO TRACHEA MORPHOGENESIS,0.029754,0.07101,0.13709,1,1
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0024941,0.070904,0.10245,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0099244,0.070124,0.10029,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.047827,0.06968,0.069783,1,1
5,GO TEMPERATURE HOMEOSTASIS,0.023419,0.06932,0.08849,1,1
5,GO MITOPHAGY,0.01016,0.069168,0.10821,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.01995,0.069164,0.085809,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.037139,0.069047,0.082186,1,1
5,GO REGULATION OF AUTOPHAGY,0.031311,0.069025,0.071899,1,1
5,GO CELLULAR HOMEOSTASIS,0.058247,0.068759,0.058848,1,1
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.05357,0.067291,0.069871,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.055093,0.067055,0.067886,1,1
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.065596,0.066907,0.061443,1,1
5,GO CELLULAR SENESCENCE,0.02128,0.066533,0.096828,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.056128,0.06638,0.1361,1,1
5,GO DETECTION OF STIMULUS,0.013546,0.066235,0.074098,1,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.034636,0.0659,0.079067,1,1
5,GO RESPONSE TO PEPTIDE,0.059879,0.064685,0.072297,1,1
5,GO REGULATION OF PROTEIN TARGETING,0.047827,0.063876,0.076307,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.049681,0.063672,0.065427,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.048285,0.063033,0.077906,1,1
5,GO MACROAUTOPHAGY,0.028264,0.062892,0.071647,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.055609,0.06279,0.061763,1,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.031311,0.061415,0.072002,1,1
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.038258,0.06027,0.075115,1,1
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.061549,0.059644,0.095782,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.02174,0.059507,0.080627,1,1
5,GO REGULATION OF ATPASE ACTIVITY,0.018693,0.059181,0.073405,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.052575,0.05651,0.073699,1,1
5,GO BLASTOCYST DEVELOPMENT,0.035336,0.054638,0.059753,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.037509,0.054249,0.075465,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.055609,0.047725,0.075749,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.020166,0.040679,0.081091,1,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.03006,0.037347,0.083869,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.00048316,0.31852,0.33192,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.9844e-05,0.29035,0.27718,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.018693,0.28622,0.17895,1,0
5,GO RESPONSE TO FORSKOLIN,0.0040509,0.24911,0.24424,1,0
5,GO NOTOCHORD DEVELOPMENT,0.0077327,0.24133,0.20793,1,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0039992,0.23366,0.26271,1,0
5,GO SUCKLING BEHAVIOR,0.0044298,0.23023,0.24692,1,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00012804,0.22512,0.26961,1,0
5,GO CGMP METABOLIC PROCESS,0.0084096,0.2196,0.2246,1,0
5,GO CATECHOLAMINE UPTAKE,0.00069207,0.21768,0.23975,1,0
5,GO DENDRITIC TRANSPORT,1.7385e-05,0.21514,0.30935,1,0
5,GO COPULATION,0.0010558,0.21453,0.20334,1,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.013093,0.20952,0.12854,1,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0018006,0.20576,0.27723,1,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0034243,0.20186,0.23048,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0028872,0.20003,0.27395,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.013243,0.19785,0.15756,1,0
5,GO NEUROTRANSMITTER REUPTAKE,0.0021798,0.18897,0.19433,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.017699,0.18647,0.21438,1,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0012705,0.18315,0.17564,1,0
5,GO EPITHELIAL CELL CELL ADHESION,0.022686,0.18003,0.205,1,0
5,GO REVERSE CHOLESTEROL TRANSPORT,0.026013,0.17852,0.18367,1,0
5,GO MAINTENANCE OF CELL POLARITY,0.0099244,0.17657,0.16986,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.024687,0.17491,0.18322,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.003654,0.17064,0.17248,1,0
5,GO RESPONSE TO INSECTICIDE,0.021973,0.17007,0.19162,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00099681,0.16874,0.36665,1,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.017125,0.16609,0.25233,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.056652,0.16383,0.13226,1,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0062877,0.15878,0.20015,1,0
5,GO KERATINOCYTE DEVELOPMENT,0.041383,0.15771,0.22145,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.050154,0.15668,0.10338,1,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0066851,0.15573,0.16775,1,0
5,GO TRNA CATABOLIC PROCESS,0.058787,0.15455,0.1617,1,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.00159,0.1543,0.18445,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0046018,0.15279,0.15109,1,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.030994,0.14919,0.13571,1,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.00072342,0.14761,0.18113,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.037509,0.14699,0.13897,1,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.013546,0.14498,0.22205,1,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0080166,0.14401,0.18428,1,0
5,GO CARDIOBLAST DIFFERENTIATION,0.046921,0.14347,0.13622,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.044292,0.14253,0.16554,1,0
5,GO LIPOPROTEIN LOCALIZATION,0.02915,0.14051,0.11777,1,0
5,GO MEMBRANE FISSION,0.0018508,0.1388,0.18329,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.040582,0.13869,0.10337,1,0
5,GO NEPHRON DEVELOPMENT,0.0076401,0.13661,0.13941,1,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.03006,0.13555,0.13219,1,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.040582,0.13276,0.1415,1,0
5,GO BLASTODERM SEGMENTATION,0.037139,0.13226,0.15225,1,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.0043737,0.13168,0.21047,1,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.052083,0.13081,0.11784,1,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.032938,0.13037,0.12703,1,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.010041,0.12825,0.11187,1,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0046018,0.12725,0.2037,1,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.0050269,0.12702,0.20217,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.040981,0.12664,0.12245,1,0
5,GO REGULATION OF DOPAMINE SECRETION,0.008211,0.12627,0.29153,1,0
5,GO BRONCHUS DEVELOPMENT,0.018091,0.12478,0.22553,1,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.022686,0.12383,0.089557,1,0
5,GO AMINE TRANSPORT,0.00075607,0.12327,0.23926,1,0
5,GO LYMPHANGIOGENESIS,0.035336,0.12205,0.14324,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.059331,0.12075,0.082979,1,0
5,GO PYRUVATE METABOLIC PROCESS,0.021509,0.12023,0.095736,1,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.02915,0.11888,0.20021,1,0
5,GO MAGNESIUM ION TRANSPORT,0.038258,0.11887,0.1028,1,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.011411,0.11859,0.14844,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.065596,0.11739,0.090884,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.020166,0.11711,0.13188,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.040187,0.11586,0.1145,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.040582,0.11581,0.12408,1,0
5,GO PLASMA MEMBRANE TUBULATION,0.038637,0.11528,0.11353,1,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.001704,0.11497,0.1361,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.057711,0.11403,0.13542,1,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0055559,0.114,0.15955,1,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0050269,0.11375,0.19797,1,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.03902,0.11179,0.15465,1,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.01849,0.11133,0.10974,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.011813,0.10953,0.1522,1,0
5,GO N GLYCAN PROCESSING,0.02174,0.1093,0.17928,1,0
5,GO DENDRITE EXTENSION,0.0010558,0.10875,0.22676,1,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.023419,0.10863,0.13275,1,0
5,GO GLUTAMATE SECRETION,0.038637,0.10747,0.15284,1,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.018693,0.10648,0.18406,1,0
5,GO STRIATED MUSCLE ADAPTATION,0.033271,0.10519,0.10768,1,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.022686,0.10515,0.16962,1,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.024173,0.1048,0.073548,1,0
5,GO POSITIVE REGULATION OF MYELINATION,0.016938,0.1044,0.10705,1,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.011544,0.10335,0.13209,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.03068,0.10328,0.084089,1,0
5,GO WALKING BEHAVIOR,0.016386,0.10324,0.13657,1,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.058787,0.10255,0.15017,1,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.030994,0.10135,0.107,1,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.052083,0.10034,0.10022,1,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.032607,0.1001,0.13379,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.009139,0.10004,0.15615,1,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.029754,0.09994,0.11027,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023668,0.09872,0.15719,1,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.033271,0.098541,0.13652,1,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.062114,0.097359,0.092505,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011022,0.097115,0.086357,1,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0058389,0.096415,0.12609,1,0
5,GO APICAL JUNCTION ASSEMBLY,0.055093,0.093298,0.12551,1,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0084096,0.092721,0.088094,1,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.0063654,0.09228,0.1173,1,0
5,GO MRNA TRANSCRIPTION,0.034984,0.090377,0.11109,1,0
5,GO CARNITINE SHUTTLE,0.0065235,0.08956,0.18265,1,0
5,GO REGULATION OF CATABOLIC PROCESS,0.046921,0.086851,0.062977,1,0
5,GO ASTROCYTE DIFFERENTIATION,0.028852,0.08678,0.10933,1,0
5,GO MULTI ORGANISM LOCALIZATION,0.046921,0.086683,0.063588,1,0
5,GO CELL CELL JUNCTION ASSEMBLY,0.037509,0.086239,0.10952,1,0
5,GO RNA STABILIZATION,0.0068504,0.086202,0.12417,1,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.02915,0.085409,0.083759,1,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.043866,0.085061,0.15529,1,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.035691,0.084608,0.12322,1,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.054074,0.084557,0.1701,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.044722,0.082683,0.082827,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.060988,0.082068,0.10572,1,0
5,GO WATER HOMEOSTASIS,0.011949,0.081968,0.15067,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.030368,0.081581,0.14991,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.03902,0.080747,0.10925,1,0
5,GO PROTEIN MANNOSYLATION,0.065596,0.079508,0.10641,1,0
5,GO ACTION POTENTIAL,0.022446,0.078556,0.12638,1,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.031953,0.078493,0.094021,1,0
5,GO MYOFIBRIL ASSEMBLY,0.052575,0.077755,0.093158,1,0
5,GO REGULATION OF URINE VOLUME,0.027686,0.077387,0.10122,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.044292,0.075772,0.057548,1,0
5,GO CELLULAR RESPONSE TO ALKALOID,0.01995,0.075714,0.099732,1,0
5,GO REGULATION OF CARDIAC CONDUCTION,0.017506,0.075507,0.12804,1,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.055093,0.075041,0.097615,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.020605,0.072856,0.11634,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.020385,0.07258,0.081645,1,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.043866,0.071795,0.11886,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.043025,0.071573,0.13206,1,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.046474,0.070234,0.072973,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.062114,0.069784,0.091525,1,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.048285,0.068968,0.089469,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.046474,0.063934,0.078904,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.052575,0.063699,0.11316,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.03006,0.063434,0.10304,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.053071,0.061876,0.0558,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.031631,0.060724,0.081742,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.062114,0.060494,0.073618,1,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.056128,0.060259,0.073984,1,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.038258,0.05896,0.089223,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.043866,0.058586,0.077297,1,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.044722,0.057013,0.1333,1,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.058247,0.05499,0.10981,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.046474,0.0549,0.10139,1,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.037139,0.052855,0.083995,1,0
5,GO CALCIUM MEDIATED SIGNALING,0.035336,0.049766,0.067687,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.059879,0.04692,0.092593,1,0
5,GO SKELETAL MUSCLE CONTRACTION,0.022686,0.046623,0.12674,1,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.049681,0.045746,0.072219,1,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.039795,0.042989,0.10371,1,0
5,GO AMINO ACID TRANSPORT,0.054074,0.040669,0.096847,1,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.040981,0.036162,0.087146,1,0
5,GO REGULATION OF DENDRITE EXTENSION,0.056652,0.030675,0.19221,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.059331,-0.035071,-0.15561,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.007921,-0.039992,-0.15159,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.046031,-0.040269,-0.10934,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.022928,-0.041857,-0.092673,1,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.017506,-0.050053,-0.10977,1,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.029754,-0.05172,-0.097864,1,0
5,GO RIBOSOME ASSEMBLY,0.011678,-0.05285,-0.16038,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.042609,-0.05398,-0.13284,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,0.054582,-0.055699,-0.084367,1,0
5,GO NEUTROPHIL MIGRATION,0.03429,-0.056548,-0.090113,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.048746,-0.05742,-0.070108,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0075485,-0.060111,-0.15345,1,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.02174,-0.060122,-0.15054,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.051111,-0.060496,-0.13001,1,0
5,GO NEUTROPHIL CHEMOTAXIS,0.023419,-0.06074,-0.08651,1,0
5,GO RESPONSE TO INTERLEUKIN 7,0.062684,-0.061691,-0.071282,1,0
5,GO URONIC ACID METABOLIC PROCESS,0.050154,-0.062288,-0.076436,1,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.065005,-0.062728,-0.058534,1,0
5,GO NEGATIVE T CELL SELECTION,0.017894,-0.062921,-0.13527,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.037882,-0.064676,-0.094782,1,0
5,GO CYTOKINE METABOLIC PROCESS,0.046921,-0.065316,-0.098869,1,0
5,GO GRANULOCYTE MIGRATION,0.016205,-0.065419,-0.10449,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.01499,-0.06547,-0.118,1,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.059331,-0.065718,-0.090292,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.032278,-0.066231,-0.091294,1,0
5,GO RESPONSE TO MANGANESE ION,0.033271,-0.06739,-0.086441,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.036409,-0.067841,-0.10909,1,0
5,GO PROSTANOID METABOLIC PROCESS,0.059331,-0.069834,-0.14595,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.062114,-0.070526,-0.089276,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.021053,-0.070775,-0.10305,1,0
5,GO MATURATION OF LSU RRNA,0.056128,-0.072328,-0.14996,1,0
5,GO MITOCHONDRIAL TRANSLATION,0.0022701,-0.074219,-0.16975,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.051111,-0.074698,-0.15879,1,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.017699,-0.075627,-0.10698,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.045591,-0.077206,-0.076079,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.035336,-0.077908,-0.10106,1,0
5,GO INTERLEUKIN 13 PRODUCTION,0.052083,-0.078149,-0.16033,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.042609,-0.078638,-0.13531,1,0
5,GO RNA 5 END PROCESSING,0.028852,-0.078811,-0.13704,1,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.055093,-0.078908,-0.090304,1,0
5,GO AMP METABOLIC PROCESS,0.045155,-0.079822,-0.14855,1,0
5,GO INTERLEUKIN 2 PRODUCTION,0.027118,-0.080545,-0.10027,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.011678,-0.080953,-0.18123,1,0
5,GO CELLULAR DEFENSE RESPONSE,0.024687,-0.08119,-0.13412,1,0
5,GO LYTIC VACUOLE ORGANIZATION,0.057711,-0.081673,-0.066961,1,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.064418,-0.084017,-0.091407,1,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.043025,-0.084413,-0.079323,1,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.044722,-0.08475,-0.11059,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.060432,-0.084924,-0.13319,1,0
5,GO TRANSLATIONAL ELONGATION,0.0074579,-0.086614,-0.12791,1,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.029754,-0.088579,-0.118,1,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0030839,-0.088668,-0.13902,1,0
5,GO T CELL MEDIATED IMMUNITY,0.058247,-0.090607,-0.12626,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.063258,-0.090701,-0.12229,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.039795,-0.091287,-0.10096,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0088198,-0.091419,-0.15213,1,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.021973,-0.091814,-0.10167,1,0
5,GO REGULATION OF CELL KILLING,0.057179,-0.094052,-0.10715,1,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.043866,-0.094575,-0.14956,1,0
5,GO CD40 SIGNALING PATHWAY,0.044722,-0.094577,-0.11346,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.024947,-0.094878,-0.15215,1,0
5,GO GRANULOCYTE CHEMOTAXIS,0.014494,-0.095325,-0.10114,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.056652,-0.096046,-0.069287,1,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.022686,-0.096483,-0.13349,1,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017125,-0.097191,-0.077982,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.037882,-0.09731,-0.10211,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.036409,-0.097658,-0.13113,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.007921,-0.098797,-0.12981,1,0
5,GO COPPER ION HOMEOSTASIS,0.037509,-0.09897,-0.091776,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.051111,-0.099248,-0.079449,1,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.024428,-0.099583,-0.086768,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.060432,-0.10146,-0.098701,1,0
5,GO CELLULAR RESPIRATION,0.025743,-0.10231,-0.096878,1,0
5,GO B CELL PROLIFERATION,0.041789,-0.10248,-0.10328,1,0
5,GO PHAGOSOME MATURATION,0.050154,-0.10364,-0.077678,1,0
5,GO B CELL APOPTOTIC PROCESS,0.048746,-0.10391,-0.097268,1,0
5,GO CELL KILLING,0.046031,-0.10401,-0.092824,1,0
5,GO RESPONSE TO DSRNA,0.019312,-0.10458,-0.092025,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0051547,-0.10486,-0.148,1,0
5,GO TYPE 2 IMMUNE RESPONSE,0.036048,-0.10521,-0.15627,1,0
5,GO AEROBIC RESPIRATION,0.0095807,-0.10558,-0.11122,1,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.030994,-0.10624,-0.083473,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.025475,-0.10698,-0.12888,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0078263,-0.10699,-0.11411,1,0
5,GO HEME METABOLIC PROCESS,0.0078263,-0.10847,-0.16309,1,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0012177,-0.10898,-0.11652,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.034984,-0.10946,-0.10278,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.051595,-0.11002,-0.10426,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0098086,-0.11026,-0.14277,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0043737,-0.11171,-0.15717,1,0
5,GO TRANSLATIONAL TERMINATION,0.00042128,-0.11236,-0.19546,1,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0065235,-0.1132,-0.11245,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0054192,-0.11338,-0.18874,1,0
5,GO PROTEASOME ASSEMBLY,0.012367,-0.11352,-0.1214,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.026838,-0.1139,-0.14666,1,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0023637,-0.11414,-0.15366,1,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0098086,-0.11511,-0.14919,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.012367,-0.11513,-0.16114,1,0
5,GO PROTEIN TRIMERIZATION,0.043866,-0.11551,-0.099749,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.008211,-0.11555,-0.18523,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.056652,-0.11568,-0.096775,1,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.041383,-0.11633,-0.16521,1,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0075485,-0.11667,-0.12057,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.019523,-0.11706,-0.15894,1,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.062114,-0.1177,-0.09256,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.015329,-0.11899,-0.1196,1,0
5,GO TRNA 5 END PROCESSING,0.0042636,-0.11913,-0.14591,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.022446,-0.1198,-0.15474,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027401,-0.11991,-0.10984,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0137,-0.12067,-0.15729,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.039795,-0.12381,-0.10914,1,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.044292,-0.12508,-0.14158,1,0
5,GO INTERLEUKIN 8 PRODUCTION,0.0087156,-0.12557,-0.14715,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.031311,-0.12559,-0.15479,1,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.0047198,-0.1261,-0.13584,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.042609,-0.12611,-0.156,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0095807,-0.12657,-0.15414,1,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0077327,-0.12661,-0.14929,1,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.055093,-0.12695,-0.1303,1,0
5,GO NUCLEOTIDE SALVAGE,0.016027,-0.12856,-0.17047,1,0
5,GO LIPOXYGENASE PATHWAY,0.030994,-0.12919,-0.21454,1,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.03006,-0.12926,-0.14512,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.043025,-0.12944,-0.1288,1,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00073415,-0.13053,-0.16864,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0065235,-0.13093,-0.12375,1,0
5,GO COPPER ION TRANSPORT,0.008211,-0.13209,-0.1464,1,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0050904,-0.13261,-0.15159,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.02128,-0.13282,-0.12741,1,0
5,GO INTERLEUKIN 10 PRODUCTION,0.023919,-0.13333,-0.12264,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0028492,-0.13339,-0.1546,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.041383,-0.13344,-0.1593,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.042197,-0.13354,-0.13203,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.065596,-0.13388,-0.11352,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.01251,-0.13592,-0.13255,1,0
5,GO MONONUCLEAR CELL MIGRATION,0.0059852,-0.13744,-0.13824,1,0
5,GO OXIDATIVE PHOSPHORYLATION,0.00033432,-0.1376,-0.14047,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00029511,-0.13962,-0.20525,1,0
5,GO INTERFERON GAMMA PRODUCTION,0.0063654,-0.13999,-0.12227,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,0.051595,-0.14093,-0.082961,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0076401,-0.14191,-0.14091,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.018693,-0.14411,-0.19359,1,0
5,GO TRNA 5 LEADER REMOVAL,0.0020367,-0.14418,-0.1586,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.020828,-0.14632,-0.13602,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.056128,-0.14671,-0.10031,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0023009,-0.14872,-0.18849,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.00022208,-0.15006,-0.16788,1,0
5,GO ACTIN FILAMENT SEVERING,0.064418,-0.15031,-0.13646,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0062108,-0.15134,-0.15906,1,0
5,GO REGULATION OF BONE DEVELOPMENT,0.00055343,-0.1515,-0.15509,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.0063654,-0.15243,-0.19092,1,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.014494,-0.15301,-0.14812,1,0
5,GO VITAMIN D METABOLIC PROCESS,0.027686,-0.15304,-0.14304,1,0
5,GO RESPONSE TO PROTOZOAN,0.004156,-0.15374,-0.17901,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.05063,-0.15455,-0.13272,1,0
5,GO CELL REDOX HOMEOSTASIS,0.0013633,-0.15527,-0.14188,1,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.033608,-0.15584,-0.11136,1,0
5,GO ETHANOL METABOLIC PROCESS,0.03429,-0.15699,-0.14488,1,0
5,GO REGULATION OF B CELL PROLIFERATION,0.015501,-0.16027,-0.12801,1,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0083098,-0.16163,-0.14265,1,0
5,GO CERAMIDE CATABOLIC PROCESS,0.028264,-0.16402,-0.13674,1,0
5,GO VASODILATION,0.013243,-0.16424,-0.13993,1,0
5,GO GERMINAL CENTER FORMATION,0.042609,-0.16499,-0.17661,1,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0045438,-0.1652,-0.20292,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0094686,-0.16624,-0.1431,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0011668,-0.16646,-0.19015,1,0
5,GO DETECTION OF BIOTIC STIMULUS,0.041383,-0.16711,-0.14622,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0023009,-0.16779,-0.13266,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.01829,-0.16809,-0.25699,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.02915,-0.1685,-0.13934,1,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.010645,-0.1688,-0.2029,1,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.0005789,-0.17025,-0.17068,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0013443,-0.1709,-0.14754,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0068504,-0.17251,-0.17439,1,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00052901,-0.17264,-0.16714,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.010279,-0.17275,-0.14203,1,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.013243,-0.17322,-0.14783,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.048746,-0.17418,-0.16887,1,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.008211,-0.17609,-0.16129,1,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.011678,-0.17731,-0.13925,1,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.020828,-0.17806,-0.18626,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.020605,-0.17834,-0.1507,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,0.0010558,-0.18033,-0.17575,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.035336,-0.18164,-0.15789,1,0
5,GO GALACTOSE METABOLIC PROCESS,0.023419,-0.18211,-0.16923,1,0
5,GO HISTAMINE TRANSPORT,0.035691,-0.18291,-0.15301,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.047827,-0.18385,-0.12814,1,0
5,GO REGULATION OF MYOBLAST FUSION,0.043444,-0.18422,-0.13448,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.014823,-0.18443,-0.23147,1,0
5,GO RESPONSE TO INTERFERON ALPHA,0.052083,-0.185,-0.24601,1,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.021053,-0.18702,-0.16082,1,0
5,GO MONOCYTE CHEMOTAXIS,0.001955,-0.18775,-0.18403,1,0
5,GO REGULATION OF FIBRINOLYSIS,0.0019819,-0.18782,-0.21809,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0005789,-0.18875,-0.29733,1,0
5,GO FIBRINOLYSIS,0.0024281,-0.19727,-0.24038,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0045438,-0.19752,-0.25081,1,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00021511,-0.19778,-0.26353,1,0
5,GO RESPONSE TO EPINEPHRINE,0.044292,-0.19828,-0.15082,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.034984,-0.19974,-0.13551,1,0
5,GO PLASMINOGEN ACTIVATION,0.0023321,-0.20058,-0.22133,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.014658,-0.20076,-0.17182,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.015674,-0.20227,-0.25013,1,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0024941,-0.20301,-0.19127,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.036048,-0.20374,-0.19104,1,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.010279,-0.20592,-0.18753,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0059116,-0.20625,-0.23233,1,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.065596,-0.2067,-0.10699,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.011678,-0.20787,-0.20566,1,0
5,GO INTERLEUKIN 5 PRODUCTION,0.025475,-0.21035,-0.19672,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.038258,-0.21234,-0.28701,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0066851,-0.21349,-0.20747,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.019735,-0.2135,-0.18231,1,0
5,GO INTERLEUKIN 17 PRODUCTION,0.00040235,-0.21417,-0.20963,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,9.2585e-06,-0.21686,-0.22029,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0098086,-0.21918,-0.20331,1,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.033608,-0.2219,-0.21052,1,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.6562e-05,-0.22194,-0.28982,1,0
5,GO TROPHOBLAST CELL MIGRATION,0.001776,-0.22786,-0.21393,1,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.040981,-0.22788,-0.1384,1,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.013093,-0.22881,-0.18219,1,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.058247,-0.22929,-0.14027,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00029976,-0.2337,-0.23423,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.021053,-0.2352,-0.16142,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.049681,-0.23602,-0.1923,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.01016,-0.2395,-0.22123,1,0
5,GO HISTAMINE SECRETION,0.0085105,-0.24286,-0.22073,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0021215,-0.24324,-0.23475,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0037985,-0.24434,-0.24622,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.4184e-05,-0.24589,-0.3425,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,2.5424e-05,-0.24611,-0.23637,1,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.00092737,-0.24614,-0.16898,1,0
5,GO GLYCINE TRANSPORT,0.02945,-0.24655,-0.17442,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0018006,-0.24996,-0.24884,1,0
5,GO SIGNAL PEPTIDE PROCESSING,0.0005133,-0.25311,-0.19848,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.0020092,-0.25363,-0.22304,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0014624,-0.25452,-0.25146,1,0
5,GO CHRONIC INFLAMMATORY RESPONSE,3.3214e-05,-0.25801,-0.29335,1,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,9.1829e-05,-0.26363,-0.21676,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00023667,-0.2654,-0.25907,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0074579,-0.27073,-0.22454,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0050904,-0.272,-0.2595,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0012177,-0.27672,-0.27918,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0095807,-0.28138,-0.17508,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00032408,-0.28429,-0.29281,1,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.016205,-0.28677,-0.23145,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.024947,-0.29224,-0.26336,1,0
5,GO CYCLOOXYGENASE PATHWAY,0.014332,-0.29607,-0.19925,1,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.014494,-0.30382,-0.21901,1,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.046474,-0.30948,-0.17898,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,7.8911e-05,-0.31108,-0.30848,1,0
5,GO EOSINOPHIL MIGRATION,0.0017517,-0.32533,-0.22983,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0015463,-0.3264,-0.41574,1,0
5,GO FRUCTOSE METABOLIC PROCESS,0.046921,-0.32647,-0.1696,1,0
5,GO ETHANOL OXIDATION,0.00044781,-0.33009,-0.34312,1,0
5,GO RESPONSE TO INTERFERON BETA,0.00027716,-0.33506,-0.36696,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.0035146,-0.37468,-0.23212,1,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.056652,-0.41968,-0.2266,1,0
5,GO MUCUS SECRETION,0.00080175,-0.43148,-0.41429,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.10734,0.18914,0.1097,0,1
5,GO REFLEX,0.29689,0.18656,0.084653,0,1
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.071756,0.17604,0.12419,0,1
5,GO REGULATION OF VASCULOGENESIS,0.085497,0.17266,0.12725,0,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.29315,0.16437,0.10296,0,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.093126,0.164,0.12815,0,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.06986,0.15974,0.10893,0,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.078382,0.15843,0.12363,0,1
5,GO MITOTIC DNA REPLICATION,0.088486,0.15291,0.12243,0,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.13549,0.14888,0.091801,0,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.082591,0.14827,0.1275,0,1
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.086237,0.14714,0.07963,0,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.071756,0.14435,0.10183,0,1
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.086981,0.14281,0.090654,0,1
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.086237,0.14116,0.078929,0,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.090782,0.14027,0.10473,0,1
5,GO INTRACELLULAR STEROL TRANSPORT,0.081877,0.13983,0.11207,0,1
5,GO MITOCHONDRIAL DNA REPLICATION,0.65734,0.13978,0.01664,0,1
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.11367,0.13835,0.17393,0,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.074349,0.1383,0.20365,0,1
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.067397,0.13812,0.087734,0,1
5,GO QUINONE METABOLIC PROCESS,0.41203,0.13709,0.043258,0,1
5,GO ER OVERLOAD RESPONSE,0.12322,0.1369,0.091759,0,1
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.11183,0.13669,0.066573,0,1
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.12924,0.13628,0.12346,0,1
5,GO GRANULOCYTE DIFFERENTIATION,0.10912,0.13564,0.088792,0,1
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.066792,0.13484,0.10431,0,1
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.10471,0.13355,0.12973,0,1
5,GO RRNA TRANSCRIPTION,0.37173,0.13247,0.029056,0,1
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.091558,0.13173,0.10456,0,1
5,GO NOTCH RECEPTOR PROCESSING,0.093918,0.12919,0.10947,0,1
5,GO KERATINOCYTE PROLIFERATION,0.11002,0.1283,0.09599,0,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.11647,0.12828,0.10731,0,1
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.071119,0.12623,0.076666,0,1
5,GO CYTOPLASM ORGANIZATION,0.10646,0.12604,0.10918,0,1
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.11837,0.12284,0.11965,0,1
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.17029,0.12134,0.076657,0,1
5,GO MANNOSYLATION,0.1313,0.11849,0.075956,0,1
5,GO RESPONSE TO WATER,0.075674,0.11797,0.11763,0,1
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.19697,0.11752,0.086227,0,1
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.074349,0.11626,0.069618,0,1
5,GO MUSCLE CELL MIGRATION,0.11933,0.11602,0.082994,0,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.29877,0.11592,0.049227,0,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.068619,0.1157,0.10031,0,1
5,GO LIPID HOMEOSTASIS,0.08331,0.11529,0.075734,0,1
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.093918,0.11438,0.07014,0,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.073694,0.11319,0.094699,0,1
5,GO RECEPTOR RECYCLING,0.13979,0.11243,0.06324,0,1
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.071756,0.1122,0.13113,0,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.072397,0.11198,0.10956,0,1
5,GO RNA INTERFERENCE,0.11647,0.11182,0.077218,0,1
5,GO REGULATION OF MAPK CASCADE,0.070488,0.11136,0.070843,0,1
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.29877,0.11073,0.045757,0,1
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.4451,0.10889,0.034073,0,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.084763,0.10885,0.10026,0,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.40058,0.10851,0.024687,0,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.069238,0.10838,0.070281,0,1
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.19003,0.10836,0.068653,0,1
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.22658,0.10788,0.075474,0,1
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.15565,0.10781,0.12469,0,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.20554,0.10775,0.061655,0,1
5,GO REGULATORY T CELL DIFFERENTIATION,0.18194,0.10682,0.08333,0,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.61117,0.10656,0.0096139,0,1
5,GO C4 DICARBOXYLATE TRANSPORT,0.10299,0.10621,0.091421,0,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.082591,0.10613,0.092362,0,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.18866,0.10607,0.095954,0,1
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.20554,0.10596,0.090239,0,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.088486,0.10566,0.090787,0,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14869,0.10549,0.078931,0,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.11837,0.10508,0.068842,0,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.1754,0.10484,0.056297,0,1
5,GO FIBROBLAST MIGRATION,0.077018,0.10459,0.085543,0,1
5,GO AORTA DEVELOPMENT,0.1387,0.10457,0.09083,0,1
5,GO SHORT TERM MEMORY,0.10558,0.10395,0.094794,0,1
5,GO BONE GROWTH,0.073694,0.10357,0.13037,0,1
5,GO VASCULATURE DEVELOPMENT,0.077018,0.10287,0.078648,0,1
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.078382,0.10211,0.086256,0,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.072397,0.10155,0.061562,0,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.19697,0.10101,0.083179,0,1
5,GO REGULATION OF FATTY ACID TRANSPORT,0.073694,0.10052,0.083937,0,1
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.23445,0.10045,0.062732,0,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.10385,0.10019,0.10773,0,1
5,GO REGULATION OF LIPID STORAGE,0.089246,0.099722,0.083138,0,1
5,GO RNA SURVEILLANCE,0.69286,0.099363,0.003185,0,1
5,GO RESPONSE TO STEROID HORMONE,0.076344,0.099228,0.072279,0,1
5,GO SEQUESTERING OF TRIGLYCERIDE,0.30066,0.098469,0.088173,0,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.13444,0.098335,0.065898,0,1
5,GO FEVER GENERATION,0.27317,0.098066,0.068669,0,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.1313,0.097774,0.11791,0,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.39832,0.097648,0.060056,0,1
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.1453,0.097323,0.054783,0,1
5,GO RESPONSE TO FATTY ACID,0.14308,0.097264,0.063505,0,1
5,GO OSTEOBLAST DIFFERENTIATION,0.17669,0.097242,0.057162,0,1
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.26964,0.096392,0.065249,0,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.085497,0.095582,0.067513,0,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.34008,0.09536,0.051738,0,1
5,GO ENDOTHELIAL CELL PROLIFERATION,0.16904,0.095028,0.07591,0,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.26789,0.09457,0.053985,0,1
5,GO VESICLE ORGANIZATION,0.21587,0.094543,0.048811,0,1
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.38267,0.094492,0.029893,0,1
5,GO RESPONSE TO HORMONE,0.071756,0.09423,0.069188,0,1
5,GO DOPAMINE METABOLIC PROCESS,0.068619,0.0941,0.13688,0,1
5,GO OSSIFICATION,0.10471,0.092101,0.069253,0,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.31021,0.091899,0.028002,0,1
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.18194,0.091812,0.070127,0,1
5,GO MYELOID CELL HOMEOSTASIS,0.15098,0.091657,0.069872,0,1
5,GO REGULATION OF PROTEIN BINDING,0.080464,0.091545,0.077852,0,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.20122,0.09152,0.057742,0,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.10646,0.091438,0.058674,0,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.10558,0.091385,0.083707,0,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.10214,0.091038,0.068605,0,1
5,GO RESPONSE TO VITAMIN D,0.10214,0.090349,0.10419,0,1
5,GO RESPONSE TO ALCOHOL,0.077698,0.090312,0.07079,0,1
5,GO RESPONSE TO METAL ION,0.11647,0.090126,0.06145,0,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.10912,0.089924,0.062751,0,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.08331,0.089868,0.065233,0,1
5,GO MYOTUBE DIFFERENTIATION,0.093918,0.088963,0.089094,0,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.10734,0.088741,0.068389,0,1
5,GO GENITALIA DEVELOPMENT,0.17669,0.088162,0.064894,0,1
5,GO GLYCOSYLATION,0.23605,0.087337,0.04142,0,1
5,GO AORTIC VALVE DEVELOPMENT,0.53406,0.08702,0.036665,0,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.14419,0.086665,0.064379,0,1
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.18461,0.086359,0.076786,0,1
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.091558,0.08615,0.058687,0,1
5,GO THIOESTER METABOLIC PROCESS,0.73212,0.085347,-0.0016977,0,1
5,GO LAMELLIPODIUM ORGANIZATION,0.22348,0.085148,0.058966,0,1
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.11553,0.085001,0.14895,0,1
5,GO HISTONE MRNA METABOLIC PROCESS,0.1914,0.084495,0.04114,0,1
5,GO AMELOGENESIS,0.066792,0.084136,0.12965,0,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.10214,0.083866,0.070338,0,1
5,GO RNA PROCESSING,0.089246,0.083724,0.064076,0,1
5,GO CARTILAGE DEVELOPMENT,0.10734,0.083567,0.073564,0,1
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.15683,0.083077,0.056443,0,1
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.1793,0.082869,0.043696,0,1
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.13234,0.082841,0.077763,0,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.089246,0.081859,0.068566,0,1
5,GO NUCLEOTIDE TRANSPORT,0.44752,0.081684,0.043579,0,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.12322,0.081421,0.074879,0,1
5,GO PROTEIN IMPORT,0.10385,0.081378,0.062735,0,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.19003,0.081331,0.079983,0,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.096327,0.079778,0.077134,0,1
5,GO ENDOSOME ORGANIZATION,0.12924,0.079709,0.056966,0,1
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.073043,0.079622,0.065209,0,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.098784,0.079163,0.060631,0,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.19697,0.079012,0.069591,0,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.6515,0.078684,0.02556,0,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.10214,0.077424,0.072142,0,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.57476,0.077241,0.017686,0,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.096327,0.076927,0.073752,0,1
5,GO RESPONSE TO UV C,0.094715,0.07678,0.084767,0,1
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.13338,0.076734,0.061892,0,1
5,GO ATP TRANSPORT,0.20699,0.076717,0.077078,0,1
5,GO ENDOCYTOSIS,0.073043,0.075996,0.075803,0,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.52874,0.075979,0.026678,0,1
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.20265,0.075742,0.049769,0,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.27853,0.075176,0.046287,0,1
5,GO RESPONSE TO DRUG,0.16778,0.074166,0.054215,0,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.18194,0.074138,0.076603,0,1
5,GO RESPONSE TO KETONE,0.081877,0.07411,0.072021,0,1
5,GO REGULATION OF CELL DEATH,0.082591,0.073909,0.061517,0,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.20409,0.073343,0.042406,0,1
5,GO REGULATION OF OSSIFICATION,0.1873,0.073295,0.062666,0,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.22348,0.07328,0.055035,0,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.075674,0.073102,0.068154,0,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.068619,0.072662,0.074855,0,1
5,GO ION HOMEOSTASIS,0.086237,0.071863,0.059492,0,1
5,GO RESPONSE TO MECHANICAL STIMULUS,0.19278,0.070085,0.065289,0,1
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.20122,0.070026,0.074894,0,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.10558,0.06973,0.073054,0,1
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.50776,0.069457,0.033269,0,1
5,GO RESPONSE TO PROSTAGLANDIN,0.089246,0.069421,0.090027,0,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.1873,0.069391,0.045536,0,1
5,GO COBALAMIN METABOLIC PROCESS,0.11933,0.06933,0.070527,0,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.087731,0.069237,0.068143,0,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.1533,0.068965,0.067418,0,1
5,GO CELLULAR RESPONSE TO IRON ION,0.28033,0.068738,0.067152,0,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.18866,0.068683,0.073478,0,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.16042,0.068663,0.054891,0,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.08331,0.068269,0.057286,0,1
5,GO GOLGI TO ENDOSOME TRANSPORT,0.27673,0.06731,0.054056,0,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.25924,0.06639,0.046473,0,1
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.15921,0.066346,0.05834,0,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.42838,0.065637,0.070567,0,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.067397,0.064851,0.073779,0,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.073694,0.064565,0.075408,0,1
5,GO MESODERMAL CELL DIFFERENTIATION,0.31997,0.064101,0.041129,0,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.63408,0.063755,0.0086375,0,1
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.12924,0.062664,0.062409,0,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.1262,0.06206,0.061859,0,1
5,GO PROTEIN TETRAMERIZATION,0.084034,0.061852,0.057262,0,1
5,GO OSTEOCLAST DIFFERENTIATION,0.30066,0.061738,0.053621,0,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.28213,0.061436,0.048987,0,1
5,GO RESPONSE TO SALT,0.22658,0.06054,0.049601,0,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.1387,0.060244,0.074216,0,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.093918,0.059352,0.078992,0,1
5,GO LIPID METABOLIC PROCESS,0.24416,0.059151,0.042179,0,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.093918,0.058863,0.057994,0,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.10045,0.058521,0.070452,0,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.23445,0.05796,0.080691,0,1
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.098784,0.057711,0.081082,0,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.1453,0.057181,0.046496,0,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.10214,0.057133,0.060067,0,1
5,GO RUFFLE ASSEMBLY,0.13549,0.056665,0.078918,0,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.24745,0.056466,0.050725,0,1
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.71391,0.055258,0.016642,0,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.19557,0.054892,0.066278,0,1
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.072397,0.054877,0.053137,0,1
5,GO MUSCLE ADAPTATION,0.36741,0.054393,0.043907,0,1
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.16285,0.053948,0.046739,0,1
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.13027,0.052711,0.11619,0,1
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.34835,0.051796,0.057217,0,1
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.17411,0.051063,0.062171,0,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.28213,0.050704,0.03909,0,1
5,GO POSITIVE REGULATION OF URINE VOLUME,0.21587,0.050572,0.064517,0,1
5,GO T CELL HOMEOSTASIS,0.38933,0.04998,0.049155,0,1
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.12721,0.049928,0.067133,0,1
5,GO SECRETION,0.25078,0.049845,0.04414,0,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.48976,0.049651,0.033296,0,1
5,GO GLUCOSE METABOLIC PROCESS,0.10299,0.047659,0.07025,0,1
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.96284,0.046246,-0.0030609,0,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.14197,0.04621,0.063448,0,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.28395,0.045497,0.054312,0,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.20554,0.041654,0.048918,0,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.23286,0.041609,0.045605,0,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.24252,0.040027,0.047943,0,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.43075,0.038852,0.031696,0,1
5,GO RESPONSE TO NITRIC OXIDE,0.49487,0.038196,0.033711,0,1
5,GO PROTEIN AUTOPROCESSING,0.37827,0.036326,0.044708,0,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.55558,0.035673,0.030327,0,1
5,GO ACTIVATED T CELL PROLIFERATION,0.60834,0.035386,0.045211,0,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.50516,0.030559,0.025249,0,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.20554,0.029918,0.082349,0,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.21288,0.020745,0.056013,0,1
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0002443,0.46307,0.41725,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,2.971e-06,0.42833,0.52496,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00081356,0.32697,0.31806,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.01585,0.32489,0.38791,0,0
5,GO GROWTH HORMONE SECRETION,5.1304e-06,0.31687,0.40597,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,9.6562e-05,0.30017,0.38523,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.00040235,0.28332,0.28911,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.00023667,0.28189,0.3591,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.001235,0.28143,0.27106,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.8839e-05,0.27432,0.2831,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.027973,0.2703,0.32448,0,0
5,GO NEURAL RETINA DEVELOPMENT,3.4296e-07,0.2676,0.30109,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,5.7582e-06,0.25799,0.30913,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00046165,0.25626,0.28508,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,2.7452e-06,0.25302,0.31664,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.00014599,0.24177,0.27003,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.080464,0.23899,0.15234,0,0
5,GO SEGMENT SPECIFICATION,0.00020504,0.23708,0.28063,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0011021,0.23628,0.24005,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.0095807,0.23391,0.25942,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.0018508,0.23205,0.27336,0,0
5,GO MICROTUBULE SEVERING,3.2859e-07,0.22979,0.28827,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0010113,0.22607,0.23446,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0021215,0.22354,0.24911,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,5.7051e-07,0.22012,0.25714,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,1.2534e-06,0.21774,0.22141,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0104,0.21337,0.25249,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.001776,0.21051,0.19021,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.067397,0.21001,0.28679,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,7.8911e-05,0.20981,0.21703,0,0
5,GO REGULATION OF PLATELET AGGREGATION,0.17283,0.20931,0.11942,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00082553,0.20701,0.23908,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0052197,0.20512,0.32291,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.031953,0.20315,0.14148,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.1252,0.20229,0.13511,0,0
5,GO CELL FATE DETERMINATION,0.0072795,0.20064,0.15366,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.00038422,0.20012,0.25514,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0042636,0.20009,0.18917,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.001422,0.19892,0.21023,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,9.0235e-07,0.19882,0.29644,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.038637,0.19731,0.25988,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,4.0314e-05,0.1965,0.24179,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.016205,0.18794,0.15285,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,2.8814e-05,0.18787,0.21583,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.00068191,0.18614,0.26753,0,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.19003,0.18595,0.075101,0,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.081168,0.18473,0.14153,0,0
5,GO INCLUSION BODY ASSEMBLY,0.0066039,0.1811,0.19478,0,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.073043,0.18098,0.12935,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0070192,0.17823,0.15252,0,0
5,GO REGULATION OF BEHAVIOR,6.2175e-05,0.16727,0.19022,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.1252,0.16651,0.17798,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0011668,0.1659,0.23126,0,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0005789,0.16384,0.24711,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.11275,0.1637,0.12721,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.069238,0.16288,0.1784,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.1873,0.16242,0.11116,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.0012527,0.16068,0.20365,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.31997,0.1589,0.048485,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.00019541,0.15777,0.17784,0,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.19697,0.15546,0.11476,0,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.14197,0.15414,0.1003,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.022928,0.15288,0.19288,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.1252,0.14923,0.1059,0,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.094715,0.14836,0.095045,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0010865,0.14809,0.15752,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.021509,0.14809,0.15855,0,0
5,GO RESPONSE TO GLUCAGON,0.00012594,0.14782,0.19591,0,0
5,GO BONE MATURATION,0.00041488,0.14503,0.20588,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.28761,0.14483,0.073526,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.01829,0.14473,0.16331,0,0
5,GO MALE MEIOSIS I,0.02915,0.14395,0.16492,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.01128,0.14285,0.18831,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.074349,0.14215,0.16505,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.072397,0.14202,0.11147,0,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00016629,0.13906,0.18415,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.024687,0.1387,0.20992,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.48722,0.1382,0.067712,0,0
5,GO ARTERY DEVELOPMENT,0.08331,0.13757,0.091796,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.096327,0.13737,0.082468,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.35463,0.13653,0.062476,0,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.39606,0.13626,0.038484,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.1754,0.13616,0.14542,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.0043184,0.13498,0.15563,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0095807,0.13474,0.18001,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.13763,0.13363,0.058364,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.15683,0.13333,0.081979,0,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.21587,0.1326,0.087683,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.018091,0.13253,0.16157,0,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.19697,0.13,0.09724,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.035336,0.1297,0.11928,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.078382,0.1292,0.14568,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.003166,0.12904,0.18039,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0089251,0.12893,0.13794,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.050154,0.12865,0.175,0,0
5,GO RENAL ABSORPTION,0.26267,0.12688,0.10291,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0099244,0.12688,0.19943,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.073694,0.12612,0.1104,0,0
5,GO NEUROBLAST DIVISION,0.10823,0.1256,0.1243,0,0
5,GO CELL AGGREGATION,0.012653,0.12557,0.12956,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0013069,0.12522,0.19566,0,0
5,GO ALANINE TRANSPORT,0.19278,0.12497,0.090402,0,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.2114,0.12476,0.086292,0,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.7814,0.12393,0.023752,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.073043,0.12386,0.14368,0,0
5,GO REGULATION OF OOGENESIS,0.0040509,0.12384,0.11703,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.092339,0.12344,0.094877,0,0
5,GO PARTURITION,0.062684,0.12324,0.1008,0,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.2913,0.1229,0.10051,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.14419,0.12246,0.15044,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.023668,0.1222,0.15236,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.093918,0.12133,0.16019,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.014172,0.12125,0.17348,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.013394,0.12109,0.17376,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.037509,0.12081,0.14412,0,0
5,GO LIVER MORPHOGENESIS,0.078382,0.12079,0.097889,0,0
5,GO RESPONSE TO CATECHOLAMINE,0.0019285,0.11989,0.14421,0,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.081168,0.11888,0.17195,0,0
5,GO SKIN MORPHOGENESIS,0.318,0.11876,0.078491,0,0
5,GO RESPONSE TO COLD,0.11933,0.11862,0.078751,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.11553,0.11842,0.17139,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.091558,0.11823,0.083434,0,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.37608,0.11757,0.04935,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.13763,0.11756,0.112,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.0018006,0.1161,0.14445,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.068619,0.11604,0.11904,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.054582,0.116,0.10518,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.10734,0.11576,0.11815,0,0
5,GO MICROVILLUS ASSEMBLY,0.21889,0.11547,0.10169,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.015159,0.11536,0.12292,0,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.073694,0.11482,0.16485,0,0
5,GO DIET INDUCED THERMOGENESIS,0.30066,0.1145,0.048158,0,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.89526,0.11448,-0.0013744,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00030449,0.11384,0.16438,0,0
5,GO CELL MATRIX ADHESION,0.14869,0.1136,0.081425,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.041789,0.11276,0.1865,0,0
5,GO STEROID HORMONE SECRETION,0.11647,0.11236,0.084224,0,0
5,GO REGULATION OF CELL MATRIX ADHESION,0.17156,0.11215,0.089228,0,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.093918,0.11164,0.12024,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.32792,0.11137,0.04259,0,0
5,GO BODY MORPHOGENESIS,0.027686,0.11113,0.12391,0,0
5,GO RESPONSE TO INACTIVITY,0.13549,0.11098,0.11253,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.34008,0.11097,0.10353,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.066192,0.11029,0.10342,0,0
5,GO LIPID OXIDATION,0.20845,0.11012,0.051628,0,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.28761,0.10973,0.075931,0,0
5,GO VITAMIN CATABOLIC PROCESS,0.046031,0.10966,0.26716,0,0
5,GO REGULATION OF DNA METHYLATION,0.15802,0.10948,0.063047,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.22195,0.10946,0.098828,0,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.27317,0.10921,0.07891,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.01251,0.10878,0.1359,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.15565,0.10816,0.096987,0,0
5,GO RHYTHMIC BEHAVIOR,0.0037016,0.10801,0.12946,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.003607,0.10787,0.11492,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.30637,0.10742,0.069837,0,0
5,GO DETECTION OF CALCIUM ION,0.073043,0.1073,0.15503,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.15683,0.10694,0.10327,0,0
5,GO DORSAL AORTA DEVELOPMENT,0.11367,0.10652,0.12604,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.040582,0.10637,0.10044,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.080464,0.1062,0.12363,0,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.095518,0.10552,0.0859,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.1262,0.10504,0.090172,0,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.24416,0.10484,0.093421,0,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.36526,0.10466,0.065874,0,0
5,GO PHOSPHOLIPID TRANSPORT,0.11275,0.10459,0.074557,0,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.24089,0.10421,0.071045,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.50516,0.10402,0.064813,0,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.23766,0.10393,0.13931,0,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.1533,0.1036,0.13315,0,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.10646,0.10348,0.076739,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.23927,0.10342,0.073573,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.026838,0.10339,0.11087,0,0
5,GO AUTOPHAGY OF NUCLEUS,0.31021,0.10331,0.057477,0,0
5,GO PODOSOME ASSEMBLY,0.1313,0.1033,0.11899,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.06986,0.10326,0.10126,0,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.003607,0.10315,0.12554,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.1387,0.1029,0.098361,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10823,0.10224,0.069813,0,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.016752,0.10222,0.11853,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.02174,0.1011,0.13259,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.18327,0.10104,0.04749,0,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.18327,0.10086,0.07928,0,0
5,GO HORMONE CATABOLIC PROCESS,0.50776,0.10084,0.040319,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.00087508,0.10067,0.13214,0,0
5,GO STEROL HOMEOSTASIS,0.12822,0.10028,0.068714,0,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.31997,0.10027,0.068013,0,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.16904,0.10017,0.10776,0,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.10045,0.099887,0.11362,0,0
5,GO OSTEOBLAST PROLIFERATION,0.34213,0.099329,0.072761,0,0
5,GO EPIBOLY,0.50258,0.099088,0.03726,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.099614,0.099071,0.066558,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.19979,0.099049,0.06415,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.10912,0.098485,0.10962,0,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.16042,0.098207,0.082279,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.016027,0.097395,0.16552,0,0
5,GO NEURONAL ACTION POTENTIAL,0.10129,0.097369,0.12458,0,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.26964,0.097247,0.069373,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.21738,0.09714,0.10927,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0098086,0.096927,0.11872,0,0
5,GO VIRAL LATENCY,0.1262,0.096899,0.082417,0,0
5,GO RESPONSE TO CAFFEINE,0.1793,0.096844,0.072927,0,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.68689,0.096512,0.057502,0,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.28761,0.096465,0.051961,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.50516,0.096445,0.025577,0,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.069238,0.096123,0.089652,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.041383,0.095977,0.11509,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.10912,0.095683,0.097572,0,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.13979,0.095488,0.13676,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.1313,0.095147,0.17331,0,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.10646,0.094646,0.070008,0,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.12721,0.094622,0.16255,0,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29689,0.094387,0.073657,0,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.16163,0.09438,0.081645,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.17411,0.093827,0.061788,0,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.20845,0.093395,0.061911,0,0
5,GO ERBB SIGNALING PATHWAY,0.13234,0.093368,0.068507,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.13656,0.092748,0.086004,0,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.27673,0.092699,0.054307,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.20554,0.092687,0.13717,0,0
5,GO TRNA METHYLATION,0.53406,0.092648,0.018208,0,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.082591,0.091961,0.0903,0,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.16904,0.091805,0.065875,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.078382,0.091782,0.061283,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.092339,0.091705,0.080986,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.12822,0.091704,0.097174,0,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.87606,0.091525,-0.0031982,0,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.45482,0.091506,0.043253,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.028264,0.091092,0.14442,0,0
5,GO SPROUTING ANGIOGENESIS,0.16904,0.090309,0.072073,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.27673,0.090232,0.088139,0,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.070488,0.089015,0.12605,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.062684,0.088906,0.15122,0,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.16654,0.088865,0.072428,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.21587,0.088436,0.08252,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.020166,0.088176,0.099334,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.071756,0.087935,0.062297,0,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.16285,0.087274,0.12187,0,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.49231,0.086899,0.024987,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.14419,0.086574,0.073577,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,9.4959e-05,0.086272,0.14357,0,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.17156,0.085986,0.078759,0,0
5,GO REGULATION OF HEART GROWTH,0.12322,0.085638,0.075285,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.11002,0.085544,0.047446,0,0
5,GO RESPONSE TO OXYGEN LEVELS,0.35463,0.085456,0.039341,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.1252,0.085327,0.066428,0,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.27853,0.084902,0.053342,0,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11837,0.084898,0.075151,0,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.19979,0.084804,0.065588,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.13656,0.084636,0.095496,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.21738,0.084562,0.070888,0,0
5,GO STEROL TRANSPORT,0.33599,0.084463,0.045193,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.42367,0.084455,0.056695,0,0
5,GO REGULATION OF GTP BINDING,0.039406,0.08422,0.15193,0,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.1146,0.084178,0.089136,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.15802,0.084024,0.063327,0,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.39381,0.083869,0.046128,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.10734,0.083724,0.07701,0,0
5,GO SNARE COMPLEX ASSEMBLY,0.572,0.083626,0.040236,0,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.15565,0.083404,0.06207,0,0
5,GO CELLULAR RESPONSE TO LIPID,0.15098,0.083032,0.058427,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.35253,0.082891,0.040711,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.61402,0.082859,0.014066,0,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.12029,0.082677,0.077255,0,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.31997,0.082422,0.057349,0,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.16904,0.082304,0.046332,0,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.22348,0.08226,0.051171,0,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.27495,0.082198,0.042805,0,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.35043,0.082048,0.055602,0,0
5,GO LYMPHOCYTE DIFFERENTIATION,0.095518,0.082027,0.058355,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.32393,0.082003,0.095205,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.19003,0.081901,0.076474,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14642,0.081802,0.10437,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.15447,0.081752,0.092034,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.10214,0.081693,0.098723,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.13338,0.08124,0.097486,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.36098,0.080925,0.059318,0,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.085497,0.080675,0.056604,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.098784,0.080669,0.087991,0,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.37608,0.080588,0.062362,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.1387,0.080379,0.10032,0,0
5,GO RESPONSE TO ALKALOID,0.010041,0.080273,0.10465,0,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.24745,0.079892,0.070782,0,0
5,GO PRIMARY MIRNA PROCESSING,0.12322,0.079878,0.079291,0,0
5,GO B CELL DIFFERENTIATION,0.13763,0.079852,0.061505,0,0
5,GO CELL SUBSTRATE ADHESION,0.20845,0.07973,0.073188,0,0
5,GO ISOPRENOID METABOLIC PROCESS,0.40743,0.078833,0.035651,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.24252,0.078716,0.093702,0,0
5,GO WATER TRANSPORT,0.070488,0.078351,0.15432,0,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.096327,0.078346,0.10156,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.1873,0.078213,0.067436,0,0
5,GO REGULATION OF EXOSOMAL SECRETION,0.30255,0.078205,0.054151,0,0
5,GO RESPONSE TO LEAD ION,0.075674,0.078169,0.099889,0,0
5,GO REGULATION OF MUSCLE CONTRACTION,0.091558,0.078128,0.070246,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.23286,0.077386,0.054585,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.25414,0.0772,0.059323,0,0
5,GO LIVER REGENERATION,0.1533,0.07694,0.05196,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.40514,0.07664,0.062768,0,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.20992,0.07638,0.084066,0,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.23605,0.076028,0.061891,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.71089,0.075963,0.0078458,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.22658,0.075891,0.082326,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.31021,0.075735,0.063294,0,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.072397,0.075521,0.083331,0,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.25078,0.07548,0.051471,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.015674,0.075386,0.13349,0,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.56376,0.075235,0.039794,0,0
5,GO RESPONSE TO CALCIUM ION,0.077018,0.075189,0.080826,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.178,0.075083,0.11385,0,0
5,GO GLOMERULUS DEVELOPMENT,0.55558,0.074992,0.054464,0,0
5,GO IMMUNE SYSTEM DEVELOPMENT,0.08331,0.074979,0.060037,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.16904,0.074929,0.082085,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.18866,0.074842,0.092224,0,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.20699,0.074234,0.065721,0,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.2644,0.07422,0.081924,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.11933,0.074178,0.0782,0,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.11092,0.073931,0.088491,0,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.20554,0.073779,0.063335,0,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.7659,0.073764,-0.034589,0,0
5,GO REGULATION OF MRNA BINDING,0.75664,0.073758,0.0041769,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.11742,0.073675,0.077429,0,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.56376,0.073665,0.047253,0,0
5,GO TRANSCYTOSIS,0.52874,0.073655,0.040708,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.25753,0.073538,0.075441,0,0
5,GO LIPID STORAGE,0.20554,0.073357,0.069131,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.24252,0.073245,0.086947,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.11092,0.073114,0.092072,0,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.11837,0.073052,0.054522,0,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.45972,0.072441,0.027975,0,0
5,GO MUSCLE HYPERTROPHY,0.20122,0.072371,0.061293,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.24252,0.072271,0.054757,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.48722,0.072243,0.045511,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.38047,0.072201,0.059399,0,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.22348,0.071974,0.038895,0,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.51819,0.071825,0.018786,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.18062,0.071582,0.063405,0,0
5,GO GOLGI VESICLE TRANSPORT,0.17411,0.071501,0.050071,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.38488,0.071355,0.044397,0,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.2714,0.071193,0.064533,0,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.58307,0.071146,0.0055873,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.16778,0.07109,0.083668,0,0
5,GO POSITIVE T CELL SELECTION,0.12322,0.070995,0.06379,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.68094,0.070702,0.033732,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.46218,0.070632,-0.052704,0,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.14088,0.070573,0.064379,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.24252,0.070345,0.070144,0,0
5,GO REGULATION OF ENDOCRINE PROCESS,0.18866,0.070296,0.055759,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.51296,0.070122,0.045098,0,0
5,GO RNA MODIFICATION,0.6055,0.069935,0.0078437,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.57752,0.069723,0.0388,0,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.178,0.069565,0.06793,0,0
5,GO LUNG ALVEOLUS DEVELOPMENT,0.12924,0.069559,0.10135,0,0
5,GO RNA METHYLATION,0.27317,0.069503,0.049734,0,0
5,GO METAL ION HOMEOSTASIS,0.086237,0.069411,0.062936,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.42838,0.069197,0.050908,0,0
5,GO MYELOID CELL DEVELOPMENT,0.15565,0.069178,0.066708,0,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.21889,0.069163,0.050416,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0049019,0.068952,0.11688,0,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.062684,0.068873,0.21716,0,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.53406,0.06882,0.034702,0,0
5,GO REGULATION OF CELL ADHESION,0.44269,0.06881,0.044493,0,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.318,0.068497,0.058098,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.1387,0.068453,0.097494,0,0
5,GO BONE CELL DEVELOPMENT,0.60834,0.068322,0.034059,0,0
5,GO T CELL DIFFERENTIATION,0.1252,0.068243,0.054229,0,0
5,GO GONADOTROPIN SECRETION,0.33194,0.067935,0.068193,0,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.26964,0.067789,0.07752,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.30066,0.067787,0.059892,0,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.27673,0.067655,0.038981,0,0
5,GO TERPENOID METABOLIC PROCESS,0.26614,0.067331,0.056224,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.06986,0.067328,0.071411,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.47461,0.067243,0.070331,0,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.38267,0.067184,0.038412,0,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.22814,0.066879,0.093111,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.48722,0.06686,0.03474,0,0
5,GO PORE COMPLEX ASSEMBLY,0.2714,0.066856,0.045814,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.178,0.06646,0.098222,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.47211,0.066389,0.035194,0,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.74128,0.066378,0.0023087,0,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.25078,0.066327,0.064964,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.74435,0.066302,0.031928,0,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.15921,0.066293,0.085849,0,0
5,GO MYOBLAST PROLIFERATION,0.44028,0.066257,0.019014,0,0
5,GO RESPONSE TO ETHANOL,0.1873,0.066227,0.053825,0,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.13979,0.066002,0.097236,0,0
5,GO TRNA MODIFICATION,0.97253,0.065933,-0.010437,0,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.16163,0.065925,0.054251,0,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.10214,0.065879,0.057065,0,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.16904,0.065853,0.12521,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.65734,0.065831,0.018481,0,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.26789,0.065699,0.053851,0,0
5,GO STRIATED MUSCLE CONTRACTION,0.098784,0.065669,0.084654,0,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.57752,0.065656,0.023858,0,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.14983,0.065564,0.049864,0,0
5,GO NATURAL KILLER CELL ACTIVATION,0.34627,0.06556,0.034211,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.026561,0.06551,0.11658,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.21738,0.065469,0.070689,0,0
5,GO MESENCHYME MORPHOGENESIS,0.39606,0.065438,0.043837,0,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.43075,0.065287,0.036356,0,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.79387,0.065152,0.012437,0,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.082591,0.065136,0.10318,0,0
5,GO RESPONSE TO OSMOTIC STRESS,0.11647,0.064826,0.067732,0,0
5,GO AUTOPHAGIC CELL DEATH,0.037139,0.064537,0.11518,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.075674,0.064533,0.13479,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.48468,0.064364,0.045295,0,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.18461,0.064308,0.062526,0,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.2644,0.064261,0.07721,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.73822,0.064254,-0.02861,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.41203,0.064222,0.045873,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.016752,0.06394,0.11977,0,0
5,GO CHOLESTEROL STORAGE,0.28395,0.063918,0.071352,0,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.086237,0.063887,0.084404,0,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.24745,0.063855,0.058127,0,0
5,GO HEPARIN METABOLIC PROCESS,0.81896,0.063786,-0.0014962,0,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.063836,0.063758,0.074925,0,0
5,GO ASTROCYTE DEVELOPMENT,0.45972,0.063572,0.048743,0,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.86968,0.063499,0.0092039,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.13763,0.063405,0.087247,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.30066,0.063112,0.12557,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.36311,0.063053,0.038919,0,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.078382,0.062987,0.075397,0,0
5,GO TRABECULA MORPHOGENESIS,0.34627,0.062955,0.049392,0,0
5,GO GASTRULATION,0.1793,0.062943,0.064162,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.46218,0.062913,0.056072,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.15683,0.06289,0.075864,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.44752,0.062826,0.04452,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.13656,0.062697,0.054325,0,0
5,GO P38MAPK CASCADE,0.087731,0.062585,0.10866,0,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.76281,0.062254,0.014517,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59424,0.062105,0.012963,0,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.47461,0.062091,0.036592,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.82842,0.061948,0.017724,0,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.17411,0.061871,0.095002,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.71391,0.061843,0.029482,0,0
5,GO MRNA CLEAVAGE,0.089246,0.061808,0.084014,0,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.51035,0.061792,0.035039,0,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.095518,0.061769,0.072003,0,0
5,GO REGULATION OF ANOIKIS,0.39156,0.0617,0.059347,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.20554,0.061672,0.10324,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.086981,0.061663,0.11822,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.16654,0.061631,0.12799,0,0
5,GO REGULATION OF LIPID LOCALIZATION,0.32592,0.061613,0.044654,0,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.82526,0.061601,-0.014476,0,0
5,GO FATTY ACID BETA OXIDATION,0.36956,0.061503,0.038581,0,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.66028,0.061489,0.021027,0,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.096327,0.061181,0.101,0,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.33803,0.061105,0.063664,0,0
5,GO REGULATION OF TUBE SIZE,0.11647,0.060992,0.065041,0,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.21587,0.060954,0.062468,0,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.33599,0.060952,0.083042,0,0
5,GO FATTY ACID CATABOLIC PROCESS,0.26964,0.060822,0.049538,0,0
5,GO NADH METABOLIC PROCESS,0.10912,0.06059,0.082399,0,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12126,0.060373,0.093324,0,0
5,GO REGULATION OF MUSCLE ADAPTATION,0.14642,0.060316,0.072988,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.17283,0.060116,0.069849,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.3739,0.060026,0.042505,0,0
5,GO BIOMINERALIZATION,0.25246,0.059986,0.065977,0,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16904,0.059913,0.091339,0,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.67798,0.059893,0.095433,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.084763,0.059816,0.055599,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.2458,0.05972,0.050105,0,0
5,GO REGULATION OF RNA BINDING,0.33396,0.059695,0.044085,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.13338,0.059639,0.11987,0,0
5,GO PLASMA MEMBRANE ORGANIZATION,0.086237,0.059609,0.10627,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.92094,0.059411,0.0044518,0,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.19838,0.059381,0.058483,0,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.13763,0.059363,0.054532,0,0
5,GO RESPONSE TO RETINOIC ACID,0.22971,0.059293,0.069678,0,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.18194,0.059263,0.065484,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.3442,0.059256,0.041411,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.21738,0.059235,0.063199,0,0
5,GO NCRNA 3 END PROCESSING,0.70787,0.059232,-0.04216,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.19417,0.059223,0.076668,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.44269,0.059186,0.083575,0,0
5,GO T CELL LINEAGE COMMITMENT,0.13338,0.059136,0.084247,0,0
5,GO PROTEIN KINASE A SIGNALING,0.077698,0.058955,0.08396,0,0
5,GO REGULATION OF RESPONSE TO STRESS,0.23927,0.058912,0.046248,0,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.21889,0.058876,0.054525,0,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.68988,0.058874,0.021144,0,0
5,GO REGULATION OF BLOOD PRESSURE,0.22503,0.05887,0.058077,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.50516,0.058811,0.038114,0,0
5,GO SARCOMERE ORGANIZATION,0.13444,0.058675,0.07466,0,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.62258,0.058314,0.02235,0,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.67798,0.058301,0.025643,0,0
5,GO CELLULAR RESPONSE TO KETONE,0.10045,0.058273,0.075985,0,0
5,GO MYELOID CELL DIFFERENTIATION,0.14197,0.058177,0.052099,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16285,0.058161,0.082581,0,0
5,GO PROTEIN KINASE B SIGNALING,0.13979,0.058151,0.067679,0,0
5,GO RESPONSE TO LIPID,0.26614,0.058079,0.046398,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.27853,0.058071,0.076432,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.16407,0.057995,0.048263,0,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.74741,0.057832,0.0097628,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.21738,0.057643,0.13484,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.59144,0.057569,0.041439,0,0
5,GO LOCOMOTOR RHYTHM,0.25583,0.057562,0.10886,0,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.63986,0.057494,0.022783,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.28761,0.057421,0.07111,0,0
5,GO STEROL METABOLIC PROCESS,0.34213,0.057347,0.029629,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.13027,0.057345,0.089314,0,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.32993,0.057344,0.049572,0,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.17029,0.057228,0.050841,0,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.41666,0.057167,0.047013,0,0
5,GO ERK1 AND ERK2 CASCADE,0.49231,0.057129,0.035613,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.54477,0.057069,0.024673,0,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.41899,0.05705,0.033357,0,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.39381,0.056916,-0.076414,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.22658,0.056646,0.06889,0,0
5,GO SPHINGOID METABOLIC PROCESS,0.28578,0.056588,0.067669,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.077698,0.056405,0.08292,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.30637,0.05622,0.04448,0,0
5,GO HEART FIELD SPECIFICATION,0.17669,0.056216,0.1395,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.18062,0.056099,0.079931,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.059879,0.056092,0.1388,0,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.6515,0.055937,0.020849,0,0
5,GO HEAD MORPHOGENESIS,0.35463,0.055858,0.063428,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.25924,0.055598,0.049475,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.71391,0.055486,0.020944,0,0
5,GO EPIDERMAL CELL DIFFERENTIATION,0.15098,0.055363,0.070245,0,0
5,GO MACROPHAGE DIFFERENTIATION,0.43075,0.055251,0.031469,0,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.39606,0.055143,0.044705,0,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.82526,0.054928,0.030626,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.30829,0.054758,0.064574,0,0
5,GO NEURON REMODELING,0.58029,0.054723,0.039598,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.39381,0.054528,0.048965,0,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.10299,0.054513,0.06886,0,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.15802,0.054451,0.055238,0,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.46218,0.054441,0.022864,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.42838,0.054343,0.041217,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.45972,0.054314,0.054064,0,0
5,GO SNRNA METABOLIC PROCESS,0.62258,0.054276,-0.010845,0,0
5,GO RESPONSE TO STEROL DEPLETION,0.63697,0.053904,0.020973,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.1533,0.053798,0.048584,0,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.797,0.053748,-0.05656,0,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.36741,0.053562,0.034955,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.2913,0.053548,0.12326,0,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.89846,0.053516,0.0061404,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.077018,0.053319,0.13717,0,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.14308,0.053294,0.052791,0,0
5,GO ENGULFMENT OF APOPTOTIC CELL,0.26095,0.053235,0.054489,0,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.21889,0.053071,0.072075,0,0
5,GO ANION TRANSPORT,0.081877,0.053062,0.067034,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.24416,0.052991,0.056949,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.41434,0.05298,0.045033,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.30829,0.052727,0.049814,0,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.88245,0.052617,-0.018003,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.10385,0.052502,0.15133,0,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.61402,0.052408,0.039028,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.81581,0.05228,0.022232,0,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.30066,0.052255,0.044595,0,0
5,GO NAD METABOLIC PROCESS,0.35674,0.052233,0.043718,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.47211,0.052082,0.056973,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.20554,0.052052,0.058298,0,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.52609,0.052018,0.025077,0,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.60268,0.051839,0.023385,0,0
5,GO O GLYCAN PROCESSING,0.49487,0.05172,-0.057496,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.08331,0.051607,0.13328,0,0
5,GO RRNA 3 END PROCESSING,0.77209,0.051607,-0.00087019,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.95639,0.05157,0.0019057,0,0
5,GO PROTEOLYSIS,0.12421,0.051562,0.050297,0,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.59424,0.051307,0.014711,0,0
5,GO CARNITINE METABOLIC PROCESS,0.34213,0.051253,0.067362,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.1262,0.051249,0.096567,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.46466,0.051202,0.036717,0,0
5,GO CELLULAR ION HOMEOSTASIS,0.1262,0.051197,0.057161,0,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.28578,0.051128,0.038953,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.97899,0.051124,-0.0047862,0,0
5,GO NCRNA METABOLIC PROCESS,0.64276,0.051067,-0.032458,0,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.79387,0.051056,0.0089262,0,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.91451,0.051035,-0.0095874,0,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.15214,0.051018,0.087731,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.20554,0.050924,0.056456,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.30255,0.050871,0.055486,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.19003,0.050683,0.098581,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.19697,0.050486,0.050552,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.013093,0.050469,0.10309,0,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.14308,0.050469,0.063852,0,0
5,GO LEUKOCYTE DIFFERENTIATION,0.30637,0.050443,0.037112,0,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.47712,0.050399,0.054798,0,0
5,GO RNA CAPPING,0.29877,0.050391,0.032022,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.35886,0.050379,0.019628,0,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.87926,0.05037,-0.024623,0,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.83158,0.050358,-0.0024208,0,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.6515,0.050272,0.02005,0,0
5,GO REGULATION OF GENE SILENCING,0.08331,0.050128,0.068478,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.62832,0.050031,0.021349,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.40286,0.049893,0.03554,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.82526,0.049881,-0.026273,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.70486,0.049846,0.016464,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.62258,0.049815,0.031822,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.52082,0.049758,0.024329,0,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.25753,0.049651,0.055913,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION,0.18866,0.049621,0.047294,0,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.28395,0.049425,0.041301,0,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.45482,0.049344,0.04578,0,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.094715,0.049286,0.065794,0,0
5,GO ALCOHOL CATABOLIC PROCESS,0.11002,0.049217,0.084845,0,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.70185,0.049199,0.012865,0,0
5,GO RESPONSE TO WOUNDING,0.41203,0.049186,0.047095,0,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.22042,0.049092,0.050836,0,0
5,GO REGULATION OF HEMOPOIESIS,0.28945,0.049057,0.040958,0,0
5,GO VESICLE TARGETING,0.59144,0.048964,0.025831,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.50776,0.048858,0.023588,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.16163,0.048843,0.12435,0,0
5,GO BONE MINERALIZATION,0.2644,0.048784,0.059033,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.72603,0.048671,0.023384,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.56103,0.048663,-0.054097,0,0
5,GO MESODERM MORPHOGENESIS,0.29877,0.048587,0.043458,0,0
5,GO GLYCEROLIPID METABOLIC PROCESS,0.15447,0.04848,0.055336,0,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.86968,0.048469,0.016104,0,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.11183,0.048465,0.1851,0,0
5,GO HEART TRABECULA MORPHOGENESIS,0.42838,0.048421,0.053773,0,0
5,GO REGENERATION,0.14308,0.048387,0.05749,0,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.82842,0.048077,0.023602,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.26789,0.048023,0.058466,0,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.72299,0.048,0.02714,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.59986,0.047891,0.018932,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.34213,0.047757,0.081413,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.33194,0.047753,0.049137,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.31215,0.047743,0.039809,0,0
5,GO RESPONSE TO CORTICOSTEROID,0.41666,0.04774,0.036082,0,0
5,GO CELLULAR RESPONSE TO VIRUS,0.81581,0.047699,0.0066397,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.051111,0.047688,0.081071,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.19838,0.047587,0.079595,0,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.59986,0.047407,0.025637,0,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.28945,0.047404,0.041498,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.068006,0.047254,0.05925,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.072397,0.047143,0.093364,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94993,0.04705,0.003993,0,0
5,GO RESPONSE TO PAIN,0.99515,0.047027,-0.018253,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.21288,0.046998,0.055066,0,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.64276,0.046991,0.044275,0,0
5,GO T CELL SELECTION,0.19979,0.046973,0.054288,0,0
5,GO DEVELOPMENTAL PIGMENTATION,0.21587,0.046956,0.059494,0,0
5,GO AGING,0.18461,0.046872,0.051084,0,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.99515,0.046864,-0.0095302,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.15683,0.046677,0.051926,0,0
5,GO NCRNA PROCESSING,0.47963,0.046619,-0.049219,0,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.48468,0.046617,0.02381,0,0
5,GO STORE OPERATED CALCIUM ENTRY,0.26789,0.046604,0.064019,0,0
5,GO REGULATION OF ACROSOME REACTION,0.63986,0.046585,0.037677,0,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.12029,0.046547,0.087907,0,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.28033,0.046539,0.059406,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.80953,0.046512,-0.0031017,0,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.59144,0.046486,0.034171,0,0
5,GO ERAD PATHWAY,0.99192,0.046437,0.0074664,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.093918,0.046392,0.068167,0,0
5,GO MAINTENANCE OF LOCATION,0.36956,0.046156,0.040588,0,0
5,GO OVULATION,0.63986,0.046148,0.026442,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.38488,0.046031,0.056675,0,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.11275,0.045976,0.071099,0,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.11183,0.045894,0.062077,0,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.7659,0.045875,0.0025437,0,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.30446,0.045747,-0.087735,0,0
5,GO FIBROBLAST PROLIFERATION,0.30255,0.04568,0.049714,0,0
5,GO REGULATION OF BIOMINERALIZATION,0.31604,0.045645,0.054929,0,0
5,GO THYMIC T CELL SELECTION,0.56376,0.045615,0.01414,0,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.78451,0.045575,0.013324,0,0
5,GO PROTEIN NEDDYLATION,0.79387,0.045509,-0.022588,0,0
5,GO MEMBRANE DEPOLARIZATION,0.12924,0.045419,0.099527,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.76281,0.045352,0.012719,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.74741,0.045342,0.033584,0,0
5,GO RESPONSE TO INTERLEUKIN 6,0.48468,0.04524,0.04801,0,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.97576,0.045113,0.0052727,0,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.45482,0.045013,0.037191,0,0
5,GO FLUID TRANSPORT,0.24252,0.04495,0.084947,0,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.94993,0.044906,0.0055342,0,0
5,GO SYMBIOTIC PROCESS,0.7659,0.044842,0.0089092,0,0
5,GO PROTEIN REFOLDING,0.6055,0.04471,0.038414,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.23766,0.04463,0.072343,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.24416,0.044624,0.06573,0,0
5,GO REGULATION OF BONE MINERALIZATION,0.63697,0.044369,0.032689,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.14308,0.044185,0.077585,0,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.46713,0.044122,0.043411,0,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.91772,0.04394,-0.021014,0,0
5,GO SPHINGOLIPID METABOLIC PROCESS,0.21288,0.043896,0.051195,0,0
5,GO SUPEROXIDE METABOLIC PROCESS,0.63986,0.043851,0.022784,0,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.18461,0.043752,0.080579,0,0
5,GO WOUND HEALING,0.68094,0.043669,0.028218,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.4451,0.043595,0.030037,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.77829,0.043573,0.022826,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.99515,0.043555,-0.011131,0,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.55558,0.043426,0.028651,0,0
5,GO GOLGI VESICLE BUDDING,0.96284,0.043423,0.00039856,0,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.43312,0.043172,0.031648,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.91451,0.043158,0.017869,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.12224,0.043157,0.095007,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.25246,0.043012,0.070464,0,0
5,GO VASCULAR WOUND HEALING,0.16163,0.043,0.13887,0,0
5,GO REPLICATIVE SENESCENCE,0.67798,0.042907,0.013315,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.61687,0.042849,0.025224,0,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.33396,0.042774,0.094668,0,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.31604,0.042685,0.04905,0,0
5,GO TRNA TRANSPORT,0.14869,0.042677,0.069298,0,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.43312,0.042657,0.04071,0,0
5,GO TRNA PROCESSING,0.71391,0.042618,-0.025754,0,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.78763,0.042566,0.011004,0,0
5,GO ACTIN MEDIATED CELL CONTRACTION,0.318,0.042541,0.056565,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.54746,0.042527,0.014166,0,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.58864,0.042456,0.01895,0,0
5,GO AMINOGLYCAN METABOLIC PROCESS,0.54477,0.042438,0.038057,0,0
5,GO REGULATION OF B CELL DIFFERENTIATION,0.30446,0.042315,0.050862,0,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.572,0.042251,0.024603,0,0
5,GO BICARBONATE TRANSPORT,0.23605,0.042154,0.059734,0,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.20265,0.042145,0.045933,0,0
5,GO MITOCHONDRIAL TRANSPORT,0.36741,0.042042,0.033878,0,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.67206,0.042003,0.036666,0,0
5,GO BODY FLUID SECRETION,0.29877,0.041968,0.036429,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.74435,0.041789,-0.017578,0,0
5,GO FATTY ACID METABOLIC PROCESS,0.6515,0.041544,0.014002,0,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.7814,0.041485,0.018016,0,0
5,GO VIRAL GENOME REPLICATION,0.47712,0.041446,0.020963,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.24252,0.041429,0.048247,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.61972,0.041416,0.019825,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.85376,0.041401,-0.00023514,0,0
5,GO ORGANIC ANION TRANSPORT,0.22503,0.041288,0.052598,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.11647,0.041233,0.055081,0,0
5,GO LIPID EXPORT FROM CELL,0.94671,0.041221,-0.0052975,0,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.6691,0.041022,0.00045013,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.75972,0.040993,0.022565,0,0
5,GO RESPONSE TO PROGESTERONE,0.095518,0.040833,0.096997,0,0
5,GO ANION HOMEOSTASIS,0.079071,0.040773,0.098874,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.95316,0.040637,0.010745,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.24089,0.040581,0.11514,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.22658,0.040504,0.060709,0,0
5,GO NODAL SIGNALING PATHWAY,0.15447,0.040405,0.10705,0,0
5,GO CELL AGING,0.096327,0.040401,0.064257,0,0
5,GO RESPONSE TO NUTRIENT,0.46218,0.04037,0.038412,0,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.72299,0.040347,0.031844,0,0
5,GO AMINO ACID IMPORT,0.71996,0.04021,0.018186,0,0
5,GO STEROID METABOLIC PROCESS,0.55287,0.040176,0.014313,0,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.7814,0.040168,0.059485,0,0
5,GO DIGESTION,0.13444,0.040141,0.05983,0,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.56925,0.040101,0.029946,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.85059,0.04003,-0.018886,0,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.50258,0.039856,0.033151,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.54746,0.039835,0.020039,0,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.48468,0.03982,0.022125,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.17669,0.039669,0.11233,0,0
5,GO VIRAL LIFE CYCLE,0.9306,0.039442,-0.0016673,0,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.98222,0.039418,-0.0031674,0,0
5,GO REGULATION OF PROTEIN STABILITY,0.25414,0.039397,0.04561,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.38047,0.039363,0.052442,0,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.20554,0.039235,0.052364,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.71996,0.039214,0.018908,0,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.54746,0.038757,0.034643,0,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.58864,0.038698,0.044403,0,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.56103,0.038453,0.062473,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.88565,0.038132,0.0064445,0,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.71089,0.038116,0.0070541,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.25924,0.037984,0.079063,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.47712,0.037916,0.041637,0,0
5,GO LIPID LOCALIZATION,0.43312,0.037876,0.03639,0,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.98546,0.037787,-0.025438,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.34627,0.037691,0.079949,0,0
5,GO B CELL MEDIATED IMMUNITY,0.44994,0.0375,-0.046719,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.49487,0.037394,0.053906,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.19557,0.037375,0.10336,0,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.29315,0.037249,0.13094,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.51819,0.037247,0.019286,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.21587,0.03707,0.039843,0,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.92094,0.037036,0.009096,0,0
5,GO PROTEIN DEMANNOSYLATION,0.55016,0.037023,0.022793,0,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.58307,0.036993,0.026176,0,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.68689,0.036967,0.022691,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.25078,0.036915,-0.090439,0,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.26614,0.036904,0.055686,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.25246,0.036707,0.091121,0,0
5,GO REGULATION OF ANION TRANSPORT,0.24089,0.036604,0.053177,0,0
5,GO REGULATION OF PINOCYTOSIS,0.66616,0.036552,0.021984,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.2114,0.036404,0.062809,0,0
5,GO ALPHA BETA T CELL ACTIVATION,0.85059,0.036294,-0.0038457,0,0
5,GO CELLULAR RESPONSE TO CAMP,0.33194,0.036272,0.049343,0,0
5,GO RESPONSE TO AMYLOID BETA,0.1914,0.036261,0.081702,0,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.55558,0.036238,0.03892,0,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.11553,0.036226,0.053892,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.35253,0.036225,-0.013166,0,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.43075,0.03621,0.058575,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.33599,0.036131,0.053813,0,0
5,GO ELASTIC FIBER ASSEMBLY,0.70185,0.03611,0.016646,0,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.73517,0.036092,0.021965,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.32592,0.036087,0.08453,0,0
5,GO RNA CATABOLIC PROCESS,0.69586,0.035944,0.0026207,0,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.74128,0.035899,-0.039871,0,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.59424,0.035826,0.038128,0,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.92738,0.035743,0.0082948,0,0
5,GO BLEB ASSEMBLY,0.87287,0.035674,-0.059886,0,0
5,GO ASTROCYTE ACTIVATION,0.14869,0.035544,0.084856,0,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.16407,0.035522,0.13772,0,0
5,GO POSITIVE REGULATION OF WOUND HEALING,0.49487,0.035511,0.058324,0,0
5,GO LYMPHOCYTE ACTIVATION,0.54477,0.035469,0.020245,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.19697,0.035226,0.019502,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.30066,0.035091,0.097358,0,0
5,GO RESPONSE TO ESTROGEN,0.75048,0.035068,0.019276,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.64567,0.035024,-0.018535,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22195,0.035012,0.064844,0,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.6515,0.03497,-0.031661,0,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.99838,0.034854,0.0011536,0,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.5314,0.034847,0.011735,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.97253,0.034796,0.013676,0,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.81581,0.03478,-0.015432,0,0
5,GO RRNA MODIFICATION,0.32393,0.034774,-0.073511,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.75972,0.034732,0.011148,0,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.31021,0.034696,0.049124,0,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.97576,0.034691,0.0063433,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.77829,0.03458,-0.0034839,0,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.32195,0.034579,0.065739,0,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.41203,0.034575,0.062452,0,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.20554,0.034543,0.051649,0,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.59705,0.034513,0.015314,0,0
5,GO REGULATION OF GLUCONEOGENESIS,0.09796,0.034491,0.090892,0,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.37827,0.034421,0.03154,0,0
5,GO RESPONSE TO ANTIBIOTIC,0.4451,0.034419,0.039386,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.66028,0.034258,0.032211,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.58585,0.034246,0.047654,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.40743,0.03422,0.037451,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.24089,0.034134,0.056188,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.48215,0.034113,0.061262,0,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.80326,0.034095,0.017251,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.12224,0.034061,0.13423,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.98546,0.034038,0.0092185,0,0
5,GO CELLULAR RESPONSE TO ATP,0.15098,0.033953,0.075963,0,0
5,GO NCRNA CATABOLIC PROCESS,0.1793,0.033919,0.056164,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.83158,0.033864,-0.010316,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.12421,0.033662,0.052917,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.61117,0.033657,0.027119,0,0
5,GO CARBOHYDRATE TRANSPORT,0.19557,0.033464,0.053346,0,0
5,GO MITOCHONDRION ORGANIZATION,0.75356,0.033419,0.017351,0,0
5,GO IRON ION HOMEOSTASIS,0.73517,0.033413,-0.0088177,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.95316,0.033343,0.0011779,0,0
5,GO POLYOL BIOSYNTHETIC PROCESS,0.44269,0.033233,0.046523,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.34627,0.033166,0.043715,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.44994,0.03296,0.057073,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.87606,0.032917,-0.015554,0,0
5,GO REGULATION OF BODY FLUID LEVELS,0.54208,0.032881,0.039012,0,0
5,GO MANGANESE ION TRANSPORT,0.59144,0.032824,0.028435,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.39832,0.032814,0.039748,0,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.87287,0.032658,0.0093048,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.79387,0.032573,-0.0049913,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.56376,0.03253,0.056823,0,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.88245,0.032529,-0.008441,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.32993,0.032503,0.074706,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.82842,0.032447,-0.013961,0,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.5,0.03241,0.03154,0,0
5,GO MRNA MODIFICATION,0.27673,0.032383,0.053963,0,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.44269,0.032356,0.030274,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.70185,0.032353,0.018549,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.099614,0.032343,0.065777,0,0
5,GO ALCOHOL METABOLIC PROCESS,0.48722,0.032252,0.022779,0,0
5,GO MITOCHONDRIAL FUSION,0.53406,0.032168,0.038907,0,0
5,GO RESPONSE TO TESTOSTERONE,0.5394,0.032088,0.033696,0,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.99192,0.032075,-0.0080018,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.50776,0.031963,0.042288,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.73212,0.03194,0.016981,0,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60268,0.031921,0.022881,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.77209,0.031757,0.0037498,0,0
5,GO DRUG CATABOLIC PROCESS,0.39381,0.031697,0.039522,0,0
5,GO HORMONE METABOLIC PROCESS,0.37827,0.031661,0.038417,0,0
5,GO TRNA METABOLIC PROCESS,0.72907,0.031626,-0.023084,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.22658,0.031556,0.047146,0,0
5,GO POSITIVE CHEMOTAXIS,0.4451,0.031513,0.040538,0,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.59986,0.031468,0.018607,0,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.85059,0.031425,-0.0013366,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.41203,0.031259,0.042194,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.89846,0.03113,-0.0039598,0,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.5583,0.031068,0.038619,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.62258,0.030984,-0.038389,0,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.42838,0.03092,0.03273,0,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.28395,0.030905,0.070644,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.94671,0.030813,0.0054517,0,0
5,GO DIGESTIVE SYSTEM PROCESS,0.12029,0.030793,0.066732,0,0
5,GO ORGANELLE FUSION,0.85694,0.030695,0.017731,0,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.89526,0.030566,0.0079831,0,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.80953,0.030485,0.021709,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.92416,0.030094,-0.030152,0,0
5,GO RRNA METHYLATION,0.5583,0.030092,-0.042356,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.84741,0.030053,-0.0047372,0,0
5,GO APOPTOTIC SIGNALING PATHWAY,0.77829,0.030039,0.01935,0,0
5,GO ORGANELLE DISASSEMBLY,0.47712,0.02991,0.035067,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.41899,0.029772,0.054449,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.35674,0.029765,0.044708,0,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.6055,0.029725,0.023756,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.52082,0.029606,0.063148,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.37608,0.029515,0.053855,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.46713,0.029407,0.049668,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.9693,0.02937,-0.011208,0,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.91772,0.029315,0.0096736,0,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.78451,0.029264,-0.0033351,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.72603,0.029138,0.016447,0,0
5,GO REGULATION OF ERAD PATHWAY,0.31997,0.029131,0.044039,0,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.79387,0.029111,-0.0083463,0,0
5,GO ESTROGEN METABOLIC PROCESS,0.69586,0.029099,-0.020934,0,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.82211,0.029064,0.012908,0,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.20554,0.029051,0.050273,0,0
5,GO LIPID CATABOLIC PROCESS,0.69885,0.029031,0.015519,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.87287,0.028892,0.0036553,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.74741,0.028887,0.021272,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.99515,0.028756,-0.0068744,0,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.62545,0.02866,0.04623,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.54208,0.028645,0.035228,0,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.58307,0.028581,0.037914,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.28578,0.028541,0.057682,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.49743,0.028499,0.035371,0,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.51819,0.028493,0.025695,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.52874,0.028482,0.070373,0,0
5,GO CERAMIDE METABOLIC PROCESS,0.41203,0.028431,0.041111,0,0
5,GO CARTILAGE MORPHOGENESIS,0.36741,0.028411,0.086996,0,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.85694,0.028383,0.012359,0,0
5,GO MEMBRANE REPOLARIZATION,0.29315,0.028369,0.067849,0,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.99838,0.0283,0.0073993,0,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.92416,0.028157,0.00010531,0,0
5,GO PROTEIN DESTABILIZATION,0.50776,0.028082,0.034261,0,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.57476,0.028077,0.029259,0,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.94671,0.028013,0.0022724,0,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.80953,0.02798,0.014907,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.3739,0.027725,0.049082,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16042,0.027546,0.060543,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.10558,0.027318,0.10606,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.65442,0.027315,0.025265,0,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.55016,0.027253,-0.03617,0,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.48976,0.027139,0.038853,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.6312,0.0271,0.050247,0,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.41434,0.02694,0.056223,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.41666,0.026862,0.037162,0,0
5,GO PROTEIN TARGETING,0.81267,0.026823,-0.010384,0,0
5,GO ACYLGLYCEROL HOMEOSTASIS,0.47963,0.026745,0.05193,0,0
5,GO PIGMENT GRANULE ORGANIZATION,0.89526,0.026731,-0.011639,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.797,0.026637,0.037808,0,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.97576,0.026612,0.010064,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.94671,0.026554,-0.0051146,0,0
5,GO HEART GROWTH,0.10129,0.026374,0.077756,0,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.38488,0.026374,0.034674,0,0
5,GO B CELL ACTIVATION,0.77209,0.026351,0.0082101,0,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.49743,0.026289,0.032987,0,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.6691,0.026105,0.022374,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.76281,0.026048,0.0087025,0,0
5,GO FACE DEVELOPMENT,0.27673,0.025999,0.068214,0,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.99515,0.025997,0.011982,0,0
5,GO ORGAN INDUCTION,0.22971,0.025868,0.084464,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.81896,0.02577,0.010699,0,0
5,GO RUFFLE ORGANIZATION,0.46962,0.02575,0.049179,0,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.46713,0.025729,0.075136,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.20122,0.025592,0.045497,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.72299,0.02555,0.026739,0,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.06986,0.025538,0.062571,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.24089,0.025487,0.055391,0,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.54746,0.025432,-0.042592,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.43789,0.025427,0.053611,0,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.51557,0.025379,0.036621,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.69586,0.02523,0.0079606,0,0
5,GO MAST CELL ACTIVATION,0.87606,0.025217,0.017772,0,0
5,GO GLUTAMATE METABOLIC PROCESS,0.1252,0.025149,0.077674,0,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.72603,0.024927,0.0054438,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.75048,0.024766,0.020455,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.48976,0.024648,0.030268,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.91772,0.024645,0.0023876,0,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.86968,0.024639,0.01842,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.52345,0.024509,0.034356,0,0
5,GO L AMINO ACID TRANSPORT,0.318,0.024291,0.047996,0,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.49231,0.024242,0.039165,0,0
5,GO REGULATION OF PROTEOLYSIS,0.78763,0.024198,0.010613,0,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.10045,0.024193,0.065642,0,0
5,GO ORGANELLE INHERITANCE,0.30066,0.02415,0.044359,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.56925,0.02413,0.042609,0,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.81267,0.024035,0.019463,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.46962,0.023934,0.098744,0,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.47211,0.023813,0.036007,0,0
5,GO T CELL ACTIVATION,0.75356,0.023772,0.006926,0,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.22814,0.023712,0.049287,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.83474,0.023602,-0.020318,0,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.94993,0.023504,0.0031018,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.84107,0.0235,-0.00434,0,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.85694,0.02346,0.0060451,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.68392,0.023327,0.048141,0,0
5,GO MALE GENITALIA DEVELOPMENT,0.46962,0.023232,0.025748,0,0
5,GO DNA DEAMINATION,0.86331,0.023197,-0.023081,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.55016,0.02316,0.052294,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.49487,0.023157,0.043585,0,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.51035,0.023144,0.011393,0,0
5,GO FATTY ACID TRANSPORT,0.72299,0.023127,-0.0046987,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.5583,0.023094,-0.037318,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.3871,0.023083,0.047948,0,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.16407,0.023056,0.085612,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.90809,0.022916,-0.014518,0,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.94671,0.022812,-0.008617,0,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.64276,0.022809,0.030678,0,0
5,GO RRNA METABOLIC PROCESS,0.42133,0.022586,-0.058522,0,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.45727,0.022519,0.038736,0,0
5,GO SALIVARY GLAND DEVELOPMENT,0.26095,0.022456,0.089759,0,0
5,GO REGULATION OF PH,0.32592,0.022436,0.037919,0,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.25078,0.022379,0.059928,0,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.41434,0.0223,-0.035696,0,0
5,GO ENDODERM DEVELOPMENT,0.48215,0.022262,0.041436,0,0
5,GO RENAL SODIUM EXCRETION,0.20992,0.022186,0.08247,0,0
5,GO COPII COATED VESICLE BUDDING,0.95639,0.022043,-0.001528,0,0
5,GO RESPONSE TO INTERLEUKIN 2,0.2644,0.022029,0.086599,0,0
5,GO INTERACTION WITH HOST,0.97576,0.021913,-0.0060542,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.71391,0.02185,0.070413,0,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.43789,0.021812,0.031072,0,0
5,GO HAIR FOLLICLE MATURATION,0.39381,0.021746,0.045878,0,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.61687,0.02172,0.03927,0,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.57752,0.021653,-0.020196,0,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.47963,0.02165,0.041161,0,0
5,GO FOAM CELL DIFFERENTIATION,0.84107,0.021555,-0.0027204,0,0
5,GO MIRNA METABOLIC PROCESS,0.71996,0.021508,0.011237,0,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.82526,0.021492,0.0013651,0,0
5,GO RESPONSE TO HEAT,0.37173,0.021437,0.041018,0,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.79387,0.021418,0.019287,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23766,0.021408,0.084854,0,0
5,GO ORGANELLE MEMBRANE FUSION,0.98222,0.021355,0.01012,0,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.73212,0.021174,0.022183,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.87606,0.021114,-0.0013812,0,0
5,GO RESPONSE TO PH,0.69286,0.020991,-0.013403,0,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.9693,0.020986,0.0020154,0,0
5,GO CARDIAC MUSCLE CONTRACTION,0.34627,0.020766,0.060732,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.86649,0.020646,0.0024517,0,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.54746,0.020605,0.048282,0,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.89846,0.020462,0.0024732,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98869,0.020385,0.0098888,0,0
5,GO RESPONSE TO OXIDATIVE STRESS,0.91451,0.020325,0.010847,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.68392,0.020294,0.024377,0,0
5,GO HOMOTYPIC CELL CELL ADHESION,0.95639,0.020261,0.0066152,0,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.88885,0.020215,-0.0071567,0,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.56103,0.020192,-0.021667,0,0
5,GO KERATINOCYTE MIGRATION,0.96607,0.020127,0.0067499,0,0
5,GO PANCREATIC JUICE SECRETION,0.46218,0.020041,0.03815,0,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.28213,0.020035,0.03484,0,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.63697,0.020002,-0.022385,0,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.58864,0.019994,0.028207,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.13656,0.019915,0.064903,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.97253,0.019853,0.013738,0,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.61972,0.019635,0.024665,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.35886,0.019332,-0.069225,0,0
5,GO TISSUE MIGRATION,0.61402,0.019241,0.030723,0,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.59705,0.0192,0.021779,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.32592,0.019099,0.076855,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.87926,0.018985,0.020995,0,0
5,GO RESPONSE TO LEPTIN,0.48976,0.018788,0.049051,0,0
5,GO ATP METABOLIC PROCESS,0.94026,0.01861,0.0010488,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.45727,0.018487,0.037374,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.36311,0.018437,0.061233,0,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.65734,0.018339,-0.026044,0,0
5,GO ACETYL COA METABOLIC PROCESS,0.61687,0.017849,0.023579,0,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.6691,0.017823,-0.025845,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.9113,0.017814,-0.0035967,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.79387,0.017798,0.036199,0,0
5,GO CYTOKINETIC PROCESS,0.54477,0.017718,0.035111,0,0
5,GO INTERFERON ALPHA PRODUCTION,0.9306,0.017712,0.0052731,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.74741,0.017683,0.014681,0,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.83158,0.017652,0.0097763,0,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.87606,0.017579,0.014028,0,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.74435,0.017574,-0.018274,0,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.90167,0.017413,0.0026105,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.9693,0.017223,0.0036568,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.36526,0.017176,0.043897,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.86012,0.017053,0.0057469,0,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.90809,0.01699,0.014847,0,0
5,GO EXOCYTOSIS,0.797,0.016808,-0.0017223,0,0
5,GO INTERFERON BETA PRODUCTION,0.62545,0.016774,0.032602,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.92416,0.016766,0.010198,0,0
5,GO TOXIN METABOLIC PROCESS,0.54746,0.016672,0.047967,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.91772,0.016579,0.0079988,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.83474,0.016133,-0.00055797,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.8379,0.01594,0.0188,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.41203,0.015896,0.037069,0,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.98222,0.015819,-0.014347,0,0
5,GO VIRAL GENE EXPRESSION,0.26964,0.015777,-0.071335,0,0
5,GO CELLULAR PIGMENTATION,0.36311,0.015771,0.040202,0,0
5,GO REGULATION OF TISSUE REMODELING,0.81267,0.0157,-0.014197,0,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.40973,0.015496,-0.05929,0,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.47211,0.015459,0.039783,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.51819,0.01543,0.037797,0,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.88565,0.015162,0.036574,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.98222,0.015055,0.0085229,0,0
5,GO COAGULATION,0.86649,0.014922,0.0024035,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.84424,0.014794,0.019022,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.93704,0.014785,0.002369,0,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.90488,0.014373,-0.00073933,0,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.40286,0.014315,0.057473,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.88565,0.01431,0.0081309,0,0
5,GO GASTRIC ACID SECRETION,0.28578,0.014301,0.065309,0,0
5,GO BLASTOCYST GROWTH,0.80326,0.014217,0.012961,0,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.48215,0.014136,0.024758,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.98222,0.014026,0.016978,0,0
5,GO RECEPTOR CATABOLIC PROCESS,0.92738,0.01393,0.00072638,0,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.71089,0.013881,0.017461,0,0
5,GO MATURATION OF 5 8S RRNA,0.17669,0.013805,-0.11176,0,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.97253,0.013782,-0.0018806,0,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.73517,0.013663,-0.018124,0,0
5,GO ORGANIC ACID CATABOLIC PROCESS,0.61402,0.013561,0.017204,0,0
5,GO STEROID BIOSYNTHETIC PROCESS,0.94993,0.013466,-0.00063332,0,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.34008,0.013416,0.086998,0,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.92738,0.013393,0.0042498,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.89526,0.013392,0.0020141,0,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.42602,0.013301,0.055523,0,0
5,GO RIBOSOME BIOGENESIS,0.25924,0.013282,-0.083981,0,0
5,GO REGULATION OF VACUOLE ORGANIZATION,0.8379,0.0132,0.017556,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.98869,0.013121,0.014452,0,0
5,GO REGULATION OF LIPID TRANSPORT,0.50516,0.013115,0.032435,0,0
5,GO LYMPHOCYTE COSTIMULATION,0.94671,0.01311,0.0024204,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.10912,0.012947,-0.084097,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.92094,0.012929,-0.0006342,0,0
5,GO SNRNA PROCESSING,0.81896,0.012914,-0.047649,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.98546,0.012861,0.0074621,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.49743,0.012856,-0.050738,0,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.96607,0.012752,-0.0019135,0,0
5,GO HISTONE H2B UBIQUITINATION,0.68988,0.012738,0.031124,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.39156,0.012736,0.083844,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.27317,0.012649,0.10151,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.27317,0.012622,0.06349,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.58029,0.012569,0.033075,0,0
5,GO CRISTAE FORMATION,0.44269,0.012533,-0.036847,0,0
5,GO SLEEP,0.36098,0.01253,0.045828,0,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.61687,0.012522,-0.018382,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.6312,0.012436,0.031981,0,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.8379,0.012292,-0.0050286,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.86012,0.012236,-0.013829,0,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.81581,0.012202,0.023384,0,0
5,GO ACID SECRETION,0.091558,0.01218,0.1006,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.797,0.011993,-0.0037848,0,0
5,GO CELLULAR KETONE METABOLIC PROCESS,0.93382,0.011921,0.0059078,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.40743,0.011844,0.03957,0,0
5,GO PEROXISOME ORGANIZATION,0.61687,0.011674,-0.023613,0,0
5,GO VIRAL TRANSLATION,0.48215,0.011641,-0.05918,0,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.9693,0.01159,0.0021847,0,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.74435,0.01153,-0.02325,0,0
5,GO MAST CELL MEDIATED IMMUNITY,0.87926,0.011315,0.0012153,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.90809,0.011264,-0.0050774,0,0
5,GO RESPONSE TO CADMIUM ION,0.93382,0.011191,0.00026943,0,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.75048,0.01114,0.023418,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.77519,0.011082,-0.0056832,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.094715,0.011008,0.11559,0,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.84741,0.010827,0.019769,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.81581,0.01067,0.012243,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.50516,0.010564,0.03832,0,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.99838,0.010557,0.0019237,0,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.72907,0.010408,-0.029238,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.94671,0.010406,0.0013421,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.84424,0.010277,0.015053,0,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.50776,0.01025,0.028336,0,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.7659,0.010186,-0.010283,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.76281,0.010178,0.012794,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.52082,0.01011,0.029416,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.32792,0.010107,0.036946,0,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.44028,0.010102,-0.062061,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.99515,0.010098,0.010861,0,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.71391,0.010056,-0.016608,0,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.92094,0.0098588,0.0065437,0,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.5314,0.0098423,0.033859,0,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.3739,0.0097602,0.0512,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.97253,0.009403,0.0041264,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.18327,0.0093524,0.088856,0,0
5,GO KERATINOCYTE DIFFERENTIATION,0.4451,0.0093302,0.033735,0,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.85694,0.009027,0.01242,0,0
5,GO LEUKOTRIENE METABOLIC PROCESS,0.58307,0.0087728,-0.033734,0,0
5,GO FATTY ACID HOMEOSTASIS,0.7814,0.0087445,0.024719,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.35253,0.0085825,0.13996,0,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.73212,0.0085498,0.022463,0,0
5,GO ENDOCRINE PROCESS,0.99192,0.0085315,0.0060817,0,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.31604,0.0085042,0.048271,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.93704,0.008484,0.00036632,0,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.86331,0.0083254,0.0086138,0,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.7659,0.0080649,0.013632,0,0
5,GO ORGANIC ACID TRANSPORT,0.40743,0.0079296,0.040554,0,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.93704,0.0078308,0.017383,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.70185,0.0076956,0.018031,0,0
5,GO LYSOSOME LOCALIZATION,0.69586,0.007634,0.028645,0,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.5394,0.0076231,-0.027121,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.46218,0.0075564,0.035662,0,0
5,GO TISSUE REGENERATION,0.45727,0.0075525,0.039707,0,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.35886,0.0072764,0.033237,0,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.59424,0.0072589,0.026955,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.93382,0.0072522,0.014476,0,0
5,GO SECONDARY METABOLIC PROCESS,0.33194,0.0072488,0.062446,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.80639,0.0071925,-0.010469,0,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.75972,0.007126,-0.0038791,0,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.95316,0.0070773,0.02034,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.83474,0.006944,0.013542,0,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.47461,0.0069248,0.038292,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.88565,0.0069122,-0.0070655,0,0
5,GO REGULATION OF CELL CELL ADHESION,0.78451,0.0068888,0.015121,0,0
5,GO RESPONSE TO AMINE,0.77829,0.0068371,0.013039,0,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.47963,0.0066553,-0.03386,0,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.97899,0.0066117,-0.012719,0,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.44269,0.0064946,0.040878,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.85376,0.0064856,-0.023176,0,0
5,GO REGULATION OF RESPONSE TO WOUNDING,0.59144,0.0063965,0.03954,0,0
5,GO VACUOLE ORGANIZATION,0.73517,0.006358,0.024888,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.28578,0.0061146,-0.036611,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.44994,0.0060827,0.062743,0,0
5,GO PEPTIDYL ARGININE METHYLATION,0.97253,0.0060198,0.0038582,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.69586,0.0059928,0.05017,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.7659,0.005985,-0.0071603,0,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.65734,0.0059696,-0.031781,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.85376,0.0058245,-0.0097128,0,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.68689,0.0056965,-0.026928,0,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.89846,0.0056589,-0.0056602,0,0
5,GO HUMORAL IMMUNE RESPONSE,0.28761,0.0056397,-0.054816,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.81267,0.005639,-0.014568,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.63986,0.0055885,0.036861,0,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.69286,0.0053969,0.022985,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.82842,0.0052846,0.010399,0,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.92094,0.005278,-0.0032816,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.74741,0.0052361,-0.0072753,0,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.51819,0.0051883,0.041538,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.71089,0.0051881,0.042595,0,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.74741,0.0051702,-0.0037624,0,0
5,GO PROTEIN MATURATION,0.94671,0.0050632,0.0055114,0,0
5,GO ARGININE METABOLIC PROCESS,0.84741,0.0047956,0.015735,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.81267,0.004669,0.027737,0,0
5,GO RESPONSE TO DEXAMETHASONE,0.85059,0.0046649,0.013022,0,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.89205,0.0044666,0.0056669,0,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.92416,0.0044509,-0.0019679,0,0
5,GO REGULATION OF CHEMOTAXIS,0.67798,0.0043668,0.030778,0,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.6515,0.0042618,-0.014754,0,0
5,GO PEROXISOMAL TRANSPORT,0.43789,0.0041061,-0.033689,0,0
5,GO PROTEIN O LINKED GLYCOSYLATION,0.86649,0.0040768,-0.016433,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.69586,0.0040475,-0.0085196,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.56925,0.0039691,0.077097,0,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.74741,0.0039053,-0.0086344,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.71996,0.0037924,0.020547,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.34008,0.0036983,0.082549,0,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.64567,0.003632,0.037636,0,0
5,GO SNORNA METABOLIC PROCESS,0.9306,0.0034855,-0.019683,0,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.97899,0.0034283,-0.0099537,0,0
5,GO ZINC ION TRANSPORT,0.97899,0.0034095,0.0089685,0,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.78451,0.0033696,-0.033757,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.97576,0.0032661,0.010998,0,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.85376,0.0032594,0.021593,0,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.7659,0.0031843,-0.0077576,0,0
5,GO MEMBRANE FUSION,0.83158,0.0029943,0.025267,0,0
5,GO RETINOL METABOLIC PROCESS,0.43312,0.0029331,-0.052536,0,0
5,GO IRON ION TRANSPORT,0.93704,0.0028639,0.014802,0,0
5,GO RESPONSE TO CYTOKINE,0.40286,0.002655,-0.031524,0,0
5,GO RESPONSE TO VITAMIN,0.58864,0.0025972,0.041787,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.72907,0.0025714,0.003684,0,0
5,GO DEFENSE RESPONSE,0.48468,0.0024833,-0.026309,0,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.572,0.0024258,-0.014696,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.67206,0.0023131,0.019281,0,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.99515,0.0021624,0.00090157,0,0
5,GO KERATINIZATION,0.797,0.002005,0.0097194,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.46962,0.0019061,0.046495,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.64567,0.0018932,0.033048,0,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.95639,0.0018438,0.0091603,0,0
5,GO PROTEIN FOLDING,0.70486,0.0017967,-0.014113,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.94348,0.0017565,0.0019285,0,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.95639,0.0017059,0.0028247,0,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.80639,0.0015013,0.013436,0,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.46962,0.0014957,0.041839,0,0
5,GO DEFENSE RESPONSE TO VIRUS,0.75356,0.0013751,-0.025864,0,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.4451,0.0010434,-0.022998,0,0
5,GO REGULATION OF HEART RATE,0.5,0.0008729,0.046311,0,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.99838,0.00060394,-0.0019405,0,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.96284,0.00058189,0.0081368,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.93382,0.00051459,0.015799,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.45482,0.00047637,0.052799,0,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.94026,0.00040366,0.0033711,0,0
5,GO INTERLEUKIN 4 PRODUCTION,0.46713,0.00030623,-0.044302,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.79387,0.00026608,0.020849,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.98546,0.00011763,0.00023081,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.98222,7.9621e-05,0.016684,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.90488,7.4279e-05,0.012332,0,0
5,GO CELL ACTIVATION,0.6691,3.8617e-05,-0.012952,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.97899,-2.8742e-05,0.0042145,0,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.82211,-7.5362e-05,0.016844,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.71089,-0.00010654,0.027962,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.7814,-0.00019667,0.024879,0,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.66321,-0.00022317,0.062471,0,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.63697,-0.00033529,-0.019787,0,0
5,GO NIK NF KAPPAB SIGNALING,0.4451,-0.00040179,-0.036237,0,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.6312,-0.00060502,-0.018568,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.32393,-0.00060616,0.13717,0,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.82211,-0.000708,0.0092689,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.95961,-0.00076553,0.0045535,0,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.82211,-0.00076986,0.017785,0,0
5,GO PH REDUCTION,0.70486,-0.00080175,0.020144,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.71996,-0.00082756,-0.020428,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.74435,-0.00086275,0.029565,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.85376,-0.00086888,-0.0066776,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.36741,-0.0008951,-0.044621,0,0
5,GO TOXIN TRANSPORT,0.22348,-0.00095959,0.068786,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.92738,-0.00096666,0.0089099,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.95316,-0.0011172,-0.0024994,0,0
5,GO RESPONSE TO BIOTIC STIMULUS,0.37173,-0.0011737,-0.035496,0,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.76899,-0.0011756,-0.0093587,0,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.79075,-0.0011989,0.019917,0,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.78451,-0.0012202,0.012908,0,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.5583,-0.001293,-0.031963,0,0
5,GO PEPTIDE METABOLIC PROCESS,0.36098,-0.0013013,-0.032581,0,0
5,GO PHAGOCYTOSIS RECOGNITION,0.50258,-0.0013589,0.048184,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.23766,-0.0014598,0.059703,0,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.62545,-0.0015224,0.045907,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.54746,-0.0015851,-0.022524,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.52345,-0.001618,0.032781,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.81896,-0.001696,0.011951,0,0
5,GO SULFATE TRANSPORT,0.69586,-0.0017316,0.026256,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.62832,-0.0017594,0.035051,0,0
5,GO REGULATION OF CELLULAR PH,0.80012,-0.0018286,0.018152,0,0
5,GO REGULATION OF CELL ACTIVATION,0.93382,-0.0018723,-0.002811,0,0
5,GO RESPONSE TO ANGIOTENSIN,0.43789,-0.0020069,-0.04306,0,0
5,GO REGULATION OF LIPASE ACTIVITY,0.52345,-0.0020715,-0.017476,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.68094,-0.0021124,-0.016363,0,0
5,GO RESPONSE TO DIETARY EXCESS,0.91451,-0.0021322,0.00037567,0,0
5,GO REGULATION OF DEFENSE RESPONSE,0.43075,-0.0021537,-0.029344,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.75356,-0.0021806,-0.029841,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.80012,-0.0023908,-0.009649,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65442,-0.0023992,0.027416,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.64858,-0.0024854,0.039961,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.71391,-0.0025479,0.0094611,0,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.1146,-0.0026899,-0.10667,0,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.63697,-0.0026948,0.02893,0,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.94671,-0.0027276,0.0088467,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.46218,-0.0027299,-0.036812,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.69586,-0.0027683,0.027964,0,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.94671,-0.0027729,-0.0010144,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.7659,-0.0028258,0.017776,0,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.47461,-0.0028417,-0.016133,0,0
5,GO NECROTIC CELL DEATH,0.42838,-0.003165,-0.036511,0,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.61687,-0.0032461,-0.024659,0,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.5314,-0.003468,-0.02108,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.74741,-0.0035483,0.021313,0,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.9693,-0.0036626,0.020208,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.63408,-0.0036702,-0.02093,0,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.68988,-0.0037251,0.034926,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.78451,-0.0038737,0.0195,0,0
5,GO VIRAL BUDDING,0.77209,-0.0039851,0.025739,0,0
5,GO DE NOVO PROTEIN FOLDING,0.96607,-0.0040935,0.0075983,0,0
5,GO CYTOKINE SECRETION,0.61972,-0.0041022,-0.015383,0,0
5,GO RESPONSE TO CORTICOSTERONE,0.98222,-0.0041734,0.0098531,0,0
5,GO PROTEIN NITROSYLATION,0.32195,-0.0042909,-0.080471,0,0
5,GO LINOLEIC ACID METABOLIC PROCESS,0.71693,-0.0045196,-0.041532,0,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.30255,-0.0045466,0.086421,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.82526,-0.004615,0.018493,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.64567,-0.0047097,-0.015811,0,0
5,GO KETONE BIOSYNTHETIC PROCESS,0.99838,-0.0047282,-0.0061874,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.84424,-0.0047847,-0.00048452,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.61687,-0.0048003,0.033963,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.83474,-0.0048035,-0.0087645,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.36741,-0.0048095,0.064069,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.77209,-0.0048228,0.018613,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.76281,-0.0048431,-0.0019335,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.98222,-0.0048453,7.6579e-05,0,0
5,GO REGULATION OF EXCRETION,0.38047,-0.0048631,0.060782,0,0
5,GO CELLULAR EXTRAVASATION,0.63408,-0.0051039,-0.015318,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.51296,-0.0053775,-0.040723,0,0
5,GO TISSUE REMODELING,0.75356,-0.0056593,-0.008497,0,0
5,GO REGULATION OF PROTEIN MATURATION,0.92738,-0.0057307,0.0035208,0,0
5,GO ORGANIC ACID METABOLIC PROCESS,0.85059,-0.0057563,0.009883,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.67501,-0.0057771,0.050485,0,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.97576,-0.0060202,0.0020482,0,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.85694,-0.0060364,0.026274,0,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.51557,-0.0061849,-0.056777,0,0
5,GO PLATELET ACTIVATION,0.93382,-0.0062558,0.02168,0,0
5,GO REGULATION OF PHAGOCYTOSIS,0.63697,-0.0063816,-0.023929,0,0
5,GO INTERLEUKIN 6 PRODUCTION,0.83158,-0.0064409,-0.0046455,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72603,-0.0064708,0.01032,0,0
5,GO TRANSITION METAL ION TRANSPORT,1,-0.0064972,0.0099056,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.68392,-0.0065216,-0.041433,0,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.74128,-0.0065403,-0.0051802,0,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.77209,-0.006598,0.015451,0,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.3871,-0.0066899,-0.047195,0,0
5,GO BLASTOCYST FORMATION,0.80639,-0.0066926,0.00016725,0,0
5,GO LYMPH NODE DEVELOPMENT,0.94993,-0.006769,0.01754,0,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.70787,-0.0067822,0.023918,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.42838,-0.0068799,0.043518,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.94671,-0.0069184,0.0063422,0,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.9306,-0.0069921,0.0047019,0,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.89526,-0.0070187,0.0024614,0,0
5,GO RESPONSE TO LITHIUM ION,0.38047,-0.0071047,0.11789,0,0
5,GO ANIMAL ORGAN REGENERATION,0.7814,-0.0071479,0.015624,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66321,-0.007168,0.02683,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.52082,-0.0071966,-0.039521,0,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.71391,-0.0072107,-0.038716,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.67798,-0.0072685,-0.016657,0,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.50516,-0.0073458,-0.028933,0,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.91451,-0.0073808,0.013623,0,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.26267,-0.0074315,-0.080492,0,0
5,GO RESPONSE TO HYPEROXIA,0.65442,-0.0074511,0.041751,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.86012,-0.0074643,-0.022339,0,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.92094,-0.0075998,-0.0044677,0,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.39381,-0.0077214,-0.023936,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.63697,-0.0077285,-0.038511,0,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.84741,-0.0078088,0.020371,0,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.93704,-0.0078521,0.03381,0,0
5,GO SELECTIVE AUTOPHAGY,0.67798,-0.0080102,0.023473,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.67206,-0.0080548,0.050933,0,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.70486,-0.0080723,0.023686,0,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.32592,-0.0080765,-0.096828,0,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.8379,-0.0081482,0.0093424,0,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.3739,-0.008189,-0.06894,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.90488,-0.0082875,0.015135,0,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.82526,-0.0083825,-0.0088568,0,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.6691,-0.0084414,-0.021747,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.42367,-0.0085404,0.054604,0,0
5,GO ACTIN NUCLEATION,0.6312,-0.0085441,-0.0067087,0,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.2913,-0.0085597,-0.038402,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.34213,-0.0086352,0.075948,0,0
5,GO REGULATION OF STEROL TRANSPORT,0.6055,-0.0086436,-0.032881,0,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.92738,-0.0086954,-0.012692,0,0
5,GO RESPONSE TO ATP,0.90809,-0.0087493,0.018627,0,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.45238,-0.0087594,-0.023661,0,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.54746,-0.00892,-0.053105,0,0
5,GO MUSCLE CELL PROLIFERATION,0.90488,-0.0089478,0.013194,0,0
5,GO GTP METABOLIC PROCESS,0.37608,-0.0089891,-0.042424,0,0
5,GO I KAPPAB PHOSPHORYLATION,0.5583,-0.0090501,-0.032339,0,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.98869,-0.0091498,0.012309,0,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.90167,-0.0092023,-0.0013002,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.80639,-0.0092076,-0.002332,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.70185,-0.0092664,-0.0077213,0,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.47211,-0.0094831,-0.013839,0,0
5,GO TRANSFERRIN TRANSPORT,0.86331,-0.0094842,0.023442,0,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.77209,-0.0095432,0.012551,0,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.84424,-0.009633,0.017137,0,0
5,GO SYNCYTIUM FORMATION,0.88565,-0.0097156,0.0090974,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.61117,-0.0097433,-0.012515,0,0
5,GO BONE RESORPTION,0.30255,-0.0097678,-0.049677,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.36526,-0.0099352,0.078004,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.9306,-0.010028,0.021171,0,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.60834,-0.010033,-0.035248,0,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.98222,-0.010046,0.015089,0,0
5,GO RESPONSE TO ZINC ION,0.80639,-0.010065,-0.020785,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.71391,-0.010165,-0.020314,0,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.69286,-0.010405,0.032602,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.10646,-0.010494,-0.11844,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.93704,-0.010526,0.017816,0,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.34008,-0.010835,-0.040695,0,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.75972,-0.01085,-0.0094073,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.82211,-0.01095,-0.00072267,0,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.42838,-0.010963,-0.047461,0,0
5,GO DENDRITIC CELL CHEMOTAXIS,0.60834,-0.01103,0.03338,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.81267,-0.011037,-0.015293,0,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.52345,-0.011054,-0.02347,0,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.52082,-0.011088,-0.017675,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.44269,-0.011094,-0.047503,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.86968,-0.011095,0.015343,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.78763,-0.011217,0.035811,0,0
5,GO BONE REMODELING,0.81896,-0.011297,-0.0065604,0,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.57752,-0.011321,-0.038218,0,0
5,GO AMINO ACID ACTIVATION,0.084763,-0.011415,-0.11445,0,0
5,GO RESPONSE TO VIRUS,0.68988,-0.011501,-0.024907,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.49743,-0.011527,-0.033196,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.97253,-0.01154,-0.02327,0,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.67798,-0.011654,0.044025,0,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.45972,-0.011656,-0.031317,0,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.98222,-0.011676,0.0090441,0,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.37827,-0.011729,-0.035277,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.14197,-0.011766,-0.085456,0,0
5,GO REGULATION OF T CELL ACTIVATION,0.89526,-0.011774,-0.0079707,0,0
5,GO CORNIFICATION,0.98869,-0.011776,-0.010878,0,0
5,GO RESPONSE TO ISCHEMIA,0.5583,-0.01184,0.041539,0,0
5,GO CELLULAR RESPONSE TO DSRNA,0.40743,-0.011952,-0.04643,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.58585,-0.012088,-0.027684,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67501,-0.012134,0.002517,0,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.63408,-0.012194,-0.040761,0,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.2913,-0.012206,-0.054291,0,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.29502,-0.012215,-0.039094,0,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.35253,-0.01231,-0.049406,0,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.73517,-0.012368,0.027941,0,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.97253,-0.012389,0.028101,0,0
5,GO PROTEIN DEGLYCOSYLATION,0.72299,-0.01243,-0.023577,0,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.28213,-0.012457,-0.096304,0,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.95961,-0.012509,0.0089352,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.94993,-0.012533,0.030418,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.27317,-0.012586,-0.062727,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.65734,-0.012642,-0.0077311,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.78763,-0.012724,-0.016006,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.98222,-0.012794,0.0036182,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.5,-0.012799,-0.034698,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.80953,-0.012813,-0.0077878,0,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.55016,-0.012914,-0.01414,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.34835,-0.013337,-0.048808,0,0
5,GO PEPTIDE CATABOLIC PROCESS,0.53406,-0.013351,-0.022193,0,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.94348,-0.013503,-0.0028395,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.87926,-0.013538,-0.0069446,0,0
5,GO OXIDATION REDUCTION PROCESS,0.76281,-0.013572,-0.0091509,0,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.21889,-0.013635,-0.071819,0,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.35886,-0.013669,-0.047821,0,0
5,GO CELL CELL RECOGNITION,0.38488,-0.0137,-0.024334,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.97576,-0.013765,0.0045351,0,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.72299,-0.013816,-0.0095581,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.5665,-0.013903,-0.0036183,0,0
5,GO NUCLEOSIDE SALVAGE,0.75972,-0.013948,-0.010762,0,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.36741,-0.014043,-0.050421,0,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.39156,-0.01405,-0.028469,0,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.35253,-0.014051,-0.062038,0,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.67206,-0.014069,-0.016883,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.71693,-0.01414,-0.0055073,0,0
5,GO NEUROINFLAMMATORY RESPONSE,0.87926,-0.014155,-0.00304,0,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.69885,-0.014165,-0.021923,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.75356,-0.014184,0.01994,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.51296,-0.0142,-0.014644,0,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.85059,-0.014276,-0.0067596,0,0
5,GO MIDBODY ABSCISSION,0.97899,-0.014394,0.019289,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.68094,-0.014447,0.032519,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.47963,-0.014512,-0.046348,0,0
5,GO CGMP MEDIATED SIGNALING,0.99515,-0.01452,0.0096528,0,0
5,GO ENDOTHELIAL CELL MIGRATION,0.93382,-0.014569,0.010368,0,0
5,GO MYOBLAST FUSION,0.54746,-0.014624,-0.031457,0,0
5,GO RESPONSE TO TOXIC SUBSTANCE,0.74741,-0.014656,0.018674,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.80953,-0.014776,-0.001424,0,0
5,GO PROTEIN PROCESSING,0.46962,-0.014842,-0.017354,0,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.40973,-0.015159,-0.056246,0,0
5,GO VESICLE BUDDING FROM MEMBRANE,0.62258,-0.015182,-0.011727,0,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.073043,-0.0152,-0.095605,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.86649,-0.01532,0.019157,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.72299,-0.015429,-0.013683,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.71391,-0.015565,-0.013378,0,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.61972,-0.015978,-0.046117,0,0
5,GO TRANSLATIONAL INITIATION,0.22348,-0.016045,-0.083686,0,0
5,GO VESICLE CARGO LOADING,0.92738,-0.016339,0.00054733,0,0
5,GO AMYLOID BETA FORMATION,0.75972,-0.016346,0.040906,0,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.61972,-0.016462,-0.0046424,0,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.51035,-0.016488,-0.031367,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.4451,-0.016534,-0.039191,0,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.31997,-0.016558,-0.033672,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.39606,-0.01665,-0.017822,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.94348,-0.01674,-0.0078289,0,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.94348,-0.016836,0.00067338,0,0
5,GO RESPONSE TO AMPHETAMINE,0.61687,-0.01686,0.038219,0,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.45972,-0.017052,-0.056794,0,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.67798,-0.017053,-0.016487,0,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.74741,-0.017245,-0.0098981,0,0
5,GO REGULATION OF IMMUNE RESPONSE,0.29689,-0.017247,-0.039184,0,0
5,GO LEUKOCYTE HOMEOSTASIS,0.32592,-0.01729,-0.032253,0,0
5,GO PHOSPHATE ION TRANSPORT,0.72907,-0.017345,0.0072126,0,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.83474,-0.017361,-0.010766,0,0
5,GO ZYMOGEN INHIBITION,0.54477,-0.017361,-0.060527,0,0
5,GO AMYLOID FIBRIL FORMATION,0.94026,-0.017408,0.018236,0,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.42602,-0.01742,-0.056325,0,0
5,GO INFLAMMATORY RESPONSE,0.34213,-0.017542,-0.035241,0,0
5,GO DIOL METABOLIC PROCESS,0.86331,-0.01755,0.025133,0,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.79075,-0.01757,0.003837,0,0
5,GO RESPONSE TO CAMP,0.62832,-0.017593,0.035636,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.26095,-0.017607,-0.035637,0,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.15214,-0.017719,-0.08193,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.88565,-0.01782,-0.015211,0,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.24416,-0.017861,-0.073013,0,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.3739,-0.017874,-0.017264,0,0
5,GO ENTRY INTO HOST,0.28033,-0.017898,-0.070058,0,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.36956,-0.017913,-0.072804,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.76281,-0.017995,0.044,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.73822,-0.018053,0.0084106,0,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.78763,-0.018096,-0.026928,0,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.25753,-0.018236,-0.051441,0,0
5,GO REGULATION OF BONE REMODELING,0.75356,-0.018268,-0.016633,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.67501,-0.018376,-0.0026472,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.75664,-0.018433,-0.020201,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.68988,-0.018644,-0.013782,0,0
5,GO REGULATION OF ODONTOGENESIS,0.99515,-0.018657,-0.01491,0,0
5,GO CHOLESTEROL EFFLUX,0.65442,-0.018757,0.028848,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.68392,-0.018762,-0.012516,0,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.79387,-0.018885,-0.014341,0,0
5,GO STEROID ESTERIFICATION,0.35886,-0.018898,-0.085104,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.67798,-0.018933,-0.029085,0,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.37173,-0.018969,-0.039988,0,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.69586,-0.019029,-0.033751,0,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.46713,-0.019053,-0.028159,0,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.28761,-0.019562,-0.044804,0,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.38267,-0.019594,-0.045663,0,0
5,GO SNORNA 3 END PROCESSING,0.70486,-0.019633,-0.037236,0,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.52345,-0.019637,-0.033897,0,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.71996,-0.019653,0.024638,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.91772,-0.019677,0.036097,0,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.23927,-0.019844,-0.060729,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.84107,-0.019868,0.00054198,0,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.26614,-0.020176,-0.065037,0,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.27673,-0.0202,-0.078658,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.84741,-0.020244,0.011864,0,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.85694,-0.020756,-0.0093684,0,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.5,-0.020783,-0.031663,0,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.77519,-0.020803,0.0011359,0,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.36526,-0.020877,-0.038442,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.72299,-0.020888,-0.02036,0,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.46466,-0.020925,-0.031899,0,0
5,GO AMINE CATABOLIC PROCESS,0.41899,-0.020983,-0.062689,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.58864,-0.021125,-0.015272,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.90488,-0.021136,-0.0051414,0,0
5,GO MEMBRANE INVAGINATION,0.60268,-0.021226,-0.016678,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.54477,-0.021419,-0.031201,0,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.92416,-0.021421,0.0012324,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.85059,-0.021523,0.0015312,0,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.48468,-0.021529,-0.053392,0,0
5,GO AUTOPHAGOSOME MATURATION,0.77829,-0.021563,-0.00065567,0,0
5,GO HYPOTONIC RESPONSE,0.59986,-0.021621,0.068748,0,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.94671,-0.02187,0.0013969,0,0
5,GO MUSCLE CELL FATE COMMITMENT,0.318,-0.021903,-0.08056,0,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.36956,-0.021973,-0.035278,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1653,-0.022072,-0.058526,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.54477,-0.022082,-0.04347,0,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.53672,-0.022227,-0.035917,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.36956,-0.022245,-0.032331,0,0
5,GO AMYLOID BETA METABOLIC PROCESS,0.76899,-0.022646,0.00395,0,0
5,GO MICROVILLUS ORGANIZATION,0.82211,-0.022696,-0.013406,0,0
5,GO REGULATION OF GASTRULATION,0.80639,-0.022761,0.01731,0,0
5,GO CYTOKINE PRODUCTION,0.44994,-0.022786,-0.033522,0,0
5,GO PLATELET AGGREGATION,0.37608,-0.02283,-0.035687,0,0
5,GO DENDRITIC CELL MIGRATION,0.65442,-0.022901,0.027583,0,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.72907,-0.022906,-0.022644,0,0
5,GO VITAMIN METABOLIC PROCESS,0.35043,-0.022955,-0.021629,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.78451,-0.023193,0.031153,0,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.51819,-0.023201,-0.040617,0,0
5,GO POSITIVE REGULATION OF CELL ADHESION,0.70185,-0.023283,-0.013886,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.37827,-0.02358,-0.023385,0,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.48468,-0.023585,-0.060726,0,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.7659,-0.023626,-0.010886,0,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.72907,-0.023649,-0.0082529,0,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.6515,-0.023793,-0.027159,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.54746,-0.023934,-0.046034,0,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.3442,-0.023971,-0.037728,0,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.48215,-0.023992,-0.029426,0,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.19697,-0.024113,-0.061043,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.55287,-0.024167,-0.039298,0,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.57476,-0.024257,-0.029649,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.75972,-0.02428,0.021512,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.74435,-0.024351,0.001312,0,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.68094,-0.024409,-0.016679,0,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.32393,-0.024525,-0.060826,0,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.49231,-0.024787,-0.028262,0,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.15447,-0.024812,-0.063175,0,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.75048,-0.024849,-0.017684,0,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.66616,-0.024869,0.036111,0,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.36956,-0.024912,-0.076112,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.8379,-0.024996,-0.016288,0,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.55016,-0.025431,-0.034194,0,0
5,GO CYTOPLASMIC TRANSLATION,0.40058,-0.025762,-0.066347,0,0
5,GO REGULATION OF WOUND HEALING,0.7814,-0.025847,-0.0038719,0,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.31604,-0.025911,-0.040478,0,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.40743,-0.026052,-0.03411,0,0
5,GO RESPONSE TO ACIDIC PH,0.35043,-0.026159,-0.066079,0,0
5,GO INTESTINAL ABSORPTION,0.78451,-0.026271,-0.014,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.72299,-0.026661,-0.030388,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.36098,-0.026671,-0.039003,0,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.4451,-0.026708,-0.018618,0,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.39832,-0.026727,-0.050362,0,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.38933,-0.026742,-0.043131,0,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.31021,-0.026978,-0.057279,0,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.74128,-0.027014,-0.013292,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.35674,-0.027129,-0.069804,0,0
5,GO INTERACTION WITH SYMBIONT,0.31604,-0.027206,-0.041014,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.63408,-0.027645,0.040259,0,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.73517,-0.027676,-0.010573,0,0
5,GO HEART TRABECULA FORMATION,0.54208,-0.027687,-0.047052,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.61117,-0.027689,-0.018442,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.79075,-0.027691,-0.008073,0,0
5,GO RESPONSE TO INTERLEUKIN 18,0.56103,-0.027723,-0.072898,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.11092,-0.027801,-0.10034,0,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.71391,-0.028162,-0.041234,0,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.90167,-0.028229,0.011152,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.63986,-0.028245,-0.020362,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.90488,-0.028311,-0.014316,0,0
5,GO HYALURONAN METABOLIC PROCESS,0.58029,-0.028449,-0.021702,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.80639,-0.028457,0.0099387,0,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.23927,-0.028482,-0.037666,0,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.47211,-0.028541,-0.025962,0,0
5,GO RESPONSE TO REDOX STATE,0.81896,-0.028541,-0.0059175,0,0
5,GO RESPONSE TO THYROID HORMONE,0.32393,-0.028612,-0.074778,0,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.53672,-0.028746,-0.017074,0,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.1653,-0.028786,-0.064834,0,0
5,GO RIG I SIGNALING PATHWAY,0.14869,-0.028798,-0.073837,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.88245,-0.028906,0.0038865,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.8379,-0.028919,-0.00011521,0,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.51035,-0.029448,-0.048411,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.86331,-0.029566,0.0095833,0,0
5,GO PHAGOCYTOSIS,0.22348,-0.029567,-0.043609,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.61687,-0.029815,-0.0040994,0,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.49743,-0.029971,-0.020128,0,0
5,GO GLIAL CELL ACTIVATION,0.41203,-0.030029,-0.032841,0,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.36098,-0.030064,-0.086234,0,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.32393,-0.03043,-0.04416,0,0
5,GO BIOLOGICAL PHASE,0.86012,-0.030497,0.0016519,0,0
5,GO REGULATION OF VESICLE FUSION,0.69586,-0.030635,-0.02519,0,0
5,GO REGULATION OF RECEPTOR BINDING,0.9113,-0.030973,0.016569,0,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.64276,-0.031009,-0.015989,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.94348,-0.031011,-0.01125,0,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.36956,-0.031209,-0.042223,0,0
5,GO SEQUESTERING OF CALCIUM ION,0.7814,-0.031507,0.00048881,0,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.33803,-0.031684,-0.08761,0,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.2458,-0.031691,-0.06109,0,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.14869,-0.031879,-0.074821,0,0
5,GO EMBRYO IMPLANTATION,0.43075,-0.031909,-0.033339,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.40973,-0.031914,-0.039552,0,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.63986,-0.031933,-0.03596,0,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.55016,-0.031953,-0.013784,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.38267,-0.032114,-0.032864,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.40973,-0.032146,-0.042997,0,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.54208,-0.032274,-0.02569,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.84424,-0.032302,0.026885,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.48722,-0.032337,-0.020745,0,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.71996,-0.032381,-0.023235,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.85694,-0.032472,0.0041034,0,0
5,GO MACROPHAGE PROLIFERATION,0.96607,-0.032507,0.01178,0,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.14308,-0.03252,-0.087391,0,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.178,-0.032526,-0.065634,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.06986,-0.032695,-0.14051,0,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.57476,-0.032816,-0.02281,0,0
5,GO PLASMA MEMBRANE FUSION,0.42133,-0.033145,-0.077284,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.23927,-0.033155,-0.051056,0,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.48976,-0.033224,-0.017692,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.46466,-0.033264,-0.039329,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.54477,-0.033273,-0.010827,0,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.11837,-0.033273,-0.070029,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.72907,-0.033305,-0.0013433,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.1146,-0.033519,-0.094027,0,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.49231,-0.033631,-0.022529,0,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.36526,-0.033756,-0.057799,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.31215,-0.033772,-0.033404,0,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.22348,-0.033847,-0.053322,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.39832,-0.0339,-0.037463,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.21889,-0.033953,-0.073783,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.72299,-0.034165,0.02045,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,1,-0.034173,0.02498,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.20845,-0.034263,-0.052683,0,0
5,GO REGULATION OF RUFFLE ASSEMBLY,0.99192,-0.034319,0.017313,0,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.68988,-0.034326,-0.033133,0,0
5,GO LEUKOCYTE CELL CELL ADHESION,0.5,-0.034337,-0.034346,0,0
5,GO IMMUNOGLOBULIN SECRETION,0.36956,-0.034365,-0.04878,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.54208,-0.034517,-0.026709,0,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.98869,-0.034624,0.022998,0,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.55558,-0.034674,-0.036108,0,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.21738,-0.034741,-0.043377,0,0
5,GO ICOSANOID METABOLIC PROCESS,0.18194,-0.034824,-0.08032,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.19278,-0.03519,-0.067414,0,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.45238,-0.035211,-0.044185,0,0
5,GO STEROID CATABOLIC PROCESS,0.68988,-0.035266,-0.018786,0,0
5,GO AMYLOID BETA CLEARANCE,0.70486,-0.035405,-0.021518,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.93382,-0.035447,0.01321,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.82526,-0.035531,-0.026218,0,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.22814,-0.035557,-0.071318,0,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.49231,-0.035598,-0.048857,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.098784,-0.035644,-0.081789,0,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.15921,-0.035726,-0.051361,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.67206,-0.035841,0.14925,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.26789,-0.035897,-0.046314,0,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.45238,-0.035969,-0.025573,0,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.9113,-0.035976,-0.014437,0,0
5,GO CELLULAR RESPONSE TO DRUG,0.35043,-0.036031,-0.012144,0,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.37173,-0.036237,-0.03996,0,0
5,GO RESPONSE TO TUMOR CELL,0.19838,-0.03627,-0.087006,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.72299,-0.036305,-0.0054196,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.28395,-0.036483,-0.057459,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.56376,-0.036503,-0.013602,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.86649,-0.036548,0.015068,0,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.43075,-0.036612,-0.065969,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.84741,-0.036649,-0.00056054,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.72603,-0.03688,-0.017498,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.73517,-0.036911,-0.011499,0,0
5,GO REGULATION OF FERTILIZATION,0.84741,-0.036971,0.020012,0,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.49231,-0.037113,-0.031967,0,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.98546,-0.037178,0.017937,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.20992,-0.037389,-0.062518,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.35463,-0.037391,-0.045837,0,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.19557,-0.037464,-0.092589,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.52345,-0.037797,-0.029021,0,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.3739,-0.037865,-0.05099,0,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.41434,-0.037905,-0.03326,0,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.30446,-0.037927,-0.046607,0,0
5,GO CELL CHEMOTAXIS,0.43075,-0.03803,-0.025048,0,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.10558,-0.03803,-0.049923,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.3739,-0.038161,-0.044129,0,0
5,GO SPERM EGG RECOGNITION,0.43075,-0.038209,-0.017255,0,0
5,GO T CELL PROLIFERATION,0.30446,-0.038371,-0.046259,0,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.55016,-0.038378,-0.015005,0,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.82211,-0.038434,-0.0029264,0,0
5,GO INNATE IMMUNE RESPONSE,0.21889,-0.03856,-0.062154,0,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.82211,-0.038579,-0.0028923,0,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.26964,-0.038675,-0.039309,0,0
5,GO GAP JUNCTION ASSEMBLY,0.53672,-0.038689,-0.030408,0,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.11183,-0.03871,-0.071979,0,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.5314,-0.038777,-0.057573,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.46466,-0.038798,-0.047785,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.34008,-0.038802,-0.038247,0,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.75048,-0.038811,-0.0045559,0,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.18595,-0.038934,-0.049728,0,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.38267,-0.038979,-0.036496,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.88245,-0.039113,0.03687,0,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.75356,-0.039295,-0.015218,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.23128,-0.03939,-0.090073,0,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.25924,-0.039402,-0.08755,0,0
5,GO L SERINE METABOLIC PROCESS,0.71391,-0.039551,-0.0071689,0,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.44994,-0.039628,-0.024531,0,0
5,GO COENZYME A METABOLIC PROCESS,0.81581,-0.039737,0.03131,0,0
5,GO PROSTAGLANDIN TRANSPORT,0.40058,-0.039815,-0.040951,0,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.15683,-0.039834,-0.080961,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.50776,-0.039842,-0.042784,0,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.51035,-0.039887,-0.038218,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.90809,-0.039938,0.030136,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.50776,-0.039941,-0.030758,0,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.48722,-0.04,-0.025977,0,0
5,GO LEUKOCYTE PROLIFERATION,0.32993,-0.040364,-0.041035,0,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.20699,-0.040368,-0.055885,0,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.39156,-0.040369,-0.029742,0,0
5,GO METHIONINE METABOLIC PROCESS,0.87287,-0.040462,0.0128,0,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.71391,-0.040834,-0.019874,0,0
5,GO DISACCHARIDE METABOLIC PROCESS,0.95639,-0.040884,0.0047734,0,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.30066,-0.041024,-0.055838,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.19278,-0.041302,-0.047821,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.62545,-0.041431,-0.026727,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.15921,-0.041445,-0.062867,0,0
5,GO LEUKOCYTE CHEMOTAXIS,0.22814,-0.041516,-0.042734,0,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.40058,-0.041537,-0.038012,0,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.23445,-0.041569,-0.12693,0,0
5,GO NADPH REGENERATION,0.21587,-0.041657,-0.075462,0,0
5,GO ACUTE PHASE RESPONSE,0.64276,-0.041726,-0.021499,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.36956,-0.042264,-0.037369,0,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.51296,-0.04234,-0.021256,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.86012,-0.042444,-0.00028158,0,0
5,GO LEUKOCYTE MIGRATION,0.46466,-0.042494,-0.022291,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.48468,-0.042505,-0.040027,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.94026,-0.042592,0.0066634,0,0
5,GO RESPONSE TO CHEMOKINE,0.26964,-0.042627,-0.03526,0,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.94026,-0.042646,0.060794,0,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.35043,-0.042911,-0.051942,0,0
5,GO NEUTROPHIL HOMEOSTASIS,0.58585,-0.043082,-0.050711,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.59424,-0.043101,-0.028729,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.44752,-0.043289,-0.0521,0,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.53406,-0.043301,-0.049654,0,0
5,GO RELAXATION OF MUSCLE,0.2114,-0.043322,-0.062591,0,0
5,GO ADHESION OF SYMBIONT TO HOST,0.38933,-0.043376,-0.057896,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.67501,-0.043498,-0.023415,0,0
5,GO RESPONSE TO GROWTH HORMONE,0.21587,-0.043518,-0.050858,0,0
5,GO MUSCLE FILAMENT SLIDING,0.71996,-0.043545,-0.0054658,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.20265,-0.04368,-0.045122,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.1873,-0.043737,-0.054103,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.39606,-0.043898,-0.030388,0,0
5,GO RESPONSE TO FUNGUS,0.63408,-0.043948,0.002791,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.25924,-0.043981,0.10688,0,0
5,GO ACTIVATION OF IMMUNE RESPONSE,0.13338,-0.044058,-0.051206,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.34627,-0.04435,-0.067939,0,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.11647,-0.044535,-0.074568,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.87287,-0.044568,0.0025731,0,0
5,GO IMMUNE EFFECTOR PROCESS,0.19557,-0.044603,-0.053026,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10129,-0.044723,-0.10216,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.84424,-0.044821,0.00021733,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.15921,-0.044947,-0.063379,0,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.66028,-0.045058,-0.027152,0,0
5,GO PEPTIDE CROSS LINKING,0.072397,-0.045229,-0.14331,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.11647,-0.045336,-0.057056,0,0
5,GO OXYGEN TRANSPORT,0.57476,-0.045359,-0.065121,0,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.89846,-0.045594,0.0099013,0,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.088486,-0.045661,-0.075951,0,0
5,GO RESPONSE TO INTERLEUKIN 1,0.090782,-0.045745,-0.065763,0,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.13234,-0.04592,-0.069046,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.088486,-0.045932,-0.10585,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.21889,-0.045959,-0.088552,0,0
5,GO RESPONSE TO BACTERIUM,0.11092,-0.046007,-0.063634,0,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.36956,-0.046037,-0.033559,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.97253,-0.046188,0.0015969,0,0
5,GO ACUTE INFLAMMATORY RESPONSE,0.28578,-0.046404,-0.055102,0,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.6691,-0.046539,-0.0080924,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.9693,-0.046548,0.035486,0,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.46218,-0.046636,-0.036549,0,0
5,GO T CELL CYTOKINE PRODUCTION,0.23927,-0.046873,-0.066453,0,0
5,GO VIRION ASSEMBLY,0.44994,-0.046955,-0.015434,0,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.1453,-0.047121,-0.059162,0,0
5,GO BLOOD VESSEL REMODELING,0.43789,-0.047146,-0.030986,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.26095,-0.047151,-0.072644,0,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.16904,-0.047189,-0.068824,0,0
5,GO ENDODERM FORMATION,0.53672,-0.047492,-0.037885,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.58585,-0.047546,-0.021718,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.55287,-0.047565,-0.028531,0,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.39832,-0.047733,-0.053459,0,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.17029,-0.04787,-0.069645,0,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.20409,-0.048,-0.1439,0,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.42838,-0.048098,-0.030672,0,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.13444,-0.048117,-0.044607,0,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.48215,-0.048285,-0.042504,0,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.7659,-0.048386,0.011765,0,0
5,GO RESPONSE TO MINERALOCORTICOID,0.64858,-0.048444,-0.020179,0,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.2114,-0.048481,-0.056802,0,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.70787,-0.048561,-0.014664,0,0
5,GO AMINE METABOLIC PROCESS,0.28213,-0.048579,-0.035855,0,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.17411,-0.048802,-0.10296,0,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.79075,-0.049026,-0.01475,0,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.1313,-0.049046,-0.059768,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.5,-0.049201,-0.029395,0,0
5,GO RESPONSE TO MAGNESIUM ION,0.34213,-0.049216,-0.078885,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.36526,-0.049411,-0.059496,0,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.56376,-0.049582,-0.023769,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.60834,-0.049624,-0.022,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.68392,-0.049998,-0.061847,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.35043,-0.049999,-0.046226,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.65442,-0.050026,-0.012177,0,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.43075,-0.050036,-0.032747,0,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.48468,-0.050223,-0.013619,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.23927,-0.050475,-0.028661,0,0
5,GO T CELL APOPTOTIC PROCESS,0.20992,-0.050661,-0.06333,0,0
5,GO LYMPHOCYTE HOMEOSTASIS,0.1754,-0.050825,-0.046743,0,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.6055,-0.050931,-0.0077221,0,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.74435,-0.051083,0.033534,0,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.070488,-0.051176,-0.081794,0,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.65442,-0.051299,-0.030278,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.10299,-0.051343,-0.096423,0,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.16407,-0.051354,-0.063142,0,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.51557,-0.051449,-0.066783,0,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.19697,-0.051502,-0.063666,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.51557,-0.051641,-0.033442,0,0
5,GO T CELL EXTRAVASATION,0.47712,-0.051698,-0.06598,0,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.48976,-0.051743,-0.028618,0,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,-0.051752,-0.067907,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.20845,-0.051922,-0.047458,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.35886,-0.052153,-0.033136,0,0
5,GO REGULATION OF AMYLOID BETA FORMATION,0.76899,-0.052168,0.014395,0,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.65734,-0.052287,-0.02441,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.38488,-0.052624,-0.045661,0,0
5,GO CHEMOKINE PRODUCTION,0.23286,-0.052915,-0.065215,0,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.97899,-0.05296,0.014719,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.47211,-0.053218,-0.031524,0,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.074349,-0.053382,-0.083228,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.178,-0.05341,-0.070125,0,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.44028,-0.053427,-0.029229,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.19417,-0.053555,-0.047996,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10045,-0.053672,-0.11884,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.32592,-0.053828,-0.083541,0,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.062684,-0.053835,-0.065052,0,0
5,GO FOLIC ACID METABOLIC PROCESS,0.16163,-0.05387,-0.060134,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.62258,-0.054131,-0.027893,0,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.56925,-0.054223,-0.027495,0,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.22814,-0.054313,-0.034798,0,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.3739,-0.054543,-0.016367,0,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.09714,-0.054832,-0.104,0,0
5,GO MYELOID LEUKOCYTE MIGRATION,0.11002,-0.054907,-0.061179,0,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.22658,-0.055074,-0.048817,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.15683,-0.055113,-0.10516,0,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.46962,-0.055195,-0.054231,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.067397,-0.055315,-0.088703,0,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.18866,-0.055342,-0.073527,0,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.35463,-0.055611,-0.055152,0,0
5,GO OLIGOPEPTIDE TRANSPORT,0.47963,-0.055918,-0.042953,0,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.14197,-0.056015,-0.047759,0,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.20122,-0.056213,-0.075253,0,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.3871,-0.056271,-0.05278,0,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.62258,-0.056338,-0.0019526,0,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.48976,-0.056508,-0.061331,0,0
5,GO TYPE I INTERFERON PRODUCTION,0.37608,-0.056549,-0.033365,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.14642,-0.056651,-0.057353,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.37827,-0.056713,-0.042703,0,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.079071,-0.056805,-0.080807,0,0
5,GO PIGMENT METABOLIC PROCESS,0.08331,-0.056901,-0.075713,0,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.18194,-0.056928,-0.060322,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.2644,-0.057066,-0.063807,0,0
5,GO MITOCHONDRIAL DEPOLARIZATION,0.29877,-0.057383,-0.057215,0,0
5,GO VAGINA DEVELOPMENT,0.89205,-0.057399,0.011172,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.53406,-0.057668,-0.039234,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.11002,-0.05768,-0.12357,0,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.071756,-0.057796,-0.096891,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.17029,-0.057988,-0.072739,0,0
5,GO REGULATION OF B CELL ACTIVATION,0.31021,-0.058061,-0.045914,0,0
5,GO REGULATION OF PLATELET ACTIVATION,0.39832,-0.058163,-0.061278,0,0
5,GO ARACHIDONIC ACID SECRETION,0.32792,-0.058479,-0.020881,0,0
5,GO MACROPHAGE ACTIVATION,0.15565,-0.058489,-0.054103,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.47461,-0.058492,-0.017952,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.47211,-0.058524,-0.056222,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.19697,-0.058811,-0.036008,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.98546,-0.058892,0.018229,0,0
5,GO PINOCYTOSIS,0.2913,-0.059139,-0.048849,0,0
5,GO PROTEIN HYDROXYLATION,0.1262,-0.059194,-0.12519,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.51296,-0.059226,-0.017566,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.21437,-0.059594,-0.053923,0,0
5,GO XENOBIOTIC TRANSPORT,0.85694,-0.05964,0.031293,0,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.071756,-0.05977,-0.11944,0,0
5,GO LYMPHOCYTE MIGRATION,0.44994,-0.059771,-0.020587,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.72603,-0.06018,0.034069,0,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.80953,-0.060229,0.023557,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.30255,-0.060234,-0.041285,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.30446,-0.060308,-0.025079,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.37173,-0.060402,-0.040915,0,0
5,GO ANDROGEN METABOLIC PROCESS,0.15802,-0.060536,-0.086513,0,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.87287,-0.060585,-0.0018675,0,0
5,GO VITAMIN TRANSPORT,0.22042,-0.061124,-0.046744,0,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.077018,-0.061289,-0.077059,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.89205,-0.061301,0.0039131,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.64276,-0.061331,-0.053623,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.25583,-0.061612,-0.046179,0,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.40286,-0.061638,-0.10784,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.06986,-0.06178,-0.097639,0,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.2644,-0.061986,-0.057773,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.18062,-0.062026,-0.056405,0,0
5,GO RESPONSE TO INTERLEUKIN 12,0.077698,-0.062121,-0.095658,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.21437,-0.062404,-0.091169,0,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.21889,-0.062422,-0.085072,0,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.089246,-0.062609,-0.06674,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.37827,-0.062789,-0.08148,0,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.29877,-0.063027,-0.061579,0,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.077018,-0.063161,-0.063938,0,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.2114,-0.063636,-0.079957,0,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.19278,-0.063872,-0.094628,0,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.13234,-0.064311,-0.098881,0,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.33194,-0.064313,-0.034831,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.21889,-0.064468,-0.083649,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.23927,-0.06455,-0.13379,0,0
5,GO FIBROBLAST ACTIVATION,0.47461,-0.064677,-0.029802,0,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.086237,-0.065044,-0.080496,0,0
5,GO SULFUR COMPOUND TRANSPORT,0.66616,-0.065073,0.0031218,0,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.22042,-0.065185,-0.066828,0,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.26789,-0.065248,-0.074776,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.3871,-0.065266,-0.062074,0,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.1533,-0.065319,-0.082532,0,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.46962,-0.065487,-0.0091943,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.45727,-0.065736,-0.0331,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.36526,-0.066069,-0.044458,0,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.069238,-0.066101,-0.09477,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.14983,-0.066337,-0.12916,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.61117,-0.066433,-0.042117,0,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.41666,-0.066733,-0.026202,0,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.22971,-0.067284,-0.057761,0,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.092339,-0.067321,-0.078535,0,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.36098,-0.067406,-0.048255,0,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.85059,-0.067617,-0.0041107,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.20992,-0.067723,-0.056074,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.1387,-0.067784,-0.076589,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.039795,-0.067959,-0.1209,0,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.088486,-0.068102,-0.098616,0,0
5,GO KERATAN SULFATE METABOLIC PROCESS,0.24911,-0.068485,-0.053709,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.25246,-0.068526,-0.059723,0,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.1914,-0.068715,-0.071449,0,0
5,GO SENSORY PERCEPTION OF TASTE,0.73212,-0.068955,-0.031515,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.25414,-0.06896,-0.071633,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.30066,-0.068985,-0.05198,0,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.31215,-0.069156,-0.064862,0,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.25414,-0.069166,-0.071783,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.70185,-0.069405,0.0045767,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.26095,-0.069684,-0.043013,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.25414,-0.069686,-0.044765,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.13656,-0.06974,-0.084553,0,0
5,GO PIGMENT ACCUMULATION,0.19003,-0.07004,-0.073594,0,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.090011,-0.070448,-0.16009,0,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.20122,-0.070498,-0.13558,0,0
5,GO TRABECULA FORMATION,0.64858,-0.070529,-0.031876,0,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.24911,-0.071185,-0.055715,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.15447,-0.071526,-0.091437,0,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.36311,-0.071741,-0.055854,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.24416,-0.071975,-0.057586,0,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.081877,-0.071997,-0.10256,0,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.21288,-0.072102,-0.0832,0,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.84107,-0.072406,-0.0068494,0,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.52609,-0.072529,-0.042915,0,0
5,GO MACROPHAGE MIGRATION,0.37827,-0.072785,-0.024008,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.25246,-0.072915,-0.041278,0,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.68392,-0.072944,-0.043317,0,0
5,GO RETINAL METABOLIC PROCESS,0.86331,-0.073086,-0.011035,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.16407,-0.073113,-0.069983,0,0
5,GO DRUG METABOLIC PROCESS,0.34627,-0.073195,-0.045963,0,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.22348,-0.073198,-0.063733,0,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.16654,-0.073263,-0.068832,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.41434,-0.073411,-0.066081,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23605,-0.073618,-0.03445,0,0
5,GO RESPONSE TO INTERLEUKIN 15,0.077698,-0.073704,-0.096975,0,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.21288,-0.073787,-0.043227,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.94348,-0.073941,0.0019389,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.8379,-0.073949,-0.013614,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.94671,-0.073949,0.042849,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.318,-0.074121,-0.054915,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.97253,-0.074184,0.01243,0,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.096327,-0.074214,-0.095589,0,0
5,GO COMPLEMENT ACTIVATION,0.075009,-0.07437,-0.11205,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.017699,-0.074592,-0.091935,0,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.18327,-0.074634,-0.055529,0,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.65734,-0.074641,-0.018456,0,0
5,GO CERAMIDE TRANSPORT,0.18461,-0.074731,-0.0706,0,0
5,GO PROTEIN OXIDATION,0.10646,-0.07508,-0.13493,0,0
5,GO POSITIVE REGULATION OF COAGULATION,0.33599,-0.075688,-0.051234,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.082591,-0.075698,-0.10536,0,0
5,GO SUPEROXIDE ANION GENERATION,0.35043,-0.075717,-0.072208,0,0
5,GO REGULATION OF T CELL MIGRATION,0.090011,-0.076011,-0.068794,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.35674,-0.07606,-0.019169,0,0
5,GO REGULATION OF MAST CELL ACTIVATION,0.28945,-0.076177,-0.049335,0,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.076344,-0.0762,-0.068243,0,0
5,GO DETOXIFICATION,0.1146,-0.076311,-0.065629,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.1793,-0.076391,-0.051896,0,0
5,GO PENTOSE METABOLIC PROCESS,0.26789,-0.076525,-0.059398,0,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.081168,-0.076864,-0.075144,0,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.178,-0.077284,-0.061351,0,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.079765,-0.077475,-0.094423,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.19838,-0.077536,-0.042083,0,0
5,GO MACROPHAGE CHEMOTAXIS,0.22503,-0.077559,-0.055563,0,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.092339,-0.077966,-0.10974,0,0
5,GO SECRETION BY TISSUE,0.3442,-0.078267,-0.037076,0,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.10912,-0.078588,-0.070555,0,0
5,GO T CELL CHEMOTAXIS,0.22348,-0.07862,-0.047417,0,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.16654,-0.07876,-0.07308,0,0
5,GO PHAGOSOME ACIDIFICATION,0.2644,-0.078838,-0.042004,0,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.27673,-0.078923,-0.080333,0,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.39156,-0.079131,-0.064252,0,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.35043,-0.079575,-0.11072,0,0
5,GO INTERLEUKIN 12 PRODUCTION,0.074349,-0.079717,-0.086815,0,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.32993,-0.079817,-0.031451,0,0
5,GO B CELL HOMEOSTASIS,0.082591,-0.08015,-0.084389,0,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.15683,-0.080302,-0.10191,0,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.22348,-0.080425,-0.073941,0,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.11183,-0.080599,-0.10303,0,0
5,GO RESPIRATORY BURST,0.30066,-0.080977,-0.050553,0,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.046921,-0.081063,-0.084638,0,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.5665,-0.081633,-0.05135,0,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.48468,-0.08188,-0.025203,0,0
5,GO RESPONSE TO TYPE I INTERFERON,0.15447,-0.082039,-0.15013,0,0
5,GO INTERLEUKIN 1 PRODUCTION,0.17156,-0.082076,-0.075125,0,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.33599,-0.082257,-0.046095,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.31215,-0.083593,-0.060739,0,0
5,GO ALPHA BETA T CELL PROLIFERATION,0.15565,-0.083786,-0.090569,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.32195,-0.083881,-0.070153,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.06986,-0.083891,-0.11322,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.32993,-0.084021,-0.08568,0,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.75972,-0.084031,-0.0037834,0,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.19838,-0.084059,-0.063085,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.69586,-0.084227,-0.017682,0,0
5,GO BASEMENT MEMBRANE ORGANIZATION,0.84107,-0.084309,0.020991,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.16407,-0.084323,-0.0471,0,0
5,GO RESPONSE TO GONADOTROPIN,0.25753,-0.084677,-0.052798,0,0
5,GO MATURATION OF SSU RRNA,0.30446,-0.084764,-0.077281,0,0
5,GO HEART INDUCTION,0.42367,-0.084919,-0.05368,0,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.10214,-0.085324,-0.10799,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.26267,-0.085355,-0.04768,0,0
5,GO GAS TRANSPORT,0.45482,-0.085453,-0.062717,0,0
5,GO ALDITOL METABOLIC PROCESS,0.34835,-0.08587,-0.037276,0,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.42367,-0.085906,-0.053047,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.64567,-0.086147,0.015255,0,0
5,GO APOPTOTIC CELL CLEARANCE,0.23286,-0.086202,-0.077487,0,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.036048,-0.086268,-0.18217,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.11002,-0.086363,-0.12212,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.16904,-0.086437,-0.038887,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.33803,-0.086578,-0.035802,0,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.16042,-0.086678,-0.097957,0,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.70486,-0.087261,-0.042213,0,0
5,GO VACUOLAR ACIDIFICATION,0.069238,-0.087331,-0.074894,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40973,-0.087589,-0.080428,0,0
5,GO ZINC ION HOMEOSTASIS,0.10214,-0.087734,-0.12848,0,0
5,GO LEUKOCYTE AGGREGATION,0.43312,-0.088138,-0.057292,0,0
5,GO COLLAGEN CATABOLIC PROCESS,0.47461,-0.088197,-0.029617,0,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.11002,-0.088732,-0.09507,0,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.068619,-0.089128,-0.08503,0,0
5,GO LIPID DIGESTION,0.31215,-0.089249,-0.10406,0,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.17283,-0.089273,-0.061099,0,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.12924,-0.089351,-0.1015,0,0
5,GO NADP METABOLIC PROCESS,0.25078,-0.08967,-0.050312,0,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.54746,-0.089807,-0.047279,0,0
5,GO PROSTAGLANDIN SECRETION,0.073694,-0.089882,-0.087557,0,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.38933,-0.090437,-0.06906,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.36098,-0.090753,-0.12226,0,0
5,GO POSITIVE REGULATION OF CELL KILLING,0.15214,-0.090822,-0.090881,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.1262,-0.091179,-0.062636,0,0
5,GO PLATELET DEGRANULATION,0.10385,-0.091506,-0.087947,0,0
5,GO REGULATION OF TOLERANCE INDUCTION,0.51557,-0.091603,-0.064205,0,0
5,GO ETHER METABOLIC PROCESS,0.20409,-0.091891,-0.075704,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.36956,-0.092156,-0.025005,0,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.067397,-0.092225,-0.10597,0,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.089246,-0.092727,-0.086818,0,0
5,GO SEQUESTERING OF METAL ION,0.09796,-0.093211,-0.089885,0,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.22658,-0.093648,-0.07174,0,0
5,GO INTEGRIN ACTIVATION,0.14419,-0.094071,-0.067118,0,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.10734,-0.094426,-0.11635,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.066792,-0.094709,-0.09089,0,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.10299,-0.09491,-0.11427,0,0
5,GO RESPONSE TO INTERLEUKIN 4,0.052083,-0.09591,-0.071489,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.19979,-0.095915,-0.063564,0,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.075674,-0.096277,-0.12009,0,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.052083,-0.096704,-0.087115,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.61972,-0.097022,-0.013555,0,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.318,-0.097204,-0.056659,0,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.25583,-0.098012,-0.063128,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17283,-0.098391,-0.064771,0,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.32993,-0.098583,-0.073753,0,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.11002,-0.098883,-0.066826,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.30255,-0.098948,-0.025401,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.25246,-0.099043,-0.10438,0,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.081168,-0.099697,-0.11593,0,0
5,GO RESPONSE TO INTERFERON GAMMA,0.06986,-0.099866,-0.13613,0,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.077018,-0.10033,-0.10125,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.36098,-0.10035,-0.058672,0,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.12924,-0.10042,-0.056612,0,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.50776,-0.10156,-0.044717,0,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.20992,-0.10183,-0.1546,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.35043,-0.10196,-0.12703,0,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.27317,-0.10201,-0.066854,0,0
5,GO T CELL MIGRATION,0.13763,-0.10241,-0.065075,0,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.077698,-0.1026,-0.10943,0,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.11183,-0.1032,-0.061486,0,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.14755,-0.10322,-0.12341,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.19697,-0.10436,-0.077235,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.19417,-0.10482,-0.086659,0,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.17029,-0.10535,-0.071116,0,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.32393,-0.1054,-0.078323,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.3871,-0.10575,-0.10695,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.27317,-0.1058,-0.11303,0,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.41203,-0.10678,-0.023483,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.070488,-0.107,-0.13702,0,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0028492,-0.10803,-0.12526,0,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.086237,-0.10804,-0.0907,0,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.3871,-0.10837,-0.084189,0,0
5,GO MEMBRANE RAFT ORGANIZATION,0.13444,-0.10884,-0.15012,0,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54477,-0.11027,-0.016066,0,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.36956,-0.11041,-0.073781,0,0
5,GO DECIDUALIZATION,0.81896,-0.11045,-0.011462,0,0
5,GO PLATELET MORPHOGENESIS,0.22042,-0.11125,-0.038898,0,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.13656,-0.11258,-0.10003,0,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.10558,-0.11305,-0.10972,0,0
5,GO DENDRITIC CELL DIFFERENTIATION,0.084763,-0.11323,-0.1281,0,0
5,GO POSITIVE REGULATION OF HEART RATE,0.081877,-0.11332,-0.090622,0,0
5,GO COLLAGEN METABOLIC PROCESS,0.69586,-0.11372,-0.012887,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.074349,-0.11417,-0.10613,0,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.30637,-0.11454,-0.15632,0,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.073694,-0.11507,-0.09658,0,0
5,GO GLYCINE METABOLIC PROCESS,0.16904,-0.11587,-0.10008,0,0
5,GO RESPONSE TO MUSCLE STRETCH,0.18866,-0.11629,-0.080162,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.39832,-0.11725,-0.080056,0,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.081168,-0.11736,-0.15447,0,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.088486,-0.11815,-0.13856,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.45482,-0.1187,-0.045402,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.22971,-0.11882,-0.082614,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.2714,-0.11896,-0.028947,0,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17156,-0.12042,-0.11803,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.24089,-0.12157,-0.050449,0,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.14088,-0.12172,-0.1042,0,0
5,GO IMP METABOLIC PROCESS,0.14419,-0.12185,-0.10598,0,0
5,GO CYTOLYSIS,0.10214,-0.12212,-0.12837,0,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.36311,-0.12276,-0.063729,0,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.13234,-0.12422,-0.062998,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.23128,-0.12447,-0.095918,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.17669,-0.12571,-0.090918,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.016205,-0.1268,-0.15463,0,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.078382,-0.12754,-0.11404,0,0
5,GO DETECTION OF OTHER ORGANISM,0.076344,-0.12842,-0.15845,0,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.16407,-0.12843,-0.087742,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.48215,-0.13179,-0.048078,0,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.092339,-0.13319,-0.08498,0,0
5,GO REGULATION OF COAGULATION,0.073694,-0.13325,-0.10947,0,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.13444,-0.13455,-0.19864,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.23766,-0.13493,-0.12442,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.076344,-0.13556,-0.10947,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.25753,-0.1359,-0.12053,0,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.1262,-0.13659,-0.088686,0,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.079071,-0.13684,-0.12369,0,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.09796,-0.13788,-0.14155,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.072397,-0.13824,-0.10726,0,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.80012,-0.13852,-0.014681,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.43789,-0.13875,-0.068897,0,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.32393,-0.13917,-0.090043,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.19003,-0.14078,-0.11122,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.0012177,-0.14111,-0.12148,0,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.087731,-0.14219,-0.072721,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.43789,-0.14241,-0.057809,0,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.27853,-0.14322,-0.055963,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.64567,-0.1454,-0.055545,0,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.16778,-0.14541,-0.12292,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.12126,-0.14735,-0.08104,0,0
5,GO MATURE B CELL DIFFERENTIATION,0.06986,-0.14793,-0.13461,0,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.33396,-0.14882,-0.036626,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.0039992,-0.14991,-0.13488,0,0
5,GO PROTEIN DENEDDYLATION,0.012945,-0.14992,-0.10644,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.21288,-0.15058,-0.053656,0,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.19557,-0.15084,-0.092177,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.58307,-0.15267,-0.16912,0,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.081168,-0.15329,-0.12895,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.13979,-0.15501,-0.083628,0,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.19838,-0.15662,-0.085158,0,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.18866,-0.15663,-0.1089,0,0
5,GO LIPID IMPORT INTO CELL,0.13338,-0.15872,-0.057472,0,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.24745,-0.15927,-0.092976,0,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.094715,-0.16047,-0.13444,0,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.081168,-0.16166,-0.15484,0,0
5,GO ZYMOGEN ACTIVATION,0.067397,-0.16274,-0.13033,0,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.093126,-0.16688,-0.079651,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.28761,-0.16751,-0.05663,0,0
5,GO RESPONSE TO COPPER ION,0.14419,-0.16814,-0.10592,0,0
5,GO TOLERANCE INDUCTION,0.094715,-0.17708,-0.16417,0,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.16407,-0.17925,-0.12281,0,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.15565,-0.18262,-0.19447,0,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.0043737,-0.20119,-0.14036,0,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.20699,-0.2017,-0.11775,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.055093,-0.20326,-0.095485,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.088486,-0.20403,-0.14275,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.09714,-0.2064,-0.16675,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.038637,-0.20959,-0.13431,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.081168,-0.21041,-0.16167,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015038,-0.2132,-0.17509,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.18461,-0.21452,-0.29016,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.13027,-0.21564,-0.09225,0,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.094715,-0.22622,-0.15118,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.15683,-0.24431,-0.26992,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.2032e-06,-0.25544,-0.29197,0,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0044864,-0.26229,-0.23822,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.02521,-0.28493,-0.21656,0,0
